LGCS Pharma Cat 2012 13 LR Web

+
Content
Content
Introduction
Introduction 3
Pharmaceutical impurities
Background Certificate of Analysis List of products
11
13 15 21
European Pharmacopoeia
ATCC microbiological products Certified liquids for viscosity measurements International commission on pharmaceutical enzymes European Pharmacopoeia reagents WHO International Standards for Antibiotics
247
309 311 312 313 318
British Pharmacopoeia
ATCC microbiological products Pharmacope Franaise Pharmacopoeia Helvetica International Pharmacopeia
319
336 338 340 341
United States Pharmacopeia and National Formulary

ATCC microbiological products
347
422
Secondary standards Institute of Dyes and Organic products

Refractive index CRMs
425 431
434
Publications and subscriptions High purity solvents
435 439
Edition 2012/2013
All your needs for pharmaceutical analysis email pharma@lgcstandards.com
Introduction
Introduction
About LGC Standards
LGC Standards has successfully established a global reputation for the production of impurities and working standards, and as a single source for the supply of pharmacopeia reference materials. Our menu of custom services, including custom synthesis of impurities and metabolites, characterisation, certification, packaging and distribution, adds value to the scientific support we provide to our pharmaceutical customers. Our relationships with the worlds leading pharmacopoeias and their range of Chemical Reference Substances (CRS) and Reference Standards (RS), combined with in-house production of certified reference materials and pharmaceutical impurities, enable us to meet our customers specific needs. LGC Standards is also the exclusive European distributor for ATCC cultures and bio products. LGC Standards extensive network of sales offices and distribution centres means we offer the widest range of reference materials from one single source for rapid delivery. Our staff can provide scientific and technical guidance, including shipping and customs advice, in the local language. Our range of products also includes reference materials for clinical and forensic applications, phytochemicals, environmental analysis, physical properties determination, and food and beverage analysis. For more information about our range of services, or to receive any of our catalogues, please refer to our website www.lgcstandards.com or contact your local office.
About LGC
LGC Standards is part of LGC. LGC, whose Science and Technology Division acts as the designated UK National Measurement Institute (NMI) for Chemical and Biochemical measurement, has a long history in the development and validation of analytical methods and the production of reference materials. Many of the analytical methods, which cover the food, environment, industrial, clinical and pharmaceutical sectors, are accredited to ISO/IEC 17025 (Requirements for the competency of testing and calibration laboratories). Full details of the accreditation schedule can be found on the UKAS website (www.ukas.com). LGCs Science and Technology Division is accredited to ISO Guide 34 (General Requirements for the competence of reference materials producers) for the production of (certified) reference materials as is also our production site in Germany. The measurement capabilities used to produce certified reference materials in its capacity as the UK NMI are verified through participation on key comparison studies organised by the Consultative Committee for the Amount of Substance (CCQM) of the International Weights and Measures Organisation (BIPM). The certificates are recognised by other National Measurement Institutes, under the Mutual Recognition Arrangement. In its role as the NMI, LGC serves on the International Organisation for Standardisation (ISO) Committee for Reference Materials (REMCO), which aims to carry out and encourage a broad international effort for the harmonization, production and application of certified reference materials (CRMs).
About the catalogue

The 2012/2013 edition of the LGC Standards catalogue Pharmaceutical reference substances and impurities, replaces the Pharmaceutical reference substances and impurities 2011/2012 edition and the newsletter updates. The information provided in this catalogue as regards compendial articles is based on the official pharmacopoeial lists and is correct at the time of print. Original descriptions and spellings used by the producers are retained. In some cases additional information has been included to make the lists more convenient to use. The catalogue will be updated with three to four newsletters; these will be downloadable under www.lgcstandards.com. You can also contact your local LGC Standards office and ask to be provided with the newsletters once they are published.
Edition 2012/2013
Pharmaceutical reference substances
Pharmaceutical reference substances

Certification
The products described in this catalogue include pharmacopeial reference substances for use in pharmaceutical analysis. Pharmacopeial CRSs and RSs should be distinguished from certified reference materials (CRMs), which are produced in conformity with the ISO guides 30 to 35, and supplied with a detailed certification document. Pharmacopeial reference substances are produced for a specific purpose, and the manufacturers follow rigorous protocols to ensure the reference substance is fit for the intended purpose. The certification processes follow the basic requirements of the relevant ISO REMCO guides, but are modified by the pharmacopoeias to reflect the particular demands of the associated pharmaceutical monograph. Details are given in the introduction to each section listing the various CRS collections in this catalogue.
Shelf Life, storage, expiry dates and unit sizes

Pharmacopeial CRSs and RSs should be purchased when required and not stored for a prolonged period. Pack sizes are designed to allow a limited number of replicate analyses, as required by Good Analytical Practice, but the opened pack should not be kept for future use. Please check all individual storage temperature requirements and note that the substances should be kept away from humidity and light (unless otherwise stated). Specific lot numbers or letters are allocated to all pharmacopeial reference substances, but no expiry dates are set. New lots are normally prepared well in advance of the expected "sell-out" of the current lot. Please note, that new lots can have different unit sizes, especially with pharmacopoeial reference standards, and LGC Standards is not responsible for such cases. If the unit size of a new batch changes, LGC Standards will provide this information to customers in new lot lists. When a substance is withdrawn from sale because the lot has depleted a final expiry date is given, by which any material from the outgoing lot held by users must be used. This means that for a period of time both lots are official. Lot information is provided by USP and EP in their literature and is available from LGC Standards. If a material is withdrawn by the producer, then all stocks held by the users are no longer valid and have to be destroyed. Should this occur, LGC Standards will inform all customers who have purchased the withdrawn substance. Please note that such a situation is outside LGC Standards control and products are not refundable. Once opened, LGC Standards and the pharmacopoeias can no longer guarantee the stability of the material and any of the CRS/BRP and RS not used should be disposed of and not kept for future use.
Impurity standards
Impurities in a pharmaceutical substance can change the effects and side effects of a drug significantly. Therefore, it is important to have an accurate detection of impurities. The pharmaceutical monographs regulate the legal definition, the analysis and the limits of impurities of a given substance. An official range of impurity standards is available from the main pharmacopoeias where a CRS or RS is required in the monograph. Over 2800 other impurity standards are listed in the pharmaceutical impurities section of this catalogue. These materials are produced by LGC, whose Science & Technology Division acts as the designated UK National Measurement Institute for Chemical and Biochemical Measurements. They are produced at our facility in Luckenwalde near Berlin, Germany and are supplied with a certificate of analysis. Our impurity reference standards are intended for the identification and control of impurities in drug substances and drug preparations, as well as for method development and validation.
Controlled substances
A number of the pharmaceutical substances, such as narcotics and tranquillisers, described in this catalogue are Controlled Substances in their country of origin and are marked Controlled Substance against the product description. The purchase, possession and use of Controlled Substances are subject to national and international regulations designed to limit their abuse. It is the responsibility of the customer to obtain any authorisation necessary to both purchase and possess Controlled Substances, complying with the laws of the importing country, before ordering. Customers wishing to obtain Controlled Substances must contact their LGC Standards sales office before ordering, and clarify with the sales specialists the relevant national requirements, the associated charges and consequential delivery times. All orders for Controlled Substances must be provided in writing and signed by an authorised person. The orders must be accompanied with the original import permit and/or possession permit.
Edition 2012/2013
Pharmaceutical reference substances Use, safety and handling

Please read any documents supplied with the product before opening or using it. Particular attention must be paid to instructions referring to pre-mixing, addition of diluent to lyophilised materials and to the minimum size of sample to be used. The latter point is particularly important as it has normally been set by the producer after considering fully the homogeneity testing data obtained as a part of the certification exercise. The use of smaller than recommended samples is one of the most common sources of error. Some pharmaceutical substances are toxic and require special handling. Virtually all pharmaceutical reference substances have a pharmacological and/or biological activity. We therefore recommend that all the products described in this catalogue should be handled as if they were bio-active, toxic or infective, and that opened packs should only be handled by trained laboratory personnel. We also strongly recommend to read the information provided by material safety data sheets coming with our impurity reference standards and the reference standards from major pharmacopoeias. All pharmaceutical reference substances and standards are for laboratory analytical use only and not for use in humans.
General ordering information

Prices and delivery procedures are described in the price list that accompanies this catalogue, or are available from your local LGC Standards office. For products requiring special delivery procedures (cooled shipping, special licensing, Controlled Substances) additional charges may be applied. Please note that once delivered to the customer, reference substances are not returnable. Customers requiring assistance with the purchase, use or application of a particular reference substance should contact LGC Standards where technical staff are available to advise on the use and suitability of the products.
10
Edition 2012/2013
Background
The pharmacopeial monographs regulate the legal definition but also the analysis and the limits of impurities in a given substance. Impurities in a pharmaceutical substance can change the effects and side effects of a drug significantly. It is therefore important to have an accurate detection of impurities. The increasing importance of impurity reference materials is also becoming apparent in the registration of drugs, where an exact identification and quantification of susceptible impurities is required for an assured documentation. A wide range of known impurities is listed in individual pharmacopeial monographs. However, by far not all of these standards are available from the pharmcopoeias. The impurity standards listed below from LGC are filling this gap to a large extent. Guidelines and limits for impurities have been laid out in compendial monographs, in specifications from the manufacturer internally or in the International Conference on Harmonisation (ICH) Guidelines which have been agreed by Europe, Japan and the United States. The ICH conducted four guidelines on impurity issues: ICH Q3A (R1): Impurities in New Drug Substances ICH Q3B (R2): Impurities in New Drug Products ICH Q3C (R5): Impurities: Guideline for Residual Solvents ICH Q3D: Impurities: Guideline for Metal Impurities. The full wording of the ICH guidelines is available at the official website of the ICH: www.ich.org. The ICH guidelines on impurities were originally developed for new, original drug substances and products. However, it is now commonly agreed in the three ICH regions by FDA, EMA and Japanese regulation documents that these guidelines need to be applied to generic compounds as well, in addition to the pharmacopoeial monographs.
About LGC
The pharmaceutical impurities listed in this section are produced by LGC, whose Science & Technology Division acts as the designated UK National Measurement Institute for Chemical and Biochemical Measurements. LGC is an independent, science-based service company providing chemical, biochemical and DNA based analytical and diagnostic services, and reference standards. As Europe's largest, independent analytical laboratory, LGC's services include analytical testing, research, consultancy, validation, training and knowledge transfer. LGC Standards, a division of LGC, provides the most comprehensive source of certified reference materials and standards, pharmaceutical reference substances and impurities, biomaterials, cell lines and high purity solvents to the scientific community worldwide. LGC Standards has successfully established a global reputation for the production of impurities and working standards, and as a single source for the supply of pharmacopeia reference materials. Our menu of custom services, including custom synthesis of impurities and metabolites, characterisation, certification, packaging and distribution, adds value to the scientific support we provide to our pharmaceutical customers. For more information about these services, please contact your local LGC Standards office.
Edition 2012/2013
13
Pharmaceutical impurities Certification

Each product is accompanied by a detailed certificate of analysis, which gives information on the identity and purity, together with the various analytical methods and their conditions. A sample of such a certificate is printed on the following pages. In the past, we received some inquiries from a few customers wondering why there is no declaration on the certificates of analysis (CofA) for LGC products stating that the substances are fulfilling the specifications for reagents, as described for example in chapter 4 of the European Pharmacopeia. The LGC impurity standards are thoroughly tested chemical reference substances and are used for reliable identification and quantification of impurities in pharmaceutical ingredients and products. They are also valuable tools for spiking experiments during validation studies of specificity and accuracy of analytical methods. The abbreviations EP, Pharmeuropa, BP and USP in the article description are indicating that the particular substance is mentioned as an impurity in that particular compendial publication. They do not indicate that certain specification of reagents or drug substances mentioned in the publications are fulfilled. The standards where they are actually listed as reagents or drug substances may fulfill this specification, but this is not the intention and is not certified on the CofA. The production of our 2800+ LGC impurities reference standards follows the principles of ISO Guide 34 "General requirements for the competence of reference materials producers". This applies to new products and new batches of already existing products. In combination with ISO 17025, the ISO Guide 34 principles provide the best approach to the production of reference materials.
Narcotics and drug precursors

Some of the substances described in this section are subject to narcotics respective drug precursors legislation. These are marked as [Controlled Substance] or [Drug Precursor], respectively. Please contact your local LGC Standards office for information on the legal requirements in order to purchase these products.
Delivery time
The majority of products mentioned in this section are available from stock; others may have a delivery time of approximately four weeks. For substances marked with "on request", longer delivery times may apply. For custom synthesis, the time is estimated from previous experience. Customers will be notified if unforeseen complications arise during the synthesis. In the unlikely event that a synthesis does not reach the expected result, LGC Standards reserves the right to cancel the order.
14
Edition 2012/2013
Code Product Price Unit
4-Aminobenzoic Acid
MM 0094.00 Imp. B (EP): Benzocaine
H2N O O
(A)
500 mg
MM 0093.17
Imp. C (EP) as Hydrochloride: Aniline Hydrochloride

H2N
x HCl
(B)
100 mg
Acebutolol Hydrochloride
MM 0435.00 Acebutolol Hydrochloride
O N H O O OH H N
(A)
500 mg
x HCl
MM 0435.01
Imp. A (EP): N-[3-Acetyl-4-[(2RS)-oxiran2-ylmethoxy]phenyl]butanamide
O O N H O O
(A)
50 mg
MM 0435.02
Imp. B (EP) as Hydrochloride:N-[3-Acetyl-4-[(2RS)2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide Hydrochloride (Diacetolol Hydrochloride) Imp. C (EP): N-(3-Acetyl-4-hydroxyphenyl)butanamide
O O N H O
OH
H N
(A)
x HCl
100 mg
MM 0435.03
O O N H OH
(A)
100 mg
MM 0435.04
Imp. D (EP) as Hydrochloride: 1-[5-Amino-2[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]ethanone Dihydrochloride

H2N
O O
OH
H N
(A)
x 2 HCl
50 mg
MM 0435.05
Imp. E (EP) as Hydrochloride: N-[4-[(2RS)-2Hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide Hydrochloride Imp. F (EP): N-[3-Acetyl-4-[(2RS)2,3-dihydroxypropoxy]phenyl]butanamide
OH O N H O
H N
(A)
x HCl
50 mg
MM 0435.06
O O N H O
OH OH
(A)
50 mg
MM 0435.07
Imp. G (EP): N,N'-[[(1-Methylethyl)imino]bis[(2-hydroxypropane-1,3-diyl)oxy(3-acetyl1,4-phenylene)]]dibutanamide (Acebutolol Biamine) Imp. H (EP): N,N'-[(2-Hydroxypropane1,3-diyl)bis[oxy(3-acetyl-1,4-phenylene)]]dibutanamide
O O HN O
OH N
OH O
(A)
50 mg
NH O
MM 0435.08
O O HN O
OH O
(A)
50 mg
NH O
O O N H O OH H N
MM 0435.09
Imp. I (EP): N-[3-Acetyl-4-[(2RS)-3-(ethylamino)2-hydroxypropoxy]phenyl]butanamide
(A)
50 mg
MM 0435.10
Imp. J (EP) as Hydrochloride: N-[3-Acetyl-4[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]propanamide Hydrochloride Imp. K (EP) as Hydrochloride: N-[3-Butanoyl4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide Hydrochloride
O O N H O
OH
H N
(A)
x HCl
50 mg
MM 0435.11
O O N H O
OH
H N
(A)
x HCl
50 mg
Edition 2012/2013
21
Aceclofenac
MM 0181.00 Aceclofenac
O NH Cl Cl O O OH
(A)
250 mg
MM 0006.20
Imp. A (EP): [2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid (Diclofenac)

Cl
OH O NH Cl
(A)
100 mg
MM 0006.10
Imp. B (EP): Methyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Methyl Ester of Diclofenac)

Cl
O O NH Cl
(A)
100 mg
MM 0006.11
Imp. C (EP): Ethyl 2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetate (Ethyl Ester of Diclofenac)

Cl
O O NH Cl
(A)
100 mg
MM 0181.01
Imp. D (EP): Methyl [[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (Methyl Ester of Aceclofenac)

Cl
O O O NH Cl O
(A)
100 mg
MM 0181.02
Imp. E (EP): Ethyl [[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (Ethyl Ester of Aceclofenac)

Cl
O O O NH Cl O
(A)
100 mg
MM 0181.03
Imp. F (EP): ): Benzyl[[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (Benzyl Ester of Aceclofenac)

Cl
O O O NH Cl O
(A)
100 mg
MM 0181.04
Imp. G (EP): [[[[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl]oxy]acetic Acid (Acetic Aceclofenac)

Cl
O O O NH Cl O O OH
(A)
100 mg
MM 0181.05
Imp. H (EP): [[[[[[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl]oxy]acetyl]oxy]acetic Acid (Diacetic Aceclofenac)
O O O NH Cl Cl O O O
O OH
(A)
50 mg
MM 0006.01
Imp. I (EP):1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one
N Cl
O Cl
(A)
100 mg
MM 0181.06
Isopropyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Isopropyl Ester of Diclofenac)

Cl
O O NH Cl
(A)
100 mg
Acesulfame Potassium
MM 1093.01 Imp. A (EP): 3-Oxobutanamide (Acetylacetamide)
O NH2 O
(A)
100 mg
Acetazolamide
MM 0648.00 MM 0648.04 Acetazolamide
O H N S N N O O S NH2
(A) (A)
500 mg 50 mg
Imp. A (EP): N-(5-Chloro-1,3,4-thiadiazol-2-yl)acetamide
Cl
S N N
H N O
22
Edition 2012/2013
Code Product Price
S N N H N O
Unit
MM 0648.01
Imp. B (EP): N-(1,3,4-Thiadiazol-2-yl)acetamide
(A)
50 mg
Acetylcysteine
MM 0024.00 N-Acetyl-L-cysteine
HS HN O O OH
(A)
500 mg
MM 0024.03
Imp. A (EP): L-Cystine
NH2 HO O S S
O OH NH2
O HS NH2 OH
(B)
100 mg
MM 0024.02 MM 0024.04
Imp. B (EP): L-Cysteine Imp. C (EP): N,N-Diacetyl-L-cystine

HO O
(B) (A)
100 mg 100 mg
O NH S S HN O O OH
MM 0024.01
Imp. D (EP): N,S-Diacetyl-L-cysteine
O S HN
O OH O
(A)
100 mg
MM 0024.05
Sodium 2-Methyl-4,5-dihydro-1,3-thiazol-4-carboxylate
O N S ONa
(A)
100 mg
MM 0024.06
N-Propionyl-L-cysteine
HS HN
O OH
(A)
100 mg
Acetylsalicylic Acid
MM 0133.00 Acetylsalicylic Acid
O HO O O
(A)
500 mg
MM 0045.01
Imp. A (EP): 4-Hydroxybenzoic Acid

HO
(B)
OH
100 mg
MM 0045.02
Imp. B (EP): 4-Hydroxybenzene-1,3-dicarboxylic Acid (4-Hydroxyisophthalic Acid) Imp. C (EP): Salicylic Acid
O HO
O OH OH
(A)
100 mg
MM 0045.00
O OH OH
(A)
500 mg
MM 0133.01
Imp. D (EP): 2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid (Acetylsalicylsalicylic Acid)

O
O OH O O O
(A)
100 mg
MM 0133.03
Imp. E (EP):2-[(2-Hydroxybenzoyl)oxy]benzoic Acid (Salicylsalicylic Acid)

O
O OH O OH
(A)
100 mg
MM 0133.02
Imp. F (EP): 2-(Acetyloxy)benzoic Anhydride (Acetylsalicylic Anhydride)
O O O O O O O
(A)
100 mg
Edition 2012/2013
23
Code Product Price
O OH O OH
Unit
MM 0133.04
2-(2,4-Dihydroxybenzoyl)benzoic Acid
(A)
100 mg
OH
MM 0133.08
4-Acetoxyisophthalic Acid
HO
O OH O O
(A)
50 mg
MM 0133.09
Acetylsalicylsalicylsalicylic Acid
O OH O O O O O O
(A)
50 mg
N-Acetyltryptophan
MM 1267.01 Imp. A (EP): Tryptophan
H N NH2 OH O
(A)
100 mg
MM 0172.03
Imp. D (EP): (S)-2-Amino-3-(5-hydroxy1H-indol-3-yl)propanoic Acid (5-Hydroxy-tryptophan)

HO
H N
NH2 OH O
(A)
100 mg
Aciclovir
MM 0061.00 Aciclovir
HN H2 N N O N N O OH
(A)
500 mg
MM 0061.01
Imp. A (EP): 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin9-yl)methoxy]ethyl Acetate

H2N
O HN N N O N O O
(A)
100 mg
MM 0061.02
Imp. B (EP): 2-Amino-1,7-dihydro-6H-purin-6-one (Guanine)

H2N
O HN N
O N N N
H N N
OH
(B)
100 mg
New MM 0061.03
Imp. C (EP): 2-Amino-7-[(2-hydroxyethoxy)methyl]-1,7-dihydro-6H-purin6-one Aciclovir Imp. D (EP): 2-[(2-Amino-6-oxo-1,6-dihydro9H-purin-9-yl)methoxy]ethylBenzoate

H2N
O HN H2N
(A)
100 mg
MM 0061.04
O HN N N O N O
O O N H HN N
O O HN N H N N N O O O
(A)
O
100 mg
MM 0061.06
Imp. F (EP): N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo6,9-dihydro-1H-purin-2-yl]acetamide
(A)
N OH N O
100 mg
MM 0061.07
Imp. G (EP): 2-[[(2-(Acetylamino)-6-oxo-1,6-dihydro9H-purin-9-yl]methoxy]ethyl Acetate Aciclovir Imp. H (EP): 2-[[2-(Acetylamino)-6-oxo1,6-dihydro-9H-purin-9-yl]methoxy]ethyl Benzoate
(A)
100 mg
MM 0061.08
O O N H HN N N O N O
Cl N Cl N N N H
(A)
O
100 mg
MM 0061.10
2,6-Dichloropurine
(B)
100 mg
24
Edition 2012/2013
Adapalene
MM 0681.03 Imp. A (EP): 2,2'-Binaphthalene-6,6'-dicarboxylic Acid
HO O
(A)
50 mg
OH O
MM 0681.01
Imp. C (EP): 1-(2-Methoxyphenyl)tricyclo3,7 [3.3.1.1 ]decane Imp. D (EP): 1,1'-[4,4'Bis(methoxy)biphenyl-3,3'3,7

O
(A)
50 mg
New MM 0681.02
(A)
O
50 mg
diyl]bis(tricyclo[3.3.1.1 ]decane)
Adenosine
MM 0784.00 Adenosine
N HO N O NH 2 N N
(A)
500 mg
OH OH
MM 0784.01
Imp. A (EP) as Sulphate: 7H-Purin-6-amine Sulphate (Adenine Sulphate)
NH2 N N N N H x H2SO4 2
(A)
100 mg
MM 0784.02
Imp. F (EP): 1--D-Ribofuranosylpyrimidine2,4(1H,3H)-dione (Uridine)

HO
O HN O O N
(A)
100 mg
OH OH
MM 0784.03
Imp. G (EP): 9--D-Ribofuranosyl-1,9-dihydro6H-purin-6-one (Inosine)
O HN HO N O N N
(A)
100 mg
OH OH
MM 0784.04
Imp. H (EP): 2-Amino-9--D-ribofuranosyl1,9-dihydro-6H-purin-6-one (Guanosine)
O HN H2N HO N O N N
(A)
100 mg
OH OH
Adiphenine Hydrochloride
MM 1172.00 Adiphenine Hydrochloride
O O N x HCl
(A)
250 mg
Adrenaline Tartrate
MM 0614.00 Adrenaline Tartrate
HO OH OH H N x HO O OH OH OH O OH
(A)
500 mg
MM 0614.02
L-Adrenaline
HO OH
H N
(A)
500 mg
MM 0614.13
Imp. C (EP) as Hydrochloride: 1-(3,4-Dihydroxyphenyl)-2-(methylamino)ethanone Hydrochloride (Adrenalone Hydrochloride)
O HO HO
H N
(A)
x HCl
100 mg
Edition 2012/2013
25
Code Product Price
SO 3 H H N
Unit
MM 0614.01
(1R)-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanesulphonic Acid (Adrenaline -Sulphonate)

HO OH
(A)
100 mg
Alanine
MM 0566.00 Alanine
NH2 OH O
(A)
500 mg
Albendazole
MM 0382.00 Albendazole
S H N N O O NH
(A)
500 mg
MM 0382.01
Imp. A (EP): 5-(Propylsulphanyl)-1H-benzimidazol-2-amine

S
H N NH2 N
H N S O N O O NH
(A)
100 mg
MM 0382.02
Imp. B (EP): Methyl [5-Propylsulphinyl)-1H-benzimidazol2-yl]carbamate Imp. C (EP): Methyl [5-Propylsulphonyl)-1H-benzimidazol2-yl]carbamate

S O O
(A)
100 mg
MM 0382.03
H N N
O O NH
(A)
100 mg
MM 0382.04
Imp. D (EP): 5-(Propylsulphonyl)-1H-benzimidazol-2-amine

O S O
H N N NH2
(A)
100 mg
MM 2500.00
Imp. E (EP): Methyl (1H-Benzimidazol-2-yl)carbamate (Carbendazim)
H N N
O O NH
(A)
100 mg
Alfuzosin Hydrochloride
MM 0085.04 Imp. B (EP): 2-Chloro-6,7-dimethoxyquinazolin-4-amine
O O N N NH2 Cl
(A)
100 mg
MM 1004.04
Imp. D (EP) as Dihydrochloride: N-(4-Amino-6,7-dimethoxyquinazolin-2-yl)N-methylpropane-1,3-diamine Dihydrochloride
O O
N N NH2
NH2 x 2 HCl
(A)
50 mg
Allobarbital
MM 0899.00 Allobarbital [Controlled Substance]
O H N O NH O
(A)
100 mg
Allopurinol
MM 0034.00 Allopurinol
N N H N O NH
(A)
500 mg
MM 0034.01
Imp. A (EP) as Hemisulphate: 5-Amino-1H-pyrazole4-carboxamide Hemisulphate Imp. D (EP): Ethyl 5-Amino1H-pyrazole-4-carboxylate
O N N H NH2 NH2 O N N H O NH2 O N N H N H O N N H N H NH O O O x 1/2 H2SO4
(A)
100 mg
MM 0034.05
(A)
100 mg
MM 0034.06
Imp. E (EP): Ethyl 5-(Formylamino)-1H-pyrazole-4-carboxylate
(A)
100 mg
MM 0034.07
Oxypurinol
(A)
100 mg
26
Edition 2012/2013
Alprazolam
New MM 0136.00 Alprazolam [Controlled Substance]
N Cl N N N
(A)
100 mg
MM 0028.03
Imp. E (EP): (2-Amino-5-chlorophenyl)phenylmethanone

Cl
NH2 O
(B)
100 mg
Alverine Citrate
MM 0454.00 Alverine Citrate
N x O OH OH O OH OH O
(A)
250 mg
MM 0454.02 MM 0454.03 MM 0454.04 MM 0454.05
Imp. A (EP): 1-Chloro-3-phenyl-propane

Cl
(A) (A)
OH x HCl
100 mg 100 mg 100 mg 100 mg
Imp. B (EP): 3-Phenylpropan-1-ol Imp. C (EP) as Hydrochloride: N-Ethyl3-phenylpropan-1-amine Hydrochloride Imp. D (EP) as Hydrochloride: N-(3Cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine Hydrochloride Imp. E (EP) as Hydrochloride: 3-PhenylN,N-bis(3-phenylpropyl)propan-1-amine Hydrochloride
N
(A) (A)
NH
x HCl
MM 0454.06
(A)
x HCl
100 mg
Amantadine Hydrochloride
MM 0564.00 Amantadine Hydrochloride
NH2 x HCl
(A)
500 mg
Ambroxol Hydrochloride
MM 0005.00 Ambroxol Hydrochloride
Br N H NH2 Br OH x HCl
(A)
500 mg
MM 0005.01
Imp. A (EP): (2-Amino-3,5-dibromophenyl)methanol
Br
OH NH2 Br
(A)
100 mg
MM 0005.04
Imp. B (EP) as Hydrochloride: trans-4-(6,8-Dibromo1,4-dihydroquinazolin-3(2H)-yl)cyclohexanol Hydrochloride
OH Br N H OH Br N NH2 Br N Br x HCl
(A)
100 mg
MM 0005.03
Imp. C (EP): trans-4-[[(E)-2-Amino3,5-dibromobenzyliden]amino]cyclohexanol
(A)
100 mg
MM 0005.05
Imp. D (EP) as Hydrochloride: cis-4-[(2-Amino3,5-dibromobenzyl)amino]cyclohexanol Hydrochloride
OH Br N H NH2 Br x HCl
(A)
100 mg
MM 0005.02
Imp. E (EP): 2-Amino-3,5-dibromobenzaldehyde
Br
O NH2 Br
(A)
100 mg
MM 0005.06
trans-4-Aminocyclohexanol Hydrochloride
H2 N
OH x HCl
(A)
100 mg
Edition 2012/2013
27
Code Product Price
OH x HCl H2 N
Unit
MM 0005.07
cis-4-Aminocyclohexanol Hydrochloride
(A)
100 mg
Amfetamine Sulfate
New MM 0741.00 Amfetamine Sulfate [Controlled Substance]
NH2 x H2SO4 2
(A)
100 mg
Amiloride Hydrochloride
MM 0560.00 Amiloride Hydrochloride Dihydrate
O Cl H2N N N N H NH2 NH NH2 x HCl x 2 H2O
(A)
500 mg
Aminocaproic Acid
MM 0896.00 Aminocaproic Acid
O H 2N OH
(A)
500 mg
Amiodarone Hydrochloride
MM 0697.00 Amiodarone Hydrochloride
O O I N O I x HCl
(A)
250 mg
MM 0697.11
Imp. A (EP) as Oxalate: (2-Butylbenzofuran-3-yl)[4-[2-(diethylamino)ethoxy]phenyl]methanone Oxalate Imp. B (EP) as Hydrochloride: (2-Butylbenzofuran3-yl)[4-[2-(ethylamino)ethoxy]-3,5diiodophenyl]methanone Hydrochloride (Desethylamiodarone Hydrochloride) Imp. C (EP) as Hydrochloride: (2-Butylbenzofuran3-yl)[4-[2-(diethylamino)ethoxy]3-iodophenyl]methanone Hydrochloride Imp. D (EP): (2-Butylbenzofuran-3-yl) (4-hydroxy-3,5-diiodophenyl)methanone
O HO O O N x HO O O
(A)
100 mg
MM 0697.03
O I O O I H N x HCl
(D)
100 mg
MM 0697.04
O I O O N x HCl
(A)
100 mg
MM 0697.05
O I O OH I
(A)
100 mg
MM 0697.06
Imp. E (EP): (2-Butylbenzofuran3-yl)(4-hydroxyphenyl)methanone
O O OH
(A)
100 mg
MM 0697.07
Imp. F (EP): (2-Butylbenzofuran-3-yl)(4-hydroxy3-iodophenyl)methanone
O I O OH
(A)
100 mg
MM 0697.09
Imp. H (EP) as Hydrochloride: 2-Chloro-N,N-diethylethanamine Hydrochloride (2-Chlorotriethylamine Hydrochloride; (2-Chloroethyl)diethylamine Hydrochloride) Amiodarone N-Oxide Hydrochloride
O O
Cl
x HCl
(C)
100 mg
MM 0697.10
I O I N O x HCl
(A)
100 mg
Amisulpride
MM 0051.01 Imp. A (EP): [(2RS)-1-Ethylpyrrolidin-2-yl]methanamine
H2N N
(A)
100 mg
New MM 0793.02
Imp. B (EP): 4-Amino-N-[[(2RS)-1-ethylpyrrolidin-2-yl]methyl]-5-(ethylsulphonyl)2-hydroxybenzamide
O O S H2N
O N H OH
(A)
N
50 mg
28
Edition 2012/2013
Code Product Price
O I H2N O O N H O
O O S H2N
Unit
MM 0793.03
Imp. C (EP): 4-Amino-N-[[(2RS)-1-ethyl-pyrrolidin2-yl]methyl]-5-iodo-2-methoxy-benzamide
(A)
N H N
50 mg
MM 0793.04
Imp. D (EP): 4-Amino-N-[[(2RS)-1-ethyl-pyrrolidin-2-yl]methyl]2-methoxy-5-(methylsulphonyl)benzamide
O O S H2N
(A)
N
50 mg
MM 0793.05
Imp. E (EP): 4-Amino-5-(ethylsulphonyl)2-methoxybenzoic Acid
O OH O
(A)
100 mg
Amitraz
MM 1018.01 MM 1018.02 Imp. A (BP): 2,4-Dimethylaniline (2,4-Xylidine) Imp. B (BP): Form-2',4'-xylidide
H N
NH2
(A) (A)
100 mg 100 mg
Amitriptyline Hydrochloride
MM 0062.00 Amitriptyline Hydrochloride
N x HCl
(A)
500 mg
MM 0062.01
Imp. A (EP): 10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-one (Dibenzosuberone)
(B)
O
100 mg
MM 0062.02
Imp. B (EP) as Hydrochloride: 3-(5H-Dibenzo[a,d][7] annulen-5-ylidene)-N,N-dimethylpropan-1-amine Hydrochloride (Cyclobenzaprine Hydrochloride)
(A)
N x HCl
100 mg
MM 0079.00
Imp. C (EP) as Hydrochloride: 3-(10,11-Dihydro-5Hdibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1amine Hydrochloride (Nortriptyline Hydrochloride)
(A)
N H x HCl
500 mg
MM 0062.03
Imp. D (EP): 5-[3-(Dimethylamino)propyl]-10,11-dihydro-5Hdibenzo[a,d][7]annulen-5-ol
(A)
OH N
100 mg
MM 0062.05
Imp. F (EP): (5EZ,10RS)-5-[3-(Dimethyl-amino)propylidene]10,11-dihydro-5H-dibenzo[a,d][7]annulen-10-ol

HO
(A)
100 mg
MM 0062.14
Imp. G (EP): 10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ol (Dibenzosuberol)
(A)
OH
100 mg
MM 0062.12
Amitriptyline N-Oxide Hydrochloride

N O x HCl
(B)
10 mg
MM 0062.13
10,11-Dihydro-5H-dibenzo[a,d]cycloheptene (Dibenzosuberane)
(A)
100 mg
Edition 2012/2013
29
Amlodipine Besilate
MM 0383.00 Amlodipine Besilate
O O O Cl H N O O NH 2 O O S OH
(D)
100 mg
MM 0383.06
Amlodipine
O O
H N
O O O Cl
NH2
(A)
100 mg
MM 0383.01
Imp. A (EP): 3-Ethyl-5-Methyl (4RS)-4-(2-Chlorophenyl)2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
O H N O O O Cl O O N O
(D)
100 mg
MM 0383.02
Imp. B (EP): 3-Ethyl 5-Methyl (4RS)4-(2-Chlorophenyl)-6-methyl2-[[2-[[2-(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5-dicarboxylate Ethyl Methyl (4RS)-2,6-Bis[(2-aminoethoxy)methyl]4-(2-chlorophenyl)-1,4-dihydropyridine3,5-dicarboxylate Dihydrochloride
H N O O O Cl
O O
H N
O N H
(D)
100 mg
MM 0383.03
H2N
O O O
H N
O O O Cl
NH2
(D)
100 mg
x 2 HCl
NH2
MM 0383.04
Imp. D (EP): 3-Ethyl-5-Methyl 2-[(2-Aminoethoxy)methyl]4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate
N O O O Cl
O O
(D)
100 mg
MM 0383.10
Imp. E (EP): Diethyl (4RS)-2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6methyl-1,4-dihydropyridine-3,5-dicarboxylate
H N O O O Cl
O O
NH2
on request
MM 0383.09
Imp. F (EP): Dimethyl (4RS)-2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6methyl-1,4-dihydropyridine-3,5-dicarboxylate
H N O O O Cl
O O
NH2
(D)
100 mg
MM 0383.07
Imp. G (EP): Dimethyl 4-(2-Chlorophenyl)2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
H N O O O Cl O
(A)
100 mg
MM 0383.11
Imp. H (EP): 2-[[2-[[(4RS)-4-(2-Chlorophenyl)3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6methyl-1,4-dihydropyridin-2-yl]methoxy]ethyl]carbamoyl]benzoic Acid
H N O O O Cl
O O
H N O O OH
(D)
100 mg
MM 0383.05
Benzenesulfonic Acid
O O S OH
(B)
100 mg
Amlodipine Maleate
MM 0631.00 Amlodipine Maleate
O O O Cl H N O O NH2 x O O OH OH
(D)
100 mg
30
Edition 2012/2013
Amlodipine Mesilate
MM 0592.00 Amlodipine Mesilate
O O O Cl H N O O x NH2 O O S
(D)
100 mg
HO
Amobarbital
New MM 1353.00 Amobarbital [Controlled Substance]
O H N O NH O
(A)
100 mg
Amodiaquine Dihydrochloride Dihydrate

MM 0617.00 Amodiaquine Dihydrochloride Dihydrate
Cl N N HN OH x 2 HCl x 2 H2O
(A)
500 mg
MM 0617.01
4-Acetamido-2-diethylaminomethylphenol
H N O N
(A)
100 mg
OH N
MM 0617.02
7-Chloro-4-(4-hydroxyphenylamino)quinoline
Cl
(A)
100 mg
HN OH
MM0617.03
4,7-Dichloroquinoline
Cl
(C)
100 mg
Cl
MM 0617.04
Monodesethylamodiaquine Dihydrochloride
Cl
N HN HN OH
(A)
x 2 HCl
100 mg
Amoxicillin Trihydrate
MM 0232.00 Amoxicillin Trihydrate
O NH 2 H N N S H
O O N H2N S H
O O NH2 H N N S H OH
OH
(A)
x 3 H2O
500 mg
HO
MM 0026.04
Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid) Imp. B (EP): (2S,5R,6R)-6-[[(2S)-2-Amino-2(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane2-carboxylic Acid (L-Amoxicillin)
HO
OH
(B)
100 mg
MM 0232.02
(D)
100 mg
MM 0232.03
Imp. C (EP): (4S)-2-[5-(4-Hydroxyphenyl)3,6-dioxopiperazin-2-yl]-5,5-dimethyl-thiazolidine4-carboxylic Acid (Amoxicillin Diketopiperazines)

HO
O HN S O
OH
(A)
100 mg
H N N H
MM 0232.04
Imp. D (EP) as Sodium Salt:(4S)-2-[[[(2R)-2-Amino2-(4-hydroxyphenyl)acetyl]amino]carboxymethyl]5,5-dimethylthiazolidine-4-carboxylic Acid Sodium Salt (Penicilloic Acids of Amoxicillin Sodium Salt)
HO
O NH 2 HN S O
ONa
(A)
100 mg
H N
O HO
Edition 2012/2013
31
Code Product Price
O NH 2 HN S OH
Unit
MM 0232.05
Imp. E (EP): (2RS,4S)-2-[[[(2R)-2-Amino2-(4-hydroxyphenyl)acetyl]amino]methyl]5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Amoxicillin)

HO
(A)
50 mg
H N
O
HO N N HO
MM 0232.06
Imp. F (EP): 3-(4-Hydroxyphenyl)pyrazin-2-ol
(A)
100 mg
New MM 0232.07
Imp. G (EP): (2S,5R,6R)-6-[[(2R)-2-[[(2R)-2Amino-2-(4-hydroxyphenyl)acetyl]amino]-2(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2carboxylic Acid (D-(4-Hydroxyphenyl)glycylamoxicillin) Imp. H (EP): (2R)-2-[(2,2-Dimethylpropanoyl)amino]-2(4-hydroxyphenyl)acetic Acid
NH2 O O HO NH H N N
(A)
OH
100 mg
S H
HO
MM 0232.08
O NH OH HO O
NH 2 OH HO O
NH2 NH2 HO O
(A)
100 mg
MM 0232.09
Imp. I (EP): (2R)-2-Amino-2-(4-hydroxyphenyl)acetic Acid
(B)
100 mg
MM 0232.12
(2R)-2-Amino-2-(4-hydroxy-phenyl)-acetamide
(A)
100 mg
Ampicillin Sodium
MM 0253.00 Ampicillin Sodium
O NH2 H N N S H
O O NH 2 H N N S H x 3 H2O
ONa
(A)
500 mg
MM 0253.15
Ampicillin Trihydrate
OH
(A)
500 mg
MM 0026.04
Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid) Imp. B (EP): (2S,5R,6R)-6-[[(2S)-2-Amino2-phenylacetyl]amino]-3,3dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2carboxylic Acid (L-Ampicillin) Imp. C (EP): (4S)-2-(3,6-Dioxo-5-phenylpiperazin-2-yl)5,5-dimethylthiazolidine-4-carboxylic Acid (Diketopiperazines of Ampicillin)
O O N H2N S H
OH
(B)
100 mg
MM 0253.02
O O NH2 H N N S H
O HN S O
OH
(A)
100 mg
MM 0253.03
OH
(A)
100 mg
H N N H
MM 0253.04
Imp. D (EP) as Sodium Salt: (4S)-2-[[[(2R)-2-Amino2-phenylacetyl]amino]carboxymethyl]5,5-dimethylthiazolidine-4-carboxylic Acid Sodium Salt (Penicilloic Acids of Ampicillin Sodium Salt) Imp. F (EP): (2RS,4S)-2-[[[(2R)-2-Amino2-phenylacetyl]amino]methyl]-5,5-dimethyl-thiazolidine4-carboxylic Acid (Penilloic Acids of Ampicillin)
O NH2 HN S O
ONa
(A)
100 mg
H N
O HO
MM 0253.06
O NH 2 HN S
OH
(A)
100 mg
H N
MM 0253.08
Imp. H (EP): 3-Phenylpyrazin-2-ol
HO
N N
(A)
100 mg
32
Edition 2012/2013
Code Product Price
O NH OH O
Unit
MM 0253.11
Imp. K (EP): (2R)-2-[(2,2-Dimethylpropanoyl)-amino]-2phenylacetic Acid
(A)
100 mg
MM 0253.12
Imp. L (EP): (2R)-2-Amino-2-phenylacetic Acid (D-Phenylglycine) Ampicillin, anhydrous

O NH 2 H N N
NH 2 OH O
(B)
100 mg
MM 0253.16
OH
(A)
500 mg
S H
Androstanolone
MM 0565.00 Androstanolone
OH
(A)
250 mg
Anise Oil
MM 0164.01 MM 0164.02 MM 0164.03 MM 0164.05 trans-Anethole
O
(C) (C)
O
100 mg 100 mg 100 mg 100 mg
Estragole Anisaldehyde
O O
(C) (C)
Linalol
HO
MM 0164.06
cis-Anethole
O
(D)
100 mg
Antazoline Hydrochloride
MM 0171.00 Antazoline Hydrochloride
N N N H x HCl
(A)
500 mg
MM 0171.01
Imp. A (EP) as Dihydrochloride: N-(2-Aminoethyl)2-(benzylphenylamino)acetamide Dihydrochloride

N
(A)
O N H NH 2
N N H x HCl
100 mg
x 2 HCl
MM 0171.04
Imp. B (Pharmeuropa) as Hydrochloride: 2-(Chloromethyl)-4,5-dihydro-1H-imidazole Hydrochloride

Cl
(A)
100 mg
MM 0171.03
N-Benzylaniline
NH
(B)
100 mg
Antazoline Phosphate
MM 0561.00 Antazoline Phosphate
N N H N x H3PO4
(A)
500 mg
Apomorphine Hydrochloride Hemihydrate

MM 0562.00 Apomorphine Hydrochloride Hemihydrate
HO N OH x HCl x H2O
(A)
H
250 mg
MM 0037.00
Imp. B (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate [Controlled Substance]

HO O
N x HCl x 3 H2O OH
(A)
250 mg
Edition 2012/2013
33
Aprindine Hydrochloride
MM 0467.00 Aprindine Hydrochloride
N N HCl
on request
Arginine
MM 0568.00 Arginine
H2N H N NH NH2 OH O
(A)
500 mg
Arginine Hydrochloride
MM 0569.00 Arginine Hydrochloride
H2N H N NH NH2 OH O x HCl
(A)
500 mg
Aripiprazole
New MM 0961.00 Aripiprazole
Cl Cl N N
(A)
100 mg
N H
Articaine Hydrochloride
MM 0369.00 Articaine Hydrochloride
O S O H N O
O S O H N O
(A)
N H x HCl
100 mg
MM 0369.01
Imp. A (EP) as Hydrochloride: Methyl 3-[[2-(Propylamino)acetyl]amino]-4-methylthiophene2-carboxylate Hydrochloride (Acetamidoarticaine Hydrochloride) Imp. B (EP) as Hydrochloride: 4-Methyl-3-[[(2RS)2-(propylamino)propanoyl]amino]thiophene-2-carboxylic Acid Hydrochloride (Articaine Acid Hydrochloride) Imp. C (EP) as Hydrochloride: 1-Methylethyl 4-Methyl3-[[(2RS)-2-(propylamino)propanoyl]amino]thiophene2-carboxylate Hydrochloride (Articaine Isopropyl Ester Hydrochloride) Imp. D (EP) as Hydrochloride: Methyl 3-[[(2RS)2-(Ethylamino)propanoyl]amino]-4-methylthiophene2-carboxylate Hydrochloride (Ethylarticaine Hydrochloride) Imp. E (EP) as Hydrochloride: Methyl 4-Methyl-3-[[(2RS)2-[(1-methylethyl)amino]propanoyl]amino]thiophene2-carboxylate Hydrochloride (Isopropylarticaine Hydrochloride) Imp. F (EP) as Hydrochloride: 4-Methyl-N-propyl3-[[(2RS)-2-(propylamino)propanoyl]amino]thiophene2-carboxamide Hydrochloride (Articaine Acid Propionamide Hydrochloride) Imp. G (EP) as Hydrochloride: Methyl 3-[[(2RS)2-(Butylamino)propanoyl]amino]-4-methylthiophene2-carboxylate Hydrochloride (Butylarticaine Hydrochloride) Imp. H (EP) as Hydrochloride: Methyl 3-[[(2RS)2-(Dipropylamino)propanoyl]amino]-4-methylthiophene2-carboxylate Hydrochloride (Dipropylarticaine Hydrochloride) Imp. I (EP): Methyl 3-Amino-4-methylthiophene-2-carboxylate (3-Aminoarticaine) Imp. J (EP): Methyl 3-[[(2RS)-2-Bromopropanoyl]amino]4-methylthiophene-2-carboxylate (Bromo Compound)
(A)
N H x HCl
100 mg
MM 0369.02
HO S
H N O
(A)
N H x HCl
50 mg
MM 0369.03
O S
H N O
(A)
N H x HCl
100 mg
MM 0369.04
O S
H N O
(B)
N H x HCl
10 mg
MM 0369.05
O S
H N O
(A)
N H x HCl
100 mg
MM 0369.06
H N S
H N O
(A)
N H x HCl
50 mg
MM 0369.07
O S
H N O
(A)
N H x HCl
100 mg
MM 0369.08
O S
H N O
(A)
N x HCl
100 mg
MM 0369.09
O S
O NH2
(C)
100 mg
MM 0369.10
O S
H N O
(B)
Br
10 mg
34
Edition 2012/2013
Ascorbic Acid
MM 0166.00 L-Ascorbic Acid
HO HO OH O O OH
(A)
500 mg
Asparagine Monohydrate
MM 0765.01 Phenylacetylasparagine
O H 2N O HN OH O
(C)
50 mg
Aspartame
MM 0314.00 Aspartame
HO O NH2 H N O O O
(A)
500 mg
MM 0314.01
Imp. A (EP): 2-(5-Benzyl-3,6-dioxopiperazin-2-yl)acetic Acid (Diketopiperazine)

HO
O O HN NH O
(A)
100 mg
MM 0314.02
Imp. B (EP): L-Aspartyl-L-phenylalanine

HO
NH2 H N O
O OH
(A)
100 mg
MM 0314.03
Imp. C Aspartame (EP): Phenylalanine
O H2N OH
(B)
100 mg
Aspartic Acid
MM 0567.00 MM 0460.10 Aspartic Acid
HO O O NH2 OH
(A) (B)
500 mg 100 mg
Imp. B (Pharmeuropa): (E)-Butenedioic Acid (Fumaric Acid) Imp. D (Pharmeuropa): (S)-2-Aminopropanoic Acid (Alanine) Imp. F (Pharmeuropa): (2S)-2,5-Diamino-5oxopentanoic Acid (L-Glutamine)
O HO O OH
NH2 OH O
MM 0566.00
(A)
500 mg
MM 0169.00
NH2 H2N O O OH
(A)
500 mg
Astemizole
MM 0184.00 Astemizole
F N N HN N O
(A)
250 mg
MM 0184.13
Desmethyl Astemizole Hydrochloride
F N
HN N N OH x HCl
(B)
10 mg
Atenolol
MM 0013.00 Atenolol
O H2 N OH O H N
(A)
500 mg
MM 0013.03 MM 0013.05
Imp. A (EP): 2-(4-Hydroxyphenyl)acetamide

H2 N
OH
(B) (A)
100 mg 100 mg
Imp. B (EP): 2-[4-[(2RS)2,3-Dihydroxypropoxy)phenyl]acetamide

H2 N
OH O O OH
MM 0013.01
2-[4-[[(2RS)-Oxiran-2-yl]methoxy]phenyl]acetamide
H2 N
(A)
100 mg
Edition 2012/2013
35
Code Product Price
OH O H2 N O Cl
Unit
MM 0013.06
Imp. D (EP): 2-[4-[(2RS)-3-Chloro2-hydroxypropoxy]phenyl]acetamide Imp. E (EP): 2,2'-[(2-Hydroxypropane-1,3diyl)bis(oxy-4,1-phenylene)]diacetamide

H2 N
(A)
50 mg
MM 0013.07
OH O O O O NH2 OH O H2 N OH O HO O H N O N OH O O NH2
(A)
50 mg
MM 0013.02
Imp. F (EP): 2,2'-[[(1-Methylethyl)imino]bis[(2-hydroxypropane-3,1diyl)oxy-4,1-phenylene]]diacetamide
(A)
50 mg
MM 0013.04
Imp. G (EP): 2-[4-[(2RS)-2-Hydroxy3-[(1-methylethyl)amino]propoxy]phenyl]acetic Acid Imp. H (EP): 2-[4-[(2RS)-2-Hydroxy3-[(1-methylethyl)amino]propoxy]phenyl]acetonitrile Imp. I (EP): 2-[4-[(2RS)-3-(Ethylamino)-2hydroxypropoxy]phenyl]acetamide
H2N
(A)
50 mg
MM 0013.08
OH O N
H N
(A)
100 mg
MM 0013.17
OH O O
H N
(A)
50 mg
MM 0013.13
4-Hydroxyphenylacetic Acid
HO
OH
(B)
100 mg
Atorvastatin Calcium Trihydrate

MM 0400.00 Atorvastatin Calcium
O N H N OH O O OH -
(D)
100 mg
Ca2+
2
O N H O O F O
New MM 0400.11
Imp. D (EP): 3-[(4-Fluorophenyl)carbonyl]-2-(2methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide Imp. G (Pharmeuropa) as Calcium Salt: (3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4(phenylcarbamoyl)-5-(propan-2-yl)-1Hpyrrol-1-yl]-5-hydroxy-3-methoxyheptanoic Acid Calcium Salt (3-O-Methylatorvastatin Calcium Salt) Imp. G (Pharmeuropa) as Lithium Salt: (3R,5R)-7[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)5-(propan-2-yl)-1H-pyrrol-1-yl]-5-hydroxy-3-methoxyheptanoic Acid Lithium Salt (3-O-Methylatorvastatin Lithium Salt)
(D)
100 mg
MM 0400.12
O O N H N OH O O -
(D)
100 mg
Ca2+
2
O
MM 0400.16
(D)
OLi
100 mg
O N H N
OH O
MM 0400.01
Imp. H (Pharmeuropa): (2R,4R)-2-[2-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan2-yl)-1H-pyrrol-1-yl]ethyl]-4-hydroxytetrahydro-2Hpyran-6-one (Atorvastatin Lactone)
O O N H N O OH
(D)
100 mg
MM 0400.04
1,1-Dimethylethyl (4R-cis)6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)3-phenyl-4-[(phenylamino)carbonyl]-1-H-pyrrol1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate
(A)
O N H N O O O O
100 mg
MM 0400.05
1,1-Dimethylethyl (4R-cis)-6-Aminoethyl-2,2-dimethyl1,3-dioxane-4-acetate
H2N
(A)
O O O O
100 mg
36
Edition 2012/2013
Code Product Price
O O N H N O
Unit
MM 0400.13
1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]-ethyl]5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1Hpyrrole-3-carboxamide (Atorvastatin eliminated Lactone)
(A)
100 mg
Atracurium Besilate
MM 0858.13 Imp. J (EP): Methyl Benzenesulphonate
O O S O
(A)
100 mg
Atropine
MM 0289.18 Atropine
H O H O N
(A)
250 mg
H OH and enantiomer
MM 0289.00
Atropine Sulphate
H O H O OH H N 2
H O H O H N x HCl
(A)
x H2SO4 x H2O and enantiomer
500 mg
MM 0289.01
Imp. A (EP) as Hydrochloride: (1R,3r,5S)-8-Methyl8-azabicyclo[3.2.1]oct-3-yl 2-Phenylpropenoate Hydrochloride (Apoatropine Hydrochloride) Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (Tropic Acid) Imp. F (EP) as Hydrobromide Trihydrate: Hyoscine Hydrobromide Trihydrate
(D)
100 mg
MM 0601.03
O OH OH
(A)
100 mg
MM 0546.00
H O H O OH N H
H O H
O OH
(A)
x HBr x 3 H2O
500 mg
MM 0289.03
Atropic Acid
(A)
100 mg
Avobenzone
MM 0902.00 Avobenzone
O O
(A)
O
500 mg
Azelaic Acid
MM 0687.00 Azelaic Acid
HO O O OH
(A)
500 mg
Azelastine Hydrochloride
MM 0362.00 Azelastine Hydrochloride
O N N x HCl N
(A)
100 mg
Cl
MM 0362.04
Imp. A (EP): Benzoyldiazane (Benzohydrazide) Imp. B (EP) as Dihydrochloride: 1-Benzoyl2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl] diazane Dihydrochloride
O NH NH2
(C)
100 mg
MM 0362.07
H N O
N N H
(A)
x 2 HCl
100 mg
Edition 2012/2013
37
Code Product Price
O OH O
Unit
MM 0362.05
Imp. C (EP): 2-[(4-Chlorophenyl)acetyl]benzoic Acid
(A)
100 mg
Cl
MM 0362.01
Imp. D (EP): 4-(4-Chlorobenzyl)phthalazin-1(2H)-one
O NH N
(A)
100 mg
Cl
MM 0362.06
Imp. E (EP) Z-Isomer: (Z)-3-(4-Chlorobenzylidene)isobenzofuran-1(3H)-one
O O
(A)
100 mg
Cl
MM 0362.03
1-Methylazepan-4-one Hydrochloride
O
x HCl
(A)
100 mg
Azithromycin
MM 1075.00 Azithromycin
HO O O N OH OH O OO N OH HO O O
(A)
100 mg
MM 1075.01
Imp. A (EP): 6-Demethylazithromycin (Azaerythromycin A)

HO OO OH N OH OO O
H N OH HO O O
(D)
100 mg
Baclofen
MM 1235.03 Imp. B (EP): (3RS)-5-Amino-3-(4-chlorophenyl)5-oxopentanoic Acid
Cl O H2N O OH
(A)
100 mg
MM 1235.01
3-(4-Chlorophenyl)glutaric Acid
HO
O O OH Cl
(A)
100 mg
Bambuterol Hydrochloride
MM 0773.04 Imp. D (EP): 5-[(1RS)-1-Hydroxyethyl]-1,3-phenylene Bis(dimethylcarbamate)
OH N O N O O O
(A)
100 mg
MM 0773.05
Imp. E (EP): 5-Acetyl-1,3-phenylene Bis-(dimethylcarbamate)
O N O N O O O
(A)
100 mg
Basic Butylated Methacrylate Copolymer

MM 0753.01 MM 0753.02 Imp. A (EP): Butyl Methacrylate Imp. B (EP): Methyl Methacrylate
O O
(A)
O O
100 mg 100 mg
(A)
38
Edition 2012/2013
Code Product Price
O O N
Unit
MM 0753.03
Imp. C (EP): 2-(Dimethylamino)ethyl Methacrylate
(A)
100 mg
Beclometasone Dipropionate
MM 0199.00 Beclometasone Dipropionate
O O HO Cl O O O O
(A)
250 mg
MM 0199.02
Imp. A (EP): 9-Chloro-11,17-dihydroxy-16methyl-3,20-dioxopregna-1,4-dien-21-yl Propanoate (Beclometasone 21-Propionate)

O
O O HO O OH
(A)
100 mg
Cl
MM 0199.06
Imp. B (EP): 21-(Acetyloxy)-9-chloro-11hydroxy-16-methyl-3,20-dioxopregna-1,4dien-17-yl Propanoate (Beclometasone 21-Acetate 17-Propionate)

O
O O HO O O O
(A)
100 mg
Cl
MM 0199.05
Imp. C (EP): 9-Chloro-11-hydroxy-16-methyl3,20-dioxo-17-(propanoyloxy)-pregna-1,4-dien21-yl Butanoate (Beclometasone 21-Butyrate 17-Propionate)

O
O O HO O O O
(A)
100 mg
Cl
MM 0199.01
Imp. H (EP): 9-Chloro-11,21-dihydroxy-16methyl-3,20-dioxopregna-1,4-dien-17-yl Propanoate (Beclometasone 17-Propionate)

O
O HO O
OH O
(A)
100 mg
Cl
MM 0199.03
9-Chloro-11,17,21-trihydroxy-16-methylpregna1,4-diene-3,20-dione (Beclometasone)
O HO
OH OH
(A)
100 mg
Cl O
Benazepril Hydrochloride
MM 1229.00 Benazepril Hydrochloride
O H N O O N O OH x HCl
(A)
100 mg
Bendroflumethiazide
MM 0674.01 Imp. A (EP): 4-Amino-6-(trifluoromethyl)benzene1,3-disulphonamide
O O H2N S F F F O S O NH2
(A)
100 mg
NH2
Benfluorex Hydrochloride
New MM 1298.01 Imp. A (EP) as Hydrochloride: 2-[[(1RS)1-Methyl-2-[2-(trifluoromethyl)phenyl] ethyl]amino]ethyl Benzoate Hydrochloride Imp. B (EP) as Hydrochloride: 2-[[(1RS)-1Methyl-2-[4-(trifluoromethyl)phenyl]ethyl]amino]ethyl Benzoate Hydrochloride Imp. C (EP): Benzoic Acid
HO
H N F F F
O O x HCl
(A)
50 mg
New MM 1298.02
H N F F F
O O x HCl
(A)
50 mg
MM 0278.01
(B)
100 mg
Edition 2012/2013
39
New MM 1298.05
Imp. E (EP): N-(2-Hydroxyethyl)-N-[(1RS)-1-methyl2-[3-(trifluoromethyl)phenyl]ethyl]benzamide
(A)
O N OH
50 mg
F F
New MM1298.06
Imp. F (EP): 2-[Benzoyl[(1RS)-1-methyl-2-[3-(trifluoromethyl)phenyl]ethyl]amino]ethyl Benzoate
(A)
O N O O
50 mg
F F
Benperidol
MM 0113.00 Benperidol
O N F O NH N
(A)
100 mg
MM 0113.03
Imp. A (EP): 1-(Piperidin-4-yl)-1,3-dihydro-2Hbenzimidazol-2-one

HN
O NH N
(A)
100 mg
MM 0113.07
4-Chloro-4'-fluorobutyrophenone
F
O Cl
(B)
100 mg
Benzalkonium Chloride
MM 0224.00 MM 0795.00 MM 0224.01 MM 0224.02 MM 0224.03 Benzalkonium Chloride
N
n
Cl
(A) (A)
OH
500 mg 500 mg 500 mg 500 mg 500 mg
Imp. A (EP): Benzyl Alcohol Benzyldimethyldodecylammonium Chloride

N
5
Cl
(A) (A)
6
Benzyldimethyltetradecylammonium Chloride
N
Cl
Benzyldimethylhexadecylammonium Chloride
N
Cl
7
(A)
Benzbromarone
MM 0456.00 Benzbromarone
O OH Br O Br
(A)
500 mg
Benzocaine
MM 0094.00 Benzocaine
H2N O O
(A)
500 mg
MM 0094.01
Benzocaine Acetylsalicylamide
O N H O O
O O
(C)
50 mg
MM 0094.02
N-Acetylbenzocaine
O N H
O O
(A)
100 mg
MM 0094.03
4-Aminobenzoic Acid
H2N
O OH
(B)
100 mg
40
Edition 2012/2013
Code Product Price
O O O 2N
Unit
MM 0094.04
Ethyl 4-Nitrobenzoate
(B)
100 mg
Benzydamine Hydrochloride
MM 0142.00 Benzydamine Hydrochloride
N N O N x HCl
(A)
500 mg
MM 0142.04
Imp. C (BP): 1-Benzyl-1H-indazol-3-ol

N N OH
(A)
100 mg
MM 0142.08
Benzydamine N-Oxide Hydrochloride

N N O N O
x HCl
(A)
x HCl
100 mg
MM 0290.02
1-Chloropropyl(dimethyl)amine Hydrochloride (N,N-Dimethyl-3-chloropropylamine Hydrochloride)
Cl
(B)
100 mg
Benzyl Alcohol
MM 0795.00 MM 0795.02 Benzyl Alcohol
OH
(A)
OH
500 mg 100 mg
Imp. B (EP): Cyclohexylmethanol
(A)
Benzyl Benzoate
MM 0570.00 Benzyl Benzoate
O O
(A)
500 mg
Benzyl Nicotinate
MM 0104.00 Benzyl Nicotinate
N O O
(A)
500 mg
MM 0553.00
Nicotinic Acid
N
O OH
(A)
500 mg
Benzylpenicillin Benzathine
MM 0513.00 Benzylpenicillin Benzathine
O H N x N H O O H N N S H 2
HN NH2
OH
(A)
500 mg
MM 0513.02
Imp. A (EP): Monobenzylethylendiamine
(C)
100 mg
MM 0160.03 MM 0160.07
Imp. B (EP): Phenylacetic Acid [Drug Precursor]

O
OH
(B) (A)
100 mg 100 mg
Imp. D (EP): (3S,7R,7aR)-5-Benzyl-2,2-dimethyl-2,3,7,7atetrahydroimidazo[5,1-b]-thiazole-3,7-dicarboxylic Acid (Penillic Acid of Benzylpenicillin)

HO
O N O O H N O O HN S OH O H N O HN S N H S
OH
MM 0160.01
Imp. E (EP): (4S)-2-[Carboxy[(phenylacetyl)amino]methyl]5,5-dimethylthiazolidine-4-carboxylic Acid (Penicilloic Acids of Benzylpenicillin) Imp. F (EP): (2RS,4S)-2-[[(Phenylacetyl)amino]methyl]5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Benzylpenicillin)
OH
(A)
100 mg
MM 0160.05
OH
(A)
100 mg
Edition 2012/2013
41
Code Product Price
H N x N H HO 2
Unit
MM 0513.01
N,N-Dibenzylethylenediamine Diacetate
(C)
O
100 mg
Benzylpenicillin Potassium
MM 0160.00 Benzylpenicillin Potassium
O O N H N H S O O H2 N N H S O OK
(A)
250 mg
MM 0026.04
Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid) Imp. B (EP): Phenylacetic Acid [Drug Precursor] Imp. D (EP): (3S,7R,7aR)-5-Benzyl-2,2-dimethyl-2,3,7,7atetrahydroimidazo[5,1-b]-thiazole-3,7-dicarboxylic Acid (Penillic Acid of Benzylpenicillin)
OH
(B)
100 mg
MM 0160.03 MM 0160.07
O OH O N HO O O H N O O HN S OH O H N O HN S OH OH N H S OH
(B) (A)
100 mg 100 mg
MM 0160.01
Imp. E (EP): (4S)-2-[Carboxy[(phenylacetyl)amino]methyl]5,5-dimethyl-thiazolidine-4-carboxylic Acid (Penicilloic Acids of Benzylpenicillin) Imp. F (EP): (2RS,4S)-2-[[(Phenylacetyl)amino]methyl]5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Benzylpenicillin)
(A)
100 mg
MM 0160.05
(A)
100 mg
Benzylpenicillin Procaine
MM 0094.03 Imp. A (EP): 4-Aminobenzoic Acid
H2N O OH
(B)
100 mg
MM 0160.01
Imp. B (EP): (4S)-2-[Carboxy[(phenyl-acetyl)amino]methyl]5,5-dimethyl-thiazolidine-4-carboxylic Acid (Penicilloic Acids of Benzylpenicillin)

O
O HN S OH
O HN S
OH
(A)
100 mg
H N O
MM 0160.05
Imp. C (EP): (2RS,4S)-2-[[(Phenylacetyl)-amino]methyl]5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Benzylpenicillin)

O
OH
(A)
100 mg
H N
MM 0160.07
Imp. D (EP): (3S,7R,7aR)-5-Benzyl-2,2-dimethyl-2,3,7,7atetrahydroimidazo[5,1-b]thiazole-3,7-dicarboxylic Acid (Penillic Acid of Benzylpenicillin)

HO
O N S H O
OH
(A)
100 mg
MM 0160.03
Imp. E (EP): Phenylacetic Acid [Drug Precursor]

O
OH
(B)
100 mg
Betahistine Dihydrochloride
MM 0587.00 Betahistine Dihydrochloride
N H N
(A)
x 2 HCl
500 mg
MM 0587.01 MM 0587.02 MM 0587.03
Imp. A (EP): 2-Ethenylpyridine (2-Vinylpyridine) Imp. B (EP): 2-(Pyridin-2-yl)ethanol (2-(2-Hydroxyethyl)pyridine) Imp. C (EP) as Trihydrochloride: N-Methyl-2-(pyridin2-yl)-N-[2-(pyridin-2-yl)ethyl]ethanamine Trihydrochloride Imp. C (EP) as Trimesilate: N-Methyl-2-(pyridin-2-yl)N-[2-(pyridin-2-yl)ethyl]ethanamine Trimesilate
N N
(C)
OH
100 mg 100 mg 100 mg
(B) (A)
x 3 HCl
MM 0587.04
x3
O OH
(A)
100 mg
42
Edition 2012/2013
Betaine Hydrochloride
MM 0611.00 Betaine Hydrochloride
O N OH Cl
(A)
500 mg
Betamethasone
MM 0200.00 Betamethasone
HO O OH OH
(A)
250 mg
F O
MM 0213.00
Imp. A (EP): Dexamethasone

HO
O OH OH
(A)
250 mg
F O
MM 0200.01
Imp. B (EP): 21-Chloro-9-fluoro-11,17-dihydroxy-16methylpregna-1,4-diene-3,20-dione (Clobetasol)
O HO OH Cl
(A)
100 mg
F O
Betamethasone Acetate
MM 0201.00 Betamethasone Acetate
HO F O O O O OH
(A)
250 mg
MM 0200.00
Imp. A (EP): Betamethasone

HO F O
OH OH
(A)
250 mg
MM 0445.00
Imp. B (EP): Dexamethasone Acetate

HO F O
O O O OH
(A)
250 mg
MM 0201.03
Imp. C (EP): Betamethasone 11,21-Diacetate
O O
O OH O
(A)
100 mg
F O
Betamethasone Dipropionate
MM 0200.00 Imp. A (Pharmeuropa): 9-Fluoro-11,17,21trihydroxy-16-methylpregna-1,4-diene-3,20dione (Betamethasone)
O O HO OH OH
(A)
250 mg
MM 0202.00
Betamethasone Dipropionate
O O HO F O O
O O
(A)
250 mg
MM 0202.04
Imp. C (Pharmeuropa): 9-Fluoro-11,17-dihydroxy16-methyl-3,20-dioxopregna-1,4-dien-21-yl Propanoate (Betamethasone 21-Propionate)
O O HO O OH
(A)
100 mg
F O
Edition 2012/2013
43
Code Product Price
O O HO O O O
Unit
MM 0199.00
Imp. E (Pharmeuropa): 9-Chloro-11-hydroxy16-methyl-3,20-dioxopregna-1,4-diene-17,21diyl Dipropanoate (Beclometasone Dipropionate)
(A)
250 mg
Cl O
Betamethasone Sodium Phosphate

MM 0303.00 Betamethasone Sodium Phosphate
O HO F O O O P ONa ONa OH
(A)
250 mg
Betamethasone 17-Valerate
MM 0203.00 Betamethasone 17-Valerate
HO F O O OH O O
(A)
250 mg
MM 0200.00
Imp. A (EP): Betamethasone

HO
OH OH
(A)
250 mg
F O
Betaxolol Hydrochloride
MM 0436.01 Imp. A (EP) as Hydrochloride: (2RS)1-(4-Ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol Hydrochloride Imp. B (EP): (2RS)-1-[4-(2-Hydroxyethyl)phenoxy]3-[(1-methylethyl)amino]propan-2-ol
HO
OH O H N
(A)
x HCl
50 mg
MM 0027.10
OH O
H N
(A)
100 mg
MM 0436.03
Imp. C (EP): 2-[[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane

O
(A)
50 mg
MM 0436.04
Imp. D (EP): 4-[2-(Cyclopropylmethoxy)ethyl]phenol

O
OH
(A)
50 mg
MM 0436.05
Imp. E (EP) as Hydrochloride: (2RS)1-[4-(2-Butoxyethyl)phenoxy]3-[(1-methylethyl)amino]propan-2-ol Hydrochloride 1-[4-(2-Cyclobutoxyethyl)phenoxy]3-(isopropylamino)propan-2-ol Hydrochloride
OH O O x HCl
H N
(A)
50 mg
MM 0436.06
OH O O
H N
(D)
50 mg
x HCl
Bezafibrate
MM 0063.00 Bezafibrate
O N H Cl O O OH
(A)
500 mg
MM 0063.01
Imp. A (EP): 4-Chloro-N-[2-(4-hydroxyphenyl)ethyl] benzamide (4-Chlorobenzoyltyramine)

Cl
O N H
OH
(A)
100 mg
MM 0063.03
Imp. B (EP): 4-Chlorobenzoic Acid

Cl
O OH
(B)
100 mg
MM 0063.04
Imp. C (EP): Methyl2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]2-methylpropanoate

Cl
O O N H O O
(A)
100 mg
44
Edition 2012/2013
Code Product Price
O O N H Cl O O
Unit
MM 0063.02
Imp. D (EP): Ethyl 2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoate
(A)
100 mg
MM 0063.05
Imp. E (EP): Butyl 2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoate

Cl
O O N H O O
(A)
100 mg
MM 0063.06 MM 0063.07
Tyramine
H2 N
OH
(B) (A)
100 mg 100 mg
N,O-Bis-(4-chlorobenzoyl)tyramine
O N H Cl O O
Cl
Bicalutamide
MM 0894.00 Bicalutamide
F S O O N O N H
H N O N
(A)
100 mg
F F
F
OH
F
F F
MM 0894.01
N-[4-Cyano-3-(trifluoromethyl)phenyl]3-[(4-fluorophenyl)sulfinyl]-2-hydroxy2-methylpropanamide
O HO S F
(A)
50 mg
Bifonazole
MM 0318.00 Bifonazole
N N
(A)
500 mg
MM 0318.01
Imp. A (EP): (RS)-(Biphenyl-4-yl)phenylmethanol

OH
(A)
100 mg
MM 0015.02 MM 0318.03
Imp. C (EP): 1H-Imidazole (Imidazole) Imp. D (EP) as Chloride: 1,3-Bis[(biphenyl-4-yl)phenylmethyl]-1H-imidazolium Chloride

N+ N
H N N
(B) (D)
100 mg 100 mg
Cl-
Bisacodyl
MM 0031.00 Bisacodyl
O N O O O
(A)
500 mg
MM 0031.01
Imp. A (EP): 4,4'-(Pyridin-2-ylmethylene)diphenol
HO
OH
(A)
100 mg
MM 0031.04
Imp. B (EP): 2-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl) methyl]phenol

N
OH
OH
(A)
50 mg
MM 0031.02
Imp. C (EP): 4-[(RS)-(4-Hydroxyphenyl)(pyridin2-yl)methyl]phenyl Acetate
HO
O O N
(A)
100 mg
Edition 2012/2013
45
Code Product Price
O O O O N
Unit
MM 0031.03
Imp. E (EP): 2-[(RS)-[4-(Acetyloxy)phenyl](pyridin2-yl)methyl]phenyl Acetate
(A)
50 mg
MM 0054.01
4-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl)-methyl]phenyl Sodium Sulphate (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl Sodium Sulphate) 2-[(RS)-(Pyridin-2-yl)[4-(sulphonatooxy)phenyl]methyl]phenyl Disodium Sulphate (2,4'-[(Pyridin-2-yl)methylene]bisphenyl Bis (Sodium Sulphate))
HO
ONa S O O
(A)
100 mg
MM 0054.02
NaO O
O O O O ONa O
(D)
50 mg
Bisoprolol Fumarate
MM 0460.00 Bisoprolol
O O OH O H N
(A)
100 mg
MM 0460.08
Bisoprolol Fumarate
O
OH
H N x
OH O
(A)
100 mg
O O 2
OH O
HO
H N
MM 0460.01
Imp. A (EP): (RS)-1-(4-Hydroxymethylphenoxy)-3-isopropylaminopropan-2-ol

OH
(A)
100 mg
MM 0460.07
Imp. B (EP): (RS)-1-Isopropylamino-3-[4-(2propoxyethoxymethyl)phenoxy]propan-2-ol

O O
OH O
H N
(A)
100 mg
MM 0460.15
Imp. C (EP): (RS)-1-[4-[4-(2-Hydroxy3-isopropylaminopropoxy)benzyl]phenoxy]-3-isopropylaminopropan-2-ol Imp. G (EP): (2RS)-1-[4-[[(2-Isopropoxyethoxy)methoxy]methyl]phenoxy]-3-isopropylaminopropan-2-ol
H N
OH O O
OH
H N
(A)
100 mg
MM 0460.21
OH O
H N
(D)
100 mg
O
OH O OH
MM 0460.24
Imp. J (Pharmeuropa): (2RS)-3-[4-((2-Isopropoxyethoxy)methyl)phenoxy]-1,2-propanediol Imp. K (EP): 2-Isopropoxyethyl 4-[[(2RS)2-Hydroxy-3-(isopropylamino)propyl]oxy]benzoate (Bisoprolol Ester) Imp. L (EP) as Hydrochloride: 4-[[(2RS)-2-Hydroxy3-(isopropylamino)propyl]oxy]benzaldehyde Hydrochloride (4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzaldehyde Hydrochloride) Imp. M (Pharmeuropa): 4-[(2-Isopropoxyethoxy) methyl]phenol Imp. N (EP): [(2RS)-1-[4-[(2-Ethoxyethoxy)methyl]phenoxy]-3-isopropylaminopropan-2-ol Imp. Q (EP): (2RS)-1-(Isopropylamino)-3-[4-(2methoxyethoxy)methyl]phenoxypropan-2-ol Imp. R (EP): (2RS)-1-(Isopropylamino)-3-(4methylphenoxy)propan-2-ol
(A)
100 mg
O O
MM 0460.18
OH O O O O
H N
(A)
100 mg
MM 0027.24
OH O
H N x HCl
(A)
100 mg
MM 0460.02
O O
OH
(A)
100 mg
MM 0460.25
OH O O O
H N
(A)
100 mg
MM 0460.05
OH O O O
H N
(A)
100 mg
MM 0460.28
OH O
H N
(A)
50 mg
46
Edition 2012/2013
Code Product Price
OH O
Unit
MM 0460.14 MM 0460.17
Imp. S (EP): 4-Hydroxybenzaldehyde Imp. T (EP): 4-[(3-Isopropyl-2-oxo-1,3-oxazolidin-5yl)methoxy]benzaldehyde (Bisoprolol Oxazolidinonebenzaldehyde)

O O O O N
(C) (A)
100 mg 50 mg
MM 0460.16
Imp. U (EP): 5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-isopropyl-1,3-oxazolidin-2-one (Bisoprolol Oxazolidinonebenzylalcohol)

HO
O O O N
(A)
50 mg
MM 0460.27
(2RS)-4-[2-Hydroxy-3-(isopropylamino)propoxy]benzoic Acid Hydrochloride

HO O
OH O
H N x HCl
(A)
50 mg
MM 0460.03 MM 0460.06 MM 0460.10 MM 0460.23
2-[4-(2-Isopropoxyethoxymethyl)phenoxymethyl]oxirane
O O
(A) (B) (B)
100 mg 100 mg 100 mg 50 mg
4-Hydroxybenzyl Alcohol
HO
OH
Fumaric Acid (2RS)-1-[4-((2-Hydroxyethoxy)methyl)phenoxy]3-(isopropylamino)-2-propanol
O HO O OH
OH HO O O
H N
(A)
Boldenone
MM 0864.00 Boldenone
OH
(A)
100 mg
Brimonidine Tartrate
MM 1324.00 Brimonidine Tartrate
N H N N H N N Br x HO O OH OH O OH
(A)
100 mg
Bromazepam
MM 0064.00 Bromazepam [Controlled Substance]
Br N H N N O
(A)
100 mg
MM 0064.01
Imp. A (EP): (2-Amino-5-bromophenyl)(pyridin-2-yl)methanone

Br
NH2 O N
(A)
100 mg
MM 0064.02
Imp. B (EP): N-[4-Bromo-2-(pyridin-2ylcarbonyl)phenyl]-2-chloroacetamide

Br
O NH O N
Cl
(A)
50 mg
MM 0064.09
Imp. C (EP): 7-Bromo-5-(6-methylpyridin-2-yl)-1,3-dihydro-2H1,4-benzodiazepin-2-one

Br N
H N N
(A)
50 mg
MM 0064.04
Imp. D (EP): 3-Amino-6-bromo-4-(pyridin2-yl)quinolin-2(1H)-one

Br N
H N
O NH2
(A)
50 mg
Edition 2012/2013
47
Code Product Price
O NH Br N O Br
Unit
MM 0064.07
Imp. E (EP): 2-Bromo-N-[4-bromo-2-(pyridin2-ylcarbonyl)phenyl]acetamide
(A)
50 mg
Bromhexine Hydrochloride
MM 0065.00 Bromhexine Hydrochloride
Br NH 2 Br
(A)
N x HCl
500 mg
MM 0005.01
Imp. A (EP): (2-Amino-3,5-dibromophenyl)methanol
Br
OH NH2 Br
(A)
100 mg
MM 0005.02
Imp. B (EP): 2-Amino-3,5-dibromobenzaldehyde
Br
O NH2 Br
(A)
100 mg
MM 0065.02
Imp. C (EP): N-(2-Aminobenzyl)-N-methylcyclohexanamine

N NH 2
(A)
100 mg
MM 0065.03
Imp. D (EP) as Dihydrochloride: N-(2-Amino-5-bromobenzyl)-Nmethylcyclohexanamine Dihydrochloride
Br N NH2 x 2 HCl
(A)
100 mg
MM 0065.01
N-(2-Nitrobenzyl)-N-cyclohexyl-N-methylamine
N NO2
(A)
100 mg
MM 0065.05
6,8-Dibromo-3-cyclohexyl-3,4-dihydro-2(1H)-quinazolinone
Br
Br
(A)
100 mg
HN O
MM 0065.09
Bromhexine N-Oxide
Br
Br
(A)
N
100 mg
NH2
Bromisoval
MM 1128.01 Ethyl 2-Bromoisovalerate
Br O O
(A)
100 mg
Brompheniramine Maleate
MM 0060.00 Brompheniramine Maleate
N x N Br O O OH OH
(A)
500 mg
MM 0090.00
Imp. A (EP) as Maleate: Chlorphenamine Maleate

N x N Cl
O OH OH O O N x N Cl O OH OH
(A)
500 mg
MM 1114.00
Imp. B (EP) as Maleate: Dexchlorpheniramine Maleate
(A)
100 mg
MM 0059.01
Imp. C (EP): (3RS)-N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine (Pheniramine)
(A)
N N
100 mg
48
Edition 2012/2013
Code Product Price
O N x N O OH OH
Unit
MM 0059.00
Imp. C (EP) as Maleate: (3RS)-N,N-Dimethyl3-phenyl-3-(pyridin-2-yl)propan-1-amine Maleate (Pheniramine Maleate) Brompheniramine N-Oxide
(A)
100 mg
MM 0060.12
on request
N N Br
MM 0060.16
Desmethylbrompheniramine Maleate
N x N H Br
O OH OH O
(A)
100 mg
Buclizine Hydrochloride
MM 0380.04 Imp. A (BP): 1,4-Bis(4-chlorobenzhydryl)piperazine (1,4-Bis[(4-chlorophenyl)phenylmethyl]piperazine)
Cl N N Cl
(A)
100 mg
MM 0380.09
4-Chlorobenzhydrol
Cl OH
(B)
100 mg
MM 0380.10
4-Chlorobenzophenone
Cl O
(B)
100 mg
MM 0380.01
1-(4-Chlorobenzhydryl)piperazine((RS)1-[(4-Chlorophenyl)phenylmethyl]piperazine)
Cl N
NH
(A)
100 mg
Budesonide
MM 0204.01 Imp. A (EP): 11,16,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione (16-Hydroxy-prednisolone)
O O HO OH OH OH
(A)
100 mg
MM 0204.02
Imp. B (EP): 16,17-[(1RS)-Ethylidenebis(oxy)]11,21-dihydroxypregna-1,4-diene-3,20-dione
O HO O
OH
(A)
50 mg
New MM 0204.07
Imp. G (EP): 16,17-[(1RS)-Butylidenebis(oxy)]11,21-dihydroxypregn-4-ene-3,20-dione (1,2-Dihydrobudesonide)

O
O HO O
OH
(A)
50 mg
New MM 0204.12
Imp. H (EP): 16,17-[(1RS)-Butylidenebis(oxy)]21-hydroxypregna-1,4,9(11)-triene-3,20-dione
O O
OH
(A)
50 mg
New MM 0204.13
Imp. I (EP): 11,17,21-Trihydroxy-3,20-dioxopregna1,4-dien-16-yl Butanoate
O HO
OH OH O O
(A)
50 mg
Edition 2012/2013
49
Code Product Price
O HO O O Br O OH
Unit
New MM 0204.14
Imp. J (EP): 16,17-[(1RS)-Butylidenebis(oxy)]-9bromo-11,21-dihydroxypregna-1,4-diene-3,20-dione
(A)
50 mg
Bufexamac
MM 0179.00 MM 0179.01 MM 0179.02 MM 0179.03 MM 0179.04 MM 0179.05 Bufexamac
O O H N OH
(A) (A) (A) (A)
500 mg 100 mg 100 mg 100 mg 100 mg 100 mg
Imp. A (EP): 2-(4-Butoxyphenyl)acetic Acid

O O
OH
Imp. B (EP): Methyl 2-(4-Butoxyphenyl)acetate

O O O O O
Imp. C (EP): Butyl 2-(4-Butoxyphenyl)acetate Imp. D (EP): 2-(4-Butoxyphenyl)acetamide

O
NH2 O O
(A) (A)
4'-Butoxyacetophenone
O
MM 0179.06
Ethyl 2-(4-Butoxyphenyl)acetate
O O
on request
Buflomedil Hydrochloride
MM 0066.00 Buflomedil Hydrochloride
O O O N x HCl O OH O N O O O O N HO O
N
(A)
500 mg
MM 0066.01
Imp. A (EP) as Hydrochloride: 4-(Pyrrolidin-1-yl)-1(2-hydroxy-4,6-dimethoxyphenyl)butan-1-one Hydrochloride (o-Desmethyl-Buflomedil Hydrochloride) Imp. B (EP) as Hydrochloride: 4-(Pyrrolidin-1-yl)1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one Hydrochloride (p-Desmethyl-Buflomedil Hydrochloride) 4-(1-Pyrrolidino)butyronitrile 1,3,5-Trimethoxybenzene
(A)
x HCl
100 mg
MM 0066.02
(A)
x HCl
100 mg
MM 0066.03 MM 0066.05
N O
(C) (C)
O
100 mg 100 mg
Bunolol Hydrochloride
MM 0642.00 Bunolol Hydrochloride
O O OH H N
(A)
x HCl
100 mg
Buphenine Hydrochloride
MM 0710.00 Buphenine Hydrochloride
HO OH x HCl
(A)
500 mg
HN
Bupivacaine Hydrochloride
MM 0613.00 Bupivacaine Hydrochloride Monohydrate
H N O N x HCl x H2O
(A)
500 mg
MM 0368.03
Imp. A (EP): N-(2,6-Dimethylphenyl)pyridine2-carboxamide Imp. E (EP) as Hydrochloride: 6-(Butylamino)-N(2,6-dimethylphenyl)hexanamide Hydrochloride Imp. F (EP): 2,6-Dimethylaniline
H N O
H N O
(A)
N
100 mg
MM 0613.05
(A)
N H x HCl
50 mg
MM 0102.02
NH2
(B)
100 mg
50
Edition 2012/2013
Code Product Price
H N O
Unit
MM 0613.07
Bupivacaine N-Oxide
(A)
N O
100 mg
Buprenorphine
New MM 0120.00 Buprenorphine [Controlled Substance]
N OH
(A)
100 mg
HO
H O
Bupropion Hydrochloride
MM 0745.00 Bupropion Hydrochloride
O Cl H N
(A)
x HCl
100 mg
MM 0745.02
2-(tert-Butylamino)-4'-chloropropiophenone Hydrochloride
Cl
H N
(A)
x HCl
100 mg
MM 0745.03
2-(tert-Butylamino)-3'-bromopropiophenone Hydrochloride
O Br
H N
(A)
x HCl
100 mg
MM 0745.05
2-(tert-Butylamino)propiophenone Hydrochloride
H N
(A)
x HCl
100 mg
MM 0745.07
1-(3-Chlorophenyl)-1-hydroxy-2-propanone
OH Cl O
(D)
100 mg
MM 0745.08
3-Chloropropiophenone
O Cl
(B)
100 mg
New MM 0745.14
Hydroxybupropion (as (RS,RS)-cyclic Hemiketal)

Cl HO
O NH
(A)
100 mg
and Enantiomer
Buspirone Hydrochloride
MM 0464.00 Buspirone Hydrochloride
O N O N N N N x HCl
(A)
500 mg
MM 0464.02
Imp. A (EP) as Dihydrochloride: 2-(Piperazin1-yl)pyrimidine Dihydrochloride Imp. C (EP): 2,2'-[Butane1,4-diylbis(piperazine1,4-diyl)]dipyrimidine

N N N N
HN N N N x 2 HCl
(A)
100 mg
MM 0464.04
(A)
N N N N
50 mg
New MM 0464.19
Imp. E (EP) as Hydrochloride: [1-[2-Oxo-2-[[4-[4(pyrimidin-2-yl)piperazin-1-yl]butyl]amino]ethyl]cyclopentyl]acetic Acid Hydrochloride
O O OH x HCl HN N N N N
(A)
50 mg
New MM 0464.20
Imp. F (EP) as Dioxalate: 4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl [1-[2-Oxo-2-[[4-[4-(pyrimidin2-yl)piperazin-1-yl]butyl]amino]ethyl]cyclopentyl]acetate Dioxalate
O O O O x2 O OH OH
N N N N N N
(A)
N N N N N N N N
50 mg
HN
MM 0464.12
Imp. G (EP): 2,2'-(Piperazine-1,4-diyl)dipyrimidine
(A)
50 mg
Edition 2012/2013
51
Butalbital
MM 0899.00 5,5-Diallybarbituric acid (Allobarbital) [Controlled Substance]
O H N O NH O
(A)
100 mg
Butetamate Citrate
MM 0606.00 Butetamate Citrate
x O O O N O OH OH O OH OH
(A)
500 mg
Butorphanol Tartrate
New MM 1192.00 Butorphanol Tartrate
N HO x HO O HO OH OH O OH
(A)
100 mg
Butyl Parahydroxybenzoate
MM 0496.00 Butyl Parahydroxybenzoate
HO O O
(A)
500 mg
MM 0045.01

HO
O OH
(B)
100 mg
MM 0431.00
Imp. B (EP): Methyl 4-Hydroxybenzoate (Methyl Parahydroxybenzoate)

HO
O O
(A)
500 mg
MM 0498.00
Imp. C (EP): Ethyl 4-Hydroxybenzoate (Ethyl Parahydroxybenzoate)

HO
O O
(A)
500 mg
MM 0432.00
Imp. D (EP): Propyl 4-Hydroxybenzoate (Propyl Parahydroxybenzoate)

HO
O O
(A)
500 mg
MM 0496.05
Imp. E (Pharmeuropa): 2-Methylpropyl 4Hydroxybenzoate (Isobutyl Parahydroxybenzoate)

HO
O O
(A)
100 mg
Butylhydroxytoluene
MM 0679.00 Butylhydroxytoluene
OH
(A)
500 mg
Caffeine
MM 0494.00 Caffeine
N O N O N N
(A)
500 mg
MM 0176.00
Imp. A (EP): Theophylline

N O
H N N
(A)
500 mg
MM 0176.02
Imp. B (EP): N-(6-Amino-1,3-dimethyl-2,4-dioxo1,2,3,4-tetrahydropyrimidin-5-yl)formamide

O
O N N
H N NH2 O
(A)
100 mg
MM 0494.03
Imp. C (EP): 1,3,9-Trimethyl-3,9-dihydro1H-purine-2,6-dione (Isocaffeine)

O
(A)
N N
50 mg
N N
52
Edition 2012/2013
Butylhydroxytoluene
MM 0679.00 Butylhydroxytoluene
OH
(A)
500 mg
Caffeine
MM 0494.00 Caffeine
N O N
O N O N
O N N
(A)
500 mg
MM 0176.00
H N N
(A)
500 mg
MM 0176.02
Imp. B (EP): N-(6-Amino-1,3-dimethyl-2,4-dioxo1,2,3,4-tetrahydropyrimidin-5-yl)formamide

O
O N N
H N NH2 O
(A)
100 mg
MM 0494.03
Imp. C (EP): 1,3,9-Trimethyl-3,9-dihydro1H-purine-2,6-dione (Isocaffeine)

O
N N
N N
(A)
50 mg
MM 0577.00
Imp. D (EP): Theobromine

HN O
O N N N
(A)
500 mg
MM 0494.06
Imp. E (EP) as Nitrate: N,1-Dimethyl-4(methylamino)-1H-imidazole-5-carboxamide Nitrate (Caffeidine Nitrate) Imp. F (EP): 1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione (Paraxanthine; 1,7-Dimethylxanthine)
O N H HN N N x HNO3
(A)
100 mg
MM 0494.04
O N O N H
O NaO N HN O N N
(D)
N N
50 mg
New MM 0494.10
Sodium 4-[N-Methyl-N-(N-methylaminocarbonyl)amino]1-methylimidazole-5-carboxylate
(A)
50 mg
Candesartan Cilexetil
MM 0776.00 Candesartan Cilexetil
O O N N O O O O N N N NH
(A)
100 mg
MM 0776.01
Imp. A (Pharmeuropa): Ethyl 2-Ethoxy-1-[[2'-(1H-tetrazol5-yl)-4-biphenylyl]methyl]-1H-benzimidazole-7-carboxylate
O O N N O N N N NH
(A)
100 mg
MM 0776.07
Imp. H (EP): (1RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-Ethoxy-1-[[2'-[1-(triphenylmethyl)-1Htetrazol-5-yl]biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (N-Tritylcandesartan Cilexetil)
O O O N N O O O N N N N
(A)
100 mg
Edition 2012/2013
53
Code Product Price
O OH N N O N N N NH
Unit
MM 0776.09
Imp. G (EP): 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7carboxylic Acid (Candesartan)
(A)
100 mg
MM 0776.08
Trityl Candesartan
O OH N N O N N N N
(A)
100 mg
Capecitabine
MM 0992.00 Capecitabine
HN N O O OH N O O F
(A)
100 mg
OH
MM 0992.02
2,3-O-Carbonyl-5-deoxy-5-fluoroN4-(pentyloxycarbonyl)cytidine
O O O O
O HN N N O F
(A)
100 mg
Captopril
MM 0067.00 Captopril
HS O O N O N OH OH
(A)
500 mg
MM 0067.01
Imp. A (EP): 1,1'-[Disulfanediylbis-[(2S)-2-methyl1-oxopropane-3,1-diyl]]bis[(2S)-pyrrolidine-2-carboxylic] Acid (Captopril Disulfide) Imp. B (EP): (2S)-1-[(2S)-3-Bromo-2methylpropanoyl]pyrrolidine-2-carboxylic Acid Imp. C (EP): (2RS)-2-Methyl-3-sulfanylpropanoic Acid
O N HO O O S S
(A)
100 mg
New MM 0067.07
O Br
O N
OH
(A)
50 mg
MM 0067.02 MM 0067.06 MM 0067.08
O HS OH
(A) (A)
OH
100 mg 100 mg 100 mg
Imp. D (EP): (2RS)-3-Bromo-2-methylpropanoic Acid

Br
Imp. E (EP): (2S)-1-[2-Methylpropanoyl]pyrrolidine-2carboxylic Acid Imp. J (EP) as Hydrate: (2S)-1-[(2S)-3(Acetylsulfanyl)-2-methylpropanoyl]pyrrolidine-2-carboxylic Acid Hydrate Imp. K (Pharmeuropa): (2S)-3-(Acetylthio)-2methylpropanoic Acid Imp. N (EP): 3,3'-Disulfanediylbis[(2S)-2-methylpropanoic] Acid Imp. O (EP): 1,1'-[Propane-2,2-diylbis[sulfanediyl[(2S)-2-methyl-1-oxopropane3,1-diyl]]]bis[(2S)-pyrrolidine-2-carboxylic] Acid Captopril Ethyl Ester
HS O S O O N
O N
OH
(A)
MM 0067.05
OH x H2O
(A)
100 mg
MM 0067.04 MM 0067.15
O S
O OH
(C) (A)
OH
100 mg 50 mg
O HO O S S
O N
New MM 0067.16
HO
O N
O S S
OH
(A)
50 mg
MM 0067.03
O N
on request
54
Edition 2012/2013
Carbamazepine
MM 0076.00 Carbamazepine
N O NH2
(A)
250 mg
MM 0076.04
Imp. A (EP): 10,11-Dihydro-5H-dibenzo[b,f]-azepine5-carboxamide (10,11-Dihydrocarbamazepine)
O N NH2
(A)
100 mg
MM 0076.09
Imp. B (EP): 9-Methylacridine

N
(A)
100 mg
MM 0076.12
Imp. C (EP): (5H-Dibenzo[b,f]azepin-5-yl-carbonyl)urea (N-Carbamoylcarbamazepine)
O N N H
O NH2
(A)
100 mg
MM 0076.08
Imp. D (EP): 5H-Dibenzo[b,f]azepine (Iminostilbene)

NH
(B)
100 mg
MM 0076.06
Imp. E (EP): 10,11-Dihydro-5H-dibenzo[b,f]-azepine (Iminodibenzyl)
(B)
NH
100 mg
MM 0076.05
Imp. G (EP): 10-Bromo-5H-dibenzo[b,f]azepine5-carboxamide (10-Bromocarbamazepine)

Br
O N NH2
(A)
100 mg
MM 0076.01
Carbamazepine 10,11-Epoxide
N O
O NH2
(A)
100 mg
MM 0076.10
10-Hydroxy-10,11-dihydrocarbamazepine
N
O NH2
(A)
100 mg
HO
MM 0076.17
Oxcarbazepine
N
O NH2
(A)
100 mg
Carbasalate Calcium
MM 0133.02 Imp. A (EP): 2-(Acetyloxy)benzoic Anhydride (Acetylsalicylic Anhydride)
O O O O O O O
(A)
100 mg
MM 0133.01
Imp. B (EP): 2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid (Acetylsalicylsalicylic Acid)

O
O OH O O O
(A)
100 mg
MM 0045.00
Imp. C (EP): Salicylic Acid
O OH OH
(A)
500 mg
Edition 2012/2013
55
Code Product Price
O OH O O OH
Unit
MM 0133.03
Imp. D (EP): 2-[(2-Hydroxybenzoyl)oxy]benzoic Acid (Salicylsalicylic Acid)
(A)
100 mg
Carbendazim
MM 2500.00 Carbendazim
H N N O O NH
(A)
100 mg
MM 2500.01 MM 2500.02
2,3-Diaminophenazine 2-Amino-3-hydroxyphenazine
N N N N
NH2 NH2 NH2 OH
(A) (A)
100 mg 100 mg
Carbenicillin Sodium
MM 0805.00 Carbenicillin Sodium
O O N H O ONa N S H O ONa
(A)
250 mg
Carbocisteine
MM 0236.00 Carbocisteine
O HO O S NH2 O HO O S O O NH S O OH OH NH2 OH
(A)
500 mg
MM 0236.01
(S)-Carboxymethyl-L-cysteine (R/S)-Sulphoxide Lactam of (S)-Carboxymethyl-L-cysteine
(A)
100 mg
MM 0236.02
(A)
100 mg
MM 0236.03
L-Cysteinesulfinic Acid
O HO S O OH NH2
(C)
100 mg
Carisoprodol
MM 0782.03 Imp. C (EP): 2-Methyl-2-propylpropane-1,3-diol
HO OH
(A)
100 mg
Carvedilol
MM 0291.00 Carvedilol
OH O H N
(A)
O O
100 mg
HN
MM 0291.02
Imp. B (EP): 1,1'-[[2-(2-Methoxyphenoxy)ethyl]nitrilo]bis[3-(9H-carbazol-4-yloxy)propan-2-ol]

OH O N
(A)
OH O O O HN NH
100 mg
MM 0291.03
Imp. C (EP): (2RS)-1-[Benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy)propan-2-ol

O
(A)
OH N O O HN
100 mg
MM 0291.04
Toluene
(C)
100 mg
56
Edition 2012/2013
Code Product Price
O O
Unit
MM 0291.10
4-(2,3-Epoxypropoxy)carbazole
(A)
100 mg
HN
MM 0291.11
2-(2-Methoxyphenoxy)ethylamine Hydrochloride
H2N
O O x HCl
(A)
100 mg
Cefaclor
MM 0326.00 Cefaclor Monohydrate
O NH 2 H N N H S O OH Cl x H2O
(A)
100 mg
MM 0253.12
Imp. A (EP): (2R)-2-Amino-2-phenylacetic Acid (D-Phenylglycine) Imp. F (EP): 3-Phenylpyrazin-2-ol

N N
NH 2 OH O
(B)
100 mg
MM 0253.08
OH
(A)
100 mg
Cefadroxil Monohydrate
MM 0232.09 Imp. A (EP): (2R)-2-Amino-2-(4-hydroxyphenyl)acetic Acid
HO NH2 OH O
(B)
100 mg
MM 0811.01
Imp. B (EP): (6R,7R)-7-Amino-3-methyl-8-oxo5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-ADCA; 7-Aminodesacetoxycephalosporanic Acid)
O O N H2N H S
OH
(A)
100 mg
Cefalexin Monohydrate
MM 0605.00 Cefalexin Monohydrate
NH2 H N O O O N H S OH x H2O
(A)
500 mg
MM 0253.12
Imp. A (EP): (2R)-2-Amino-2-phenylacetic Acid (D-Phenylglycine) Imp. B (EP): (6R,7R)-7-Amino-3-methyl-8-oxo-5-thia1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-Aminodesacetoxycephalosporanic Acid; 7-ADCA)
NH 2 OH O
(B)
100 mg
MM 0811.01
O O N H 2N H S
OH
(A)
100 mg
Cefazolin Sodium
MM 0238.00 Cefazolin Sodium
O H N O N H S S S N N O ONa
(A)
100 mg
N N
N N
MM 0238.05
Imp. E (EP): 5-Methyl-1,3,4-thiadiazol-2-thiol (MMTD)

S
SH N N
(A)
100 mg
MM 0238.08
Imp. H (EP): (6R,7R)-3-[(Acetyloxy)methyl]-7-amino-8-oxo5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-ACA)
O O N H2N H S
OH O
(A)
100 mg
Cefetamet
MM 0811.01 7-Aminodesacetoxycephalosporanic Acid
O N H 2N H S O OH
(A)
100 mg
Edition 2012/2013
57
Cefoperazone Sodium
MM 0853.03 Imp. C (EP): 1-Methyl-1H-tetrazole-5-thiol
N SH N
(A)
100 mg
N N
MM 0238.08
Imp. E (EP): (6R,7R)-3-[(Acetyloxy)methyl]-7-amino-8-oxo5-thia-1-azabicyclo-[4.2.0]oct-2-ene-2-carboxylic Acid (7-ACA)
O O N H2N H S
OH O
(A)
100 mg
Cefradine
MM 0811.01 Imp. A (EP): (6R,7R)-7-Amino-3-methyl-8-oxo-5-thia1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-Aminodeacetoxycephalosporanic Acid, 7-ADCA)
O O N H2N H S OH
(A)
100 mg
Celecoxib
MM 0344.00 Celecoxib
O O S NH2 N N F F F
(D)
100 mg
MM 0344.02
4-[5-[4-(Hydroxymethyl)phenyl]-3-(trifluoromethyl)1H-pyrazol-1-yl]-benzenesulfonamide
HO O O S NH2 N N F F F
O O O S NH2 N N F F F
(D)
100 mg
MM 0344.03
4-[1-[4-(Aminosulfonyl)phenyl]-3-(trifluoromethyl)1H-pyrazol-5-yl]benzoic Acid
HO
(D)
100 mg
Celiprolol Hydrochloride
MM 0128.00 Celiprolol Hydrochloride
O N N H O O OH H N x HCl
(A)
100 mg
MM 0128.01
Imp. A (EP): 1-[5-Amino-2-[(2RS)3-[(1,1-dimethylethyl)amino]2-hydroxypropoxy]phenyl]ethanone

H2N
O O
OH
H N
(A)
100 mg
MM 0128.03
Imp. C (EP): 1-[3-Acetyl-4-[(2RS)3-[(1,1-dimethylethyl)amino]2-hydroxypropoxy]phenyl]-3-(1,1-dimethylethyl)urea

N H
O O N H
O O N N H O
OH O
H N
(A)
100 mg
MM 0128.10
Imp. D (EP):3-[3-Acetyl-4-[(RS)-3-(diethylamino)2-hydroxypropoxy]phenyl]-1,1-diethylurea
OH N
(D)
100 mg
MM 0128.05
Imp. E (EP): 1,1'-[[(1,1-Dimethylethyl)imino]bis[(2-hydroxypropane-1,3-diyl)oxy(3-acetyl1,4-phenylene)]]bis(3,3-diethylurea)
O O HN O N
OH N
OH O
(D)
50 mg
NH N O
58
Edition 2012/2013
Code Product Price
O O N N H OH
Unit
MM 0128.07
Imp. F (EP): 3-(3-Acetyl-4-hydroxyphenyl)1,1-diethylurea
(A)
100 mg
MM 0128.06
Imp. G (EP): 3-[3-Acetyl-4-[[(RS)-oxiranyl]methoxy] phenyl]-1,1-diethylurea

N
O O N H O O N N H O O O
(A)
100 mg
MM 0128.04
Imp. H (EP): 3-[3-Acetyl-4-[(2RS)-3-bromo2-hydroxypropoxy]phenyl]-1,1-diethylurea (Bromhydrin Compound)
OH Br
(A)
100 mg
MM 0128.11
3-Acetyl-4-hydroxyaniline Hydrochloride
O OH x HCl H2N
(A)
100 mg
MM 0128.58
5-Acetamido-2-hydroxyacetophenone
O N H
O OH
(A)
100 mg
Cethexonium Bromide
MM 0501.01 rac-trans-2-Dimethylaminocyclohexanol Hydrochloride
N OH x HCl
(A)
100 mg
and enantiomer
Cetirizine Dihydrochloride
MM 0380.00 Cetirizine Dihydrochloride
O Cl N x 2 HCl N O OH
(A)
100 mg
MM 0380.01
Imp. A (EP): (RS)-1-[(4-Chlorophenyl)phenylmethyl] piperazine

N Cl NH
N N O x 2 HCl OH
(A)
100 mg
MM 0380.02
Imp. B (EP) as Dihydrochloride: (RS)2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]acetic Acid Dihydrochloride Imp. C (EP) as Dihydrochloride: (RS)-2-[2-[4-[(2-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic Acid Dihydrochloride
Cl
(A)
100 mg
MM 0380.03
O N N Cl x 2 HCl O OH
(A)
100 mg
MM 0380.04
Imp. D (EP): 1,4-Bis[(4-chlorophenyl)phenylmethyl]piperazine

Cl N N Cl
(A)
100 mg
MM 0380.05
Imp. E (EP) as Dihydrochloride: (RS)2-[2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]ethoxy]acetic Acid Dihydrochloride (Ethoxycetirizine Dihydrochloride) Imp. F (EP) as Dihydrochloride: [2-[4-[Diphenylmethyl]piperazin-1-yl]ethoxy] acetic Acid Dihydrochloride
Cl N
O O x 2 HCl
OH
(D)
100 mg
MM 0380.06
O N N x 2 HCl O OH
(A)
100 mg
Edition 2012/2013
59
Code Product Price
Cl N x 2 HCl N OH
Unit
MM 0380.11
Imp. G (EP) as Dihydrochloride: 2-[4-[(RS)(4-Chlorophenyl)phenylmethyl]piperazin-1-yl] ethanol Dihydrochloride Isopropyl Ester of Cetirizine
(A)
100 mg
MM 0380.08
O Cl N N O O
(A)
100 mg
MM 0380.09
4-Chlorobenzhydrol
OH Cl
(B)
100 mg
MM 0380.10
4-Chlorobenzophenone
O Cl
(B)
100 mg
MM 0380.13
Cetirizine N-Oxide
Cl N
O N
O O OH
(A)
100 mg
MM 0380.15
Ethyl Ester of Cetirizine Dihydrochloride
O Cl N x 2 HCl N O O
(A)
100 mg
MM 0380.16
Methyl Ester of Cetirizine Dihydrochloride
O Cl N x 2 HCl N O O
(A)
100 mg
MM 0380.17
3-Chlorocetirizine Dihydrochloride ((RS)2-[2-[4-[(3-Chlorophenyl)phenylmethyl]piperazin1-yl]ethoxy]acetic Acid Dihydrochloride)
O N Cl N x 2 HCl O OH
(A)
100 mg
Chlorambucil
MM 0821.00 Chlorambucil
Cl N O OH
(A)
500 mg
Cl
Chloramphenicol
MM 0516.00 Chloramphenicol
Cl Cl O N H OH NO2
(A)
500 mg
OH OH NO2
MM 0516.01
(D)-(-)-threo-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
H2N
(A)
100 mg
OH
Chlordiazepoxide Hydrochloride
New MM 0028.08 Chlordiazepoxide [Controlled Substance]
Cl N N O H N
(A)
100 mg
60
Edition 2012/2013
Code Product Price
H N Cl N O O
Unit
MM 0028.02
Imp. A (EP): 7-Chloro-5-phenyl-1,3-dihydro2H-1,4-benzodiazepin-2-one 4-Oxide (Demoxepam)
(A)
100 mg
MM 0028.04
Imp. B (EP): 6-Chloro-2-(chloromethyl)-4-phenylquinazoline 3-Oxide
N Cl N O
Cl
(A)
100 mg
MM 0028.03
Imp. C (EP): (2-Amino-5-chlorophenyl)phenyl-methanone (Aminochlorobenzophenone)
NH2 Cl O
(B)
100 mg
Chlorhexidine Diacetate
MM 0162.00 Chlorhexidine Diacetate
H N Cl H N NH H N NH x2 O OH NH N H N H NH N H Cl
(A)
500 mg
MM 0162.05 MM 0162.07
4-Chloroaniline
Cl
NH2
(B) (A)
100 mg 100 mg
(4-Chlorophenyl)urea
Cl
H N O H N Cl NH2 NH
NH2
MM 0162.08
(4-Chlorophenyl)guanidine Hydrochloride
(C)
x HCl
50 mg
Chlorhexidine Dihydrochloride
MM 0946.00 Chlorhexidine Dihydrochloride
Cl Cl N H H N H N NH NH N H H N NH x 2 HCl NH N H
(A)
500 mg
Chlormezanone
MM 0017.00 Chlormezanone
O S O N O Cl
(A)
250 mg
MM 0017.02
2-(4-Chlorophenyl)-3-methylperhydro-1,3-thiazin-4-one
S N O
Cl
on request
MM 0017.03
4-Chlorobenzaldehyde
O Cl H
(B)
100 mg
Chlorobutanol Hemihydrate
MM 0535.00 Chlorobutanol Hemihydrate
OH Cl Cl x H2O
(A)
500 mg
Cl
Chlorocresol
MM 0459.00 Chlorocresol
Cl OH
(A)
500 mg
Edition 2012/2013
61
Chlorphenamine Maleate
MM 0090.00 Chlorphenamine Maleate
Cl O x N O OH OH
(A)
500 mg
MM 0090.03
Imp. A (EP) as Dihydrochloride: 2-(4-Chlorophenyl)4-(dimethylamino)-2-[2-(dimethylamino)ethyl]butanenitrile Dihydrochloride
Cl N
(D)
x 2 HCl N
100 mg
MM 0090.04 MM 0090.13
Imp. B (EP): N-(Pyridin-2-yl)pyridin-2-amine (2,2'-Dipyridylamine) Imp. C (EP) as Maleate: (3RS)-3-(4-Chloro-phenyl)-Nmethyl-3-(pyridin-2-yl)propan-1-amine Maleate

N Cl
H N N
(A) (A)
OH OH O
100 mg 100 mg
O x NH
MM 0090.05
Imp. D (EP) as Maleate: (2RS)-2-(4-Chloro-phenyl)-4(dimethylamino)-2-(pyridin-2-yl)butanenitrile Maleate
Cl O N x N N O OH OH
(D)
100 mg
MM 0090.11
Chlorphenamine N-Oxide Dihydrochloride
Cl
(A)
x 2 HCl
100 mg
Chlorphenoxamine Hydrochloride
MM 1291.00 Chlorphenoxamine Hydrochloride
O Cl N x HCl
(A)
100 mg
Chlorpromazine Hydrochloride
MM 0420.00 Chlorpromazine Hydrochloride
N S Cl N x HCl
(A)
500 mg
MM 0420.01
Imp. A (EP): 3-(2-Chloro-10H-phenothiazin10-yl)-N,N-dimethylpropan-1-amine S-Oxide (Chlorpromazine Sulfoxide)
(A)
N O S Cl N
100 mg
MM 0420.06
Imp. B (EP) as Dihydrochloride: N-[3-(2-Chloro10H-phenothiazin-10-yl)propyl]-N,N',N'-trimethylpropane-1,3-diamine Dihydrochloride
(A)
N S x 2 HCl Cl N N
100 mg
MM 0290.00
Imp. C (EP) as Hydrochloride: 3-(10H-Phenothiazin10-yl)-N,N-dimethylpropan-1-amine Hydrochloride (Promazine Hydrochloride) Imp. D (EP) as Hydrochloride: 3-(2-Chloro-10Hphenothiazin-10-yl)-N-methylpropan-1-amine Hydrochloride (Desmethylchlorpromazine Hydrochloride)
(A)
N S N x HCl
500 mg
MM 0420.07
(A)
N S Cl NH x HCl
100 mg
62
Edition 2012/2013
MM 0420.04
Imp. E (EP): 2-Chloro-10H-phenothiazine

NH S Cl
(A)
100 mg
MM 0420.02
Chlorpromazine Sulphoxide N-Oxide Maleate

N O S Cl N O x
O OH OH O
(B)
10 mg
Chlorprothixene Hydrochloride
MM 1321.01 Imp. A (EP): (RS)-2-Chloro-9-[3-(dimethylamino)propyl]-9H-thioxanthen-9-ol
S Cl OH N
(A)
100 mg
MM 1321.07
Imp. B (EP) as Hydrochloride: N,N-Dimethyl-3(9H-thioxanthen-9-ylidene)propan-1-amine Hydrochloride

S
(A)
N x HCl
50 mg
MM 1321.05
Imp. E (EP): 2-Chloro-9H-thioxanthen-9-one

O S Cl
(A)
100 mg
Chlorquinaldol
MM 0390.00 Chlorquinaldol
OH Cl N
(A)
500 mg
Cl
Chlortalidone
MM 0297.00 Chlortalidone
O H2N S Cl O HO HN O
(A)
250 mg
Chlortetracycline Hydrochloride
MM 0607.00 Chlortetracycline Hydrochloride
OH O H Cl OH O H Cl OH O H HO OH O OH H N OH O OH H N OH O OH H N O NH2 OH x HCl O NH2 OH x HCl O NH2 OH x HCl
(A)
500 mg
MM 0636.00
Imp. B (EP) as Hydrochloride: Demeclocycline Hydrochloride
OH
(A)
250 mg
MM 0452.00
Tetracycline Hydrochloride
OH
(A)
500 mg
Cholecalciferol
MM 0249.02 Imp. B (EP): Cholesta-5,7-dien-3-ol (7,8-Didehydrocholesterol; Provitamin D3) (A) 100 mg
HO
Ciclopirox Olamine
MM 0418.00 Ciclopirox Olamine
OH N O x H2N OH
(A)
250 mg
Edition 2012/2013
63
Code Product Price
H N
Unit
MM 0418.03
Imp. C (EP): 6-Cyclohexyl-4-methylpyridin-2(1H)-one
(A)
O
50 mg
Cimetidine Hydrochloride
MM 0020.00 Cimetidine
HN N S N H N N S N H N N S N H
NH2 N S N H N H x 2 HCl
N N N H
(A)
500 mg
MM 0020.08
Imp. A (EP): 3-Cyano-2-methyl-1-[2[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]isothiourea Imp. B (EP): 3-Cyano-2-methyl-1-[2-[[(5-methyl1H-imidazol-4-yl)methyl]sulphanyl]ethyl]isourea
(A)
100 mg
HN
N S
MM 0020.12
(A)
100 mg
HN
N O
MM 0020.03
Imp. C (EP) as Dihydrochloride: 1-[(Methylamino)[[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]amino]methylene]urea Dihydrochloride (Cimetidine Amide Dihydrochloride) Imp. D (EP) as Dihydrochloride:1-Methyl3-[2-[[(5-methyl-1H-imidazol4-yl)methyl]sulphanyl]ethyl]guanidine Dihydrochloride Imp. E (EP): 2-Cyano-1-methyl-3-[2-[[(5-methyl1H-imidazol-4-yl)methyl]sulphinyl]ethyl]guanidine (Cimetidine Sulphoxide) Imp. G (EP): 2-Cyano-1,3-dimethylguanidine
O HN N
(A)
100 mg
MM 0020.06
HN
N S N H
NH N H x 2 HCl
(A)
100 mg
MM 0020.04
N N HN O S N H
N N N H N H
(A)
100 mg
N N H
MM 0020.15
(A)
100 mg
MM 0020.07
Imp. H (EP): 1,1'-(Disulphanediyldiethylene)bis (2-cyano-3-methylguanidine)

N H
N N N H S S
(A)
H N N N H N
100 mg
MM 0020.50 MM 0020.10 MM 0056.01
Imp. J (EP) as Dihydrobromide: 2-[[(5-Methyl-1Himidazol-4-yl)methyl]sulphanyl]ethanamine Dihydrobromide 1,1-Dimethyl-3-cyanoguanidine Cyanoguanidine
HN
N S NH2 x 2 HBr
(A) (A)
100 mg 100 mg 100 mg
H N NH N
H2 N
H N NH N
(B)
Cinchocaine Hydrochloride
MM 0604.00 Cinchocaine Hydrochloride
O N O N H N x HCl
(A)
500 mg
MM 0604.02
Imp. B (EP): 2-Hydroxyquinoline-4-carboxylic Acid
O HO N OH
(A)
100 mg
New MM 0604.03
Imp. C (EP): N-[2-(Diethylamino)ethyl]-2hydroxyquinoline-4-carboxamide
O HO N N H N
(A)
50 mg
64
Edition 2012/2013
Code Product Price
O O N N H N O
Unit
MM 0604.05
Cinchocaine N-Oxide
(A)
100 mg
Cinnarizine
MM 1038.01 Imp. A (EP): 1-(Diphenylmethyl)piperazine
N NH
(A)
100 mg
MM 1038.03
Imp. B (EP): (Z)-1-(Diphenylmethyl)-4(3-phenylprop-2-enyl)piperazine

N N
(A)
100 mg
MM 1038.04
Imp. C (EP): (4-(Diphenylmethyl)-1,1-bis[(E)3-phenylprop-2-enyl]piperazinium Chloride
N+ N Cl-
(A)
100 mg
MM 1038.06
Imp. E (EP): 1,4-Bis(diphenylmethyl)piperazine

N N
(A)
100 mg
Ciprofloxacin Hydrochloride
MM 0018.06 Ciprofloxacin Hydrochloride Monohydrate
HN N F O O N OH x HCl x H2O
(A)
500 mg
MM 0018.01
Imp. A (EP): 7-Chloro-1-cyclopropyl-6-fluoro-4-oxo1,4-dihydroquinoline-3-carboxylic Acid (Fluoroquinolonic Acid) Imp. B (EP): 1-Cyclopropyl-4-oxo-7-(piperazin-1-yl)1,4-dihydroquinoline-3-carboxylic Acid (Desfluoro Compound) Imp. C (EP): 7-(2-Aminoethylamino)-1-cyclopropyl-6fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (Ethylenediamine Compound) Imp. D (EP): 7-Chloro-1-cyclopropyl-4-oxo-6(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid
(A)
Cl F O O N OH
100 mg
MM 0018.05
HN N N OH O O
(A)
100 mg
MM 0018.04
H2 N
H N F
(D)
N OH O O
50 mg
MM 0018.02
(D)
Cl N HN O
HN N F O N
50 mg
N OH O
MM 0018.03
Imp. E (EP): 1-Cyclopropyl-6-fluoro-7-(piperazin-1-yl)quinolin-4(1H)-one (Decarboxylated Compound)
(A)
100 mg
MM 0018.10
6-(2-Aminoethylamino)-7-chloro-1-cyclopropyl-4-oxo1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride

H2N
(D)
Cl N H N OH O O x HCl
100 mg
Edition 2012/2013
65
Citalopram Hydrobromide
MM 0242.00 Citalopram Hydrobromide
F x HBr
(A)
250 mg
N O N
MM 0242.14
Imp. A (EP): (1RS)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide (CitalopramAmide)

H2N O
(A)
100 mg
N O
MM 0242.17
Imp. C (EP): (3RS)-6-Cyano-3-[3-(dimethylamino)propyl]-3-(4-fluorophenyl)isobenzofuran-1(3H)-one
(A)
100 mg
N O N O
MM 0242.09
Imp. D (EP) as Hydrochloride: (1RS)-1-(4-Fluorophenyl)1-[3-(methylamino)propyl]-1,3-dihydroisobenzofuran5-carbonitrile Hydrochloride (Desmethylcitalopram Hydrochloride)

N
F x HCl N H
(A)
100 mg
MM 0242.12
Imp. E (EP) as Oxalate: 3-[(1RS)-5-Chloro1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]N,N-dimethylpropan-1-amine Oxalate
F HO x N O Cl HO O O
(A)
50 mg
MM 0242.13
Imp. F (EP) as Hydrogen Oxalate: 3-[(1R)-5-Bromo1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]N,N-dimethylpropan-1-amine Hydrogen Oxalate
F x
HO HO N O
O O
(A)
100 mg
Br
Citric Acid Anhydrous

MM 0988.00 Citric Acid Anhydrous
HO O O HO OH O OH
(A)
250 mg
Citric Acid Monohydrate

MM 0575.00 Citric Acid Monohydrate
HO O O HO OH O OH x H 2O
(A)
500 mg
Clarithromycin
MM 0057.05 Imp. E (EP): 6,11-Di-O-methylerythromycin A
O OO OH N OH OO O O OH O O O
(D)
100 mg
Clindamycin Hydrochloride
MM 0259.00 Clindamycin Hydrochloride
N H N O HO OH S OH Cl
(A)
x HCl
100 mg
66
Edition 2012/2013
Clioquinol
MM 0312.00 Clioquinol
OH I N
(A)
500 mg
Cl
MM 0312.01
Imp. A (EP): 5-Chloroquinolin-8-ol
OH N
(B)
100 mg
Cl
MM 0312.02
Imp. B (EP): 5,7-Dichloroquinolin-8-ol
OH Cl N
(B)
100 mg
Cl
MM 0312.03
Imp. C (EP): 5,7-Diiodoquinolin-8-ol
OH I N
(B)
100 mg
Clobenzorex Hydrochloride
MM 0649.00 Clobenzorex Hydrochloride
H N Cl
(A)
x HCl
500 mg
Clobetasol Propionate
MM 0769.00 Clobetasol Propionate
HO O O Cl O
(A)
100 mg
F O
MM 0200.01
Imp. G (EP): 21-Chloro-9-fluoro-11,17-dihydroxy-16methylpregna-1,4-diene-3,20-dione (Clobetasol)
O HO
Cl
(A)
100 mg
OH
F O
MM 0202.04
Imp. K (EP):9-Fluoro-11,17-dihydroxy16-methyl-3,20-dioxopregna-1,4-dien21-yl Propanoate (Betamethasone 21-Propionate)

O
O O HO O
(A)
100 mg
OH
Clobutinol Hydrochloride
MM 0038.00 Clobutinol Hydrochloride
OH Cl N
on request
x HCl
MM 0038.01
1-Dimethylamino-2-methylbutan-3-one
O
(A)
100 mg
Clomifene Citrate
MM 0650.00 Clomifene Citrate
O Cl and Z-Isomer N x O OH OH O OH OH O
(A)
250 mg
MM 0650.01
Clomifene N-Oxide Hydrochloride

O Cl and Z-Isomer x HCl N O
(A)
100 mg
Edition 2012/2013
67
MM 0650.03
Desethylclomifene Hydrochloride
O Cl and Z-Isomer x HCl N H
(A)
100 mg
Clomipramine Hydrochloride
MM 0545.00 Clomipramine Hydrochloride
Cl
(A)
N N x HCl
500 mg
MM 0545.01
Imp. A (EP) as Dihydrochloride: N-[3-(3Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin5-yl)propyl]-N,N',N'-trimethylpropane-1,3diamine Dihydrochloride
Cl
on request
N N N
x 2 HCl
MM 0077.00
Imp. B (EP) as Hydrochloride: Imipramine Hydrochloride
(A)
N N x HCl
500 mg
MM 0545.03
Imp. C (EP) as Hydrochloride: 3-(3-Chloro-5Hdibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine Hydrochloride
Cl
(C)
N N x HCl
10 mg
MM 0545.04
Imp. D (EP) as Hydrochloride: 3-(3,7-Dichloro10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine Hydrochloride
Cl
(A)
N N x HCl
10 mg
Cl
MM 0076.06
Imp. E (EP): 10,11-Dihydro-5H-dibenzo[b,f]-azepine (Iminodibenzyl)
(B)
NH
100 mg
MM 0545.06
Imp. F (EP): 3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
Cl
(A)
NH
100 mg
MM 0545.07
Imp. G (EP): 3-Chloro-5-(prop-2-enyl)-10,11-dihydro-5Hdibenzo[b,f]azepine
Cl
(C)
N
50 mg
MM 0545.08
Desmethylclomipramine Hydrochloride
Cl
(A)
N N H x HCl
100 mg
MM 0545.09
Clomipramine N-Oxide
Cl
on request
N N
68
Edition 2012/2013
Code Product Price
Cl
Unit
MM 0545.13
3-Chloro-10-[3(dimethylamino)propyl]-9-acridanone
(A)
N N
100 mg
Clonazepam
New MM 0945.00 Clonazepam [Controlled Substance]
O 2N H N N Cl O
(A)
100 mg
MM 0945.01
Imp. A (EP): (2-Amino-5-nitrophenyl)(2chlorophenyl)methanone
NH2 O2 N O Cl
(A)
100 mg
MM 0945.02
Imp. B (EP): 3-Amino-4-(2-chlorophenyl)-6nitroquinolin-2(1H)-one

O2 N
H N
O NH2 Cl
(A)
50 mg
MM 0945.04
Methylclonazepam
O2 N
N N
(A)
50 mg
Cl
MM 0945.05
2-Bromo-2'-(2-chlorobenzoyl)-4'-nitroacetanilide
O2 N
O NH O
Br
(A)
50 mg
Cl
Clonidine Hydrochloride
MM 0983.00 Clonidine Hydrochloride
Cl Cl HN N N H
HN O O N
(A)
x HCl
100 mg
MM 0983.04
Imp. A (EP): 1-Acetylimidazolidin-2-one
(A)
100 mg
MM 0983.03
Imp. B (EP): 1-Acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole

Cl
Cl N H
N N O
(A)
50 mg
MM 0006.21
Imp. C (EP): 2,6-Dichloroaniline
Cl NH2 Cl
(B)
100 mg
MM 0983.02
1-(2,6-Dichlorophenyl)thiourea
Cl
Cl N H
S NH2
(A)
100 mg
Clopidogrel Hydrogen Sulphate

MM 0455.10 Clopidogrel Hydrogen Sulphate
Cl N S O O x H2SO4
(A)
100 mg
MM 0455.09
Clopidogrel Alcohol
Cl N S OH
(D)
100 mg
Edition 2012/2013
69
MM 0455.13
Imp. B (EP) as Racemate Hydrogen Sulfate: Methyl (2RS)-(2-Chlorophenyl)[4,7-dihydrothieno[2,3-c]pyridin-6(5H)-yl]acetate Hydrogen
(A)
Cl S N O O x H2SO4
100 mg
MM 0455.12
Imp. C (EP) as Hydrogen Sulfate: Methyl (2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetate Hydrogen Sulfate

S
(A)
Cl N O O x H2SO4
100 mg
Clotrimazole
MM 0015.00 Clotrimazole
Cl
(A)
N N
500 mg
MM 0015.01
Imp. A (EP): (2-Chlorophenyl)diphenylmethanol

Cl OH
(A)
100 mg
MM 0015.10
Imp. B (EP): 1-[(4-Chlorophenyl)diphenylmethyl]1H-imidazole
Cl
(A)
100 mg
N N
MM 0015.03
Imp. C (EP): 1-Chloro-2-(chlorodiphenylmethyl)benzene

Cl Cl
H N N
(A)
100 mg
MM 0015.02 MM 0015.06
Imp. D (EP): Imidazole Imp. E (EP): (2-Chlorophenyl)phenylmethanone (2-Chlorobenzophenone)

Cl O
(B) (A)
100 mg 100 mg
MM 0015.11
Imp. F (EP): 1-(Triphenylmethyl)-1H-imidazole (Deschloroclotrimazole)

N N
(A)
100 mg
MM 0015.04
(2-Chlorophenyl)diphenylmethane
Cl
(A)
100 mg
MM 0015.05
(2-Chlorophenyl)diphenylmethyl Ethyl Ether
(A)
100 mg
Cl
MM 0015.07
(2-Chlorophenyl)phenyldichloromethane
Cl Cl Cl
(A)
100 mg
MM 0015.08
(2-Chlorophenyl)trichlormethane
Cl Cl Cl Cl
(A)
100 mg
MM 0015.09
1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole
(C)
50 mg
Cl
Cloxacillin Sodium
MM 0682.00 Cloxacillin Sodium Monohydrate
Cl O N O O H N N S H x H2O O ONa
(A)
500 mg
70
Edition 2012/2013
Code Product Price
O O N H2N S H
Cl N
Unit
MM 0026.04
Imp. C (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid (6-Aminopenicillanic Acid) Imp. D (EP): 3-(2-Chlorophenyl)-5-methylisoxazole-4carboxylic Acid
OH
(B)
100 mg
MM 0682.04
(A)
OH
100 mg
O O
Cloxiquine
MM 0391.00 Cloxiquine
OH N
(A)
500 mg
Cl
Clozapine
MM 0480.00 Clozapine
Cl N HN N N
(A)
100 mg
MM 0480.01
Imp. A (EP): 8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4] diazepin-11-one
Cl
H N HN
(A)
100 mg
MM 0480.03
Imp. C (EP): 8-Chloro-11-(piperazin-1-yl)-5Hdibenzo[b,e][1,4]diazepine
Cl N HN N
NH
(A)
100 mg
Cocaine Hydrochloride
New MM 1345.00 Cocaine Hydrochloride [Controlled Substance]
N O O O O x HCl
(A)
100 mg
New MM 1345.04
Benzoylecgonine [Controlled Substance]
O OH O O
(A)
100 mg
Codeine
MM 0442.00 Codeine Phosphate Hemihydrate [Controlled Substance]
O O N x H3 PO 4 x H2 O OH N x H2 O O O OH N
(A)
100 mg
MM 0004.00
Codeine Monohydrate [Controlled Substance]
(A)
100 mg
MM 0004.03
Imp. A (EP): 7,8-Didehydro-4,5-epoxy-3,6-dimethoxy17-methylmorphinan (O-Methylcodeine) [Controlled Substance]

O O
(A)
100 mg
MM 0037.00

HO O
N x HCl x 3 H2O OH
(A)
250 mg
MM 0280.00
Imp. B (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate [Controlled Substance]

HO O
N x H 2SO 4x 5 H2O
(A)
250 mg
OH 2
Edition 2012/2013
71
Code Product Price
N HO O O
Unit
MM 0037.02
Imp. C (EP): 7,7',8,8'-Tetradehydro-4,5:4',5'-diepoxy3,3'-dimethoxy-17,17'-dimethyl-2,2'-bimorphinanyl-6,6'diol (Codeine Dimer; Dimethyl Pseudomorphine)
(A)
100 mg
O N
OH
MM 0004.01
Codeine N-Oxide [Controlled Substance]
O N
(A)
250 mg
O N
OH
MM 0004.02
Codeinone
(A)
100 mg
O N
MM 0004.04
Codeimethine
O HN
(C)
50 mg
OH
MM 0004.05
Norcodeine [Controlled Substance]
(A)
100 mg
O N
OH
MM 0004.06
Acetylcodeine [Controlled Substance]
(A)
100 mg
O O
MM 0004.08
Isocodeine [Controlled Substance]
(A)
100 mg
O N
OH
MM 0037.01
Pseudomorphine
HO O OH
(A)
100 mg
HO N
OH
Colchicine
MM 1083.00 Colchicine
O NH O O O O O
(A)
100 mg
MM 1083.04
Imp. D (EP): N-[(7S,12aRa)-3-(-D-Glucopyranosyloxy)-1,2,10-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide (Colchicoside)
HO O OH HO OH O NH O O O O O
(A)
100 mg
New MM 1083.06
Imp. F (EP): N-[(7S,12aRa)-10-Hydroxy-1,2,3trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a] heptalen-7-yl]acetamide (Colchiceine)
O NH O O OH O O
(A)
50 mg
Cortisone
MM 0214.00 Cortisone
O O OH OH
(A)
500 mg
72
Edition 2012/2013
Cortisone Acetate
MM 0186.00 Cortisone Acetate
O O OH O O
(A)
500 mg
MM 0187.00
Imp. A (EP): Hydrocortisone Acetate

HO
O OH O
(A)
500 mg
Cyclizine Hydrochloride
MM 1265.01 MM 0490.02 Imp. A (EP): 1-Methylpiperazine
HN N
(A) (B)
100 mg 100 mg
Imp. B (EP): Diphenylmethanol (Benzhydrol)

OH
Cyclobenzaprine Hydrochloride
MM 0062.02 Cyclobenzaprine Hydrochloride
N x HCl
(A)
100 mg
Cyclopentolate Hydrochloride
MM 0580.00 Cyclopentolate Hydrochloride
HO O O N x HCl
(A)
500 mg
MM 0580.01
Imp. A (EP): (2RS)-(1-Hydroxycyclopentyl)(phenyl) acetic Acid

HO
O OH
(A)
100 mg
MM 0160.03 MM 0580.03
Imp. B (EP): Phenylacetic Acid [Drug Precursor] Imp. C (EP) as Hydrochloride: 2-(Dimethylamino)ethyl Phenylacetate Hydrochloride
O O N
O OH
x HCl
(B) (A)
100 mg 100 mg
Cynarine
MM 0048.01 3,4-Dihydroxycinnamic Acid (Caffeic Acid)
O HO HO OH
(B)
100 mg
Cyproheptadine Hydrochloride
MM 0609.00 Cyproheptadine Hydrochloride Sesquihydrate
N x HCl x 1 /2 H2O
1
(A)
500 mg
MM 0609.01
Imp. A (EP): 5H-Dibenzo[a,d][7]annulene (Dibenzocycloheptene)
(A)
50 mg
MM 0062.01
Imp. B (EP): 10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-one (Dibenzosuberone)
(B)
O
100 mg
MM 0609.07
Imp. C (EP) as Hydrochloride: 5-(1-Methylpiperidin-4-yl)-5H-dibenzo[a,d][7]annulen-5ol Hydrochloride
OH
N x HCl
(A)
50 mg
Edition 2012/2013
73
MM 0609.02
5H-Dibenzo[a,d]cyclohepten-5-one (Dibenzosuberenone)
(C)
O
100 mg
MM 0609.04
Demethylcyproheptadine Hydrochloride
NH x HCl
(A)
100 mg
MM 0609.05
Cyproheptadine -N-Oxide
O N
(A)
100 mg
MM 0609.06
Cyproheptadine -N-Oxide
O N
(A)
100 mg
Cyproterone Acetate
MM 0215.00 Cyproterone Acetate
O O O O Cl
(A)
250 mg
Dacarbazine
MM 1289.00 Dacarbazine
N HN N N N O NH2
(A)
50 mg
MM 1289.02
Imp. B (EP): 5-Amino-1H-imidazole-4-carboxamide
HN H2N
N NH2 O
(A)
100 mg
MM 0056.06
Imp. D (EP) as Hydrochloride: N-Methylmethanamine Hydrochloride
H N
x HCl
(C)
100 mg
DDT
MM 2513.01 2,2-Bis(4-chlorophenyl)-1-chloroethane
Cl
(A)
100 mg
Cl
Cl
MM 2513.02
1-Chloro-3-[1-(4-chlorophenyl)ethyl]benzene
Cl Cl
(A)
100 mg
MM 2513.05
1,1-Bis(4-chlorophenyl)ethane
Cl Cl
(A)
100 mg
Delorazepam
New MM 1371.00 Delorazepam [Controlled Substance]
Cl H N N Cl O
(A)
100 mg
Dembrexine Hydrochloride Monohydrate

MM 1200.03 Imp. C (EP): 3,5-Dibromo-2-hydroxybenzaldehyde
Br O OH Br
O OH
(A)
100 mg
MM 1200.04
Imp. D (EP): 2-Hydroxybenzaldehyde (Salicylaldehyde)
(A)
100 mg
74
Edition 2012/2013
Code Product Price
Br OH Br Br
Unit
MM 1200.05
Imp. E (EP): 2,4,6-Tribromophenol
(A)
100 mg
Demeclocycline Hydrochloride
MM 0636.00 Demeclocycline Hydrochloride
OH O H Cl OH OH O OH H N O NH2 OH x HCl
(A)
250 mg
Desipramine Hydrochloride
MM 0589.00 Desipramine Hydrochloride
N N H x HCl
(A)
250 mg
MM 0077.00
Imipramine Hydrochloride
N N x HCl
(A)
500 mg
MM 0076.06
Iminodibenzyl
NH
(B)
100 mg
Dexamethasone
MM 0213.00 Dexamethasone
HO O OH OH
(A)
250 mg
F O
MM 0200.00
Imp. B (EP): Betamethasone

HO
O OH OH
(A)
250 mg
F O
MM 0213.01
Imp. C (EP): 9--Fluoro-11,17,21trihydroxy-16-methylpregn-4-ene-3,20-dione
O HO OH OH
(D)
50 mg
F O
MM 0445.00
Imp. G (EP): Dexamethasone Acetate

HO
O OH O
(A)
250 mg
F O
Dexamethasone Acetate
MM 0445.00 Dexamethasone Acetate
HO O OH O O
(A)
250 mg
F O
MM 0213.00
Imp. A (EP): 9-Fluoro-11,17,21-trihydroxy16-methylpregna-1,4-diene-3,20-dione (Dexamethasone)

O
O HO OH OH
(A)
250 mg
MM 0201.00
Imp. D (EP): 9-Fluoro-11,17-dihydroxy-16methyl-3,20-dioxopregna-1,4-dien-21-yl Acetate (Betamethasone Acetate)

O
O HO OH O
(A)
250 mg
Edition 2012/2013
75
Dexamethasone Sodium Phosphate

MM 0210.00 Dexamethasone Sodium Phosphate
HO O OH O O P ONa ONa
(A)
250 mg
F O
MM 0213.00
Imp. A (EP): 9-Fluoro-11,17,21-trihydroxy-
O HO OH OH
16-methylpregna-1,4-diene-3,20-dione (Dexamethasone)
(A)
250 mg
F O
MM 0303.00
Imp. B (EP) as Sodium Salt: 9-Fluoro-11,17dihydroxy-16-methyl-3,20-dioxopregna-1,4dien-21-yl Dihydrogen Phosphate Disodium Salt (Betamethasone Sodium Phosphate)
O
O HO OH
O O P
ONa ONa
(A)
250 mg
Dexchlorpheniramine Maleate
MM 1114.00 Dexchlorpheniramine Maleate
Cl O x N N O OH OH
(A)
100 mg
MM 0059.00
Imp. A (EP) as Maleate: (3RS)-N,N-Dimethyl-3phenyl-3-(pyridin-2-yl)propan-1-amine Maleate (Pheniramine Maleate)
O x N O OH OH
(A)
100 mg
Dexpanthenol
New MM 1352.04 D,L-Pantolactone
O HO O
(A)
100 mg
MM 1352.05
Calcium (D,L)-Pantoate (Calcium (RS)-2,4-Dihydroxy3,3-dimethylbutyrate)
O HO OH OCa2+ 2
(A)
50 mg
Dextroamphetamine Sulfate
New MM 1359.00 Dextroamphetamine Sulfate [Controlled Substance]
N O O O O x HCl
(A)
100 mg
Dextromethorphan Hydrobromide
MM 0033.00 Dextromethorphan Hydrobromide Monohydrate
N x HBr x H2 O O
(A)
500 mg
MM 0033.10
Imp. A (EP) as Hydrochloride: ent-3-Methoxymorphinan Hydrochloride

O
HN x HCl
(A)
100 mg
MM 0033.09
Imp. B (EP) as (L)-Tartrate: ent-17-Methylmorphinan-3-ol (L)-Tartrate

HO
N
x
(A)
OH HO O OH O OH
100 mg
MM 0033.02
Imp. C (EP): ent-3-Methoxy-17-methylmorphinan-10-one
(D)
100 mg
76
Edition 2012/2013
Code Product Price
O N x HCl
Unit
MM 0033.11
Dextromethorphan N-Oxide Hydrochloride
(A)
100 mg
Dextropropoxyphene Hydrochloride
MM 0098.01 Dextropropoxyphene Hydrochloride [Controlled Substance]
N O O x HCl
(A)
50 mg
MM 0098.00
Dextropropoxyphene [Controlled Substance]
N O O
(A)
50 mg
MM 0098.06
Imp. A (EP): (2S,3R)-4-(Dimethylamino)-1,2-diphenyl3-methylbutan-2-ol
(A)
100 mg
OH
MM 0098.07
Imp. B (EP) as Hydrochloride: (1S,2R)-1-Benzyl3-(dimethylamino)-2-methyl-1-phenylpropyl Acetate Hydrochloride (Acetoxyphene Hydrochloride)
N O O x HCl
(A)
100 mg
MM 0098.08
Imp. C: (EP) as Hydrochloride: (1S,2R)-1-Benzyl3-(dimethylamino)-2-methyl-1-phenyl-propyl Butanoate Hydrochloride (Butyroxyphene Hydrochloride)
N O O x HCl
(A)
50 mg
MM 0291.04 MM 0098.11
Toluene Imp. F (EP) as Hydrochloride: (2RS)-3-(Dimethylamino)-2-methyl-1-phenylpropan-1-one Hydrochloride
(C) (A)
N O x HCl
100 mg 50 mg
Diazepam
MM 0023.00 Diazepam [Controlled Substance]
Cl N N O
(A)
100 mg
MM 0023.02
Imp. A (EP): 7-Chloro-5-phenyl-1,3-dihydro-2H1,4-benzodiazepin-2-one (Nordazepam) [Controlled Substance]
H N Cl N
(A)
100 mg
MM 0023.04
Imp. B (EP): 2-Chloro-N-(4-chloro-2-benzoylphenyl)-Nmethylacetamide

Cl
O N O
Cl
(A)
100 mg
MM 0023.03
Imp. C (EP): 3-Amino-6-chloro-1-methyl-4-phenylquinolin2(1H)-one

Cl
O NH2
(A)
100 mg
Edition 2012/2013
77
Code Product Price
NH Cl O
Unit
MM 0023.01
Imp. D (EP): [5-Chloro-2-(methylamino)phenyl]phenylmethanone (5-Chloro-2-(methylamino)benzophenone)
(B)
100 mg
MM 0023.05
2'-Benzoyl-2,4'-dichloroacetanilide
O NH Cl O
Cl
(A)
100 mg
Dibutyl Sebacate
MM 0925.00 Dibutyl Sebacate
O O
(A)
500 mg
Dichlorobenzyl Alcohol
MM 0739.01 Bis-(2,4-dichlorobenzyl)Ether
Cl Cl O Cl Cl
(A)
100 mg
Diclofenac Sodium
MM 0006.00 Diclofenac Sodium
O ONa
(A)
500 mg
NH Cl Cl
MM 0006.01
Imp. A (EP): 1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one

N Cl
O Cl
(A)
100 mg
MM 0006.03
Imp. B (EP): 2-[(2,6-Dichlorophenyl)amino]benzaldehyde

Cl
O NH Cl
(A)
100 mg
MM 0006.04
Imp. C (EP): [2-[(2,6-Dichlorophenyl)amino]phenyl]methanol

Cl
OH NH Cl
(A)
100 mg
MM 0006.09
Imp. D (EP): 2-[2-[(2-Bromo-6-chlorophenyl)amino]phenyl]acetic Acid

O NH Br
OH
(D)
100 mg
Cl
MM 0006.05
Imp. D (EP) as Sodium Salt: Sodium 2-[2-[(2-Bromo6-chlorophenyl)amino]phenyl]acetate

Br
ONa O NH Cl
(D)
100 mg
MM 0006.02 MM 0006.06
Imp. E (EP): 1,3-Dihydro-2H-indol-2-one

N H
(B) (C)
100 mg 10 mg
1-(2-Bromo-6-chlorophenyl)indolin-2-one
N Br
O Cl
MM 0006.10
Methyl 2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Methyl Ester of Diclofenac)

Cl
O O NH Cl
(A)
100 mg
MM 0006.11
Ethyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Ethyl Ester of Diclofenac)

Cl
O O NH Cl
(A)
100 mg
78
Edition 2012/2013
Code Product Price
O O NH Cl Cl
Unit
MM 0181.06
Isopropyl 2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Isopropyl Ester of Diclofenac)
(A)
100 mg
MM 0006.12
2-(2,6-Dichlorophenylamino)benzoic Acid
Cl
O OH NH Cl
(A)
100 mg
MM 0006.15
2,6-Dichlorodiphenylamine
NH Cl Cl
(A)
100 mg
MM 0006.16
2-Bromo-6-chlorodiphenylamine
NH Br Cl
(A)
100 mg
MM 0006.17
1-(2,6-Dichlorophenyl)indolin-2,3-dione
Cl
O O N Cl
(A)
100 mg
MM 0006.18
Diclofenac Potassium
O NH Cl
OK
(A)
100 mg
Cl
MM 0006.19
2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide
Cl
Cl N O Cl
(A)
100 mg
MM 0006.20
2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid (Diclofenac)

Cl
OH O NH Cl
(A)
100 mg
MM 0006.21
2,6-Dichloroaniline
NH2 Cl Cl
(B)
100 mg
MM 0006.22
2-Bromo-6-chloroaniline
NH2 Br Cl
on request
MM 0006.27
N-Acetyl-N-phenyl-2,6-dichloroaniline
N Cl
(A)
Cl
100 mg
MM 0006.28
Diethyl Phthalate
O O O O
(C)
100 mg
Dicloxacillin Sodium
MM 0026.04 Imp. C (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid)
O O H2 N N H S OH
(B)
100 mg
Diflucortolone Valerate
MM 0600.00 Diflucortolone Valerate
HO O O O
(A)
100 mg
F O F
Edition 2012/2013
79
Digitoxin
MM 0336.01 Digitoxigenin
O O
(A)
50 mg
OH HO
Digoxin
MM 0212.00 Digoxin
OH O O
(A)
250 mg
OH OO OO OH OO OH HO OH H
Dihydrocodeine Hydrogen Tartrate

MM 0812.07 Dihydrocodeine Hydrochloride [Controlled Substance]
O N x HCl
(A)
100 mg
OH OH O OH O OH
New MM 0812.00
Dihydrocodeine Hydrogen Tartrate [Controlled Substance]

O
N x HO
(A)
100 mg
OH
MM 0004.00
Imp. A (EP) as Monohydrate: Codeine Monohydrate [Controlled Substance]

O O N
N x H2O
(A)
100 mg
OH
MM 0442.00
Imp. A (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O O
(A)
x H3PO4 x 1/2 H2O
100 mg
OH
N x H2SO4 x 5 H2O
MM 0280.00

HO O
(A)
250 mg
OH
N
MM 0037.00

HO O
(A)
x HCl x 3 H2O
250 mg
OH
Diltiazem Hydrochloride
MM 0068.00 Diltiazem Hydrochloride
S O N O O x HCl O
(A)
500 mg
MM 0068.02
Imp. B (EP): (2S,3S)-2-(4-Methoxyphenyl)-4-oxo2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl Acetate

S O N H O
(A)
100 mg
80
Edition 2012/2013
Code Product Price
O
Unit
MM 0068.03
Imp. D (EP) as Hydrochloride: (2S,3S)-2-(4-Methoxyphenyl)5-[2-(methylamino)ethyl]-4-oxo-2,3,4,5-tetrahydro1,5-benzothiazepin-3-yl Acetate Hydrochloride (N-Desmethyldiltiazem Hydrochloride)
(A)
x HCl
100 mg
S O N O O
HN
MM 0068.04
Imp. E (EP):(2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)2,3-dihydro-1,5-benzothiazepin-4(5H)-one
S OH N H O
(A)
100 mg
MM 0068.05
Imp. F (EP):(2S,3S)-5-[2-(Dimethylamino)ethyl]-3hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5benzothiazepin-4(5H)-one
(A)
100 mg
S OH N O
MM 0068.07
Diltiazem Sulphoxide
O S O N
(A)
100 mg
O O
MM 0068.08
Diltiazem Maleate
S O N
O O x O OH OH
(A)
100 mg
O O
Dimenhydrinate
MM 0599.00 Dimenhydrinate
O N x O N N O H N Cl N
(A)
500 mg
MM 0176.00

N O
O H N N N
(A)
500 mg
MM 0599.04
Dimenhydrinate Imp. B (Pharmeuropa): 8-[(2-(Diphenylmethoxy)-ethyl)(methlyl)amino]1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
O N O N H N N N O
(A)
100 mg
MM 0494.00
Imp. C (EP): Caffeine

N O
O N N N
(A)
500 mg
MM 0599.08
Imp. E (EP): 8-Chloro-1,3,7-trimethyl-3,7dihydro-1H-purine-2,6-dione (8-Chlorocaffeine) Imp. F (EP) as Hydrochloride: 2-(Diphenylmethoxy)-N-methylethanamine Hydrochloride (Diphenhydramine Imp. A Hydrochloride; Nordiphenhydramine Hydrochloride) Imp. G (EP) as Hydrochloride: N,N-Dimethyl-2-[(4-methylphenyl)(phenyl)methoxy]ethanamine Hydrochloride (4-Methyldiphenhydramine Hydrochloride)
O N O N N Cl N
(A)
50 mg
MM 0490.03
(A)
O H N x HCl
100 mg
MM 0490.04
(A)
x HCl O N
100 mg
Edition 2012/2013
81
MM 0640.00
Imp. H (EP) as Hydrochloride: 2-[(RS)-(4Bromophenyl)(phenyl)methoxy]-N,N-dimethylethanamine Hydrochloride (4-Bromodiphenhydramine Hydrochloride; Bromazine Hydrochloride) Imp. I (EP): Diphenylmethanol (Benzhydrol)
(A)
O Br N x HCl
100 mg
MM 0490.02
(B)
OH
100 mg
MM 0630.01
Imp. J (EP): Diphenylmethanone (Benzophenone)

O
(B)
100 mg
MM 0599.14
Imp. K (EP): [Oxybis(methanetriyl)]tetrabenzene (Bis(diphenylmethyl) Ether)

O
(A)
50 mg
MM 0490.00
Diphenhydramine Hydrochloride
O N x HCl
(A)
500 mg
MM 0155.02
8-Chlorotheophylline
N O
H N Cl N
(B)
100 mg
MM 0599.03
8-[N-(2-Diphenylmethoxyethyl)-N,Ndimethylaminium]-1,3-dimethylxanthine inner salt
O N O N NN N O
+
(A)
100 mg
Dimetindene Maleate
MM 0595.01 MM 0595.02 Imp. A (EP): 2-Ethylpyridine Imp. B (EP) as Hydrochloride: 2-(1H-Inden2-yl)-N,N-dimethylethanamine Hydrochloride Imp. D (EP) as Hydrochloride: (2RS)-2-Benzyl4-(dimethylamino)butanoic Acid Hydrochloride
HO O N
N
(B) (A)
100 mg 50 mg
x HCl
New MM 0595.04
(A)
x HCl
50 mg
MM 0595.10
Imp. E (EP) as Hydrochloride: (2RS)-2-[2-(Dimethylamino)ethyl]indan-1-one Hydrochloride

O
(A)
x HCl N
50 mg
MM 0595.06
Imp. F (EP) as Hydrochloride: 2-(3-Butyl-1Hinden-2-yl)-N,N-dimethylethanamine Hydrochloride Imp. G (EP) as Hydrochloride: N,N-Dimethyl2-(3-phenyl-1H-inden-2-yl)ethanamine Hydrochloride
(A)
N x HCl
50 mg
MM 0595.07
(A)
N x HCl
50 mg
New MM 0595.11
Imp. I (EP) as Maleate: N-Methyl-2-[3-[(1RS)1-( yridine-2-yl)ethyl]-1H-inden-2-yl]ethanamine Maleate
O N H x O OH OH
(A)
50 mg
82
Edition 2012/2013
Diphemanil Metilsulfate
MM 1163.00 Diphemanil Metilsulfate
N+ x O O -O S O
(D)
100 mg
Diphenhydramine Hydrochloride
MM 0490.00 Diphenhydramine Hydrochloride
O N x HCl
(A)
500 mg
MM 0490.03
Imp. A (EP) as Hydrochloride: 2-(Diphenylmethoxy)-Nmethylethanamine Hydrochloride (Nordiphenhydramine Hydrochloride)
(A)
O H N x HCl
100 mg
MM 0490.04
Imp. B (EP) as Hydrochloride: 2-[(RS)(4-Methylphenyl)phenylmethoxy]-N,Ndimethylethanamine Hydrochloride (4-Methyldiphenhydramine Hydrochloride) Imp. C (EP) as Hydrochloride: 2-[(RS)(4-Bromophenyl)phenylmethoxy]-N,Ndimethylethanamine Hydrochloride (Bromazine Hydrochloride)
Br
(A)
O N x HCl
100 mg
MM 0640.00
(A)
O N x HCl
100 mg
MM 0490.02
Imp. D (EP): Diphenylmethanol (Benzhydrol)

OH
(B)
100 mg
MM 0630.01
Imp. E (EP): Diphenylmethanone (Benzophenone)

O
(B)
100 mg
MM 0490.01
Diphenhydramine N-Oxide
O N O
(A)
100 mg
Diphenylpyraline Hydrochloride
MM 0557.00 Diphenylpyraline Hydrochloride
O N x HCl
(A)
500 mg
MM 0155.01
Diphenylpyraline
O N
(A)
100 mg
MM 0490.02
Diphenylmethanol (Benzhydrol)
OH
(B)
100 mg
MM 0630.01
Diphenylmethanone (Benzophenone)
O
(B)
100 mg
MM 0557.04
Diphenylpyraline N-Oxide
O N O
(A)
100 mg
Edition 2012/2013
83
MM 0468.04
N-Desmethyldiphenylpyraline Hydrochloride (4-(Diphenylmethoxy)piperidine Hydrochloride)

O
(A)
NH x HCl
100 mg
Dipipanone Hydrochloride
MM 0760.01 1,1-Diphenylbut-1-ene (A) 100 mg
MM 0760.02
1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride
x HCl N
(A)
100 mg
Dipotassium Clorazepate
MM 0028.03 Imp. A (EP): (2-Amino-5-chlorophenyl)phenylmethanone (Aminochlorobenzophenone)
NH 2 Cl O
(B)
100 mg
MM 0023.02
Imp. B (EP): 7-Chloro-5-phenyl-1,3-dihydro-2H1,4-benzodiazepin-2-one (Nordazepam) [Controlled Substance]
H N Cl N
(A)
100 mg
Diprafenon Hydrochloride
MM 0428.01 2'-Hydroxy-3-phenylpropiophenone
O
(A)
100 mg
OH
Diprenorphine
New MM 1384.00 Diprenorphine
N
(D)
50 mg
OH HO O O
Diprophylline
MM 0176.01 Imp. A (EP): N-Methyl-5-(methylamino)-1Himidazole-4-carboxamide (Theophyllidine)
O N H HN H N N
(A)
100 mg
MM 0176.00
Imp. B (EP): 1,3-Dimethyl-3,7-dihydro-1Hpurine-2,6-dione (Theophylline)

O
O N N H N N
(A)
500 mg
MM 0603.00
Imp. C (EP): 7-(2-Hydroxyethyl)-1,3-dimethyl3,7-dihydro-1H-purine-2,6-dione (Etofylline)

O
O N N N N OH
(A)
500 mg
Dipyridamole
MM 0462.03 Imp. C (EP): 2,2'-[[6-Chloro-4,8-di(piperidin-1yl)pyrimido[5,4-d]pyrimidin-2-yl]nitrilo]diethanol
N Cl N N OH N N N N OH
(A)
100 mg
84
Edition 2012/2013
Disopyramide
MM 0108.00 Disopyramide
N N NH2 O
(A)
500 mg
New MM 0108.03
Imp. B (EP) as Dihydrogen Phosphate: (3RS)N,N-Bis(1-methylethyl)-3-phenyl-3-(pyridin-2yl)propan-1-amine Dihydrogen Phosphate

N
(A)
N x H3PO4
50 mg
Dithranol
MM 0137.00 Dithranol
OH O OH
(A)
500 mg
MM 0137.04
Imp. A (EP): Anthracen-9(10H)-one (Anthrone)
(A)
100 mg
MM 0137.01
Imp. B (EP): 1,8-Dihydroxyanthracene-9,10-dione (Danthron)
OH
OH
(A)
100 mg
MM 0137.02
Imp. C (EP): 4,4',5,5'-Tetrahydroxy-9,9'-bianthracenyl10,10'(9H,9'H)-dione (Dithranol Dimer)
OH
OH
(A)
100 mg
OH
OH
Dobutamine Hydrochloride
MM 0384.00 MM 0675.02 Imp. A (EP) as Hydrochloride: Dopamine Hydrochloride Imp. B (EP): 4-(4-Hydroxyphenyl)butan-2-one
O HO HO OH NH2 x HCl
(A) (C)
500 mg 100 mg
Dodecylguanidinium Acetate
MM 0451.03 MM 0451.05 Dodecylnitrile Dimethyldodecylamine
N N
(B) (B)
100 mg 100 mg
Domperidone
MM 0107.00 Domperidone
HN O N N N O NH
(D)
100 mg
Cl
MM 0107.06
Imp. A (EP): 5-Chloro-1-(piperidin-4-yl)1,3-dihydro-2H-benzimidazol-2-one
O HN N NH
(A)
100 mg
Cl
MM 0107.05
Imp. B (EP): 4-(5-Chloro-2-oxo-2,3-dihydro1H-benzimidazol-1-yl)-1-formylpiperidine
O N N
O NH
(A)
100 mg
Cl
MM 0107.03
Imp. F (EP): 1,3-Bis[3-[4-(5-chloro-2-oxo2,3-dihydro-1H-benzimidazol-1-yl)piperidin1-yl]propyl]-1,3-dihydro-2H-benzimidazol2-one
O HN N N N
O N N N
O NH
(A)
50 mg
Cl
Cl
Edition 2012/2013
85
Code Product Price
H N O N H
Unit
MM 0107.07
1,3-Dihydro-2H-benzimidazol-2-one
(B)
100 mg
Donepezil Hydrochloride
MM 0677.00 Donepezil Hydrochloride
N O O O x HCl
(D)
100 mg
MM 0677.01
Donepezil
N O O O
(D)
100 mg
MM 0677.02
2,3-Dihydro-5,6-dimethoxy-2-[(4-piperidinyl)methyl]indan-1-one Hydrochloride
NH O O O x HCl
(A)
100 mg
MM 0677.16
1-Benzyl-4-[(5,6-dimethoxy-1H-inden2-yl)methyl]piperidine
O O
(A)
N
50 mg
New MM 0677.14
Donepezil N-Oxide
O O O
O N
(A)
50 mg
New MM 0677.08
5,6-Dimethoxy-2-[(4-pyridyl)methyl]indan-1-one
O O
N O
(A)
100 mg
New MM 0677.09
1,1-Dibenzyl-4-[(5,6-dimethoxy-1oxo-2,3-dihydro1H-inden-2-yl)methyl]piperidinium Bromide
N+ O O O
Br-
(A)
50 mg
Dopamine Hydrochloride
MM 0384.00 MM 0384.02 Dopamine Hydrochloride Imp. A (EP) as Hydrochloride: 5-(2-Aminoethyl)2-methoxyphenol Hydrochloride (4-O-Methyldopamine Hydrochloride) Imp. C (EP): 2-(3,4-Dimethoxyphenyl)ethanamine (R,S)--Methyldopamine Hydrobromide
HO HO HO HO HO O NH2 x HCl NH2 x HCl
(A) (A)
500 mg 100 mg
MM 0384.04 MM 0384.01
O O
NH2
NH2
(A) (A)
100 mg 100 mg
x HBr
Dorzolamide Hydrochloride
MM 0403.00 Dorzolamide Hydrochloride
O H2N HN O S S O O S x HCl
(A)
50 mg
Dosulepin Hydrochloride
MM 0510.00 Dosulepin Hydrochloride
N x HCl S
(A)
100 mg
86
Edition 2012/2013
MM 0510.02
Imp. B (EP): Dibenzo[b,e]thiepin-11(6H)-one

O S
(A)
100 mg
MM 0510.08
Nordosulepin Hydrochloride
N H x HCl S
(A)
50 mg
Doxazosin Mesilate
MM 0386.00 Doxazosin Mesilate
N O O N N NH2 x N O S
O N O O N N NH2 N O O
O O O O OH
(A)
100 mg
MM 0386.08
Doxazosin
(A)
100 mg
MM 0386.04
Imp. A (EP): (2RS)-2,3-Dihydro-1,4-benzodioxine-2carboxylic Acid
O HO O O
(A)
100 mg
MM 0386.05
Imp. B (EP) as Hydrochloride: 1-[(2RS)-2,3-Dihydro1,4-benzodioxin-2-ylcarbonyl]piperazine Hydrochloride

HN
O N O O x HCl
(A)
100 mg
MM 0386.06
Imp. C (EP): 1,4-Bis(2,3-dihydro-1,4-benzodioxin2-ylcarbonyl)piperazine

O
O O N O N O O
(A)
100 mg
MM 0085.07
Imp. D (EP): 6,7-Dimethoxyquinazoline-2,4(1H,3H)-dione
O O
H N
O NH
(C)
100 mg
MM 0085.06
Imp. E (EP): 2,4-Dichloro-6,7-dimethoxyquinazoline
O O
N N Cl
Cl
(A)
100 mg
MM 0386.01
Imp. F (EP): 2-Chloro-6,7-dimethoxyquinazolin-4-amine
O O
N N NH2
Cl
(A)
100 mg
MM 0386.12
Imp. F (EP) as Mesilate: 2-Chloro-6,7-dimethoxyquinazolin-4-amine Mesilate Imp. G (EP): 6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin4-amine
O O
N N NH2
Cl x O S O OH
(A)
100 mg
MM 0085.01
NH O O N N NH2 N
(A)
100 mg
MM 0085.03
Imp. H (EP): 2,2'-(Piperazine1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)

N O O N N NH2 N
NH2 N N O O
(D)
100 mg
Edition 2012/2013
87
Doxepin Hydrochloride
MM 0032.00 Doxepin Hydrochloride
N x HCl O
(A)
500 mg
MM 0032.03
Imp. A (EP): Dibenzo[b,e]oxepin-11(6H)-one (Doxepinone)

O
(A)
O
100 mg
MM 0032.04
Imp. B (EP): (11RS)-11-[3-(Dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin11-ol (Doxepinol)

O
N OH
(A)
50 mg
MM 0032.08
Imp. C (EP) as E/Z-Mixture: (E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine ((E,Z)-Desmethyldoxepin)

O
NH
(A)
50 mg
Doxycycline Hyclate
New MM 0276.00 Doxycycline Hyclate
OH O H OH O OH H OH N O NH2 OH
(A)
100 mg
x HCl x 1/2 C2H5OH x 1/2 H2O
Doxylamine Hydrogen Succinate

MM 0101.00 Doxylamine Hydrogen Succinate
N O N x O O OH OH
(A)
500 mg
MM 0101.02
Imp. B (EP) as Hydrochloride: (1RS)-1-Phenyl1-(pyridin-2-yl)ethanol Hydrochloride

N OH
(A)
x HCl
50 mg
MM 0101.03
Imp. C (EP) as Hydrogen Fumarate: N,NDimethyl-2-[(RS)-1-phenyl(pyridin-2-yl)methoxy]ethanamine Hydrogen Fumarate Imp. D (EP): Phenyl(pyridin-2-yl)methanone (2-Benzoylpyridine)
O x OH HO O
(A)
50 mg
MM 0101.04
(A)
N O
100 mg
MM 0101.05
Doxylamine N-Oxide Dihydrochloride

N O N O x 2 HCl
(A)
100 mg
MM 0101.08
N-Desmethyldoxylamine Hydrogen Succinate

N O H N x
O OH OH O
(A)
50 mg
Drofenine Hydrochloride
MM 0768.00 Drofenine Hydrochloride
O O x HCl N
(A)
500 mg
88
Edition 2012/2013
MM 0768.01
Drofenine N-Oxide Hydrochloride

O O x HCl N O
(A)
100 mg
Droperidol
MM 0138.01 Imp. A (EP): 1-(1,2,3,6-Tetrahydropyridin4-yl)-1,3-dihydro-2H-benzimidazol-2-one
HN N O NH
(A)
50 mg
New MM 0138.03
Imp. C (EP): 1-[4-(4-Fluorophenyl)-4-oxobutyl]-4-(2-oxo-2,3-dihydro-1H-benzimidazol1-yl)pyridinium Chloride
ClN O
+
(A)
50 mg
N O NH
MM 0138.04
Imp. D (EP) as Hydrochloride: (1RS)1-[4-(4-Fluorophenyl)-4-oxobutyl]4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)1,2,3,6-tetrahydro-pyridine 1-Oxide Hydrochloride
F O N O O N NH x HCl
(A)
100 mg
Dropropizine
MM 1017.00 Dropropizine
N N OH OH
(A)
500 mg
Duloxetine Hydrochloride
MM 1122.00 Duloxetine Hydrochloride
S O N H x HCl
(A)
100 mg
MM 0043.04
Imp. D (EP): Naphthalen-1-ol (1-Naphthol)

OH
(B)
100 mg
Dydrogesterone
New MM 0328.02 Imp. B (EP): Pregna-4,6-diene-3,20-dione (6-Progesterone)
O
(A)
100 mg
Ebastine
MM 0468.00 Ebastine
N O O
(A)
100 mg
MM 0490.02
Imp. A (EP): Diphenylmethanol (Benzhydrol)

OH
(B)
100 mg
MM 0468.03
Imp. B (EP): 1-[4-(1,1-Dimethylethyl)phenyl]ethanone
(A)
100 mg
MM 0468.04
Imp. C (EP) as Hydrochloride: 4-(Diphenylmethoxy)piperidine Hydrochloride

O
(A)
NH x HCl
100 mg
MM 0468.05
Imp. D (EP): 1-[4-(1,1-Dimethylethyl)phenyl]4-(4-hydroxypiperidin-1-yl)butan-1-one

N HO O
(A)
100 mg
Edition 2012/2013
89
MM 0468.06
Imp. E (EP) as Hydrogen Fumarate: 1-[4-(1,1-Dimethylpropyl)phenyl]4-[4-(diphenylmethoxy)piperidin1-yl]butan-1-one Hydrogen Fumarate
(A)
N O x HO O O OH O
100 mg
Econazole Nitrate
MM 0524.00 Econazole Nitrate
Cl O Cl N N Cl
(A)
x HNO3
500 mg
MM 0281.01
Imp. A (EP): (1RS)-1-(2,4-Dichlorophenyl)-2(1H-imidazol-1-yl)ethanol

Cl HO
Cl
(A)
100 mg
N N
MM 0524.02
Imp. B (EP) as Nitrate: (2RS)-2-[(4-Chlorobenzyl)oxy]2-(2,4-dichlorophenyl)ethanamine Nitrate

Cl O Cl
Cl
(D)
100 mg
x HNO3 NH2
Cl
MM 0524.03
Imp. C (EP) as Chloride: 1-(4-Chlorobenzyl)3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4dichlorophenyl)ethyl]imidazolium Chloride
(A)
100 mg
Cl O Cl N+ N Cl-
Cl
Emedastine Difumarate
MM 1277.02 Imp. B (EP): 2-Chloro-1-(2-ethoxyethyl)-1HBenzimidazole
O
(A)
N N Cl
100 mg
Enalapril Maleate
MM 0010.00 Enalapril Maleate
H N O O O O N O OH x O OH OH
(A)
100 mg
MM 0010.05
Imp. B (EP): (2S)-2-[[(1S)-1-(Ethoxycarbonyl)3-phenylpropyl]amino]propanoic Acid

O
H N O
O OH
(A)
100 mg
MM 0010.01
Imp. C (EP): (2S)-1-[(2S)-2-[[(1S)-1-Carboxy3-phenylpropyl]amino]propanoyl]pyrrolidine-2carboxylic Acid (Enalaprilat)

HO
H N O
O N
OH
(D)
100 mg
MM 0010.06
Imp. D (EP): Ethyl (2S)-2-[(3S,8aS)-3-Methyl-1,4-dioxooctahydropyrrolo[1,2-]pyrazin-2-yl]-4-phenylbutanoate (Enalapril diketopiperazine)

O
H O N O N O
(A)
100 mg
MM 0015.02
Imp. I (EP): 1H-Imidazole (Imidazole)
H N N
(B)
100 mg
90
Edition 2012/2013
Code Product Price
H N O O O O x HCl
Unit
MM 0010.15
(2S)-2[[(1S)-1-(Ethoxycarbonyl)3-phenylpropyl]amino]propanoic Acid Ethyl Ester Hydrochloride
(A)
100 mg
Enilconazole
MM 0281.01 Imp. E (EP): (1RS)-1-(2,4-Dichlorophenyl)-2(1H-imidazol-1-yl)ethanol
Cl HO N N Cl
(A)
100 mg
Enrofloxacin
MM 0395.00 Enrofloxacin
N N F O O N OH
(A)
100 mg
MM 0018.01
Imp. A (EP): 7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline3-carboxylic Acid
(A)
Cl F O O N OH
100 mg
MM 0018.06
Imp. B (EP) as Hydrochloride Monohydrate: Ciprofloxacin Hydrochloride Monohydrate
HN N F O O N OH x HCl x H 2O
(A)
500 mg
MM 0395.01
Imp. C (EP) as Hydrochloride: 1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-4oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride (Desfluoroenrofloxacin Hydrochloride) Imp. G (EP): 7-[(2-Aminoethyl)amino]-1cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline3-carboxylic Acid Enrofloxacin N-Oxide Hydrochloride
N N N OH O
H2N HN F O O N OH
(A)
x HCl
100 mg
MM 0018.04
(D)
50 mg
MM 0395.07
O N N F O O N OH x HCl
(A)
100 mg
Entacapone
MM 1221.02 Imp. A (EP): (2Z)-2-Cyano-3-(3,4-dihydroxy5-nitrophenyl)-N,N-diethylprop-2-enamide
HO HO NO2 O N N
(A)
50 mg
MM 1221.04
Imp. B (EP): Ethyl (2E)-2-Cyano-3-(3,4dihydroxy-5-nitrophenyl)prop-2-enoate
O O 2N HO OH O N
(A)
50 mg
MM 1221.01
Imp. C (EP): 3,4-Dihydroxy-5-nitrobenzaldehyde
O2 N HO OH
(A)
100 mg
MM 1221.05
Imp. D (EP): (2E)-2-Cyano-3-(3-ethoxy-4hydroxy-5-nitrophenyl)-N,N-diethylprop-2enamide
O O 2N HO O N N
(A)
50 mg
MM 1221.06
Imp. E (EP): 3,5-Dinitrobenzene-1,2-diol
O2 N HO OH
NO2
(A)
50 mg
Edition 2012/2013
91
Code Product Price
O O 2N HO OH OH N O O 2N HO OH N N O O 2N HO OH O N
Unit
MM 1221.07
Imp. F (EP): (2E)-2-Cyano-3-(3,4-dihydroxy5-nitrophenyl)prop-2-enoic Acid
(A)
50 mg
MM 1221.03
Imp. H (EP): (2E)-3-(3,4-Dihydroxy-5-nitrophenyl)-2-(piperidin-1-ylcarbonyl)prop-2ennitrile Imp. I (EP): Propyl (2E)-2-Cyano-3-(3,4dihydroxy-5-nitrophenyl)prop-2-enoate
(A)
50 mg
MM 1221.09
(A)
50 mg
Ephedrine Hydrochloride
MM 0652.00 Ephedrine Hydrochloride [Drug Precursor] Imp. B (EP) as Hydrochloride: Pseudoephedrine Hydrochloride [Drug Precursor] (1S,2R)-(+)-Ephedrine Hydrochloride [Drug Precursor] Methylephedrine (1R,2S)-Methylephedrine)
OH H N
(A)
x HCl
500 mg
MM 2115.00
OH
H N
(A)
x HCl
500 mg
MM 0652.03
OH
H N
(A)
x HCl
100 mg
New MM 0652.04
OH N
(A)
100 mg
Ephedrine Sulphate
MM 1147.00 Ephedrine Sulphate [Drug Precursor]
OH H N 2
(A)
x H2SO4
250 mg
Erdosteine
MM 0544.00 Erdosteine
S O N H O S O OH
(A)
100 mg
MM 0544.01
2-Chloro-N-(2-oxotetrahydrothiophen-3-yl)acetamide
O N H
O Cl
(A)
100 mg
Ergometrine Maleate
New MM 1385.00 Ergometrine Maleate [Drug Precursor]
H HN O O N H N x OH O OH OH
(A)
100 mg
Erythromycin
MM 0132.13 Imp. B (EP): N-Demethylerythromycin A
HO OO OH NH OH OO O O OH HO O O
(D)
100 mg
MM 0132.10
Imp. E (EP): Erythromycin A Enol Ether

O HO OO OH N OH OO O O O OH
(A)
50 mg
92
Edition 2012/2013
Esomeprazole Magnesium Trihydrate

MM 0095.03 Imp. A (EP): 5-Methoxy-1H-benzimidazole-2-thiol
O N NH SH
(A)
100 mg
MM 0095.04
Imp. B (EP): 2-[(RS)-[(3,5-Dimethylpyridin2-yl)methyl]sulphinyl]-5-methoxy-1H-benzimidazole
O N
NH S O N
(A)
100 mg
MM 0095.06
Imp. C (EP): 5-Methoxy-2-[[(4-methoxy3,5-dimethylpyridin-2-yl)methyl]sulphanyl]-1H-benzimidazole (Ufiprazole) Imp. D (EP): 5-Methoxy-2-[[(4-methoxy3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1Hbenzimidazole (Omeprazole Sulphone) Imp. E (EP): 4-Methoxy-2-[[(RS)-(5-methoxy-1Hbenzimidazol-2-yl)sulphinyl]methyl]-3,5-dimethylpyridine 1-Oxide (Omeprazole N-Oxide)
O N
NH S N O
(A)
100 mg
MM 0095.05
O N
NH S O O O N
(A)
100 mg
MM 0095.07
O N
NH S O O N O
(A)
100 mg
Estazolam
New MM 1354.00 Estazolam [Controlled Substance]
N Cl N N N
(A)
100 mg
Estradiol Benzoate
MM 0301.00 Estradiol Benzoate
O O OH
(A)
500 mg
MM 0300.00
Imp. A (EP) as Hemihydrate: Estradiol Hemihydrate
OH x 1/2 H2O HO
(A)
500 mg
MM 0301.02
Imp. C (EP): Estra-1,3,5(10)-triene-3,17-diyl Dibenzoate (Estradiol 3,17-Dibenzoate)

O O
O O
(A)
100 mg
MM 0301.07
Imp. D (EP): 3-Hydroxyestra-1,3,5(10)-trien-17yl Benzoate (Estradiol 17-Benzoate)
O O
(A)
100 mg
HO
MM 0301.03
Imp. E (EP): 17-Hydroxyestra-1,3,5(10)-trien-3-yl Benzoate (17-epi-Estradiol Benzoate)

O O
OH
(C)
10 mg
MM 0301.08
Imp. G (EP): 17-Oxoestra-1,3,5(10)-trien-3-yl Benzoate (Estrone Benzoate)

O O
(A)
100 mg
MM 0278.01
Benzoic Acid
O OH
(B)
100 mg
Edition 2012/2013
93
Estradiol Enanthate
MM 0473.00 Estradiol Enanthate
O O
(A)
100 mg
HO
Estradiol Hemihydrate
MM 0300.00 Estradiol Hemihydrate
OH
1
(A)
x /2 H2O
500 mg
HO
MM 0282.00
Imp. A (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-one (Estrone)

HO
(A)
500 mg
MM 0300.01
Imp. B (EP): Estra-1,3,5(10)-triene-3,17-diol (17-Estradiol; 17-epi-Estradiol)

HO
OH
(A)
100 mg
MM 0300.06
Imp. C (EP): 4-Methylestra-1,3,5(10)-triene-3,17-diol (4-Methylestradiol)

HO
OH
(A)
100 mg
MM 0300.02
Imp. D (EP): Estra-1,3,5(10),9(11)-tetraene-3,17-diol (9,11-Didehydroestradiol)

HO
OH
(D)
100 mg
New MM 0300.04
6alpha-Hydroxyestradiol
OH
(A)
100 mg
HO OH
MM 0300.03
6-Hydroxyestradiol
HO OH
OH
(D)
50 mg
MM 0300.08
6-Ketoestradiol
OH
(A)
100 mg
HO O
Estradiol Valerate
MM 0209.00 Estradiol Valerate
O O
(A)
500 mg
HO
MM 0300.00
Imp. A (EP) as Hemihydrate: Estradiol Hemihydrate
OH x 1/2 H2O HO
(A)
500 mg
MM 0209.06
Imp. B (EP): 17-Hydroxyestra-1,3,5(10)-trien-3-yl Pentanoate (Estradiol 3-Valerate)

O O
OH
(A)
100 mg
MM 0209.01
Imp. C (EP): 3-Hydroxyestra-1,3,5(10),9(11)-tetraen17-yl Pentanoate (9,11-Didehydroestradiol Valerate)
O O
(D)
100 mg
HO
94
Edition 2012/2013
Code Product Price
O O
Unit
MM 0209.07
Imp. D (EP): 3-Hydroxy-4-methylestra-1,3,5(10)-trien17-yl Pentanoate (4-Methylestradiol Valerate)
(D)
100 mg
HO
MM 0209.02
Imp. E (EP): Estra-1,3,5(10)-trien-3,17-diyl Dipentanoate (Estradiol 3,17-Divalerate)

O O
O O
(A)
100 mg
MM 0209.04
Imp. F (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-yl Butanoate (Estradiol Butyrate)
O O
(A)
100 mg
HO
MM 0209.03
17-epi-Estradiol Valerate (17-Estradiol Valerate)

O
(D)
100 mg
HO
Estramustine Sodium Phosphate

MM 0100.01 Estramustine
O Cl Cl N O OH
(D)
100 mg
MM 0100.02
17-17'Bis3-{bis(2-chloroethyl)carbamoyloxy}estra-1,3,5(10)trienyl Pyrophosphate Disodium Salt
NaO O O ONa P P O O O
(D)
50 mg
O Cl Cl N O O
O N Cl Cl
Estriol
MM 0130.00 Estriol
OH OH HO
(A)
100 mg
MM 0130.06
Imp. A (EP): Estra-1,3,5(10),9(11)-tetraene-3,16,17-triol (9,11-Didehydroestriol)

HO
OH OH
(D)
100 mg
MM 0282.00
Imp. B (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-one (Estrone)

HO
(A)
500 mg
MM 0130.01
Imp. C (EP): 3-Methoxyestra-1,3,5(10)-triene-16,17-diol (Estriol 3-Methyl Ether)

O
OH OH
(D)
100 mg
MM 0300.00
Imp. D (EP) as Hemihydrate: Estradiol Hemihydrate

HO
OH
1
(A)
x /2 H2O
500 mg
MM 0130.05
Imp. E (EP): Estra-1,3,5(10)-triene-3,16,17-triol (17-epi-Estriol)

HO
OH OH
(D)
100 mg
MM 0130.04
Imp. F (EP): Estra-1,3,5(10)-triene-3,16,17-triol (16-epi-Estriol)

HO
OH OH
(D)
100 mg
Edition 2012/2013
95
Code Product Price
OH OH HO
Unit
MM 0130.03
Imp. G (EP): Estra-1,3,5(10)-triene-3,16,17-triol (16,17-epi-Estriol)
(D)
100 mg
MM 0130.22
Imp. I (EP): 3-Hydroxy-17-oxa-D-homoestra-1,3,5(10)trien-17a-one

HO
O O
on request
MM 0130.02
6-Hydroxyestriol
OH OH HO OH
(D)
100 mg
MM 0130.14
Estriol 16,17-Diacetate
O O O O HO
(D)
100 mg
MM 0130.15
Estriol Triacetate
O O
O O O O
(D)
100 mg
MM 0130.16
Estriol 3-Benzyl Ether

O
OH OH
(D)
100 mg
MM 0130.17
16-Oxoestradiol
OH O
(D)
100 mg
HO
MM 0130.18
6-Oxoestriol
OH OH
(D)
100 mg
HO O
Estrogens conjugated
MM 0282.00 Imp. I (EP): 3-Hydroxyestra-1,3,5(10)-trien17-one (Estrone)
HO O
(A)
500 mg
Estrone
MM 0282.00 Estrone
O
(A)
500 mg
HO
MM 0282.01
Estrone 3-Methyl Ether
(A)
100 mg
Ethacridine Lactate Monohydrate

MM 0798.00 Ethacridine Lactate Monohydrate
H2N NH2 O N x OH O OH x H2O
(A)
250 mg
Ethinylestradiol
MM 0123.00 Ethinylestradiol
OH
(A)
500 mg
HO
MM 0123.02
Imp. B (EP): 19-Nor-17-pregna-1,3,5(10),9(11)-tetraen20-yne-3,17-diol (9,11-Didehydroethinylestradiol)

HO
OH
(D)
50 mg
96
Edition 2012/2013
Code Product Price
O
Unit
MM 0282.00
Imp. C (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-one (Estrone)

HO
(A)
500 mg
MM 0300.00
Imp. D (EP) as Hemihydrate: Estradiol Hemihydrate

HO
OH
1
(A)
x /2 H2O
500 mg
MM 0123.07
Imp. E (EP): 19-Nor-17-pregna1,3,5(10)-trien-20-yne-3,6,17-triol (6-Hydroxyethinylestradiol)

HO OH
OH
(D)
100 mg
MM 0123.06
Imp. F (EP): 19-Nor-17-pregna1,3,5(10)-trien-20-yne-3,6,17-triol (6-Hydroxyethinylestradiol)

HO OH
OH
(D)
25 mg
MM 0123.05
Imp. G (EP): 3,17-Dihydroxy-19nor-17-pregna-1,3,5(10)-trien-20-yn-6-one (6-Oxoethinylestradiol, 6-Ketoethinylestradiol)

HO O
OH
(D)
100 mg
MM 0123.08
Imp. I (EP): 19-Nor-17-pregna1,3,5(10),6-tetraen-20-yne-3,17-diol (6,7-Didehydroethinylestradiol)

HO
OH
(D)
50 mg
MM 0300.01
Imp. L (EP): Estra-1,3,5(10)-triene3,17-diol (17-Estradiol; 17-epi-Estradiol)

HO
OH
(A)
100 mg
Ethionamide
MM 0845.00 Ethionamide
N S NH 2
(A)
250 mg
MM 0845.01
Ethionamide Sulphoxide
N
O S NH 2
(D)
100 mg
Ethosuximide
MM 0750.00 Ethosuximide
O H N O
(A)
500 mg
Ethyl Parahydroxybenzoate
MM 0498.00 Ethyl Parahydroxybenzoate
HO O O
(A)
500 mg
MM 0498.05
Sodium Ethyl Parahydroxybenzoate

NaO
O O
(A)
500 mg
MM 0045.01

HO
O OH
(B)
100 mg
MM 0431.00

HO
O O
(A)
500 mg
MM 0432.00
Imp. C (EP): Propyl 4-Hydroxybenzoate (Propyl Parahydroxybenzoate)

HO
O O
(A)
500 mg
MM 0496.00
Imp. D (EP): Butyl 4-Hydroxybenzoate (Butyl Parahydroxybenzoate)

HO
O O
(A)
500 mg
Edition 2012/2013
97
Ethylmorphine Hydrochloride
MM 0037.00 Imp. B (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate [Controlled Substance]
HO O
N x H2SO4 x 5 H2O HO O OH
N x H2O
N x HCl x 3 H2O
(A)
250 mg
OH
MM 0280.00
(A)
250 mg
MM 0004.00
Imp. C (EP) as Monohydrate: Codeine Monohydrate [Controlled Substance]
(A)
100 mg
O N
OH
MM 0442.00
Imp. C (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O O
(A)
x H3PO4 x 1/2 H2O
100 mg
OH
Etilefrine Hydrochloride
MM 0035.00 Etilefrine Hydrochloride
OH HO H N
(A)
x HCl
500 mg
MM 0081.00
Imp. B (EP) as Hydrochloride: (1RS)1-(3-Hydroxyphenyl)-2-(methylamino)ethanol Hydrochloride (Phenylephrine Hydrochloride) Imp. C (EP) as Hydrochloride: (1RS)-2-Amino1-(3-hydroxyphenyl)ethanol Hydrochloride (Norfenefrine Hydrochloride) Imp. D (EP) as Hydrochloride: 2-(Benzylethyl-amino)1-(3-hydroxyphenyl)ethanone Hydrochloride (Benzyletilefrone Hydrochloride)
OH HO
H N
(A)
x HCl
500 mg
MM 0973.00
OH HO NH2 x HCl
(A)
500 mg
MM 0035.08
(A)
O HO N x HCl
100 mg
MM 0035.05
Imp. E (EP): 1-(3-Hydroxyphenyl)ethanone (3-Hydroxyacetophenone) Imp. F (EP): N-Benzylethanamine (Benzylethylamine)
O HO
(C)
100 mg
MM 0035.06
(C)
HN
100 mg
MM 0035.50
3-Benzoyloxyacetophenone
O O
(A)
100 mg
MM 0035.51
3-Benzoyloxy--bromoacetophenone
O
O O Br
on request
Etizolam
New MM 1386.00 Etizolam
S N N Cl N N
(A)
100 mg
Etodolac
MM 0911.00 Etodolac
H N O O OH
(A)
250 mg
98
Edition 2012/2013
Code Product Price
O H N OH
Unit
MM 0911.01
Imp. A (EP): 2-[(1RS)-1-Ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (8-Desethyl Etodolac) Imp. B (EP): 2-[(1RS)-1-Ethyl-8-methyl-1,3,4,9tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (8-Methyl Etodolac) Imp. C (EP): 2-[(1RS)-8-Ethyl-1-methyl-1,3,4,9tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (1-Methyl Etodolac) Imp. D (EP): 2-[(1RS)-1-Ethyl-8-(1-methylethyl)1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (8-Isopropyl Etodolac) Imp. F (EP): 2-[(1RS)-8-Ethyl-1-(1-methylethyl)1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (1-Isopropyl Etodolac) Imp. G (EP): 2-[(1RS)-8-Ethyl-1-propyl-1,3,4,9tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (1-Propyl Etodolac)
(A)
100 mg
MM 0911.02
O H N OH
(A)
100 mg
MM 0911.03
O H N OH
(A)
100 mg
MM 0911.04
O H N OH
(A)
50 mg
MM 0911.06
O H N OH
(A)
100 mg
MM 0911.07
O H N OH
(A)
100 mg
MM 0911.08
Imp. H (EP): 2-(7-Ethylindol-3-yl)ethanol
H N
OH
(A)
100 mg
MM 0911.10
Imp. J (EP): (1RS)-1,8-Diethyl-1-methyl-1,3,4,9tetrahydropyrano[3,4-b]indole (Decarboxy Etodolac Imp. K (EP): Methyl 2-[(1RS)-1,8-Diethyl-1,3,4,9tetrahydropyrano[3,4-b]indol-1-yl]acetate (Etodolac Methyl Ester)
(A)
H N O
100 mg
MM 0911.11
O H N O
(A)
100 mg
Etofenamate
MM 0410.00 Imp. A (EP): 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic Acid (Flufenamic Acid)
O OH NH
(A)
500 mg
F F F
MM 0105.02
Imp. B (EP): Butyl 2-[[3-(Trifluoromethyl)phenyl]amino]benzoate (Butyl Flufenamate)
O O NH
(A)
100 mg
F F F
MM 0105.03
Imp. C (EP): N-Phenyl-3-(trifluoromethyl)aniline

NH
(A)
100 mg
F F F
MM 0105.04
Imp. D (EP): 2,2'-Oxybis(ethylene) Bis[2-[[3-(trifluoromethyl)phenyl]amino]benzoate]
O O NH O O
(A)
100 mg
HN
F F F
F F F
Edition 2012/2013
99
Code Product Price
O O NH O O
Unit
MM 0105.05
Imp. E (EP): 2-(2-Butoxyethoxy)ethyl 2-[[3(Trifluoromethyl)phenyl]amino]benzoate
(A)
100 mg
F F F
HO O OH
MM 0105.06 MM 0105.07
Imp. F (EP): 2,2'-Oxydiethanol Imp. G (EP): 2-Hydroxyethyl 2-[[3-(Trifluoromethyl)phenyl]amino]benzoate
(A) (A)
100 mg 100 mg
O O NH OH
F F F
MM 0105.08
Etofenamate Myristate
O O NH O O
(A)
100 mg
F F F
MM 0105.09
Etofenamate Palmitate
O O NH O O
(A)
100 mg
F F F
MM 0105.10
Etofenamate Stearate
O O NH O O
(A)
100 mg
F F F
MM 0105.11
Triethylene Glycol Flufenamate
O O NH O O OH
(A)
100 mg
F F F
Etofylline
MM 0603.00 Etofylline
N O N O N N OH
(A)
500 mg
Etomidate
MM 1264.00 Etomidate
N N O O
(A)
100 mg
MM 1264.04
Imp. A (EP) as R-Enantiomer: 1-[(1R)-1Phenylethyl]-1H-imidazole-5-carboxylic Acid (Etomidate Acid)
N N O OH
(A)
50 mg
100
Edition 2012/2013
Famciclovir
MM 0620.01 9-[4-Acetoxy-3-(acetoxymethyl)butyl]-2-amino6-chloropurine
H2N Cl N N N N O O O O
(A)
100 mg
Famotidine
MM 0029.00 Famotidine
H2N N S NH2 N S NH2 N S O O NH2
(A)
250 mg
MM 0029.06
Imp. A (EP) as Hydrochloride: 3-[[[2[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanimidamide Hydrochloride Imp. B (EP) as Dimaleate: 3,5-Bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]ethyl]-4H1,2,4,6-thiatriazine 1,1-Dioxide Dimaleate
NH2 H2 N N N S S
NH NH2 x HCl
(A)
100 mg
MM 0029.05
O H2N NH2 N N S S N
S N H
O N S O N N S OH OH O H2 N NH2
(D)
50 mg
x2
MM 0029.01
Imp. C (EP) as Hydrochloride: 3-[[[2-[(Diaminomethylene)amino]thiazol4-yl]methyl]sulphanyl]-N-sulphamoylpropanamide Hydrochloride Imp. D (EP): 3-[[[2-[(Diaminomethylene)amino] thiazol-4-yl]methyl]sulphanyl]propanamide Imp. E (EP): 2,2'-[Disulphanediylbis(methylenethiazole-4,2-diyl)]diguanidine Imp. F (EP): 3-[[[2-[(Diaminomethylene)amino] thiazol-4-yl]methyl]sulphanyl]propanoic Acid Imp. G (EP) as Maleate: N-Cyano3-[[[2-(diaminomethylene)amino]thiazol4-yl]methyl]sulphanyl]propanimidamide Maleate Famotidine Sulphoxide
NH 2 H 2N N S N S
N H x HCl
O O S NH 2
(A)
100 mg
MM 0029.02
NH 2 H 2N N S
NH2 N N S S S N S
O N S NH 2
(A)
100 mg
MM 0029.07 MM 0029.03
H2 N N
H2 N
NH2
(A) (A)
100 mg 100 mg
NH2 H2N N S N S
O OH
MM 0029.09
H2N
NH2 N N S S
NH N H
O N x O OH OH
(A)
100 mg
MM 0029.04
NH 2 H 2N N S N S O
NH 2 N S O O NH 2
(A)
100 mg
MM 0029.10
Imp. I (Pharmeuropa): 3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulfinyl]-N-sulfamoylpropanamide 2-[(Diaminomethylene)amino]-4-(4-cyanobutyl) thiazole Hydrochloride
NH2 H2N N S
N N H2 N NH2 S
O N S O
N H
O O S NH2
(D)
50 mg
MM 0029.51
N x HCl
on request
Felodipine
MM 0139.00 Felodipine
O O O Cl Cl H N O
(A)
100 mg
MM 0139.01
Imp. A (EP): Ethyl Methyl 4-(2,3-Dichlorophenyl)2,6-dimethylpyridine-3,5-dicarboxylate
N O O O Cl Cl O
(D)
50 mg
Edition 2012/2013
101
Code Product Price
H N O O O Cl Cl O
Unit
MM 0139.02
Imp. B (EP): Dimethyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl1,4-dihydropyridine-3,5-dicarboxylate
(A)
100 mg
MM 0139.03
Imp. C (EP): Diethyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl1,4-dihydropyridine-3,5-dicarboxylate
H N O O O Cl Cl O
(A)
100 mg
Fenbendazole
MM 2500.00 Imp. A (EP): Methyl (1H-Benzimidazol-2-yl)carbamate (Carbendazim) Fenbendazole Sulphoxide (Oxfendazole)
S O
H N N
O O NH
O O NH
(A)
100 mg
MM 0518.01
H N N
(A)
100 mg
MM 0518.02
Fenbendazole Sulphone
S O O
H N N
O O NH
(A)
100 mg
Fenbufen
MM 0918.00 Fenbufen
O OH O
(A)
500 mg
MM 0918.03
Imp. C (EP): Biphenyl
(A)
100 mg
MM 0918.05
4-(4-Chlorophenyl)-4-oxobutanoic Acid (3-(4-Chlorobenzoyl)propionic Acid)

Cl
O OH O
(A)
100 mg
Fencamfamine Hydrochloride
New MM 0995.01 Camfetamine Hydrochloride (N-Methyl-3phenylnorbornan-2-amine Hydrochloride)
HN
(A)
x HCl
100 mg
Fenfluramine Hydrochloride
MM 0608.00 Fenfluramine Hydrochloride
F F F
NH 2 x HCl F F F
H N x HCl
(A)
500 mg
MM 0608.01
Norfenfluramine Hydrochloride
(A)
100 mg
MM 0608.02
N-Nitrosofenfluramine
N N
(A)
100 mg
F F F
Fenofibrate
MM 0505.00 Fenofibrate
O Cl O O
(A)
500 mg
MM 0505.01
Imp. A (EP): (4-Chlorophenyl)(4-hydroxyphenyl)methanone
Cl
OH
(C)
100 mg
102
Edition 2012/2013
Code Product Price
O Cl O
Unit
MM 0505.03
Imp. C (EP): (3RS)-3-[4-(4-Chlorobenzoyl)phenoxy]butan-2-one
(A)
100 mg
MM 0505.04
Imp. D (EP): Methyl 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoate
O Cl O O
(A)
100 mg
MM 0505.05
Imp. E (EP): Ethyl 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoate
O Cl O O
(A)
100 mg
MM 0505.06
Imp. F (EP): (4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone Imp. G (EP): 1-Methylethyl 2-[[2-[4-(4-Chlorobenzoyl)phenoxy]-2methylpropanoyl]oxy]-2-methylpropanoate
Cl
(A)
100 mg
MM 0505.07
O Cl O O O O O
(A)
50 mg
Fenoprofen Calcium
MM 0790.00 Fenoprofen Calcium Dihydrate
O O O2 Ca 2+ x 2 H 2O
(A)
500 mg
Fentanyl
MM 0528.00 Fentanyl [Controlled Substance]
O N N
(A)
100 mg
MM 0528.09
Imp. A (EP) as Hydrochloride: N-Phenyl-N[cis,trans-1-oxido-1-(2-phenylethyl)piperidin4-yl]propanamide Hydrochloride (Fentanyl N-Oxide Hydrochloride)
O O N N x HCl
(A)
100 mg
MM 0528.08
Imp. B (EP): N-Phenyl-N-(piperidin-4-yl)propanamide
O N
NH
(A)
100 mg
MM 0528.03
Imp. C (EP): N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide
(A)
O N N
100 mg
MM 0528.04
Imp. D (EP): N-phenyl-1-(2-phenylethyl)piperidin-4-amine

N HN
(A)
100 mg
MM 0093.17 MM 0528.07
Imp. F (EP) as Hydrochloride: Aniline Hydrochloride (Phenylamine Hydrochloride) Imp. G (EP): N-Phenylpropanamide
NH2 x HCl
(B) (A)
100 mg 100 mg
O NH
Edition 2012/2013
103
Fexofenadine Hydrochloride
MM 0507.01 Imp. A (EP): 2-[4-[4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]2-methylpropanoic Acid (Ketofexofenadine) (A)
OH O N O OH
100 mg
MM 0507.03
Imp. C (EP): (1RS)-4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)phenyl]butan-1-ol
(A)
OH OH N
100 mg
MM 0055.02
Imp. E (EP): Diphenyl(piperidin-4-yl)methanol

OH
(B)
100 mg
NH
Finasteride
MM 0415.00 Finasteride
O H N
(A)
100 mg
N H
MM 0415.01
Imp. A (EP): N-(1,1-Dimethylethyl)-3-oxo4-aza-5-androstane-17-carboxamide (Dihydrofinasteride)

O N H H
H N
(A)
100 mg
MM 0415.02
Imp. B (EP): Methyl 3-Oxo-4-aza-5-androst1-ene-17-carboxylate (-1-Aza Ester)
(A)
100 mg
N H H
MM 0415.04
3-Oxo-4-aza-5alpha-androstane-17beta-carboxylic Acid
OH
(A)
100 mg
N H H
Flavoxate Hydrochloride
MM 0156.00 Flavoxate Hydrochloride
O x HCl O O O N O
(A)
100 mg
MM 0156.01
Imp. A (EP): 3-Methyl-4-oxo-2-phenyl-4H-1benzopyran-8-carboxylic Acid (3-Methyl-flavone-8-carboxylic Acid) Imp. B (EP): Ethyl 3-Methyl-4-oxo-2-phenyl4H-1-benzopyran-8-carboxylate (3-Methylflavone-8-carboxylic Acid Ethyl Ester)
O
(A)
100 mg
O O OH
MM 0156.02
(A)
100 mg
O O O
MM 0156.05
Imp. C (EP): 1-Methylethyl-3-Methyl-4-oxo2-phenyl-4H-1-benzopyran-8-carboxylate (3-Methylflavone-8-carboxylic Acid Isopropyl Ester)
(A)
50 mg
O O O
104
Edition 2012/2013
Flecainide Acetate
MM 0488.02 MM 0488.04 Imp. B (EP): (RS)-(Piperidin-2-yl)methanamine Imp. D (EP): 2,5-Bis(2,2,2-trifluoroethoxy) benzoic Acid
F F F O O F
H2N HN
O OH F F
(A) (A)
100 mg 100 mg
Fluanisone
MM 1247.02 1-(2-Methoxyphenyl)piperazine Dihydrochloride
N HN O x 2 HCl
(A)
100 mg
Flubendazole
MM 0463.00 Flubendazole
F H N N O O O NH
(A)
100 mg
MM 0463.02
Imp. B (EP): (2-Amino-1H-benzimidazol5-yl)(4-fluorophenyl)methanone Imp. C (EP): (4-Fluorophenyl)(2-hydroxy-1Hbenzimidazol-5-yl)methanone Imp. D (EP): (1H-Benzimidazol-5-yl)(4-fluorophenyl) methanone Imp. E (EP): Methyl [5-(2-Fluorobenzoyl)-1Hbenzimidazol-2-yl]carbamate
H N N O NH2
(A)
100 mg
MM 0463.03
H N OH N O
(C)
50 mg
MM 0463.04
H N N O
on request
MM 0463.05
H N N F O
O O NH
(C)
50 mg
MM 0463.06
Imp. F (EP): Methyl [5-(4-Fluorobenzoyl)-1-methyl-1Hbenzimidazol-2-yl]carbamate Imp. G (EP): Methyl [5-[4-(1-Methylethoxy)benzoyl]-1Hbenzimidazol-2-yl]carbamate
O N NH N O O
(C)
50 mg
MM 0463.07
H N N O
O O NH
(D)
100 mg
Flucloxacillin Sodium
MM 0489.00 Flucloxacillin Sodium Hydrate
Cl O N O O F H N N S H O F H N O O HN S ONa
O F HN NH S O O O H2 N N H Cl N O O F OH S OH OH
ONa x H 2O
(A)
500 mg
MM 0489.01
Imp. A (EP) as Disodium Salt: (4S)-2-[Carboxy[[[3-(2-chloro6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl]amino]methyl]5,5-dimethylthiazolidine-4-carboxylic Acid Disodium Salt (Penicilloic Acids of Flucloxacillin Disodium Salt) Imp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)5-methylisoxazol-4-yl]carbonyl]amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin) Imp. C (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid) Imp. D (EP): 3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole4-carboxylic Acid
Cl N O
ONa
(A)
100 mg
MM 0489.02
Cl N O
(A)
50 mg
MM 0026.04
(B)
100 mg
MM 0489.03
(C)
100 mg
Edition 2012/2013
105
Fluconazole
MM 0235.00 Fluconazole
N N N N N N
F F HO N N N N
F F HO
(A)
100 mg
MM 0235.11
Imp. A (EP): (2RS)-2-(2,4-Difluorophenyl)-1(1H-1,2,4-triazol-1-yl)-3-(4H-1,2,4-triazol-4-yl)propan-2-ol

N N
(A)
100 mg
MM 0235.12
Imp. B (EP): 2-[2-Fluoro-4-(1H-1,2,4-triazol-1yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol

N N N N N F HO
N N
(D)
100 mg
MM 0235.13
Imp. C (EP): 1,1'-(1,3-Phenylene)di-1H-1,2,4-triazole

N N N
N N
(A)
50 mg
MM 0235.14
Imp. D (EP): 2-(4-Fluorophenyl)-1,3-bis(1H1,2,4-triazol-1-yl)propan-2-ol

N N N N N HO
(A)
100 mg
MM 0235.02
Imp. F (EP): (2RS)-2-(2,4-Difluorophenyl)-3(1H-1,2,4-triazol-1-yl)propane-1,2-diol

N N N
F F HO
(A)
50 mg
OH
MM 0235.07
Imp. H (EP): (2RS)-1-Bromo-2-(2,4-difluorophenyl)3-(1H-1,2,4-triazol-1-yl)propan-2-ol

N N N
F F HO
(A)
50 mg
Br
MM 0235.01
2-(2,4-Difluorophenyl)propane-1,2,3-triol
F HO HO OH
(A)
100 mg
MM 0235.03 MM 0235.04
1H-1,2,4-Triazol
N
H N
(B)
N
F
100 mg 100 mg
2-Chloro-2',4'-difluoroacetophenone
F O
(C)
Cl
MM 0235.06
1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol
F HO N
(A)
100 mg
N N
N N H2N N
MM 0235.09
4-Amino-1,2,4-triazole
(C)
100 mg
106
Edition 2012/2013
Flucytosine
MM 0593.00 Imp. A (EP): 5-Fluoropyrimidine-2,4(1H,3H)-dione (Fluorouracil)
O HN O N H F
(A)
500 mg
Flufenamic Acid
MM 0410.00 Flufenamic Acid
O OH NH
(A)
500 mg
F F F
Flumetasone Pivalate
MM 0427.01 Imp. A (EP): 6,9-Difluoro-11,17,21-trihydroxy-16methylpregna-1,4-diene-3,20-dione (Flumetasone)
O HO OH OH
(A)
100 mg
F O F
Flunarizine Dihydrochloride
MM 0175.00 Flunarizine Dihydrochloride
F N x 2 HCl N
(A)
500 mg
MM 0175.04
Imp. A (EP): 1-[Bis(4-fluorophenyl)methyl]piperazine
F N
NH
(A)
100 mg
MM 0175.03
Imp. C (EP) as Dihydrochloride: 1-[(RS)-(2-Fluorophenyl)(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop2-enyl]piperazine Dihydrochloride Chlorobis-(4-fluorophenyl)methane
F N F
N x 2 HCl
(A)
100 mg
MM 0175.02
Cl
(B)
F
100 mg
MM 0175.05
1-Bis(4-fluorophenyl)methyl-4-(ethoxycarbonyl)piperazine
O N N
(B)
10 mg
MM 0175.06
Flunarizine N-Oxide Dihydrochloride
F N
O N
(A)
100 mg
x 2 HCl
Flunitrazepam
MM 0069.00 Flunitrazepam [Controlled Substance]
O2N N N F O
(A)
100mg
MM 0069.02
Imp. B (EP): 5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-2H1,4-benzodiazepin-2-one (Demethylflunitrazepam)

O2N
H N N
(A)
100 mg
Edition 2012/2013
107
Flunixin Meglumine
MM 0915.00 Flunixin Meglumine
F OH N NH OH O x HO HO OH F F H N OH
(A)
100 mg
MM 0915.01
Imp. A (EP): 2-Chloropyridine-3-carboxylic Acid
Cl OH O
(A)
100 mg
MM 0915.03
Imp. C (EP): Ethyl 2-Chloropyridine-3-carboxylate
Cl O O
(A)
100 mg
Fluorescein Sodium
MM 0294.01 MM 0133.04 Imp. A (EP): Resorcinol
HO OH
(B) (A)
OH O HO OH O
100 mg 100 mg
Imp. C (EP): 2-(2,4-Dihydroxybenzoyl)benzoic Acid
Fluorouracil
MM 0593.00 Fluorouracil
HN O N H O F
(A)
500 mg
MM 0265.03
Imp. A (EP): Pyrimidine-2,4,6-(1H,3H,5H)trione (Barbituric Acid)
O HN O N H
O HN O N H O
(C)
O
100 mg
MM 0593.01
Imp. B (EP): Dihydropyrimidine-2,4,5(3H)trione (Isobarbituric Acid or 5-Hydroxyuracil)
(A)
100 mg
MM 0593.03
Imp. C (EP): Pyrimidine-2,4(1H,3H)-dione (Uracil)

HN O
(C)
100 mg
N H
O Cl N H O F N H
MM 0593.05
Imp. E (EP): 5-Chloropyrimidine-2,4(1H,3H)dione (5-Chlorouracil)
(A)
100 mg
HN O
MM 0593.06
Imp. F (EP): 2-Ethoxy-5-fluoropyrimidin4(1H)-one (2-Ethoxy-5-fluorouracil)

O
(A)
100 mg
Fluoxetine Hydrochloride
MM 0256.00 Fluoxetine Hydrochloride
F F F
H N
H N x HCl
(A)
50 mg
MM 0256.01
Imp. A (EP): (1RS)-3-(Methylamino)-1-phenylpropan-1-ol
HO
(A)
100 mg
MM 0256.02
Imp. B (EP) as Hydrochloride: N-Methyl-3phenylpropan-1-amine Hydrochloride (Methyl-3-phenylpropylamine Hydrochloride) [Controlled Substance] Imp. C (EP) as Hydrochloride:(3RS)-N-Methyl-3phenyl-3-[3-(trifluoromethyl]phenoxy]propan-1-amine Hydrochloride
O H N
H N x HCl
(A)
100 mg
MM 0256.03
(A)
x HCl
100 mg
F F F
108
Edition 2012/2013
Code Product Price
OH F F F Cl F F F
OH N
Unit
MM 0256.05
4-Hydroxybenzotrifluoride
(B)
100 mg
MM 0256.06
4-Chlorobenzotrifluoride
(B)
100 mg
MM 0256.10
3-Dimethylamino-1-phenylpropan-1-ol
(A)
100 mg
MM 0256.16
N-Formylfluoxetine
O F F F
F F O H N
O N
(A)
100 mg
MM 256.17
(3RS)-N-Methyl-3-phenyl-3-[2-(trifluoromethyl)phenoxy]propan-1-amine Hydrochloride (2-Trifluoromethylisomer of Fluoxetine Hydro-chloride)
(A)
100 mg
x HCl
New MM 0256.18
Norfluoxetine Oxalate
F F F
NH2 x
HO HO
O O
(A)
100 mg
Fluoxymesterone
MM 0959.00 Fluoxymesterone
OH HO
(A)
100 mg
F O
Flupentixol Decanoate
MM 0182.08 Imp. B (BP): 2-Trifluoromethylthioxanthone
O CF3 S
(A)
100 mg
MM 0182.05 MM 0182.06
1-(2-Hydroxyethyl)piperazine cis/trans-3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propene
HN N
OH
(B)
100 mg on request
CF3 S
MM 0182.07 MM 0182.09
4-Chloro-3-nitrobenzotrifluoride 4-Fluoro-3-nitrobenzotrifluoride
O2N Cl O2 N F
CF3
(B) (B)
100 mg 100 mg
CF3
Flupentixol Dihydrochloride
MM 0182.08 Imp. G (EP): 2-(Trifluoromethyl)-9H-thioxanthen-9-one (2-Trifluoromethylthioxanthone) 1-(2-Hydroxyethyl)piperazine cis/trans-3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propene
CF3 S HN N O CF3 S
(A)
100 mg
MM 0182.05 MM 0182.06
OH
(B)
100 mg on request
MM 0182.07 MM 0223.06
4-Chloro-3-nitrobenzotrifluoride Flupentixol Dihydrochloride

N S F F F
O 2N Cl
CF3
(B) (A)
100 mg 100 mg
OH
x 2 HCl
Edition 2012/2013
109
Fluphenazine Dihydrochloride
MM 0114.00 Fluphenazine Dihydrochloride
N S F F F N N OH x 2 HCl
(A)
500 mg
MM 0114.01
Imp. A (EP): 2-[4-[3-[5-Oxo-2-(trifluoromethyl)410H-5 phenothiazin-10-yl]propyl]piperazin-1yl]ethanol (Fluphenazine S-Oxide)
(A)
N O S F F F
F F S N N S F F F N N F
100 mg
N N OH
MM 0114.07
Imp. D (EP): 10,10'-[Piperazine-1,4-diylbis(propane3,1-diyl)]bis[2-(trifluoromethyl)-10H-phenothiazine]
(A)
100 mg
MM0826.00
Imp. E (EP): 2-[4-[3-[2-Chloro-10H-phenothiazin10-yl]propyl]piperazin-1-yl]ethanol (Perphenazine)

S
(A)
N N N Cl OH
100 mg
MM 0114.04
Fluphenazine N,N',S-Trioxide Dihydrochloride

N O S F F F
O N N O OH x 2 HCl
(A)
100 mg
Flurazepam Monohydrochloride
MM 0070.01 Imp. A (EP): [5-Chloro-2-[[2-(diethylamino)ethyl]amino] phenyl]-(2-fluorophenyl)methanone
Cl H N O F N
on request
MM 0070.02
Imp. B (EP): 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro2H-1,4-benzodiazepin-2-one

Cl
H N N
(A)
100 mg
MM 0070.03
2-Chloro-10-(2-diethylaminoethyl)-9,10-dihydroacridin-9-one
N Cl O
(A)
100 mg
MM 0070.06
Flurazepam [Controlled Substance]
N O
(A)
100 mg
N Cl N
New MM 0070.07
2-Hydroxyethylflurazepam
HO O
(A)
50 mg
N Cl N
110
Edition 2012/2013
Flurbiprofen
MM 0727.01 Imp. A (EP): (2RS)-2-(Biphenyl-4-yl)propanoic Acid
OH O
(A)
50 mg
MM 0727.03
Imp. C (EP): (2RS)-2-(2-Fluorobiphenyl-4-yl)2-hydroxypropanoic Acid
HO F O OH
(A)
50 mg
Flutamide
MM 0161.00 Flutamide
O H N F F F NO2
(A)
500 mg
MM 0161.03
Imp. A (EP): 4-Nitro-3-(trifluoromethyl)aniline
F H2N
F F NO2
(A)
100 mg
MM 0161.04
Imp. B (EP): N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide

O
H N
F F NO2
(A)
100 mg
MM 0161.05
Imp. C (EP): N-[4-Nitro-3-(trifluoromethyl)phenyl]propanamide

O
H N
F F NO2
(A)
100 mg
MM 0161.06
Imp. D (EP): 3-(Trifluoromethyl)aniline
F H2N
F F
(B)
100 mg
MM 0161.07
Imp. E (EP): 2-Methyl-N-[3-(trifluoromethyl)phenyl]propanamide

O
H N
F F
(A)
100 mg
MM 0161.08
Imp. F (EP): 2-Methyl-N-[2-nitro5-(trifluoromethyl)phenyl]propanamide 2-Hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide) Trifluoromethylbenzene

HO
H N O O2N
F F
(D)
100 mg
MM 0161.01
H N O
F F NO2
(A)
100 mg
MM 0161.09
F F
(B)
100 mg
MM 0161.10
3-Nitrobenzotrifluoride
F O2 N
F F
(B)
100 mg
MM 0161.12
3-Trifluoromethyl-4-nitrophenol
F HO
F F NO2
(A)
100 mg
Edition 2012/2013
111
Fluticasone Propionate
MM 1244.10 6,9-Difluoro-11,17-dihydroxy-16-methyl3-oxoandrosta-1,4-diene-17-carboxylic Acid
O HO OH OH
(A)
100 mg
F O F
Fluvastatin Sodium
MM 0676.00 Fluvastatin Sodium
F
(D)
100 mg
OH N OH O ONa
Folic Acid
MM 0621.00 Folic Acid
O N H2N N H N N O N H H2N O N H O O N H O OH
(A)
OH
500 mg
MM 0621.01
Imp. A (EP): (2S)-2-[(4-Aminobenzoyl)amino] pentanedioic Acid (N-(4-Aminobenzoyl)-L-glutamic Acid)
OH
(A)
OH
100 mg
MM 0621.02
Imp. B (EP) as Sulphate: 2,5,6-Triaminopyrimidin4(1H)-one Sulphate

H2N
O N N H NH2 NH2
(A)
x H2 SO4
100 mg
MM 0621.04
Imp. D (EP): 4-[[(2-Amino-4-oxo-1,4-dihydropteridin6-yl)methyl]amino]benzoic Acid (Pteroic Acid)

N H2N
O O N N H N
O OH H2N
(D)
OH
50 mg
N H
MM 0094.03
4-Aminobenzoic Acid
(B)
100 mg
MM 0169.00 New MM 0621.09
L-Glutamine 6-Formylpterin
NH2 H2N O O OH
(A) (D)
500 mg 50 mg
O N H2N N H N N
Formoterol Fumarate Dihydrate

MM 0447.00 Formoterol Fumarate Dihydrate
HO HN O and enantiomer O x HO O OH x 2 H2O OH H N O 2
(D)
50 mg
New MM 0447.07
Imp. G (EP) as Hydrochloride: (2RS)-1(4-Methoxy-phenyl)propan-2-amine Hydrochloride [Controlled Substance]
H2N x HCl O
(A)
100 mg
Fumaric Acid
New MM 0352.03 Monomethyl Fumarate
O O
(A)
100 mg
O HO
112
Edition 2012/2013
Furosemide
MM 0014.00 Furosemide
H 2N O O OH H N S O Cl O
(A)
500 mg
MM 0014.02
Imp. A (EP): 2-Chloro-4-[(furan-2-ylmethyl)amino]5-sulphamoylbenzoic Acid

H2N O S
OH Cl
(A)
100 mg
HN
O
O
OH Cl
MM 0014.03
Imp. B (EP): 2,4-Dichloro-5-sulphamoylbenzoic Acid

H 2N O S
(B)
100 mg
O O
Cl OH NH 2
MM 0014.01
Imp. C (EP): 2-Amino-4-chloro-5-sulphamoylbenzoic Acid

H 2N O S
(A)
100 mg
Cl
MM 0014.04
Imp. D (EP): 2,4-Bis[(furan-2-ylmethyl)amino]5-sulphamoylbenzoic Acid

H2N O S
OH H N O
(D)
100 mg
O HN
O
O OH Cl
MM 0014.05
Imp. E (EP): 2,4-Dichlorobenzoic Acid
(B)
100 mg
Cl
MM 0014.50
Ethyl 2,4-Dichloro-5-sulphamoylbenzoate
H2N O
O Cl
(A)
100 mg
S O Cl
Gabapentin
MM 0684.01 Imp. A (EP): 2-Azaspiro[4.5]decan-3-one (3,3-Pentamethylene-4-butyrolactam)
O HN
(A)
100 mg
MM 0684.07
Imp. E (EP): 1-(Carboxymethyl)cyclohexanecarboxylic Acid
O HO
O OH
(A)
100 mg
Ganciclovir
MM 0485.00 Ganciclovir
HN H2N N O N N O HO OH
(A)
100 mg
MM 0061.02
Imp. F (EP): 2-Amino-1,9-dihydro-6H-purin-6-one (Guanine)

HN H2N
O N N N H
(B)
100 mg
New MM 0485.08
Imp. H (EP): 2-Amino-7-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-1,7-dihydro-6H-purin-6one (N-7 Isomer of Ganciclovir)

H2N
HO O HN N N N O OH
(A)
50 mg
MM 0485.09
Imp. I (EP): 2-[(2-Amino-6-oxo-1,6-dihydro9H-purin-9-yl)methoxy]propane-1,3-diyl Dipropanoate (Ganciclovir Dipropionate)
O HN H2N N N N O O O O O
(A)
100 mg
Edition 2012/2013
113
Code Product Price
O O HN N H N N N O O O O O
Unit
MM 0485.10
Imp. J (EP): 2-[2-(Propanoylamino)-6-oxo1,6-dihydro-9H-purin-9-yl]methoxy] propane-1,3-diyl dipropanoate (Ganciclovir Tripropionate)
(A)
100 mg
Gemcitabine Hydrochloride
MM 1257.00 Gemcitabine Hydrochloride
N HO O O F OH F N x HCl NH2
(A)
100 mg
MM 0749.05
Imp. A (EP): 4-Aminopyrimidin-2(1H)-one (Cytosine)

O
NH2 N N H
(A)
100 mg
Gemfibrozil
MM 0641.00 Gemfibrozil
O O OH
(A)
250 mg
MM 0641.08 MM 0641.07
Imp. A (EP): 2,5-Dimethylphenol (p-Xylenol) Imp. E (EP): 5-[2,5-Dimethyl-4-(prop-1-enyl)phenoxy]-2,2-dimethylpentanoic Acid Imp. H (EP): 1,3-Bis(2,5-dimethylphenoxy)propane 3-(2,5-Dimethylphenoxy)propyl Chloride (3-(2,5-Xylyloxy)propyl Chloride) Gemfibrozil Isobutyl Ester
OH
(A) (D)
100 mg 100 mg
O O
OH
MM 0641.02 MM 0641.01 MM 0641.03
(A)
Cl
100 mg 100 mg 100 mg
(A) (A)
Gestodene
MM 0124.06 Imp. L (EP): 13-Ethyl-17-hydroxy-18,19dinor-17-pregna-5,15-dien-20-yn-3-one (56)-Gestodene)
O OH
(A)
100 mg
GHB Sodium Salt

MM 1355.00 GHB Sodium Salt (Sodium Gammahydroxybutyrate) [Controlled Substance]
O HO ONa
(A)
100 mg
Glibenclamide
MM 0008.00 Glibenclamide
O Cl O N H
(A)
500 mg
MM 0008.01
Imp. A (EP): 5-Chloro-2-methoxy-N(2-(4-sulfamoylphenyl)ethyl)benzamide
(A)
O Cl O N H
100 mg
MM 0008.02
Imp. B (EP): Methyl [[4-[2-[(5-Chloro2-methoxybenzoyl)amino]ethyl]phenyl]-sulphonyl]carbamate

Cl
(A)
O N H O
100 mg
114
Edition 2012/2013
MM 0942.09
Imp. C (Pharmeuropa): 1-[[4-[2-[(Cyclohexylcarbamoyl)amino]ethyl]phenyl]sulfonyl]-3-cyclohexylurea (N-(Cyclohexylcarbamoyl)-4-[2-[(cyclohexylcarbamoyl)amino]ethyl] benzene-Sulphonamide) Imp. D (Pharmeuropa): 1-[[4-[2-[(5-Chloro2-methoxybenzoyl)amino]ethyl]phenyl]-sulfonyl]-3-butylurea

Cl
(A)
O N H N H
100 mg
MM 0008.07
(A)
O N H O
50 mg
New MM 0008.08
Imp. E (Pharmeuropa): 1-[[4-[2-[(3,5-Di-chloro2-methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]-3-cyclohexylurea
(A)
O Cl O Cl N H
50 mg
MM 0008.03
5-Chloro-2-methoxybenzoic Acid
O Cl O OH
(B)
100 mg
MM 0008.04
5-Chloro-N-(2-phenylethyl)-2-methoxybenzamide
Cl
O N H O
(A)
100 mg
Gliclazide
MM 0325.00 Gliclazide
O S O N H O N H N
(A)
500 mg
MM 0325.01
Imp. A (EP): 4-Methylbenzenesulphonamide
O S
O NH2
(C)
100 mg
MM 0325.02
Imp. B (EP): 2-Nitroso-octahydrocyclopenta[c]pyrrole

O N N
(A)
100 mg
MM 0325.03
Imp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]Carbamate
O O O S N O H
(A)
100 mg
MM 0325.06
Imp. F (EP): 1-(Hexahydrocyclopenta[c]pyrrol2(1H)-yl)-3-[(2-methylphenyl)sulphonyl]urea
O O O S N N N H H
(A)
100 mg
MM 0325.09
Methyl N-Methyl-p-tolylsulphoncarbamate
O O O S N O
(A)
100 mg
Glimepiride
MM 0647.00 Glimepiride
O O N N H O S
(D)
100 mg
MM 0647.02
Imp. A (EP): 1-[[4-[2-[[(3-Ethyl-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol1-yl)carbonyl]-amino]ethyl]phenyl]sulphonyl]-3-(cis4-methylcyclohexyl)urea (cis-Glimepiride)
O S O O N N H
(D)
100 mg
MM 0647.01
Imp. B (EP): 3-Ethyl-4-methyl-2-oxo-N[2-(4-sulphamoylphenyl)ethyl]-2,3-dihydro-1Hpyrrole-1-carboxamide (Glimepiride Sulphonamide)
(A)
O N O N H
100 mg
Edition 2012/2013
115
MM 0647.01
Imp. B (EP): 3-Ethyl-4-methyl-2-oxo-N[2-(4-sulphamoylphenyl)ethyl]-2,3-dihydro-1Hpyrrole-1-carboxamide (Glimepiride Sulphonamide)
(A)
O N O N H
100 mg
MM 0647.03
Imp. C (EP): Methyl [[4-[2-[[(3-Ethyl-4-methyl2-oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]carbamate (Glimepiride Carbamate)
(A)
O N O N H
100 mg
MM 0647.04
Imp. D (EP): 1-[[3-[2-[[(3-Ethyl-4-methyl-2-oxo2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]-3-(trans-4-methylcyclohexyl)urea

O
(D)
100 mg
N O
H N
MM 0647.08
cis-4-Methylcyclohexylamine Hydrochloride
H2N
x HCl
(A)
100 mg
Glipizide
MM 0942.01 Imp. A (EP): 5-Methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide
N N O N H O O S NH2
(A)
100 mg
MM 0678.03 MM 0942.04
Imp. B (EP): Cyclohexanamine

H2N
(C)
O O S NH2 N H
100 mg 100 mg
Imp. D (EP): 6-Methyl-N[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide

N N
(A)
MM 0942.05
Imp. E (EP): 1-Cyclohexyl-3-[[4-[2-[[(6-methylpyrazin-2-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]urea
O N N N H
O O O S N N H H
(A)
100 mg
MM 0942.06
Imp. F (EP): Ethyl [2-(4-Sulphamoylphenyl)ethyl]carbamate

O
O N H
O O S NH2
(A)
100 mg
MM 0942.07
Imp. G (EP): Methyl [[4-[2-[[(5-Methylpyrazin2-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]carbamate Imp. H (EP): 4-[2-[(Cyclohexylcarbamoyl)amino]ethyl]benzenesulphonamide
O N N N H
O O O S N O H
(A)
100 mg
MM 0942.08
O N H N H
O O S NH2
(A)
100 mg
MM 0942.09
Imp. I (EP): N-(Cyclohexylcarbamoyl)4-[2-[(cyclohexylcarbamoyl)amino]ethyl]benzenesulphonamide
O N H N H
O O O S N N H H
(A)
100 mg
Glutamine
MM 0169.00 MM 0169.01 L-Glutamine N-Phenylacetyl-L-glutamine (Phenylacetylglutamine)
H2N O O NH2 O NH2 H2N O O HN OH O OH
(A) (A)
500 mg 100 mg
MM 0169.02
Phenylacetamide
(A)
100 mg
116
Edition 2012/2013
Code Product Price
NH2 H2N O O OH
Unit
MM 0169.03
D-Glutamine
(A)
100 mg
Glycopyrronium Bromide
MM 0834.00 Glycopyrronium Bromide
O O OH and enantiomer N+ Br-
(A)
100 mg
MM 0834.05
Imp. B (EP): Oxophenylacetic Acid (Benzoylformic Acid)

O
O OH
(A)
100 mg
MM0792.03
Imp. C (EP): (2RS)-2-Hydroxy-2-phenylacetic Acid (Mandelic Acid) Imp. D (EP): Benzoic Acid
O OH OH
(A)
100 mg
MM 0278.01
(B)
OH O
100 mg
MM 0834.07
Imp. H (EP): Methyl 2-oxo-2-Phenylacetate (Methyl Benzoylformate)

O
O O
(A)
100 mg
MM 0834.01
Imp. J (EP): 2-(RS)-Cyclopentyl-2-hydroxy2-phenylacetic Acid (-Cyclopentylmandelic Acid) Imp. K (EP): (2RS)-2-Cyclopentyl-2-phenylacetic Acid
O OH OH
(A)
100 mg
MM 0834.08
O OH
(A)
100 mg
MM 0834.06
Imp. M (EP): Cyclopentylphenylmethanone

O
(A)
100 mg
Granisetron Hydrochloride
New MM 0398.02 Imp. B (EP): N-[(1R,3r,5S)-9-Methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide
H HN N H N O H
H H N O H
N N OH O
(A)
N
50 mg
New MM 0398.03
Imp. C (EP): N-[(1R,3r,5S)-9-Azabicyclo[3.3.1]non3-yl]-1-methyl-1H-indazole-3-carboxamide
N N
(A)
NH
50 mg
MM 0398.04
Imp. D (EP): 1-Methyl-1H-indazole-3-carboxylic Acid
(A)
100 mg
MM 0398.07
Imp. G (EP): 2-Methyl-2H-indazole-3-carboxylic Acid
N N OH O
(A)
100 mg
MM 0398.08
Imp. H (EP): 1H-Indazole-3-carboxylic Acid
HN N OH O
(A)
100 mg
New MM 0398.09
Imp. I (EP): 1-Methyl-1H-indazole-3-carboxylic Anhydride
N N O O O
N N
(A)
50 mg
Griseofulvin
MM 0582.00 Griseofulvin
O Cl O O O O O
(A)
500 mg
Edition 2012/2013
117
Guaiacol
MM 0354.04 MM 0814.04 MM 0045.11 MM 0814.06 MM 0814.08 Guaiacol Imp. A (EP): Benzene-1,2-diol (Pyrocatechol) Imp. B (EP): Phenol Imp. C (EP): 1,2-Dimethoxybenzene (Veratrole) Imp. E (EP): Methyl Benzoate
O O
OH O
OH OH
(A) (C) (B) (C) (C)
500 mg 100 mg 100 mg 100 mg 100 mg
OH
O O
MM 1131.00 MM 0007.09
Imp. G (EP): 4-Methoxyphenol (Mequinol)

O
OH
(A) (B)
500 mg 100 mg
Imp. H (EP): 3-Methoxyphenol

O
OH
Guaifenesin
MM 0354.00 Guaifenesin
OH O O OH
(A)
500 mg
MM 0354.04 MM 0354.01
Imp. A (EP): 2-Methoxyphenol (Guaiacol) Imp. B (EP): 2-(2-Methoxyphenoxy)propane-1,3-diol (B-Isomer) Imp. C (EP): 1,1'-Oxybis[3-(2-methoxyphenoxy) propan-2-ol] (Bisether) Imp. D (EP): 1,3-Bis(2-methoxyphenoxy)propan-2-ol
OH O O O
OH O
HO O O OH
(A) (A)
500 mg 100 mg
MM 0354.02
OH O O
(A)
100 mg
MM 0354.03
OH O O O O
(A)
100 mg
Guanidine Thiocyanate
MM 1315.00 Guanidine Thiocyanate
H2N NH NH2 x HS N
(A)
100 mg
Haloperidol Decanoate
MM 1276.12 Imp. L (EP): 1-(4-Fluorophenyl)ethanone
F
(A)
O
100 mg
Harpagoside
MM 0370.01 Methyl trans-Cinnamate
O O
(B)
100 mg
Hexetidine
MM 0337.03 Imp. C (EP): 2,6-Bis(2-ethylhexyl)-7a-methylhexahydro-1Himidazo[1,5-c]imidazole (Hexedine) (A)
N N
100 mg
Hexylresorcinol
MM 0111.00 Hexylresorcinol
HO OH
(A)
500 mg
MM 0045.11
Imp. A (EP): Phenol
OH
(B)
100 mg
118
Edition 2012/2013
Code Product Price
HO OH
Unit
MM 0294.01
Imp. B (EP): Resorcinol
(B)
100 mg
Homatropine Methylbromide
MM 0792.00 Homatropine Methylbromide
H O H O OH N
+
(A)
Br
-
250 mg
H and enantiomer
O OH OH
MM 0792.03
Imp. C (EP): (2RS)-2-Hydroxy-2-phenylacetic Acid (Mandelic Acid) Imp. D (EP) as Bromide: (1R,2R,4S,5S,7s)-7-[[(2S)3-Hydroxy-2-phenylpropanoyl]oxy]-9,9-dimethyl3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide (Methylhyoscine Bromide) Imp. F (EP): Methyl (2RS)-2-Hydroxy-2-phenylacetate (Methyl Mandelate)
H O H O OH H N
+
(A)
100 mg
MM 0792.04
H O H Br
-
(A)
100 mg
MM 0792.06
O O OH
(A)
100 mg
Hydrochlorothiazide
MM 0011.00 Hydrochlorothiazide
O H2N S Cl O O S N H
O S Cl O S N O S O NH2 O NH
O NH
(A)
500 mg
MM 0011.03
Imp. A (EP): Chlorothiazide
O H2N
(A)
500 mg
MM 0011.01
Imp. B (EP): 4-Amino-6-chlorobenzene-1,3-disulphonamide (Salamide)
O H2N S Cl
(B)
100 mg
NH2
Hydrocodone Hydrogen Tartrate 2.5-Hydrate

New MM 1113.00 Hydrocodone Hydrogen Tartrate 2.5-Hydrate [Controlled Substance]
N x
(A)
100 mg
MM 0037.00
Imp. A (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate [Controlled Substance]

HO O
(A)
250 mg
OH
MM 0280.00
Imp. A (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate [Controlled Substance]

HO O
(A)
250 mg
OH
MM 0004.00
Imp. C (EP) as Monohydrate: Codeine Monohydrate [Controlled Substance]
(A)
100 mg
OH
MM 0442.00
Imp. C (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O O
(A)
100 mg
OH
MM 0672.00
Imp. D (EP) as Hydrochloride: 4,5-Epoxy-14hydroxy-3-methoxy-17-methylmorphinan-6one Hydrochloride (Oxycodone Hydrochloride) [Controlled Substance]

O
N HO x
(A)
100 mg
Edition 2012/2013
119
Code Product Price
N
Unit
MM 0004.02
Imp. E (EP): 7,8-Didehydro-4,5-epoxy-3-methoxy17-methylmorphinan-6-one (Codeinone)

O O N
(A)
100 mg
MM 0004.03
Imp. F (EP): 7,8-Didehydro-4,5-epoxy-3,6-dimethoxy17-methylmorphinan (Methylcodeine; O-Methylcodeine) [Controlled Substance]

O O
(A)
100 mg
O
O
MM 0630.01
Imp. H (EP): Diphenylmethanone (Benzophenone)
(B)
100 mg
Hydrocortisone
MM 0185.00 Hydrocortisone
HO O OH OH
(A)
500 mg
MM 0193.00
Imp. A (EP): Prednisolone

HO
O OH OH
(A)
500 mg
MM 0214.00
Imp. B (EP): 17,21-Dihydroxypregn-4-ene3,11,20-trione (Cortisone)

O
O O OH OH
(A)
500 mg
MM 0187.00
Imp. C (EP): Hydrocortisone Acetate (Hydrocortisone 21-Acetate)

O
O HO OH O
(A)
500 mg
MM 0185.06
Imp. D (EP): 6,11,17,21-Tetrahydroxypregn-4ene-3,20-dione (6-Hydroxyhydrocortisone)

O
O HO OH OH
(A)
100 mg
OH
MM 0185.07
Imp. E (EP): 11,17,21-Trihydroxypregna-4,6diene-3,20-dione (-Hydrocortisone)

O
O HO OH OH
(D)
100 mg
MM 0185.08
Imp. F (EP): 17,21-Dihydroxypregn-4-ene-3,20-dione (Reichstein's Substance S)

O
O OH OH
(A)
100 mg
MM 0185.13
6-Hydroxyhydrocortisone
HO
O OH OH
(D)
50 mg
O OH
Hydrocortisone Acetate
MM 0187.00 Hydrocortisone Acetate
HO O OH O O
(A)
500 mg
MM 0185.00
Imp. A (Pharmeuropa): 11,17,21-Trihydroxypregn-4-ene-3,20-dione (Hydrocortisone)
O HO OH OH
(A)
500 mg
120
Edition 2012/2013
Code Product Price
O O O O O O O O
Unit
MM 0187.06
Hydrocortisone 11,17,21-Triacetate
(B)
10 mg
MM 0187.09
11,17,21-Trihydroxypregna-4,6-diene-3,20-dione 21-Acetate
HO
O O O OH
(D)
100 mg
MM 0194.00
Imp. C (Pharmeuropa): 11,17-Dihydroxy-3,20dioxopregna-1,4-dien-21-yl Acetate (Prednisolone Acetate)

O
O HO OH O
(A)
500 mg
MM 0186.00
Imp. D (Pharmeuropa): 17-Hydroxy-3,11,20Trioxopregn-4-en-21-yl Acetate (Cortisone Acetate)

O
O O OH O
(A)
500 mg
Hydrocortisone 17-Butyrate
MM 0188.00 Hydrocortisone 17-Butyrate
HO O O OH O O
(A)
500 mg
MM 0188.01
Hydrocortisone 21-Butyrate
HO
O O O OH
(A)
100 mg
Hydrocortisone Hydrogen Succinate

MM 0185.00 Imp. A (EP): Hydrocortisone
HO O OH OH
(A)
500 mg
MM 0187.00
Imp. B (EP): Hydrocortisone Acetate

HO
O OH O
(A)
500 mg
Hydromorphone Hydrochloride
New MM 0371.00 Hydromorphone Hydrochloride [Controlled Substance]
N x HCl
(A)
100 mg
HO
MM 0037.00
Imp. C (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate [Controlled Substance]

HO O
N
N x HCl x 3 H2O OH
(A)
250 mg
MM 0280.00
Imp. C (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate [Controlled Substance]

HO O
(A)
x H2SO4 x 5 H2O OH 2
250 mg
Hydroxychloroquine Sulphate
MM 0764.00 Hydroxychloroquine Sulphate
Cl N x H2SO4 HN OH
(A)
500 mg
Edition 2012/2013
121
Code Product Price
Cl N x 2 HCl HN OH
Unit
MM 0764.02
Desethylhydroxychloroquine Dihydrochloride
(D)
100 mg
N H
MM 0764.04
O-Acetylhydroxychloroquine
Cl
(A)
O O
100 mg
HN
MM 0764.05
Hydroxychloroquine N-Oxide Dihydrochloride
Cl
(B)
x 2 HCl OH O
10 mg
HN
Hydroxyethyl Salicylate
MM 0112.00 Hydroxyethyl Salicylate
O O OH OH
(A)
500 mg
MM 0045.00
Imp. A (EP): Salicylic Acid
O OH OH
(A)
500 mg
Hydroxyzine Hydrochloride
MM 0852.00 Hydroxyzine Hydrochloride
Cl N x 2 HCl N O OH
(A)
250 mg
MM 0380.01
Imp. A (EP): (RS)-1-[(4-Chlorophenyl) phenylmethyl]piperazine
Cl N
NH
(A)
100 mg
MM 0852.02
Imp. B (EP) as Dihydrochloride: 2-[2-[4-(Diphenylmethyl)piperazin-1-yl]ethoxy]ethanol Dihydrochloride (Decloxizine Dihydrochloride)
N N
OH x 2 HCl
(A)
50 mg
Hymechromone
MM 0294.00 Hymecromone
HO O O
(A)
500 mg
MM 0294.01 MM 0294.02
Imp. A (EP): 1,3-Dihydroxybenzene (Resorcinol) Imp. B (EP): 7-Hydroxy-2-methyl-4H-1-benzopyran-4-one

HO
HO
OH
(B) (A)
100 mg 100 mg
MM 0294.03
2,4-Dihydroxyacetophenone
HO
OH O
(B)
100 mg
MM 0294.04
Hymecromone Acetate
O
(A)
100 mg
MM 0294.50
7-Acetoxy-3-acetyl-2-4H-1-benzopyran-4-one
O
(A)
O
100 mg
122
Edition 2012/2013
Hyoscine Butylbromide
MM 0683.00 Hyoscine Butylbromide
H O H O OH H
H O H O OH H N H H O x HBr x 3 H2O
(A)
+ N O Br
500 mg
MM 0546.00
Imp. A (EP) as Hydrobromide Trihydrate: Hyoscine Hydrobromide Trihydrate
(A)
500 mg
MM 0601.03
Imp. B (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (DL-Tropic Acid; Tropic Acid)
O OH OH
(A)
100 mg
Hyoscine Hydrobromide
MM 0546.00 Hyoscine Hydrobromide Trihydrate
H O H O OH H
O
H N H
H H O H N H H O
(A)
O x HBr x 3 H2O
500 mg
MM 0546.06
Imp. C (EP): (1R,2R,4S,5S,7s)-9-Methyl-3-oxa9-azatricyclo[3.3.1.02,4]non-7-yl 2-Phenylprop2-enoate (Apohyoscine) Imp. D (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (DL-Tropic Acid; Tropic Acid) Hyoscine N-Oxide Hydrobromide
(A)
100 mg
MM 0601.03
O OH OH
(A)
100 mg
MM 0546.07
H O H O OH H N
H O H x HBr
(A)
100 mg
Hyoscyamine Sulphate
MM 0601.03 Imp. A (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (DL-Tropic Acid; Tropic Acid) Imp. D (EP) as Hydrobromide Trihydrate: Hyoscine Hydrobromide Trihydrate
H O H O OH H
O
O OH OH
(A)
100 mg
MM 0546.00
H N H
H
(A)
O x HBr x 3 H2O
500 mg
MM 0289.01
Imp. G (EP) as Hydrochloride: (1R,3r,5S)-8-Methyl8-azabicyclo[3.2.1]oct-3-yl 2-Phenylprop-2-enoate Hydrochloride (Apoatropine Hydrochloride)
(D)
N x HCl
100 mg
H O H
Ibandronate Sodium Monohydrate

MM 1326.00 Ibandronate Sodium Monohydrate
N OH O OH HO P x H2O OH P ONa O
(A)
100 mg
Ibuprofen
MM 0002.00 Ibuprofen
O OH
(A)
500 mg
MM 0002.13
Imp. A (EP): (2RS)-2-[3-(2-Methylpropyl)phenyl]propanoic Acid

O
OH
(A)
100 mg
MM 0002.01
Imp. B (EP):(2RS)-2-(4-Butylphenyl)propanoic Acid

O
OH
(A)
100 mg
MM 0002.10
Imp. C (EP): (2RS)-2-[4-(Methylpropyl)phenyl]propanamide

O
NH2
(A)
100 mg
Edition 2012/2013
123
Code Product Price
OH O
Unit
MM 0002.11
Imp. D (EP): (2RS)-2-(4-Methylphenyl)propanoic Acid
(A)
100 mg
MM 0002.04
Imp. E (EP): 1-[4-(2-Methylpropyl)phenyl]ethanone
(A)
100 mg
MM 0002.28
Imp. F (EP): 3-[4-(2-Methylpropyl)phenyl]propanoic Acid
O OH
(A)
100 mg
MM 0002.38
Imp. G (EP): (1RS,4RS)-7-(2-Methylpropyl)-1[4-(2-methylpropyl)phenyl]-1,2,3,4-tetrahydronaphthalene-1,4-dicarboxylic Acid
OH
(D)
50 mg
OH O
and enantiomer
MM 0002.30
Imp. H (EP):(3RS)-1,3-Bis[4-(2-methylpropyl) phenyl]butan-1-one Imp. I (EP): 1-(2-Methylpropyl)-4-[(3RS)-3[4-(2-methylpropyl)phenyl]butyl]benzene Imp. J (EP): (2RS)-2-[4-(2-Methylpropanoyl)phenyl] propanoic Acid
(D)
100 mg
MM 0002.31
(A)
50 mg
MM 0002.02
OH O O
(A)
100 mg
MM 0002.26
Imp. K (EP): (2RS)-2-(4-Formylphenyl) propanoic Acid Imp. L (EP): 2-[4-(1-Hydroxy-2-methylpropyl)phenyl] propanoic Acid (1-Hydroxyibuprofen)
OH O O
(A)
100 mg
MM 0002.24
OH O OH
(A)
100 mg
MM 0002.34
Imp. M (EP): (2RS)-2-Hydroxy2-[4-(2-methylpropyl)phenyl]propanoic Acid Imp. N (EP): (2RS)-2-(4-Ethylphenyl)propanoic Acid
OH OH O
(A)
100 mg
MM 0002.35 MM 0002.33
OH O
(A) (A)
100 mg 100 mg
Imp. O (EP): 2-[4-(1-Methylpropyl)phenyl]propanoic Acid

O
OH
MM 0002.19 MM 0002.36 MM 0002.37 MM 0002.03
Imp. P (EP):(2RS)-2-[4-(2-Methylpropyl)phenyl]propan-1-ol Imp. Q (EP): 2-[4-(2-Methylpropyl)phenyl]ethanol Imp. R (EP): 1,1'-(Ethane-1,1-diyl)-4,4'-(2methylpropyl)dibenzene 4-Isobutylbenzoic Acid
O
OH
(A) (A) (A) (A)
100 mg 100 mg 100 mg 100 mg
OH
OH
MM 0002.07
2-(4-Isobutyrylphenyl)propanamide
O O
NH2
(A)
100 mg
MM 0002.08
4-Acetylbenzoic Acid
O
O OH
(A)
100 mg
MM 0002.09
4-Isobutyrylacetophenone
O
(A)
100 mg
MM 0002.14
2-(4-Isobutyrylphenyl)propane
O
(A)
100 mg
124
Edition 2012/2013
Code Product Price
OH O O
Unit
MM 0002.15
2-Hydroxypropyl 2-(4-Isobutylphenyl)propanoate
(A)
100 mg
MM 0002.16
1-Hydroxyprop-2-yl 2-(4-Isobutylphenyl)propanoate
O
on request
OH
MM 0002.17
2,3-Dihydroxypropyl 2-(4-Isobutylphenyl)propanoate
O
OH O OH
(D)
50 mg
MM 0002.18
1,3-Dihydroxyprop-2-yl 2-(4-Isobutylphenyl)propanonate
O
on request
OH OH
MM 0002.20
2-(4-n-Propylphenyl)propanoic Acid
O
OH
(A)
100 mg
MM 0002.21
2-(4-Isobutylphenyl)propionitrile
N
(A)
100 mg
MM 0002.23
Isopropyl 2-(4-Isobutylphenyl)propanonate
O
(A)
100 mg
MM 0002.25
1-Ethyl-4-isobutylbenzene
(A)
100 mg
MM 0002.29
(1RS,4SR)-7-(2-Methylpropyl)-1-[4-(2-methylpropyl)phenyl]-1,2,3,4-tetrahydronaphthalene1,4-dicarboxylic Acid
OH
(D)
100 mg
OH O
and enantiomer
MM 0002.32
2-[4-(2-Hydroxy-2-methylpropyl)phenyl]propanoic Acid (2-Hydroxyibuprofen)

HO
OH O
(A)
100 mg
MM 0002.45
(2SR)-2-(4-Isobutylphenyl)-N-((SR)1-phenylethyl)propanamide
O and enantiomer
H N
(A)
100 mg
MM 0002.46
(2SR)-2-(4-Isobutylphenyl)-N-((RS)1-phenylethyl)propanamide
O and enantiomer
H N
(A)
100 mg
MM 0002.48 MM 0002.50
4-Isobutylstyrene 1-(4-Isobutylphenyl)ethanol
OH
(B) (A)
10 mg 100 mg
MM 0002.51
4-(1-Hydroxy-2-methylpropyl)acetophenone
OH
(A)
100 mg
New MM 0002.56
Ibuprofen Ethyl Ester

O
(A)
100 mg
MM 0002.53
Ibuprofen Methyl Ester

O
(A)
100 mg
MM 0002.57
1-(4-Isopropylphenyl)ethanone (4-Isopropylacetophenone) 2-(4-Isopropylphenyl)acrylic Acid

O
(A)
100 mg
MM 0002.59
OH
(C)
50 mg
Edition 2012/2013
125
Idoxuridine
MM 0791.00 Idoxuridine
HN HO O O N O I
(A)
500 mg
OH
Imidocarb Dipropionate
MM 0742.00 Imidocarb Dipropionate
H N N O N H N H H N N O x2 OH
(A)
100 mg
Imipramine Hydrochloride
MM 0077.00 Imipramine Hydrochloride
N N x HCl
(A)
500 mg
MM 0589.00
Imp. A (EP) as Hydrochloride: 3-(10,11-Dihydro5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1amine Hydrochloride (Desipramine Hydrochloride) Imp. B (EP): 3-(5H-Dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine (Depramine; 10,11-Dehydroimipramine)
(A)
N N H x HCl
250 mg
MM 0077.05
(A)
N N
100 mg
MM 0077.08
Imp. C (EP) as Hydrochloride: 10-[3-(Dimethylamino)propyl]acridin-9(10H)-one Hydrochloride

O
(A)
N N x HCl
100 mg
MM 0077.03
N-[3-(10,11-Dihydro-5H-dibenzo-[b,f]azepin-5-yl) propyl]-N,N',N'-trimethylpropane-1,3-diamine Dihydrochloride
(B)
N N N
10 mg
x 2 HCl
MM 0077.04
10-Hydroxyimipramine BH3-Aduct
N N x BH3
(A)
100 mg
HO
MM 0076.06
Iminodibenzyl
NH
(B)
100 mg
MM 0077.12
Imipramine N-Oxide
N N O
(A)
100 mg
Indanazoline Hydrochloride
MM 0588.02 4-Aminoindan Hydrochloride
x HCl NH2
(A)
100 mg
Indapamide
MM 0477.00 Indapamide
O H2 N Cl O S O N H N
(A)
250 mg
MM 0477.01
Imp. A (EP): (2RS)-2-Methyl-1-nitroso2,3-dihydro-1H-indole
(A)
ON N
100 mg
126
Edition 2012/2013
Code Product Price
O O S H2N Cl O N H N
Unit
MM 0477.02
Imp. B (EP): 4-Chloro-N-(2-methyl-1Hindol-1-yl)-3-sulphamoylbenzamide 4-Chloro-3-sulfamoylbenzoic Acid
(A)
100 mg
MM 0477.04
O H2N
O S
O OH
(C)
100 mg
Cl
MM 0477.05
N-(4-Chloro-3-sulfamoylbenzoyl)-2-methylindoline
O H2 N
O S
O N
(D)
100 mg
Cl
MM 0477.07 MM 0477.08 MM 0477.09
Triethylamine
N
(C) (A)
HN
100 mg 100 mg 100 mg
2-Methylindoline 1-Amino-2-methylindoline Hydrochloride

H2N N
x HCl
(D)
Indometacin
MM 0584.00 Indometacin
Cl O O N O OH
(A)
500 mg
MM 0063.03
Imp. A (EP): 4-Chlorobenzoic Acid

Cl
O OH
(B)
100 mg
MM 0584.02
3,4-Dichloroindometacin ([1-(3,4-Dichlorobenzoyl)5-methoxy-2-methylindol-3-yl]acetic Acid)
O Cl Cl O N O OH
(A)
50 mg
Indoramin Hydrochloride
MM 0802.02 Imp. A (BP): 3-(2-Bromoethyl)indole
H N
(A)
Br
100 mg
New MM 0802.05
Imp. B (BP): N-(1-Benzyl-4-piperidyl)benzamide

N
H N O
(A)
50 mg
Ipecacuanha
MM 0131.02 Emetine Dihydrochloride
O O N H HN x 2 HCl O O
(A)
100 mg
Ipratropium Bromide
MM 0601.03 Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (dl-Tropic Acid) Imp. D (EP): 2-Phenylpropenoic Acid (Atropic Acid)
O OH OH
(A)
100 mg
MM 0289.03
O OH
(A)
100 mg
Iprindole Hydrochloride
MM 0478.00 Iprindole Hydrochloride
N N x HCl
(A)
100 mg
Edition 2012/2013
127
Irbesartan
MM 0862.01 Imp. A (EP): 1-(Pentanoylamino)-N-[[2'-(1Htetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide
O N H N N HN N
(A)
50 mg
NH O
Isoamyl Benzoate
MM 1086.00 Isoamyl Benzoate
O O
(A)
500 mg
Isoconazol Nitrate
MM 0541.00 Isoconazole Nitrate
Cl Cl O Cl N N Cl
(A)
x HNO3
100 mg
MM 0281.01

HO Cl
(A)
100 mg
Cl
MM 0541.02
Imp. B (EP) as Nitrate: (2RS)-2-[(2,6-Dichlorobenzyl)oxy]2-(2,4-dichlorophenyl)ethanamine Nitrate

Cl Cl O Cl
Cl
(D)
x HNO3 NH2
100 mg
MM 0281.00
Imp. C (EP) as Nitrate: 1-[(2RS)2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]1H-imidazole Nitrate (Miconazole Nitrate)
Cl
(A)
x HNO3
500 mg
Cl O Cl Cl N N
Isoflurane
MM 0500.02 Imp. B (EP): 2-(Difluoromethoxy)-1,1,1-trifluoroethane
F F F F
Cl F F F Cl F F F Cl O F F F O F Cl
(A)
F
100 mg
MM 0500.03
Imp. C (EP): (2RS)-2-Chloro-2-(chlorodifluoromethoxy)1,1,1-trifluoroethane Imp. D (EP): 1,1-Dichloro-1-(difluoromethoxy)-2,2,2-trifluoroethane
(A)
100 mg
MM 0500.04
(A)
100 mg
MM 0500.05 MM 0500.06
Imp. E (EP): 1,1-Dichloro-1-(chlorodifluoromethoxy)-2,2,2trifluoroethane Imp. F (EP): Acetone
Cl F F F
Cl F O
F Cl
(A) (C)
100 mg 100 mg
Isoproturon
MM 2503.02 3-(2-Isopropylphenyl)-1,1-dimethylurea
H N O
(A)
N
100 mg
MM 2503.03
3-(3-Isopropylphenyl)-1,1-dimethylurea
H N O
(A)
100 mg
Isosorbide Dinitrate
MM 0126.05 Imp. B (EP): Isosorbide 2-Nitrate
O O HO H H O NO2
(A)
100 mg
128
Edition 2012/2013
Code Product Price
H O O O2 N O H
H O O HO H O
Unit
MM 0502.00
Imp. C (EP): Isosorbide Mononitrate (Isosorbide 5-Nitrate)
OH
(A)
500 mg
MM 0126.01
2-Monomethyl Isosorbide
on request
MM 0126.02
Dimethyl Isosorbide
H O
(B)
100 mg
O O H H O O HO H OH
MM 0126.03
Isosorbide
(A)
500 mg
MM 0126.04
Isomannit initrate
O
O NO2
on request
O O2 N O H
Isosorbide Mononitrate
MM 0502.00 Isosorbide Mononitrate
H O O O2 N O H O NO2 OH
(A)
500 mg
MM 0126.05
Imp. C (EP): Isosorbide 2-Nitrate

O
(A)
100 mg
O HO H H O O HO H OH
MM 0126.03
Isosorbide
(A)
500 mg
Isoxsuprine Hydrochloride
MM 0576.00 Isoxsuprine Hydrochloride
HO and enantiomere OH H N
(A)
O x HCl
500 mg
Itraconazole
MM 0258.00 Itraconazole
N N N O
(A)
100 mg
N N Cl O O O N N N and enantiomer Cl
MM 0258.02
Imp. A (EP): 4-[4-[4-(4-Methoxyphenyl)piperazin1-yl]phenyl]-2-[(1RS)-1-methylpropyl]-2,4-dihydro3H-1,2,4-triazol-3-one
(A)
N N N O
100 mg
N N
Edition 2012/2013
129
MM 0258.04
Imp. C (EP): 4-[4-[4-[4-[[cis-2-(2,4-Dichlorophenyl)2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-propyl2,4-dihydro-3H-1,2,4-triazol-3-one
(A)
N N N O
100 mg
MM 0258.05
Imp. D (EP): 4-[4-[4-[4-[[cis-2-(2,4-Dichlorophenyl)2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-(1methylethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
(A)
N N N O
100 mg
MM 0258.07
Imp. F (EP): 2-Butyl-4-[4-[4-[4-[[cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2,4dihydro-3H-1,2,4-triazol-3-one
(A)
N N N O
100 mg
N N Cl O O O N N N
N NH N O
and enantiomer Cl
MM 0258.10
2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]3H-1,2,4-triazol-3-one
(A)
100 mg
N N
MM 0258.11
cis-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)1,3-dioxolane-4-methanol Mesilate
S O O O
and enantiomer Cl O O N N N Cl
(A)
100 mg
Ketamine Hydrochloride
MM 0144.00 Ketamine Hydrochloride
O NH x HCl Cl
(A)
500 mg
MM 0144.01
Imp. A (EP): 1-[(2-Chlorophenyl)(methylimino)methyl]cyclopentanol
HO
Cl
(A)
100 mg
130
Edition 2012/2013
Code Product Price
O OH Cl
Unit
MM 0144.02
Imp. B (EP): (2RS)-2-(2-Chlorophenyl)-2-hydroxycyclohexanone Dehydronorketamine Hydrochloride

O
(A)
100 mg
New MM 0144.07
NH2
Cl x HCl
(A)
50 mg
Ketoconazole
MM 0145.00 Ketoconazole
O N O N and enantiomer Cl O O N N Cl
(A)
500 mg
MM 0145.04
Imp. D (EP): 1-[4-[[(2RS,4SR)2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)1,3-dioxolan-4-yl]methoxy]phenyl]piperazine

N HN
Cl O O O N N and enantiomer
O N N
Cl
(A)
100 mg
MM 0145.05
1-Acetyl-4-(4-hydroxyphenyl)piperazine
OH
(A)
100 mg
Ketoprofen
MM 0001.00 Ketoprofen
O OH O
(A)
500 mg
MM 0001.01
Imp. A (EP):1-(3-Benzoylphenyl)ethanone (3-Acetylbenzophenone) Imp. B (EP): (3-Benzoylphenyl)acetic Acid

O
(A)
100 mg
MM 0001.03
OH O
(A)
100 mg
MM 0001.07
Imp. C (EP):3-[(1RS)-1-Carboxylethyl]benzoic Acid

HO
O OH O
(A)
100 mg
MM 0001.12
Imp. D (EP): (2RS)-2-[3-(4-Methylbenzoyl)phenyl] propanoic Acid Imp. E (EP):(2RS)-2-(3-Benzoylphenyl)propanamide
O OH O O NH2 O
(D)
100 mg
MM 0001.05
(A)
100 mg
MM 0001.04
Imp. F (EP): (2RS)-2-(3-Benzoylphenyl)propanenitrile
O N
(A)
100 mg
MM 0001.20
Imp. G (EP): 3-[(1RS)-1-Cyanoethyl]benzoic Acid

HO
O N
(A)
100 mg
MM 0001.22
Imp. H (EP): 3-(Cyanomethyl)benzoic Acid

HO
(A)
N
100 mg
MM 0001.14
Imp. I (EP): (3-Benzoylphenyl)ethanenitrile
O N
(A)
100 mg
MM 0001.23
Imp. J (EP): (2RS)-2-[3-(2,4-Dimethylbenzoyl)phenyl]propanoic Acid 3-Ethylbenzophenone
O OH O
(D)
50 mg
MM 0001.02
(A)
100 mg
MM 0001.11
3-(1-Hydroxyethyl)benzophenone
OH
(A)
100 mg
Edition 2012/2013
131
Code Product Price
O
Unit
MM 0001.13
3-Methylbenzophenone
(B)
100 mg
MM 0001.17
3-(1-Methoxyethyl)benzophenone
(A)
100 mg
MM 0001.18
2-[3-(-Hydroxybenzyl)phenyl]propanoic Acid
OH OH O
(A)
100 mg
MM 0001.19
Ethyl 2-(3-Benzoylphenyl)propionate (Ketoprofen Ethyl Ester) Isopropyl 2-(3-Benzoylphenyl)propionate
O O O O O O
(A)
100 mg
MM 0001.21
(A)
100 mg
MM 0001.50
3-(1-Acetoxyethyl)benzophenone
O O
(A)
100 mg
MM 0001.32
Methyl 2-(3-Benzoylphenyl)propionate (Ketoprofen Methyl Ester) 2-Ethylhexyl 2-(3-Benzoylphenyl)propionate (Ketoprofen 2-Ethylhexyl Ester)
O
O O O
(A)
100 mg
MM 0001.33
(A)
O O
100 mg
Ketorolac Trometamol
MM 0851.00 Ketorolac Trometamol
N O O OH x HO OH NH 2 OH
(A)
250 mg
MM 0851.03
Imp. I (EP): Phenyl(2,3-dihydro-1H-pyrrolizin5-yl)methanone

O
(A)
N
100 mg
Ketotifen Hydrogen Fumarate

MM 0180.00 Ketotifen Hydrogen Fumarate
O S N O x HO O OH
(A)
250 mg
MM 0180.04
Ketotifen
O
(A)
100 mg
MM 0180.08
Imp. B (EP): (4RS)-10-Methoxy-4-(1-methylpiperidin-4-yl)-4H-benzo[4,5]cyclohepta[1,2b]thiophen-4-ol
S O OH
(A)
100 mg
MM 0180.07
Imp. D (EP): 4-[(aRaS)-1-Methylpiperidin-4ylidene]-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one N-Oxide (Ketotifen N-Oxide) 10-Methoxy-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-one
O S O N
(A)
100 mg
MM 0180.11
S O O
(A)
100 mg
New MM 0180.12
N-Desmethylketotifen Hydrogen Fumarate

O
NH O x HO O OH
(A)
50 mg
132
Edition 2012/2013
Labetalol Hydrochloride
MM 0438.00 Labetalol Hydrochloride
HO O NH2
OH H N x HCl HO O OH
OH
H N x HCl
(A)
500 mg
New MM 0438.01
Imp. A (EP) as Hydrochloride: 2-Hydroxy5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)-amino]ethyl]benzoic Acid Hydrochloride
(A)
50 mg
Lacidipine
MM 0407.00 Lacidipine
O O O H N O O O
(A)
100 mg
MM 0407.01
Imp. A (BP): Ethyl Methyl (E)-4-{2-[2-(tertButoxycarbonyl)vinyl]phenyl}-1,4-dihydro-2,6dimethyl-pyridine-3,5-dicarboxylate
H N O O O O O O
(A)
100 mg
MM 0407.02
Imp. B (BP): Diethyl (E)-4-{2-[2-(tert-Butoxycarbonyl)vinyl]phenyl}-2,6-dimethylpyridine3,5-dicarboxylate
N O O O O O O
(A)
100 mg
Lamivudine
MM 0749.00 Lamivudine
N O O S HO N NH2
(A)
100 mg
MM 0045.00
Imp. C (EP): Salicylic Acid
O OH OH
(A)
500 mg
MM 0749.05
Imp. E (EP): 4-Aminopyrimidin-2(1H)-one(Cytosine)

N O
NH2
(A)
100 mg
N H O HN
MM 0593.03
Imp. F (EP): Pyrimidine-2,4(1H,3H)-dione (Uracil)

O
(C)
100 mg
N H
Edition 2012/2013
133
Lamotrigine
MM 0922.00 Lamotrigine
N N N Cl Cl NH2 NH2
(A)
100 mg
MM 0922.01
Imp. A (EP): 3-Amino-6-(2,3-dichlorophenyl)1,2,4-triazin-5(4H)-one

Cl
NH2 NH
(A)
100 mg
Cl
MM 0922.03
Imp. C (EP): (2Z)-[2-(Diaminomethylidene)diazanylidene](2,3-dichlorophenyl)acetonitrile

Cl
NH2 NH2 N
(A)
100 mg
Cl
MM 0922.04
Imp. D (EP): 6-(2,3-Dichlorophenyl)-1,2,4triazine-3,5(2H,4H)-dione
H N
O NH
(A)
50 mg
Cl Cl
MM 0922.05
Imp. E (EP): 2,3-Dichlorobenzoic Acid
O OH Cl Cl
(A)
100 mg
MM 0922.07
Imp. G (EP): 6-(2,4-Dichlorophenyl)-1,2,4triazine-3,5-diamine

Cl
Cl
N N NH2
NH2
(A)
50 mg
Lansoprazole
MM 0474.00 Lansoprazole
N NH S O N O F F F
(A)
100 mg
MM 0474.07
Imp. A (EP): 2-[(RS)-[[3-Methyl-1-oxido4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphinyl]-1H-benzimidazole (Lansoprazole N-Oxide) Imp. B (EP): 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphonyl]-1Hbenzimidazole (Lansoprazole Sulphone) Imp. C (EP): 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphanyl]-1Hbenzimidazole Imp. D (EP): 1H-Benzimidazol-2-ol
NH N S O O N O
F F
(D)
100 mg
MM 0474.01
NH N S O O O N
F F
(A)
100 mg
MM 0474.06
NH N S N O
F F
(A)
100 mg
MM 0474.03
NH N OH
NH N SH
(B)
100 mg
MM 0474.05
Imp. E (EP): 1H-Benzimidazole-2-thiol
(A)
100 mg
MM 0474.02
Imp. F (EP): 2-[(RS)-[(4-Chloro-3-methylpyridin2-yl)methyl]sulphinyl]-1H-benzimidazole

N
NH S O N
O
(A)
Cl
100 mg
MM 0474.04
4-Ethoxyacetophenone
O
(C)
100 mg
MM 0474.08
Lansoprazole Sulphone N-Oxide

N
NH S O O N O
F Cl N O
F O
F F
(A)
100 mg
MM 0474.09
2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy pyridine Hydrochloride
F F x HCl
(A)
100 mg
134
Edition 2012/2013
Code Product Price
S O N N N
Unit
MM 0474.13
1-Methyl-12-thioxopyrido[1',2':3,4]imidazo[1,2-a] benzimidazol-2(12H)-one
(D)
100 mg
Leflunomide
MM 0859.00 Leflunomide
N O O F H N F F
(D)
100 mg
MM 0859.01
Imp. A (EP) as Hydrochloride: 4-(Trifluoromethyl)aniline Hydrochloride Imp. B (EP): (2Z)-2-Cyano-3-hydroxy-N-[4(trifluoromethyl)phenyl]but-2-enamide (Teriflunomide)
H2N F F F x HCl
(A)
100 mg
MM 0859.02
N H N OH O F F F
F F
(A)
100 mg
MM 0859.03
Imp. C (EP): 5-Methyl-N-[3-(trifluoromethyl)phenyl]isoxazole-4-carboxamide Imp. D (EP): 5-Methylisoxazole-4-carboxylic Acid
N O O H N
(A)
100 mg
MM 0859.04
N O O OH
(A)
100 mg
MM 0859.05
Imp. E (EP): 3-Methyl-N-[4-(trifluoromethyl)phenyl] isoxazole-4-carboxamide
N O O F H N F F
(A)
50 mg
MM 0859.06
Imp. F (EP): 5-Methyl-N-[2-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
N O O H N
F F
(A)
100 mg
MM 0859.07
Imp. G (EP): 5-Methyl-N-(4-methylphenyl)isoxazole-4-carboxamide Imp. H (EP): 2-Cyano-N-[4-(trifluoromethyl)phenyl]acetamide
N O O H N
(A)
100 mg
MM 0859.08
N H N O F F F
(A)
50 mg
Letrozole
New MM 1143.02 Imp. A (EP): 4,4'-(4H-1,2,4-Triazol-4-ylmethylene)dibenzonitrile
N N
(A)
50 mg
N N N
Levamisole Hydrochloride
MM 0706.00 MM 0706.04 Levamisole Hydrochloride Imp. D (EP): 6-Phenyl-2,3-dihydro-imidazo[2,1-b]thiazole
N N
N N
S x HCl
S
(A) (A)
100 mg 100 mg
Levetiracetam
New MM 1372.00 Levetiracetam
O O N NH2
(A)
50 mg
Levocetirizine Dihydrochloride
MM 1035.00 Levocetirizine Dihydrochloride
O Cl N x 2 HCl N O OH
(D)
100 mg
Edition 2012/2013
135
Levodopa
MM 0262.00 Levodopa
O HO HO NH 2 OH
(A)
500 mg
MM 0634.00
Imp. B (EP): (2S)-2-Amino-3-(4-hydroxyphenyl)propanoic Acid (Tyrosine)

HO
O OH NH2
O OH HO O NH2
(A)
100 mg
MM 0262.05
Imp. C (EP): (2RS)-2-Amino-3-(4-hydroxy3-methoxyphenyl)propanoic Acid (3-Methoxy-DL-tyrosine; (DL)-3-O-Methyldopa) 4-Hydroxy-3-methoxymandelic Acid
(A)
100 mg
MM 0262.06
OH OH HO O O
(A)
100 mg
Levodropropizine
MM 1246.02 Imp. B (EP) as Hydrochloride: 1-Phenylpiperazine Hydrochloride
NH N x HCl
(A)
100 mg
Levofloxacin
MM 0846.00 Levofloxacin
N N F O O O N OH
(A)
100 mg
Levomenthol
MM 0388.00 Levomenthol
OH
(A)
500 mg
Levomepromazine Hydrochloride
MM 0266.00 Levomepromazine Hydrochloride
N S O N x HCl
(A)
500 mg
Levomepromazine Maleate
MM 0019.00 Levomepromazine Maleate
N S O N x O O OH OH
(A)
100 mg
MM 0019.02
Imp. A (EP): 2-Methoxyphenothiazine

NH S O
(A)
100 mg
MM 0019.01
Imp. B (EP): 10-[(2R)-3-(Dimethylamino)-2methylpropyl]-2-methoxy-10H-phenothiazine 5-Oxide (Levomepromazine S-Oxide)

O
(A)
N S O N
100 mg
MM 0019.07
N-Demethyllevomepromazine Hydrochloride
N S O N H x HCl
(D)
100 mg
MM 0019.09
Levomepromazine Sulphone Hydrochloride

N O S O O N x HCl
(A)
100 mg
136
Edition 2012/2013
Levonorgestrel
MM 0121.00 Levonorgestrel
OH
(A)
250 mg
MM 0121.08
Imp. G (Pharmeuropa): 13-Ethyl-617dihydroxy-18,19-dinor-17-pregn-4-en20-yn-3-one (6-Hydroxylevonorgestrel)

O OH
OH
(D)
50 mg
MM 0121.01
Imp. H (Pharmeuropa): 13-Ethyl-617dihydroxy-18,19-dinor-17-pregn-4-en20-yn-3-one (6-Hydroxylevonorgestrel)

O OH
OH
(D)
100 mg
MM 0121.02
Imp. J (Pharmeuropa): 13-Ethyl-17-hydroxy18,19-dinor-17-pregn-4-en-20-yn-3,6-dione (6-Oxolevonorgestrel, 6-Ketolevonorgestrel)

O O
OH
(D)
100 mg
MM 0121.12
Imp. L (Pharmeuropa): 13-Ethylgon-4-ene-3,17dione (Levodione, 18-Methyl-19-norandrost-4ene-3,17-dione)

O
(D)
100 mg
MM 0121.11
Imp. M (Pharmeuropa): 13-Ethyl-17-hydroxy18,19-dinor-17-pregna-4,6-dien-20-yn-3-one (6-Levonorgestrel, 6,7-Didehydrolevonorgestrel)

O
OH
(D)
100 mg
Lidocaine Hydrochloride
MM 0102.04 MM 0102.00 Lidocaine Hydrochloride Monohydrate Lidocaine
H N O H N O N x HCl x H2O
(A) (A)
500 mg 500 mg
MM 0102.02
Imp. A (EP): 2,6-Dimethylaniline
NH2
(B)
100 mg
MM 0102.01
Imp. B (EP): 2-(Diethylazinoyl)-N-(2,6dimethylphenyl)acetamide (Lidocaine N2Oxide) Imp. C (EP): N-(2,6-Dimethylphenyl)acetamide Imp. D (EP) as Hydrochloride: N-(2,6Dimethylphenyl)-2-(ethylamino)acetamide Hydrochloride (Monoethylglycinexylidide Hydrochloride) Imp. E (EP) as Hydrochloride: 2,2'(Azanediyl)bis[N-(2,6-dimethylphenyl)acetamide] Hydrochloride Imp. F (EP) as Hydrochloride: 2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide Hydrochloride Imp. G (EP) as Hydrochloride: N-(2,6Dimethylphenyl)-2-[(1-methylethyl)amino]acetamide Hydrochloride Imp. H (EP): 2-Chloro-N-(2,6-dimethylphenyl)acetamide
H N O
O N
(A)
100 mg
MM 0102.08
H N O
(A)
100 mg
MM 0102.05
H N O
(A)
N H x HCl
100 mg
MM 0102.09
H N O
N H
H N O
(A)
x HCl
100 mg
MM 0102.10
H N O
H N O
(A)
N x HCl
100 mg
MM 0102.11
(A)
N H x HCl
100 mg
MM 0102.03
H N O
(B)
Cl
100 mg
MM 0102.12 MM 0102.13
Imp. I (EP) as Hydrochloride: 2-(Diethylamino)N-(2,4-dimethylphenyl)acetamide Hydrochloride
H N O H N O
(A)
x HCl
100 mg 50 mg
Imp. J (EP) as Hydrochloride: 2-(Diethylamino)N-(2,5-dimethylphenyl)acetamide Hydrochloride
(A)
x HCl
Edition 2012/2013
137
Code Product Price
H N O
Unit
MM 0102.14
Imp. K (EP) as Hydrochloride: N-(2,6-Dimethylphenyl)-2-(ethylmethylamino)acetamide Hydrochloride
(A)
N x HCl
100 mg
Liothyronine Sodium
MM 0626.00 Liothyronine Sodium
HO I I O I O
I O HO I I O NH2 OH
(A)
NH2 ONa
50 mg
MM 0626.01
Liothyronine
(A)
100 mg
Lisinopril Dihydrate
MM 0598.00 Lisinopril Dihydrate
H N HO O H2N O N O OH x 2 H2O
(A)
100 mg
MM 0598.01
Imp. A (EP): (2RS)-2-Amino-4-phenylbutanoic Acid

NH2 HO O
(A)
100 mg
MM 0598.02
Imp. B (EP) as Hydrate: 4-Methylbenzenesulphonic Acid Hydrate
O O S OH
(C)
x H2O
100 mg
Lomustine
MM 0923.02 MM 0923.03 Imp. B (EP): 1-(2-Chloroethyl)-3-cyclohexylurea
N H O N H O N H N H Cl
(A) (A)
100 mg 100 mg
Imp. C (EP): 1,3-Dicyclohexylurea
Loperamide Hydrochloride
MM 0025.00 Loperamide Hydrochloride
Cl OH
(A)
500 mg
x HCl N
MM 0025.14
Imp. A (EP): 4-[4-(4'-Chlorobiphenyl-4-yl)-4hydroxypiperidin-1-yl]-N,N-dimethyl-2,2diphenylbutanamide
Cl
(A)
OH
50 mg
N O
MM 0025.15
Imp. B (EP) as Bromide: 4-(4-Chlorophenyl)1,1-bis[4-(dimethylamino)-4-oxo3,3-diphenylbutyl]-4-hydroxypiperidinium Bromide

Cl
N OH N+
on request
BrN
MM 0025.04
Imp. C (EP): 4-(4-Chlorophenyl)piperidin-4-ol
Cl OH
(B)
100 mg
N H
138
Edition 2012/2013
MM 0025.05
Imp. D (EP): 4-(4-Hydroxy-4-phenylpiperidin-1-yl)N,N-dimethyl-2,2-diphenylbutanamide

N
(A)
OH
100 mg
N O
MM 0025.09
Imp. F (EP): Loperamide Oxide
Cl OH
(A)
100 mg
N O
MM 0025.11
Imp. H (EP): 4-[4-(4-Chlorophenyl)-3,6dihydropyridin-1(2H)-yl]-N,N-dimethyl-2,2diphenylbutanamide
Cl
(A)
100 mg
N O
MM 0025.07
Ethyl Diphenylacetate
O O
(A)
100 mg
MM 0025.08
,-Diphenyl--butyrolactone
O O
(A)
100 mg
MM 0025.10
Dimethyl-(tetrahydro-3,3-diphenyl-2-furilidine) ammonium Bromide
O N+ Br-
(A)
100 mg
Loratadine
MM 0257.00 Loratadine
Cl N O O
(A)
100 mg
MM 0257.03
Imp. A (EP): Ethyl 4-[(11RS)-8-Chloro-11hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1carboxylate
Cl OH N
O O
(A)
100 mg
MM 0257.02
Imp. B (EP): 8-Chloro-5,6-dihydro-11Hbenzo[5.6]cyclohepta[1,2-b]pyridin-11-one
Cl O N
(A)
100 mg
MM 0257.08
Imp. C (EP): Ethyl 4-(4,8-Dichloro-5,6-dihydro11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11ylidene)piperidine-1-carboxylate
Cl N
O O
(D)
100 mg
N Cl
Edition 2012/2013
139
Code Product Price
Cl NH
Unit
MM 0257.01
Imp. D (EP): 8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5Hbenzo[5,6]cyclohepta[1,2-b]pyridine (Descarboethoxyloratadine; Desloratadine)
(A)
50 mg
MM 0257.05
Imp. G (EP): 8-Chloro-11-(1-methylpiperidin-4ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
Cl N
(A)
100 mg
MM 0257.07
Imp. H (EP): Ethyl 4-Oxopiperidine-1-carboxylate

N O
O O
(A)
100 mg
MM 0257.06
(11RS)-8-Chloro-11-hydroxy-11-(1-methylpiperidin-4-yl)6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
Cl OH N
(A)
100 mg
Lorazepam
MM 0071.00 Lorazepam [Controlled Substance]
Cl H N N Cl O OH
(A)
100 mg
MM 0071.01
Imp. A (EP): (2-Amino-5-chlorophenyl)(2-chlorophenyl) methanone (2-Amino-2',5-dichlorobenzophenone)
NH2 Cl O Cl
(B)
100 mg
MM 0071.07
Imp. B (EP): (3RS)-7-Chloro-5-(2-chlorophenyl)2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl Acetate (Lorazepam Acetate) [Controlled Substance] Imp. C (EP): 7-Chloro-5-(2-chlorophenyl)1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-Oxide
H N Cl N
O O O Cl
(A)
100 mg
MM 0071.06
H N Cl N
(A)
100 mg
O Cl
MM 0071.03
Imp. D (EP): (5RS)-7-Chloro-5-(2-chlorophenyl)4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione

Cl
H N
O O NH Cl
(A)
100 mg
MM 0071.02
Imp. E (EP): 6-Chloro-4-(2-chlorophenyl)quinazoline-2-carbaldehyde

Cl
O N N Cl
(A)
100 mg
MM 0071.04
6-Chloro-4-(2-chlorophenyl)-2-quinazolinecarboxylic Acid
Cl
O N N Cl OH
(A)
100 mg
MM 0071.08
6-Chloro-4-(2-chlorophenyl)-2-quinazolinemethanol
Cl
OH N N Cl
(A)
100 mg
140
Edition 2012/2013
Code Product Price
H N Cl N Cl O
Unit
MM 0071.09
6-Chloro-4-(2-chlorophenyl)-2(1H)-quinazolinone
(A)
100 mg
Lormetazepam
New MM 0072.00 Lormetazepam [Controlled Substance]
Cl N N Cl O OH
(A)
100 mg
Losartan Potassium
MM 0168.00 Losartan
Cl N OH N N N N NH
on request
MM 0168.14
Imp. B (Pharmeuropa) : [2'-(1H-Tetrazol-5-yl) biphenyl-4-yl]methanol
N N HO HN N
(A)
50 mg
MM 0168.04
Imp. C (Pharmeuropa) : [2-Butyl-5-chloro-1-[[2'(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol4-yl]methanol
Cl N HO N
N N HN N
(D)
50 mg
MM 0168.08
Imp. D (EP) : 2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde

Cl
O NH N
(A)
100 mg
MM 0168.05
Imp. E (EP): 5-(4'-Methylbiphenyl-2-yl)-1H-tetrazole
N N HN N
(A)
50 mg
MM 0168.15
Imp. F (EP) : 5-[4'[[2-Butyl-4-chloro-5-[[(1methylethyl)oxy]methyl]-1H-imidazol-1-yl]methyl]biphenyl-2-yl]-1H-tetrazole (Losartan Isopropyl Ether)
O N N
N N HN N
(A)
100 mg
Cl
MM 0173.04
Imp. G (EP) : Triphenylmethanol

OH
(A)
100 mg
MM 0168.16
Imp. H (EP) : [2-Butyl-4-chloro-1-[[2'-[2(triphenylmethyl)-2H-tetrazol-5-yl]biphenyl4-yl]methyl]-1H-imidazol-5-yl]methanol

Cl
(A)
OH N N
100 mg
N N N N
New MM 0168.17
Imp. I (Pharmeuropa) : 5-[4'-[[2-Butyl-4-chloro5-[[(triphenylmethyl]oxy]methyl]-1H-imidazol1-yl]methyl]biphenyl-2-yl]-1H-tetrazole

Cl
(A)
O N N N N HN N
50 mg
Edition 2012/2013
141
Code Product Price
O O N N N N HN N
Unit
MM 0168.18
Imp. J (EP) : [2-Butyl-4-chloro-1-[[2'-(1Htetrazol-5-yl)biphenyl-4-yl]methyl]-1Himidazol-5-yl]methyl Acetate

Cl
(A)
100 mg
MM 0168.11
Losartan Butyl Ether

Cl
O N N
(A)
N N HN N
50 mg
MM 0168.12
Losartan Methyl Ether

Cl
O N N
N N HN N
(A)
100 mg
Lovastatin
MM 0050.00 Lovastatin
O H OH O O O
(A)
100 mg
MM 0377.00
Imp. A (EP): (1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy6-oxotetrahydro-2H-pyran-2-yl]ethyl]-7-methyl-1,2,3,7,8,8ahexahydronaphthalen-1-yl (2S)-2-Methylbutanoate (Mevastatin)
O O OH O O
(A)
100 mg
MM 0050.01
Imp. B (EP) as Sodium Salt: (3R,5R)-7-[(1S,2S,6R,8S,8aR)2,6-Dimethyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8ahexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic Acid Sodium Salt (Lovastatin Hydroxy Acid Sodium Salt)
O OH H O O ONa OH
(A)
100 mg
MM 0050.03
Imp. C (EP): (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen1-yl (2S)-2-Methylbutanoate (Dehydrolovastatin)
O O H
(A)
100 mg
Malic Acid
MM 1332.01 Imp. A (EP): (E)-Butenedioic Acid (Fumaric Acid)
O HO O OH
(B)
100 mg
Maprotiline Hydrochloride
MM 0820.00 Maprotiline Hydrochloride
N H x HCl
(A)
250 mg
MM 0820.01
Imp. A (EP): 3-(9,10-Ethanoanthracen-9(10H)-yl)prop-2-enal

O
(A)
50 mg
MM 0820.02
Imp. B (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen-9(10H)-yl)-N[3-(9,10-ethanoanthracen-9(10H)-yl)propyl]-Nmethylpropan-1-amine Hydrochloride
(C)
N x HCl
10 mg
142
Edition 2012/2013
MM 0820.03
Imp. C (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen9(10H)-yl)propan-1-amine Hydrochloride
(C)
NH 2 x HCl
10 mg
MM 0820.04
Imp. D (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen9(10H)-yl)-N-methylprop-2-en-1-amine Hydrochloride (Dehydromaprotiline Hydrochloride)
(A)
N H x HCl
50 mg
MM 0820.05
Imp. E (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen9(10H)-yl)-N,N-dimethylpropan-1-amine Hydrochloride
(A)
N x HCl
100 mg
Mebendazole
MM 0882.02 Imp. B (EP): (2-Hydroxy-1H-benzimidazol-5yl)phenylmethanone
O H N OH N
(A)
50 mg
MM 0882.04
Imp. D (EP): Methyl (5-Benzoyl-1-methyl-1Hbenzimidazol-2-yl)carbamate

O
O N NH N O
(A)
50 mg
MM 0882.05
Imp. E (EP): Ethyl (5-Benzoyl-1H-benzimidazol2-yl)carbamate

O
H N N
O O NH
(A)
50 mg
MM 0882.06
Imp. F (EP): Methyl [5-(4-Methylbenzoyl)-1Hbenzimidazol-2-yl]carbamate

O
H N N
O O NH
(A)
50 mg
Mebeverine Hydrochloride
MM 0319.00 Mebeverine Hydrochloride
N O O x HCl O O O
(A)
100 mg
MM 0319.02
Imp. A (Pharmeuropa): 4-Methoxyphenylacetone

O
(B)
100 mg
MM 0319.03
Imp. B (Pharmeuropa) as Hydrochloride: N-[(1RS)1-[(4-Methoxyphenyl)methyl]ethyl]ethanamine Hydrochloride [Controlled Substance]

O
(A)
NH x HCl
100 mg
MM 0319.01
Imp. D (Pharmeuropa): 3,4-Dimethoxybenzoic Acid (Veratric Acid)
O HO O O
(B)
100 mg
Mechlorethamine Hydrochloride
MM 0823.00 Mechlorethamine Hydrochloride
Cl N
x HCl
Cl
(A)
500 mg
Edition 2012/2013
143
Meclofenoxate Hydrochloride
MM 0044.00 Meclofenoxate Hydrochloride
Cl O O O N x HCl
(A)
500 mg
MM 0044.02
(4-Chlorophenoxy)acetic Acid
Cl
O O OH
(B)
100 mg
Meclozine Hydrochloride
MM 0586.00 Meclozine Dihydrochloride
N Cl N x 2 HCl
(A)
500 mg
MM 0380.09
Imp. B (EP): (RS)-(4-Chlorophenyl)phenylmethanol (4-Chlorobenzhydrol)

OH Cl
(B)
100 mg
MM 0380.10
Imp. C (EP): (4-Chlorophenyl)phenylmethanone (4-Chlorobenzophenone)

O Cl
(B)
100 mg
MM 0586.08
Imp. D (EP): 1,1'(1,3-Phenylenebismethylene)bis[4-[(4-chlorophenyl)phenylmethyl] piperazine]

N Cl N
(A)
N N Cl
50 mg
MM 0586.09
Imp. E (EP): 1-(Diphenylmethyl)-4-[(3-methylphenyl)methyl]piperazine

N N
(A)
50 mg
MM 0380.04
Imp. F (EP): 1,4-Bis[(4-chlorophenyl)phenylmethyl]-piperazine

N Cl N Cl
(A)
100 mg
MM 0380.01
Imp. H (EP): 1-[(RS)-(4-Chlorophenyl)phenylmethyl]piperazine ((RS)-1-[(4-Chlorophenyl)phenylmethyl]piperazine)

Cl
(A)
N NH
100 mg
MM 0586.05
Meclozine N-Oxide
N Cl N O
(B)
10 mg
MM 0586.07
N-(3-Methylbenzyl)piperazine Dihydrochloride
HN N x 2 HCl
(A)
100 mg
Medroxyprogesterone
MM 0635.00 Medroxyprogesterone
O OH
(A)
100 mg
144
Edition 2012/2013
Medroxyprogesterone Acetate
MM 0532.00 Medroxyprogesterone Acetate
O O O O
(A)
100 mg
MM 0532.01
Imp. A (EP): 6-Hydroxy-6-methyl-3,20-dioxopregn-4en-17-yl Acetate (6-Hydroxymedroxyprogesterone Acetate)

O OH
O O O
(D)
100 mg
MM 0635.00
Imp. B (EP):17-Hydroxy-6-methylpregn-4-ene-3,20-dione (Medroxyprogesterone)

O
O OH
(A)
100 mg
MM 0532.05
Imp. E (EP): 6-Methylidene-3,20-dioxopregn-4-en-17-yl Acetate (6-Methylenehydroxyprogesterone Acetate)
O O O
(A)
100 mg
MM 0532.06
Imp. F (EP): 6-Methyl-3,20-dioxo-5-pregnan-17-yl Acetate (4,5-Dihydromedroxyprogesterone Acetate)
O O O
(D)
50 mg
H O O O
MM 0532.07
Imp. G (EP): 6-Methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate (Megestrol Acetate)
(A)
250 mg
MM 0532.09
Imp. H (EP): 3,20-Dioxopregn-4-en-17-yl Acetate (Hydroxyprogesterone Acetate)
O O O O
(A)
100 mg
Mefenamic Acid
MM 0327.00 Mefenamic Acid
O OH NH
(A)
500 mg
MM 0327.01
NH2
(B)
100 mg
MM 0327.02
Imp. B (EP): N-(2,3-Dimethylphenyl)2-[(2,3-dimethylphenyl)amino]benzamide
(A)
O N H NH
100 mg
MM 0217.14
Imp. C (EP): 2-Chlorobenzoic Acid
O OH Cl
(A)
100 mg
MM 0278.01
Imp. D (EP): Benzoic Acid
O OH
(B)
100 mg
Edition 2012/2013
145
Mefloquine Hydrochloride
MM 1198.01 2,8-Bis-(trifluoromethyl)-4-quinolinol
F F F N F F F
(A)
100 mg
OH
Megestrol Acetate
MM 0532.07 Megestrol Acetate
O O O O
(A)
250 mg
MM 0532.00
Imp. A (EP): 6-Methyl-3,20-dioxopregn-4-en-17-yl Acetate (Medroxyprogesterone Acetate)
O O O O
(A)
100 mg
MM 0532.09
Imp. K (Pharmeuropa): 3,20-Dioxopregn-4-en-17-yl Acetate
O O O O
(A)
100 mg
Melatonin
New MM 1373.00 Melatonin
HN O N H O
(A)
100 mg
Meloxicam
MM 0246.00 Meloxicam
O S O N H N O S
(A)
N
500 mg
OH
MM 0084.03
Imp. A (EP): Ethyl 4-Hydroxy-2-methyl2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide Imp. B (EP): 5-Methylthiazol-2-amine
O N O
(A)
100 mg
OH O
MM 0246.01
H2N S
(A)
100 mg
MM 0246.16
Imp. C (EP): N-[(2Z)-3,5-Dimethylthiazol-2(3H)ylidene]-4-hydroxy-2-methyl-2H-1,2-benzothiazine3-carboxamide 1,1-Dioxide
O O S N N OH O S N
(A)
50 mg
MM 0246.17
Imp. D (EP): N-[(2Z)-3-Ethyl-5-methylthiazol-2(3H)-ylidene]4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide
O O S N N OH O S N
(A)
50 mg
MM 0084.02
Imp. E (EP): Methyl 4-Hydroxy-2-methyl2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide Imp. F (EP): Isopropyl 4-Hydroxy-2-methyl-2H1,2-benzothiazine-3-carboxylate 1,1-Dioxide (1-Methylethyl 4-Hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxylate 1,1-Dioxide)
O N O O
(A)
100 mg
OH
MM 0084.12
O O S N O OH O
(A)
100 mg
146
Edition 2012/2013
Melperone
MM 0321.00 Melperone
N F O
(A)
100 mg
Memantine Hydrochloride
MM 1045.01 1-Hydroxy-3,5-dimethyladamantane
OH
(A)
100 mg
MM 1045.04
1-Chloro-3,5-dimethyladamantane
Cl
(A)
100 mg
Mephenesin
MM 0810.00 Mephenesin
OH O OH
(A)
500 mg
Mephentermine Hemisulphate
MM 0740.00 Mephentermine Hemisulfate
H N x H2 SO4
(A)
500 mg
Mepivacaine Hydrochloride
MM 0368.00 Mepivacaine Hydrochloride
H N O
(A)
N x HCl
500 mg
MM 0102.02
NH2
(B)
100 mg
MM 0368.02
Imp. B (EP) as Hydrochloride: (RS)-N-(2,6Dimethylphenyl)piperidine-2-carboxamide Hydrochloride Imp. C (EP): N-(2,6-Dimethylphenyl)pyridine-2-carboxamide
H N O
(A)
N H x HCl
50 mg
MM 0368.03
H N O
(A)
N
100 mg
MM 0368.07
Imp. E (EP): (RS)-N-(4-Chloro-2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide

Cl
H N O
(A)
N
50 mg
MM 0368.06
Mepivacaine N-Oxide
H N O
(A)
N O
100 mg
Mepyramine Maleate
MM 0559.00 Mepyramine Maleate
N O N O O N
(A)
OH OH
500 mg
MM 0559.02
Imp. A (EP): N-(4-Methoxybenzyl)pyridin-2-amine

O N
NH
(A)
100 mg
MM 0164.03 MM 0084.01
Imp. B (EP): 4-Methoxybenzaldehyde (Anisaldehyde)

O
(C) (B)
100 mg 100 mg
Imp. C (EP): Pyridin-2-amine

N
NH 2
MM 0559.05
Mepyramine N-Oxide Dihydrochloride

N O N
O x 2 HCl
(A)
100 mg
Edition 2012/2013
147
Mequinol
MM 1131.00 Mequinol
HO O
(A)
500 mg
Mesalazine
MM 0217.00 Mesalazine
O H2N OH OH
(A)
500 mg
MM 0042.01 MM 0042.07 MM 0217.06
Imp. A (EP): 4-Aminophenol Imp. B (EP): 3-Aminophenol
H2N OH
(B) (B)
100 mg 100 mg 100 mg
H2N
OH
Imp. C (EP): 2-Aminophenol

OH NH2
(A)
MM 0217.07
Imp. D (EP): 3-Aminobenzoic Acid
O OH
(A)
100 mg
NH2
MM 0217.09
Imp. F (EP): 3-Amino-2-hydroxybenzoic Acid (3-Aminosalicylic Acid)

NH2
O OH OH
(A)
100 mg
MM 0217.10
Imp. G (EP): 2,5-Dihydroxybenzoic Acid
O HO OH OH
(A)
100 mg
MM 0045.00
Imp. H (EP): 2-Hydroxybenzoic Acid (Salicylic Acid) Imp. I (EP): 2-Hydroxy-5-(phenyldiazenyl)benzoic Acid (Phenylazosalicylic Acid) Imp. K (EP) as Hydrochloride: Aniline Hydrochloride Imp. L (EP): 2-Chlorobenzoic Acid
O OH OH
(A)
500 mg
MM 0217.12
O N N OH OH
(A)
50 mg
MM 0093.17 MM 0217.14
H2N x HCl
(B) (A)
100 mg 100 mg
O OH Cl
MM 0217.15
Imp. M (EP): 2-Chloro-5-nitrobenzoic Acid
O O2N Cl OH
(A)
100 mg
MM 0217.16
Imp. N (EP): 2-Hydroxy-5-nitrobenzoic Acid (5-Nitrosalicylic Acid) Imp. O (Pharmeuropa): 4-Aminobenzenesulphonic Acid (Sulphanilic Acid) 5-Acetaminosalicylic Acid
O O2N OH OH
(A)
100 mg
MM 0227.04
H2N S
O O N H
(A)
OH O O
100 mg
MM 0217.02
OH OH
(A)
100 mg
Metamizole Sodium
MM 0052.00 Metamizole Sodium Monohydrate
O N N N O S O ONa x H2O
(A)
500 mg
MM 0052.02
Imp. A (EP): 4-Formylamino-1,5-dimethyl-2-phenyl-1,2dihydro-3H-pyrazol-3-one (4-Formylaminophenazone)
O N N
H N
(A)
100 mg
148
Edition 2012/2013
Code Product Price
O N N NH2
Unit
MM 0052.04
Imp. B (EP): 4-Amino-1,5-dimethyl-2-phenyl-1,2-dihydro3H-pyrazol-3-one (Ampyrone) Imp. C (EP) as Hydrochloride: 4-Methylamino-1,5-dimethyl2-phenyl-1,2-dihydro-3H-pyrazol-3-one Hydrochloride (4-Methylaminophenazone Hydrochloride) Imp. D (EP): 4-Dimethylamino-1,5-dimethyl-2-phenyl-1,2dihydro-3H-pyrazol-3-one (4,4-Dimethylaminophenazone) 4-Acetylaminophenazone
O N O N N
(A)
100 mg
MM 0052.10
H N x HCl
(A)
100 mg
MM 0052.05
O N N
(A)
100 mg
MM 0052.01
H N
(A)
100 mg
MM 0052.50
4-Benzylideneaminoantipyrine
O N N
(A)
N
100 mg
Metformin Hydrochloride
MM 0056.00 MM 0056.01 MM 0056.07 Metformin Hydrochloride
H2 N NH N H NH N x HCl
(A) (B) (A)
500 mg 100 mg 100 mg
Imp. A (EP): Cyanoguanidine

H2N
NH N H
Imp. B (EP) as Nitrate: (4,6-Diamino-1,3,5triazin-2-yl)guanidine Nitrate

H2N
NH2 N N N N H NH NH2 x HNO3
MM 0056.03
Imp. C (EP): N,N-Dimethyl-1,3,5-triazine-2,4,6-triamine
H2 N N
N N NH2
(A)
100 mg
MM 0056.04
Imp. D (EP): 1,3,5-Triazine-2,4,6-triamine (Melamine)
H2 N N
N N NH2
NH2
(B)
100 mg
MM 0056.05 MM 0056.06
Imp. E (EP) as Hydrochloride:1-Methylbiguanide Hydrochloride

H2 N
NH N H
NH N H
H N
x HCl
(A) (C)
100 mg 100 mg
Imp. F (EP) as Hydrochloride: N-Methylmethanamine Hydrochloride
x HCl
Methadone Hydrochloride
New MM 0531.00 Methadone Hydrochloride [Controlled Substance]
N
(A)
x HCl
100 mg
MM 0531.04
Imp. C (EP) as Hydrochloride: (3RS)-4-(Dimethylamino)-3-methyl-2,2-diphenylbutanenitrile Hydrochloride (Isodidiavalo Hydrochloride)
(A)
x HCl N
50 mg
MM 0531.06
Imp. E (EP): Diphenylacetonitrile
(A)
100 mg
Methamphetamine Hydrochloride
MM 0964.00 New MM 0964.03 Methamphetamine Hydrochloride [Controlled Substance] rac-Methamphetamine Hydrochloride [Controlled Substance]
H N
(A)
x HCl
100 mg 100 mg
H N
x HCl
(A)
Edition 2012/2013
149
Methaqualone
New MM 1356.00 Methaqualone [Controlled Substance]
N N O
(A)
100 mg
Methohexital
New MM 1347.00 Methohexital
O N O NH O
(A)
100 mg
Methotrexate
MM 0040.00 Methotrexate
NH 2 N H 2N N N N N O O O N H OH
(A)
OH
500 mg
MM 0040.08
Imp. A (EP) as Hydrochloride: (2,4-Diaminopteridin6-yl)methanol Hydrochloride

H2N
NH 2 N N N N OH x HCl
(A)
100 mg
Methoxsalen
MM 0555.00 Methoxsalen
O O O O
(A)
500 mg
MM 0555.01
5-Methoxypsoralen (Bergapten)
(A)
100 mg
Methoxyphenamine Hydrochloride
MM 0655.00 Methoxyphenamine Hydrochloride
O H N x HCl
(A)
500 mg
Methyl Nicotinate
MM 0549.00 Methyl Nicotinate
N O O
(A)
500 mg
MM 0553.00
Imp. A (EP): Nicotinic Acid

N
O OH
(A)
500 mg
Methyl Parahydroxybenzoate
MM 0431.00 Methyl Parahydroxybenzoate
HO O O
(A)
500 mg
MM 0045.01

HO
O OH
(B)
100 mg
MM 0498.00
Imp. B (EP): Ethyl 4-Hydroxybenzoate (Ethyl Parahydroxybenzoate)

HO
O O
(A)
500 mg
MM 0432.00
Imp. C (EP): Propyl 4-Hydroxybenzoate (Propyl Parahydroxybenzoate)

HO
O O
(A)
500 mg
MM 0496.00

HO
O O
(A)
500 mg
MM 0431.01
Sodium Methyl Parahydroxybenzoate

NaO
O O
(A)
500 mg
150
Edition 2012/2013
Methylphenidate Hydrochloride
New MM 1031.00 Methylphenidate Hydrochloride [Controlled Substance]
O O H N H and enantiomer x HCl
(A)
100 mg
MM 1031.04
Ritalinic Acid
OH H N
(A)
100 mg
New MM 1031.11
Ritalinic Acid Hydrochloride
OH H N x HCl
(A)
100 mg
Methylprednisolone
MM 0190.00 Methylprednisolone
HO O OH OH
(A)
100 mg
MM 0190.01
Imp. A (EP): 17,21-Dihydroxy-6-methylpregna1,4-diene-3,11,20-trione

O
O O
OH OH
(D)
50 mg
Methylprednisolone Acetate
MM 0191.00 Methylprednisolone Acetate
HO O O O OH
(D)
100 mg
MM 0190.00
Imp. B (EP): Methylprednisolone

HO
OH OH
(A)
100 mg
MM 0194.00
Imp. E (EP): Prednisolone Acetate

HO
O O O OH
(A)
500 mg
Methylprednisolone Hydrogen Succinate

MM 0192.00 Methylprednisolone Hydrogen Succinate Sodium Salt
HO O O O OH ONa O
on request
MM 0190.00
Imp. A (EP): Methylprednisolone

HO
OH OH
(A)
100 mg
MM 0191.00
Imp. C (EP): Methylprednisolone Acetate

HO
O O O OH
(D)
100 mg
Edition 2012/2013
151
Methyltestosterone
MM 0558.00 Methyltestosterone
OH
(A)
250 mg
MM 0323.00
Testosterone
OH
(A)
500 mg
Metixene Hydrochloride
MM 0125.01 Imp. A (EP): 9H-Thioxanthene
S
(A)
100 mg
MM 0125.02
Imp. B (EP): 9H-Thioxanthen-9-one (Thioxanthone)

S
(B)
O
100 mg
MM 0125.03
3-Chloromethyl-1-methylpiperidine
Cl N
on request
Metoclopramide
MM 0073.00 Metoclopramide Hydrochloride Monohydrate
Cl H2N O O O Cl N H O O O Cl N H O O Cl H2 N O O O N H O O OH O N H N O N H N x HCl x H2O
(A)
500 mg
MM 0073.03
Imp. A (EP): 4-(Acetylamino)-5-chloro-N[2-(diethylamino)ethyl]-2-methoxybenzamide Imp. B (EP): Methyl 4-(Acetylamino)-5-chloro2-methoxybenzoate Imp. C (EP): 4-Amino-5-chloro-2-methoxybenzoic Acid
(A)
100 mg
MM 0073.04
(A)
100 mg
MM 0073.02
(B)
100 mg
MM 0073.05
Imp. D (EP): Methyl 4-(Acetylamino)-2-methoxybenzoate
(A)
100 mg
MM 0073.01 MM 0073.06
Imp. E (EP): N,N-Diethylethane-1,2-diamine

H2 N N
(B)
O Cl H2 N N H OH O Cl H2 N O O O N H OH OH O O H2 N OH O O N H O OH N H N O N
100 mg 100 mg
Imp. F (EP): 4-Amino-5-chloro-N-[2-(diethylamino)ethyl]2-hydroxybenzamide Imp. G (EP): N'-(4-Amino-5-chloro-2-methoxybenzoyl)-N,Ndiethylethane-1,2-diamine N-Oxide (Metoclopramide N-Oxide) Imp. H (EP): 4-(Acetylamino)-2-hydroxybenzoic Acid
(A)
MM 0073.07
(A)
100 mg
MM 0073.08
(A)
100 mg
MM 0073.09
Methyl 4-Amino-2-hydroxybenzoate
(A)
100 mg
MM 0073.10
Methyl 4-(Acetylamino)-2-hydroxybenzoate
(A)
100 mg
152
Edition 2012/2013
Metoprolol Succinate
MM 0279.00 Metoprolol Succinate
O O x HO O OH OH O H N 2
(A)
100 mg
MM 0027.04
Imp. A (EP): (2RS)-1-(Ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol

O
OH O
H N
(A)
100 mg
MM 0027.01 MM 0027.24
Imp. B (EP): 4-(2-Methoxyethyl)phenol

O
OH
(A) (A)
100 mg 100 mg
Imp. C (EP) as Hydrochloride: 4-[(2RS)-2Hydroxy-3-[(1-methylethyl)amino]propoxy]benzaldehyde Hydrochloride Imp. D (EP): (2RS)-3-[4-(2-Methoxyethyl)phenoxy] propane-1,2-diol
OH O O
H N
x HCl
MM 0027.06
OH O O OH
(A)
100 mg
MM 0027.07
Imp. E (EP): (2RS)-1-[2-(2-Methoxyethyl)phenoxy]3-[(1-methylethyl)amino]propan-2-ol Imp. F (EP): (2RS)-1-[(1-Methylethyl)amino]-3phenoxy-propan-2-ol Imp. G (EP): 2-(4-Hydroxyphenyl)ethanol

HO
OH O O
H N
(A)
100 mg
MM 0027.08
OH O
H N
(A)
100 mg
MM 0027.09 MM 0027.10
OH
(A) (A)
100 mg 100 mg
Imp. H (EP): (2RS)-1-[4-(2-Hydroxyethyl)phenoxy]3-[(1-methylethyl)amino]propan-2-ol

HO
OH O
H N
MM 0027.11
(2RS)-1-(4-Ethenylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol Imp. J (EP): 1-[2-Hydroxy3-[(1-methylethyl)amino]propoxy]3-[4-(2-methoxyethyl)phenoxy]propan-2-ol (2RS)-1-[4-[(EZ)-2-Methoxyethenyl]phenoxy]3-[(1methylethyl)amino]propan-2-ol Imp. M (EP) as Dihydrochloride: 1,3-Bis[(1-methylethyl)amino]propan-2-ol Dihydrochloride Imp. N (EP): (2RS)-3-[(1-Methylethyl)amino]propane-1,2-diol Imp. O (EP): 1,1'-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]propan-2-ol]
O
OH O
H N
(A)
100 mg
MM 0027.12
OH O O O
OH
H N
(A)
50 mg
MM 0027.13
OH O O
H N
(A)
100 mg
MM 0027.28 MM 0027.16 MM 0027.03
H N
OH
H N
(A)
x 2 HCl
100 mg 100 mg 100 mg
OH HO
H N
(A) (A)
OH O N
OH O O
Metoprolol Tartrate
MM 0027.00 Metoprolol Tartrate
O OH x HO O OH
OH O O H N
OH O
H N 2
(A)
500 mg
O OH
MM 0027.04
Imp. A (EP): (2RS)-1-(Ethylamino)3-[4-(2-methoxyethyl)phenoxy]propan-2-ol Imp. B (EP): 4-(2-Methoxyethyl)phenol

O
(A)
100 mg
MM 0027.01
OH
(A)
100 mg
Edition 2012/2013
153
Code Product Price
OH O O OH O O OH H N
Unit
MM 0027.24
Imp. C (EP) as Hydrochloride: 4-[(2RS)-2Hydroxy-3-[(1-methylethyl)amino]propoxy]benzaldehyde Hydrochloride Imp. D (EP): (2RS)-3-[4-(2-Methoxyethyl)phenoxy] propane-1,2-diol Imp. E (EP): (2RS)-1-[2-(2-Methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol Imp. F (EP): (2RS)-1-[(1-Methylethyl)amino]3-phenoxypropan-2-ol Imp. G (EP): 2-(4-Hydroxyphenyl)ethanol
(A)
x HCl
100 mg
MM 0027.06
(A)
100 mg
MM 0027.07
OH O O
H N
(A)
100 mg
MM 0027.08
OH O
H N
(A)
100 mg
MM 0027.09 MM 0027.10
OH HO
(A) (A)
100 mg 100 mg
Imp. H (EP): (2RS)-1-[4-(2-Hydroxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol

HO
OH O
H N
MM 0027.11
(2RS)-1-(4-Ethenylphenoxy)-3-[(1-methylethyl)amino] propan-2-ol Imp. J (EP): 1-[2-Hydroxy3-[(1-methylethyl)amino]propoxy]-3-[4(2-methoxyethyl)phenoxy]propan-2-ol (2RS)-1-[4-[(EZ)-2-Methoxyethenyl]phenoxy]3-[(1methylethyl)amino]propan-2-ol Imp. M (EP) as Dihydrochloride: 1,3-Bis[(1-methylethyl)amino]propan-2-ol Dihydrochloride Imp. N (EP): (2RS)-3-[(1-Methylethyl)amino]propane-1,2-diol Imp. O (EP): 1,1'[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]propan2-ol] 1-[4-(2-Methoxyethyl)phenoxy]-2,3-epoxypropane
O
OH O
H N
(A)
100 mg
MM 0027.12
OH O O O
OH
H N
(A)
50 mg
MM 0027.13
OH O O
H N
(A)
100 mg
MM 0027.28 MM 0027.16 MM 0027.03
H N
OH
H N
(A)
x 2 HCl
100 mg 100 mg 100 mg
OH HO
H N
(A) (A)
OH O O N
OH O O
MM 0027.02 MM 0027.17
(A) (A)
100 mg 100 mg
1-Chloro-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
O
OH O Cl
MM 0027.18
4,4'-(2-Hydroxy-1,3-propandiyldioxy)bis[(2-methoxyethyl)benzene)]
O
OH O O O OH Cl
O
(A)
100 mg
MM 0027.22 MM 0027.26
3-Chloropropane-1,2-diol 1-[2-(2-Methoxyethyl)phenyoxy]-2,3-epoxypropane
OH
(B) (C)
100 mg 50 mg
Metronidazole
MM 0012.00 MM 0012.02 MM 0012.05 MM 0012.06 MM 0012.07 Metronidazole
O2N N N OH
(A) (B) (C) (A) (A)
500 mg 100 mg 100 mg 100 mg 100 mg
Imp. A (EP): 2-Methyl-4-nitroimidazole Imp. B (EP): 4-Nitroimidazole Imp. C (EP): 2-(4-Nitro-1H-imidazol-1-yl)ethanol Imp. D (EP): 2-(5-Nitro-1H-imidazol-1-yl)ethanol
O2 N
O 2N N
O2N
NH
NH N
N N
OH
O2 N N N
OH
MM 0012.01
Imp. E (EP): 2-(2-Methyl-4-nitro-1H-imidazol-1-yl)ethanol
O2N
N N
OH
(A)
100 mg
154
Edition 2012/2013
Code Product Price
O2N N N O OH
Unit
MM 0012.09
Imp. G (EP): 2-(2-Methyl-5-nitro-1Himidazol-1-yl)acetic Acid 1-(2-Hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole (Hydroxymetronidazole)
(A)
100 mg
MM 0012.04
O2N N N
OH OH
(A)
100 mg
Metronidazole Benzoate
MM 0278.00 Metronidazole Benzoate
O2 N N N
(A)
O O
100 mg
MM 0012.00
Imp. A (EP): Metronidazole
O2N N N
OH
(A)
500 mg
MM 0012.02
Imp. B (EP): 2-Methyl-5-nitroimidazole (2-Methyl-4-nitroimidazole) Imp. C (EP): Benzoic Acid
O2N NH N
(B)
100 mg
MM 0278.01
O OH
(B)
100 mg
MM 0278.04
2-(2-Methyl-4-nitro-1H-imidazol-1-yl)ethyl Benzoate
O2 N N N O O
(A)
100 mg
Mevastatin
MM 0377.00 Mevastatin
O OH O O O
(A)
100 mg
Mexiletine Hydrochloride
MM 0146.00 Mexiletine Hydrochloride
NH2 O x HCl
(A)
500 mg
MM 0146.01
Imp. A (EP): 2,6-Dimethylphenol
OH
(A)
100 mg
MM 0146.02
Imp. B (EP): 1-(2,6-Dimethylphenoxy)propan-2-one
O O
(A)
100 mg
MM 0146.06
Imp. D (EP) as Hydrochloride: (2RS)-2-(2,6-Dimethylphenoxy)propan-1-amine Hydrochloride
(A)
NH2 x HCl
50 mg
Mianserin Hydrochloride
MM 0147.00 Mianserin Hydrochloride
N N x HCl
(A)
100 mg
MM 0147.01
Imp. A (EP): [2-[(2RS)-4-Methyl-2-phenylpiperazin-1-yl]phenyl]methanol
N N
(A)
100 mg
OH
MM 0147.04
Imp. C (EP): (2-Aminophenyl)methanol
H2N
(B)
OH
100 mg
New MM 0147.05
Imp. E (EP) as Hydrochloride: (14bRS)1,2,3,4,10,14b-Hexahydrodibenzo[c,f]pyrazino[1,2a]azepine Hydrochloride (Desmethylmianserin Hydrochloride)
HN N x HCl
(A)
50 mg
Edition 2012/2013
155
Code Product Price
O N N
Unit
MM 0147.06
Mianserin N-Oxide
(D)
100 mg
Miconazole Nitrate
MM 0281.00 Miconazole Nitrate
Cl O Cl Cl N N Cl
(A)
x HNO3
500 mg
MM 0074.00
Miconazole
Cl O Cl Cl
Cl
(A)
250 mg
N N
MM 0281.01

Cl HO
Cl
(A)
100 mg
N N
MM 0524.00
Imp. B (EP) as Nitrate: 1-[(2RS)-2-[(4-Chlorobenzyl)oxy]2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate (Econazole Nitrate)
Cl
(A)
x HNO3
500 mg
Cl O Cl N N
MM 0281.03
Imp. C (EP) as Nitrate: (2RS)-2-[(2,4-Dichlorobenzyl)oxy]2-(2,4-dichlorophenyl)ethanamine Nitrate

Cl O Cl Cl
Cl
(D)
x HNO3 NH2
100 mg
MM 0541.00
Imp. D (EP) as Nitrate: 1-[(2RS)-2-[(2,6-Dichlorobenzyl)oxy]2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate (Isoconazole Nitrate)
Cl
(A)
x HNO3
100 mg
Cl
Cl O Cl N N
MM 0281.06
Imp. F (EP) as Nitrate: 1-[(2RS)2-[(3,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]1H-imidazole Nitrate
Cl
(A)
x HNO3
100 mg
Cl O Cl Cl N N Cl
MM 0281.07
Imp. G (EP) as Nitrate: 1-[(2RS)2-[(2,5-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]1H-imidazole Nitrate

Cl
(A)
x HNO3
100 mg
Cl O Cl N N
MM 0281.08
Imp. H (EP) as Nitrate: 1-[(2RS)-2-Benzyloxy2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate

Cl O
Cl
(A)
x HNO3 N N
100 mg
156
Edition 2012/2013
Code Product Price
Cl
Unit
MM 0281.09
Imp. I (EP) as Nitrate: 1-[(2RS)-2-[(2-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate

Cl O Cl
(A)
x HNO3 N N
100 mg
MM 0281.10
1-(2,4-Dichlorobenzoylmethyl)imidazole
Cl O
Cl
(A)
100 mg
N N
Midazolam
New MM 1106.00 Midazolam [Controlled Substance]
N Cl N F N
(A)
100 mg
MM 0070.02
Imp. F (EP): 7-Chloro-5-(2-fluorophenyl)-1,3dihydro-2H-1,4-benzodiazepin-2-one (1-Des[(diethylamino)ethyl]flurazepam)
H N Cl N
(A)
100 mg
Minoxidil
MM 0521.00 Minoxidil
N N N NH2 NH2 O
(A)
500 mg
MM 0521.01
Imp. A (EP): 6-Chloropyrimidine-2,4-diamine 3-Oxide
Cl
N N NH2
NH2 O
(A)
100 mg
MM 0521.02
Imp. B (EP): 6-Chloropyrimidine-2,4-diamine
Cl
N N NH2
NH2
(C)
100 mg
MM 0521.05
Imp. E (EP): 6-(Piperidin-1-yl)pyrimidine-2,4-diamine (Desoxyminoxidil)
(A)
N N N NH2 NH2
100 mg
Mirtazapine
MM 1005.00 Mirtazapine
N N N
(A)
100 mg
MM 1005.02
Imp. A (EP): (14bRS)-2-Methyl-1,2,3,4,1014b-hexahydropyrazino[2,1-a]pyrido[2,3c][2]benzazepine 2-Oxide

N
(A)
O N N
100 mg
MM 1005.03
Imp. B (EP): [2-[(2RS)-4-Methyl-2-phenylpiperazin-1-yl]pyridin-3-yl]methanol

HO N N
(A)
N
100 mg
MM 1005.09
Imp. D (EP) as Maleate: (14bRS)-1,2,3,4,10,14bHexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine Maleate

N
O NH N x O OH OH
(A)
50 mg
Edition 2012/2013
157
MM 1005.01
Imp. E (EP): (2RS)-4-Methyl-1-(3-methylpyridin-2-yl)-2-phenylpiperazine

N N
(A)
N
100 mg
MM 1005.07
1-Methyl-3-phenylpiperazine
N HN
(A)
100 mg
Moclobemide
MM 0250.00 Moclobemide
Cl O N H N O
(A)
100 mg
Modafinil
MM 540.01 Imp. A (EP): [(RS)-(Diphenylmethyl)sulfinyl]acetic Acid
O S O OH
(A)
50 mg
MM 0540.02
Imp. B (EP): 2-[(Diphenylmethyl)sulfonyl]acetamide
O O S
O NH2
(A)
50 mg
MM 0540.03
Imp. C (EP): Methyl [(RS)-(Diphenylmethyl)sulfinyl]acetate
O S
O O
(A)
50 mg
MM 0599.14
Bis(diphenylmethyl) Ether
O
(A)
50 mg
MM 0540.04
2-[(Diphenylmethyl)sulfenyl]acetamide
S
O NH2
(A)
50 mg
MM 540.06
Bis(diphenylmethyl)disulfide
S S
(A)
50 mg
Molsidomine
MM 0267.00 Molsidomine
O O N O NN+
(A)
N O
250 mg
MM 0267.02
Imp. A (EP) as Hydrochloride: 3-(Morpholin-4-yl)sydnonimine Hydrochloride (Linsidomine Hydrochloride) Imp. B (EP): 4-Nitrosomorpholine
O HN
NN+
(A)
N O x HCl
100 mg
MM 0267.03
O N N O
(A)
100 mg
MM 0267.01 MM 0267.06
Imp. C (EP): (2E)-(Morpholin-4-ylimino)acetonitrile Imp. E (EP): Morpholine
N O
(A) (A)
O
100 mg 100 mg
HN
158
Edition 2012/2013
Mometasone Furoate
New MM 1272.00 Mometasone Furoate
HO O O O Cl O Cl O
(A)
100 mg
Montelukast Sodium
MM 0698.00 Montelukast Sodium
Cl N S HO O ONa
100 mg
Morphine Hydrochloride
MM 0037.00 Morphine Hydrochloride Trihydrate [Controlled Substance]
HO O N x H3 PO4 x H2O O O OH N HO O OH N x HCl x 3 H2O OH
(A)
250 mg
MM 0442.00
Imp. A (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance] Imp. B (EP): 7,7',8,8'-Tetradehydro-4,5:4',5'-diepoxy17,17'-dimethyl-2,2'-bimorphinanyl-3,3',6,6'-tetrol (Pseudomorphine; 2,2'-Bimorphine)
(A)
100 mg
MM 0037.01
(A)
100 mg
HO N
OH
MM 0037.03
Imp. F (EP): (17S)-7,8-Didehydro-4,5-epoxy-17methylmorphinan-3,6-diol17-Oxide (Morphine N-Oxide) [Controlled Substance]

HO
O N
(A)
100 mg
O N
OH
MM 0037.02
7,7',8,8'-Tetradehydro-4,5a:4',5'a-diepoxy-3,3'-dimethoxy17,17'-dimethyl-2,2'-bimorphinanyl-6a,6'a-diol (Codeine Dimer; Dimethyl Pseudomorphine)
(A)
100 mg
HO
O N
OH
New MM 0037.09
Morphine Anhydrate [Controlled Substance]
(A)
100 mg
HO
OH
Morphine Sulphate
MM 0280.00 Morphine Hemisulphate Pentahemihydrate [Controlled Substance]
HO O N x H2SO4 x 5 H2O OH
2
(A)
250 mg
MM 0442.00
Imp. A (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O O
N x H3 PO4 x H2O OH N HO O OH
(A)
100 mg
MM 0037.01
Imp. B (EP): 7,7',8,8'-Tetradehydro-4,5:4',5'-diepoxy17,17'-dimethyl-2,2'-bimorphinanyl-3,3',6,6'-tetrol (Pseudomorphine;2,2'-Bimorphine)
(A)
100 mg
HO N
OH
Edition 2012/2013
159
Code Product Price
O N
Unit
MM 0037.03
Imp. F (EP): (17S)-7,8-Didehydro-4,5-epoxy17-methylmorphinan-3,6-diol 17-Oxide (Morphine N-Oxide) [Controlled Substance]

HO
(A)
100 mg
OH
Moxifloxacin Hydrochloride
MM 0885.00 Moxifloxacine Hydrochloride
HN H H O N F O O N OH x HCl
(D)
100 mg
Moxonidine
MM 1278.02 Imp. B (EP): N-(Imidazolidin-2-ylidene)-4,6dimethoxy-2-methylpyrimidin-5-amine (4-Methoxymoxonidine)
N N O O N
(A)
HN N H
100 mg
Mycophenolate Mofetil
MM 1001.00 Mycophenolate Mofetil
O O O OH O O N O
(D)
100 mg
MM 1001.05
Imp. E (EP): Methyl (4E)-6-(4-Hydroxy-6methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate Imp. F (EP): (4E)-6-(4-Hydroxy-6-methoxy-7methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)4-methylhex-4-enoic Acid (Mycophenolic Acid) Imp. G (EP): 2-(Morpholin-4-yl)ethyl (4E)-6-(4-Hydroxy-6-methoxy-7-methyl3-oxo-1,3-dihydroisobenzofuran-5-yl)4-methylhex-4-enoate N-Oxide Imp. H (EP): 7-Hydroxy-5-methoxy-4-methyl6-[2-[(2RS)-2-methyl-5-oxotetrahydrofuran-2yl]ethyl]isobenzofuran-1(3H)-one
O O OH
O O
OH O O O
(A)
100 mg
MM 1001.06
O O
OH OH O O
(A)
100 mg
MM 1001.07
O O O
O N O
(A)
100 mg
MM 1001.08
O O
OH O O
(A)
O
100 mg
Nabumetone
MM 0153.00 Nabumetone
O O
(A)
500 mg
MM 0153.02
Imp. A (EP): 3-(6-Methoxynaphthalen-2-yl)5-methylcyclohexanone

O
(A)
100 mg
MM 0153.03
Imp. B (EP): (5RS)-5-(6-Methoxynaphthalen-2-yl)3-methylcyclohex-2-enone

O
(A)
100 mg
MM 0153.04
Imp. C (EP): (2RS)-4-(6-Methoxynaphthalen-2-yl)butan-2-ol

O
OH
(A)
100 mg
MM 0153.05
Imp. D (EP): (E)-4-(6-Methoxynaphthalen-2-yl)but-3-en-2-one

O
(A)
100 mg
MM 0153.06
Imp. E (EP): 1,5-Bis(6-methoxynaphthalen2-yl)pentan-3-one

O
(A)
O
O
50 mg
MM 0153.07
Imp. F (EP): 6,6'-Dimethoxy-2,2'-binaphthalenyl

O
(A)
100 mg
160
Edition 2012/2013
Code Product Price
OH O O
Unit
MM 0152.01
(6-Methoxy-2-naphthyl)acetic Acid ((6-Methoxynaphthalen2-yl)acetic Acid, -Demethylnaproxen)
(A)
100 mg
Nadolol
MM 0439.00 Nadolol
OH HO O OH H N
on request
and enantiomers
MM 0439.06
Imp. F (EP) as Hydrochloride: (2RS)-1-[(1,1Dimethylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol Hydrochloride Imp. G (EP) as Hydrochloride: (2RS)-1-[(1,1Dimethylethyl)amino]-3-[(5,6,7,8-tetrahydronaphtalen-1-yl)oxy]-propan-2-ol Hydrochloride
OH O
H N
(A)
x HCl
50 mg
MM 0439.07
OH O
H N
(A)
x HCl
50 mg
Nafcillin Sodium
MM 0392.00 Nafcillin Sodium
O N O NH O H S O ONa
on request
MM 0392.02
Penilloic Acids of Nafcillin

O H N O
HO HN S
(D)
100 mg
MM 0392.04
2-Ethoxynaphthoic Acid
OH O
(B)
100 mg
Naftidrofuryl Hydrogen Oxalate

MM 0373.00 Naftidrofuryl Hydrogen Oxalate
O O O N x O OH O OH
(A)
500 mg
Naloxone Hydrochloride Dihydrate

MM 0272.00 Naloxone Hydrochloride Dihydrate
N OH x HCl x 2 H2O
(A)
250 mg
HO
Naltrexone
MM 0233.00 Naltrexone Hydrochloride
HO N x HCl
(A)
100 mg
HO
Nandrolone
MM 0660.00 Nandrolone
H OH
(A)
250 mg
MM 0660.01
19-Norandrost-4-ene-3,17-dione (Estr-4-ene-3,17-dione)
H
(A)
100 mg
Edition 2012/2013
161
Nandrolone Decanoate
MM 0982.00 Nandrolone Decanoate
O H O
(A)
100 mg
MM 0660.00
Imp. D (EP): 17-Hydroxyestr-4-en-3-one (Nandrolone)

O
OH H
(A)
250 mg
Naphazoline Hydrochloride
MM 0075.00 Naphazoline Hydrochloride
HN N x HCl
(A)
500 mg
MM 0075.06
Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)2-(naphthalen-1-yl)acetamide Hydrochloride (Naphthylacetylethylenediamine Hydrochloride) Imp. B (EP): (Naphthalen-1-yl)acetic Acid (1-Naphthylacetic Acid)
O N H NH2 x HCl
(A)
100 mg
MM 0075.02
O OH
(B)
100 mg
MM 0075.04
Imp. C (EP): (Naphthalen-1-yl)acetonitrile (1-Naphthylacetonitrile)
(B)
100 mg
New MM 0075.03
Imp. D (EP) as Hydrochloride: 2-(Naphthalen2-ylmethyl)-4,5-dihydro-1H-imidazole Hydrochloride (-Naphazoline Hydrochloride) Ethyl (1-Naphthyl)acetate
HN
N x HCl
(A)
50 mg
MM 0075.05
O O
(A)
100 mg
MM 0075.07
(Naphthalen-1-y)lacetamide (1-Naphthylacetamide)
O NH 2
(A)
100 mg
Naphazoline Nitrate
MM 0286.00 Naphazoline Nitrate
HN N x HNO 3
(A)
500 mg
MM 0075.06
Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide Hydrochloride (Naphthylacetylethylenediamine Hydrochloride) Imp. B (EP): (Naphthalen-1-yl)acetic Acid (1-Naphthylacetic Acid)
O N H NH 2 x HCl
(A)
100 mg
MM 0075.02
O OH
(B)
100 mg
MM 0075.04
Imp. C (EP): (Naphthalen-1-yl)acetonitrile (1-Naphthylacetonitrile)
(B)
100 mg
MM 0075.05
Ethyl (1-Naphthyl)acetate
O O
(A)
100 mg
162
Edition 2012/2013
Code Product Price
O NH2
Unit
MM 0075.07
(Naphthalen-1-yl)acetamide (1-Naphthylacetamide)
(A)
100 mg
Naproxen
MM 0152.00 Naproxen
O O OH
(A)
500 mg
MM 0152.06
Imp. A (EP): (2S)-2-(6-Hydroxynaphthalen-2-yl)propanoic Acid (O-Demethylnaproxen)

HO
OH O
(A)
100 mg
MM 0152.09
Imp. B (EP): (2S)-2-(5-Chloro-6-methoxynaphthalen-2-yl)propanoic Acid (5-Chloronaproxen) Imp. C (EP): (2S)-2-(5-Bromo-6-methoxynaphthalen-2-yl)propanoic Acid (5-Bromonaproxen) Imp. D (EP): (2S)-2-(5-Iodo-6-methoxynaphthalen-2-yl)propanoic Acid (5-Iodonaproxen) Imp. E (EP): Methyl (2S)-2-(6-Methoxynaphthalen-2-yl)propanoate (Naproxen Methyl Ester) Imp. F (EP): Ethyl (2S)-2-(6-Methoxynaphthalen-2-yl)propanoate (Naproxen Ethyl Ester) Imp. H (EP): 6-Methoxynaphthalen-2-ol (Hydroxynerolin) Imp. I (EP):(6-Methoxynaphthalen-2-yl)acetic Acid (-Demethylnaproxen) Imp. J (EP): 2-Ethyl-6-methoxynaphthalene (Ethylnerolin) Imp. K (EP): (1RS)-1-(6-Methoxynaphthalen-2-yl)ethanol
OH O Cl O
(A)
100 mg
MM 0152.10
OH O Br O
(A)
100 mg
MM 0152.11
OH O I O
(A)
100 mg
MM 0152.02
O O O
(A)
100 mg
MM 0152.12
O O O
OH O OH O O
(A)
100 mg
MM 0152.14 MM 0152.01 MM 0152.18 MM 0152.16
(A) (A) (A)
100 mg 100 mg 100 mg 100 mg
O OH
(A)
MM 0152.07
Imp. L (EP): 1-(6-Methoxynaphthalen-2-yl)ethanone (Acetylnerolin)

O
(B)
100 mg
MM 0152.08 MM 0152.17 MM 0152.04
Imp. M (EP): 2-Methoxynaphthalene (Nerolin)

O
(B)
Br O
100 mg 100 mg 500 mg
Imp. N (EP): 2-Bromo-6-methoxynaphthalene Naproxen Sodium

O O
O
(C) (A)
ONa
MM 0152.15
2-Carboxy-6-methoxynaphthalene
O
(A)
OH
100 mg
Nateglinide
MM 0847.00 Nateglinide
H N O OH O
on request
MM 0847.03
Imp. B (Pharmeuropa): N-[[trans-4-(Propan2-yl)cyclohexyl]carbonyl]-L-phenylalanine

O
(A)
H N O OH
50 mg
Edition 2012/2013
163
Code Product Price
O H2N OH
Unit
MM 0314.03
Imp. D Nateglinide (EP): Phenylalanine
(B)
100 mg
MM 0847.04
Imp. E (Pharmeuropa): N-[(trans-4-Ethylcyclohexyl)carbonyl]-D-phenylalanine (Nateglinide Ethyl Analog)

O
(A)
H N O OH
50 mg
MM 0847.09
Imp. F (EP) as Dicyclohexylammonium Salt: N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]D-phenylalanyl-D-phenylalanine Dicyclohexylammonium Salt (Nateglinide IPP Impurity Dicyclohexylammonium Salt)
x
(A)
H N O O N H OH O
50 mg
H N
MM 0847.06
Imp. G (Pharmeuropa): Ethyl N-[[trans-4-(Propan2-yl)cyclohexyl]carbonyl]-D-phenylalaninate (Nateglinide Ethyl Ester)

O
(A)
H N O O
50 mg
Nevirapine Anhydrous
MM 1146.01 Imp. A (EP): 11-Ethyl-4-methyl-5,11-dihydro6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-one
N N N
(A)
100 mg
NH O
MM 1146.02
Imp. B (EP): 4-Methyl-5,11-dihydro-6Hdipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
H N
(A)
100 mg
NH O
MM 1146.03
Imp. C (EP): 4-Methyl-11-propyl-5,11-dihydro6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
(D)
N N N
100 mg
NH O
MM 1146.04
3-Amino-2-chloro-4-methylpyridine
Cl H2N
(A)
100 mg
Nicardipine Hydrochloride
MM 0465.00 Nicardipine Hydrochloride
O O O NO2 H N O N x HCl
(A)
250 mg
MM 0465.01
3-Methyl 5-[Methyl(phenylmethyl)amino]ethyl 2,6-Dimethyl-4-(3-nitrophenyl)pyridine3,5-dicarboxylate Dihydrochloride
N O O O NO2 O N x 2 HCl
on request
Nicergoline
MM 0115.00 Nicergoline
N O H Br N O O
Cl N O O O N
(A)
N
100 mg
MM 0115.02
Imp. A (EP): [(6aR,9R,10aS)-10a-Methoxy4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]methyl 5-Chloropyridine-3-carboxylate (Chloronicergoline)
H N
(D)
50 mg
164
Edition 2012/2013
Code Product Price
H N O N OH
Unit
MM 0115.04
Imp. C (EP): [(6aR,9R,10aS)-10a-Methoxy-4,7-dimethyl4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin9-yl]methanol (Methylmethoxylumilysergol) Imp. D (EP): 5-Bromopyridine-3-carboxylic Acid
(D)
100 mg
MM 0115.06
Br
(B)
N
100 mg
HO O
MM 0115.03
5-Debromonicergoline
N
N O N O
on request
Nicorandil
MM 0924.00 Nicorandil
N O N H O NO 2
(A)
100 mg
Nicotinamide
MM 0552.00 Nicotinamide
N O NH2
(A)
500 mg
MM 0552.01
Isonicotinamide
N
O NH2
(A)
100 mg
Nicotine
MM 0517.00 Nicotine
N N
(A)
500 mg
MM 0517.03
Imp. C (EP): (5S)-1-Methyl-5-(pyridin-3-yl)pyrrolidin-2-one (Cotinine) Imp. G (EP): 3-[(2S)-Piperidin-2-yl]pyridine (Anabasine)
(A)
N N O
100 mg
MM 0517.01
(A)
N N H
100 mg
Nicotinic Acid
MM 0553.00 Nicotinic Acid
N O OH
(A)
500 mg
MM 0553.06
Imp. B (EP): 2,2'-Bipyridine-5,5'-dicarboxylic Acid (6,6'-Dinicotinic Acid)

HO O N
O N OH
(A)
100 mg
MM 0553.03
Imp. E (EP): Pyridine-4-carboxylic Acid (Isonicotinic Acid)

N
O OH
(A)
100 mg
MM 0549.00
Methyl Nicotinate
N
O O
(A)
500 mg
MM 0104.00
Benzyl Nicotinate
N
O O
(A)
500 mg
Nifedipine
MM 0003.00 Nifedipine
O O H N O O NO2
(A)
500 mg
Edition 2012/2013
165
Code Product Price
N O O O O NO2
Unit
MM 0003.02
Imp. A (EP): Dimethyl 2,6-Dimethyl-4-(2-nitrophenylpyridine3,5-dicarboxylate (Nitrophenylpyridine Analogue of Nifedipine)
(A)
100 mg
MM 0003.01
Imp. B (EP): Dimethyl 2,6-Dimethyl-4-(2-nitrosophenylpyridine3,5-dicarboxylate (Nitrosophenylpyridine Analogue of Nifedipine)
N O O O O NO
(A)
100 mg
MM 0003.07
Imp. C (EP) as E/Z-Mixture: Methyl (E/Z)-2-(2-Nitrobenzylidene)3-oxobutanoate
O O O NO2
(A)
100 mg
MM 0003.08
Imp. D (EP): Methyl 3-Aminobut-2-enoate
H2N O O
(C)
100 mg
MM 0003.03
2-Nitrobenzaldehyde
O NO 2
(B)
100 mg
Niflumic Acid
MM 0850.00 Niflumic Acid
N O OH NH
(A)
250 mg
F F F
MM 0915.01
Imp. A (EP): 2-Chloropyridine-3-carboxylic Acid (2-Chloronicotinic Acid) Imp. B (EP): 2-Hydroxy-N-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Imp. C (EP): 3-(Trifluoromethyl)aniline
N OH H N O
Cl OH O
(A)
100 mg
MM 0850.05
F F
(A)
100 mg
MM 0161.06
F F
(B)
100 mg
NH2
MM 0850.01
Imp. F (EP): Methyl 2-[[3-(Trifluoromethyl)phenyl]amino]pyridine-3-carboxylate (Niflumic Acid Methyl Ester)
F F
(A)
100 mg
NH O O
Nifuroxazide
MM 0574.00 Nifuroxazide
O 2N O N OH H N O
(A)
500 mg
MM 0574.01
Imp. A (EP): 4-Hydroxybenzohydrazide (p-Hydroxybenzohydrazide) Imp. B (EP): Methyl 4-Hydroxybenzoate (Methyl Parahydroxybenzoate) Imp. C (EP): (5-Nitrofuran-2-yl)methylidene Diacetate ((5-Nitrofuran-2-yl)methylene Diacetate)
OH H2N H N O
(C)
100 mg
MM 0431.00
OH O O
(A)
500 mg
MM 0943.02
O O O2N O O O
(A)
100 mg
166
Edition 2012/2013
Nifursol
MM 0444.00 Nifursol
OH O 2N O N H NO2 N O NO2
(A)
100 mg
MM 0444.01 MM 0444.02 MM 0444.03
5-Nitro-2-furfural 5-Nitrofurfural Hydrazone 3,5-Dinitrosalicylic Acid Hydrazide
O O H2N N OH O 2N NO2
(C) (A) (A)
100 mg 100 mg 100 mg
O O N H NO2
NO2
NH2
Nikethamide
MM 0627.00 Nikethamide
N O N
(A)
500 mg
Nimesulide
MM 0378.00 Nimesulide
O2 N H N S
(A)
250 mg
O O O
MM 0378.01
Imp. A (EP): N-(2,4-Dinitro-6-phenoxyphenyl) methanesulphonamide

O 2N
NO2 H N O O
(A)
S O
100 mg
MM 0378.02
Imp. B (EP): N-(2-Phenoxyphenyl)methanesulphonamide
H N O O
(A)
S O
100 mg
MM 0378.03
Imp. C (EP): 2-Phenoxyaniline
NH 2 O
(A)
100 mg
MM 0378.04
Imp. D (EP): 4-Nitro-2-phenoxyaniline

O2N
NH2 O
(A)
100 mg
MM 0378.05
Imp. E (EP): N,N-Bis(methylsulphonyl)-2phenoxyaniline
O O S S O O O N
(A)
100 mg
MM 0378.06
Imp. F (EP): N,N-Bis(methylsulphonyl)-4nitro-2-phenoxyaniline

O2 N
O O S S O O O N
(A)
100 mg
MM 0378.07
Imp. G (EP): 4-Nitro-2-phenoxyphenol

O 2N
OH O
(A)
50 mg
Edition 2012/2013
167
Nimodipine
MM 0416.00 Nimodipine
O O O NO 2 H N O O
(A)
100 mg
MM 0416.01
Imp. A (EP): 2-Methoxyethyl 1-Methylethyl 2,6Dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate
N O O O NO 2 O O
(A)
100 mg
MM 0416.02
Imp. B (EP): Bis(1-methylethyl) 2,6-Dimethyl-4(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
H N O O O NO2 O
(A)
100 mg
MM 0416.03
Imp. C (EP): Bis(2-methoxyethyl) 2,6-Dimethyl4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

O
H N O O O NO2 O O
(A)
100 mg
Nitrazepam
MM 0078.00 Nitrazepam [Controlled Substance]
O2N H N N O
(A)
100 mg
MM 0078.02
Imp. A (EP): 3-Amino-6-nitro-4-phenylquinolin-2(1H)-one

O2N
H N
O NH2
(A)
100 mg
MM 0078.01
Imp. B (EP): (2-Amino-5-nitrophenyl)phenylmethanone (2-Amino-5-nitrobenzophenone)
NH2 O2N O
(B)
100 mg
MM 0078.03
Imp. C (EP): 2-Bromo-N-[4-nitro-2-(phenylcarbonyl)phenyl]acetamide

O2 N
O NH O
Br
(A)
50 mg
MM 0078.05
Imp. D (EP): 2-(1,3-Dioxo-1,3-dihydro-2Hisoindol-2-yl)-N-[4-nitro-2-(phenylcarbonyl)phenyl]acetamide

O2 N
O O NH O N
(A)
50 mg
MM 0078.07
7-Aminonitrazepam
H 2N
H N N
(A)
100 mg
Nitrendipine
MM 0092.00 Nitrendipine
O O O NO 2 H N O
(A)
500 mg
MM 0092.03
Imp. A (EP): Ethyl Methyl 2,6-Dimethyl-4(3-nitrophenyl)pyridine-3,5-dicarboxylate (Photolysis Product)
N O O O NO 2 O
(A)
100 mg
168
Edition 2012/2013
Code Product Price
H N O O O NO 2 O
Unit
MM 0092.01
Imp. B (EP): Dimethyl 2,6-Dimethyl-4-(3-nitrophenyl)1,4-dihydropyridine-3,5-dicarboxylate
(A)
100 mg
MM 0092.02
Imp. C (EP): Diethyl 2,6-Dimethyl-4-(3-nitrophenyl)1,4-dihydropyridine-3,5-dicarboxylate
H N O O O NO2 O
(A)
100 mg
MM 0092.04
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5dicarboxylic Acid Methyl Ester
H N O O O NO2 OH
(A)
50 mg
MM 0092.05
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5dicarboxylic Acid Ethyl Ester
H N O O O NO2 OH
(A)
50 mg
Nitrofural
MM 0943.00 MM 0943.02 Nitrofural Imp. B (EP): (5-Nitrofuran-2-yl)methylene Diacetate
O O2 N O O O
O2N
H N O
NH2
(A) (A)
500 mg 100 mg
Nitrofurantoin
MM 0506.00 Nitrofurantoin
O 2N O O N N H N O
(A)
500 mg
Nizatidine
MM 0220.00 Nizatidine
N S N S N H N H NO2 NO2
(A)
500 mg
MM 0220.01
Imp. A (EP): N,N-Dimethyl-2-nitroethene-1,1-diamine

N H
(A)
100 mg
N H NO2
MM 0220.09
Imp. B (EP): (EZ)-N-Methyl-1-methylsulphanyl)-2nitroethen-1-amine

S
(A)
100 mg
N H NO2
MM 0220.02
Imp. C (EP): (EZ)-N-[2-[[[2-[(Dimethylamino)methyl]thiazol4-yl]methyl]sulphinyl]ethyl]-N-methyl-2-nitroethene1,1-diamine Imp. D (EP) as Dioxalate: 2-[[[2-[(Dimethylamino)methyl]thiazol-4-yl]methyl]sulphanyl]ethanamine Dioxalate Imp. G (EP): N,N'-Bis[2-[[[2-[(dimethylamino)methyl]thiazol-4-yl]methyl]sulphanyl]ethyl]-2nitroethene-1,1-diamine
N N S
N S
N S N O S N H
(C)
50 mg
N H
O O
MM 0220.04
HO N S NH2 x2 HO
(A)
50 mg
MM 0220.10
N NO2 N H N H S N
(A)
S
50 mg
MM 0220.11 New MM 0220.06
Imp. H (EP) as Hydrochloride: 2-(Dimethylamino) thioacetamide Hydrochloride Imp. I (EP): N-[2-[[[2-[(Dimethylamino)methyl]thiazol-4-yl]methyl]sulphanyl]ethyl]-N'-methylurea

N S N
S N x HCl NH2
(A) (A)
100 mg 50 mg
O S N H N H
Edition 2012/2013
169
Code Product Price
S N N N H OH
Unit
MM 0086.07
Imp. K (EP): 3-(Methylamino)-5,6-dihydro-2H1,4-thiazin-2-one Oxime
(A)
100 mg
Nonivamide
MM 1033.00 Nonivamide
O O HO N H
O HO
(A)
500 mg
MM 1033.01 MM 1033.02
4-(Aminomethyl)-2-methoxyphenol Hydrochloride (Vanillylamine Hydrochloride) N-[(4-Hydroxy-3-methoxyphenyl)methyl]octanamide (N-Vanillyloctanamide) N-[(4-Hydroxy-3-methoxyphenyl)methyl]decanamide (N-Vanillyldecanamide) N,O-Dinonanoylvanillylamine

O HO
NH 2
x HCl
(A) (A)
100 mg 100 mg
O N H O O HO N H O O O O N H
MM 1033.03
(A)
100 mg
MM 1033.04
(A)
100 mg
Noradrenaline Tartrate
MM 0614.02 Imp. A (EP): Adrenaline (L-Adrenaline)
OH HO HO H N
(A)
500 mg
MM 0384.00
Imp. C (EP) as Hydrochloride: Dopamine Hydrochloride
HO HO
NH2 x HCl
(A)
500 mg
Norethisterone
MM 0218.00 Norethisterone
OH
(A)
250 mg
MM 0218.04
Imp. A (EP): 17-Hydroxy-19-nor-17-pregna4,6-dien-20-yn-3-one (6,7-Didehydronorethisterone)

O
OH
(D)
100 mg
MM 0660.01
Imp. B (EP): Estr-4-ene-3,17-dione (Norandrostenedione)
(A)
100 mg
MM 0218.01
Imp. H (EP): 6,17-Dihydroxy-19-nor-17-pregn4-en-20-yn-3-one (6-Hydroxynorethisterone)

O OH
OH
(D)
100 mg
MM 0218.02
6-Hydroxynorethisterone
OH
(D)
50 mg
O OH
MM 0218.03
6-Ketonorethisterone
OH
(D)
100 mg
O O
Norethisterone Acetate
MM 0219.00 Norethisterone Acetate
O O
(A)
100 mg
170
Edition 2012/2013
Code Product Price
OH
Unit
MM 0218.00
Imp. A (EP): Norethisterone
(A)
250 mg
MM 0219.10
Imp. B (EP): 3-Oxo-19-nor-17-pregn-5(10)en-20-yn-17-yl Acetate
O O
on request
MM 0219.01
Imp. F (EP): 6-Hydroxy-3-oxo-19-nor-17pregn-4-en-20-yn-17-yl Acetate (6-Hydroxynorethisterone Acetate)

O OH
O O
(D)
100 mg
MM 0219.03
Imp. G (EP): 3,6-Dioxo-19-nor-17-pregn4-en-20-yn-17-yl Acetate (6-Ketonorethisterone Acetate)

O O
O O
(D)
100 mg
MM 0219.02
6-Hydroxynorethisterone Acetate
O
(D)
50 mg
O OH
MM 0219.04
6,7-Didehydronorethisterone Acetate
O
(D)
100 mg
Norfenefrine Hydrochloride
MM 0973.00 Norfenefrine Hydrochloride
OH HO NH 2 x HCl
(A)
500 mg
Norfloxacin
MM 0350.00 Norfloxacin
HN N F O O N OH
(A)
250 mg
MM 0350.01
Imp. A (EP): 7-Chloro-1-ethyl-6-fluoro-4-oxo1,4-dihydroquinoline-3-carboxylic Acid
(A)
Cl F O O N OH
100 mg
MM 0350.03
Imp. D (EP): 1-Ethyl-6-fluoro-7-(piperazin-1-yl) quinolin-4(1H)-one
HN N F O N
(D)
100 mg
MM 0350.04
Imp. G (EP): 1-Ethyl-6-fluoro-7-(4-formyl-piperazin-1-yl)4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
N N F O O N OH
(D)
100 mg
Nortriptyline Hydrochloride
MM 0079.00 Nortriptyline Hydrochloride
x HCl N H
(A)
500 mg
MM 0062.01
Imp. A (EP): 10,11-Dihydro-5H-dibenzo[a,d][7] annulen-5-one (Dibenzosuberone)

O
(B)
100 mg
MM 0079.01
Imp. B (EP) as Hydrochloride: 3-(5H-Dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1amine Hydrochloride (Norcyclobenzaprine Hydrochloride)
(A)
N H x HCl
50 mg
Edition 2012/2013
171
Code Product Price
N OH
Unit
MM 0062.03
Imp. D (EP): 5-[3-(Dimethyl-amino)propyl]10,11-dihydro-5H-dibenzo-[a,d][7]annulen-5-ol
(A)
100 mg
MM 0062.02
Imp. E (EP) as Hydrochloride: 3-(5HDibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine Hydrochloride (Cyclobenzaprine Hydrochloride) Imp. F (EP) as Hydrochloride: Amitriptyline Hydrochloride
(A)
N x HCl
100 mg
MM 0062.00
(A)
N x HCl
500 mg
MM 0062.12
Imp. J (EP) as Hydrochloride: [3-(10,11Dihydro-5H-dibenzo[a,d][7]annulen5-ylidene)propyl]-dimethylamine Oxide Hydrochloride (Amitriptyline N-Oxide Hydrochloride)
O N x HCl
(B)
10 mg
Nucleosides
MM 1316.01 Cytidine
N HO O O OH OH NH2 N HO O O OH N N NH2
(A)
100 mg
MM 1316.02
2'-Deoxycytidine
(A)
100 mg
Ofloxacin
MM 0228.00 Ofloxacin
N N F O O O N OH
(A)
500 mg
MM 0228.04
Imp. A (EP): (RS)-9,10-Difluoro-3-methyl-7-oxo2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6carboxylic Acid (FPA) Imp. B (EP): (RS)-9-Fluoro-3-methyl-10-(4methylpiperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazin-7-one Imp. E (EP): (RS)-9-Fluoro-3-methyl-7-oxo-10-(piperazin1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine6-carboxylic Acid Imp. F (EP) as Hydrochloride: 4-[(RS)-6-Carboxy9-fluoro-3-methyl-7-oxo-2,3-dihydro-7Hpyrido[1,2,3-de]-1,4-benzoxazine-10-yl]1-methylpiperazine 1-Oxide Hydrochloride (Ofloxacin N-Oxide Hydrochloride)
O F F O O
O N F O N
(A)
N OH
100 mg
MM 0228.05
(A)
100 mg
MM 0228.08
HN N F
O N OH O O
(A)
100 mg
MM 0228.10
N N F
O N x HCl OH O O
(A)
100 mg
Olanzapine
MM 0329.00 Olanzapine
N HN S N N
on request
172
Edition 2012/2013
Code Product Price
N
Unit
MM 0329.08
Imp. A (EP): 5-Methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile

O2 N HN
(A)
50 mg
MM 0329.02
Imp. B (EP): 2-Methyl-5,10-dihydro-4Hthieno[2,3-b][1,5]benzodiazepin-4-one (Olanzapine Lactame) Imp. C (EP): 1-(Chloromethyl)-1-methyl-4-(2methyl-10H-thieno[2,3-b][1,5]benzodiazepin4-yl)piperazin-1-ium Chloride (Olanzapine-N-Chloromethyl Chloride) Imp. D (EP): 1-Methyl-4-(2-methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-yl)piperazin-1-oxide (Olanzapine N-Oxide)
HN S
H N HN S
(A)
50 mg
MM 0329.07
Cl N+ N HN S N Cl-
(A)
100 mg
MM 0329.03
O N N N
(A)
50 mg
Omeprazole
MM 0095.00 Omeprazole
H N S O N O H N SH O N N O
(A)
500 mg
MM 0095.03 MM 0095.04
Imp. A (EP): 5-Methoxy-1H-benzimidazole-2-thiol Imp. B (EP): 2-[(RS)-[(3,5-Dimethylpyridin -2-yl)methyl]sulphinyl]-5-methoxy-1Hbenzimidazole Imp. C (EP): 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin2-yl)methyl]sulphanyl]-1H-benzimidazole (Ufiprazole)
O
(A) (A)
100 mg 100 mg
H N O N S O N
MM 0095.06
O H N S N O H N O N S N O O N
(A)
100 mg
MM 0095.05
Imp. D (EP): 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin2-yl) methyl]sulphonyl]-1H-benzimidazole (Omeprazole Sulphone) Imp. E (EP): 4-Methoxy-2-[[(RS)-(5-methoxy-1Hbenzimidazol-2-yl)sulphinyl]methyl]-3,5-dimethylpyridine 1-Oxide (Omeprazole N-Oxide) Imp. F (EP): 8-Methoxy-1,3-dimethyl12-thioxopyrido[1',2':3,4]imidazo[1,2-a]-benzimidazol2(12H)-one Imp. G (EP): 9-Methoxy-1,3-dimethyl12-thioxopyrido[1',2':3,4]imidazo[1,2-a]-benzimidazol2(12H)-one Imp. H (EP): 2-[(RS)-[(4-Chloro-3,5-dimethylpyridin2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole
O
O
(A)
100 mg
MM 0095.07
NH N S O O N O
(A)
100 mg
MM 0095.01
S N N
O N N N S O
(D)
N O
50 mg
MM 0095.02
(D)
50 mg
MM 0095.15
NH N S O N Cl
(D)
100 mg
MM 0095.16
Imp. I (EP): 4-Methoxy-2-[[(5-methoxy-1H-benzimidazol2-yl)sulphonyl]methyl]-3,5-dimethylpyridine 1-Oxide (Omeprazole Sulphone N-Oxide) 5-Methoxy-2-[[(3,5-dimethylpyridin-2-yl)methyl] sulphanyl]-1H-benzimidazole
O N
NH S O O N O NH N S N O
(A)
100 mg
MM 0095.08
(A)
100 mg
MM 0095.19
5-Methoxy-2-[[(4-chloro-3,5-dimethylpyridin-2-yl) methyl]sulphanyl]-1H-benzimidazole
O N
NH S N Cl
(D)
100 mg
Edition 2012/2013
173
Code Product Price
O N H NH O
Unit
MM 0095.20
5-Methoxy-1,3-dihydrobenzimidazol-2-one
(A)
100 mg
MM 0095.23
2-[[(4-Methoxy-3,5-dimethylpyridin-2-yl)methyl] sulphinyl]-1H-benzimidazole
N
NH S O N O
(A)
100 mg
MM 0095.24
5-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)-1Hbenzimidazole
O N
NH O N
(A)
100 mg
Ondansetron Hydrochloride Dihydrate

MM 0252.00 Ondansetron Hydrochloride Dihydrate
N N O N
(A)
x HCl x 2 H2 O
100 mg
MM 0252.09
Ondansetron
N N O
(A)
100 mg
MM 0252.03
Imp. A (EP): (3RS)-3-(Dimethylamino)methyl9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one Imp. B (EP): 6,6'-Methylene bis[(3RS)9-methyl-3-[(2-methyl-1H-imidazol1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol4-one] Imp. C (EP): 9-Methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one Imp. D (EP): 9-Methyl-3-methylene-1,2,3,9tetrahydro-4H-carbazol-4-one Imp. E (EP): 1H-Imidazole (Imidazole)
N N O
(A)
100 mg
MM 0252.02
(D)
50 mg
MM 0252.01
(A)
O
100 mg
MM 0252.04
(A)
O
100 mg
MM 0015.02 MM 0252.06 MM 0252.07
N N H
(B) (B) (A)
100 mg 100 mg 100 mg
Imp. F (EP): 2-Methyl-1H-imidazole

N H
Imp. G (EP): (3RS)-3-[(1H-Imidazol-1-yl)methyl]-9methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one (C-Demethylondansetron) Imp. H (EP): (3RS)-3-[(2-Methyl-1H-imidazol-1-yl) methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one (N-Demethylondansetron)
N N O
H N N O
MM 0252.08
(A)
100 mg
Opipramol Dihydrochloride
MM 0422.01 5-(3-Piperazin-1-yl-propyl)-5H-dibenzo[b,f]azepine Dihydrochloride (A)
N N NH x 2 HCl
100 mg
Ornidazole
MM 0948.00 Ornidazole
O2 N N N OH
O2 N NH N
(A)
Cl
500 mg
MM 0012.02
2-Methyl-4-nitroimidazole
(B)
100 mg
MM 0948.02
3-(2-Methyl-5-nitro-1H-imidazol-1-yl)propane-1,2-diol
O2 N N N OH OH
(A)
100 mg
174
Edition 2012/2013
Code Product Price
O2 N N N O
Unit
MM 0948.03
3-(2-Methyl-5-nitro-1H-imidazol-1-yl)-1,2-epoxypropane
(A)
100 mg
MM 0948.04
1-(3-Chloro-2-hydroxypropyl)-2-methyl-4-nitroimidazole
O2 N N
N OH
Cl
(A)
100 mg
Orphenadrine Hydrochloride
MM 0801.00 Orphenadrine Hydrochloride
O N x HCl
(A)
500 mg
MM 0801.01
Imp. A (EP): (RS)-(2-Methylphenyl)phenylmethanol (2-Methylbenzhydrol)

OH
(A)
100 mg
MM 0801.02
Imp. B (EP): (2-Methylphenyl)phenylmethanone (2-Methylbenzophenone)

O
(A)
100 mg
MM 0801.03
Imp. C (EP) as Hydrochloride: (RS)-2-[(2-Methylphenyl)phenylmethoxy]ethanamine Hydrochloride

O NH2
(A)
x HCl
50 mg
MM 0490.00
Imp. D (EP) as Hydrochloride: Diphenhydramine Hydrochloride

O N
(A)
x HCl
500 mg
MM 0801.05
Imp. E (EP) as Hydrochloride: (RS)-N,N-Dimethyl2-[(3-methylphenyl)phenylmethoxy]ethanamine Hydrochloride (meta-Methylbenzyl Isomer Hydrochloride)

O
(A)
N x HCl
100 mg
MM 0490.04
Imp. F (EP) as Hydrochloride: (RS)-N,N-Dimethyl2-[(4-methylphenyl)phenylmethoxy]ethanamine Hydrochloride (para-Methylbenzyl Isomer Hydrochloride; 4-Methyldiphenhydramine Hydrochloride) N-Desmethylorphenadrine Hydrochloride
(A)
O N x HCl
100 mg
MM 0801.07
(A)
O H N x HCl
100 mg
Oxacillin Sodium
MM 0686.00 Oxacillin Sodium Monohydrate
O O N O N H N S H x H 2O O ONa
(A)
250 mg
MM 0026.04
Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2carboxylic Acid (6-Aminopenicillanic Acid) Imp. E (EP) as Sodium Salt Monohydrate: Cloxacillin Sodium Monohydrate
Cl O N O O H N N
O O N H2N S H
OH
(B)
100 mg
MM 0682.00
ONa x H2O
(A)
500 mg
S H
Oxalic Acid Dihydrate

MM 0928.00 Oxalic Acid Dihydrate
O O OH x 2 H2O OH
(A)
500 mg
Edition 2012/2013
175
Code Product Price
O O OH OH
Unit
MM 0928.01
Oxalic Acid
(A)
500 mg
Oxaliplatin
MM 0928.00 Imp. A (EP) as Dihydrate: Ethanedioic Acid Dihydrate (Oxalic Acid Dihydrate)
O O OH x 2 H2O OH
(A)
500 mg
Oxazepam
MM 0080.00 Oxazepam [Controlled Substance]
Cl H N N O OH
(D)
100 mg
MM 0028.03
Imp. D (EP): (2-Amino-5-chlorophenyl)phenylmethanone (2-Amino-5-chlorobenzophenone)
NH2 Cl O
(B)
100 mg
MM 0028.02
Imp. E (EP): 7-Chloro-5-phenyl-1,3-dihydro2H-1,4-benzodiazepin-2-one 4-Oxide (Demoxepam)
H N Cl N
(A)
100 mg
MM 0080.03
6-Chloro-4-phenyl-3,4-dihydroquinazoline-2carboxylic Acid
Cl
O N NH OH
(A)
100 mg
Oxcarbazepine
MM 0076.17 Oxcarbazepine
O
(A)
N
100 mg
NH2
MM 0076.10
10-Hydroxy-10,11-dihydrocarbamazepine
HO
(A)
N
100 mg
NH2
Oxeladin Hydrogen Citrate

MM 0547.00 Oxeladin Hydrogen Citrate
O O O N x OH OH O O OH O OH
(A)
500 mg
MM 0547.02 MM 0547.01
Imp. A (EP): 2-[2-(Diethylamino)ethoxy]ethanol Oxeladin N-Oxide
HO
(A) (B)
100 mg 10 mg
O O O N O
Oxfendazole
MM 0518.02 Imp. B (EP): Methyl [5-(Phenylsulphonyl)1H-benzimidazol-2-yl]carbamate (Fenbendazole Sulphone)
H N S O O N O O NH
(A)
100 mg
Oxiracetam
New MM 1406.00 Oxiracetam
HO O N O NH2
(A)
250 mg
176
Edition 2012/2013
Oxolinic Acid
MM 0898.00 Oxolinic Acid
O O O O N OH
(A)
250 mg
Oxomemazine
MM 0957.00 Oxomemazine
N S O O N
(A)
100 mg
MM 0958.00
Trimeprazine Tartrate
N S
N x HO O 2
OH
O OH
(A)
500 mg
OH
MM 0958.02
Trimeprazine Sulphoxide Hydrochloride

N S O
N x HCl
(A)
100 mg
MM 0958.04
Oxomemazine N-Oxide Hydrochloride (Trimeprazine Sulphone N-Oxide Hydrochloride)

N S O O
(A)
x HCl
100 mg
Oxprenolol Hydrochloride
MM 0129.00 Oxprenolol Hydrochloride
OH O O H N
(A)
x HCl
500 mg
MM 0129.01
1-(2-Hydroxyphenoxy)-3-(isopropylamino)-2-propanol Hydrochloride
OH O OH
H N
(A)
x HCl
50 mg
Oxybuprocaine Hydrochloride
MM 0543.00 Oxybuprocaine Hydrochloride
H2N O O O N x HCl
(A)
500 mg
MM 0094.03
Imp. A (EP): 4-Aminobenzoic Acid

H2 N
O OH
(B)
100 mg
MM 0543.02
Imp. B (EP): 4-Amino-3-butoxybenzoic Acid

H2N O
O OH
(A)
100 mg
MM 0543.03
Imp. C (EP): 4-Amino-3-hydroxybenzoic Acid

H2N OH
O OH
(A)
100 mg
MM 0543.05
Oxybuprocaine N-Oxide Dihydrochloride

H2N O
O O N O x 2 HCl
(A)
100 mg
Oxybutynin Hydrochloride
MM 0047.00 Oxybutynin Hydrochloride
O O OH N x HCl
(A)
250 mg
Edition 2012/2013
177
MM 0047.06
Imp. B (EP): 4-(Diethylamino)but-2-ynyl 2-Hydroxy-2,2-diphenylacetate (Diphenyl analogue of Oxybutynin) Imp. C (EP) as Hydrochloride: 4-(Ethylmethylamino)but2-ynyl (RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetate Hydrochloride (Methylethyl analogue of Oxybutynin Hydrochloride) Imp. D (EP): (RS)-2-Cyclohexyl-2-hydroxy2-phenylacetic Acid (Phenylcyclohexylglycolic Acid)
(A)
HO O O N
100 mg
MM 0047.04
(D)
HO O O N x HCl
100 mg
MM 0047.01
(A)
HO OH O
100 mg
MM 0047.07
Imp. E (EP): 4-(Ethylpropylamino)but-2-ynyl (RS)2-Cyclohexyl-2-hydroxy-2-phenylacetate (Ethylpropyl analogue of Oxybutynin) Methyl (RS)-2-Cyclohexyl-2-hydroxy-2phenylacetate (Phenylcyclohexylglycolic Acid Methyl Ester) 4-Diethylaminobut-2-yn-1-ol Desethyloxybutynin Hydrochloride
HO
(A)
HO O O N
100 mg
MM 0047.02
O O OH
(A)
100 mg
MM 0047.03 MM 0047.11
HO
(A) (D)
100 mg 100 mg
O O
N H
x HCl
MM 0047.50
Propargyl (RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetate (Phenylcyclohexylglycolic Acid Propargyl Ester)
(B)
HO O O
10 mg
Oxycodone Hydrochloride
MM 0672.00 Oxycodone Hydrochloride [Controlled Substance]
N HO x HCl
(A)
100 mg
O
N HO
New MM 0672.10
Oxycodone [Controlled Substance]
(A)
100 mg
MM 0672.03
Imp. C (EP) as Hydrochloride: 4,5-Epoxy-14hydroxy-3-methoxymorphinan-6-one Hydrochloride (Noroxycodone Hydrochloride)

O
H N HO x HCl
(D)
50 mg
MM 0672.05
4,5-Epoxy-3-methoxy-17-methylmorphinan6,14-diol Hydrochloride
O
N HO x HCl
on request
OH
O N
MM 0672.06
Oxycodone N-Oxide
(D)
50 mg
HO
Oxymetazoline Hydrochloride
MM 0177.00 Oxymetazoline Hydrochloride
HO HN N
(A)
x HCl
250 mg
MM 0177.01
Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)2-[4-(1,1-dimethylethyl)-3-hydroxy2,6-dimethylphenyl)]acetamide Hydrochloride
HO O
H N
(A)
NH2 x HCl
100 mg
178
Edition 2012/2013
MM 0089.00
Imp. B (EP) as Hydrochloride: Xylometazoline Hydrochloride Imp. C (EP): 2-[4-(1,1-Dimethylethyl)-3hydroxy-2,6-dimethylphenyl]acetamide
(A)
N N H x HCl
500 mg
MM 0177.07
OH O NH2
(A)
100 mg
MM 0177.04
Imp. D (EP): [4-(1,1-Dimethylethyl)-3hydroxy-2,6-dimethylphenyl]acetic Acid
OH O OH
(A)
100 mg
MM 0177.05
Imp. E (EP): [4-(1,1-Dimethylethyl)-3hydroxy-2,6-dimethylphenyl]acetonitrile
OH N
(D)
100 mg
Oxymorphone Hydrochloride Monohydrate

New MM 0673.00 Oxymorphone Hydrochloride Monohydrate [Controlled Substance]
N HO x HC x H2O
(A)
100 mg
HO
O
H N HO x HCl
New MM 0673.03
Noroxymorphone Hydrochloride
(A)
100 mg
HO
Oxyphenbutazone
MM 0933.00 Oxyphenbutazone Monohydrate
OH O N N O x H2O
(A)
250 mg
Oxytetracycline Hydrochloride
MM 0554.00 Oxytetracycline Hydrochloride
OH O H HO OH O OH H OH O H HO N O NH2 OH N x HCl O NH2 OH x HCl
(A)
500 mg
MM 0452.00
Imp. B (EP) as Hydrochloride: Tetracycline Hydrochloride
OH
OH O OH H
(A)
500 mg
Pantoprazole Sodium Sesquihydrate

MM 0099.00 Pantoprazole Sodium
F F N O NNa S O N O O
(D)
100 mg
MM 0099.01
Pantoprazole
F
O F N
NH S O N
O O
(D)
100 mg
MM 0099.02
Imp. A (EP): 5-(Difluoromethoxy)-2-[[(3,4dimethoxypyridin-2-yl)methyl]sulphonyl]1H-benzimidazole (Pantoprazole Sulphone)
O F F N
NH
(A)
O S O O O N
100 mg
MM 0099.03
Imp. B (EP): 5-(Difluoromethoxy)-2-[[(3,4dimethoxypyridin-2-yl)methyl]sulphanyl]1H-benzimidazole Imp. C (EP): 5-(Difluoromethoxy)-1Hbenzimidazole-2-thiol
O F F N
NH S N
O O
(A)
100 mg
MM 0099.04
O F F N
NH SH
(A)
100 mg
Edition 2012/2013
179
Code Product Price
O F F F O F N N S O N
O Cl N O x HCl
Unit
MM 0099.11
Mixture of Imp. D and F (EP): 5- and 6-(Difluoromethoxy)-2-[(RS)-[(3,4-dimethoxypyridin2-yl)methyl]sulphinyl]-1-methyl-1H-benzimidazole
N N S O + N
O O
(D)
100 mg
O O
MM 0099.05
2-Chloromethyl-3,4-dimethoxypyridine Hydrochloride
(A)
100 mg
MM 0099.06
Pantoprazole N-Oxide
F
O F N
NH S O O N
O O
(D)
100 mg
MM 0099.07
Pantoprazole Sulphone N-Oxide

F
O F N
NH S O O N O
O O
(A)
100 mg
Paracetamol
MM 0042.00 MM 0042.08 Paracetamol
HO H N O
(A) (B)
O
500 mg 100 mg
Imp. A (EP): N-(2-Hydroxyphenyl)acetamide (2-Acetamidophenol) Imp. B (EP): N-(4-Hydroxyphenyl)propanamide (N-Propionyl-4-aminophenol) Imp. C (EP): N-(3-Chloro-4-hydroxyphenyl)acetamide (3-Chloro-4-hydroxyacetanilide) Imp. D (EP): N-Phenylacetamide (Acetanilide) Imp. E (EP): 1-(4-Hydroxyphenyl)ethanone (4-Hydroxyacetophenone)
HO
OH
H N
MM 0042.05 MM 0042.09
H N HO O
(A) (A)
O
H N O
100 mg 100 mg
Cl HO
H N
MM 0042.10 MM 0042.11
(B)
O
100 mg 100 mg
(B)
MM 0042.03 MM 0042.12
Imp. F (EP): 4-Nitrophenol

HO
NO 2
(B) (A)
100 mg 100 mg
Imp. G (EP): 1-(4-Hydroxyphenyl)ethanone Oxime (4-Hydroxyacetophenone Oxime)

HO
HO
MM 0042.04 MM 0042.13
Imp. H (EP): 4-(Acetylamino)phenyl Acetate (N,O-Diacetyl-4-aminophenol) Imp. I (EP): 1-(2-Hydroxyphenyl)ethanone (2-Hydroxyacetophenone) Imp. J (EP): N-(4-Chlorophenyl)acetamide (4-Chloroacetanilide) Imp. K (EP): 4-Aminophenol
O O
H N O O
(A) (B)
100 mg 100 mg
OH
MM 0042.02 MM 0042.01 MM 0042.07
H N Cl O NH2 HO
(B) (B) (B)
100 mg 100 mg 100 mg
3-Aminophenol
HO
NH2
Paroxetine Hydrochloride Anhydrous

New MM 1032.01 Imp. A (EP) as Hydrochloride: (3S,4R)-3-[(1,3Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine Hydrochloride (Desfluoroparoxetine Hydrochloride) (A)
O O O NH x HCl
50 mg
180
Edition 2012/2013
Code Product Price
O O OH
Unit
MM 1032.02 MM 1032.07
Imp. B (EP): 1,3-Benzodioxol-5-ol (Sesamol) Imp. G (EP) as Hydrochloride: 4-(4-Fluorophenyl)1-methyl-1,2,3,6-tetrahydropyridine Hydrochloride [(3S,4R)-4-(4-Fluorophenyl)-1-methylpiperidin-3-yl] methanol
F
(A) (A)
100 mg 100 mg
x HCl N
MM 1032.12
(A)
HO N
100 mg
Paroxetine Hydrochloride Hemihydrate

New MM 0264.00 Paroxetine Hydrochloride Hemihydrate
O O F x HCl x 1/2 H2O
(A)
O NH
100 mg
Pentetrazol
MM 0692.00 Pentetrazol
N N N N
(A)
500 mg
Pentobarbital
New MM 1357.00 Pentobarbital [Controlled Substance]
O H N O NH O
(A)
100 mg
Pentobarbital Sodium
New MM 1368.00 Pentobarbital Sodium [Controlled Substance]
O H N N O ONa
(A)
100 mg
Pentoxifylline
MM 0761.00 Pentoxifylline
O N O N O N N
(A)
500 mg
MM 0577.00
Imp. A (EP): Theobromine

HN O
O N N
O HN O N O N O N O N O N N N H N N H N N
(A)
N
500 mg
MM 0176.03
Imp. B (EP): 3-Methyl-3,7-dihydro-1H-purine2,6-dione (3-Methylxanthine)
(A)
100 mg
MM 0176.00
Imp. C (EP): Theophylline
(A)
500 mg
MM 0494.00
Imp. F (EP): Caffeine
(A)
500 mg
Pentoxyverine Hydrogen Citrate

MM 1268.01 Imp. A (EP): 1-Phenylcyclopentanecarboxylic Acid
O OH
(A)
100 mg
Peppermint Oil
MM 0388.00 (-)-Menthol (Levomenthol)
OH
(A)
500 mg
Edition 2012/2013
181
MM 0163.12
(+)-(R)-Pulegone
O
(A)
100 mg
Perazine Dimaleate
MM 0815.00 Perazine Dimaleate
N N S x 2 N HO HO O O
(A)
100 mg
Perazine Dimalonate
MM 0157.00 Perazine Dimalonate
N N S x2 O HO
N N N S O
N O OH
on request
MM 0157.01
Perazine Sulphoxide
(A)
100 mg
MM 0157.02 MM 0157.03
Phenothiazine 1-(3-Chloropropyl)-4-methylpiperazine
Cl
H N S N N
(B)
100 mg on request
Perphenazine
MM 0826.00 Perphenazine
N S Cl N N OH
(A)
100 mg
MM 0826.01
Imp. A (EP): 2-[4-[3-(2-Chloro-5-oxido-10Hphenothiazin-10-yl)propyl]piperazin-1-yl]ethanol (Perphenazine Sulphoxide)

O
(A)
N S Cl N N OH
100 mg
MM 0826.02
Imp. B (EP): 2-[4-[3-(10H-Phenothiazin-10yl)propyl]piperazin-1-yl]ethanol

S
(A)
N N N OH
50 mg
Pethidine Hydrochloride
New MM 0315.00 Pethidine Hydrochloride [Controlled Substance]
O O
N
N x HCl
(A)
100 mg
New MM 0315.13
Prepethidine [Controlled Substance]

N
(A)
100 mg
New MM 0315.04
Imp. D (EP): Methyl 1-Methyl-4-phenylpiperidine-4-carboxylate [Controlled Substance] Imp. E (EP): Ethyl 4-Phenylpiperidine-4carboxylate [Controlled Substance]
(A)
100 mg
O NH
New MM 0315.05
(A)
100 mg
Phenazepam
New MM 0828.00 Phenazepam
Br H N N Cl O
(A)
100 mg
182
Edition 2012/2013
Phenacetin
MM 0551.00 Phenacetin
O H N O H N HO O
(A)
100 mg
MM 0042.00 MM 0042.01
Paracetamol 4-Aminophenol
HO
(A)
NH2
500 mg 100 mg
(B)
Phenethyl Alcohol
MM 0953.00 Phenylethyl Alcohol
OH
(A)
500 mg
Pheniramine Maleate
MM 0059.00 Pheniramine Maleate
N N x O O OH OH
(A)
100 mg
MM 0059.02
Imp. A (EP): 2-Benzylpyridine
(C)
100 mg
MM 0059.03
Imp. B (EP): 4-Benzylpyridine
(C)
100 mg
MM 0059.09
Imp. C (EP) as Sesquifumarate: (3RS)-N,NDimethyl-3-phenyl-3-(pyridin-4-yl)propan1-amine Sesquifumarate
N N x 1,5 HO O
O OH
(A)
100 mg
MM 0059.08
Imp. D (EP) as Dihydrochloride: N,N,N',N'Tetramethyl-3-phenyl-3-(pyridin-2-yl)pentane1,5-diamine Dihydrochloride
N x 2 HCl N
(D)
100 mg
MM 0059.01
Pheniramine
N N
(A)
100 mg
MM 0059.05
Pheniramine N-Oxide Dihydrochloride
N N
O x 2 HCl
(A)
100 mg
MM 0059.06
Norpheniramine Maleate
H N x
O OH OH O
(A)
100 mg
Phentolamine Mesilate
MM 0171.04 Imp. B (EP) as Hydrochloride: 2-(Chloromethyl)4,5-dihydro-1H-imidazole Hydrochloride
Cl N N H x HCl
(A)
100 mg
Phenobarbital
MM 0265.07 Imp. B (EP): (5RS)-5-Ethyl-6-imino-5phenyldihydropyrimidine-2,4(1H,3H)dione
HN H N O NH O
(A)
50 mg
Edition 2012/2013
183
Code Product Price
O H N O NH O
Unit
MM 0265.08
Imp. C (EP): 5-Methyl-5-phenylpyrimidine2,4,6(1H,3H,5H)-trione
(A)
50 mg
MM 0265.01
Phenylethylacetylurea (2-Phenylbutyrylurea)
O N H
O NH2
(A)
100 mg
MM 0265.02
N-Benzoyl-N'-(2-phenyl)butanoylurea
O N H
O N H
(A)
100 mg
MM 0265.03
Barbituric Acid
H N
O NH
(C)
100 mg
Phenoxyethanol
MM 0952.00 Phenoxyethanol
O OH
(A)
500 mg
Phenoxymethylpenicillin Potassium
MM 0026.00 Phenoxymethylpenicillin Potassium
O H N O N S H
O O H N O N S H OK
OK
(A)
250 mg
MM 0160.00
Imp. A (EP) as Potassium Salt: Benzylpenicillin Potassium
(A)
250 mg
MM 0026.03
Imp. B (EP): Phenoxyacetic Acid

O O OH
(B)
100 mg
MM 0026.04
Imp. C (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid) Imp. D (EP): (2S,5R,6R)-3,3-Dimethyl-7-oxo6-[[2-(4-hydroxyphenoxy)acetyl]amino]-4-thia1-azabicyclo[3.2.0]heptane-2-carboxylic Acid (4-Hydroxyphenoxymethylpenicillin) Imp. E (EP): (4S)-2-[Carboxy[(phenoxyacetyl) amino]methyl]-5,5-dimethylthiazolidine-4carboxylic Acid (Penicilloic Acids of Phenoxymethylpenicillin) Imp. F (EP): (2RS,4S)-5,5-Dimethyl-2[[(phenoxyacetyl)amino]methyl]thiazolidine4-carboxylic Acid (Penilloic Acids of Phenoxymethylpenicillin)
O O N H 2N S H
OH
(B)
100 mg
MM 0026.02
O HO O O O H N N S H
O HN S OH
O HN S O O NH
OH
(A)
100 mg
MM 0026.01
OH
(A)
100 mg
O O
H N O
MM 0026.05
OH
(A)
100 mg
Phenylbutazone
MM 0548.00 Phenylbutazone
N N O O
(A)
500 mg
MM 0548.01
Imp. A (EP): (2RS)-2-[(1,2-Diphenyldiazanyl)carbonyl]hexanoic Acid
O N NH O OH
(D)
100 mg
184
Edition 2012/2013
Code Product Price
O N N O OH
Unit
MM 0548.02
Imp. B (EP): 4-Butyl-4-hydroxy-1,2diphenylpyrazolidine-3,5-dione
(A)
50 mg
MM 0548.03
Imp. C (EP): 1,2-Diphenyldiazane (1,2-Diphenylhydrazine) Imp. D (EP): 1,2-Diphenyldiazene
H N
(A)
N H
100 mg
MM 0548.04
(C)
N N
100 mg
MM 0548.05
Imp. E (EP) as Dihydrochloride: Biphenyl-4,4'diamine Dihydrochloride (Benzidine Dihydrochloride)
H2N
NH2
x 2 HCl
(A)
100 mg
Phenylephrine Hydrochloride
MM 0081.00 Phenylephrine Hydrochloride
OH HO H N
(A)
x HCl
500 mg
MM 0081.03
Imp. C (EP) as Hydrochloride: 1-(3-Hydroxyphenyl)2-(methylamino)ethanone Hydrochloride (Phenylephrone Hydrochloride) Imp. E (EP) as Hydrochloride: 2-(Benzylmethylamino)-1-(3-hydroxyphenyl)ethanone Hydrochloride (Benzylphenylephrone Hydrochloride) 1,2,3,4-Tetrahydro-4,6-dihydroxy-2methylisoquinoline Hydrochloride 1,2,3,4-Tetrahydro-4,8-dihydroxy-2methylisoquinoline Hydrochloride
HO
O HO
H N
(D)
x HCl
100 mg
MM 0081.08
O N x HCl
(D)
100 mg
MM 0081.05
OH HO N OH x HCl x HCl
(A)
100 mg
MM 0081.06
(A)
50 mg
N OH
Phenylpropanolamine Hydrochloride
MM 0656.00 Phenylpropanolamine Hydrochloride [Drug Precursor]
OH NH2 x HCl
(A)
500 mg
and enatiomere
Phenyltoloxamine Citrate
MM 0770.00 Phenyltoloxamine Citrate
O N x O OH OH O OH OH O
(A)
500 mg
Phenytoin
MM 0630.00 Phenytoin
H N
(A)
O NH
500 mg
MM 0630.01
Imp. A (EP): Diphenylmethanone (Benzophenone)

O
(B)
100 mg
MM 0630.02
Imp. B (EP): Diphenylethanedione (Benzil)
(B)
O
100 mg
MM 0630.04
Imp. C (EP): Amino(diphenyl)acetic Acid (2,2-Diphenylglycine)

NH2 OH O
(A)
100 mg
New MM 0630.05
Imp. D (EP): 3a,6a-Diphenyltetrahydroimidazo[4,5-d]imidazole2,5(1H, 3H)-dione
O HN HN NH O NH
(A)
50 mg
Edition 2012/2013
185
Code Product Price
O HN NH2 OH O
Unit
MM 0630.06
Imp. E (EP): (Carbamoylamino)(diphenyl)acetic Acid
(A)
50 mg
MM 0630.08
Imp. F (EP): 5-(4-Methylphenyl)-5-phenylimidazolidine2,4-dione
H N
O NH
(A)
100 mg
MM 0630.07
1-Methyl-5,5-diphenylimidazolidine-2,4-dione
N
O NH
(D)
100 mg
MM 0630.03
5-(4-Methylphenyl)hydantoin
H N
O NH
(A)
100 mg
Phenytoin Sodium
MM 0622.00 Phenytoin Sodium
H N N O ONa
(A)
500 mg
MM 0630.01
Imp. A (EP): Diphenylmethanone (Benzophenone)

O
(B)
100 mg
MM 0630.02
Imp. B (EP): Diphenylethanedione (Benzil)

O
(B)
100 mg
MM 0630.04
Imp. C (EP): Amino(diphenyl)acetic Acid (2,2-Diphenylglycine)
(A)
NH2 OH O
100 mg
MM 0630.08
Imp. F (EP): 5-(4-Methylphenyl)-5phenylimidazolidine-2,4-dione
H N
O NH
(A)
100 mg
MM 0630.07
1-Methyl-5,5-diphenylimidazolidine-2,4-dione
N
O NH
(D)
100 mg
MM 0630.03
5-(4-Methylphenyl)hydantoin
H N
O NH
(A)
100 mg
Pholcodine
MM 0037.00 Imp. A (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate [Controlled Substance]
HO O N x HCl x 3 H 2O OH
(A)
250 mg
MM 0280.00
Imp. A (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate [Controlled Substance]

HO O
N x H2SO4 x 5 H2O OH 2
N x H3PO4 x 1/2 H2O O
(A)
250 mg
MM 0442.00
Imp. B (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O
(A)
100 mg
OH
186
Edition 2012/2013
Code Product Price
N x H2O
Unit
MM 0004.00
Imp. B (EP) as Monohydrate: Codeine Monohydrate [Controlled Substance]
(A)
100 mg
OH
Pilocarpine Hydrochloride
MM 0338.00 Pilocarpine Hydrochloride
N N O O x HCl
(A)
500 mg
MM 0338.01
Imp. A (EP) as Hydrochloride: (3R,4R)-3-Ethyl-4[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran2(3H)-one Hydrochloride (Isopilocarpine Hydrochloride) Imp. B (EP) as Sodium Salt: (2S,3R)-2-Ethyl-3(hydroxymethyl)-4-(1-methyl-1H-imidazol-5yl)butanoic Acid Sodium Salt (Pilocarpic Acid Sodium Salt) Imp. C (EP) as Sodium Salt: (2R,3R)-2-Ethyl-3(hydroxymethyl)-4-(1-methyl-1H-imidazol-5yl)butanoic Acid Sodium Salt (Isopilocarpic Acid Sodium Salt)
N N
O x HCl
(A)
100 mg
MM 0338.02
N N
OH O ONa
(A)
100 mg
MM 0338.03
N N
OH O ONa
(A)
100 mg
Pindolol
MM 0082.00 Pindolol
O OH N H N H
(A)
250 mg
MM 0082.08
Imp. B (EP): 1-[4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-1H-indol-1-yl]-3-[(1methylethyl)amino]propan-2-ol Imp. C (EP): 1,1'-[(1-Methylethyl)imino]bis[3(1H-indol-4-yloxy)propan-2-ol] Imp. D (EP): (2RS)-3-(1H-Indol-4-yloxy) propane-1,2-diol Imp. E (EP): 1H-Indol-4-ol
HN
H N
OH N O
OH
H N
(D)
100 mg
MM 0082.06
OH O N
OH O NH
(A)
100 mg
MM 0082.02
OH HN O OH
(A)
100 mg
MM 0082.01
OH
(A)
100 mg
N H
New MM 0082.04
Imp. F (EP): (2RS)-1-Chloro-3(1H-indol-4-yloxy)propan-2-ol
OH HN O Cl
(A)
50 mg
Pioglitazone Hydrochloride
MM 0616.06 Imp. C (Pharmeuropa): (5RS)-5-[4-[2(5-Ethylpyridin-2-yl)ethoxy]benzyl]-3[2-(5-ethylpyridin-2-yl)ethyl]-1,3thiazolidine-2,4-dione Imp. E (Pharmeuropa): Ethyl 3-[4-[2-(5Ethylpyridin-2-yl)ethoxy]phenyl]propanoate 5-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl]2-iminothiazolidin-4-one
N O O S N O N
(A)
50 mg
MM 0616.08
O O O
(A)
50 mg
MM 0616.04
NH S NH O
(A)
100 mg
Pipazetate Hydrochloride
MM 0486.06 MM 0486.02 Bis-(2-piperidinoethyl)ether Dihydrochloride (BPEE Dihydrochloride) 1,2-Dipiperidinoethane (DPE)
N N
x 2 HCl
(A) (A)
100 mg 100 mg
MM 0486.05
2-(2-Piperidinoethoxy)ethanol Hydrochloride
HO
x HCl
(A)
100 mg
Edition 2012/2013
187
Pipemidic Acid Trihydrate

MM 0401.00 Pipemidic Acid Trihydrate
HN N N O O N N OH x 3 H2O
(A)
250 mg
Pipenzolate Bromide
MM 0783.00 Pipenzolate Bromide
N+ O OH O Br-
(A)
500 mg
MM 0630.01
Diphenylmethanone (Benzophenone)
O
(B)
100 mg
MM 0783.09
Benzilic Acid
HO
(B)
OH
100 mg
Piperacillin
MM 0295.00 Piperacillin
O O N N NH O O H N O N S H O
(A)
OH
100 mg
Piperacillin Sodium
MM 0296.00 Piperacillin Sodium
O O N N NH O O H N O N S H NaO O NH 2 H N N S H NaO
(A)
O
100 mg
MM 0253.00
Imp. A (EP) as Sodium Salt: Ampicillin Sodium
(A)
500 mg
MM 0296.05
Imp. E (EP): 1-Ethylpiperazine-2,3-dione

O
N NH O
(A)
100 mg
MM 0296.07
Imp. G (EP): (2R)-2-[[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2-phenylacetic Acid
N O O N NH OH O O
(A)
100 mg
MM 0026.04
Imp. H (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid)
O O H2 N N H S
OH
(B)
100 mg
Pipradrol Hydrochloride
New MM 1099.00 Pipradrol Hydrochloride [Controlled Substance]
NH OH x HCl
(A)
100 mg
188
Edition 2012/2013
Piprinhydrinate
MM 0155.00 Piprinhydrinate
O N O N N O H N Cl N
on request
MM 0155.01
Diphenylpyraline
O N
(A)
100 mg
MM 0155.02
8-Chlorotheophylline
N O
H N Cl N
(B)
100 mg
MM 0490.02
Diphenylmethanol (Benzhydrol)
OH
(B)
100 mg
Piracetam
MM 0083.00 Piracetam
N O O NH2
(A)
500 mg
MM 0083.05 MM 0083.04 MM 0083.02 MM 0083.01 MM 0083.03 MM 0083.06
Imp. A (EP): Pyrrolidin-2-one (2-Pyrrolidone)

O
NH
(B) (A)
100 mg 100 mg 100 mg 100 mg 100 mg 100 mg
Imp. B (EP): Methyl (2-Oxopyrrolidin-1-yl)acetate

O
O N O
Imp. C (EP): Ethyl (2-Oxopyrrolidin-1-yl)acetate

O
O N O
(A) (A)
OH
Imp. D (EP): (2-Oxopyrrolidin-1-yl)acetic Acid

O
O N
N-Vinyl-2-pyrrolidone
O
(A) (C)
NH2
2-Chloroacetamide
O Cl
Piroxicam
MM 0084.00 Piroxicam
O S O N H N N
(A)
500 mg
OH O
MM 0084.01 MM 0084.08
Imp. A (EP): Pyridin-2-amine (2-Pyridylamine) Imp. B (EP): 4-Hydroxy-N-(pyridin-2-yl)-2H-1,2benzothiazine-3-carboxamide 1,1-Dioxide

O S O NH
NH2
(B) (A)
100 mg 100 mg
H N O
OH
MM 0084.09
Imp. C (EP): 4-Hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide1,1-Dioxide Imp. D (EP): Methyl (1,1-Dioxido-3-oxo-1,2benzisothiazol-2(3H)-yl)acetate Imp. E (EP): Ethyl (1,1-Dioxido-3-oxo-1,2benzisothiazol-2(3H)-yl)acetate Imp. F (EP): 1-Methylethyl (1,1-Dioxido-3-oxo1,2-benzisothiazol-2(3H)-yl)acetate
O N NH2
(A)
100 mg
OH O
MM 0084.07
O O S N O O O
(A)
100 mg
MM 0084.05
O O S N O O O
(A)
100 mg
MM 0084.10
O O S N O O O
(A)
100 mg
Edition 2012/2013
189
Code Product Price
O S O NH O OH O
Unit
MM 0084.04
Imp. G (EP): Methyl 4-Hydroxy- 2H-1,2benzothiazine-3-carboxylate 1,1-Dioxide Imp. H (EP): Ethyl 4-Hydroxy- 2H-1,2benzothiazine-3-carboxylate 1,1-Dioxide Imp. I (EP): 1-Methylethyl 4-Hydroxy-2H1,2-benzothiazine-3-carboxylate 1,1-Dioxide Imp. J (EP): Methyl 4-Hydroxy-2-methyl-2H1,2-benzothiazine-3-carboxylate 1,1-Dioxide Imp. K (EP): Ethyl 4-Hydroxy-2-methyl-2H1,2-benzothiazine-3-carboxylate 1,1-Dioxide Imp. L (EP): 1-Methylethyl 4-Hydroxy-2-methyl-2H1,2-benzothiazine-3-carboxylate 1,1-Dioxide N-(2-Pyridinyl)oxamic Acid
O O
(A)
100 mg
MM 0084.06
O NH O
(A)
100 mg
OH O
MM 0084.11
O NH O
(A)
100 mg
OH O
MM 0084.02
O N O
(A)
100 mg
OH O
MM 0084.03
O N O
(A)
100 mg
OH O
MM 0084.12
O N O
(A)
100 mg
OH O
New MM 0084.14
H N O
O OH
(A)
100 mg
MM 0084.13
N-Methylsaccharin
O O S N O
(A)
100 mg
MM 0084.15
4-Isopropoxy-2-methyl-N-(2-pyridinyl)-2H1,2-benzothiazine-3-carboxamide 1,1-Dioxide
O N O H N N
(A)
100 mg
MM 0084.16
N,N'-Di-(2-pyridinyl)oxamide
N
H N O
O N H N
(C)
50 mg
MM 0084.17
N-(2-Pyridinyl)oxamic Acid Hydrochloride
H N O
O OH x HCl
on request
MM 0084.20
2-(1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetamide
O O S N O O NH2
(A)
100 mg
MM 0084.21
N-(6-Methyl-2-pyridyl)-4-hydroxy-2-methyl-2H1,2-benzothiazine-3-carboxamide-1,1-Dioxide
O N H N N
(B)
10 mg
OH O
MM 0084.22
4-Methoxy-2-methyl-N-(2-pyridyl)-2H-1,2benzothiazine-3-carboxamide-1,1-Dioxide
O N O
O N O O O NH NH2 OH O H N N
(C)
H N N
10 mg
MM 0084.23
2-Methyl-N-2-(1-methylpyridinium)-2H-1,2benzothiazine-3-carboxamide-4-olate 1,1-Dioxide 4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide
(B)
10 mg
MM 0084.24
(B)
10 mg
Potassium Sorbate
MM 0955.00 Potassium Sorbate
O OK
(A)
500 mg
Povidone
MM 0083.03 Imp. A (EP): 1-Ethenylpyrrolidin-2-one (1-Vinylpyrrolidin-2-one, N-Vinyl-2-pyrrolidone) (A)
N O
100 mg
190
Edition 2012/2013
Code Product Price
H N O
Unit
MM 0083.05 MM 0537.01
Imp. B (EP): Pyrrolidin-2-one (2-Pyrrolidone) Vinyl Acetate
(B) (B)
100 mg 100 mg
O O
Pralidoxime Methyl Sulphate

MM 0689.00 Pralidoxime Methyl Sulphate
N N OH O O S O O
(A)
100 mg
MM 0689.01
2-Carboxy-N-methylpyridinium Iodide
O N OH I-
(A)
100 mg
MM 0689.02
2-Carbamoyl-N-methylpyridinium Methanesulfonate
O N NH2 O O S O
(A)
100 mg
Prasterone
MM 0651.00 Prasterone
O
(A)
500 mg
HO
MM 0651.02
16-Dehydropregnenolone Acetate Oxime

O O
N OH
(A)
100 mg
Pravastatin Sodium
MM 0503.00 Pravastatin Sodium
OH H O ONa OH O O
(A)
100 mg
OH
MM 0503.04
Imp. D (EP): (1S,3S,7S,8S,8aR)-3-Hydroxy-8-[2-[(2R,4R)4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-7-methyl1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-Methylbutanoate (Pravastatin Lactone)
O O H OH O O
(D)
100 mg
OH
Prazepam
New MM 1258.00 Prazepam [Controlled Substance]
N Cl N O
(A)
100 mg
MM 0023.02
Imp. A (EP): 7-Chloro-5-phenyl-1,3-dihydro2H-1,4-benzodiazepin-2-one (Nordazepam) [Controlled Substance]
H N Cl N
(A)
100 mg
MM 0028.03
Imp. C (EP): (2-Amino-5-chlorophenyl)phenylmethanone
NH2 Cl O
(B)
100 mg
Edition 2012/2013
191
Praziquantel
MM 0615.00 Praziquantel
O N N H O
(A)
250 mg
MM 0615.02
Imp. B (EP): 2-(Cyclohexylcarbonyl)2,3,6,7-tetrahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
O N N O
on request
Prazosin Hydrochloride
MM 0085.00 Prazosin Hydrochloride
N O O N N NH2 N O x HCl O
(A)
100 mg
MM 0085.04
Imp. A (EP): 2-Chloro-6,7-dimethoxyquinazoline4-amine Imp. B (EP): 1,4-Bis(furan-2-ylcarbonyl)piperazine

O
O O
N N NH2
Cl
(A)
100 mg
MM 0085.05
O N N O O
(A)
100 mg
MM 0085.01
Imp. C (EP): 6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin4-amine
NH O O N N NH2 N
(A)
100 mg
MM 0085.02
Imp. D (EP): 1-(Furan-2-ylcarbonyl)piperazine

N HN
(A)
O
100 mg
MM 0085.03
Imp. E (EP): 2,2'-(Piperazin-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)

N O O N N NH2 N
NH2 N N O O
(D)
100 mg
MM 0085.06
2,4-Dichloro-6,7-dimethoxyquinazoline
O O
N N Cl
Cl
(A)
100 mg
MM 0085.07
6,7-Dimethoxyquinazoline-2,4(1H,3H)-dione
O O
H N NH O
(C)
100 mg
Prednisolone
MM 0193.00 Prednisolone
HO O OH OH
(A)
500 mg
MM 0185.00
Imp. A (EP): Hydrocortisone

HO
O OH OH
(A)
500 mg
MM 0482.00
Imp. B (EP): 17,21-Dihydroxypregna-1,4diene-3,11,20-trione (Prednisone)
O O OH OH
(A)
250 mg
192
Edition 2012/2013
Code Product Price
O HO O OH O
Unit
MM 0194.00
Imp. C (EP): 11,17-Dihydroxy-3,20-dioxo-pregna1,4-dien-21-yl Acetate (Prednisolone Acetate)
(A)
500 mg
MM 0193.01
(20R)-Hydroxyprednisolone
HO
HO OH OH
(C)
10 mg
MM 0193.02
(20S)-Hydroxyprednisolone
HO
HO OH OH
(D)
50 mg
Prednisolone Acetate
MM 0194.00 Prednisolone Acetate
HO O O O OH
(A)
500 mg
MM 0187.00
Imp. A (EP): Hydrocortisone Acetate

HO
O O O OH
(A)
500 mg
MM 0193.00
Imp. B (EP): Prednisolone

HO
O OH OH
(A)
500 mg
MM 0194.04
Prednisolone 17-Acetate
HO
O O OH O O
(C)
50 mg
MM 0194.07
Prednienic Acid
HO
OH OH
(A)
100 mg
Prednisolone Pivalate
MM 0304.00 Prednisolone Pivalate
HO O OH O O
(D)
250 mg
Prednisolone Sodium Phosphate

MM 0305.00 Prednisolone Sodium Phosphate
HO O OH O O P ONa ONa
(A)
100 mg
Prednisolone Sodium Sulfobenzoate

MM 0484.01 Sodium 3-Sulfobenzoate
HO O O O S ONa
(C)
100 mg
Edition 2012/2013
193
Prednisone
MM 0482.00 Prednisone
O O OH OH
(A)
250 mg
Prednisone Acetate
MM 0196.00 Prednisone Acetate
O O O O OH
(A)
250 mg
Pregabalin
New MM 1376.00 New MM 1376.01 Pregabalin rac-Pregabalin
NH2 O OH NH2 O OH
(A) (A)
100 mg 100 mg
Prilocaine Hydrochloride
MM 0563.00 Prilocaine Hydrochloride
H N O
(A)
N H x HCl
500 mg
MM 0563.01
Imp. A (EP): (RS)-2-Chloro-N-(2-methylphenyl)Propanamide Imp. B (EP): 2-Methylbenzenamine (o-Toluidine) Imp. C (EP) as Hydrochloride: (RS)-2-EthylaminoN-(2-methylphenyl)propanamide Hydrochloride Imp. D (EP) as Hydrochloride: (RS)-N-(3-Methylphenyl)-2-(propylamino)propanamide Hydrochloride
H N O
H N O N H
H N O
(A)
Cl
100 mg
MM 0563.02 MM 0563.03
NH2
(A) (A)
100 mg 50 mg
x HCl
MM 0563.04
(A)
N H x HCl
50 mg
MM 0563.05
Imp. E (EP) as Hydrochloride: (RS)-N-(4-Methylphenyl)2-(propylamino)propanamide Hydrochloride
H N O
(A)
N H x HCl
50 mg
Primidone
MM 1030.01 Imp. A (EP) as Hydrate: 2-Ethyl-2-phenylpropanediamide Hydrate (Ethylphenylmalonamide Hydrate)
O NH2 NH2 O x H 2O
(A)
100 mg
MM 1030.03
Imp. C (EP): (2RS)-2-Phenylbutanamide

NH2 O
(A)
100 mg
MM 1030.04
Imp. D (EP): (2RS)-2-Cyano-2-phenylbutanamide
N NH2 O
(A)
50 mg
MM 1030.05
Imp. E (EP): (2RS)-2-Phenylbutanoic Acid

OH O
(A)
100 mg
Probenecid
MM 0657.00 Probenecid
N S O O O OH
(A)
500 mg
194
Edition 2012/2013
Procainamide Hydrochloride
MM 0550.00 Procainamide Hydrochloride
H2 N O N H N x HCl
(A)
500 mg
MM 0550.02
Procainamide N-Oxide Dihydrochloride

H2N
O N H N
O x 2 HCl
(A)
100 mg
Procaine Hydrochloride
MM 0596.00 Procaine Hydrochloride
H2N O O N x HCl
(A)
500 mg
MM 0094.03
4-Aminobenzoic Acid
H2N
O OH
(B)
100 mg
New MM 0550.03
N-Acetylprocainamide
O N H
O N H N
(A)
100 mg
Progesterone
MM 0222.00 Progesterone
O
(A)
500 mg
MM 0222.03
Imp. C (EP): (20R)-20-Hydroxypregn-4-en-3-one
HO
(A)
100 mg
MM 0222.01
Imp. E (EP): (20R)-3-Oxopregn-4-en-20-yl Acetate
O O
(D)
100 mg
MM 0222.08
11-Hydroxyprogesterone
HO
(A)
100 mg
MM 0222.12
11-Ketoprogesterone
O
(A)
100 mg
MM 0222.14
Pregnanediol (5-Pregnane-3,20(S)-diol)
HO
(A)
100 mg
HO
H HO OH
MM 0222.15
Pregnanetriol (5-Pregnane-3,17,20(S)-triol)
on request
HO
Proguanil Hydrochloride
MM 0162.05 Imp. B (EP): 4-Chloroaniline
Cl NH2
(B)
100 mg
Edition 2012/2013
195
Prolintane Hydrochloride
MM 0663.00 Prolintane Hydrochloride
N x HCl
(A)
100 mg
Promazine Hydrochloride
MM 0290.00 Promazine Hydrochloride
N S N x HCl
(A)
500 mg
MM 0290.01
Imp. A (EP): 3-(10H-Phenothiazin-10-yl)-N,Ndimethylpropan-1-amine S-Oxide (Promazine Sulphoxide)
N N S O
(A)
100 mg
MM 0290.02 MM 0157.02
N,N-Dimethyl-3-chloropropylamine Hydrochloride Phenothiazine
Cl
N H N S
x HCl
(B) (B)
100 mg 100 mg
Promethazine Hydrochloride
MM 0412.00 Promethazine Hydrochloride
N S N x HCl
(A)
500 mg
MM 0157.02
Imp. A (EP): Phenothiazine

NH S
(B)
100 mg
MM 0412.02
Imp. B (EP) as Hydrochloride: (2RS)-N,NDimethyl-2-(10H-phenothiazin-10-yl)propan1-amine Hydrochloride (Isopromethazine Hydrochloride) Imp. C (EP) as Hydrochloride: (2RS)-N-Methyl1-(10H-phenothiazin-10-yl)propan-2-amine Hydrochloride (Norpromethazine Hydrochloride) Imp. D (EP): (2RS)-N,N-Dimethyl-1-(10H-phenothiazin10-yl)propan-2-amine S-Oxide (Promethazine Sulphoxide)
(A)
N S N x HCl
100 mg
MM 0412.03
N S
H N x HCl
(A)
50 mg
MM 0412.04
(A)
N O S N
100 mg
MM 0412.05
Promethazine Sulphoxide N-Oxide Hydrochloride

N O S N
O x HCl
(A)
100 mg
MM 0412.06
(2RS)-N-Methyl-2-(10H-phenothiazin-10-yl)propan1-amine Hydrochloride (Norisopromethazine Hydrochloride)
N S
H N x HCl
(A)
100 mg
Propafenone Hydrochloride
MM 0405.00 Propafenone Hydrochloride
O O N OH H
(A)
x HCl
500 mg
MM 0405.02
Imp. A (EP): 1-(2-Hydroxyphenyl)-3-phenylpropan1-one Imp. B (EP) as Hydrochloride: (2E)-1-[2-[(2RS)2-Hydroxy-3-(propylamino)propoxy]phenyl]3-phenylprop-2-en-1-one Hydrochloride

O O OH N H
OH
(A)
100 mg
MM 0405.03
(A)
x HCl
50 mg
196
Edition 2012/2013
Code Product Price
O O O
Unit
MM 0405.04
Imp. C (EP): 1-[2-[[(2RS)-Oxiranyl]methoxy] phenyl]-3-phenylpropan-1-one Imp. D (EP): 1-[2-[(2RS)-2,3-Dihydroxy-propoxy] phenyl]-3-phenylpropan-1-one Imp. E (EP): 1-[2-[(2RS)-3-Chloro-2-hydroxypropoxy]phenyl]-3-phenylpropan-1-one Imp. F (EP): 1,1'-[2-Hydroxypropane1,3-diylbis(oxy-2,1-phenylene)]bis(3phenylpropan-1-one) Imp. H (EP): (2RS)-2-Phenyl-2,3-dihydro-4H-1benzopyran-4-one
O O OH O O
(A)
50 mg
MM 0405.05
O OH
OH
(A)
50 mg
MM 0405.06
O OH
Cl
(A)
50 mg
MM 0405.07
(A)
50 mg
MM 0405.09
(A)
O O
100 mg
MM 0405.01
5-Hydroxypropafenone Hydrochloride
O OH
N H x HCl
(A)
100 mg
OH
Propentofylline
MM 0875.01 3-Methyl-7-propylxanthine
HN O N O N N
(A)
100 mg
MM 0875.02
1-(3-Hydroxypropyl)-3-methyl-7-propylxanthine
HO O N
O N N N
(A)
100 mg
MM 0875.03
1,7-Bis-(5-oxohexyl)-3-methylxanthine
O N O N O N N
(A)
100 mg
Propofol
MM 0461.00 Propofol
OH
(A)
250 mg
MM 0461.03
Imp. A (EP): 2,4-Bis(1-methylethyl)phenol
OH
(A)
100 mg
MM 0461.04
Imp. C (EP): 2-(1-Methylethyl)phenol
OH
(C)
100 mg
MM 0461.02
Imp. E (EP): 3,3',5,5'-Tetrakis(1Methylethyl)bisphenyl-4,4'-diol
(A)
HO OH
100 mg
MM 0461.05 MM 0461.08
Imp. F (EP): 3-(1-Methylethyl)phenol Imp. G (EP): 2-(1-Methylethoxy)-1,3-bis (1-methylethyl)benzene
HO
(C) (A)
O
100 mg 100 mg
MM 0461.06
Imp. H (EP): 4-(1-Methylethyl)phenol
HO
(C)
100 mg
Edition 2012/2013
197
Code Product Price
O
Unit
MM 0461.07 MM 0461.13
Imp. I (EP): Oxydibenzene Imp. J (EP): 2,6-Bis(1-methylethyl)benzene-1,4-dione
(B) (A)
100 mg 50 mg
MM 0461.11
Imp. K (EP): 1-(1-Methylethoxy)-2-(1-methylethyl)benzene

O
(A)
100 mg
MM 0461.15
Imp. M (Pharmeuropa): 2,6-Diisopropylbenzoic Acid
OH
(A)
50 mg
Propranolol Hydrochloride
MM 0043.00 Propranolol Hydrochloride
O OH H N
(A)
x HCl
500 mg
MM 0043.01
Imp. A (EP): (2RS)-3-(Naphthalen-1yloxy)propane-1,2-diol (Diol Derivative) Imp. B (EP) as Hydrochloride: 1,1'-[(1Methylethyl)imino]bis[3-(naphthalen-1yloxy)propan-2-ol] Hydrochloride (Tertiary Amine Derivative Hydrochloride) Imp. C (EP): 1,3-Bis(naphthalen-1-yloxy)propan-2-ol (Bis-ether Derivative) 1-Naphthol
OH O N x HCl OH
OH O OH
(A)
100 mg
MM 0043.03
(A)
O
100 mg
MM 0043.02
OH O O
(A)
50 mg
MM 0043.04
(B)
OH
100 mg
MM 0043.05
1-(1-Naphtyloxy)-2,3-epoxypropane
(A)
100 mg
Propyl Gallate
MM 1037.00 Propyl Gallate
O HO HO OH O
(A)
500 mg
Propyl Parahydroxybenzoate
MM 0432.00 Propyl Parahydroxybenzoate
HO O O
(A)
500 mg
MM 0045.01

HO
O OH
(B)
100 mg
MM 0431.00

HO
O O
(A)
500 mg
MM 0498.00
Imp. C (EP): Ethyl 4-Hydroxybenzoate (Ethyl Parahydroxybenzoate)

HO
O O
(A)
500 mg
MM 0496.00

HO
O O
(A)
500 mg
MM 0432.01
Sodium Propyl Parahydroxybenzoate

NaO
O O
(B)
100 mg
Propylhexidrine Hydrochloride
MM 0664.00 Propylhexidrine Hydrochloride
NH x HCl
(A)
100 mg
198
Edition 2012/2013
Propyphenazone
MM 0036.00 Propyphenazone
N N O
(A)
500 mg
MM 0036.05
Imp. A (EP): Phenazone

N N
(A)
100 mg
MM 0036.04
Imp. C (EP): 4-[(1RS)-1,3-Dimethylbutyl]1,5-dimethyl-2-phenyl-1,2-dihydro-3Hpyrazol-3-one
O N N
(A)
50 mg
Protionamide
MM 0844.01 Protionamide Sulphoxide
N O S NH2
(A)
50 mg
Proxymetacaine Hydrochloride
MM 0404.00 Proxymetacaine Hydrochloride
H2N O O O N x HCl
(A)
500 mg
MM 0404.01
3-Amino-4-propoxybenzoic Acid Hydrochloride
O H2N O OH x HCl
(A)
100 mg
MM 0404.02
Proxymetacaine N-Oxide Dihydrochloride

H2N O
O O N O x 2 HCl
(C)
50 mg
Proxyphylline
MM 1284.00 Proxyphylline
N O N OH O N N
(A)
250 mg
Pseudoephedrine Hydrochloride
MM 2115.01 Methcathinone Hydrochloride (2-Methylamino-1-phenylpropan-1-one Hydrochloride) [Controlled Substance] (1S,2S)-N-Acetylpseudoephedrine
O NH x HCl
(A)
100 mg
MM 2115.04
OH N O
(A)
100 mg
MM 2115.05
(1S,2S)-N,O-Diacetylpseudoephedrine
O O N O
(A)
100 mg
MM 0652.00
Imp. A (EP) as Hydrochloride: Ephedrine Hydrochloride [Drug Precursor] Imp. A (EP) as Sulphate: Ephedrine Sulphate [Drug Precursor] (1S,2S)-O-Acetylpseudoephedrine Hydrochloride
OH
OH
H N
(A)
x HCl
500 mg
MM 1147.00
H N 2
(A)
x H2SO4
250 mg
MM 2115.03
O O NH x HCl
(A)
50 mg
New MM 2115.10
(+)-Norpseudoephedrine Hydrochloride (Cathine Hydrochloride) [Controlled Substance]
OH NH2 x HCl
(A)
100 mg
Edition 2012/2013
199
Code Product Price
OH NH
Unit
New MM 2115.11
(-)-Pseudoephedrine ((1R,2R)-Pseudoephedrine)
(A)
100 mg
Pyrazinamide
MM 0385.00 Pyrazinamide
O N N NH2
on request
MM 0385.01
Imp. A (EP): Pyrazine-2-carboxylic Acid
O N N OH
(A)
100 mg
Pyridostigmine Bromide
MM 0429.00 Pyridostigmine Bromide
N O O N+ Br-
(A)
100 mg
MM 0429.02
Imp. B (EP) as Iodide: 3-Hydroxy-1-methylpyridinium Iodide
HO
N+
I-
(A)
100 mg
Pyridoxine Hydrochloride
MM 0021.00 Pyridoxine Hydrochloride
HO OH N OH x HCl
(A)
500 mg
MM 0021.01
Imp. A (EP) as Hydrochloride: 6-Methyl1,3-dihydrofuro[3,4-c]pyridin-7-ol Hydrochloride Imp. B (EP) as Hydrochloride: 5-(Hydroxymethyl)2,4-dimethylpyridin-3-ol Hydrochloride Pyridoxine Diacetate
N HO O x HCl
(D)
100 mg
MM 0021.02
N HO
N HO O O O O
(A)
OH x HCl
100 mg
MM 0021.03
(A)
100 mg
MM 0021.05
Pyridoxal Hydrochloride
HO
N OH O x HCl
(A)
100 mg
MM 0021.06
Pyridoxamine Dihydrochloride
HO
N OH NH2 x 2 HCl
(A)
100 mg
MM 0021.07
4-Pyridoxic Acid
HO O
N OH OH
(D)
50 mg
Quetiapine Fumarate
New MM 1130.00 Quetiapine Fumarate
N S 2 HO N x O N O OH OH O
100 mg
New MM 1130.15
Imp. A (Pharmeuropa) as Maleate: 2-[2-[4(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin1-yl]ethoxy]ethyl Acetate Maleate

S
O N N N x O O O OH OH O
(A)
50 mg
MM 1130.01
Imp. B (Pharmeuropa) as Dihydrochloride: 11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine Dihydrochloride

S
NH N N x 2 HCl
(A)
100 mg
200
Edition 2012/2013
Code Product Price
N NH2 S x O O N O O OH OH OH
Unit
New MM 1130.16
Imp. F (Pharmeuropa) as Maleate: [2-[(2-Aminophenyl)thio]phenyl][4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]methanone Maleate
(A)
50 mg
MM 1130.09
Imp. G (Pharmeuropa): Dibenzo[b,f][1,4]thiazepin11(10H)-one

S
H N
(A)
100 mg
MM 1130.10
Imp. H (Pharmeuropa): 2-[2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-oxidopiperazin-1-yl]ethoxy]ethanol (Quetiapine N-Oxide)

S
O N N N
OH
(A)
50 mg
New MM 1130.14
Imp. I (Pharmeuropa) as Fumarate: 2-[4-(Dibenzo[b,f][1,4]thiazepin11-yl)piperazin-1-yl]-ethanol Fumarate

S
N N N
OH O x
OH
(A)
50 mg
O HO
O
New MM 1130.17
Imp. K (Pharmeuropa) as Fumarate: N-(2[[2-([4-[2-(2-Hydroxyethoxy)ethyl]piperazin1-yl]carbonyl)phenyl]thio]phenyl)acetamide Fumarate

O
N O S NH N
OH O x
OH
(A)
50 mg
O HO
Quinapril Hydrochloride
MM 0011.01 4-Amino-6-chlorobenzene-1,3-disulphonamide (Salamide) Imp. B (Pharmeuropa): (2S)-2-[[(1S)-1(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoic Acid
O H2 N S O O S O NH2
(B)
100 mg
Cl
NH2
MM 0010.05
H N O O
O OH
(A)
100 mg
Quinine Dihydrochloride
MM 0458.00 Quinine Dihydrochloride
HO O N H N x 2 HCl H
(A)
500 mg
Quinuclidinyl Benzilate
MM 0783.09 Benzilic Acid
HO O OH
(B)
100 mg
MM 0825.02
3-Quinuclidinol
N OH
(A)
100 mg
Rabeprazole Sodium
MM 0618.01 Rabeprazole Sodium
O Na N S N O N O
on request
MM 0618.00
Rabeprazole
O H N S N O N
on request
Edition 2012/2013
201
Code Product Price
O H N S N N O
Unit
MM 0618.02
2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl] methyl]thio]-1H-benzimidazole
(A)
100 mg
MM 0618.03
Rabeprazole Sulphone
H N N N O S O O
(A)
100 mg
MM 0618.04
Rabeprazole N-Oxide
H N S N N O O O
(D)
100 mg
MM 0618.05
Rabeprazole Sulphone N-Oxide

H N N N O O S O O
(A)
100 mg
MM 0618.07
2-Chloromethyl-3-methyl-4-(3-methoxypropoxy) pyridine Hydrochloride

Cl N
O O x HCl
(A)
100 mg
Racecadotril
New MM 1337.00 Racecadotril
O N H S O O O
(A)
100 mg
Raloxifene Hydrochloride
MM 0738.00 Raloxifene Hydrochloride
HO S OH x HCl O O N
(A)
100 mg
MM 0738.01
Imp. C (EP): [6-Hydroxy-2-(4-hydroxyphenyl)-1benzothiophen-3-yl][4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide)
O O HO
O N
(A)
50 mg
S OH
Ramipril
MM 0448.05 Imp. D (EP): Ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3Methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate (Ramipril Diketopiperazine)
O H H O N O N H O
(A)
100 mg
MM 0010.05
Imp. F (EP): (2S)-2-[[(1S)-1-(Ethoxycarbonyl)3-phenylpropyl]amino]propanoic Acid

O
H N O
O OH
(A)
100 mg
MM 0291.04 MM 0448.04
Imp. G (EP): Methylbenzene (Toluene) Imp. M (EP): (2R,3R)-2,3-Bis(benzoyloxy)butanedioic Acid (Dibenzoyltartric Acid)
O O O HO O OH O O
(C) (A)
100 mg 100 mg
202
Edition 2012/2013
MM 0448.11
(2S,3aS,6aS)-Octahydro-cyclopenta[b]pyrrole2-carboxylic Acid Phenylmethyl Ester Hydrochloride

H
(A)
O HN H O x HCl
100 mg
Ranitidine Hydrochloride
MM 0086.00 Ranitidine Hydrochloride
N O S H N H N x HCl NO2
(A)
500 mg
MM 0086.02
Imp. A (EP): N,N'Bis[2-[[[5-[(dimethylamino)methyl]furan-2-yl]methyl]sulphanyl]ethyl]-2-nitroethene1,1-diamine Imp. B (EP): 2-[[[5-[(Dimethylamino)methyl]furan-2-yl]methyl]sulphanyl]ethanamine Imp. C (EP): N-[2-[[[5-[(Dimethylamino)methyl]furan-2-yl]methyl]sulphinyl]ethyl]-N'methyl-2-nitroethene-1,1-diamine (Ranitidine Sulphoxide) Imp. D (EP) as Sodium Salt: N-[2-[[[5[(Dimethylamino)methyl]furan-2-yl]methyl]sulphanyl]ethyl]-2-nitroacetamide Sodium Salt Imp. E (EP): N-[2-[[[5-[(Dimethyloxidoamino)methyl]furan-2-yl]methyl]sulphanyl]ethyl]N'-methyl-2-nitroethene-1,1-diamine (Ranitidine N-Oxide) Imp. F (EP) as Hydrochloride: [5-[(Dimethylamino)methyl]furan-2-yl]methanol Hydrochloride Imp. G (EP): 3-(Methylamino)-5,6-dihydro-2H-1,4thiazin-2-one Oxime Imp. H (EP): N-Methyl-2-nitroacetamide
H N
H N NO2
(A)
100 mg
MM 0086.01 MM 0086.03
NH2
(A) (A)
100 mg 100 mg
S O
H N
H N
NO2
O H N
MM 0086.06
ONa
(A)
100 mg
NO2 O N H N H N
MM 0086.05
(D)
100 mg
NO2
O
MM 0086.17 MM 0086.07 MM 0086.08
OH
x HCl
(A) (A) (A)
100 mg 100 mg 100 mg
S N
N N H
OH
NO2 O N H
H N NO2 N S NO2 N H N H
NO2
MM 0086.10
Imp. I (EP): 2,2'-Methylenebis[N-[2-[[[5-[(dimethylamino)methyl]furan-2-yl]methyl]sulphanyl]ethyl]-N'methyl-2-nitroethene-1,1-diamine]
H N
(A)
100 mg
MM 0220.09
Imp. K (EP): N-Methyl-1-methylthio-2nitroethenamine ((EZ)-N-Methyl-1-(methylsulphanyl)-2-nitroethen-1-amine)
(A)
100 mg
N H
Ranolazine Dihydrochloride
MM 1320.01 2-[(2-Methoxyphenoxy)methyl]oxirane
O O O
(A)
100 mg
Reagents
MM 0334.01 Diethylhexylphthalate (Bis-(2-ethylhexyl) Phthalate)
O O O O
(C)
500 mg
MM 0334.02 MM 0334.03
3-(N-Morpholino)propane Sulfonic Acid (MOPS)

O
OH S O O
(C) (C)
500 mg 500 mg
3-(N-Morpholino)ethane Sulfonic Acid (MES)

N O
O O S OH
MM 0334.08
Salicylaldehyde Azine
N N OH
HO
(A)
100 mg
Edition 2012/2013
203
Repaglinide
MM 0944.00 Repaglinide
N N H O O O OH
(A)
100 mg
MM 0944.02
Imp. B (EP): [3-Ethoxy-4-(ethoxycarbonyl)phenyl]acetic Acid

HO
O O O
O N NH2 x HO HN O O OH
(A)
O
100 mg
MM 0944.01
Imp. C (EP) as N-Acetyl-L-glutamate: (1S)3-Methyl-1-[2-(piperidin-1-yl)phenyl]butan1-amine N-Acetyl-L-glutamate
(A)
100 mg
Ribavirin
MM 0542.00 Ribavirin
H2N HO N O OH OH N O N
(A)
250 mg
MM 0542.01
Imp. A (EP): 1--D-Ribofuranosyl-1H-1,2,4triazole-3-carboxylic Acid
O HO HO N O OH OH N N
(D)
100 mg
MM 0542.03
Imp. C (EP): 1H-1,2,4-Triazole-3-carboxylic Acid

HO
O N N N H
(D)
100 mg
MM 0542.04
Imp. D (EP): 1H-1,2,4-Triazole-3-carboxamide

H2N
O N N N H
(D)
100 mg
MM 0542.05
1-(5-O-Benzoyl--D-ribofuranosyl)-1H-1,2,4triazole-3-carboxamide (5'-O-Benzoylribavirin)
O
O H2N O N O OH OH N N
(D)
100 mg
MM 0542.06
Imp. F (EP): 1-(5-O-Acetyl--D-ribofuranosyl)-1H1,2,4-triazole-3-carboxamide (5'-O-Acetylribavirin)

O
O H2 N O N O OH OH N N
(D)
100 mg
Riboflavin
MM 0030.00 Riboflavin
OH HO OH N OH
(A)
500 mg
N N
NH O
Risedronate Sodium 2.5 Hydrate

MM 0777.00 Risedronate Sodium 2.5 Hydrate
N OH O OH HO P x 2,5 H2O OH P ONa O OH O OH HO P OH P OH O OH O OH HO P OH P OH O
(A)
100 mg
New MM 0777.02
Imp. B (Pharmeuropa): [1-Hydroxy-2-(pyridin2-yl)ethane-1,1-diyl]bis(phosphonic Acid)

N
(A)
50 mg
New MM 0777.03
Imp. C (Pharmeuropa): [1-Hydroxy-2-(pyridin4-yl)ethane-1,1-diyl]bis(phosphonic Acid)
(A)
50 mg
204
Edition 2012/2013
Risperidone
MM 0491.00 Risperidone
N O N O N N F
(A)
100 mg
MM 0491.01
Imp. A (EP): 3-[2-[4-[(E)-(2,4-Difluorophenyl)(hydroxyimino)methyl]piperidin-1-yl]ethyl]-2methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one Imp. B (EP): 3-[2-[4-[(Z)-(2,4-Difluorophenyl)(hydroxyimino)methyl]piperidin-1-yl]ethyl]-2methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one Imp. C (EP): (9RS)-3-[2-[4-(6-Fluoro1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9hydroxy-2-methyl-6,7,8,9-tetrahydro-4Hpyrido[1,2-a]pyrimidin-4-one (9-Hydroxyrisperidone) Imp. D (EP): 3-[2-[4-(5-Fluoro-1,2-benzisoxazol3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one Imp. E (EP): (6RS)-3-[2-[4-(6-Fluoro-1,2benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2,6dimethyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one Imp. F (EP): 2-[2-Methyl-4-oxo-6,7,8,9-tetrahydro4H-pyrido[1,2-a]pyrimidin-3-yl]ethyl 4-(6-Fluoro1,2-benzisoxazol-3-yl)piperidin-1-carboxylate Imp. H (EP): 3-[2-[4-(2,4-Difluorobenzoyl)piperidin1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one 3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4Hpyrido-[1,2-a]pyrimidin-4-one Imp. L (EP) as Hydrochloride: 3-(2-Chloroethyl)2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one Hydrochloride (Risperidone Piperidopyrimidinone Intermediate Hydrochloride) 3-[2-[4-[2-Fluoro-4-[4-(6-fluoro1,2-benzisoxazol-3-yl)piperidin1-yl]benzoyl]piperidin-1-yl]ethyl]-2-methyl6,7,8,9-tetrahydro-4H-pyrido-[1,2-a]pyrimidin-4-one
N N O
N N O HO N F N F
(D)
100 mg
MM 0491.02
N N O N F OH N F
(A)
100 mg
MM 0491.03
OH N N O N O N F
(D)
100 mg
MM 0491.04
N N O N
(D)
100 mg
N O
MM 0491.05
N N O N O F N
(D)
50 mg
MM 0491.08
O F O N
(A)
100 mg
N O
MM 0491.10
N N O O F N F
(A)
100 mg
MM 0491.09
N N O O OH N F
(A)
100 mg
MM 0491.13
N N O
F
(A)
Cl x HCl
100 mg
MM 0491.18
(D)
50 mg
N N O O F N N
O N
Ritodrine Hydrochloride
MM 0063.06 Imp. A (BP): Tyramine
HO NH2
(B)
100 mg
Edition 2012/2013
205
Ritonavir
MM 1034.00 Ritonavir
S N N O N H H N O OH O N H O S N
(A)
100 mg
Ronidazole
MM 1026.01 (1-Methyl-5-nitroimidazol-2-yl)methanol
O2 N N N
(A)
OH
100 mg
Rosiglitazone Maleate
MM 0522.01 Rosiglitazone Maleate
N N O S NH O O O x O OH OH
(D)
100 mg
New MM 0522.04
Imp. A (Pharmeuropa): 3-[4-[2-[Methyl(pyridin2-yl)amino]ethoxy]phenyl]propanamide
N N O NH2 O
(A)
50 mg
Rosuvastatin Calcium
MM 0936.01 4-(4-Fluorophenyl)-6-isopropyl2-[methyl(methylsulfonyl)amino]pyrimidine5-carbaldehyde
N N O O S N
(A)
100 mg
MM 0936.02
4-(4-Fluorophenyl)-6-isopropyl2-[methyl(methylsulfonyl)amino]pyrimidine5-methanol
O O S N N N
(A)
100 mg
HO
F
O O S N
New MM 0936.03
5-Oxorosuvastatin Methyl Ester

N
(A)
100 mg
O O
OH O
Rotigotine
New MM 1403.02 Despropylrotigotine ((6S)-5,6,7,8-Tetrahydro6-[[2-(2-thienyl)ethyl]amino]-1-naphthalenol)
OH
(A)
N H S
OH x OH O
50 mg
New MM 1403.03
(S)-2-Amino-5-methoxytetralin (S)-Mandelate
(A)
50 mg
NH2
New MM 1403.04
Despropylrotigotine Methyl Ether Hydrochloride
O x HCl N H S
(A)
100 mg
Roxatidine Acetate Hydrochloride

MM 0597.03 N-[3-[3-[(Piperidin-1-yl)methyl]phenoxy]propan1-yl]phthalimide Hydrochloride
O N O O N x HCl
(A)
50 mg
206
Edition 2012/2013
Rutoside Trihydrate
MM 0109.03 Imp. C (EP) as Dihydrate: 2-(3,4-Dihydroxyphenyl)3,5,7-trihydroxy-4H-1-benzopyran-4-one Dihydrate (Quercetin Dihydrate)
HO O HO O x 2 H2O OH
(A)
100 mg
OH OH
Saccharin Sodium
MM 0818.00 Saccharin Sodium
O O S NNa O
(A)
500 mg
Salbutamol Sulphate
MM 0381.00 Salbutamol Sulphate
HO OH 2
OH H N
OH
H N x H2SO4
(A)
500 mg
MM 0381.02
Imp. B (EP): (1RS)-2-[(1,1-Dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol

HO
(A)
50 mg
MM 0381.03
Imp. C (EP): (1RS)-2-[(1,1-Dimethylethyl)amino]1-(4-hydroxy-3-methylphenyl)ethanol

HO
OH
H N
(A)
50 mg
MM 0381.05
Imp. E (EP): (1RS)-2-[Benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanol

HO
(A)
OH N
100 mg
OH
MM 0381.07
Imp. G (EP) as Hydrochloride: 2-[Benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy3-(hydroxymethyl)phenyl]ethanone Hydrochloride

HO
(D)
O N x HCl
50 mg
OH
MM 0381.08
4-[2-[(1,1-Dimethylethyl)amino]ethyl]-2-methylphenol
HO
H N
(A)
100 mg
New MM 0381.09
Imp. I (EP): (1RS)-2-[(1,1-Dimethylethyl)amino]-1[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanol

O
OH
H N
(A)
50 mg
OH
MM 0381.10
Imp. J (EP) as Hydrochloride: 2-[(1,1-Dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone Hydrochloride (Salbutamone Hydrochloride) 4-[(1RS)-2-(tert-Butylamino)-1-hydroxyethyl]-2ethylphenol Hydrobromide
H N x HCl
(D)
50 mg
HO OH
MM 0381.17
OH
H N x HBr
(A)
50 mg
HO
Salicylic Acid
MM 0045.00 Salicylic Acid
O OH OH
(A)
500 mg
MM 0045.01

HO
(B)
OH
100 mg
Edition 2012/2013
207
Code Product Price
O HO O OH OH
Unit
MM 0045.02
Imp. B (EP): 4-Hydroxyisophthalic Acid
(A)
100 mg
MM 0045.11 MM 0045.12
Imp. C (EP): Phenol

OH
(B)
O O OH
100 mg 100 mg
Imidazole Salicylate
H N N H
(A)
MM 0045.13
Choline Salicylate
O O OH N OH
on request
MM 0045.14
N,N-Diethylsalicylamide
O N OH
(A)
100 mg
Salmeterol Xinafoate
MM 0536.03 Imp. B (EP): (1RS)-1-[4-Hydroxy-3-(hydroxymethyl)phenyl]-2-[[6-(2-phenylethoxy)hexyl]amino]ethanol Imp. F (EP): (1RS)-1-(4-Hydroxy-3-methylphenyl)2-[[6-(4-phenylbutoxy)hexyl]amino]ethanol
HO
OH
H N O
(A)
100 mg
HO OH
MM 0536.07
OH
H N O
(A)
50 mg
Secnidazole
MM 0119.00 Secnidazole
O2N N N OH
(A)
100 mg
MM 0012.02
2-Methyl-4-nitroimidazole
O2N
NH N
(B)
100 mg
Secobarabital
New MM 1361.00 Secobarbital [Controlled Substance]
O H N O NH O
(A)
100 mg
Selegiline Hydrochloride
New MM 0216.00 Selegiline Hydrochloride
N x HCl
(A)
100 mg
MM 0656.00
Imp. C (EP) as Hydrochloride: (1RS, 2SR)-2Amino-1-phenylpropan-1-ol Hydrochloride (Phenylpropanolamine Hydrochloride) Imp. D (EP) as Racemate Hydrochloride: N-[(1RS)-1-Methyl-2-phenylethyl]prop-2-yn-1amine Hydrochloride (rac-Demethylselegiline Hydrochloride)
OH NH2 x HCl
(A)
500 mg
and enatiomer
New MM 0216.09
H N
x HCl
(A)
100 mg
Sertraline Hydrochloride
MM 0317.01 Sertraline Hydrochloride
HN
(A)
x HCl Cl
100 mg
Cl
MM 0317.00
Sertraline
HN
(A)
100 mg
Cl Cl
208
Edition 2012/2013
Code Product Price
HN
Unit
MM 0317.05
Imp. B (EP) as Hydrochloride: (1RS,4RS)-NMethyl-4-phenyl-1,2,3,4-tetrahydronaphthalen1-amine Hydrochloride
(A)
x HCl
100 mg
and enantiomer
MM 0317.06
Imp. C (EP) as Hydrochloride: (1RS,4RS)-44-Chlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine Hydrochloride
HN
(D)
100 mg
x HCl
Cl and enantiomer
MM 0317.10
Imp. E (EP): (2R)-Hydroxyphenylacetic Acid ((R)-Mandelic Acid) Imp. E (EP) as Racemate: Hydroxyphenylacetic Acid (Mandelic Acid) Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative)
O
O OH OH
(A)
100 mg
MM 0792.03
O OH OH
(A)
100 mg
MM 0317.09
(A)
100 mg
Cl Cl
Sibutramine Hydrochloride
MM 0991.04 Imp. A (Pharmeuropa) as Hydrochloride: (1RS)1-[1-(2-Chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine Hydrochloride Imp. B (Pharmeuropa) as Hydrochloride: (1RS)1-[1-(3-Chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine Hydrochloride Imp. C (Pharmeuropa) as Hydrochloride: (1RS)1-[1-(4-Chlorophenyl)cyclobutyl]-N,N-dimethylpentan-1-amine Hydrochloride Imp. D (Pharmeuropa) as Hydrochloride: (1RS)1-[1-(4-Chlorophenyl)cyclobutyl]N,3-dimethylbutan-1-amine Hydrochloride (N-Monodesmethylsibutramine Hydrochloride) Imp. E (Pharmeuropa): (4-Chlorophenyl)acetonitrile
Cl
Cl N
Cl x HCl N
(A)
50 mg
MM 0991.05
(A)
x HCl
50 mg
MM 0991.06
(A)
x HCl Cl N
50 mg
MM 0991.02
Cl
HN x HCl
(A)
100 mg
MM 0991.07 MM 0991.03
N Cl
(A) (A)
50 mg 100 mg
Imp. G (Pharmeuropa) as Hydrochloride: (1RS)1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan1-amine Hydrochloride (N,N-Didesmethylsibutramine Hydrochloride) Imp. H (Pharmeuropa): 2-(4-Chlorophenyl)-2-(prop2-en-1-yl)pent-4-enenitrile
NH2 x HCl
MM 0991.09
(A)
N Cl
50 mg
MM 0991.10
Imp. I (Pharmeuropa): (1RS)-1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-ol

Cl OH
(A)
50 mg
MM 0991.11
Imp. J (Pharmeuropa): 1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-one

Cl O
(A)
50 mg
Sibutramine Hydrochloride Monohydrate

MM 0991.00 Sibutramine Hydrochloride Monohydrate
Cl N x HCl x H2O
(A)
100 mg
Edition 2012/2013
209
Sildenafil Citrate
MM 0254.00 Sildenafil Citrate
O N N S O
O O N N S O O O N N S O
O N N S O
O O N N O S O O HN N N N
O O HN N N N x HO
O O OH O
(D)
100 mg
HO HO
MM 0254.09
Sildenafil
O HN
(D)
N N
100 mg
MM 0254.01
4-[[2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoyl]amino]-1-methyl-3-propyl-1Hpyrazole-5-carboxamide 2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl] benzoic Acid Imp. B (Pharmeuropa): 5-[2-Ethoxy-5-[(4methyl-4-oxidopiperazin-1-yl)sulfonyl]phenyl]1-methyl-3-propyl-6,7-dihydro-1Hpyrazolo[4,3-d]pyrimidin-7-one (Desethylsildenafil) 4-Amino-1-methyl-3-propyl-1H-pyrazole5-carboxamide
on request
N N
H2N N H
MM 0254.02
O OH
(A)
100 mg
MM 0254.04
(A)
100 mg
MM 0254.05
O H 2N H2N N N
(A)
100 mg
MM 0254.06
Imp. D (Pharmeuropa): 4-Ethoxy-3-(1-methyl7-oxo-3-propyl-6,7-dihydro-1Hpyrazolo[4,3-d]pyrimidin-5-yl)benzenesulfonic Acid (3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1Hpyrazolo[4,3-d]pyrimidin-5yl]-4-ethoxybenzenesulfonic Acid) 1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1Hpyrazolo[4,3-d]pyrimidin-5-yl)4-ethoxyphenyl]sulfonyl]piperazine (Desmethylsildenafil) 3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1Hpyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxy-N[2-(methylamino)ethyl]benzenesulfonamide 2-Ethoxy-5-(4-methylpiperazine-1-sulfonyl)benzaldehyde (1-[(4-Ethoxy-3-formylphenyl)sulfonyl]-4-methylpiperazine)
O O HO S O O HN N N N
(D)
100 mg
MM 0254.08
O O N HN S O O HN N N N
(D)
100 mg
MM 0254.11
O O N H S O
O N N S O O O
(D)
N N
100 mg
HN N
NH
MM 0254.21
(A)
100 mg
MM 0254.22
Imp. C (Pharmeuropa): 5-[2-Hydroxy-5-[(4methylpiperazin-1-yl)sulfonyl]phenyl]-1methyl-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-7-one (Desethylsildenafil) 5-(2-Ethoxyphenyl)-1-methyl-3n-propyl1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one
O O N N S O HN N OH
O HN N O N N
(D)
N N
100 mg
MM 0254.29
(A)
100 mg
Silybin
MM 0472.00 Silybin
HO O OH OH O O O OH O OH
(A)
100 mg
210
Edition 2012/2013
Simvastatin
MM 0158.00 Simvastatin
O H OH O O O
(A)
100 mg
MM 0158.01
Imp. A (EP) as Sodium Salt: (3R,5R)-7[(1S,2S,6R,8S,8aR)-8-[(2,2-Dimethylbutanoyl)oxy]2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen1-yl]-3,5-dihydroxyheptanoic Acid Sodium Salt (Tenivastatin Sodium Salt; Simvastatin Hydroxy Acid Sodium Salt)
O OH H ONa OH O O
(A)
100 mg
MM 0158.02
Imp. B (EP): (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(Acetyloxy)6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8ahexahydronaphthalen-1-yl 2,2-Dimethylbutanoate (Simvastatin Acetate Ester)
O O H O O O O
(A)
100 mg
MM 0158.03
Imp. C (EP): (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen1-yl 2,2-Dimethylbutanoate (Anhydrosimvastatin)
O O H O O
(A)
100 mg
MM 0050.00
Imp. E (EP): Lovastatin

O H O
(A)
OH
100 mg
Sodium Benzoate
MM 0730.00 Sodium Benzoate
O ONa
(A)
500 mg
Sodium Cromoglicate
MM 0039.00 Sodium Cromoglicate
NaO O O OH O O O O O O ONa
(A)
500 mg
MM 0039.01
Succinophenone; Diphenacyl
(A)
O
100 mg
MM 0039.02
1,3-Bis(2-acetyl-3-hydroxyphenoxy)-2-propanol
HO OH O O O
OH
(A)
100 mg
MM 0039.03
Imp. A (EP): 1-(2,6-Dihydroxyphenyl)ethanone (2',6'-Dihydroxyacetophenone)

OH
OH
(B)
100 mg
MM 0039.04
Imp. B (EP): Diethyl 5,5'-[(2-hydroxypropane1,3-diyl)dioxy]bis(4-oxo-4H-1-benzopyran-2carboxylate (Ethyl Cromoglicate)
O O O OH O O O O O
O O
(A)
100 mg
Sodium Cyclamate
MM 0678.05 MM 0093.17 MM 0678.03 Cyclamic Acid Imp. B (EP) as Hydrochloride: Aniline Hydrochloride (Phenylamine Hydrochloride) Imp. C (EP): Cyclohexanamine
H N O
NH2 x HCl
OH O
(A) (B) (C)
100 mg 100 mg 100 mg
NH2
Edition 2012/2013
211
Code Product Price
H N
Unit
MM 0678.04
Imp. D (EP): N-Cyclohexylcyclohexanamine
(C)
100 mg
Sodium Fluoride
MM 0734.00 Sodium Fluoride
NaF
(A)
500 mg
Sodium Picosulfate
MM 0054.00 Sodium Picosulfate
NaO O S O O O O S ONa O
(A)
500 mg
MM 0054.01
Imp. A (EP): 4-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl Sodium Sulphate (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl Sodium Sulphate) Imp. B (EP): 4,4'-[(Pyridin-2-yl)methylene]diphenol (4,4'-(Pyridin-2-ylmethylene)diphenol) Imp. C (EP): 2-[(RS)-(Pyridin-2-yl)[4-(sulphonatooxy)phenyl]methyl]phenyl Disodium Sulphate (2,4'-[(Pyridin-2-yl)-methylene]bisphenyl Bis(Sodium Sulphate)) 2,4'-[(Pyridin-2-yl)methylene]bisphenol (2-[(RS)(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenol)
HO
O O
ONa O
(A)
100 mg
MM 0031.01
HO
OH
(A)
100 mg
MM 0054.02
ONa S O O
(D)
50 mg
NaO
O S N O O
HO
MM 0031.04
(A)
N OH
50 mg
Sodium Salicylate
New MM 1370.00 Sodium Salicylate
O ONa OH
(A)
250 mg
Sodium Thiophene-2-carboxylate
MM 1081.00 Sodium Thiophene-2-carboxylate
O S ONa
(A)
250 mg
Sorbic Acid
MM 0954.00 Sorbic Acid
O OH
(A)
500 mg
Sotalol Hydrochloride
MM 0046.00 Sotalol Hydrochloride
O S O N H
H N O S O N H x HCl
OH
H N x HCl
(A)
100 mg
MM 0046.01
Imp. A (EP) as Hydrochloride: N-[4-[2[(1-Methylethyl)amino]ethyl]phenyl]methanesulphonamide Hydrochloride Imp. B (EP) as Hydrochloride: N-[4-[[(1Methylethyl)amino]acetyl]phenyl]methanesulphonamide Hydrochloride Imp. C (EP):N-(4-Formylphenyl) methanesulphonamide
O S O
(A)
100 mg
MM 0046.02
H N x HCl
(A)
100 mg
N H
O O S O N H
MM 0046.03
(A)
100 mg
212
Edition 2012/2013
Spironolactone
MM 0197.00 Spironolactone
O O
(A)
500 mg
O O
MM 0197.01
Imp. F (EP): (2'R)-3',4'-Dihydro-5'H-spiro[androst4,6-diene-17,2'-furan]-3,5'-dione (Canrenone)
O O
(A)
100 mg
Stanozolol
MM 1285.00 Stanozolol
N N H H OH
(A)
100 mg
Stavudine
MM 0534.00 Stavudine
HN HO O O N O
(A)
100 mg
MM 0534.01
Imp. A (EP): 5-Methylpyrimidine-2,4(1H,3H)-dione (Thymine)

O
O HN N H
O HN HO O O N
(A)
100 mg
MM 0534.03
Imp. C (EP): 1-(2-Deoxy--D-erythro-pentofuranosyl)5-methylpyrimidine-2,4(1H,3H)-dione (Thymidine)
(A)
100 mg
OH
Strychnine Nitrate
MM 0658.00 Strychnine Nitrate
N O H H H O N x HNO3
(A)
500 mg
MM 0658.02
Strychnine N-Oxide Hydrochloride

N O
H H
O N x HCl H O
(A)
100 mg
Sulfacetamide
MM 0579.00 Sulfacetamide
H2N O O O S N H
(A)
500 mg
Sulfacetamide Sodium
MM 1087.00 Sulfacetamide Sodium Monohydrate
H2N O O O S N Na
(A)
x H2O
500 mg
MM 0227.05
Imp. A (EP): Sulfanilamide

H2N
O O S NH2
(A)
100 mg
Sulfadiazine
MM 0623.00 Sulfadiazine
H2N O O N S N N H
(A)
500 mg
Edition 2012/2013
213
Code Product Price
N H2N N
O O S OH H2N
Unit
MM 0623.03 MM 0227.04
Imp. A (EP): Pyrimidin-2-amine Imp. B (EP): 4-Aminobenzenesulfonic Acid (Sulphanilic Acid) Imp. D (EP): 4-Aminobenzenesulfonamide (Sulfanilamide)
H2N
(A) (A)
100 mg 100 mg
MM 0227.05
O O S NH2
(A)
100 mg
MM 0623.02
Imp. E (EP): N-[4-(Pyrimidin-2-ylsulfamoyl)phenyl]acetamide (Acetylsulfadiazine)
O N H
O O N S N N H
(A)
50 mg
MM 0623.07
N-[(4-Aminophenyl)sulfonyl]-N-(pyrimidin-2-yl)acetamide (Acetylsulfadiazine)
H2N
O O N S N N O
(A)
50 mg
Sulfadimidine
MM 0581.00 Imp. A (Pharmeuropa): 4-Amino-N-(4-methyl-2pyrimidyl)benzenesulphonamide (Sulfamerazine)
H2N
(A)
O O N S N N H
500 mg
MM 623.00
Imp. B (Pharmeuropa): 4-Amino-N-pyrimidin-2ylbenzenesulphonamide (Sulfadiazine)

H2N
O O N S N N H
(A)
500 mg
MM 0883.00
Imp. C (Pharmeuropa): (4-Aminophenylsulphonyl)guanidine (Sulfaguanidine)

H2N
O O NH S N NH2 H
(A)
100 mg
MM 0227.05
Imp. D (Pharmeuropa): 4-Aminobenzenesulphonamide (Sulfanilamide)

H2N
O O S NH2
(A)
100 mg
MM 0579.00
Imp. E (Pharmeuropa): N-[(4-Aminophenyl)sulfonyl]acetamide (Sulfacetamide)

H2N
O O O S N H
(A)
500 mg
MM 0227.04
Imp. F (Pharmeuropa): 4-Aminobenzenesulphonic Acid (Sulphanilic Acid)

H2N
O O S OH
(A)
100 mg
Sulfadimethoxine Sodium
MM 1020.00 Sulfadimethoxine Sodium
O O S N Na H2N N O N O
(A)
500 mg
Sulfafurazole
MM 0583.00 Sulfafurazole
H2N N O O O S N H
(A)
500 mg
Sulfaguanidine
MM 0883.00 Sulfaguanidine
H2N O O NH S N NH2 H
(A)
100 mg
MM 0227.05
Imp. A (EP): 4-Aminobenzenesulphonamide (Sulphanilamide)

H2N
O O S NH2
(A)
100 mg
MM 0883.02
Imp. B (EP): N-[(4-Aminophenyl)sulphonyl]urea (Sulphacarbamide)

H2N
O O O S N NH2 H
(A)
50 mg
214
Edition 2012/2013
Sulfamerazine
MM 0581.00 Sulfamerazine
O O N S N N H H2N
(A)
500 mg
MM 0227.05
Sulphanilamide
H2N
O O S NH2
(A)
100 mg
Sulfamethoxazole
MM 0227.00 Sulfamethoxazole
O S H2N O N H N O
(A)
500 mg
MM 0227.01
Imp. A (EP): N-[4-[(5-Methylisoxazol-3-yl)sulphamoyl]phenyl]acetamide

O N H
(A)
O S O N H N O
100 mg
MM 0227.03
Imp. B (EP): 4-[[(4-Aminophenyl)sulphonyl]amino]N-(5-methylisoxazol-3-yl)benzenesulphonamide

O O S N H H2N
O O S N H
(A)
O N
100 mg
MM 0227.02
Imp. C (EP): 5-Methylisoxazol-3-amine

O H2N N
O S H2N OH
(B)
100 mg
MM 0227.04
Imp. D (EP): 4-Aminobenzenesulphonic Acid (Sulphanilic Acid) Imp. E (EP): 4-Aminobenzenesulphonamide (Sulphanilamide)
H2N
(A)
100 mg
MM 0227.05
O S
O NH2
(A)
100 mg
Sulfamethylphenazole
MM 1108.00 Sulfamethylphenazole
O O S N H H2N
(A)
N N
100 mg
Sulfaquinoxaline Sodium
MM 0702.00 Sulfaquinoxaline Sodium
N N NH 2 Na N O S O
on request
Sulfasalazine
MM 0045.00 Imp. H (EP): Salicylic Acid
HO O OH
(A)
500 mg
Sulfathiazole
MM 0578.00 Sulfathiazole
H2N O O S N H N S
(A)
500 mg
Sulfinpyrazone
New MM 1309.02 Imp. B (EP): 1,2-Diphenyl-4-[2-(phenylsulfanyl)ethyl]pyrazolidine-3,5-dione
O N N O S
(A)
50 mg
Edition 2012/2013
215
Sulindac
MM 0624.00 Sulindac
S O F O OH
(A)
500 mg
Sulpiride
MM 0051.00 Sulpiride
O H2N O O S O N H N
(A)
500 mg
MM 0051.01
Imp. A (EP): [(2RS)-1-Ethylpyrrolidin-2-yl]methanamine

H2 N N
(A)
100 mg
MM 0051.02
Imp. B (EP): Methyl 2-Methoxy-5-sulphamoylbenzoate
H2N O
O S
O O O
(A)
100 mg
MM 0051.03
Imp. C (EP): Ethyl 2-Methoxy-5-sulphamoylbenzoate
H 2N O
O S
O O O
(A)
100 mg
MM 0051.04
Imp. D (EP): 2-Methoxy-5-sulphamoylbenzoic Acid
H2N O
O S
O OH O
(A)
100 mg
MM 0051.05
Imp. E (EP): 2-Methoxy-5-sulphamoylbenzamide
H 2N O
O S
O NH 2 O
(A)
100 mg
MM 0051.06
Imp. F (EP): 1-Ethyl-2-[[(2-methoxy-5sulphamoylbenzoyl)amino]methyl]pyrrolidine 1-Oxide (Sulpiride N-Oxide) Imp. G (EP): (RS)-N-[(1-Ethylpyrrolidin-2-yl)methyl]2-hydroxy-5-sulphamoylbenzamide 5-Sulphamoylsalicylic Acid
O O
NH 2 S
O N H O
(A)
N
100 mg
MM 0051.07
O H2N
O S
O N H OH
O OH OH
(A)
N
100 mg
MM 0051.08
H2N O
O S
(A)
100 mg
MM 0051.09
5-Sulphosalicylic Acid Dihydrate
HO O
O S
O OH OH x 2 H 2O
(C)
100 mg
Sumatriptan Succinate
MM 0310.04 Imp. D (EP) as Maleate: N,N-Dimethyl2-[5-[(methylsulfamoyl)methyl]-1H-indol3-yl]ethanamine N-Oxide Maleate
O O S N H H N x N O O O OH OH
(A)
100 mg
MM 0310.05
Imp. E (EP): [3-(2-Aminoethyl)-1H-indol-5-yl]N-methylmethanesulfonamide
O O S N H
H N
(A)
100 mg
NH2
Suplatast Tosilate
MM 0722.01 Methyl Toluene-4-sulphonate
O S O O
(B)
100 mg
Tamoxifen Citrate
MM 0053.00 Tamoxifen Citrate
O N x HO HO HO O O O OH
(A)
100 mg
216
Edition 2012/2013
MM 0053.02
Imp. B (EP): 1-[4-(2-Dimethylaminoethoxy) phenyl]-1,2-diphenylbutan-1-ol

OH
(A)
O N
100 mg
MM 0053.14
Imp. C (EP) Z-Isomer: 2-[4-[(Z)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine
on request
O N
MM 0053.15
Imp. C (EP) E-Isomer: 2-[4-[(E)1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine
(A)
50 mg
MM 0053.16
Imp. D (EP) Z-Isomer: 2-[4-[(Z)-1,2-Diphenylprop1-enyl]phenoxy]-N,N-dimethylethanamine
(A)
O N
50 mg
MM 0053.17
Imp. D (EP) E-Isomer: 2-[4-[(E)-1,2-Diphenylprop1-enyl]phenoxy]-N,N-dimethylethanamine
(A)
50 mg
MM 0053.05
Imp. E (EP):2-[2-[(EZ)-1,2-Diphenylbut-1-enyl)phenoxy]N,N-dimethylethanamine
O N
(A)
100 mg
MM 0053.12
Imp. F (EP) as Hydrochloride: 2-[4-[(Z)-1,2-Diphenylbut1-enyl]phenoxy]-N-methylethanamine Hydrochloride
(A)
O N H x HCl
100 mg
MM 0053.07
Imp. G (EP): (2RS)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]2-phenylbutan-1-one

O
(A)
O N
100 mg
MM 0053.08
1,2-Diphenylbutan-1-one
(A)
100 mg
MM 0053.09
1-(4-Methoxyphenyl)-1,2-diphenylbutan-1-ol
O OH
(A)
100 mg
MM 0053.10
(EZ)-1-(4-Hydroxyphenyl)-1,2-diphenylbut-1-ene
OH
(C)
50 mg
MM 0053.18
Tamoxifen N-Oxide
O N O
(A)
100 mg
Edition 2012/2013
217
Tamsulosin Hydrochloride
MM 0938.00 Tamsulosin Hydrochloride
O O H N O O S x HCl NH2 O
O O O O S NH2 O x HCl
(D)
100 mg
MM 0938.02
Imp. A (EP) as Hydrochloride: 5-[(2R)-2[Bis[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride

O O N
(A)
100 mg
MM 0938.03
Imp. B (EP): 5-[(2R)-2-Aminopropyl]2-methoxybenzenesulfonamide Imp. C (EP) as Hydrochloride: 2-Methoxy-5-[(2R)2-[(2-phenoxyethyl)amino]propyl]benzenesulfonamide Hydrochloride Imp. D (EP) as Hydrochloride: 2-Methoxy5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl]benzenesulfonamide Hydrochloride Imp. E (EP): 5-Formyl-2-methoxybenzeneSulfonamide Imp. F (EP) as Hydrochloride: 2-(2-Ethoxyphenoxy)ethanamine Hydrochloride
H2N
O O S NH2 O
(A)
100 mg
MM 0938.04
H N
O O S x HCl NH2 O
(A)
100 mg
MM 0938.05
O O
H N
O O S x HCl NH2 O O O S NH2 O
(A)
100 mg
MM 0938.06
(A)
50 mg
MM 0938.07
(A)
O O NH2 x HCl
100 mg
MM 0938.10
Imp. G (EP) as Racemate Hydrochloride: 5-[(2RS)-2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride (Tamsulosin Racemate Hydrochloride) Imp. H (EP) as Racemate Hydrochloride: (2RS)-N-[2-(2-Ethoxyphenoxy)ethyl]1-(4-methoxyphenyl)propan2-amine Hydrochloride Imp. I (EP): 1-(2-Bromoethoxy)-2-ethoxybenzene
O O
H N
O O S NH2 O
(A)
x HCl
50 mg
MM 0938.01
O O
H N O
(A)
x HCl
100 mg
MM 0938.09
(A)
O O Br
100 mg
Telmisartan
MM 0939.01 Imp. A (EP): 4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole
N N
(A)
100 mg
NH N
MM 0939.10
Methyl 4'-(Bromomethyl)biphenyl-2-carboxylate
Br
(A)
100 mg
Temazepam
MM 0087.00 Temazepam [Controlled Substance]
Cl N N O OH
(A)
100 mg
MM 0023.01
Imp. A (EP): [5-Chloro-2-(methylamino)phenyl]phenylmethanone (5-Chloro-2-(methylamino)benzophenone)
NH Cl O
(B)
100 mg
218
Edition 2012/2013
Code Product Price
H N Cl N O OH
Unit
MM 0080.00
Imp. B (EP): Oxazepam [Controlled Substance]
(D)
100 mg
Tenofovir Disoproxil Fumarate

MM 1329.00 Tenofovir Disoproxil Fumarate
NH2 N N N N O O P O O O O O O O O x O HO
(A)
O OH
100 mg
Tenoxicam
MM 0084.01 MM 0247.01 Imp. A (EP): Pyridin-2-amine Imp. B (EP): Methyl 4-Hydroxy-2-methyl-2H-thieno[2,3-e] 1,2-thiazine-3-carboxylate 1,1-Dioxide
S OH O
H N O
H2 N N
O O S N O
(B) (A)
100 mg 100 mg
MM 0247.04
Imp. C (EP): N-Methylthiophene-2-carboxamide

S
(A)
100 mg
MM 0247.06
Imp. E (EP): 2-Methylthieno[2,3-d]isothiazol-3(2H)-one 1,1-Dioxide

S
O O S N O
(A)
100 mg
New MM 0247.08
Imp. G (EP): 4-Hydroxy-2-methyl-2H-thieno[2,3-e]1,2-thiazine-3-carboxamide 1,1-Dioxide

S
O O S N NH2 OH O
(A)
50 mg
New MM 0247.09
Imp. H (EP): 3-[(Methylamino)sulfonyl]thiophene-2-carboxylic Acid

S
O O S N H OH O
(A)
50 mg
MM 0247.10
2-(Methoxycarbonyl)-3-thiophenesulfonyl Chloride
S
O O S Cl O O
(A)
100 mg
Terazosin Hydrochloride Dihydrate

MM 0843.00 Terazosin Hydrochloride Dihydrate
N O O N N NH2 N O x HCl x 2 H2O O
(A)
100 mg
MM 0085.04
Imp. A (EP): 2-Chloro-6,7dimethoxyquinazolin-4-amine Imp. B (EP): 1-(4-Hydroxy6,7-dimethoxyquinazolin-2-yl)-4-[[(2RS)tetrahydrofuran-2-yl]carbonyl]piperazine
O O
N N NH2
Cl
(A)
100 mg
MM 0843.02
O N O O N N OH N O
(A)
100 mg
MM 0085.01
Imp. C (EP): 6,7-Dimethoxy2-(piperazin-1-yl)quinazolin-4-amine
NH O O N N NH2 N
(A)
100 mg
Edition 2012/2013
219
Code Product Price
O N O O N N NH2 N x HCl
Unit
MM 0843.04
Imp. D (EP) as Hydrochloride: 1-(4-Amino-6,7dimethoxyquinazolin-2-yl)-4-formylpiperazine Hydrochloride
(A)
100 mg
MM 0085.03
Imp. E (EP): 2,2'-(Piperazine-1,4-diyl)bis(6,7dimethoxyquinazolin-4-amine)

N O O N N NH2 N
NH2 N N O O
(D)
100 mg
MM 0085.00
Imp. K (EP) as Hydrochloride: Prazosin Hydrochloride

O O N N NH2 N
O N O x HCl
(A)
100 mg
MM 0085.02
Imp. L (EP): 1-(Furan-2-ylcarbonyl)piperazine

N HN
(A)
O
100 mg
MM 0085.05
Imp. M (EP): 1,4-Bis(furan-2ylcarbonyl)piperazine
O O N O N O
(A)
100 mg
MM 0843.15
Imp. N (EP): 1-[[(2RS)-Tetrahydrofuran-2-yl]carbonyl] piperazine

HN
O N O
O O N O N O
(A)
100 mg
MM 0843.16
Imp. O (EP): 1,4-Bis[(tetrahydrofuran-2-yl)carbonyl] piperazine
(A)
100 mg
Terbinafine Hydrochloride
MM 0696.00 Terbinafine Hydrochloride
N x HCl
(A)
100 mg
MM 0696.02
Imp. A (EP) as Hydrochloride: N-Methyl-C-(naphthalen1-yl)methanamine Hydrochloride (Secundary Amine Hydrochloride) Imp. B (EP) as Hydrochloride: (2Z)-N,6,6-TrimethylN-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine Hydrochloride (cis-Terbinafine Hydrochloride) Imp. C (EP) as Hydrochloride: (2E)N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept2-en-4-yn-1-amine Hydrochloride (trans-isoTerbinafine Hydrochloride) Imp. D (EP) as Hydrochloride: (2E)-N,6,6-TrimethylN-[(4-methylnaphthalen-1-yl)methyl]hept-2-en-4-yn1-amine Hydrochloride (4-Methylterbinafine Hydrochloride) N-Demethylterbinafine Hydrochloride
N H
(A)
NH x HCl
100 mg
MM 0696.03
(D)
N x HCl
100 mg
MM 0696.04
x HCl
(D)
100 mg
MM 0696.05
(D)
N x HCl
100 mg
MM 0696.07
(D)
x HCl
50 mg
MM 0696.10
Imp. F (EP) as Hydrochloride: (2Z)N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept2-en-4-yn-1-amine Hydrochloride (cis-Isoterbinafine Hydrochloride)
(D)
N x HCl
50 mg
Terbutaline Sulphate
MM 0708.01 Imp. A (EP): 3,5-Dihydroxybenzoic Acid (-Resorcylic Acid)
O HO OH
(B)
100 mg
OH
220
Edition 2012/2013
Code Product Price
OH HO N OH x 1/2 H2SO4
Unit
MM 0708.03
Imp. B (EP) as Hemisulphate: (4RS)2-(1,1-Dimethylethyl)-1,2,3,4-tetrahydroisoquinoline4,6,8-triol Hemisulphate
(D)
100 mg
Terfenadine
MM 0055.00 Terfenadine
N OH OH
(A)
500 mg
MM 0055.04
Imp. A (EP): 1-[4-(1,1-Dimethylethyl)phenyl]4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butan1-one (Terfenadone)

OH
(A)
N O
100 mg
MM 0055.07
Imp. B (EP): (1RS)-1-[4-(1,1-Dimethylethyl)phenyl]4-[4-(diphenylmethyl)piperidin-1-yl]butan-1-ol

N OH
(A)
100 mg
MM 0055.12
Imp. E (EP) as Hydrochloride: 1-[(4RS)4-[4-(1,1-Dimethylethyl)phenyl]4-hydroxybutyl]piperidine-4-carboxylic Acid Hydrochloride Imp. G (EP): [1-[4-[4-(1,1-Dimethylethyl)phenyl]but-3-enyl]piperidin-4yl]diphenylmethanol
(A)
N HO O x HCl OH
100 mg
MM 0055.09
(A)
N
100 mg
OH
MM 0055.10
Imp. H (EP): [1-[4-[4-(1,1-Dimethylethyl)phenyl]butyl]piperidin4-yl]diphenylmethanol

OH
(A)
N
100 mg
MM 0055.02
Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol)

OH
NH
(B)
100 mg
MM 0055.03
Imp. J (EP): Ethyl 1-[(4RS)4-[4-(1,1-Dimethylethyl)phenyl]-4-hydroxybutyl]piperidine-4-carboxylate

O O
(A)
N OH
100 mg
Testosterone
MM 0323.00 Testosterone
OH
(A)
500 mg
MM 0323.01
Imp. A (EP): Androst-4-ene-3,17-dione (Androstenedione)

O
(A)
100 mg
MM 0323.02
Imp. B (EP): 3-Ethoxyandrosta-3,5-dien-17-one (Androstenedione Ethylenolether)

O
(A)
100 mg
Edition 2012/2013
221
Code Product Price
OH
Unit
MM 0323.03
Imp. C (EP): 17-Hydroxyandrost-4-en-3-one (Epitestosterone)

O
(A)
100 mg
MM 0323.04
Imp. D (EP): Androst-4-ene-3,17-diol (4-Androstenediol)

HO
OH
(A)
100 mg
MM 0323.05
Imp. E (EP): 3-Oxoandrost-4-en-17-yl Acetate (Testosterone Acetate)
O O
(A)
100 mg
MM 0565.00
Imp. F (EP): 17-Hydroxy-5-androstan-3-one (Androstanolone, Stanolone)

O H
OH
(A)
250 mg
MM 0323.07
Imp. G (EP): Androsta-1,4-diene-3,17-dione (Androstadienedione)

O
(A)
100 mg
MM 0864.00
Imp. H (EP): 17-Hydroxyandrosta-1,4-dien-3-one (Boldenone)

O
OH
(A)
100 mg
MM 0323.12
Imp. I (EP): 17-Hydroxyandrosta-4,6-dien-3-one (6-testosterone)

O
OH
(A)
100 mg
MM 0323.13
Imp. J (EP): 3-Methoxyandrosta-3,5-dien17-one (Androstenedione Methylenolether)

O
(A)
100 mg
Testosterone Benzoate
MM 0493.00 Testosterone Benzoate
O O
(D)
250 mg
MM 0323.00
Testosterone
OH
(A)
500 mg
MM 0278.01
Benzoic Acid
O OH
(B)
100 mg
Testosterone Enantate
MM 1119.00 Testosterone Enantate
O O
(A)
100 mg
MM 0863.08
Imp. B (EP): 3-Oxoandrost-4-en-17-yl Hexanoate (Testosterone Caproate)
O O
(A)
100 mg
222
Edition 2012/2013
Code Product Price
OH
Unit
MM 0323.00
Imp. D (EP): 17-Hydroxyandrost-4-en-3-one (Testosterone)

O
(A)
500 mg
Testosterone Isocaproate
MM 0863.00 Testosterone Isocaproate
O O
(A)
100 mg
MM 0323.00
Imp. A (EP): Testosterone
OH
(A)
500 mg
MM 0323.05
Imp. B (EP): 3-Oxoandrost-4-en-17-yl Acetate (Testosterone Acetate)
O O
(A)
100 mg
MM 0897.00
Imp. C (EP): Testosterone Propionate

O
(A)
100 mg
MM 0863.07
Imp. D (EP): 3-Oxoandrost-4-en-17-yl 2Methylpropanoate (Testosterone Isobutyrate)
O O
(A)
100 mg
MM 0863.08
Imp. E (EP): 3-Oxoandrost-4-en-17-yl Hexanoate (Testosterone Caproate)
O O
(A)
100 mg
MM 1119.00
Imp. F (EP): Testosterone Enantate

O
(A)
100 mg
MM 0863.09
Imp. G (EP): 3-Oxoandrost-4-en-17-yl 4-Methylpentanoate (Epitestosterone Isocaproate)
O O
(A)
100 mg
Testosterone Phenylpropionate
MM 1394.00 Testosterone Phenylpropionate
O O
(A)
100 mg
Testosterone Propionate
MM 0897.00 Testosterone Propionate
O O
(A)
100 mg
Edition 2012/2013
223
Code Product Price
O O
Unit
MM 0323.05
Imp. A (EP): 3-Oxoandrost-4-en-17-yl Acetate (Testosterone Acetate)
(A)
100 mg
MM 0863.07
Imp. B (EP): 3-Oxoandrost-4-en-17-yl 2-Methylpropanoate (Testosterone Isobutyrate)
O O
(A)
100 mg
MM 0323.00
Imp. C (EP): Testosterone
OH
(A)
500 mg
MM 0897.04
Imp. D (EP): 3-Oxoandrosta-1,4-dien-17-yl Propanoate
O O
(C)
50 mg
MM 0897.05
Imp. E (EP): 3-Oxoandrosta-4,6-dien-17-yl Propanoate
O O
(A)
100 mg
Tetracaine Hydrochloride
MM 0504.00 Tetracaine Hydrochloride
N H O O N x HCl
(A)
500 mg
MM 0094.03
Imp. A (EP): 4-Aminobenzoic Acid

H2N
O OH
(B)
100 mg
MM 0504.01
Imp. B (EP): 4-(Butylamino)benzoic Acid

N H
O OH
(A)
100 mg
MM 0504.04
Imp. C (EP): Methyl 4-(Butylamino)benzoate

N H
O O
(A)
100 mg
MM 0504.02
Tetracaine N-Oxide
N H
O O N
(A)
100 mg
Tetracycline Hydrochloride
MM 0452.00 Tetracycline Hydrochloride
OH O H HO OH O OH H N O NH2 OH x HCl
(A)
500 mg
Tetramisole Hydrochloride
MM 0703.00 Tetramisole Hydrochloride
N N S x HCl
(A)
500 mg
Tetrazepam
MM 0091.00 Tetrazepam [Controlled Substance]
Cl N N O
(A)
100 mg
224
Edition 2012/2013
Code Product Price
H N Cl N O
Unit
MM 0091.06
Imp. B (EP): 7-Chloro-5-cyclohexyl-1,3-dihydro-2H1,4-benzodiazepin-2-one
(A)
100 mg
MM 0091.07
Imp. C (EP): 7-Chloro-5-cyclohexyl-1-methyl1,3-dihydro-2H-1,4-benzodiazepin-2-one

Cl
N N
(A)
100 mg
MM 0091.03
Imp. E (EP): 7-Chloro-5-(cyclohex-1-enyl)-1,3dihydro-2H-1,4-benzodiazepin-2-one (Nortetrazepam)
H N Cl N
(A)
100 mg
MM 0091.04
6-Chloro-2-methyl-4-oxo-4H-3,1-benzoxazine
Cl
N O O
(A)
100 mg
MM 0091.52
2-Bromo-4'-chloro-2'-(cyclohexylcarbonyl)acetanilide
Cl
O NH O
Br
on request
Tetryzoline Hydrochloride
MM 0088.00 Tetryzoline Hydrochloride
HN N x HCl
(A)
100 mg
MM 0088.03
Imp. A (EP): (1RS)-1,2,3,4-Tetrahydronaphthalene-1carbonitrile (-Cyanotetraline) 1,2,3,4-Tetrahydro-1-naphthalenecarboxylic Acid

O
(A)
100 mg
MM 0088.02
OH
(A)
100 mg
MM 0088.04
Methyl 1,2,3,4-Tetrahydro-1-naphthalenecarboxylate
(A)
100 mg
MM 0088.05
N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-yl-carboxamide Hydrochloride ((1,2,3,4-Tetrahydro-1-naphthyl)formylethylenediamine Hydrochloride) 2-(1,2,3,4-Tetrahydro-1-naphthalenyl)-1H-imidazole Hydrochloride
H N
NH 2 x HCl
(A)
100 mg
MM 0088.06
HN
N x HCl
(A)
100 mg
Thalidomide
MM 0940.00 Thalidomide
O N NH O O O
(A)
100 mg
Thebaine
New MM 0244.00 Thebaine [Controlled Substance]
N
(A)
100 mg
Edition 2012/2013
225
Theobromine
MM 0577.00 Theobromine
HN O N O N N
(A)
500 mg
Theophylline
MM 0176.00 Theophylline
N O N O H N N
(A)
500 mg
MM 0494.00
Imp. A (EP): Caffeine

N O
O N N
O HN O N
O N O N
O N H HN N N H
(A)
N
500 mg
MM 0176.03
Imp. B (EP): 3-Methyl-3,7-dihydro-1H-purine-2,6-dione (3-Methylxanthine)
H N N
(A)
100 mg
MM 0176.02
Imp. C (EP): N-(6-Amino-1,3-dimethyl-2,4dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide
H N O NH2
(A)
100 mg
MM 0176.01
Imp. D (EP): N-Methyl-5-(methylamino)-1H-imidazole4-carboxamide (Theophyllidine)
(A)
100 mg
MM 0603.00
Imp. F (EP): Etofylline

N O
O N N N
OH
(A)
500 mg
MM 0176.04
1-Methylxanthine
N O
O N N H O HN O N H N N N H
on request
MM 0176.05
7-Methylxanthine
(A)
100 mg
Theophylline-Ethylenediamine
MM 0494.00 Imp. A (EP): Caffeine
N O N
O HN O N
O N O N O N H HN N N H
OH N N N
O HN O N N N
O N N
(A)
500 mg
MM 0176.03
Imp. B (EP): 3-Methyl-3,7-dihydro-1H-purine-2,6-dione (3-Methylxanthine)
H N N
(A)
100 mg
MM 0176.02
Imp. C (EP): N-(6-Amino-1,3-dimethyl-2,4dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide Imp. D (EP): N-Methyl-5-(methylamino)-1Himidazole-4-carboxamide (Theophyllidine)
H N O NH2
(A)
100 mg
MM 0176.01
(A)
100 mg
MM 0603.00
Imp. F (EP): Etofylline

N O
(A)
500 mg
MM 0577.00
Imp. G (EP): Theobromine
(A)
500 mg
226
Edition 2012/2013
Thiamazole
MM 0889.00 MM 0889.02 MM 0889.03 MM 0889.04 Thiamazole Imp. B (EP): 1-Methyl-1H-imidazole Imp. C (EP): 1-Methyl-2-(methylsulphanyl)-1H-imidazole Imp. C (EP) as Hydrochloride: 1-Methyl-2-(methylsulphanyl)1H-imidazole Hydrochloride
S N N x HCl
S N NH
(A) (B)
500 mg 100 mg 100 mg 100 mg
N N
S N N
(A) (A)
Thiamine Hydrochloride
MM 0049.00 Thiamine Hydrochloride (Vitamin B1)
HO S N+ ClN N NH2 x HCl
(A)
500 mg
New MM 0049.07
Imp. A (EP) as Chloride: 3-[(4-Amino-2methylpyrimidin-5-yl)methyl]-4-methyl-5[2-(sulfonatooxy)ethyl]thiazolium Chloride (Thiamine Chloride Sulfate Ester) Imp. C (EP) as Chloride Hydrochloride: 3-[(4Amino-2-methylpyrimidin-5-yl)methyl]-5-(2chloroethyl)-4-methylthiazolium Chloride Hydrochloride (Chlorothiamine Chloride Hydrochloride) Imp. E (EP): 3-[(4-Amino-2-methylpyrimidin-5-yl) methyl]-5-(2-hydroxyethyl)-4-methylthiazol-2(3H)-thione (Thioxothiamine) 5-(2-Hydroxyethyl)-4-methylthiazole 4-Amino-5-hydroxymethyl-2-methylpyrimidine Hydrochloride
Cl
S O HO S O O
S N+ Cl-
N N+ ClN N NH2 x HCl
(A)
N
100 mg
NH2
New MM 0049.09
(A)
100 mg
MM 0049.05
S HO N
N N NH2
(A)
100 mg
MM 0049.02 MM 0049.04
N S OH
(A) (A)
100 mg 100 mg
N N
OH x HCl NH 2
Thiamphenicol
MM 0737.00 Thiamphenicol
O Cl Cl N H OH O O S
(A)
500 mg
OH
Thioctic Acid
MM 0127.00 Thioctic Acid
S S O OH
(A)
500 mg
Thiopental Sodium and Sodium Carbonate

New MM 1312.03 Imp. C (EP): 5-Ethyl-5-(1-ethylpropyl)-2-thioxo-2,3dihydropyrimidine-4,6(1H,5H)-dione
O H N NH O S
(A)
50 mg
Thioridazine Hydrochloride
New MM0116.00 Thioridazine Hydrochloride
N S S N x HCl
(A)
250 mg
MM 0116.05
2-Methylthiophenothiazine
NH S S
(A)
100 mg
Edition 2012/2013
227
Tiabendazole
MM 0602.00 MM 0602.01 Tiabendazole Imp. A (EP): Benzene-1,2-diamine
H N N N NH2 NH2 S
(A) (C)
500 mg 100 mg
Tiamulin Hydrogen Fumarate

MM 0394.00 Tiamulin Hydrogen Fumarate
N S O O H O x OH HO O
O HO O OH
(A)
100 mg
HO
MM 0460.10 MM 0394.04
Fumaric Acid Imp. A (EP): (3aS,4R,5S,6S,8R,9R,9aR,10R)6-Ethenyl-5,8-dihydroxy-4,6,9,10-tetramethyloctahydro-3a,9-propano-3aH-cyclopentacycloocten-1(4H)-one (Mutilin) Imp. B (EP) as Hydrochloride: 2-(Benzylsulfanyl)N,N-diethylethanamine Hydrochloride Imp. C (EP) as Dihydrochloride: 2,2'-(Disulfane1,2-diyl)bis(N,N-diethylethanamine) Dihydrochloride Imp. J (EP): (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl5-hydroxy-4,6,9,10-tetramethyl-1-oxo-decahydro-3a,9propano-3aH-cyclopentacyclo-octen-8-yl Acetate (Mutilin 14-Acetate) Imp. P (EP): (3aS,4R,5S,6S,8R,9R,9aR,10R)-6Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl [(Phenylsulphonyl)oxy]acetate Imp. E (EP) as Hydrogen Fumarate: (3aS,4R,6S,8R,9R,9aR,10R)-6Ethenyl-4,6,9,10-tetramethyl-1,5dioxodecahydro-3a,9-propano3aH-cyclopenta-cycloocten-8-yl [[2-(Diethylamino)ethyl]sulfanyl]acetate Hydrogen Fumarate (11-Oxotiamulin Hydrogen Fumarate)
O O S O
(B) (A)
100 mg 100 mg
HO H
HO
New MM 0394.05
(A)
N S x HCl
50 mg
MM 0394.06
(A)
N S S N x 2 HCl
O O H O
50 mg
MM 0394.13
(A)
50 mg
HO
MM 0394.18
O O H
(A)
50 mg
HO
New MM 0394.23
(A)
N S O O H O
50 mg
x O HO O
OH
Tiapride Hydrochloride
MM 0073.01 MM 1331.04 Imp. C (EP): N,N-Diethylethane-1,2-diamine
H2N N
(B)
O O S O N H OH N
100 mg 100 mg
N-[2-(Diethylamino)ethyl]-2-hydroxy5-(methylsulfonyl)benzamide
(A)
Ticlopidine Hydrochloride
MM 0150.00 Ticlopidine Hydrochloride
N Cl S x HCl
(A)
500 mg
MM 0150.12 MM 0150.06
Imp. A (EP): Thieno[3,2-c]pyridine

N
(A) (A)
100 mg 100 mg
Imp. B (EP): 6,7-Dihydrothieno[3,2-c]pyridin-4(5H)-one

HN O
228
Edition 2012/2013
MM 0150.01
Imp. C (EP) as Hydrochloride: (2-Chlorophenyl)methanamine Hydrochloride

Cl
(A)
NH2 x HCl
100 mg
MM 0150.07 MM 0150.13
Imp. D (EP) as Hydrochloride: 5-Benzyl4,5,6,7-tetrahydrothieno[3,2-c]pyridine Hydrochloride Imp. E (EP) as Chloride: 5-(2-Chlorobenzyl)thieno[3,2-c]pyridinium Chloride
Cl
S N
x HCl
(A) (A)
100 mg 50 mg
S N+ Cl-
MM 0150.14
Imp. F (EP) as Hydrochloride: 6-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Hydrochloride Imp. G (EP) as Hydrochloride: 5-(3-Chlorobenzyl)4,5,6,7-tetrahydrothieno[3,2-c]pyridine Hydrochloride Imp. H (EP) as Hydrochloride: 5-(4-Chlorobenzyl)4,5,6,7-tetrahydrothieno[3,2-c]pyridine Hydrochloride Imp. I (EP) as Hydrochloride: N-(2-Chlorobenzyl)2-(thiophen-2-yl)ethanamine Hydrochloride
Cl
(A)
N Cl
S N
S N
50 mg
x HCl
MM 0150.08 MM 0150.09 MM 0150.11
x HCl
(A) (C) (A)
100 mg 50 mg 100 mg
Cl
x HCl
S NH Cl x HCl
MM 0150.10
Imp. J (EP) as Dihydrochloride: N,N'Bis(2-chlorobenzyl)ethane-1,2-diamine Dihydrochloride Imp. L (EP): 5-(2-Chlorobenzyl)-6,7-dihydrothieno [3,2-c]pyridin-4(5H)-one
NH Cl
N H Cl
(A)
x 2 HCl
100 mg
MM 0150.15
S N Cl O
(A)
50 mg
MM 0150.04
5-(2-Chlorobenzoyl)-4,5,6,7-tetrahydrothieno [3,2-c]pyridine
Cl O
S N
(A)
100 mg
Tilidine Hydrochloride Hemihydrate

MM 0134.00 Tilidine Hydrochloride Hemihydrate [Controlled Substance]
N x HCl x 1/2 H2O O O and enantiomer
(A)
100 mg
MM 0134.01
Imp. A (EP): Ethyl (1RS,2RS)-2-(Dimethylamino)-1phenylcyclohex-3-enecarboxylate (cis-Tilidine) [Controlled Substance]
(D)
100 mg
O O and enantiomer
MM 0134.03
Imp. D (EP) as Hydrochloride: Ethyl (2RS)-3Dimethylamino-2-phenylpropanoate Hydrochloride
N O O x HCl
(A)
100 mg
MM 0134.05
Tilidine [Controlled Substance]
(A)
100 mg
O O and enantiomer
Timolol Maleate
MM 0440.00 Timolol Maleate
N S N N O O
N S N N O OH
OH O
H N x
O OH OH
(A)
250 mg
MM 0440.04
Imp. D (EP): 4-(Morpholin-4-yl)-1,2,5-thiadiazol-3-ol
(A)
100 mg
MM 0440.03
N-Benzyl-tert-butylamine
HN
(B)
100 mg
MM 0440.05
3-Hydroxy-4-morpholino-1,2,5-thiadiazole 1-Oxide
N O S N
OH N O
(A)
100 mg
Edition 2012/2013
229
MM 0440.02
(S)-Isotimolol
HO N S N N O O N H
(A)
100 mg
Tinidazole
MM 0012.02 Imp. A (EP): 2-Methyl-5-nitro-1H-imidazole (2-Methyl-4-nitroimidazole)
O2 N NH N
(B)
100 mg
Tioconazole
MM 0281.01 Imp. D (EP): (1RS)-1-(2,4-Dichlorophenyl)-2(1H-imidazol-1-yl)ethanol
Cl HO N N Cl
(A)
100 mg
Tiotropium Bromide Monohydrate

MM 1293.05 Imp. E (EP): Methyl 2-Hydroxy-2,2-dithiophen-2-ylacetate
S S O O OH
(A)
100 mg
MM 1293.06
Imp. F (EP): Dithiophen-2-ylmethanone

S
S O
(A)
100 mg
Tizanidine Hydrochloride
MM 0887.04 N-Acetyltizanidine
Cl N N O NH N S N
(A)
50 mg
MM 0887.05
1-Acetylimidazolidine-2-thione
N H
O N S
(A)
50 mg
Tocopheryl Acetate (all-rac-a-)

New MM 1381.00 all-rac--Tocopheryl Acetate
O O O
(A)
250 mg
Tolazoline Hydrochloride
MM 0585.00 Tolazoline Hydrochloride
HN N x HCl
(A)
500 mg
Tolbutamide
New MM 1089.00 Tolbutamide
O O O S N N H H
(A)
100 mg
MM 0325.01
Imp. A (EP): (4-Methylphenyl)sulfonamide (Toluenesulfonamide; 4-Methylbenzene-
O O S NH2
(C)
100 mg
Tolnaftate
MM 0731.01 MM 0731.04 Imp. A (EP): Naphthalen-2-ol (-Naphthol)
HO
(A) (A)
NH
100 mg 100 mg
Imp. D (EP): N,3-Dimethylaniline (N-Methyl-m-toluidine)
230
Edition 2012/2013
Code Product Price
S Cl O
Unit
MM 0731.03
O-Naphthalen-2-yl Chlorothioformate
(A)
100 mg
Tolmetin Sodium Dihydrate

MM 0571.00 Tolmetin Sodium Dihydrate
O N O ONa x 2 H2O
on request
Tolterodine Tartrate
MM 0900.00 Tolterodine Tartrate
OH x N OH HO O OH O OH
(A)
100 mg
Topiramate
MM 1348.00 Topiramate
O O O O O O O O S NH2
(A)
100 mg
Torasemide, Anhydrous
MM 1283.02 Imp. B (EP): 4-[(3-Methylphenyl)amino]pyridine-3-Sulfonamide
N O O S NH2 NH
(A)
100 mg
MM 1283.03
Imp. C (EP): 1-Ethyl-3-[[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]urea
O O O S N N H H NH
(A)
50 mg
MM 1283.04
Imp. D (EP): 1-Butyl-3-[[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]urea
O O O S N N H H NH
(A)
50 mg
New MM 1283.05
Imp. E (EP): Ethyl [[4-[(3-Methylphenyl)amino]pyridin3-yl]sulfonyl]carbamate
O O O S N O H NH
(A)
100 mg
Tramadol Hydrochloride
MM 0007.00 Tramadol Hydrochloride
O OH N and enantiomer x HCl
(A)
500 mg
MM 0007.01
Imp. A (EP) as Hydrochloride: (1RS,2SR)2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride Imp. B (EP) as Hydrochloride: [2-(3-Methoxyphenyl)cyclohex-1-enyl]-N,Ndimethylmethanamine Hydrochloride Imp. C (EP) as Hydrochloride: (1RS)-[2-(3-Methoxyphenyl)cyclohex-2-enyl]-N,N-dimethylmethanamine Hydrochloride
O OH N and enantiomer x HCl
(A)
100 mg
MM 0007.03
(A)
x HCl N
100 mg
MM 0007.04
(A)
x HCl N
100 mg
Edition 2012/2013
231
Code Product Price
HO OH N and enantiomer x HCl
Unit
MM 0007.06
Imp. D (EP) as Hydrochloride: (1RS,2RS)-2[(Dimethylamino)methyl]-1-(3-hydroxyphenyl)cyclohexanol Hydrochloride Imp. E (EP) as Hydrochloride: (2RS)2-[(Dimethylamino)methyl]cyclohexanone Hydrochloride 3-Bromoanisole N-Desmethyltramadol Hydrochloride
O
(A)
100 mg
MM 0007.02
O N x HCl
(A)
100 mg
MM 0007.05 MM 0007.07
Br
(B) (A)
100 mg 100 mg
OH NH and enantiomer
x HCl
MM 0007.08
N,O-Didesmethyltramadol Hydrochloride
HO OH N H and enantiomer x HCl
(A)
100 mg
MM 0007.09 MM 0007.11
3-Methoxyphenol Tramadol N-Oxide

O
OH
(B) (A)
100 mg 100 mg
OH N and enantiomer O
MM 0007.50
[2-(3-Hydroxyphenyl)cyclohex-1-enyl]-N,Ndimethylmethanamine Hydrochloride
HO
(A)
x HCl N
100 mg
Tranexamic Acid
MM 0330.00 Tranexamic Acid
H2 N O OH
(A)
500 mg
MM 0330.04
Imp. D (EP): 4-Aminomethylbenzoic Acid

H2 N
O OH
(B)
100 mg
Trazodone Hydrochloride
MM 0421.00 Trazodone Hydrochloride
N O N N N N Cl x HCl
(A)
100 mg
MM 0421.13
Imp. A (BP) as Hydrochloride: 4-(3-Chloro-phenyl)-1-[3-(3-oxo-2,3dihydro-1,2,4-triazolo[4,3-a]pyridin-2yl)propyl]piperazine N1-oxide Hydrochloride (Trazodone N-Oxide Hydrochloride) Imp. B (BP): 2-[3-(4-Phenylpiperazin-1-yl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one
(A)
N O N N N O N Cl x HCl
50 mg
MM 0421.02
(A)
N O N N N N
50 mg
MM 0421.03
Imp. C (BP) as Dihydrochloride: 2-[3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl]1,2,4-triazolo[4,3-a]pyridin-3(2H)-one Dihydrochloride Imp. D (BP) as Hydrochloride: 2-3[4-(3-Bromo-phenyl)piperazin-1-yl]propyl-1,2,4-triazolo[4,3-a]-pyridin3(2H)-one Hydrochloride Imp. F (BP) as Hydrochloride: 1-(3-Chlorophenyl)4-(3-chloropropyl)piperazine Hydrochloride
Cl N N N N x 2 HCl
on request
N O
MM 0421.04
(A)
N O N N N N Br x HCl
50 mg
MM 0421.06
(A)
N Cl N Cl x HCl
100 mg
232
Edition 2012/2013
MM 0421.07
Imp. G (BP) as Hydrochloride: 3-[4-(3Chlorophenyl)piperazin-1-yl]propyl Isobutyl Ether Hydrochloride Imp. H (BP) as Dihydrochloride: 1,3-Bis-[4-(3-chlorophenyl)piperazin-1-yl]propane Dihydrochloride 3-[4-(3-Chlorophenyl)piperazin-1-yl]propanol
Cl
(D)
N O N Cl x HCl
50 mg
MM 0421.08
(A)
N N N N Cl x 2 HCl
100 mg
MM 0421.10
(A)
N HO N Cl
100 mg
MM 0421.11
1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one
N O
N NH
(A)
100 mg
MM 0421.12
1,4-Bis-3-chlorophenylpiperazine
N Cl N Cl
on request
Trenbolone
New MM 1377.00 Trenbolone
OH
(A)
100 mg
Triacetin
MM 0966.00 Triacetin
O O O O O O
(A)
500 mg
Triamcinolone
MM 0198.01 Triamcinolone
HO O OH
(A)
250 mg
OH OH F
MM 0198.02
Imp. A (EP): 9-Fluoro-11,17-dihydroxy-3,20dioxopregna-1,4-diene-16,21-diyl Diacetate (Triamcinolone 16,21-Diacetate)
O O HO O
(A)
100 mg
OH O F O OH
MM 0508.03
Imp. C (EP): 9-Fluoro-11,16,17,21-tetrahydroxypregn4-ene-3,20-dione (Pretriamcinolone)
O HO
on request
OH OH F
Triamcinolone Acetonide
MM 0198.00 Triamcinolone Acetonide
HO O O O F O OH
(A)
250 mg
MM 0198.01
Imp. A (EP): 9-Fluoro-11,16,17,21-tetra-
hydroxypregna-1,4-diene-3,20-dione (Triamcinolone)
O
O HO
OH OH OH
(A)
250 mg
Edition 2012/2013
233
Code Product Price
O O HO O OH O F O O
Unit
MM 0198.02
Triamcinolone 16,21-Diacetate
(A)
100 mg
MM 0198.05
Imp. C (Pharmeuropa): 9-Fluoro-11,21,21trihydroxy-16,17-(1-methylethylidenedioxy)pregna-1,4-diene-3,20-dione (Triamcinolone Acetonide 21-Aldehyde Hydrate)

O
O HO O
OH OH O
(A)
100 mg
Triamcinolone Hexacetonide
MM 0306.00 Triamcinolone Hexacetonide
O HO O O F O O O
(A)
100 mg
MM 0198.00
Imp. A (EP): Triamcinolone Acetonide

HO
O O
OH
(A)
250 mg
O F O
MM 0198.01
Triamcinolone
HO
OH OH OH
(A)
250 mg
F O
Triamterene
MM 0269.00 Triamterene
H2 N N N N N NH2 NH2
(A)
500 mg
MM 0269.02
Imp. A (EP): 5-Nitrosopyrimidine-2,4,6-triamine (Nitrosotriaminopyrimidine)

H2N
NH2 N N
N N N N NH2
NO NH2
NH2
(B)
100 mg
MM 0269.01
Sodium Hydroxytriamterene Sulphate

O NaO S O O
H2 N
(B)
10 mg
Triazolam
New MM 1363.00 Triazolam [Controlled Substance]
N Cl N Cl N N
(A)
100 mg
Tributyl Acetylcitrate
MM 0499.00 Tributyl Acetylcitrate
O O O O HO O O O O O O O O O O O O O O O O
on request
MM 0499.01
Imp. A (EP): Tributyl 2-Hydroxypropane1,2,3-tricarboxylate (Tributyl Citrate)
(C)
100 mg
MM 0499.02
Imp. B (EP) (E-Isomer): Tributyl (E)-Propene1,2,3-tricarboxylate (Tributyl (E)-Aconitate)
(A)
100 mg
234
Edition 2012/2013
Triclabendazole
MM 0313.00 Triclabendazole
Cl Cl O Cl H N S N
(D)
100 mg
Triclosan
MM 0610.00 Triclosan
Cl Cl O Cl OH
(A)
500 mg
Trihexyphenidyl Hydrochloride
MM 0237.00 Trihexyphenidyl Hydrochloride
OH N x HCl
(A)
500 mg
MM 0237.03
Imp. A (EP) as Hydrochloride: 1-Phenyl-3(piperidin-1-yl)propan-1-one Hydrochloride Acetophenone
O N x HCl
(A)
100 mg
MM 0237.01
(B)
100 mg
MM 0237.04
Trihexyphenidyl N-Oxide
OH O N
(C)
50 mg
Trimebutine
MM 0417.00 Trimebutine
N O O O O O
(A)
500 mg
MM 0417.05
Trimebutine Maleate
O N
O O x O O
O OH OH O
N x HCl
(A)
500 mg
MM 0417.01
Imp. A (EP) as Hydrochloride: (2RS)-2(Dimethylamino)-2-phenylbutanol Hydrochloride
(A)
100 mg
HO
MM 0093.13
Imp. B (EP): 3,4,5-Trimethoxybenzoic Acid
O O O O OH
(B)
100 mg
MM 0093.11
Imp. C (EP): Methyl 3,4,5-Trimethoxybenzoate
O O O O O
(A)
100 mg
MM 0417.11
Imp. D (EP): (1RS)-1-[(Dimethylamino)-methyl]1-phenylpropyl 3,4,5-Trimethoxybenzoate
N O O O O O
(A)
50 mg
MM 0417.07
Imp. E (EP) as Hydrochloride: (2RS)-2-(Methylamino)-2-phenylbutyl 3,4,5-Trimethoxy-benzoate Hydrochloride (N-Desmethyltrimebutine Hydrochloride) 1-Dimethylaminomethyl-1-phenyl-1-propanol Hydrochloride (alpha-[(Dimethylamino)methyl]-alphaethyl-benzenemethanol Hydrochloride)
O O O O O
H N x HCl
(A)
50 mg
MM 0417.10
HO
N x HCl
(A)
100 mg
Edition 2012/2013
235
Trimeprazine Tartrate
MM 0958.00 Trimeprazine Tartrate
N S 2
N N S O O
N x HO O
OH
O OH
(A)
500 mg
OH
MM 0957.00
Trimeprazine Sulphone (Oxomemazine)
(A)
100 mg
MM 0958.02
Trimeprazine Sulphoxide Hydrochloride

N S O
N x HCl
(A)
100 mg
MM 0958.04
Trimeprazine Sulphone N-Oxide Hydrochloride (Oxomemazine N-Oxide Hydrochloride)

N S O O
(A)
x HCl
100 mg
Trimetazidine Dihydrochloride
MM 0539.00 Trimetazidine Dihydrochloride
N HN O O O x 2 HCl
(A)
100 mg
MM 0539.01
Imp. A (EP) as Dihydrochloride: 1-(3,4,5Trimethoxybenzyl)piperazine Dihydrochloride

HN
O x 2 HCl O O
(A)
100 mg
MM 0539.02
Imp. B (EP): 1,4-Bis(2,3,4-trimethoxybenzyl)piperazine
O O O O N N O O
(A)
100 mg
MM 0539.03
Imp. C (EP): 2,3,4-Trimethoxybenzaldehyde

O
O O O
(B)
100 mg
MM 0539.04
Imp. D (EP): (2,3,4-Trimethoxyphenyl)methanol

HO
O O O
(A)
100 mg
MM 0539.05
Imp. E (EP) as Dihydrochloride: 1-(2,4,5Trimethoxybenzyl)piperazine Dihydrochloride

HN
O N O O x 2 HCl
(A)
100 mg
MM 0539.06
Imp. F (EP) as Dihydrochloride: 1-(2,4,6-Trimethoxybenzyl)piperazine Dihydrochloride

HN
O N O O x 2 HCl
(A)
100 mg
MM 0539.07 MM 0539.09
Imp. G (EP) as Hexahydrate: Piperazine Hexahydrate

HN
NH
x 6 H2O
(B) (A)
100 mg 100 mg
Imp. H (EP): Ethyl 4-(2,3,4-Trimethoxybenzyl)piperazine-1-carboxylate

O O N
O N O O
MM 0539.10
Imp. I (EP) as Dihydrochloride: 1-Methyl-4(2,3,4-trimethoxybenzyl)piperazine Dihydrochloride (N-Methyltrimetazidine Dihydrochloride) 1-Formyl-4-(2,3,4-trimethoxybenzyl)piperazine Hydrochloride

O
O N N O O x 2 HCl
(A)
100 mg
MM 0539.08
O N N O O x HCl
(A)
100 mg
236
Edition 2012/2013
Trimethoprim
MM 0093.00 Trimethoprim
O O O N N NH2 NH2
(A)
500 mg
MM 0093.06
Imp. A (EP): N 2-Methyl-5-(3,4,5-trimethoxybenzyl) pyrimidine-2,4-diamine
O O O N N NH2 NH
(A)
100 mg
MM 0093.01
Imp. B (EP): (2,4-Diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone
O O O O N N NH2 NH2
(A)
100 mg
MM 0093.08
Imp. C (EP): (RS)-(2,4-Diaminopyrimidin-5-yl) (3,4,5-trimethoxyphenyl)methanol
O O O OH N N NH2 NH2
(A)
100 mg
MM 0093.04
Imp. D (EP): 2-Amino-5-(3,4,5-trimethoxybenzyl) pyrimidin-4-ol
O O O N N OH NH2
(A)
100 mg
MM 0093.03
Imp. E (EP): 4-Amino-5-(3,4,5-trimethoxybenzyl) pyrimidin-2-ol
O O O N N NH2 OH
(A)
100 mg
MM 0093.09
Imp. F (EP): 5-(3-Bromo-4,5-dimethoxybenzyl) pyrimidine-2,4-diamine
O O Br N N NH2 NH2
(A)
100 mg
MM 0093.10
Imp. G (EP): 5-(4-Ethoxy-3,5-dimethoxybenzyl) pyrimidine-2,4-diamine
O O O N N NH2 NH2
(A)
100 mg
MM 0093.11
Imp. H (EP): Methyl 3,4,5-Trimethoxybenzoate

O O
O O O
(A)
100 mg
MM 0093.12
Imp. I (EP): 3-(Phenylamino)-2-(3,4,5-trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture) Imp. J (EP): 3,4,5-Trimethoxybenzoic Acid
O O O
H N N O O O O OH
(A)
100 mg
MM 0093.13
(B)
100 mg
MM 0093.17 MM 0093.02
Imp. K (EP) as Hydrochloride: Aniline Hydrochloride 5-(3,4,5-Trimethoxybenzyl)pyrimidin-2,4-diol

O O O
NH2 x HCl
(B) (B)
100 mg 10 mg
N N OH
OH
MM 0093.05
2-Amino-5-(4-hydroxy-3,5-dimethoxybenzyl) pyrimidin-4-ol
O HO O N N OH NH2
(A)
100 mg
MM 0093.07
N4-Methyl-5-(3,4,5-trimethoxybenzyl)pyrimidine -2,4-diamine
O O O N N NH NH2
(C)
50 mg
Trimipramine Maleate
MM 0240.00 Trimipramine Maleate
N N x O O OH OH
(A)
500 mg
Edition 2012/2013
237
MM 0240.01
Trimipramine
N N
(A)
100 mg
MM 0240.04
Imp. A (EP): (2RS)-3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine N-oxide (Trimipramine N-Oxide)
(A)
N N O
100 mg
MM 0240.02
Imp. B (EP) as Hydrochloride: (2RS)-3-(10,11Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,2-dimethylpropan-1-amine Hydrochloride (Desmethyltrimipramine Hydrochloride) Imp. C (EP) as Hydrochloride: (2RS)-3-(5HDibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan1-amine Hydrochloride
(A)
N N H x HCl
100 mg
MM 0240.05
(A)
N N x HCl
50 mg
MM 0077.00
Imp. D (EP) as Hydrochloride: Imipramine Hydrochloride
(A)
N N x HCl
500 mg
New MM 0240.07
Imp. E (EP): N-[3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-2-methylpropyl]-N,N',N',2tetramethylpropane-1,3-diamine
(A)
N N N
50 mg
MM 0076.06
Imp. F (EP): 10,11-Dihydro-5H-dibenzo[b,f]azepine (Iminodibenzyl)
(B)
NH
100 mg
Tropicamide
MM 0601.00 Tropicamide
O N OH N
(A)
250 mg
MM 0601.01 MM 0601.03
Imp. A (EP): N-(Pyridin-4-ylmethyl)ethanamine Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (Tropic Acid) Imp. D (EP): Phenylacetic Acid [Drug Precursor]
HN N O OH OH
(A) (A)
100 mg 100 mg
MM 0160.03
O OH
(B)
100 mg
Tropisetron Hydrochloride
MM 0763.01 Imp. A (EP): (1R,3r,5S)-8-Methyl-8azabicyclo[3.2.1]oct-3-ol (Tropine)
H H HO H N
(A)
100 mg
MM 0763.02
Imp. B (EP): 1H-Indole-3-carboxylic Acid

HN
O OH
(A)
100 mg
Trospium Chloride
MM 0783.09 Imp. A (EP): Hydroxydiphenylacetic Acid (Benzilic Acid)
O OH OH
(B)
100 mg
238
Edition 2012/2013
Tryptophan
MM 0172.00 L-Tryptophan
H N NH 2 OH O
(A)
500 mg
MM 0172.09
Imp. A (EP): 3,3'-[Ethylidenebis(1H-indole1,3-diyl)]bis[(2S)-2-aminopropanoic] Acid (1,1'-Ethylidenebistryptophan)

HO O NH2
(D)
N N NH2 OH O
H N NH2 OH HO O
100 mg
MM 0172.03
Imp. D (EP): (S)-2-Amino-3-(5-hydroxy-1H-indol-3-yl) propanoic Acid (5-Hydroxytryptophan)
(A)
100 mg
MM 0172.13
N-Acetyltryptophan
H N
O HN OH O
(A)
100 mg
Tyrosine
MM 0634.00 Tyrosine
HO NH2 OH O
(A)
100 mg
Valaciclovir Hydrochloride, Anhydrous

MM 0061.02 Imp. A (EP): 2-Amino-1,9-dihydro-6H-purin-6-one (Guanine) Imp. B (EP): 2-Amino-9-[(2-hydroxy-ethoxy)methyl]1,9-dihydro-6H-purin-6-one (Aciclovir)
H2N O HN N N N O OH
O HN H2N N N N H
(B)
100 mg
MM 0061.00
(A)
500 mg
MM 0619.07
Imp. G (EP): N,N-Dimethylpyridin-4-amine
N N
(A)
100 mg
MM 0061.01
Imp. I (EP): 2-[(2-Amino-6-oxo-1,6-dihydro9H-purin-9-yl)methoxy]ethyl Acetate

H2N
O HN N N N O O O
(A)
100 mg
Valproic Acid
MM 0751.00 Valproic Acid
O OH
(A)
500 mg
MM 0751.11
Sodium Valproate
O ONa
(A)
500 mg
MM 0751.01 MM 0751.02
Imp. A (EP): Pentanoic Acid (Valeric Acid) Imp. B (EP): (2RS)-2-Ethylpentanoic Acid
O OH
O OH
(C) (A)
100 mg 100 mg
MM 0751.03
Imp. C (EP): (2RS)-2-(1-Methylethyl)pentanoic Acid
O OH
(A)
100 mg
MM 0751.04
Imp. D (EP): 2,2-Dipropylpentanoic Acid
O OH
(A)
100 mg
MM 0751.05
Imp. E (EP): Pentanamide (Valeramide)
O NH2
(A)
100 mg
Edition 2012/2013
239
Code Product Price
O NH2
Unit
MM 0751.06
Imp. F (EP): 2-Propylpentanamide
(A)
100 mg
MM 0751.07
Imp. G (EP): 2,2-Dipropylpentanamide
O NH2
(A)
100 mg
MM 0751.08 MM 0751.09 MM 0751.10
Imp. H (EP): Pentanenitrile (Valeronitrile) Imp. I (EP): 2-Propylpentanenitrile Imp. J (EP): 2,2-Dipropylpentanenitrile
N
N
(C) (A) (A)
100 mg 100 mg 100 mg
Valsartan
New MM 0487.04 Imp. C (EP): (2S)-2-[Butanoyl[[2'-(1H-tetrazol-5yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid
O OH N O N N HN N
(A)
50 mg
Vancomycin Hydrochloride
MM 0239.00 Vancomycin Hydrochloride
NH 2 HO OH O HO OH HO O Cl O HO O NH O N H OH OH OH OH HN O Cl O O O NH O O NH 2 x HCl HN H N O O NH
(A)
100 mg
Venlafaxine Hydrochloride
MM 0393.00 Venlafaxine Hydrochloride
OH N O x HCl
(D)
100 mg
MM 0393.02
Imp. A (EP) as Hydrochloride: 2-(4Methoxyphenyl)-N,N-dimethylethanamine Hydrochloride Imp. B (EP) as Hydrochloride: Ethyl (2RS)-3(Dimethylamino)-2-(4-methoxyphenyl)propanoate Hydrochloride
N O
(A)
x HCl
100 mg
MM 0393.07
(A)
O O N O x HCl
100 mg
MM 0393.08
Imp. C (EP) as Hydrochloride: 1-[(1RS)-2-Amino1-(4-methoxyphenyl)ethyl]cyclohexanol Hydrochloride

O
OH NH2 x HCl
(A)
100 mg
MM 0393.04
Imp. D (EP) as Hydrochloride: 1-[(1RS)-1-(4Methoxyphenyl)-2-(methylamino)ethyl]cyclohexanol Hydrochloride

O
OH H N x HCl
(A)
100 mg
MM 0393.09
Imp. E (EP) as Hydrochloride: (5RS)-5-(4Methoxyphenyl)-3-methyl-1-oxa-3-azaspiro[5.5]undecane Hydrochloride

O
O N x HCl
(A)
100 mg
240
Edition 2012/2013
MM 0393.10
Imp. F (EP) as Hydrochloride: (2RS)-2(Cyclohex-1-enyl)-2-(4-methoxyphenyl)N,N-dimethylethanamine Hydrochloride

O
(A)
N x HCl
100 mg
MM 0393.03
Imp. G (EP) as Hydrochloride: (2RS)-2Cyclohexyl-2-(4-methoxyphenyl)-N,Ndimethylethanamine Hydrochloride

O
(A)
N x HCl
100 mg
MM 0393.11
Imp. H (EP): 1-[(1RS)-1-(4-Methoxyphenyl)2-[[2-(4-methoxyphenyl)ethyl]amino]ethyl]Cyclohexanol

O
OH H N O
(A)
50 mg
MM 0393.01
O-Desmethylvenlafaxine
OH N HO
(A)
100 mg
Verapamil Hydrochloride
MM 0022.00 Verapamil Hydrochloride
O O N x HCl N O O
(A)
500 mg
MM 0022.07
Imp. A (EP) as Dihydrochloride: N,N'Bis[2-(3,4-dimethoxyphenyl)ethyl]N,N'-dimethylpropane-1,3-diamine Dihydrochloride
O O N
x 2 HCl
O N O
(A)
100 mg
MM 0022.08
Imp. B (EP) as Hydrochloride: 2(3,4-Dimethoxyphenyl)-N-methylethanamine Hydrochloride Imp. C (EP) as Hydrochloride: 2-(3,4Dimethoxyphenyl)-N,N-dimethylethanamine Hydrochloride Imp. D (EP): 3-Chloro-N-[2(3,4-dimethoxyphenyl)ethyl]-N-methylpropan-1-amine Imp. E (EP): (3,4-Dimethoxyphenyl)methanol Imp. F (EP) as Hydrochloride: (2RS)2-(3,4-Dimethoxyphenyl)-5-(methylamino)2-(1-methylethyl)pentanenitrile Hydrochloride
O O
O O
O O NH x HCl
(A)
100 mg
MM 0022.09
(A)
N x HCl
100 mg
MM 0022.02
(A)
N
O O OH
100 mg
Cl
MM 0022.05 MM 0022.10
(B) (A)
O x HCl
100 mg 100 mg
HN N
MM 0022.04
Imp. G (EP): 3,4-Dimethoxybenzaldehyde
O O
(B)
100 mg
MM 0022.11
Imp. H (EP) as Hydrochloride: (2RS)2-(3,4-Dimethoxyphenyl)5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]2-ethylpentanenitrile Hydrochloride Imp. I (EP) as Hydrochloride: (2RS)2-(3,4-Dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]ethyl]-3-methylbutanenitrile Hydrochloride
O O O x HCl O
(A)
100 mg
N N
MM 0022.12
O O x HCl N
N O O
(A)
50 mg
Edition 2012/2013
241
Code Product Price
O x OH OH O O O N H N O O
Unit
MM 0022.21
Imp. J (EP) as Maleate: (2RS)2-(3,4-Dimethoxyphenyl)5-[[2-(3,4-dimethoxyphenyl)ethyl]amino]2-(1-methylethyl)pentanenitrile Maleate (N-Norverapamil Maleate)
(A)
100 mg
MM 0022.03
Imp. K (EP): (2RS)-2-(3,4-Dimethoxyphenyl)3-methylbutylnitrile
O O
(A)
100 mg
MM 0022.13
Imp. L (EP): 1-(3,4-Dimethoxyphenyl)-2methylpropan-1-one

O
O O
(A)
100 mg
MM 0022.15
Imp. N (EP) as Hydrochloride: 5,5'(Methylimino)bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile] Hydrochloride Imp. O (EP) as Hydrochloride: (2RS)2-(3,4-Dimethoxyphenyl)5-[2-[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]2-propylpentanenitrile Hydrochloride Diisopropylhomoveratylcyanide
O O x HCl
O O
(A)
50 mg
N N N
MM 0022.16
O O O x HCl O
(A)
100 mg
N N
MM 0022.06
O O N
(D)
100 mg
MM 0022.18
3,4-Dimethoxyphenylacetonitrile
O O
(A)
100 mg
MM 0022.19
Verapamil N-Oxide Hydrochloride

O O O N x HCl N
O O
(C)
50 mg
Vincamine
MM 0519.00 Vincamine
N HO O O H
(A)
N
100 mg
Vinpocetine
MM 0406.00 Vinpocetine
O N H N O
(D)
100 mg
MM 0406.02
Imp. A (EP): Ethyl (12RS,13aSR,13bSR)-13aEthyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (Ethyl Vincaminate)
O O HO N H N
(D)
100 mg
and enantiomer
MM 0406.01
Imp. B (EP): Methyl (13aS,13bS)-13a-Ethyl2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1de]pyrido[3,2,1-ij][1,5]naphthyridine-12carboxylate (Apovincamine)
O O N H N
(D)
100 mg
242
Edition 2012/2013
Voriconazole
MM 1094.04 Imp. A (EP): 1-(2,4-Difluorophenyl)-2(1H-1,2,4-triazol-1-yl)ethanone
F O N N N F
(A)
100 mg
Warfarin
New MM 0638.00 Warfarin
O O
(A)
100 mg
OH O
Warfarin Sodium
MM 0732.01 Imp. A (EP): (5RS)-3-(2-Hydroxyphenyl)-5-phenylcyclohex2-enone
OH
(A)
100 mg
MM 0732.02
Imp. B (EP): 4-Hydroxy-2H-1-benzopyran2-one (4-Hydroxycoumarin) Imp. C (EP): (3E)-4-Phenylbut-3-en-2-one (Benzalacetone)

O
(A)
100 mg
OH
MM 0732.03
(A)
100 mg
Xylazine Hydrochloride
MM 0515.00 Xylazine Hydrochloride
S N H N x HCl
(A)
500 mg
MM 0102.02
Imp. A (EP): 2,6-Dimethylaniline (2,6-Xylidine)
H2N
(B)
100 mg
Xylometazoline Hydrochloride
MM 0089.00 Xylometazoline Hydrochloride
N N H x HCl
(A)
500 mg
MM 0089.07
Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)-2[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]acetamide Hydrochloride Imp. B (EP): 2-(Chloromethyl)-5-(1,1-dimethylethyl)1,3-dimethylbenzene Imp. C (EP): [4-(1,1-Dimethylethyl)-2,6dimethylphenyl]acetonitrile Imp. D (EP): 1-(1,1-Dimethylethyl)-3,5dimethylbenzene Imp. F (EP): [4-(1,1-Dimethylethyl)-2,6dimethylphenyl]acetic Acid
(A)
O N H NH2 x HCl
100 mg
MM 0089.04
(A)
Cl
100 mg
MM 0089.03
(A)
N
100 mg
MM 0089.05
(C)
100 mg
MM 0089.02
(A)
O OH
100 mg
Edition 2012/2013
243
Zaleplon
New MM 1322.00 Zaleplon
N O N N N N
(A)
100 mg
MM 1322.02
N-[3-[3-(Dimethylamino)-1-oxo-2-propenyl]phenyl]N-ethylacetamide
O
(A)
N
100 mg
O N
Zidovudine
MM 0534.00 Imp. A (EP): 1-[(2R,5S)-5-(Hydroxymethyl)-2,5dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione (Stavudine) Imp. B (EP): 1-(3-Chloro-2,3-dideoxy--Derythro-pentofuranosyl)-5-methylpyrimidine2,4(1H,3H)-dione
O HN HO O O N
(A)
100 mg
MM 0173.02
O HN HO O O N
(A)
100 mg
Cl
MM 0534.01
Imp. C (EP): 5-Methylpyrimidine-2,4(1H,3H)dione (Thymine)
O HN O N H
(A)
100 mg
MM 0173.04
Imp. D (EP): Triphenylmethanol

OH
(A)
100 mg
MM 0534.03
Thymidine
HN HO O O
(A)
100 mg
OH
Zileuton
New MM 1297.01 N-(1-Benzo-[b]thien-2-ylethyl)urea
S NH2 HN O
(A)
50 mg
MM 1297.02
2-(Benzo[b]thien-2-oyl)benzo[b]thiophene
S
(A)
S
O S
50 mg
MM 1297.03
1-Benzo-[b]thien-2-ylethanone
(A)
100 mg
Ziprasidone Hydrochloride Monohydrate

MM 1273.00 Ziprasidone Hydrochloride Monohydrate
O HN x HCl x H2O
(A)
100 mg
N Cl N N S
244
Edition 2012/2013
Zolpidem Tartrate
New MM 0333.11 Zolpidem Tartrate [Controlled Substance]
N O N N 2 OH x HO O OH O OH
(A)
100 mg
MM 0333.01
Imp. A (EP): N,N-Dimethyl-2-[7-methyl2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl] acetamide
(D)
N O N N
100 mg
MM 0333.02
2-[6-Methyl-2-(4-methylphenyl)imidazo-[1,2-a]pyridin-3-yl] acetamide
(A)
N O N NH2
100 mg
MM 0333.03
2-[6-Methyl-2-(4-methylphenyl)imidazo-[1,2-a]pyridin-3-yl] acetic Acid
(A)
N O N OH
100 mg
MM 0333.04
Methyl 2-[6-Methyl-2-(4-methylphenyl)imidazo[1,2-a] pyridin-3-yl]acetate
(D)
N O N O
50 mg
MM 0333.05
6-Methyl-2-(4-methylphenyl)imidazo-[1,2-a]pyridine3-acetonitrile
(A)
N N N
100 mg
MM 0333.06
Oxozolpidem (N,N,6-Trimethyl-2-(4-methylphenyl)-oxo-imidazo [1,2-a]pyridine-3-acetamide)
(D)
N O N O N
100 mg
MM 0333.07
Zolpaldehyde (6-Methyl-2-(4-methylphenyl)-imidazo[1,2-a] pyridine-3-carboxaldehyde)
(A)
N N O
100 mg
MM 0333.08
Zolpyridine (4-Methyl-N-(5-methyl-2-pyridinyl)-benzamide)
N
H N O
(A)
100 mg
MM 0333.09
6-Methyl-2-(4-methylphenyl)--oxo-imidazo[1,2a]pyridine-3-acetamide
(A)
N O N O NH2
100 mg
MM 0333.10
Methyl -Hydroxy-6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetate
(A)
N O N HO O
100 mg
Zonisamide
New MM 1379.00 Zonisamide
O O S NH2 N O
(A)
100 mg
Zopiclone
MM 0149.00 Zopiclone
N N N N O O N O N Cl
(D)
100 mg
Edition 2012/2013
245
Code Product Price
O N O N N N O N O N Cl
Unit
MM 0149.01
Imp. A (EP): (5RS)-6-(5-Chloropyridin-2-yl)-7-oxo6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4Methylpiperazine-1-carboxylate 4-Oxide (Zopiclone Oxide) Imp. B (EP): (7RS)-6-(5-Chloropyridin-2-yl)-7hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
(D)
100 mg
MM 0149.02
HO N N N O N
Cl
(D)
100 mg
MM 0149.03
Imp. C (EP): 6-(5-Chloropyridin-2-yl)-6,7dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

N N
Cl N O
Cl H2N N
(A)
50 mg
MM 0149.04 MM 0149.05
2-Amino-5-chloropyridine 3-(5-Chloropyridine-2-carbamoyl)-2-pyrazinecarboxylic Acid

N N O
(A) (A)
250 mg 100 mg
O N H OH N
Cl
MM 0149.06
6-(5-Chloropyridin-2-yl)- 6,7-dihydro-5H-pyrrolo[3,4-b] pyrazin-5,7-dione

N N
O N O
O N N N H N
Cl N
(A)
100 mg
MM 0149.07
5-(Chloropyridine-2-yl-carbamoyl)pyrazine
Cl
(A)
100 mg
MM 0149.50
2-Acetylamino-5-chloropyridine
O N H N
Cl
(A)
100 mg
246
Edition 2012/2013
Looking for the one impurity?

Custom Synthesis
can provide you with research material for nearly every pharmaceutical impurity you want! LGC Standards
Direct contact for further information on www.lgcstandards.com
Background
The European Pharmacopoeia (EP) Commission includes in its membership delegates from nations who have adopted the European Pharmacopoeia. The EP Commission is in charge of judging the suitability of monographs. Prior to release, a new monograph must be adopted by the EP Commission, and then published in the annual Fascicule. Member States then officially adopt the new monograph on 1st January of the following year. To support the monographs of the European Pharmacopoeia, a collection of reference substances has been made available which includes: 1. 2. 3. Current, official, European Pharmacopoeia Chemical Reference Substances (EP CRS) and Biological Reference Preparations (BRP) Reference Spectra Other reference preparations, including Enzymes and Substrates from the International Commission on Pharmaceutical Enzymes and Certified Viscosity Standards from Van Swinden Laboratories. With supplement 4.3, the revised EP general method 2.2.6 replaces CRS reference liquids with certified reference materials available from suppliers of chemical reagents or materials certified for metrology. Ten liquid CRMs, certified by the Physical Chemistry Division of the Central Office of Measures (GUM), Warsaw in Poland, cover the wide range of refractive index from 1,333 (water) to 1,657 (1-bromonaphthalene). More detailed information is given in the chapter "Dyes and refractive index CRMs" of this catalogue. European Pharmacopoeia Reagents.
4.
5.
Relationship with other pharmacopoeias in Europe

Any reference substance, spectra or preparation required for a new EP monograph, is made available as soon as the monograph comes into force. Many of the member countries of the European Pharmacopoeia Commission have adopted the EP in full, and their monographs require only EP CRS/BRP. When an EP monograph is adopted by the pharmacopoeia of a member state of the Council of Europe then any reference material that may have been available from a national pharmacopoeia, e.g. BP or PF, will usually be discontinued in favour of the EP reference substance. However, a number of member countries of the EP Commission maintain national pharmacopoeial monographs, especially for finished dosage forms, which require the use of separate reference substances. A separate chapter in this catalogue includes lists of the reference substances produced for the British, French, Swiss and International pharmacopoeia monographs. The International Pharmacopoeia (IP) reference substances are described in the section referring to the WHO (World Health Organization).
Production and certification

European Pharmacopoeia reference substances and preparations are selected and verified by the EP laboratories as being suitable for the use as prescribed in the relevant monograph of the European Pharmacopoeia. Since CRS and BRP are officially certified by the European Pharmacopoeia Commission, it should be noted that neither certificates of analysis nor data not relevant to the use of the products as defined by the EP monograph are provided with the reference product or substance.
Edition 2012/2013
Looking for impurity reference standards with CofAs? See our impurity chapter from page 11 on.
249
European Pharmacopoeia Storage, shelf life and expiry dates and size units
European Pharmacopoeia CRS/BRP are subject to regular inspection and repeated analysis by EP scientific staff. Each EP CRS/BRP is, on receipt by the customer, fit for the intended use. No expiry date is indicated on the reference materials because the products or substances comply with the requirements of the corresponding monograph and are monitored regularly. When batches are to be changed, LGC Standards can provide you with the date on which the previous lot will no longer be official. In specific cases for reasons related to filling or labeling, sub-batches are obtained from the same batch of bulk material. However, all the necessary precautions are taken in order to guarantee that the quality and specifications of the sub-batches do not differ from one to another. Please note, that new lots can have different unit sizes, especially with pharmacopoeial reference standards, and LGC Standards is not responsible for such cases. If the unit size of a new batch changes, LGC Standards will provide this information to customers in new lot lists. The EP is also currently over-labelling all its reference standards vials with a secondary label. This new secondary label is useful for customs purposes as it can be peeled off. It can also be stuck onto your laboratory book to prove the use of the reference standard. All the required information to perform the tests described in the European Pharmacopoeia monographs are stated on the primary label. EP recommends only sufficient material should be purchased for immediate use and that unopened vials should be stored in the dark unless otherwise stated. Whilst most EP CRS/BRP can be shipped at ambient temperature, certain items have to be maintained at controlled temperatures at all times and are subject to special shipping charges and storage conditions (details are available on request). Where no drying conditions are stated, the substance is to be used as received. Once opened, EP can no longer guarantee the stability of the material and any of the CRS/BRP not used should be disposed of and not kept for future use.
Validation of secondary standards

All secondary in-house working standards have to be validated against the corresponding EP CRS/BRP. Please make sure that the secondary material is used only for the same official purposes for which the primary pharmacopoeial material was designed.
Proper use
EP discontinued their use code number system as of January 2006. For information on the use of the substances please refer to the monograph or contact your local LGC Standards office.
Opening
For reference substances and preparations supplied in sealed glass ampoules the following technique is suitable for opening the ampoule: tap gently to collect the material at the lower end, score the ampoule with a file, heat a glass rod to white heat and apply firmly to the file mark. If the glass does not crack, deepen and extend the file mark, and repeat the process. Eye and hand protection MUST be used. Many reference substances are supplied as lyophilised material in a septum vial. No attempt should be made to open the vial and weigh out the powder. It is important to strictly follow the monograph instructions, reconstitute the material in a buffer solvent and handle the resultant solution volumetrically.
Toxicity
The potential toxicity of certain reference substances is such that special precautions should be taken to avoid contact. Such substances should be manipulated in a glove box. If this is not possible, gloves, eye protection and a mask should be worn. Following the guidelines suggested by the EP does not replace the need to carry out a full hazard assessment. Biological and blood products should be regarded as potentially hazardous to health and therefore used and disposed of according to established laboratory safety procedures.
Controlled Substances
The EPs product range contains substances subject to Controlled Substance regulations schedules. Special ordering procedures apply, so please contact LGC Standards for details and costs.
250
Edition 2012/2013
Code Product Unit
EPY0000055 EPY0000116 EPY0000500 EPY0000354 EPY0000427 EPA0040000 EPY0000359
Acamprosate calcium - Reference Spectrum Acamprosate impurity A 3-aminopropane-1-sulphonic acid Acarbose Acarbose for identification Acarbose for peak identification Acebutolol hydrochloride Acebutolol impurity B N-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl) amino]propoxy]phenyl]acetamide (diacetolol) Acebutolol impurity C N-(3-acetyl-4-hydroxyphenyl)butanamide Acebutolol impurity I N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl)butanamide Aceclofenac - Reference Spectrum Aceclofenac for peak identification Aceclofenac impurity F benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate Aceclofenac impurity H [[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl]oxy]acetyl]oxy]acetic acid Acemetacin Acemetacin impurity A 4-chlorobenzoic acid Acemetacine impurity mixture Acesulfame potassium Acesulfame potassium impurity B 5-chloro-6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide Acetazolamide Acetazolamide for system suitability Acetylcholine chloride Acetylcysteine Acetylcysteine impurity C N,N'-diacetyl-L-cystine Acetylcysteine impurity D N,S-diacetyl-L-cysteine -Acetyldigoxin -Acetyldigoxin for peak identification Acetylsalicylic acid Acetylsulfadiazine N-Acetyltryptophan N-Acetyltyrosine Acholeplasma laidlawii BRP Aciclovir Aciclovir for system suitability Aciclovir for peak identification 1 Aciclovir for peak identification 2 Actaea racemosa HRS Actaea racemosa for assay CRS Acitretin Actaea rasemosa dry extract for system suitability HRS Adapalene Adapalene impurity C 1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane Adapalene for peak identification Adenine
unit 50 mg 94.7 mg 10 mg 40 mg 50 mg 10 mg
EPY0000127 EPY0000128 EPY0000056 EPY0001094 EPY0000085 EPY0000086 EPY0000810 EPY0000811 EPY0000842 EPA0070000 EPA0070020 EPA0100000 EPY0001084 EPY0000002 EPA0150000 EPA0152000 EPA0153000 EPY0000565 EPY0000642 EPA0200000 New EPY0001462 EPA0208000 EPA0202000 EPY0000693 EPA0220000 EPY0001264 EPY0001271 EPY0001269 New EPY0001463 New EPY0001543 EPA0225000 New EPY0001464 EPY0001121 EPY0001120 EPY0001119 EPA0230000
20 mg 0.004 mg unit 10 mg 20 mg 10 mg 100 mg 10 mg 0.06 mg 50 mg 50 mg 100 mg 0.0068 mg 50 mg 50 mg 10 mg 10 mg 50 mg 10 mg 15 mg 0.002 mg 125 mg 200 mg 1 mL 75 mg 10 mg 0.3 mg 0.004 mg 1200 mg 300 mg 100 mg 1200 mg 100 mg 6 mg 2.022 mg 50 mg
Edition 2012/2013
251
Code Product Unit
EPA0230200 EPY0000110 EPY0000882 EPY0000883 EPA0300000 EPY0000740 EPY0000707 EPY0000728 EPA0325000 EPA0325100 EPA0325200 EPA0325450 EPA0325451 EPA1225000 EPA0325500 EPA0325800 EPY0000832 EPA0349000 EPA0350000 EPA0350010 EPA0350020 EPA0350030 EPA0350040 EPA0350050 EPA0351000 EPY0000235 EPY0000255 EPA0357000 EPA0360000 EPY0000054 EPY0000606 EPY0000843 EPY0000687 EPY0000595 EPY0000607 EPA0363000 EPA0363700 EPA0900000 EPA0365000 EPA0368000 New EPY0001467 EPA0365900 EPY0001117 EPA0370000 EPY0000020
Adenosine Adipic acid Adrenaline Adrenaline with impurity F Adrenaline tartrate Adrenaline impurity mixture Adrenaline tartrate with impurity A Agnus castus fruit standardised dry extract Alanine Albendazole Alcuronium chloride Alfacalcidol Alfacalcidol - Reference Spectrum Alfadex Alfentanil hydrochloride - Reference Spectrum Alfuzosin hydrochloride Alfuzosin for system suitability Allantoin Allopurinol Allopurinol impurity A 5-amino-1H-pyrazole-4-carboxamide Allopurinol impurity B 5-formylamino-1H-pyrazole-4-carboxamide Allopurinol impurity C 5-(4H-1,2,4-triazol-4-yl)1H-pyrazole-4-carboxamide Allopurinol impurity D ethyl 5-amino-1H-pyrazole-4-carboxylate Allopurinol impurity E ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate Allylstrychnine bromide Almagate Almagate - Reference Spectrum Alprazolam Controlled Substance Alprenolol hydrochloride Alprostadil Altizide Altizide impurity B 3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene Alverine citrate Alverine for peak identification Alverine impurity D N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine Amantadine hydrochloride Ambroxol hydrochloride Amfetamine sulfate - Reference Spectrum Amidotrizoic acid dihydrate Amikacin Amikacin impurity I (2S)-4-amino-2-hydroxybutanoic acid Amikacin sulfate Amikacin for system suitability Amiloride hydrochloride Amiloride impurity A methyl-3,5-diamino-6-chloropyrazine-2-carboxylate
50 mg 50 mg 5 mg 10 mg 100 mg 0.005 mg 15 mg 200 mg 60 mg 50 mg 50 mg 5 mg unit 150 mg unit 10 mg 10 mg 60 mg 100 mg 10 mg 10 mg 10 mg 10 mg 20 mg 10 mg 25 mg unit 100 mg 100 mg 50 mg 150 mg 15 mg 5 mg 0.125 mg 10 mg 100 mg 125 mg unit 100 mg 200 mg 20 mg 200 mg 10 mg 100 mg 10 mg
252
Edition 2012/2013
Code Product Unit
EPY0000173 EPA0420000 EPA0460000 EPA0496000 EPA0496005
4-Aminobenzoic acid Aminocaproic acid 7-Aminodesacetoxycephalosporanic acid Aminoglutethimide Aminoglutethimide impurity A (3RS)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; (3-aminoglutethimide) Aminoglutethimide impurity D 3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione) (azoglutethimide) Amiodarone hydrochloride Amiodarone impurity D (2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone Amiodarone impurity E (2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone Amisulpride Amisulpride impurity B 4-amino-N-[[(2RS )-1-ethylpyrrolidin-2-yl] methyl]-5-(ethyl sulphonyl)-2-hydroxybenzamide Amitriptyline hydrochloride Amlodipine besilate Amlodipine for peak identification Amlodipine impurity A 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Amlodipine impurity B 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5-dicarboxylate Amlodipine impurity G dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Ammonio methacrylate copolymer (type A) - Reference Spectrum Ammonio methacrylate copolymer (type B) - Reference Spectrum Amobarbital Controlled Substance Amobarbital sodium Controlled Substance Amoxicillin trihydrate Amphotericin B Amphotericin B for microbiological assay Amphotericin B for peak identification Ampicillin (anhydrous) Ampicillin trihydrate Amylmetacresol Amylmetacresol for peak identification Angelica dahuria root Anhydrotetracycline hydrochloride Antazoline hydrochloride Apomorphine hydrochloride - Reference Spectrum Apomorphine hydrochloride hemihydrate Apomorphine impurity B (Morphine sulfate) (Morphinhemisulfat-Pentahemihydrat) Controlled Substance Alpha-apo-oxytetracycline Beta-apo-oxytetracycline Aprotinin solution BRP Aprotinin for system suitability L-Arabinitol Arbutin Arginine Arginine aspartate
60 mg 50 mg 20 mg 125 mg 20 mg
EPA0496020 EPA0575000 EPY0000129 EPY0000130 EPA0590000 EPA0590004 EPY0000563 EPY0000049 EPY0001067 EPY0001068
10 mg 100 mg 20 mg 20 mg 10 mg 10 mg 10 mg 150 mg 10 mg 10 mg
EPY0001069
10 mg
EPY0001070 EPY0000302 EPY0000303 EPA0650000 EPA0700000 EPA0800000 EPY0000005 EPY0001361 EPY0001014 EPA1000000 EPA1100000 EPY0001244 EPY0001245 EPY0001386 EPA1200000 EPA1210000 EPY0000172 EPY0001465 New EPY0001471 EPA1220000 EPA1230000 EPA1250000 EPY0001154 EPA1269000 EPY0000806 EPA1270000 EPY0000304
Edition 2012/2013
10 mg unit unit 500 mg 500 mg 100 mg 100 mg 100 mg 10 mg 250 mg 150 mg 285 mg 10 mg 160 mg 15 mg 50 mg unit 15 mg 40 mg 20 mg 20 mg 0.5 mL 2.7 mg 10 mg 100 mg 50 mg 20 mg
253
Code Product Unit
EPA1271000 New EPY0001323 EPY0001185 EPY0001175 EPY0000079 EPY0000080 EPY0000081
Arginine hydrochloride Aristolochia Aristolochic acid I Aristolochic acid for system suitability Articaine hydrochloride Articaine impurity A methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2-carboxylate Articaine impurity E methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl] amino]thiophene-2-carboxylate Ascorbic acid (Vitamin C) Ascorbic acid impurity C D-sorbosonic acid Ascorbic acid impurity D methyl D-xylo-hex-2-ulosonate (methyl D-sorbosonate) Ascorbyl palmitate Asparagine monohydrate Aspartame Aspartame impurity A 2-(5-benzyl-3,6-dioxopiperazin-2-yl)acetic acid (diketopiperazine) Aspartic acid Astragaloside IV Atenolol Atenolol for system suitability Atorvastatine calcium trihydrate Atorvastatin impurity A desfluoroatorvastatin Atorvastatin impurity B 3-epi-atorvastatin Atorvastatin impurity C fluoroatorvastatin Atorvastatin impurity D 3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide Atorvastatin impurity E ent-atorvastatin Atracurium besilate Atracurium for impurity F identification Atracurium for peak identification Atropine Atropine for peak identification Atropine impurity B (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate (noratropine) Atropine sulphate Azaperone Azathioprine Azathioprine impurity A 1-methyl-4-nitro-1H-imidazol-5-amine Azathioprine impurity G 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine (thiamiprine) Azelastine hydrochloride Azelastine impurity B 1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane Azelastine impurity D 4-(4-chlorobenzyl)phthalazin-1(2H)-one Azelastine impurity E 3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one
50 mg 140 mg 1 mg 1 mg 100 mg 15 mg 10 mg
EPA1300000 EPY0001024 EPY0001170 EPY0000800 EPY0000305 EPA1320000 EPA1321000 EPA1330000 EPY0001171 EPA1340000 EPY0001089 EPY0001327 EPY0001328 EPY0001329 EPY0001330 EPY0001331 EPY0001332 EPY0000424 EPY0000503 EPY0000504 EPY0000878 EPY0000845 EPY0000816 EPA1400000 EPY0000029 EPA1500000 EPY0001240 EPY0001246 EPY0000326 EPY0000327 EPY0000328 EPY0000329
100 mg 20 mg 10 mg 10 mg 60 mg 40 mg 10 mg 50 mg 40 mg 100 mg 5 mg 150 mg 10 mg 10 mg 10 mg 10 mg 10 mg 120 mg 5 mg 5 mg 30 mg 0.25 mg 10 mg 50 mg 50 mg 100 mg 10 mg 5 mg 25 mg 5 mg 5 mg 5 mg
254
Edition 2012/2013
Code Product Unit
EPY0000306 EPY0000637 EPY0000641 EPY0000307 EPY0000285 EPB0070000 EPB0100000 EPB0200000 EPB0200050 EPY0001273 EPB0250000 EPB0300000 EPY0000295 EPB0305000 EPY0000351 EPY0000352 EPY0000469 EPY0001073 EPY0001025 EPY0001038 EPY0001026
Azithromycin Azithromycin for peak identification Azithromycin for system suitability Azithromycin impurity A 6-demethylazithromycin B19 virus DNA for NAT testing BRP Bacampicillin hydrochloride Bacitracin zinc Baclofen Baclofen impurity A (RS)-4-amino-3-(4-chlorophenyl)butyric acid lactam Baicalin Bambuterol hydrochloride Barbital Controlled Substance Basic butylated methacrylate copolymer - Reference Spectrum Beclometasone dipropionate anhydrous Beclometasone dipropionate monohydrate Beclometasone dipropionate for system suitability Beclometasone dipropionate for peak identification Beclometasone dipropionate impurities F and N Benazepril hydrochloride Benazepril for system suitability Benazepril impurity A [(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5-tetrahydro-1H-1benzazepin-1-yl]acetic acid Bendroflumethiazide Bendroflumethiazide impurity A 4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide Benfluorex hydrochloride Benfluorex hydrochloride for system suitability Benperidol Benserazide hydrochloride Benserazide impurity A (RS)-2-amino-3-hydroxypropanohydrazide Benserazide impurity C (2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]propanohydrazide Benserazide for peak identification Benzaldehyde Benzalkonium chloride for system suitability Benzarone (2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone Benzathine benzylpenicillin Benzbromarone Benzethonium chloride Benzocaine Benzoic acid Benzophenone Benzyl alcohol Benzyl benzoate - Reference Spectrum S-Benzylmercaptoacetyltriglycin Benzylpenicillin potassium Benzylpenicillin sodium Berberine chloride
200 mg 15 mg 0.05 mg 10 mg 150 mg 120 mg 150 mg 50 mg 50 mg 10 mg 100 mg 500 mg unit 150 mg 10 mg 10 mg 10 mg 0.052 mg 160 mg 0.016 mg 10 mg
EPB0400000 EPY0000564 EPY0000044 EPY0000043 EPB0470000 EPB0477000 EPB0477010 EPY0001071 EPY0001079 EPY0001064 EPY0001060 EPB0490000 EPB0500000 EPY0000775 EPB0550000 EPB0600000 New EPY0001470 EPY0000647 EPY0000167 EPB0670000 EPB0680000 EPB0700000 EPB0900000 EPY0001149
100 mg 5 mg 50 mg 360 mg 100 mg 50 mg 20 mg 10 mg 10 mg 150 mg 20 mg 10 mg 125 mg 10 mg 100 mg 50 mg 30 mg 40 mg 50 mg unit 10 mg 50 mg 200 mg 20 mg
Edition 2012/2013
255
Code Product Unit
EPB0950000 EPY0000391 EPB0990000 EPB1000000 EPB1030000 EPB1040000 New EPY0001416 New EPY0001418 EPB1045000 EPB1054000 EPB1055000 EPY0001027 EPY0001065 EPY0001360 EPB1103000 EPB1103100 EPY0001354 EPB1115000 New EPY0001444 New EPY0001448 EPY0001078 EPB1110000 New EPY0001421 EPB1110004 EPY0001059 EPB1116000 EPB1120000 EPB1121000
Betadex Betahistine dihydrochloride Betahistine mesilate Betamethasone Betamethasone acetate Betamethasone diproprionate Betamethasone dipropionate for peak identification Betamethasone dipropionate for system suitability Betamethasone sodium phosphate Betamethasone-17-valerate Betamethasone-21-valerate Betamethasone valerate for system suitability Betamethasone valerate impurity mixture Betaxolol for peak identification Betaxolol hydrochloride Betaxolol impurity A (2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)-amino]propan-2-ol Betaxolol impurity C 2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane Bezafibrate Bicalutamide Bicalutamide for system suitability Bicisate labelling kit Bifonazole Bifonazole for system suitability Bifonazole impurity B 4-[(RS)-(biphenyl-4-yl)phenylmethyl]-1H-imidazole trifluoroacetate Bilberry dry extract Biotin (Vitamin H) Biperiden hydrochloride Biperiden impurity A (1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(piperidin-1-yl)propan-1-ol (endo form) Bisacodyl Bisacodyl for peak identification Bisacodyl for system suitability Bisoprolol fumarate Bisoprolol for peak identification Bisoprolol for system suitability method A CRS has been renamed as Bisoprolol for peak identification CRS Bisoprolol for system suitability Bisoprolol for system suitability method B CRS has been renamed as Bisoprolol for system suitability CRS Bleomycin sulfate Boldine Bordetella pertussis mouse antiserum BRP Bromazepam Controlled Substance Bromazepam for system suitability Controlled Substance Bromhexine hydrochloride Bromhexine impurity C N-(2-aminobenzyl)-N-methylcyclohexanamine Bromocriptine mesilate Bromocriptine mesilate for system suitability Bromperidol
200 mg 50 mg 100 mg 75 mg 100 mg 150 mg 10 mg 10 mg 100 mg 100 mg 15 mg 25 mg 0.018 mg 15 mg 60 mg 10 mg 5 mg 100 mg 100 mg 15 mg 24 mg 100 mg 10 mg 10 mg 250 mg 20 mg 60 mg 20 mg
EPB1140000 EPY0000608 EPY0000694 EPY0000812 EPY0000877
50 mg 10 mg 5 mg 50 mg 1 mg
EPY0000813
1 mg
EPB1141000 EPY0000434 EPB1142000 EPB1143000 EPY0000645 EPB1145000 EPY0000200 EPB1150000 EPY0000677 EPB1152000
7 mg 30 mg 0.5 mg 60 mg 10 mg 100 mg 10 mg 30 mg 5 mg 100 mg
256
Edition 2012/2013
Code Product Unit
EPB1152050 EPB1153000 EPY0000468 EPY0000470
Bromperidol decanoate Brompheniramine maleate Brotizolam Controlled Substance Brotizolam impurity B 2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine (demethylbrotizolam) Brucella melitensis Rev. 1 strain BRP Budesonide Budesonide for system suitability Bufexamac Buflomedil hydrochloride Buflomedil impurity B 4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one Bumetanide Bumetanide impurity A 3-nitro-4-phenoxy-5-sulphamoylbenzoic acid Bumetanide impurity B 3-amino-4-phenoxy-5-sulphamoylbenzoic acid Bupivacaine hydrochloride Bupivacaine impurity B (2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Bupivacaine impurity E 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide Buprenorphine Controlled Substance Buprenorphine hydrochloride Controlled Substance Buprenorphine for system suitability Controlled Substance Buserelin D-His-Buserelin Buspirone hydrochloride Buspirone for system suitability Busulfan Butyl methanesulfonate Butyl parahydroxybenzoate Butyl parahydroxybenzoate impurity E 2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate) Butylhydroxyanisole Butylhydroxytoluene Plastic additive 07 Cabergoline Caffeine Caffeine for system suitability Calcifediol Calcifediol - Reference Spectrum Calcipotriol (anhydrous) - Reference Spectrum Calcipotriol monohydrate Calcipotriol monohydrate - Reference Spectrum Calcitonin (salmon) Calcitonin-Gly N-acetyl-cys1-calcitonin Calcitriol Calcitriol - Reference Spectrum Calcium ascorbate - Reference Spectrum Calcium folinate Calcium glucoheptonate
60 mg 100 mg 10 mg 10 mg
EPB1155000 EPB1157300 EPY0001148 EPB1156000 EPB1157400 EPB1157410 EPB1158000 EPY0000309 EPY0000310 EPB1160000 EPY0000088 EPY0000089 EPY0001108 EPY0001109 EPY0001122 EPB1168000 EPB1168020 EPY0000131 EPY0000471 EPB1170000 EPY0001304 EPB1217000 EPY0001357 EPB1212000 EPB1215000 EPY0000472 EPC0100000 EPY0000787 EPC0166000 EPC0166001 EPY0000499 EPY0000473 EPY0000474 EPC0200000 EPY0000632 EPC0200010 EPC0225000 EPC0226000 EPC0249000 EPC0250000 EPC0299000
Edition 2012/2013
1 mL 110 mg 10 mg 100 mg 100 mg 20 mg 150 mg 5 mg 5 mg 100 mg 20 mg 20 mg 10 mg 10 mg 10 mg 2 mg 0.5 mg 5 mg 2 mg 50 mg 30 l 100 mg 15 mg 50 mg 50 mg 100 mg 70 mg 20 mg 5 mg unit unit 5 mg unit 2x0.98 mg 0.4 mL 20 mg 10 mg unit unit 100 mg 60 mg
257
Code Product Unit
EPC0300000 EPC0340000 EPC0350000 EPC0400000 EPC0405000 EPY0001388 New EPY0001387 EPY0001389 EPC0410000 EPC0426000 EPY0000671 EPC0430000 EPY0001182 EPY0001219 EPY0001220 EPY0001221 EPY0000435 New EPY0001450
Calcium gluconate Calcium levulinate dihydrate Calcium oxalate monohydrate Calcium pantothenate Camphor (racemic) Candesartan cilexetil Candesartan cilexetil for peak identification Candesartan cilexetil for system suitability Canrenone Caprylic acid Capsaicin Captopril Captopril for system suitability Captopril impurity B (2S) 1-[(2S)-3-bromo-2-methylpropanoyl]pyrrolidine-2-carboxylic acid Captopril impurity C (2RS)-2-methyl-3-sulphanylpropanoic acid Captopril impurity D (2RS)-3-bromo-2-methylpropanoic acid Captopril impurity E (2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid Captopril impurity J (2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl]pyrrolidine-2-carboxylic acid (acetylcaptopril) Carbachol Carbamazepine Carbamazepine impurity A 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide(10,11-dihydrocarbamazepine) Carbasalate calcium - Reference Spectrum Carbasalate impurity B 2-[[2-(acetyloxy)benzoyl]oxy]benzoic acid (acetylsalicylsalicylic acid) Carbenicillin sodium Carbidopa Carbimazole Carbocisteine Carbon dioxide - Reference Spectrum Carboplatin - Reference Spectrum Carboprost trometamol Carboprost trometamol - Reference Spectrum Carisoprodol Carisoprodol impurity A (2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate Carmellose Carmustine - Reference Spectrum Carmustine impurity A 1,3-bis(2-chloroethyl)urea Carprofen for veterinary use Carprofen for system suitability Carteolol hydrochloride - Reference Spectrum Carteolol for system suitability Carvedilol - Reference Spectrum Carvedilol Carvedilol for system suitability Carvedilol impurity C (2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy) propan-2-ol
100 mg 250 mg 500 mg 60 mg 50 mg 60 mg 10 mg 10 mg 50 mg 200 mg 50 mg 10 mg 20 mg 10 mg 10 mg 10 mg 10 mg 10 mg
EPY0000113 EPC0450000 EPY0000033 EPC0451000 EPY0001161 EPC0455000 EPC0460000 EPC0465000 EPC0470000 EPC0499900 EPC0550000 EPY0000475 EPY0000536 EPY0000035 EPY0000036 EPY0001214 EPC0580004 EPC0580010 EPY0000846 EPY0000884 EPY0000192 EPY0000193 EPY0000075 New EPY0001427 New EPY0001426 EPY0000103
50 mg 200 mg 10 mg unit 5 mg 50 mg 50 mg 100 mg 60 mg unit unit 40 mg unit 50 mg 10 mg 10 mg unit 20 mg 30 mg 5 mg unit 30 mg unit 50 mg 10 mg 10 mg
258
Edition 2012/2013
Code Product Unit
EPC0600000 EPC0630000 EPC0640000 EPC0650000 EPC0675000 EPC0682000 EPY0000505 EPC0682300 EPY0000240 EPC0682400 EPC0682410
Casein BRP Cefaclor Delta-3-Cefaclor Cefadroxil Cefalexin monohydrate Cefalotin sodium Cefalotin for impurity B identification Cefamandole nafate Cefapirin sodium Cefatrizine propylene glycol Cefatrizine impurity A 7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8-oxo-5-thia-1azabicyclo[4.2.O]oct-2-ene-2-carboxylic acid(7-ACA triazole) Cefazolin Cefepime dihydrochloride monohydrate Cefepime dihydrochloride monohydrate for system suitability Cefepime impurity E (6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct2-ene-2-carboxylate Cefixime Cefoperazone dihydrate Cefoperazone sodium - Reference Spectrum Cefotaxime acid Cefotaxime sodium Cefotaxime for peak identification Cefoxitin sodium Cefpodoxime proxetil Cefpodoxime proxetil for peak identification Cefpodoxime proxetil for impurity H identification Cefprozil Cefprozil impurity A (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid (p-hydroxyphenylglycine) Cefprozil for peak identification Cefprozil impurity mixture Cefradine Cefradine for peak identification Cefradine impurity mixture Ceftazidime Ceftazidime for peak identification Ceftriaxone sodium Ceftriaxone impurity A E-isomer Cefuroxime axetil Cefuroxime sodium Celecoxib Celecoxib impurity A 4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide Celecoxib impurity B 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide Celiprolol hydrochloirde Celiprolol impurity I 1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea Celiprolol for peak identification Cellulose acetate
100 g 450 mg 20 mg 250 mg 150 mg 100 mg 10 mg 125 mg 100 mg 150 mg 60 mg
EPC0682800 EPY0000633 EPY0000634 EPY0001336
150 mg 150 mg 15 mg 10 mg
EPC0684000 EPC0684750 EPC0684800 EPY0000420 EPC0685000 EPY0000506 EPC0688000 EPY0001305 EPY0001306 EPY0001318 New EPY0001371 New EPY0001372 New EPY0001367 New EPY0001368 EPC0690000 EPY0000568 EPY0001174 EPC0690500 EPY0001111 EPC0691000 EPC0692000 EPC0694990 EPC0695000 New EPY0001445 New EPY0001446 New EPY0001447 EPY0000311 EPY0000312 EPY0000239 EPY0000784
Edition 2012/2013
200 mg 100 mg unit 80 mg 30 mg 10 mg 100 mg 70 mg 10 mg 10 mg 120 mg 20 mg 10 mg 10 mg 300 mg 15 mg 0.04 mg 200 mg 10 mg 80 mg 10 mg 60 mg 150 mg 200 mg 10 mg 10 mg 10 mg 0.02 mg 20 mg 40 mg
259
Code Product Unit
EPC0698005 EPY0001054 EPC0700000 EPC0980650 EPY0001197 EPC0980651 EPC0984100 EPC0990000 EPY0000073 EPY0000074 EPC1000000 EPC1050000 EPY0000104 EPC1100000 EPY0001298 EPY0001299 EPC1200000 EPC1300000 EPC1350000 EPC1400000 EPC1425000 EPC1435000 EPC1450000 EPC1500000 EPY0000476 EPC1510000 EPC1520000 EPC1540000 EPC1530000 EPY0000569 EPC2223030 EPC1650000 EPC1700000 EPC1800000 EPY0000436 EPY0000437 EPC1900000 EPY0000507
Cellulose acetate butyrate - Reference Spectrum Cellulose acetate phthalate Cephaeline hydrochloride Cetirizine dihydrochloride Cetirizine for peak identification Cetirizine impurity A (RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine Cetostearyl isononanoate - Reference Spectrum Cetyl alcohol Cetyl palmitate 15 Cetyl palmitate 95 Cetylpyridinium chloride Chenodeoxycholic acid Chitosan hydrochloride Chlorambucil Chlorambucil for system suitability Chlorambucil with impurity G Chloramphenicol Chloramphenicol dipalmitate Chloramphenicol disodium disuccinate Chloramphenicol palmitate isomer Chloramphenicol sodium succinate Chlorcyclizine hydrochloride Chlordiazepoxide Controlled Substance Chlordiazepoxide hydrochloride Controlled Substance Chlordiazepoxide impurity A 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide Chlorhexidine Chlorhexidine diacetate Chlorhexidine dihydrochloride Chlorhexidine for performance test Chlorogenic acid 1-(4-Chlorophenyl)-1-phenylethanol Clemastine fumarate impurity C Chloroquine sulphate Chlorothiazide Chlorphenamine maleate Chlorphenamine impurity A 2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)ethyl]butanenitrile Chlorphenamine impurity C (3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine Chlorpromazine hydrochloride Chlorpromazine impurity A 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1- amine S-oxide (chlorpromazine sulphoxide) Chlorpromazine impurity D 3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine (demethylchlorpromazine) Chlorpromazine impurity E 2-chloro-10H-phenothiazine Chlorpromazine impurity F 3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine Chlorpropamide Chlorpropamide impurity B 1,3-Dipropylurea
unit 10 mg 15 mg 100 mg 1.01 mg 10 mg unit 250 mg 60 mg 50 mg 20 mg 125 mg 30 mg 100 mg 10 mg 10 mg 500 mg 100 mg 25 mg 100 mg 1500 mg 100 mg 2x50 mg 100 mg 10 mg 50 mg 10 mg 50 mg 50 mg 20 mg 15 mg 200 mg 100 mg 100 mg 0.01 mg 10 mg 200 mg 10 mg
EPY0000479 New EPY0000508 EPY0001449 EPC1905000 EPC1905020
10 mg 10 mg 2 mg 100 mg 50 mg
260
Edition 2012/2013
Code Product Unit
EPC1915000 EPC1950000 EPY0000779 EPC2000000 EPY0001451 EPC2100000 EPC2150000 EPC2155000 EPC2158000 EPY0000280 EPY0000593 EPC2160000 EPY0000040 EPC2162701 EPC2162702 EPC2162700 EPC2163000 EPY0000361 EPC2170000 EPC2174000 EPC2174002
Chlorprothixene hydrochloride Chlortalidone Chlortalidone for peak identification Chlortetracycline hydrochloride Chlortetracycline for system suitability Cholecalciferol Cholecalciferol for system suitability Cholesterol Cholic acid Chondroitin sulfate sodium Chondroitin sulfate sodium (marine) Chymotrypsin BRP Ciclopirox Ciclopirox impurity A (RS)-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic acid Ciclopirox impurity B 6-cyclohexyl-4-methyl-2H-pyran-2-one Ciclopirox olamine Ciclosporin Ciclosporin for system suitability Cilastatin sodium Cilazapril Cilazapril impurity A 1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]amino]10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate Cilazapril impurity D (1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10-oxo-octahydro-6Hpyridazino[1,2a][1,2]diazepine-1-carboxylic acid Cimetidine Cimetidine hydrochloride Cimetidine for peak identification Cimetidine for system suitability Cinchocaine hydrochloride Cineole Cinnarizine Ciprofibrate Ciprofibrate for system suitability Ciprofloxacin Ciprofloxacin hydrochloride Ciprofloxacin hydrochloride for peak identification Ciprofloxacin impurity A 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid (fluoroquinolonic acid) Cisplatin Cisplatin impurity A trans-diamminedichloroplatinium (II) Cisplatin impurity B amminetrichloroplatinate (-) Citalopram hydrobromide Citalopram hydrochloride Citalopram for system suitability Citric acid (anhydrous) Citric acid monohydrate Cladribine
50 mg 150 mg 1.017 mg 100 mg 20 mg 500 mg 1 mL 100 mg 60 mg 250 mg 100 mg 100 mg 100 mg 20 mg 20 mg 150 mg 120 mg 5 mg 10 mg 50 mg 25 mg
EPC2174005
10 mg
EPC2175000 EPC2175500 EPY0001130 EPY0001146 EPC2177000 EPY0000176 EPC2180000 EPY0000362 EPY0000363 EPY0000198 EPC2190000 EPY0000199 EPC2190050
50 mg 100 mg 10 mg 0.5085 mg 60 mg 180 mg 100 mg 5 mg 5 mg 20 mg 100 mg 10 mg 10 mg
EPC2210000 EPY0001018 EPY0001019 EPY0001008 EPY0001007 EPY0000855 EPA1202000 EPC2219000 EPY0000639

Edition 2012/2013
100 mg 10 mg 10 mg 5 mg 5 mg 0.06 mg 50 mg 50 mg 50 mg
261
Code Product Unit
EPY0000609 EPY0000610 EPY0000320 EPY0000321 New EPY0001193 EPY0000269 EPC2221000 EPC2223000 EPC2248000 EPC2248010 EPC2250000 EPC2269000 EPY0000364 EPY0000205 EPY0000241 EPY0000559 EPY0000570 EPY0000571
Cladribine for peak identification Cladribine impurity C 2-chloro-7H-purin-6-amine Clarithromycin Clarithromycin for peak identification Clazuril Clazuril for system suitability Clebopride malate Clemastine fumarate Clenbuterol hydrochloride Clenbuterol impurity B 1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino]ethanone (clenbuterol ketone) Clindamycin hydrochloride Clindamycin phosphate Clioquinol Clobazam - Reference Spectrum Clobazam impurity A 7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione Clobetasol propionate Clobetasol for peak identification Clobetasol impurity J (17R)-4'-chloro-5'-ethyl-9-fluoro-11-hydroxy-16-methylspiro[androsta-1,4-diene17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound) Clobetasone butyrate Clobetasone butyrate for system suitability Clodronate disodium tetrahydrate Clodronate impurity D (chloromethylene)bis(phosphonic acid) Clofazimine Clofazimine for system suitability Clofibrate Clomifene citrate Clomifene citrate for performance test Clomipramine hydrochloride Clomipramine impurity C 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine Clomipramine impurity D 3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl) N,N-dimethylpropan-1-amine Clomipramine impurity F 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine Clonazepam Controlled Substance Clonazepam - Reference Spectrum Clonazepam impurity B 3-Amino-4-(2-chlorophenyl)-6-nitro-1H-quinolin-2-one Clonidine hydrochloride Clonidine impurity B 1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole Clopamide Clopamide for system suitability Clopidogrel hydrogen sulfate Clopidogrel for system suitability Clopidogrel impurity A (2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid Closantel sodium dihydrate
10 mg 5 mg 160 mg 40 mg 10 mg 10 mg 100 mg 100 mg 30 mg 10 mg 200 mg 250 mg 5 mg unit 10 mg 40 mg 2 mg 0.4 mg
EPC2285000 EPY0001137 EPY0000888 EPY0000885 EPY0000313 EPY0000358 EPC2300000 EPC2320000 EPC2332000 EPC2360000 EPY0000132 EPY0000133
50 mg 30 mg 5 mg 5 mg 150 mg 10 mg 0.5 mL 50 mg 50 mg 100 mg 10 mg 10 mg
EPY0000134 EPC2385000 EPY0000286 EPC2385015 EPC2400000 EPY0000801 EPY0000833 EPY0000848 EPY0001333 EPY0001334 EPY0001335 EPY0000392
5 mg 50 mg unit 5 mg 100 mg 20 mg 40 mg 10 mg 60 mg 100 mg 10 mg 20 mg
262
Edition 2012/2013
Code Product Unit
EPY0000393 EPC2424400 EPC2424550 EPC2424500 EPC2425600 EPC2430000 EPY0000818 EPY0000849 EPC2450000 EPC2460000 EPY0000758 New EPY0001472 EPY0000162 EPC2480000 EPY0000722 EPC2500000 EPY0000334
Closantel for system suitability Clostridia (multi-component) rabbit antiserum (for vaccines-vet.use) BRP Clostridium tetani guinea pig antiserum (for vaccines-human use) BRP Clostridium tetani guinea pig antiserum (for vaccines - vet.use) BRP Clostridium tetani rabbit antiserum (for vaccines - vet.use) BRP Clotrimazole Clotrimazole impurity E (2-chlorophenyl)phenylmethanone (2-chlorobenzophenone) Clotrimazole for peak identification Cloxacillin sodium Clozapine Clozapine for peak identification Coagulation Factors V, VIII, XI and XIII plasma Cocaine hydrochloride - Reference Spectrum Cocoyl caprylocaprate Codeine Controlled Substance Codeine - Reference Spectrum Codeine impurity A 7,8-didehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan (o-methylcodeine) Controlled Substance Codeine hydrochloride dihydrate - Reference Spectrum Codergocrine mesilate Colchicine Colchicine for system suitability Colestyramine Colistimethate sodium Colistin sulfate Colistin sulfate for microbiological assay Copovidone - Reference Spectrum Cortisone acetate Coumarin Cotton wool standard for neps Crospovidone Crotamiton Crotamiton impurity A N-ethyl-N-(2-methylphenyl)but-3-enamide Cyanidin chloride Cyanocobalamin Cyclizine hydrochloride Cyclizine impurity A 1-methylpiperazine Cyclizine impurity B diphenylmethanol (benzhydrol) Cyclobenzaprine hydrochloride Cyclopentolate hydrochloride Cyclopentolate for system suitability Cyclophosphamide Cyproheptadine hydrochloride Cyproheptadine impurity C 5-(1-methylpiperidin-4-yl)-5H-dibenzo[a,d][7]annulen-5-ol
20 mg 1 mg 3x1 mg 1 mg 1 mg 100 mg 15 mg 1 mg 200 mg 60 mg 0.41 mg 2x1 mg unit 40 mg 20 mg unit 10 mg
EPC2500100 EPC2510000 EPC2580000 EPY0000209 EPY0000374 EPC2600000 EPY0000277 EPC2700000 EPC2725000 EPC2800000 EPY0000438 EPC2900000 EPY0001053 EPC2970000 EPC2970005 EPY0001061 EPC3000000 EPC3090000 EPY0000886 EPY0000887 EPC3200000 EPC3245000 EPY0001088 EPC3250000 EPC3280000 EPY0001095
unit 60 mg 15 mg 10 mg 10 mg 20 mg 25 mg 25 mg unit 250 mg 80 mg 1000 mg 5 mg 100 mg 70 mg 20 mg 20 mg 50 mg 15 mg 10 mg 100 mg 2x50 mg 60 mg 50 mg 30 mg 5 mg
Edition 2012/2013
263
Code Product Unit
EPC3283000 EPY0001390 EPY0001223 EPC3290000 EPC3300000 EPC3350000 EPY0000733 EPY0000734 EPY0000735 EPD0070000 EPY0000600 EPD0100000 EPD0125000 EPD0120000 EPD0160000 EPD0201000 EPY0000611 EPD0300000 EPD0350000 EPY0000228 EPD0406200 EPD0430000 EPD0431000 EPY0001321 EPD0480000 EPY0000879 EPY0000807 EPD0500000 EPD0600000 EPD0630000 EPD0650000 EPY0000509 EPY0000510 EPD0400000 EPY0000001 EPD0660020 EPD0700000 EPY0001177 EPD0710000 EPY0001169 EPY0000538 EPY0000511 EPD0718000 EPD0720000 New EPY0001477 EPD0720800
Cyproterone acetate Cyproterone acetate for peak identification Cyproterone impurity mixture Cysteine hydrochloride monohydrate Cystine Cytarabine Dacarbazine Dacarbazine impurity A 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2-azahypoxanthine) Dacarbazine impurity B 5-amino-1H-imidazole-carboxamide Dalteparin sodium Danaparoid sodium Dapsone Daunorubicin hydrochloride Daunorubicinone Daunorubicin aglycone Deferoxamine mesilate Dehydrohexetidine 2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl]hexan-1-amine Dembrexine hydrochloride monohydrate Demeclocycline hydrochloride N-Demethylerythromycin A Demethylflumazenil - Reference Spectrum Deptropine citrate Dequalinium chloride Dequalinium chloride for performance test Dermatan sulfate and oversulfated chondroitin sulfate Desacetylvinblastine Desflurance - Reference Spectrum Desflurane impurity A 1,1'-oxybis(1,2,2,2-tetrafluoroethane) Desipramine hydrochloride Deslanoside Desmethylmetrifonate Desmopressin Desogestrel Desogestrel for system suitability Desoxycortone acetate Detomidine hydrochloride Detomidine impurity B (RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol Dexamethasone Dexamethasone for system suitability Dexamethasone acetate Dexamethasone acetate impurity E 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl acetate Dexamethasone isonicotinate Dexamethasone isonicotinate for impurity C identification Dexamethasone pivalate Dexamethasone sodium phosphate Dexamethasone sodium phosphate for peak identification Dexchlorpheniramine maleate
30 mg 5 mg 0.01 mg 50 mg 100 mg 150 mg 20 mg 20 mg 10 mg 250 mg 10 mg 100 mg 100 mg 10 mg 30 mg 50 mg 10 mg 100 mg 10 mg unit 60 mg 50 mg 50 mg 1 mL 2x1 mg unit 1 mL 100 mg 150 mg 30 mg 0.98 mg 50 mg 10 mg 100 mg 100 mg 20 mg 50 mg 10 mg 100 mg 0.013 mg 10 mg 10 mg 50 mg 100 mg 10 mg 60 mg
264
Edition 2012/2013
Code Product Unit
EPD0730000 EPD0731000 EPD0731005 EPD0732000 EPD0733000 EPD0734000 EPD0735000 EPD0736000 EPD0737000 EPD0738000 EPD0739000 EPY0000744 EPD0740000 EPY0000261 EPY0001058 EPY0001150 EPD0940000 EPY0000596 EPD0950000 EPD0970000 EPD1000000 EPY0000480 EPY0000481 EPD1010000 EPY0000275 EPY0000259 EPY0000264 EPD1039990 EPS0765000 EPD1040000 EPD1050000 EPD1060000 EPY0000439 EPY0000440 EPY0000441 EPY0000442
Dexpanthenol Dextran Dextran 1 Dextran Vo Dextran 4 for calibration Dextran 10 for calibration Dextran 40 for calibration Dextran 70 for calibration Dextran 250 for calibration Dextran 40 for performance test Dextran 60/70 for performance test Dextranomer Dextromethorphan hydrobromide Dextromethorphan impurity A ent-3-methoxymorphinan Dextropropoxyphene hydrochloride Controlled Substance Dextropropoxyphene for system suitability Controlled Substance Diazepam Controlled Substance Diazepam for system suitability Controlled Substance Diazoxide Dibenzocycloheptene Dibenzosuberone Dibrompropamidine diisetionate Dibrompropamidine for system suitability Dibutyl phthalate Dichlorodiaminocyclohexaneplatinum Diclazuril for system suitability Diclazuril for veterinary use - Reference Spectrum Diclofenac potassium Diclofenac sodium Diclofenac impurity A 1-(2,6-dichlorophenyl)-indolin-2-one Dicloxacillin sodium Dicycloverine hydrochloride Didanosine Didanosine for system suitability Didanosine impurity A 1,7-dihydro-6H-purin-6-one (hypoxanthine) Didanosine impurity G 9-(2,3-dideoxy--D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'-dideoxyadenosine) Dienestrol Diethanolamine fusidate Diethylcarbamazine citrate Diethylene glycol (monoethyl ether) - Reference Spectrum Diethyl phthalate Diethylstilbestrol Diethylstilbestrol dimethyl ether Diethylstilbestrol monomethyl ether Difloxacin hydrochloride Difloxacin impurity G 7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Diflunisal
5 mg 25 mg 50 mg 10 mg 50 mg 50 mg 50 mg 50 mg 50 mg 50 mg 50 mg 50 mg 100 mg 5 mg 10 mg 5 mg 30 mg 0.5 mg 50 mg 20 mg 100 mg 10 mg 20 mg 1 mL 10 mg 20 mg unit 100 mg 100 mg 0.005 mg 250 mg 100 mg 10 mg 10 mg 10 mg 10 mg
EPD1200000 EPD1250000 EPD1300000 EPY0000217 EPD1410000 EPD1500000 EPD1600000 EPD1700000 New EPY0001423 New EPY0001429 EPD1750000
Edition 2012/2013
150 mg 50 mg 250 mg unit 1 mL 100 mg 10 mg 10 mg 60 mg 15 mg 30 mg

265
Code Product Unit
EPD1800000 EPY0000640 EPD1900000 EPY0000554 EPD1940001 EPY0000232 EPY0000216 EPY0000053 EPD1945000 EPD1950000 EPY0000831 EPD1952000 EPD1954000 EPY0000544 EPY0000482 EPD1980000 New EPY0001439
Digitoxin Digoxigenin Digoxin Digoxin for peak identification Dihydralazine sulphate (hydrated) - Reference Spectrum Dihydralazine for system suitability Dihydrocodeine hydrogen tartrate - Reference Spectrum 17 alpha-dihydroequilin Dihydroergocristine mesilate Dihydroergotamine mesilate Dihydroergotamine for peak identification Dihydroergotamine tartrate Dihydrostreptomycin sulfate (for LC assay) Dihydrotachysterol Dihydrotachysterol for system suitability Diltiazem hydrochloride Diltiazem impurity F (2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5benzothiazepin-4(5H)-one Diltiazem for system suitability Dimenhydrinate N,N-Dimethylacetamide - Reference Spectrum Dimenhydrinate for peak identification Dimethyl sulfoxide Dimeticone Dimetindene maleate Dinoprost trometamol Dinoprostone Dinoprostone impurity C (E)-7-[(1S,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]5-oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE2;(5E)-PGE2) Diosmin Diosmin for system suitability Diphenhydramine hydrochloride Diphenhydramine impurity A 2-(diphenylmethoxy)-N-methylethanamine Diphenoxylate hydrochloride - Reference Spectrum Diphenoxylate hydrochloride Controlled Substance Diphenoxylate for system suitability Controlled Substance Diphtheria toxin BRP Diphtheria vaccine (absorbed) BRP Dipivefrine hydrochloride Dipivefrine for system suitability Dipotassium clorazepate - Reference Spectrum Diprophylline Dipyridamole Dipyridamole for peak identification Dirithromycin Disodium edetate Disopyramide Disopyramide phosphate Disulfiram
200 mg 5 mg 30 mg 10 mg unit 10 mg unit 10 mg 250 mg 100 mg 10 mg 150 mg 25 mg 30 mg 5 mg 300 mg 10 mg
EPY0001141 EPD2000000 EPY0000234 EPY0001103 EPD2050000 EPD2200000 EPD2205000 EPD2255000 EPD2250000 EPD2250015
10 mg 100 mg unit 1 mg 1 mL 200 mg 50 mg 60 mg 100 mg 10 mg
EPY0000094 EPY0000095 EPD2600000 EPY0000135 EPD2630000 New EPY0001415 New EPY0001430 EPY0000258 EPD2700000 EPY0000376 EPY0000394 EPD2750100 EPD2800000 EPD2850000 EPY0000802 EPD2880000 EPD2900000 EPD2920000 EPD2922000 EPD2950000
70 mg 5 mg 100 mg 10 mg unit 15 mg 10 mg 1 mL 32 mg 100 mg 10 mg unit 100 mg 50 mg 2 mg 100 mg 100 mg 100 mg 100 mg 100 mg
266
Edition 2012/2013
Code Product Unit
EPD2953000 EPD2953025 EPD2953050 EPD2954000 EPY0001239 New EPY0001452
Dithranol Dithranol impurity C Dithranol-dimer 4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione Dithranol impurity D 1-hydroxyanthracen-9(10H)-one Dobutamine hydrochloride Dobutamine impurity mixture Docetaxel impurity E 5,20-epoxy-4-(acetyloxy)-1,7,10,13-tetrahydroxy-9-oxotax-11-en-2-yl benzoate (10-desacetyl-baccatin III) Docetaxel trihydrate Docetaxel for system suitability Anhydrous Docetaxel Docosahexaenoic acid ethyl ester Docusate sodium - Reference Spectrum Dodecyl gallate Domperidone Domperidone maleate Dopamine hydrochloride Dopexamine dihydrochloride Dopexamine impurity B 2-methoxy-4-[2-[[6-[(2-phenylethyl)hexyl]amino]ethyl]phenol Dopexamine impurity F 4-Chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol Dorzolamide hydrochloride Dorzolamide impurity A (4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b] thiopyran-2-sulphonamide 7,7-dioxide Dorzolamide for system suitability Dosulepin hydrochloride Dosulepin impurity A (E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)N,N'-dimethylpropan-1-amine S-oxide Doubleteeth pubescent angelica root Doxapram hydrochloride Doxapram impurity B (4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one Doxazosin mesilate Doxazosin impurity D 6,7-dimethoxyquinazoline-2,4(1H,3H)-dione Doxazosin impurity F 2-chloro-6,7-dimethoxyquinazolin-4-amine Doxepin hydrochloride Doxepin for system suitability Doxorubicin hydrochloride Doxycycline hyclate Doxylamine hydrogen succinate - Reference Spectrum Doxylamine impurity A N,N-dimethyl-2-[1(RS)-1-phenyl-1-(pyridin-4-yl)ethoxy]ethanamine Droperidol Drospirenone Drospirenone impurity E 3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa [6,7:15,16]pregn-4-ene-21,17-carbolactone (17-epidrospirenone) Duloxetine hydrochloride Duloxetine for system suitability
55 mg 20 mg 20 mg 100 mg 0.1 mg 15 mg
EPY0001133 EPY0001155 New EPY0001466 EPD2954600 EPD2954500 EPY0000365 EPD2955000 EPD2957000 EPD2960000 EPY0000612 EPY0000613 EPY0000614 EPY0000726 EPY0000727
160 mg 10 mg 15 mg 150 mg unit 30 mg 150 mg 150 mg 50 mg 10 mg 10 mg 10 mg 50 mg 5 mg
EPY0000750 EPD2962000 EPD2962005
5 mg 100 mg 50 mg
EPY0001385 EPD2963000 EPY0000208 EPY0000553 EPY0000551 EPY0000552 EPY0000838 EPY0000851 EPD2975000 EPD3000000 EPY0000163 EPY0000160 EPD3100000 EPY0001105 EPY0001115
500 mg 50 mg 10 mg 60 mg 10 mg 10 mg 5 mg 1 mg 150 mg 50 mg unit 10 mg 150 mg 60 mg 0.06 mg
New EPY0001453 New EPY0001454

Edition 2012/2013
120 mg 40 mg
267
Code Product Unit
EPY0001455 EPY0001004 EPY0001005 EPY0001006 EPY0000249 EPY0000247 EPY0000248 EPY0001236 EPY0000254 EPE0050000 EPE0085000 EPY0000537 EPY0000512 EPE0100000 EPE0110000 EPE0109000 EPY0001211 EPY0000615 EPY0000629 EPY0000678
Duloxetine impurity A (3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine Dydrogesterone Dydrogesterone impurity A 9,10-pregna-4,6,8(14)-triene-3,20-dione Dydrogesterone impurity B pregna-4,6-diene-3,20-dione Ebastine - Reference Spectrum Ebastine impurity C 4-(diphenylmethoxy)piperidine Ebastine impurity D 1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one Econazole Econazole for system suitability Econazole nitrate Eicosapentaenoic acid ethyl ester Emedastine difumarate Emedastine impurity E 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole Emetine hydrochloride Enalapril for system suitability Enalapril maleate Enalapril impurity mixture Enalaprilat dihydrate Enalaprilat for system suitability Enalaprilat impurity G (2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo [1,2-a]pyrazin-2(1H)-4-phenylbutanoic acid Enilconazole Enilconazole impurity E (1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol Endotoxin standard BRP Enoxaparin sodium Enoxolone Enrofloxacin Enrofloxacin for system suitability Entacapone Entacapone impurity A Z isomer of entacapone Enterokinase BRP Ephedrine hydrochloride (racemic) Drug Precursor Ephedrine hydrochloride Drug Precursor 4-Epianhydrotetracycline hydrochloride 4-Epidemeclocycline hydrochloride 6-Epidoxycycline hydrochloride Epinastine hydrochloride Epinastine hydrochloride for system suitability 4-Epioxytetracycline Epirubicin hydrochloride 4-Epitetracycline hydrochloride Equilin Eq influenza Subtype 1 Strain A/eq/Newmarket/77 Horse Antiserum BRP Eq influenza Subtype 2 American-like/Newmarket Horse Antiserum BRP Eq Influenza Subtype 2 European-like/Newmarket Horse Antiserum BRP
10 mg 50 mg 6 mg 5 mg unit 10 mg 10 mg 10 mg 20 mg 100 mg 200 mg 10 mg 10 mg 100 mg 20 mg 50 mg 0.06 mg 100 mg 10 mg 0.005 mg
EPY0000136 EPY0000137 EPE0150000 EPE0180000 EPE0180500 EPY0001259 EPY0001160 EPY0001249 EPY0001250 EPE0200000 EPE0305000 EPE0300000 EPE0400000 EPE0440000 EPE0500000 EPY0001139 EPY0001128 EPE0530000 EPE0550000 EPE0600000 EPY0000052 EPE0850010 EPE0850021 EPE0850022
60 mg 20 mg 10 mg 200 mg 100 mg 5 mg 10 mg 160 mg 10 mg 200 mg 50 mg 150 mg 20 mg 20 mg 50 mg 20 mg 10 mg 40 mg 100 mg 30 mg 15 mg 3x1 mg 3x1 mg 3x1 mg
268
Edition 2012/2013
Code Product Unit
EPY0000712 New EPY0001325 EPE0900000 EPE1000000 EPE1100000 EPE1200000 EPY0000051 EPY0000177 EPE1300000 EPE1305000 EPE1310000 EPE1320000 EPE1400000 EPE1500000 EPE1500800 EPE1515000 EPY0000324 EPY0000338 EPY0001028 EPY0000749 EPE1600000 EPY0000852 EPY0000045 EPE1620000 EPY0000314 EPY0000046 EPE1680000 EPE1680005 EPE1700000 EPE1800000 EPY0001263 EPE1830000 EPE1840000 EPE1850000 EPY0000803 EPA1202800 EPE1860100 EPE1900000 EPY0001124 EPE2000000 EPE2150000 EPE2250000 EPE2195000 EPE2195900 EPE2202000 EPE2205500 EPY0000617 EPE2300000 EPE2400000
Edition 2012/2013
Eq Influenza Subtype 2 American-like/South Africa Horse Antiserum BRP Equisetum palustre Ergocalciferol Ergometrine maleate Drug Precursor Ergosterol Ergotamine tartrate Drug Precursor Erysipelas ELISA coating antigen BRP Erythritol Erythromycin for microbiological assay Erythromycin A Erythromycin B Erythromycin C Erythromycin estolate Erythromycin ethylsuccinate Erythromycin stearate Erythropoietin BRP Esketamine hydrochloride - Reference Spectrum Esketamine impurity D (2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine) Esomeprazole magnesium trihydrate Essential oil Estradiol benzoate Estradiol benzoate for system suitability Estradiol butyrate Estradiol hemihydrate Estradiol for peak identification Estradiol valerate Estriol Estriol impurity A 9,11-didehydroestriol Estrone Etacrynic acid Etacrynic acid for system suitability Etamsylate Ethacridine lactate monohydrate Ethambutol hydrochloride Ethambutol for system suitability Ethanol (anhydrous) - Reference Spectrum Ethanol 96% - Reference Spectrum Ethinylestradiol Ethinylestradiol for system suitability Ethionamide Ethosuximide Ethosuximide impurity A (2RS)-2-ethyl-2-methylbutanedioic acid Ethyl acetate - Reference Spectrum Ethylcellulose - Reference Spectrum 1-N-Ethylgaramin sulfate 1,1'-Ethylidenebistryptophan Ethyl indole-3-carboxylate Ethylmorphine hydrochloride - Reference Spectrum Ethylnicotinamide
3x1 mg 200 mg 500 mg 50 mg 20 mg 100 mg 0.4 mg 1000 mg 250 mg 250 mg 50 mg 50 mg 100 mg 10 mg 50 mg 37.5 mg unit 10 mg 10 mg 1000 mg 250 mg 10 mg 10 mg 100 mg 10 mg 50 mg 50 mg 20 mg 15 mg 100 mg 10 mg 30 mg 50 mg 250 mg 10 mg unit unit 200 mg 25.31 mg 100 mg 30 mg 30 mg unit unit 50 mg 2x0.00167 mg 10 mg unit 150 mg
269
Code Product Unit
EPE2425000 EPE2450000 EPE2451000 EPE2451010 EPY0000572 EPE2470000 EPE2470050 EPY0000768 EPE2499900 EPE2499901 EPE2499914 EPE2500000 EPE2503000 EPE2503004 EPE2600000 EPY0001365 EPE5000000 EPF0005000 EPY0000382 EPY0000409 EPY0000556 EPY0000660 EPY0000731 EPY0000732 EPF0030000 EPY0000415 EPF0040000 EPF0040010 EPF0040020 EPF0041000 EPF0048000 EPF0048005 EPF0048010 EPF0048035
Ethyl parahydroxybenzoate Etifenin Etilefrine hydrochloride Etilefrine impurity A 2-ethylamino-1-(3-hydroxyphenyl)ethanone Etidronate disodium Etodolac Etodolac impurity H 2-(7-ethylindol-3-yl)ethanol Etodolac for peak identification Etofenamate Etofenamate for peak identification Etofenamate impurity G 2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate Etofylline Etomidate Etomidate impurity B methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate Etoposide Etoposide for system suitability Eugenol Famotidine Famotidine for system suitability Famotidine impurity D 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide Febantel Febantel for system suitability Felbinac Felbinac impurity A 4-acetyl biphenyl Felodipine Felypressin Fenbendazole Fenbendazole impurity A methyl(1H-benzimidazol-2-yl)carbamate Fenbendazole impurity B methyl[5(6)-chlorobenzimidazol-2-yl]carbamate Fenbufen Fenofibrate Fenofibrate impurity A (4-chlorophenyl)(4-hydroxyphenyl)methanone Fenofibrate impurity B 2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid) Fenofibrate impurity G 1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl] oxy]-2-methylpropanoate Fenoterol for peak identification Fenoterol hydrobromide Fentanyl - Reference Spectrum Fentanyl for system suitability Controlled Substance Fentanyl citrate - Reference Spectrum Fenticonazole nitrate Fenticonazole impurity D (RS)-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3[4-(phenyl suphanyl)benzyl]imidazolium nitrate
150 mg 25 mg 75 mg 20 mg 10 mg 60 mg 10 mg 10 mg 40 mg 15 mg 20 mg 100 mg 50 mg 25 mg 150 mg 10 mg 500 L 100 mg 10 mg 10 mg 110 mg 10 mg 10 mg 20 mg 120 mg 0.994 mg 150 mg 20 mg 20 mg 100 mg 100 mg 20 mg 10 mg 25 mg
EPY0000756 EPF0050000 EPF0054990 New EPY0001509 EPF0055000 EPF0060000 EPF0060040
1.2 mg 100 mg unit 25 mg unit 50 mg 20 mg
270
Edition 2012/2013
Code Product Unit
EPF0100000 EPY0001013 EPY0000789 EPY0000751
Ferrous gluconate Ferulic acid Fexofenadine hydrochloride Fexofenadine impurity A 2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl] butanoyl]phenyl]-2-methylpropanoic acid Fexofenadine impurity B 2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]phenyl]-2methylpropanoic acid Fexofenadine impurity C (1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)phenyl]butan-1-ol Filgrastim Finasteride Finasteride for system suitability Flavoxate hydrochloride Flavoxate impurity A 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid Flavoxate impurity B ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate Flecainide acetate Flecainide impurity A 3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8ahexahydroimidazo[1,5-a]pyridine Flecainide impurity B (RS)-(piperidin-2-yl)methanamine Flecainide for system suitability Flubendazole Flubendazole for system suitability Flucloxacillin magnesium octahydrate Flucloxacillin impurity C 6-aminopenicillanic acid Flucloxacillin impurity D 3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid Flucloxacillin impurity E 6-aminopenicillanic acid flucloxacillin amide Flucloxacillin sodium Fluconazole Fluconazole for peak identification Fluconazole impurity B 2-[2-fluro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol Fluconazole impurity C 1,1-(1,3-phenylene)di-1H-1,2,4-triazole Flucytosine Flucytosine for system suitability Fludarabine phosphate Fludrocortisone acetate Flumazenil - Reference Spectrum Flumazenil impurity B ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo [1,5-a][1,4]benzodiazepine-3-carboxylate Flumequine Flumequine impurity B ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j] quinolizine-2-carboxylate Flumetasone pivalate Flunarizine dihydrochloride Flunarizine dihydrochloride - Reference Spectrum
100 mg 20 mg 60 mg 5 mg
EPY0000752
0.01 mg
EPY0000753 EPY0001173 EPY0000090 EPY0000091 EPY0000736 EPY0000737 EPY0000738 EPF0120000 EPF0120005
5 mg 0.2 mL 60 mg 100 mg 10 mg 10 mg 10 mg 200 mg 50 mg
EPF0120010 EPY0001274 EPY0000138 EPY0000139 EPY0000892 EPY0000889 EPY0000890 EPY0000891 EPF0150000 EPY0000557 EPY0000558 EPY0000573 EPY0000574 EPF0175000 EPY0001262 EPY0000419 EPF0180000 EPF0188000 EPY0000335
25 mg 10 mg 25 mg 20 mg 5 mg 5 mg 5 mg 5 mg 250 mg 50 mg 10 mg 10 mg 5 mg 100 mg 10 mg 120 mg 100 mg unit 5 mg
EPF0189000 EPF0189020
60 mg 0.1 mg
EPF0188500 EPF0189900 EPY0000265

Edition 2012/2013
100 mg 100 mg unit

271
Code Product Unit
EPY0000266 EPF0190000 EPY0000169 EPY0000443 EPY0000444 EPY0000445 EPF0200000 EPF0230000 EPY0000796 EPY0000804 EPY0000454 EPF0245000 EPF0250000 EPY0000762 EPY0000763 EPY0000764 EPY0000765 EPY0000791 EPF0253000 EPF0253020 EPF0253030 EPY0000064 EPY0000067
Flunarizine dihydrochloride for system suitability Flunitrazepam Controlled Substance Flunitrazepam - Reference Spectrum Flunixin meglumine Flunixin impurity B 2-methyl-3-(trifluoromethyl)aniline Flunixin impurity C ethyl 2-chloropyridine-3-carboxylate Fluocinolone acetonide Fluocortolone pivalate Fluorescein Fluorescein impurity C 2-(2,4-dihydroxybenzoyl)benzoic acid Diacetylfluorescein Fluoresceine sodium - Reference Spectrum Fluorouracil Fluorouracil impurity A pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) Fluorouracil impurity B dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil) Fluorouracil impurity C pyrimidine-2,4(1H,3H)-dione (uracil) Fluorouracil impurity F 2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil) Fluorouracil impurity mixture Fluoxetine hydrochloride Fluoxetine impurity B methyl(3-phenylpropyl)amine Controlled Substance Fluoxetine impurity C (RS)-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl]amine Flupentixol dihydrochloride Flupentixol impurity D 2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl] piperazin-1-yl]ethoxy]ethanol Flupentixol impurity F 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9H-thioxanthen-9-yl)prop-2-enyl]piperazin-1-yl]ethanol Fluphenazine decanoate Fluphenazine enantate Fluphenazine dihydrochloride Fluphenazine impurity mixture Fluphenazine octanoate Fluphenazine sulphoxide Flurazepam monohydrochloride - Reference Spectrum Flurbiprofen Flurbiprofen impurity A (2RS)-2-(biphenyl-4-yl)propanoic acid Fluspirilene Fluspirilene impurity C 8-[4,4-bis((4-fluorophenyl)butyl]-3-(hydroxymethyl)-1phenyl-1,3,8-triazaspiro[4.5]decan-4-one Flutamide Flutamide impurity C N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide Fluticasone propionate
20 mg 100 mg unit 10 mg 10 mg 50 mg 100 mg 100 mg 120 mg 0.01 mg 100 mg unit 40 mg 10 mg 10 mg 10 mg 10 mg 0.0002 mg 250 mg 10 mg 5 mg 100 mg 15 mg
EPY0000078
25 mg
EPF0260000 EPY0000009 EPF0280000 EPY0000708 EPY0000298 EPY0000299 EPY0000211 EPF0285200 EPF0285202 EPY0000236 EPY0000375
60 mg 100 mg 50 mg 0.07 mg 20 mg 10 mg unit 50 mg 20 mg 20 mg 10 mg
EPF0285600 EPF0285603 EPY0000284
50 mg 20 mg 100 mg
272
Edition 2012/2013
Code Product Unit
EPY0000221
Fluticasone impurity D S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17a-propionyloxy-androsta1,4-diene-17-carbothioate (S-methyl derivative) Flutrimazole Flutrimazole impurity B (RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol Fluvastatin sodium Fluvastatin for system suitability Fluvoxamine maleate Fluvoxamine for system suitability Fluvoxamine impurity D 5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one Foeniculin for peak identification Anise oil Folic acid Folic acid impurity A (2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-l-glutamic acid) Folic acid impurity D 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid (pteroic acid) Formoterol fumarate dihydrate Formoterol for impurity I identification Formoterol fumarate for system suitability Formylfolic acid 10-Formylfolic acid Foscarnet sodium hexahydrate Foscarnet impurity B disodium(ethoxyoxydophosphanyl)formate Foscarnet impurity D Ethyl (diethoxyphosphinyl)formate Foscarnet impurity mixture Fosfomycin calcium Fosfomycin sodium - Reference Spectrum Fosfomycin trometamol Fosinopril sodium Fosinopril impurity A (2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl] acetyl]pyrrolidine-2-carboxylic acid Fosinopril impurity B (2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid Fosinopril impurity C mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and (2S,4S)-4-cyclohexyl-1-[[(R)[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2carboxylic acid Fosinopril impurity D (2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl1-(1-oxopropoxy)propoxy](4-phenylbutyl) phosphoryl]acetyl]pyrrolidine-2-carboxylic acid Fosinopril impurity I [(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl) phosphoryl]acetic acid Fosinopril impurity K (2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl) pyrrolidine-2-carboxylic acid Fosinopril impurity mixture Framycetin sulphate Fructose
20 mg
EPF0290000 EPF0290010 EPY0001090 EPY0001082 EPY0000854 EPY0000853 EPY0000916 EPY0000386 EPF0300000 EPY0001242
100 mg 60 mg 110 mg 0.5 mg 5 mg 1.004 mg 10 mg 100 mg 2x150mg 15 mg
EPY0001243 EPF0372000 EPY0000339 EPY0000340 EPF0380000 EPF0389000 EPF0389004 EPY0001222 EPY0001213 EPY0000782 EPF0399950 EPF0400000 EPY0001227 EPY0001228
70 mg 10 mg 10 mg 10 mg 30 mg 50 mg 10 mg 50 mg 0.012 mg 10 mg unit 1500 mg 60 mg 5 mg
EPY0001229
5 mg
EPY0001230
10 mg
EPY0001231
10 mg
EPY0001232
5 mg
EPY0001233
5 mg
EPY0001212 EPF0450000 EPF0550000
0.02 mg 2x25 mg 100 mg
Edition 2012/2013
273
Code Product Unit
New EPY0001399 New EPY0001413 EPF0600000 EPF0700000 New EPY0001493 EPF0702000 New EPY0001411 EPF1000000 New EPY0001394 New EPY0001384 EPY0001280 EPY0001281 EPY0001348 EPY0001349 EPG0049000 EPG0050000 EPY0001279 EPY0001190 EPY0001201 EPY0001191 EPG0100000 EPG0150000 EPY0001129 EPY0001144 EPY0000675 EPY0000676 EPY0000513 EPY0000514 EPG0200000 EPY0001363 EPY0001112 EPY0001110 EPY0001116 EPY0001012 EPY0001010 EPG0300000 EPG0325000 New EPY0001511 EPG0325010 EPY0000242 EPG0326000 EPG0326004 EPG0326012 EPY0000515
Fulvestrant Fulvestrant for system sitability Fumaric acid Furosemide Furosemide for peak identification Furosemide impurity A 2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid Fusidic acid Fusidic acid - Reference Spectrum Fusidic acid for peak identification Fusidic acid impurity mixture Gabapentin Gabapentin impurity A 2-azaspiro[4.5]decan-3-one Gabapentin impurity B (1-cyanocyclohexyl)acetic acid Gabapentin impurity D [1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid Galactitol Galactose Galantamine hydrobromide Galantamine natural for system suitability Galantamine racemic mixture Galantamine synthetic for system suitability Gallamine triethiodide Gammacyclodextrin Ganciclovir Ganciclovir impurity mixture Gemcitabine hydrochloride Gemcitabine impurity A 4-aminopyrimidin-2(1H)-one (Cytosine) Gemfibrozil Gemfibrozil for system suitability Gentamicin sulphate Gentamicin for peak identification Gestodene Gestodene for system suitability Gestodene impurity I 13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-20-yn-3-one Ginkgo dry extract for peak identification Ginkgolic Acid Gitoxin Glibenclamide Glibenclamide for peak identification Glibenclamide impurity A 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulphonamide Glibenclamide impurity B methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl] sulphonyl]carbamate Gliclazide Gliclazide impurity B 2-nitroso-octahydrocyclopenta[c]pyrrole Gliclazide impurity F 1-(hexahydrocyclopenta[c]pyrrol-2-(1H)-yl-3-[(2-methylphenyl)sulphonyl]urea Glimepiride
120 mg 40 mg 120 mg 100 mg 10 mg 5 mg 10 mg unit 5 mg 0.0475 mg 300 mg 20 mg 20 mg 10 mg 50 mg 60 mg 10 mg 10 mg 10 mg 5 mg 100 mg 50 mg 220 mg 0.005 mg 50 mg 20 mg 5 mg 0.196 mg 2x25 mg 10 mg 100 mg 10 mg 0.01 mg 150 mg 20 mg 30 mg 100 mg 30 mg 10 mg 20 mg 20 mg 25 mg 50 mg 60 mg
274
Edition 2012/2013
Code Product Unit
EPY0000516 EPG0340000 EPG0342000 EPY0000523 EPY0000643 EPY0001140 EPY0000191 New EPY0001406 New EPY0001381 New EPY0001407 EPG0350500 EPG0355000 EPY0000517 EPG0360000 EPG0400000 EPG0400004 New EPY0001391 EPY0000794 EPY0000795 EPG0400006 EPG0400007 EPG0400008 EPG0400101 EPG0400100 EPG0450000 EPY0001308 EPY0001309 EPY0001358 EPY0000433 EPG0460000 EPG0525000 EPY0000125 EPY0000126 New EPY0001473 EPY0000019 EPY0000194 EPG0550000 EPY0000396 EPY0000477
Glimepiride for system suitability Glipizide Glipizide impurity A 4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide Glipizide impurity C ethyl 2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl]carbamate Glipizide impurity D 6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide Glipizide impurity mixture Human glucagon Glucosamine hydrochloride Glucosamine for system suitability Glucosamine sulfate sodium chloride Glucose Glutamic acid Glutathione Glutethimide Controlled Substance Glycerol (85 per cent) - Reference Spectrum Glycerol distearate Glycerol formal Glycerol monocaprylate Glycerol monocaprylocaprate Glycerol monolinoleate Glycerol mono-oleate Glycerol monostearate 40-55 Glyceryl trinitrate - Reference Spectrum Glyceryl trinitrate solution Glycine Glycopyrronium bromide Glycopyrronium for peak identification Glycopyrronium impurity N (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium Ammonium glycyrrhizate Glycyrrhizate (monoammonium) Gonadorelin Goserelin Gosereline - Reference Spectrum Goserelin for NMR identification 4-D-Ser-goserelin Goserelin validation mixture Gramicidin Granisetron hydrochloride Granisetron impurity A 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1] non-3-yl]-2H-indazole-3-carboxamide Granisetron impurity B N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide Granisetron impurity E (1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine Griseofulvin Guaiacol Guaifenesin Halofantrine hydrochloride
0.012 mg 50 mg 10 mg 10 mg 10 mg 0.002 mg 2x2.94mg 10 mg 40 mg 15 mg 100 mg 50 mg 10 mg 50 mg unit 2000 mg 2x20 mg 400 mg 500 mg 2000 mg 2000 mg 2000 mg unit 0.5 mL 50 mg 10 mg 10 mg 10 mg 70 mg 300 mg 5 mg 2 mg unit 14 mg 0.1 mg 1 mg 250 mg 120 mg 1 mg
EPY0000478 EPY0000395 EPG0600000 EPY0000619 EPG0700000 EPY0000117
1 mg 2x15 mg 50 mg 2200 mg 100 mg 125 mg
Edition 2012/2013
275
Code Product Unit
EPY0000118 EPH0100000 New EPY0001517 New EPY0001518 EPH0100100 EPH0150000 EPY0000673 EPY0001287 EPY0001282 EPH0185000 EPH0190000 EPH0200000 EPY0001283 EPH0205010 EPY0001192 EPY0000389 EPH0210010 EPH0215000 EPH0220000 EPY0000063 EPY0000057 EPH0250000 EPH0330000 EPH0325000 EPH0400000 EPH0420000 EPH0500000 EPH0600000 EPH0700000 EPH0750000 EPH0755000 EPH0800000 EPH0830000 New EPY0001383 EPH0837000 EPH0900000 EPY0000219 EPY0000667 EPH0920000 EPH0920500 EPH0950000 EPH0990000 EPH1000000 EPY0000488 EPH1005000 EPH1100000 EPH1110000 EPY0000502 EPH1115000
Halofantrine impurity C [1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol Haloperidol Haloperidol for system suitability Haloperidol for peak identification Haloperidol decanoate Halothane - Reference Spectrum Harpagoside Heparin calcium for NMR identification Heparin for Physio-Chemical Analysis Heparin Low-Molecular-Mass for assay BRP Heparin Low-Molecular-Mass for calibration CRS Heparin sodium BRP Heparin sodium for NMR identification Hepatitis A vaccine (inactivated,absorbed) Type B BRP Hepatitis A Vaccine (Inactivated, Non-Adsorbed) Hepatitis B vaccine (rDNA) BRP method A (thiomersal free) Hepatitis B vaccine (rDNA) BRP method B Hepatitis C Virus RNA for NAT testing BRP Heptadecanol Heptaminol hydrochloride Heptaminol impurity A (2RS)-6-methylhept-5-en-2-amine alpha-Hexachlorocyclohexane Hexamidine diisetionate Hexetidine Hexobarbital Hexylresorcinol Hide Powder Histamine dihydrochloride Histamine phosphate Histidine Histidine hydrochloride monohydrate Homatropine hydrobromide Homatropine methylbromide Homatropine methylbromide for system suitability L-Homocycsteine thiolactone hydrochloride - Reference Spectrum Human albumin for electrophoresis BRP Human anti-D immunoglobulin BPR Human coagulation factor VII concentrate BRP Human coagulation factor VIII concentrate BRP Human coagulation factor IX concentrate BRP Human hepatisis A immunoglobulin BRP Human immunoglobulin BRP Human immunoglobulin for electrophoresis BRP Human immunoglobulin (molecular size) BRP Human Plasma Pools for NAT Validation Human rabies immunoglobulin BRP Human tetanus immunoglobulin BRP Human vaccinia immunoglobulin Hyaluronidase BRP
10 mg 50 mg 25 mg 25 mg 60 mg unit 1.03 mg 30 mg 300 mg 5x1 mg 25 mg 2 mL 30 mg 3x0.5 mL 3x0.8 mL 2x0.5 mL 2x1 mL 5x40 mg 2x600 mg 150 mg 20 mg 10 mg 50 mg 100 mg 500 mg 100 mg 500 mg 250 mg 250 mg 100 mg 100 mg 100 mg 25 mg 5 mg unit 1 mL unit 2x26 mg 5x37 mg 5x30 mg 3x10 mg 15800 mg 96 mg 3x700 mg 3502 mg 3x170 mg 87 mg 3x1 mL 50 mg
276
Edition 2012/2013
Code Product Unit
EPH1120000 EPY0001151 EPH1200000 New EPY0001494 EPY0000646 EPY0000710 EPH1300000 EPY0001092 EPH1400000 New EPY0001482 EPH1425000 EPH1426000 EPY0000446 EPB0650000 EPH1428000 EPY0000119 EPH1429400 EPY0001322 EPY0001277 EPH1429700 EPH1430000 EPY0000186 EPH1435000 EPY0000011 EPY0000012 EPY0000013 EPY0000483 EPY0000484
Hydralazine hydrochloride Hydrastine hyrochloride Hydrochlorothiazide Hydrochlorothiazide for peak identification Hydrocodone hydrogen tartrate 2.5-hydrate Controlled Substance Hydrocodone for peak identification Controlled Substance Hydrocortisone Hydrocortisone for peak identification Hydrocortisone acetate Hydrocortisone acetate for peak identification Hydrocortisone hydrogen succinate Hydrogenated wool fat Hydromorphone hydrochloride Controlled Substance Hydrous benzoyl peroxide - Reference Spectrum Hydroxocobalamin Hydroxycarbamide Hydroxyethyl salicylate Hydroxyethyl starch (high Mw) Hydroxyethyl starch (medium MW) 4-Hydroxyphenoxymethylpenicillin potassium D-alpha-(4-Hydroxy-phenyl)glycine (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A Hydroxypropylbetadex Hydroxyzine hydrochloride Hymecromone Hymecromone impurity A Resorcinol Hymecromone impurity B 7-hydroxy-2-methyl-4H-1-benzopyran-4-one Hyoscine Hyoscine impurity A (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2phenylpropanoate (norhyoscine) Hyoscine butylbromide Hyoscine butylbromide impurity E (1R,2R,4S,5S,7S)-9-butyl-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-3-oxa9-azoni atricyclo[3.3.1.02,4]nonane Hyoscine hydrobromide Hyoscine hydrobromide impurity B (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl(2S)3-hydroxy-2-phenylpropanoate Hyoscyamine sulfate Hyoscyamine impurity E (1R,3s,5S)-8-azabicyclo[3.2.1] oct-3-yl(2S)-3-hydroxy-2-phenylpropanoate Hypromellose phthalate Ibuprofen Ibuprofen impurity B (2RS)-2-(4-Butylphenyl)propionic acid (0,06% solution in Acetonitrile) Ibuprofen impurity F 3-[4-(2-methylpropyl)phenyl]propanoic acid Ibuprofen for peak identification Idoxuridine Ifosfamide Ifosfamide - Reference Spectrum
20 mg 20 mg 160 mg 10 mg 10 mg 10 mg 100 mg 5 mg 125 mg 15 mg 100 mg 250 mg 10 mg unit 10 mg 175 mg 125 mg 800 mg 1200 mg 20 mg 50 mg 10 mg 600 mg 100 mg 25 mg 25 mg 10 mg 10 mg
EPH1450000 EPY0000447
20 mg 10 mg
EPH1500000 EPY0000448
50 mg 10 mg
EPH1600000 EPY0000449 EPY0000915 EPI0020000 EPB1220000 EPY0000140 EPY0000881 EPI0050000 EPI0060000 EPI0060100
100 mg 10 mg 10 mg 250 mg 1.15 mL 5 mg 0.09 mg 50 mg 50 mg unit
Edition 2012/2013
277
Code Product Unit
EPI0060002 EPI0060004 EPI0060010 EPI0060012 EPI0086000 EPI0090000 EPI0100000 EPY0000893 EPY0001153 EPY0000540 EPY0001205 EPI0150000 EPI0150020 EPY0000788 EPY0000880 EPY0000746 EPI0200000 EPY0000349 EPI0305000 EPI0310000 EPY0000348 EPI0320000 EPI0320300 EPI0320301 EPY0001101 EPI0320330 EPI0320331 EPI0328000 EPY0000839 EPY0001294 EPY0001292
Ifosfamide impurity A 3-[(2-chloroethyl)amino]propyl dihydrogen phosphate Ifosfamide impurity B bis[3-[(2-chloroethyl)amino]propyl]dihydrogen diphosphate Ifosfamide impurity E 3-chloro-N-(2-chloroethyl)propan-1-amine Ifosfamide impurity F (RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide Imidazole Imipenem Imipramine hydrochloride Imipramine for system suitability Immunoglobulin for anti-A, anti-B antibodies limit test Immunoglobulin panel for anti-D antibodies test BRP Imperatorin Indapamide Indapamide impurity B 4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulphamoylbenzamide Indinavir Indinavir sulfate - Reference Spectrum Indinavir for system suitability Indometacin Insulin aspart Insulin (bovine) Insulin (human) Insulin lispro Insulin (porcine) Interferon alfa-2a Interferon alfa-2b Interferon beta-1a Interferon gamma 1b Interferon gamma-1b validation solution Iobenguane sulfate Iobenguane sulphate - Reference Spectrum Iodixanol Iodixanol impurity C 5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Iodixanol impurity E 5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide Iodixanol impurity H 5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]carbamoyl]-5-[(2,3dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Iohexol Iohexol impurity A 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3- dicarboxamide Iohexol impurity J 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3-dicarboxamide Iohexol for peak identification Iopamidol Iopamidol impurity A N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethy]-5-amino-2,4,6-tri-iodoisophthalamide
2x100 mg 20 mg 2x10 mg 10 mg 100 mg 100 mg 50 mg 10 mg 45 mg unit 20 mg 150 mg 5 mg 100 mg unit 20 mg 50 mg 8 mg 7.99 mg 8 mg 5.93 mg 8.61mg 1 mL 200 L 0.5 mL 2x0.5 mL 0.2 mL 25 mg unit 60 mg 10 mg
EPY0001291
10 mg
EPY0001293
10 mg
EPI0320800 EPI0320810 EPI0320820 EPY0000672 EPI0329000 EPI0329010
150 mg 50 mg 125 mg 10 mg 50 mg 10 mg
278
Edition 2012/2013
Code Product Unit
EPY0000406
Iopamidol impurity H 4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5(2-hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide Iopanoic acid Iopentol Iopromide Iopromide impurity A 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3- dicarboxamide Iopromide for system suitability 1 Iopromide for system suitability 2 Iotalamic acid Iotalamic acid impurity A 5-Amino-2,4,6-tri-iodo-N-methylisophthalamic acid Iotrolan Iotrolan for system suitability Ioxaglic acid Ioxaglic acid impurity A 3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid Ipratropium bromide Ipratropium impurity A (1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane Ipratropium bromide impurity B (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8azoniabicyclo[3.2.1]octane Irbesartan Irbesartan impurity A 1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide Isoconazole Isoconazole nitrate Isoemetine hydrobromide Isoflurane Isoflurane - Reference Spectrum Isoleucine Isomalt Isomaltooligosaccharide Isoniazid Isoprenaline hydrochloride Isoprenaline sulfate Isopropyl hexadecanoate Isopropyl tetradecanoate Isosorbide dinitrate Isosorbide mononitrate Isosorbide-2-nitrate Isotretinoin Isotretinoin for peak identification Isoxsuprine hydrochloride Isradipine Isradipine impurity D methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethylpyridine-3,5-dicarboxylate Itraconazole Itraconazole for system suitability Ivermectin Ivy leaf standardised tincture Josamycin
10 mg
EPI0330000 EPY0001297 EPY0001020 EPY0001077 EPY0001021 EPY0001022 EPI0340000 EPA0560000 EPY0000555 EPY0000658 EPY0000141 EPY0000142 EPI0360000 EPY0000276 EPI0361000
100 mg 10 mg 100 mg 0.125 mg 5 mg 5 mg 150 mg 20 mg 100 mg 5 mg 125 mg 20 mg 120 mg 10 mg 10 mg
EPY0001166 EPY0001156 EPI0375000 EPI0380000 EPI0400000 EPY0000858 EPY0000037 EPI0460000 EPI0465000 EPY0000070 EPI0500000 EPI0599990 EPI0600000 EPI0725000 EPI0750000 EPI0775000 EPI0775010 EPI0775020 EPI0800000 New EPY0001218 EPI0900000 EPY0000366 EPY0000367 EPI7000000 EPY0001100 EPI8000010 EPY0000575 EPY0000041
60 mg 10 mg 200 mg 200 mg 25 mg 1.5 mL unit 50 mg 3000 mg 0.9 mg 100 mg 50 mg 500 mg 100 mg 2 mL 300 mg 100 mg 50 mg 60 mg 10 mg 50 mg 125 mg 5 mg 150 mg 15 mg 150 mg 2 mL 150 mg
Edition 2012/2013
279
Code Product Unit
EPY0000042 EPY0001315 EPK0100000 EPK0200000 EPY0000450 EPK0551000 EPY0000246 EPY0000244 EPY0000245 EPK0600000 EPK1000000 EPK2000000 EPK2000010 EPK2000015 EPY0000486 EPY0000626 EPY0000164 EPY0000161 New EPY0001200 EPL0050000 EPL0129000 EPY0000257 EPA1206000 EPL0100000 EPL0130000 EPY0000188 EPY0000425 EPY0000518 EPY0000426 EPY0001030 EPY0001031 EPY0001085 EPY0001032 EPY0000773 EPY0000774 New EPY0001474 EPY0000654 EPY0000487 EPY0000674 EPY0000685 EPL0375000 EPL0376000 EPL0376001 EPY0000047 EPL0380000 EPY0000048
Josamycin propionate Josamycin for peak identification Kanamycin B sulfate Kanamycin monosulfate Ketamine hydrochloride Controlled Substance Ketamine impurity A 1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol Ketobemidone hydrochloride - Reference Spectrum Ketobemidone impurity B B 1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone Ketobemidone impurity C 1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one Ketoconazole 3-Ketofusidic acid Ketoprofen Ketoprofen impurity A 1-(3-benzoylphenyl)ethanone Ketoprofen impurity C 3-[(1RS)-1-carboxyethyl]benzoic acid Ketorolac trometamol Ketorolac trometamol for peak identification Ketotifen hydrogen fumarate - Reference Spectrum Ketotifen impurity G 4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)thiophen-9,10-dione Kudzuvine root dry extract Labetalol hydrochloride Lactitol monohydrate Lactobionic acid Lactose (anhydrous) Lactose Lactulose Lactulose for system suitability Lamivudine Lamivudine for system suitability 1 Lamivudine for system suitability 2 Lamotrigine Lamotrigine for peak identification Lamotrigine for system suitability Lamotrigine impurity E 2,3-dichlorobenzoic acid Lansoprazole Lansoprazole for peak identification Lauric acid Leflunomide Leflunomide impurity A 4-(trifluoromethyl)aniline Leflunomide for peak identification Letrozole Leucine Leuprorelin Leuprorelin - Reference Spectrum Levamisole hydrochloride for system suitability Levamisole hydrochloride Levamisole - Reference Spectrum
150 mg 25 mg 20 mg 150 mg 10 mg 50 mg unit 5 mg 5 mg 150 mg 10 mg 50 mg 10 mg 5 mg 10 mg 5 mg unit 0.0225 mg 200 mg 80 mg 60 mg 100 mg 100 mg 100 mg 3000 mg 12 mg 150 mg 10 mg 10.3 mg 10 mg 20 mg 10 mg 10 mg 60 mg 1 mg 1500 mg 100 mg 25 mg 1 mg 70 mg 50 mg 1 mg unit 60 mg 50 mg unit
280
Edition 2012/2013
Code Product Unit
EPY0001253 EPY0001254 EPY0001255 EPY0001256 EPY0001257 EPL0390000 EPL0390008
Levetiracetam Levetiracetam impurity A (2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid Levetiracetam impurity B (2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide Levetiracetam impurity C pyridin-2-ol Levetiracetam impurity D (2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam) Levocabastine hydrochloride Levocabastine impurity D 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]4-phenylpiperidine-4-carboxylic acid Levocarnitine Levocarnitine impurity A (E)-or(Z)-4-(trimethylammonio)but-2-enoate Levodopa Levodropropizine Levodropropizine impurity A (2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol(dextrodropropizine) Levodropropizine impurity B 1-phenylpiperazine Levodropropizine impurity C 2,3-epoxypropan-1-ol Levomepromazine hydrochloride Levomepromazine maleate Levonorgestrel Levonorgestrel impurity B 13-ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-5(10)-en-20-yn-3-one Levonorgestrel for system suitability Levothyroxine for peak identification Levothyroxine sodium Lidocaine Lidocaine hydrochloride Lincomycin chlorhydrate for system suitability Lincomycin hydrochloride Liothyronine sodium Liothyronine for peak identification Lisinopril for system suitability Lisinopril dihydrate Lisinopril impurity F (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]hexanoyl]pyrrolidine2-carboxylic acid (cyclohexyl analogue) Lithium clavulanate Lithocholic acid Lobeline hydrochloride Lomustine Loperamide hydrochloride Loperamide hydrochloride for system suitability Loperamide oxide monohydrate Lopinavir for system suitability Loratadine Loratadine for system suitability
110 mg 10 mg 10 mg 10 mg 10 mg 125 mg 20 mg
EPL0399900 EPL0399905 EPL0400000 EPL0420000 EPL0420002 EPY0001033 EPY0001048 EPL0500000 EPL0505000 EPL0551000 New EPY0001379 New EPY0001431 New EPY0001382 EPL0570000 EPL0595000 EPL0600000 New EPY0001393 EPL0650000 EPL0700000 EPY0000860 EPY0001235 EPL0702000 EPY0001234
125 mg 50 mg 100 mg 60 mg 20 mg 50 mg 300 mg 100 mg 50 mg 30 mg 10 mg 10 mg 10 mg 100 mg 50 mg 100 mg 10 mg 250 mg 50 mg 0.0046 mg 2 mg 50 mg 0.01 mg
EPL0720000 EPL0720800 EPY0000112 EPL0745000 EPL0750000 EPY0000322 EPY0000341 New EPY0001505 EPY0000688 EPY0000603
Edition 2012/2013
281
Code Product Unit
EPY0000604
Loratadine impurity F ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta [1,2-b]pyridin-11-yl]piperidine-1-carboxylate Loratadine impurity H ethyl 4-oxopiperidine-1-carboxylate Lorazepam Controlled Substance Lorazepam for system suitability Controlled Substance Lorazepam impurity D (5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H1,4-benzodiazepine-2,3-dione Losartan potassium Losartan impurity D 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde Losartan for system suitability Lovastatin Lovastatine for peak identification Lufenuron Lufenuron for peak identification Lufenuron impurity G 2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl] amino]phenyl phenyl carbonate Lynestrenol Lynestrenol for peak identification Lysine acetate Lysine hydrochloride Macrogol 30 dipolyhydroxystearate Macrogol 40 sorbitol heptaoleate Macrogol polyvinyl alcohol grafted polymer Magnesium aspartate dihydrate Magnolol Malathion Malathion impurity A diethyl(2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] butane dioate Malathion impurity B diethyl(2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate Maleic acid Malic acid - Reference Spectrum Maltitol Mannitol Maprotiline hydrochloride Maprotiline impurity D 3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2-en-1-amine Marbofloxacin Marbofloxacin for peak identification Measles vaccine (live) BRP Mebendazole Mebendazole for system suitability Mebendazole - Reference Spectrum Mebrofenin Meclozine dihydrochloride Meclozine impurity B 4-chlorobenzhydrol Meclozine impurity H 1-(4-chlorobenzhydryl)piperazine
10 mg
EPY0000605 EPL0750500 EPY0000576 EPY0000718
50 mg 100 mg 0.8 mg 10 mg
EPY0001062 EPY0001072 EPY0001076 EPL0790000 EPY0001136 EPY0001284 EPY0001261 EPY0001265
50 mg 6 mg 0.0015 mg 60 mg 20 mg 140 mg 0.4028 mg 15 mg
EPL0800000 EPY0001034 EPY0000397 EPL0900000 EPY0001369 EPY0000745 EPY0001157 EPM0088000 New EPY0001289 EPM0120000 EPM0120005
50 mg 20 mg 60 mg 50 mg 100 mg 20 mg 400 mg 60 mg 20 mg 250 mg 10 mg
EPM0120010 EPM0100000 EPY0000143 EPM0160000 EPM0200000 EPM0206000 EPM0206040 EPY0000819 EPY0000820 EPM0210000 EPM0215000 EPY0000144 EPY0000168 EPY0001086 EPM0220000 EPY0001310 EPY0001311
10 mg 100 mg unit 1200 mg 1200 mg 100 mg 25 mg 10 mg 20 mg 5 uc 20 mg 20 mg unit 120 mg 150 mg 15 mg 15 mg
282
Edition 2012/2013
Code Product Unit
EPM0240000 EPY0001107 EPY0001106 EPM0250000 EPM0250010 EPY0000598 EPM0252600 EPY0001081 EPM0253000 EPM0260100 New EPY0001524 New EPY0001507 EPY0001209 EPY0001080 EPY0001035 EPY0001036 EPY0001037
Medronic acid Medronic acid impurity A Tris(1-methylethoxy)phosphane Medronic acid impurity B Tetrakis(1-methylethyl)methhylenediphosphonate Medroxyprogesterone acetate Medroxyprogesterone acetate for performance test Medroxyprogesterone acetate for system suitability Mefenamic acid Mefenamic acid impurity A 2,3-dimethylaniline Mefloquine hydrochloride Megestrol acetate - Reference Spectrum Megestrol acetate for system suitability Megestrol acetate for peak identification Meglumine Meloxicam Meloxicam impurity A ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide Meloxicam impurity B 5-methylthiazol-2-amine Meloxicam impurity C N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide Meloxicam impurity D N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide Melphalan - Reference Spectrum Melphalan for system suitability Melphalan hydrochloride Menadione Menthol Mepivacaine hydrochloride Mepivacaine impurity B (RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Meprobamate Controlled Substance Mepyramine maleate Mepyramine impurity A N-(4-methoxybenzyl)pyridin-2-amine Mepyramine impurity C pyridin-2-amine Meropenem trihydrate Mesalazine Mesityl oxid Mesna - Reference Spectrum Mesna impurity C 2-(Acetylsulphanyl)ethanesulphonic acid Mesna impurity D 2,2'-(disulphanediyl)bis(ethanesulphonic acid) Meso-rich exametazime Mesterolone Mesterolone impurity A 17-hydroxy-1alpha-methylandrost-4-en-3-one Mestranol Metacresol - Reference Spectrum Metacycline hydrochloride
20 mg 60 l 40 l 100 mg 50 mg 10 mg 50 mg 100 mg 100 mg unit 50 mg 25 mg 10 mg 50 mg 5 mg 5 mg 5 mg
EPY0001039
5 mg
New EPY0001513 New EPY0001457 New EPY0001158 EPM0300000 EPM0350000 EPM0370000 EPM0370020 EPM0400000 EPM0500000 EPY0000679 EPY0000680 EPY0001252 EPY0000297 EPY0001040 EPY0000337 EPY0000316 EPY0000317 EPY0000227 EPY0000097 EPY0000096 EPM0600000 EPY0000301 EPM0600500
Edition 2012/2013
unit 10 mg 100 mg 100 mg 150 mg 100 mg 60 mg 100 mg 1000 mg 10 mg 10 mg 110 mg 125 mg 100 mg unit 10 mg 10 mg 0.5 mg 60 mg 30 mg 100 mg unit 50 mg
283
Code Product Unit
EPM0600900 EPM0600905 New EPY0001481 EPM0605000 EPY0000770 EPY0000323 EPM0610000 EPM0610030 EPM0620000 EPM0630000 EPM0800000 EPY0000428 EPM0900000 EPY0000754 EPM0950000 EPM0960000 EPM1000000 EPY0000602 EPY0000663
Metamizole sodium Metamizole impurity A 4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one Metamizole impurity E 4-N-Demethylanalgin Metformin hydrochloride Methacrylic acid-ethylacrylate copolymer (1:1) - type A Methacrylic acid-ethyl acrylate copolymer (1:1) - type B Methacrylic acid-ethylacrylate copolymer (1:1) - Reference Spectrum Methacrylic acid-ethyl acrylate copolymer (1:1), dispersion 30% - Reference Spectrum Methacrylic acid-methylmethacrylate copolymer (1:1) - Reference Spectrum Methacrylic acid-methylmethacrylate copolymer (1:2) - Reference Spectrum Methadone hydrochloride - Reference Spectrum Methanol - Reference Spectrum Methaqualone - Reference Spectrum Methenamine DL-Methionine Methionine Methotrexate Methotrexate for peak identification Methotrexate impurity C (2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6yl)methyl]methylamino]benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine) Methotrexate impurity D 4-[[(2-amino-4hydroxypteridin-6-yl)methyl]methyl-amino]benzoic acid Methotrexate impurity E 4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-amino-N10-methylpteroic acid, APA) Methylatropine bromide Methylatropine nitrate Methylcarbidopa Methyl 2-(4-chlorophenoxy)-2-methylpropionate Methyldopa Racemic methyldopa Methyldopa for system suitability Methylene chloride 2-(1-Methylethyl)pentanoic acid Methyl 12-hydroxystearate Methyl nicotinate Methylergometrine maleate Methylergometrine for system suitability Methylnitrosoindoline Methyl parahydroxybenzoate Methylphenidate hydrochloride Controlled Substance Methylphenidate impurity mixture Methylphenobarbital Controlled Substance Methylprednisolone Methylprednisolone acetate Methylprednisolone hydrogen succinate Methylprednisolone hydrogen succinate for performance test 2-Methylpyrazine N-Methylpyrrolidone - Reference Spectrum
100 mg 15 mg 15 mg 50 mg 200 mg 200 mg unit unit unit unit unit unit unit 10 mg 50 mg 50 mg 100 mg 20 mg 10 mg
EPM1000008 EPY0000664
10 mg 10 mg
EPM1300000 EPM1400000 EPM1450000 EPM1470000 EPM1500000 EPY0001374 EPY0001083 EPM1550000 EPM1551000 EPM1556000 EPY0000398 EPY0000776 EPY0000777 EPM1625000 EPM1650000 EPY0001017 EPY0000910 EPM1700000 EPM1750000 EPM1755000 EPM1755200 EPM1755220 New EPY0001376 EPY0000190
100 mg 100 mg 1 mg 0.5 mL 50 mg 5 mg 0.024 mg 2 mL 25 mg 100 mg 25 mg 10 mg 0.53 mg 110 mg 150 mg 40 mg 0.04 mg 500 mg 150 mg 100 mg 125 mg 50 mg 100 mg unit
284
Edition 2012/2013
Code Product Unit
EPM1770180 EPY0000418 EPY0000407 EPM1770200 EPM1800000 EPY0000861 EPM1800900 EPM1800902 EPM1808000 EPM1824990 EPM1825000 EPM1824995 EPM1825010 EPY0000701 EPY0000702 EPY0000171 EPM1830000 EPY0000145 EPM1845000 EPM1850000 EPM1851000 EPY0000069 EPY0000087 EPM1860000 EPY0000202 EPY0000203 EPM1875000 EPY0001041
Methyl ricinoleate Methylrosanilinium chloride Methylrosanilinium chloride for system suitability Methyl stearate Methyltestosterone Methyltestosterone for system suitability Methylthioninium chloride Methylthioninium impurity A 3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium Metixene hydrochloride Metoclopramid Metoclopramide hydrochloride Metoclopramide impurity A 4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxy benzamide Metoclopramide impurity E N,N-diethylethane-1,2-diamine Metolazone Metolazone for system suitability Metoprolol succinate - Reference Spectrum Metoprolol tartrate Metoprolol impurity A (2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol Metrifonate Metronidazole Metronidazole benzoate Metronidazole benzoate - Reference Spectrum Metronidazole impurity A 2-methyl-4-nitroimidazole Mexiletine hydrochloride Mexiletine impurity C 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]dipropan-2-amine Mexiletine impurity D (2RS)-2-(2,6-dimethylphenoxy)propan-1-amine Mianserin hydrochloride Mianserin impurity B (14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f] pyrazino[1,2-a]azepine-8-sulfonic acid Mianserin hydrochloride for system suitability Miconazole Miconazole nitrate Midazolam Controlled Substance Midazolam impurity C acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo [1,5-a][1,4]benzodiazepine-3-carboxylique Midazolam for system suitability Controlled Substance Milk thistle standardised dry extract Minocycline hydrochloride Minoxidil Minoxidil for system suitability Mirtazapine Mirtazapine for system suitability Misoprostol Misoprostol for system suitability Mitomycin
125 mg 40 mg 10 mg 100 mg 100 mg 10 mg 50 mg 20 mg 75 mg 100 mg 50 mg 25 mg 20 mg 80 mg 10 mg unit 60 mg 10 mg 100 mg 50 mg 50 mg unit 10 mg 100 mg 2 mg 2 mg 100 mg 10 mg
EPY0000862 EPM1880000 EPM1900000 EPM2200000 EPY0000562
1.01 mg 70 mg 100 mg 50 mg 0.08 mg
EPY0000599 EPY0000539 EPM2280000 EPM2300000 New EPY0001432 EPY0000705 EPY0000721 EPY0000490 EPY0001162 EPY0000378
Edition 2012/2013
285
Code Product Unit
EPM2305000 EPM2305005 EPY0000635 EPY0000636 EPY0000251 EPY0000821 EPY0000822 EPY0000823 EPM2900000 New EPY0001436 New EPY0001435 New EPY0001433 New EPY0001434 EPY0000028 EPY0000451 EPY0000452 EPY0000830 EPY0000772 EPY0000747 EPY0000703 EPY0000717 EPY0000226 EPY0000222 EPM3600000 EPM3805000 EPM3805500 EPM3806000 EPY0000489 EPY0000519 EPY0000692 EPY0000690 EPY0000691 EPY0000689 EPY0000485 New EPY0001484 EPN0020000 EPN0020020 EPN0020030 EPY0000146 EPY0001215 EPN0025000 EPY0000077 EPY0000120 EPY0000121
Mitoxantrone hydrochloride Mitoxantrone impurity A 1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione Modafinil Modafinil for system suitability Molgramostim Molsidomine Molsidomine impurity B N-Nitrosomorpholine Molsidomine impurity D morpholine-4-carbaldehyde Mometasone furoate Montelukast dicyclohexylamine Montelukast for peak identification Montelukast racemate Montelukast sodium Morantel hydrogen tartrate Morphine hydrochloride (trihydrate) Controlled Substance Morphine sulphate Controlled Substance Morphine for system suitability Controlled Substance Moxidectin Moxidectin for system suitability Moxifloxacin hydrochloride Moxifloxacin for peak identification Moxonidine Moxonidine impurity A 4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine Mumps vaccine (live) BRP Mupirocin - Reference Spectrum Mupirocin calcium - Reference Spectrum Mupirocin lithium Mycophenolate mofetil Mycophenolate mofetil for peak identification Mycoplasma fermentans BRP Mycoplasma hyorhinis BRP Mycoplasma orale BRP Mycoplasma synoviae BRP Myo-inositol Medroxyprogesterone acetate for peak identification Nabumetone Nabumetone impurity D (E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one Nabumetone impurity F 6,6'-dimethoxy-2,2'-binaphthalenyl Nadolol Nadolol impurity mixture Nadroparin calcium Naftidrofuryl - Reference Spectrum Naftidrofuryl impurity A 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid Naftidrofuryl impurity B ethyl 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoate
50 mg 5 mg 110 mg 0.1 mg 0.3 mL 5 mg 10 mg 10 mg 100 mg 150 mg 20 mg 20 mg 150 mg 50 mg 25 mg 40 mg 15 mg 70 mg 10 mg 110 mg 10 mg 50 mg 10 mg 5x33 mg unit unit 100 mg 30 mg 10 mg 1 mL 1 mL 1 mL 1 mL 1020 mg 25 mg 60 mg 10 mg 10 mg 100 mg 0.01 mg 250 mg unit 10 mg 25 mg
286
Edition 2012/2013
Code Product Unit
EPY0000331
Naftidrofuryl impurity F 2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3(tetrahydrofuran-2-yl)propanoate Nalidixic acid Naloxone hydrochloride dihydrate Naloxone for peak identification Naltrexone hydrochloride Naltrexone impurity C N-(3-butenyl)-noroxymorphone Nandrolone decanoate Nandrolone decanoate for peak identification Nandrolone decanoate for system suitability Naphazoline hydrochloride Naphazoline nitrate Naphazoline impurity A N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide (Naphthylacetylethylenediamine) Naproxen Naproxen (racemic) Naproxen impurity L 1-(6-Methoxynaphthalen-2-yl)ethanone (Acetylnerolin) Naringin Nateglinide Nateglinide impurity A trans-4-(1-methylethyl)cyclohexanecarboxylic acid Nateglinide impurity B N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (L-phenylalanine isomer) Nateglinide impurity C N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer) Neamine Neohesperidin dihydrochalcone Neohesperidin dihydrochalcone impurity B 7-[[2-O-(6-deoxy--L-mannopyranosyl)--D-glucopyranosyl]oxy]-5-hydroxy-2(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one (neodiosmin) Neomycin sulfate Neomycin sulphate for microbiological assay Neostigmine bromide Neostigmine metilsulfate Netilmicin sulphate Nevirapine (anhydrous) Nevirapine hemihydrate Nevirapine for peak identification Newcastle Disease Vaccine (inacativated) BRP Nicergoline - Reference Spectrum Nicergoline Nicergoline for peak identification Nicergoline for system suitability Nicergoline impurity A [(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl4,6,6a,7,8,9,10,10a-octahydroindol [4,3-fg]quinolin-9-yl]methyl 5-chloropyridine-3-carboxylate Nicergoline impurity D 5-bromopyridine-3-carboxylic acid Niclosamide (anhydrous) Nicotinamide Nicotine - Reference Spectrum
10 mg
EPN0050000 EPN0075000 EPY0000695 EPY0000400 EPY0000410 EPY0000542 EPY0000547 EPY0000548 EPN0080000 EPN0100000 EPN0200000 EPN0250000 EPY0000399 EPY0000631 New EPY0001378 New EPY0001437 New EPY0001440 New EPY0001441
New EPY0001442 EPN0300000 EPN0399000 EPN0399004
10 mg 0.5 mg 125 mg 10 mg
EPN0400000 EPN0401000 EPN0500000 EPN0550000 EPN0559000 EPY0000520 New EPY0001499 EPY0000521 EPY0000388 EPY0000287 EPY0001373 EPY0001362 EPY0001352 EPY0000283
50 mg 25 mg 50 mg 50 mg 2x25 mg 30 mg 15 mg 0.058 mg 4 uc unit 50 mg 1 mg 10 mg 10 mg
EPY0001356 EPN0560000 EPN0600000 EPN0590000

Edition 2012/2013
20 mg 50 mg 50 mg unit
287
Code Product Unit
EPN0590200 New EPY0001425 EPY0001023 EPN0700000 EPY0001268 EPN0750000 EPN0750010 EPN0750015 EPY0000824 EPY0000825 EPY0000826 EPY0000827 EPY0000836 EPN0800000 EPY0000829 EPY0000894 EPN0845000 EPN0845008 EPY0001237 EPN0850000 EPN0850010
Nicotine ditartrate Nicotine ditartrate dihydrate Nicotine for system suitability Nicotinic acid Nicotinic acid impurity mixture Nifedipine Nifedipine impurity A Dimethyl 2,6-dimethyl-4-(2-nitrophenyl) pyridine-3,5-dicarboxylate Nifedipine impurity B Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl) pyridine-3,5-dicarboxylate Niflumic acid Niflumic acid impurity A 2-chloropyridine-3-carboxylic acid Niflumic acid impurity B 2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide Niflumic acid impurity E 6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid Nifuroxazide Nikethamide Nilutamide Nilutamide impurity B 4-nitro-3-(trifluoromethyl)aniline Nimesulide Nimesulide impurity D 4-nitro-2-phenoxyaniline Nimesulide for peak identification Nimodipine Nimodipine impurity A 2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate Nitrazepam Controlled Substance Nitrazepam impurity A 3-amino-6-nitro-4-phenylquinol-2-one Nitrendipine Nitrendipine for peak identification Nitrendipine impurity A ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate; (nitrophenylpyridine analogue) Nitric oxide - Reference Spectrum Nitrofural Nitrofural for peak identification Nitrosotriaminopyrimidine Nizatidine Nizatidine for system suitability Nizatidine impurity F (EZ)N1,N1-[thiazole-2,4-diylbis(methylenesulphanediylethylene)] bis(N-methyl-2-nitroethene-1,1-diamine) Nomegestrol acetate Nomegestrol acetate impurity A 6-alpha-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate 1-nonadecanol Nonivamide Nonoxinol 9 Noradrenaline tartrate
120 mg 15 mg 1 mg 100 mg 0.12 mg 50 mg 20 mg 20 mg 10 mg 10 mg 10 mg 15 mg 10 mg 1 mL 110 mg 5 mg 100 mg 0.004 mg 10 mg 50 mg 1 mL
EPN0900000 EPN0900010 EPN0905000 New EPY0001456 EPN0905005
100 mg 25 mg 60 mg 10 mg 30 mg
EPN0930000 EPN0950000 EPY0001377 EPN1000000 EPN1090000 New EPY0001278 EPN1090060
unit 100 mg 0.11 mg 50 mg 250 mg 10 mg 10 mg
EPN1080000 EPN1080005 EPY0001314 EPY0000670 EPY0000755 EPN1100000
100 mg 50 mg 400 mg 10 mg 10 mg 200 mg
288
Edition 2012/2013
Code Product Unit
EPY0000681
Noradrenaline impurity D 4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (Noradrenaline methyl ether) Noradrenaline impurity E 2-chloro-1-(3,4-dihydroxyphenyl)ethanone Noradrenaline impurity F N-benzyl-1-phenylmethanamine Norcyclobenzaprine Nordazepam Controlled Substance Dipotassium clorazepate impurity B Norethisterone Norethisterone acetate Norethistherone for system suitability Norfloxacin Norfloxacin for peak identification Norfloxacin impurity A 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Norfloxacin for system suitability Norgestimate Norgestimate for system suitability Norgestrel Norpseudoephedrine hydrochloride Controlled Substance Nortriptyline for system suitability Nortriptyline hydrochloride Noscapine Nystatin Octoxinol 10 Octyl gallate Octyldodecanol Ofloxacin Ofloxacin impurity A (RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]benzoxazine-6-carboxylic acid (FPA) Ofloxacin impurity E (RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de] [1,4]benzoxazine-6-carboxylic acid Olanzapine Olanzapine for system sitability Olanzapine impurity A 5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile Oleic acid Oleuropein Olmesartan medoxomil Olmesartan medoxomil for system suitability Olsalazine sodium Olsalazine sodium for performance test Omeprazole Omeprazole magnesium Omeprazole for peak identification Omeprazole impurity D Omeprazole sulphone Ondansetron hydrochloride dihydrate Ondansetron for LC system suitability Ondansetron for TLC system suitability
15 mg
EPY0000682 EPY0000686 EPN1130000 EPN1140000 EPN1200000 EPN1225000 EPY0000522 EPN1230000 EPY0001301 EPN1230010 EPY0001015 EPY0000724 EPY0000725 EPN1250000 EPN1279000 EPY0001296 EPN1280000 EPN1300000 EPN1400000 EPO0100900 EPY0000368 EPO0101000 EPO0120000 EPO0120010
10 mg 10 mg 25 mg 50 mg 100 mg 100 mg 10 mg 50 mg 10 mg 20 mg 8 mg 10 mg 5 mg 30 mg 50 mg 20 mg 10 mg 100 mg 100 mg 300 mg 30 mg 400 mg 50 mg 20 mg
EPO0120050
20 mg
New EPY0001370 New EPY0001380 New EPY0001392 New EPY0001479 EPY0000805 New EPY0001405 New EPY0001424 EPO0146000 EPO0146010 EPO0150000 EPY0001043 EPY0001042 EPO0151000 EPY0000218 EPY0000197 EPY0000196
200 mg 10 mg 5 mg 2000 mg 20 mg 100 mg 10 mg 60 mg 60 mg 50 mg 10 mg 10 mg 10 mg 200 mg 10 mg 30 mg
Edition 2012/2013
289
Code Product Unit
EPY0001345
Ondansetron impurity A (3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9tetrahydro-4H-carbazol-4-one Ondansetron impurity D 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one Ondansetron impurity E Imidazole Ondansetron impurity F Ondansetron impurity G (3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro4H-carbazol-4-one (C-demethylondansetron) Orbifloxacin Orbifloxacin impurity mixture Orciprenaline sulfate Orciprenaline for system suitability Orphenadrine citrate Orphenadrine hydrochloride Orphenadrine for peak identification Orphenadrine impurity E (RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy]ethanamine (meta-methylbenzyl isomer) Oseltamivir phosphate impurity B free Oseltamivir impurity A (3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid Oseltamivir impurity B ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3(1-ethylpropoxy)cyclohexanecarboxylate Oseltamivir impurity C (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid Oseltamivir impurity H tributylphosphane oxide Osthole Ouabain Oxacillin sodium monohydrate Oxacillin for peak identification Oxaliplatin Oxaliplatin impurity C (OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)kO,kO]dihydroxyplatinum Oxaliplatin impurity D (SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)kO,kO ]platinum (S,S-enantiomer of oxaliplatin) Oxazepam Controlled Substance Oxazepam for peak identification Oxeladin hydrogen citrate Oxeladin impurity C 2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate Oxeladin impurity D 2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate Oxfendazole for veterinary use Oxfendazole impurity B methyl[5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate Oxfendazole with impurity D Oxitropium bromide Oxitropium bromide impurity B (1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl)oxy]-9,9-dimethyl-3-oxa-9azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)
10 mg
EPY0000195 EPY0001326 EPY0001320 EPY0001346
10 mg 10 mg 10 mg 10 mg
EPY0001125 EPY0001147 EPO0180000 EPY0000895 EPY0000101 EPY0000100 EPY0001181 EPY0000102
200 mg 0.0008 mg 100 mg 5 mg 100 mg 100 mg 0.42 mg 30 mg
EPY0001337 EPY0001338 EPY0001339
300 mg 10 mg 10 mg
EPY0001340 EPY0001341 EPY0001207 EPO0200000 EPY0000638 EPY0000560 EPY0000271 EPY0000273
10 mg 30 mg 20 mg 150 mg 110 mg 10 mg 250 mg 25 mg
EPY0000274
10 mg
EPO0225000 EPY0000543 EPY0000350 EPY0000404 EPY0000390 EPO0225800 EPY0000224 EPY0000225 EPY0000709 EPY0000715
50 mg 0.008 mg 50 mg 10 mg 20 mg 50 mg 10 mg 10 mg 50 mg 15 mg
290
Edition 2012/2013
Code Product Unit
EPY0000713
Oxitropium bromide impurity D (1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3-oxa-9azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine) Oxolinic acid Oxolinic acid impurity A 8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid Oxolinic acid impurity B ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7-carboxylate Oxprenolol hydrochloride Oxibendazole Oxybuprocaine hydrochloride Oxybutynin hydrochloride Oxybutynin impurity A 4-(diethylamino)but-2-ynyl(RS)-2-(cyclohex-3-enyl)-2-cyclohexyl-2-hydroxyacetate Oxycodone hydrochloride Controlled Substance Oxycodone impurity D 7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy-17methylmorphinan-6-one (14-hydroxycodeinone) Oxymetazoline hydrochloride Oxymetazoline impurity A N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]acetamide Oxytetracycline Oxytetracycline hydrochloride Oxytocin Oxytocin/Desmopressin validation mixture about 0.1 mg oxytocin + 0.1 mg desmopressin per vial Paclitaxel Paclitaxel impurity C N-debenzoyl-N-hexanoylpaclitaxel Paclitaxel natural for peak identification Paclitaxel semi-synthetic for peak identification Paclitaxel semi-synthetic for system suitability Palmitic acid Pamidronate disodium pentahydrate Pancrease powder (amylse and lipase) BRP Pancreas powder (protease) BRP Pancuronium bromide Vecuronium impurity B Pancuronium bromide for system suitability Pantoprazole sodium sesquihydrate Pantoprazole for system suitability Papaverine hydrochloride Paracetamol Paraffin (hard) Paraffin (liquid) - Reference Spectrum Paraffin (White soft) Paraffin (Yellow soft) Parnaparin sodium Paroxetine hydrochloride (anhydrous) Paroxetine hydrochloride hemihydrate Paroxetine impurity A (3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine (desfluoroparoxetine) Paroxetine hydrochloride (anhydrous) impurity C (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine (N-benzylparoxetine)
10 mg
EPO0240000 EPO0240005 EPO0240010 EPO0250000 EPO0260000 EPO0270000 EPO0288000 EPO0288005 EPY0000492 EPY0000453
EPO0290000 EPY0001044 EPO0400000 EPO0500000 EPO0700000 EPO0770000 EPY0000698 EPY0000699 EPY0000700 EPY0000719 EPY0000739 EPP0090000 EPY0000524 EPP0100000 EPP0200000 EPP0250000 EPY0000577 EPY0000835 EPY0001001 EPP0270000 EPP0300000 EPY0000780 EPY0000058 EPY0000913 EPY0000912 EPP0305000 EPY0000578 EPY0000281 EPY0000233 EPY0000579
80 mg 10 mg 100 mg 20 mg 1 mg 0.2 mg 40 mg 5 mg 10 mg 10 mg 1 mg 100 mg 10 mg 2000 mg 2000 mg 20 mg 20 mg 20 mg 0.5055 mg 25 mg 50 mg 10 mg unit 10 mg 10 mg 250 mg 100 mg 200 mg 15 mg 10 mg
Edition 2012/2013
291
Code Product Unit
EPY0000256
Paroxetine impurity D (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine ((+)-transparoxetine) Paroxetine impurity E (3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophenyl)piperidine (cis-paroxetine) Paroxetine hydrochloride (anhydrous) impurity H [(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol Paroxetine for system suitability Pefloxacin mesilate dihydrate Pefloxacin impurity B 1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (chlorinated homologue of pefloxacin) Pefloxacin impurity C 1-ethyl-6-fluoro-5-(4-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (isopefloxacin) Penbutolol sulfate Penbutolol impurity A (2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl)amino]propan-2-ol Penicillamine Penicillamine disulphide 3,3-(disulphanediyl)bis[(2)-2-amino-3-methylbutanoic]acid Pentamidine diisetionate Pentazocine - Reference Spectrum Pentazocine hydrochloride - Reference Spectrum Pentazocine lactate - Reference Spectrum Pentetate sodium calcium Pentobarbital Controlled Substance Pentoxifylline Pentoxyverine hydrogen citrate - Reference Spectrum Pentoxyverine impurity A 1-phenylcyclopentanecarboxylic acid Pentoxyverine impurity B 2-(diethylamino)ethyl-1-phenylcyclopentanecarboxylate (caramiphen) Pepsin powder Pergolide mesilate Perindopril impurity A (2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid Perindopril for stereochemical purity Perindopril tert-butylamine Perindopril for peak identification Perphenazine Perphenazine for system suitability Pertussis toxin BRP Pethidine hydrochloride - Reference Spectrum Pethidine impurity A 1-methyl-4-phenylpiperidine (MPP) Phenazone Phenazone impurity A 5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one Pheniramine impurity A 2-Benzylpyridine Pheniramine maleate Phenobarbital Controlled Substance Phenobarbital impurity A (5RS)-5-ethyl-2,6-diimino-5-phenyltetrahydropyrimidin-4(1H)-one Phenobarbital impurity B (5RS)-5-ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione
5 mg
EPY0000580 EPY0000581 EPY0000630 EPP0309000 EPP0309020
5 mg 10 mg 5 mg 200 mg 10 mg
EPP0309030
0.01 mg
EPP0307000 EPP0307005 EPP0310000 EPP0320000 EPP0405000 EPP0405500 EPP0405510 EPY0000417 EPY0001051 EPP0500000 EPP0510000 EPY0000076 EPY0000098 EPY0000099 EPP0525000 EPY0000010 EPY0000237 EPY0000207 EPY0000238 EPY0000771 EPP0550000 EPY0001045 EPY0000021 EPP0600000 EPP0600002 EPP0800000 EPY0001138 New EPY0001428 EPP0850000 EPP0900000 EPY0001350 EPY0001351
100 mg 20 mg 100 mg 100 mg 30 mg unit unit unit 100 mg 500 mg 100 mg unit 10 mg 10 mg 2000 mg 150 mg 10 mg 40 mg 40 mg 5 mg 100 mg 5 mg 2x0.05 mg unit 20 mg 20 mg 20 mg 20 mg 250 mg 200 mg 15 mg 15 mg
292
Edition 2012/2013
Code Product Unit
EPP0950000 EPP1000000 EPP1100000 EPP1109000 EPY0001127 EPY0001251 EPP1150000 EPP1200000 EPY0000147 EPP1240000 EPP1250000 EPY0000683 EPY0000229 EPP1255100 EPP1260000 EPP1290000 EPY0001167 EPP1300000 EPY0000493 EPY0000761 EPY0000798 EPY0000766 EPP1500000 EPP1600000 EPP1605000 EPP1609000 EPP1609010 EPP1645000 EPP1645005 EPY0000124 EPY0000123 EPP1650000 EPP1700000 EPY0000106 EPY0000525 EPY0000401 EPP1750000 EPP1800000 New EPY0001519 New EPY0001520 New EPY0001476 EPY0000061 EPP1890000 EPP1900000 EPP2000000 EPP2100000 EPY0000288 EPY0000038
Phenoxyethanol Phenoxymethylpenicillin Phenoxymethylpenicillin potassium Phentolamine mesilate - Reference Spectrum Phentolamine mesilate Phentolamine mesilate for system suitability Phenylalanine Phenylbutazone Phenylbutazone impurity B (4-butyl-4-hydroxy-1,2-diphenyl-3,5)pyrazolidinedione Phenylephrine Phenylephrine hydrochloride Phenylephrine hydrochloride for peak identification Phenylmercuric acetate - Reference Spectrum Phenylmercuric borate - Reference Spectrum Phenylpropanolamine hydrochloride (Norephedrin hydrochloride) Drug Precursor Phenytoin Phenytoin for system suitability Phenytoin sodium Phloroglucinol (anhydrous) Pholcodine Controlled Substance Pholcodine for peak identification Controlled Substance Phthalic acid benzene-1,2-dicarboxylic acid Phthalylsulfathiazole Physostigmine salicylate Physostigmine sulfate Phytomenadione trans-Epoxyphytomenadione Picotamide monohydrate Picotamide impurity A 4-methoxybenzene-1,3-dicarboxylic acid Pidolate impurity B (2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanedioic acid Pidolic acid Pilocarpine hydrochloride Pilocarpine nitrate Pilocarpine nitrate for system suitability Pimobendan Pimobendan for system suitability Pimozide Pindolol Pioglitazone for system suitability Pioglitazone hydrochloride Pipemidic acid trihydrate Pipemidic acid trihydrate - Reference Spectrum Piperacillin Piperazine adipate Piperazine citrate Piperazine hydrate Piracetam Pirenzepine dihydrochloride monohydrate
2 mL 250 mg 250 mg unit 10 mg 10 mg 60 mg 100 mg 20 mg 60 mg 50 mg 2 mg unit unit 50 mg 100 mg 20 mg 250 mg 210 mg 10 mg 10 mg 20 mg 100 mg 100 mg 100 mg 150 mg 10 mg 125 mg 25 mg 60 mg 125 mg 50 mg 50 mg 20 mg 10 mg 0.1 mg 150 mg 100 mg 15 mg 120 mg 15 mg unit 100 mg 250 mg 250 mg 250 mg 120 mg 250 mg
Edition 2012/2013
293
Code Product Unit
EPP2120000 New EPY0001458 EPP2120002 EPP2130000 EPP2150000 EPP2152000 EPP2152015
Piretanide Piretanide for system suitability Piretanide impurity A 4-phenoxy-3(1H-pyrrol-1-yl)-5-sulphamoylbenzoic acid Piroxicam Pivampicillin Pivmecillinam hydrochloride Pivmecillinam impurity C methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo-1H-azepin-1-yl) methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate Plastic additive 01 (2RS)-2-ethylhexyl)benzene-1,2-dicarboxylate Plastic additive 03 N,N'-ethylenedialcanamide Plastic additive 04 Epoxidised soya oil Plastic additive 05 Epoxidised linseed oil Plastic additive 08 Ethylene bis [3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate] Plastic additive 09 pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate] Plastic additive 10 4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)-trio[2,6-bis(1,1-dimethylethyl)phenol] Plastic additive 11 Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate Plastic additive 12 Tris(2,4-di-1,1-dimethylethylphenyl)phosphite R Plastic additive 13 1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5-triazine-2,4,6-trione Plastic additive 14 2,2'-Di(octadecycloxy)5,5'-spirobi(1,3,2,-dioxaphosphorinane) R Plastic additive 15 Dioctadecyl disulphide Plastic additive 16 Didodecyl 3,3'-thiodipropionate R Plastic additive 17 Dioctadecyl 3,3'-thiodipropionate R Plastic additive 18 Plastic additive 20 Oleamide R Plastic additive 21 Erucamide R Plastic additive 22 Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6-tetramethylpiperidin-1yl)ethanol Plastic additive 23 di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate containing about 27% of (tri(isooctyl)2,2',2''-[monooctylstannylidyne)tris(thio)]triacetate Tin-content of 15.4% Poliomyelitis vaccine (inactivated) BRP Poliomyelitis vaccine (oral) BRP Poloxamer 124 Poloxamer 188 Poloxamer 237 Poloxamer 338 Poloxamer 407 Polyacrylate - Reference Spectrum Polymyxin B sulfate
100 mg 10 mg 20 mg 100 mg 50 mg 100 mg 10 mg
EPP2155001 EPP2155003 EPE0800000 EPP2155005 EPP2155008 EPP2155009 EPP2155010 EPP2155011 EPP2155012 EPP2155013 EPP2155014 EPP2155015 EPP2155016 EPP2155017 EPP2155018 EPO0140000 EPE1260000 EPP2155022
2 mL 100 mg 500 mg 500 mg 500 mg 250 mg 250 mg 500 mg 250 mg 250 mg 250 mg 500 mg 250 mg 250 mg 100 mg 100 mg 100 mg 100 mg
EPP2155023
200 mg
EPP2160000 EPP2161000 EPP2163920 EPP2164009 EPP2164020 EPP2164021 EPP2164030 EPP2170000 EPP2400000

294
5x0.5 mL 5x1 mL 30 mg 100 mg 100 mg 100 mg 100 mg unit 25 mg

Edition 2012/2013
Code Product Unit
EPY0000355 EPY0000289 EPY0000290 EPY0000291 EPY0000007 EPY0000792 EPP2600000 EPP2649610 EPY0001168 EPY0000315 EPP2650000 EPY0001275 EPP2660000 EPY0000466 EPY0001266 EPY0001187 EPY0001267 EPY0000215 EPY0000223
Polymyxin B sulfate for microbiological assay Polysorbate 20 - Reference Spectrum Polysorbate 40 - Reference Spectrum Polysorbate 60 - Reference Spectrum Polysorbate 80 - Reference Spectrum Poly(vinyl acetate) dispersion 30% Poly(vinyl chloride) Potassium clavulanate - Reference Spectrum Potassium clavulanate impurity G Potassium hydrogen aspartate hemihydrate Potassium sorbate Potassium sucrose octasulfate Povidone Povidone (iodinated) Pramipexole dihydrochloride monohydrate Pramipexole for system suitability Pramipexole impurity D (6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Pravastatin sodium - Reference Spectrum Pravastatin impurity A (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid (6'-epipravastatin) Pravastatin 1,1,3,3-tetramethylbutylamine Prazepam Controlled Substance Praziquantel Praziquantel impurity A (11bRS)-2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one Prazosin hydrochloride Prednicarbate Prednicarbate for system suitability Prednicarbate impurity F 1,2-dihydroprednicarbate Prednisolone Prednisolone for peak identification Prednisolone for system suitability Prednisolone acetate Prednisolone acetate for peak identification Prednisolone hexanoate Prednisolone pivalate Prednisolone sodium phosphate Prednisone Pregnenolone isobutyrate Prekallikrein activator in albumin BRP Prilocaine Prilocaine hydrochloride Prilocaine impurity B 2-methylbenzenamine hydrochloride Prilocaine impurity E (RS)-N-(methylphenyl)-2-(propylamino)propanamide Primaquine diphosphate Primidone Primidone for peak identification
25 mg unit unit unit unit 1500 mg 100 mg unit 5 mg 50 mg 100 mg 100 mg 50 mg 10 mg 5 mg 15 mg 5 mg unit 0.1 mg
EPY0000204 EPP2669000 EPP2670000 EPP2675000 EPP2680000 EPP2698000 New EPY0001443 EPP2698060 EPP2700000 EPY0001359 EPY0001355 EPP2800000 EPY0000582 EPP2804000 EPP2805000 EPP2810000 EPP2900000 EPP2920000 EPY0000263 EPP2939000 EPP2939060 New EPY0001408 EPP2939025 EPP2940000 EPP2950000 EPY0000369
30 mg 50 mg 150 mg 10 mg 50 mg 100 mg 10 mg 10 mg 150 mg 10 mg 10 mg 120 mg 10 mg 10 mg 100 mg 100 mg 100 mg 150 mg 3x1 mL 150 mg 100 mg 80 mg 25 mg 500 mg 150 mg 5 mg
Edition 2012/2013
295
Code Product Unit
EPP3000000 EPP3050000 EPP3090000 EPP3100000 EPP3200000 EPP3300000 EPY0000148 EPY0000179 EPY0000181 EPY0000182 EPP3350000 EPP3390000 EPP3400000 EPY0000769 EPY0000797 EPP3490000 EPY0000455 EPY0000456
Probenecid Procainamide hydrochloride Procaine benzylpenicillin Procaine hydrochloride Prochlorperazine maleate Progesterone Progesterone impurity C (20R)-20-hydroxypregn-4-en-3-one Proguanil hydrochloride - Reference Spectrum Proguanil impurity C 1,5-bis(4-chlorophenyl)biguanide Proguanil impurity D 1,5-bis(1-methylethyl)biguanide Proline Promazine hydrochloride Promethazine hydrochloride Promethazine impurity D (2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide Promethazine for peak identification Propacetamol hydrochloride - Reference Spectrum Propafenone hydrochloride Propafenone impurity B 2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy] phenyl]-3-phenylprop-2-en-1-one Propanol - Reference Spectrum Propofol Propofol for peak identification Propofol impurity J 2,6-bis (1-methylethyl)-1,4-benzoquinone Propranolol hydrochloride Propranolol hydrochloride for performance test Propylene glycol dilaurate Propylene glycol monolaurate Propyl gallate Propyl parahydroxybenzoate Propylthiouracil Propyphenazone Protirelin D-His Protirelin Proxyphylline Pseudoephedrine hydrochloride Drug Precursor Pseudoisoeugenyl 2-methylbutyrate for peak identification Purpureaglycoside A Purpureaglycoside B Pyrantel embonate Pyrantel impurity A 1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine Pyrazinamide Pyridostigmine bromide Pyridostigmine impurity A pyridin-3-yl-dimethylcarbamate Pyridostigmine bromide impurity B 3-hydroxy-1-methylpyridinium Pyridoxine hydrochloride
100 mg 100 mg 250 mg 100 mg 100 mg 50 mg 10 mg unit 10 mg 10 mg 60 mg 100 mg 50 mg 10 mg 10 mg unit 10 mg 10 mg
EPY0000278 EPY0000016 EPY0000017 EPY0000018 EPP3500000 EPP3600000 EPY0000318 EPY0000319 EPP3640000 EPP3650000 EPP3700000 EPP3750000 EPP3760000 EPP3760020 EPP3800000 EPP3850000 EPY0000387 EPP3900000 EPP4000000 EPY0000402 EPY0000403 EPP4050000 EPP4099900 EPP4099910 New EPY0001486 EPP4100000
unit 290 mg 0.1 mL 20 mg 30 mg 20 mg 100 mg 100 mg 50 mg 150 mg 100 mg 200 mg 2x5.03 mg 0.1 mg 100 mg 50 mg 100 mg 25 mg 25 mg 10 mg 20 mg 30 mg 50 mg 20 mg 10 mg 100 mg
296
Edition 2012/2013
Code Product Unit
EPY0001226 EPP4200000 EPY0000659 EPY0001009 EPQ0100000 EPQ0200000 EPR0100000 EPY0000896 EPY0000897 EPY0000898 EPY0000902 EPY0001134 EPY0001135 EPR0145000 EPR0145005
Pyridoxine impurity A 6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol Pyrimethamine Pyrrolidone Quercetin dihydrate Quinidine sulfate Quinine sulfate Rabies vaccine (inactivated) for veterinary use BRP Racecadotril Racecadotril impurity A Ethanethioic acid Racecadotril impurity G benzyl[[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate Racecadotril for peak identification Raloxifene hydrochloride Raloxifene hydrochloride for peak identification Ramipril Ramipril impurity A (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino] propanoly]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril methylester) Ramipril impurity B (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3-phenylpropyl] amino] propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril isopropyl ester) Ramipril impurity C (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino] propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (hexahydroramipril) Ramipril impurity D ethyl(2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro -1H-cyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate (ramipril diketopiperazine) Ranitidine hydrochloride Ranitidine impurity J 1,1'-N-[methylenebis(sulphanediylethylene)]bis (N'-methyl-2-nitroethene-1,1-diamine) Ranitidine for system suitability Repaglinide Repaglinide for system suitability Repaglinide impurity E 2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]2-oxoethyl]benzoic acid Reserpine Residual solvents solution class I Resorcinol Retinol acetate Retinol ester Reviparin sodium Ribavirin Riboflavin (Vitamine B2) Riboflavin for peak identification Riboflavine sodium phosphate Ribonucleic acid Rifabutin Rifabutin impurity A 1-(2-methylpropyl)piperidin-4-one Rifampicin Rifampicin quinone
5 mg 250 mg 20 mg 20 mg 300 mg 300 mg 3x86 mg 110 mg 1 mL 10 mg 5 mg 110 mg 10 mg 20 mg 10 mg
EPR0145010
10 mg
EPR0145015
10 mg
EPR0145020
10 mg
EPR0150000 EPY0000416
100 mg 0.00025 mg
EPY0000411 EPY0000457 EPY0000458 EPY0000459 EPR0200000 EPR0250000 EPY0000767 EPR0300000 EPR0290000 EPR0500500 EPY0000377 EPR0600000 EPY0000757 EPR0630000 EPY0000662 EPY0000149 EPY0000184 EPR0700000 EPR0800000
Edition 2012/2013
20 mg 20 mg 6 mg 10 mg 100 mg 1.4 mL 20 mg 1000 mg 100 mg 250 mg 2x150 mg 100 mg 0.12 mg 250 mg 100 mg 150 mg 20 mg 100 mg 100 mg
297
Code Product Unit
EPR0900000 EPR0950000 EPR1000000 EPY0001074 EPY0001075 EPY0000250 EPY0000187 EPR1000600 EPY0000370 EPY0001276
Rifamycin B Rifamycin S Rifamycin sodium Rifaximin Rifaximin for system suitability Rilmenidine dihydrogenophosphate - Reference Spectrum Rilmenidine for system suitability Risperidone Risperidone for system suitability Risperidone impurity K 3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4Hpyrido[1,2a]pyrimidin-4-one (desfluoro risperidone) Ritonavir Ritonavir for peak identification Rivastigmine for system suitability Rizatriptan benzoate Rizatriptan for system suitability RK 13 cells cell lines (kidney,rabbit) titration of live measles, mumps and rubella vaccines Rocuronium bromide - Reference Spectrum Rocuronium for peak identification Ropivacaine hydrochloride monohydrate Ropivacaine impurity G (+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)-ropivacaine) Rosmarinic acid Roxithromycin Roxithromycin for system suitability Rubella vaccine (live) BRP Ruscogenins Rutoside trihydrate Saccharin Saccharin Sodium Salbutamol Salbutamol impurity B (1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol Salbutamol impurity D 5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2hydroxybenzaldehyde Salbutamol impurity F 1,1'[oxybis[methylene(4-hydroxy-1,3-phenylene)]]bis [2-[(1,1-dimethylethyl)amino]ethanol] Salbutamol impurity G 2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-hydroxymethyl) phenyl]ethanone Salbutamol impurity I (1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4-benzyloxyphenyl] ethanol Salbutamol impurity J 2-[(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone (salbutamone) Salbutamol sulfate Salbutamol sulfate for system suitability Salicin Salicylic acid Salicylic acid impurity B 4-hydroxyisophthalic acid Salmeterol xinafoate
50 mg 50 mg 300mg 160 mg 10 mg unit 30 mg 50 mg 20 mg 0.015 mg
EPY0000714 EPY0000706 New EPY0001485 New EPY0001302 New EPY0001303 EPR1300000
80 mg 10 mg 1.0114 mg 200 mg 15 mg 2x1 mL
EPY0000594 EPY0000527 EPY0000742 EPY0000743 EPY0000786 EPR1500000 EPY0000220 EPR2000000 EPY0000494 EPY0000105 EPS0040000 EPS0050000 EPS0100000 EPY0000030 EPY0000071
unit 10 mg 10 mg 5 mg 40 mg 125 mg 5 mg 5x18 mg 10 mg 100 mg 30 mg 50 mg 50 mg 5 mg 5 mg
EPY0000031
5 mg
EPY0000034
5 mg
EPY0000032 EPY0001186 EPS0150000 EPY0001288 EPY0000669 EPS0200000 EPY0000405 EPY0000422

298
0.006 mg 0.00045 mg 50 mg 10 mg 50 mg 100 mg 10 mg 50 mg

Edition 2012/2013
Code Product Unit
EPY0000423 EPY0001052 EPY0001049 EPY0001056 New EPY0001483 EPY0000814 EPY0000815 EPS0360000 EPS0360090 EPS0400000 EPS0450000 EPS0460000 EPY0000828 EPY0000866 EPY0000867 EPY0001285 EPY0000371 EPY0001046 EPS0500000 EPS0600000 EPS0650000 EPY0001066 EPS0660000 EPY0000014 EPS0695000 EPY0000300 EPY0000039 EPS0700000 EPS0710000 EPS0750000 EPY0001300 EPS0760000 New EPY0001410 EPS0781000 EPS0780000 New EPY0001468 EPY0000620 EPY0000808 EPY0000809 EPS0785000 EPY0001104 EPY0000210 EPY0000268 EPS0800000 EPS0808000 EPS0808060 EPS0900000 EPS0930000 EPS0945000 EPS0947000
Salmeterol xinafoate for system suitability Santonin Saquinavir mesilate Saquinavir for system suitability Saw palmetto extract Selamectin Selamectin for system suitability Selegiline hydrochloride (RS)-Selegiline hydrochloride Senna extract Serine Sertaconazole nitrate Sertraline hydrochloride Sertraline for peak identification Sertraline for system suitability Sertraline impurity E Sestamibi labelling kit Sevoflurane Silicone elastomer Silicone oil Simvastatin Simvastatin for peak identification Sisomicin sulfate Sodium alendronate Sodium amidotrizoate Sodium aminosalicylate dihydrate - Reference Spectrum Sodium ascorbate Sodium calcium edetate Sodium cetostearyl sulfate Sodium cromoglicate Sodium cromoglicate for system suitability Sodium cyclamate Sodium fusidate Sodium hyaluronate - Reference Spectrum Sodium hyaluronate BRP Sodium iodohippurate Sodium laurilsulfate Sodium phenylbutyrate Sodium phenylbutyrate impurity C 4-cyclohexylbutanoic acid Sodium picosulfate Picosulfate for system suitability Sodium polystyrene sulphonate - Reference Spectrum Sodium propionate - Reference Spectrum Sodium salicylate Sodium stearyl fumarate Sodium stearyl maleate Sodium taurocholate BRP Sodium valproate Somatostatin Somatropin
25 mg 20 mg 70 mg 0.3033 mg 8g 100 mg 5 mg 50 mg 25 mg 50 mg 50 mg 125 mg 200 mg 5.4 mg 6.18 mg 15 mg 22 mg 1 mL 2000 mg 1 mL 100 mg 10 mg 50 mg 150 mg 125 mg unit 50 mg 100 mg 100 mg 10 mg 20 mg 100 mg 10 mg unit 300 mg 15 mg 40 mg 5 mg 10 mg 100 mg 0.5 mg unit unit 100 mg 50 mg 10 mg 10000 mg 150 mg 2.45 mg 55 mg
Edition 2012/2013
299
Code Product Unit
EPY0000711 EPS0950000 EPY0000385 EPS1000000 EPY0000114 EPY0000115 EPY0001011 EPY0000597 EPY0000549 EPY0000655 EPY0001126 EPS1100000 EPY0000381 EPY0000332 EPS1200000 EPY0001295 EPY0000185 EPY0001050 EPY0001091 EPS1250000 EPS1250010 New EPY0001420 EPS1300000 EPY0000408 EPY0000421 EPS1340000 EPS1350000 EPY0000868 EPS1400000 EPS1500000 EPY0001324 EPY0001344 EPY0001342
Somatropin/desamidosomatropin resolution mixture Sorbic acid 1,4-Sorbitan Sorbitol Sotalol hydrochloride Sotalol impurity B N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide Spanish sage oil for peak identification Spectinomycin hydrochloride Spectinomycin for system suitability Spectinomycin sulphate tetrahydrate Spike lavender oil Spiramycin Spirapril hydrochloride monohydrate Spirapril for system suitability Spironolactone Spironolactone for system suitability Squalane St.John's wort standardised dry extract Standardised artichoke leaf dry extract Stanozolol Stanozolol impurity A (5,17)-17-hydroxy-17-methylandrostan-3-one Stanozolol impurity B Starch BRP Stavudine Stavudine for system suitability Stearic acid Plastic additive 19 Stearyl alcohol Streptokinase for system suitability Streptomycin sulphate Succinylsulfathiazole Sucralfate Sucralose Sucralose impurity B 1,6-dichloro-1,6-dideoxy--D-fructofuranosyl 6-chloro-6-deoxy--D-glucopyranoside (1,6,6-trichloro-1,6,6-trideoxysucrose) Sucrose Sufentanil - Reference Spectrum Sufentanil citrate - Reference Spectrum Sulbactam sodium Sulbactam Sulbactam for peak identification Sulfacetamide sodium Sulfadiazine Sulfadiazine impurity A 2,6-dimethylaniline Sulfadiazine for identification of impurity F Sulfadimidine Sulfadoxine Sulfafurazole Sulfaguanidine
33 mg 10 mg 50 mg 1200 mg 25 mg 20 mg 250 mg 100 mg 20 mg 10 mg 400 l 200 mg 60 mg 15 mg 150 mg 2.055 mg 0.25 mL 500 mg 60 mg 50 mg 10 mg 10 mg 50000 mg 100 mg 10 mg 100 mg 250 mg 30 l 100 mg 100 mg 10 mg 550 mg 0.5 mg
EPS1600000 EPS1608100 EPS1609000 EPY0000529 EPY0000528 EPY0000550 EPS1700000 EPS1800000 New EPY0001469 New EPY0001480 EPS1900000 EPS1950000 EPS1975000 EPS1975600
300
100 mg unit unit 10 mg 150 mg 20 mg 50 mg 100 mg 20 mg 15 mg 100 mg 50 mg 100 mg 60 mg

Edition 2012/2013
Code Product Unit
EPS2000000 EPS2050000 EPS2100000 EPY0000412 EPY0000413 EPS2150000 EPS2151000 EPS2159100 EPS2155000 EPS2155010 EPS2158000 EPS2159000 EPY0001238 EPS2159010 EPS2159015 EPS2160000 EPS2180000 EPS2190000 EPS2191000 EPS2192000 EPY0000530 EPY0000531 EPY0000532 EPY0000022 EPY0000026 EPY0000027 EPS2200000 EPS2400000 EPS2400004 EPS2400006 EPS5000001 EPS5000002 New EPY0001417 EPT0010000 EPT0014000 EPT0015000 EPY0000650 EPY0000653 EPY0000651 EPY0000652 EPY0001102 EPY0001047 EPY0000648
Sulfamerazine Sulfamethizole Sulfamethoxazole Sulfamethoxazole impurity A N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide Sulfamethoxazole impurity F 4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide Sulfamethoxypyridazine Sulfanilamide Sulfapyridine Sulfasalazine Sulfasalazine derivative for resolution 2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic acid Sulfathiazole Sulfinpyrazone Sulfinpyrazone for system suitability Sulfinpyrazone impurity A 1,2-diphenyl-4-(2-phenylsulphonylethyl)pyrazolidine-3,5-dione Sulfinpyrazone impurity B 1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione Sulfisomidine Sulindac Sulpiride Sulpiride impurity A [(2RS)-1-ethylpyrrolidin-2-yl]methanamine Sulpiride impurity B methyl 2-methoxy-5-sulphamoylbenzoate Sultamicillin Sultamicillin tosilate Sultamicillin for peak identification Sumatriptan succinate Sumatriptan impurity mixture Sumatriptan for system suitability Suxamethonium chloride Suxibuzone Suxibuzone impurity B (4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate Suxibuzone impurity C 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione Swine erysipelas bacteria, serotyp 1 (for vaccines-vet.use) BRP Swine erysipelas bacteria, serotyp 2 (for vaccines-vet.use) BRP Tadalafil Talampicillin hydrochloride Tamoxifen citrate Tamoxifen citrate for performance test Tamsulosin hydrochloride Tamsulosin racemate Tamsulosin impurity D 2-methoxy-5[(2R)-2-[[2-(2-methyoxyphenoxy)ethyl]amino]propyl]benzenesulfonamide Tamsulosin impurity H (2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine Teicoplanin Teicoplanin for identification Telmisartan
100 mg 100 mg 50 mg 5 mg 5 mg 50 mg 100 mg 20 mg 2x250 mg 20 mg 100 mg 30 mg 0.5 mg 20 mg 20 mg 50 mg 50 mg 100 mg 20 mg 20 mg 10 mg 200 mg 10 mg 50 mg 3 mg 2 mg 1000 mg 50 mg 10 mg 10 mg 1 mg 1 mg 200 mg 50 mg 80 mg 30 mg 10 mg 10 mg 10 mg 10 mg 52 mg 40 mg 30 mg
Edition 2012/2013
301
Code Product Unit
EPY0000649 EPY0001003 EPT0040000 EPY0000344
Telmisartan for peak identification Telmisartan for system suitability Temazepam Controlled Substance Temazepam impurity C (3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl acetate Controlled Substance Temazepam impurity D (3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one Controlled Substance Temazepam impurity F (5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione Temazepam impurity G (5RS)-7-chloro-1,4-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione Tenoxicam Tenoxicam impurity mixture Terazosin hydrochloride dihydrate Terazosin for system suitability Terazosin impurity A 2-chloro-6,7-dimethoxyquinazolin-4-amine Terazosin impurity E 2,2`-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine) Terazosin impurity L 1-(furan-2-ylcarbonyl)piperazine Terazosin impurity N 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine Terbinafine hydrochloride Terbinafine for system suitability Terbutaline sulfate Terbutaline impurity C 1-(3,5-dihydroxyphenyl)-2-[(1,1- dimethylethyl)amino]-ethanone Terconazole Terfenadine Terfenadine impurity A 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl] butan-1-one (ketone) Testosterone Testosterone caproate Testosterone decanoate Testosterone decanoate for system suitability Testosterone enantate Testosterone enantate for peak identification Testosterone enantate for system suitability Testosterone enantate impurity H delta-5-testosterone-3,17-dienantate Testosterone for impurity D identification Testosterone for system suitability Testosterone isocaproate Testosterone isocaproate for system suitability Testosterone propionate Testosterone propionate for system suitability Tetanus vaccine (adsorbed) BRP Tetra-O-acetyl-mannose triflate Tetracaine hydrochloride Tetracaine for system suitability Tetracosactide
10 mg 0.26 mg 50 mg 5 mg
EPY0000345
5 mg
EPY0000346 EPY0000347 EPT0040800 EPY0001114 EPY0000621 EPY0000666 EPY0000622 EPY0000665 EPY0000623 EPY0000624 EPY0000535 EPY0001143 EPT0050000 EPT0050015 EPT0060000 EPT0071000 EPT0080000
5 mg 5 mg 100 mg 0.0042 mg 40 mg 0.5 mg 10 mg 10 mg 10 mg 10 mg 10 mg 10 mg 100 mg 15 mg 250 mg 100 mg 20 mg
EPT0100000 EPT0210000 EPT0240000 EPY0000696 EPT0250000 EPY0001312 EPY0001317 EPY0001313 EPY0000342 EPY0000343 EPT0260000 EPY0000716 EPT0300000 New EPY0001409 EPT0400000 EPY0001087 EPT0500000 EPY0001002 EPT0550000
30 mg 50 mg 50 mg 0.4 mg 100 mg 10 mg 20 mg 10 mg 20 mg 20 mg 50 mg 5 mg 60 mg 5 mg 30 mg 60 mg 100 mg 2 mg 2x0.366mg
302
Edition 2012/2013
Code Product Unit
EPT0600000 EPY0001165 EPY0000015 EPY0000008 EPY0000460 EPY0000723 EPT0700000 EPT0800000 EPY0000294 EPY0000336 EPY0000372 EPY0000373 EPY0000467 EPY0000059
Tetracycline hydrochloride Tetrandrine Tetrazepam - Reference Spectrum Tetrazepam impurity C 7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one Tetryzoline hydrochloride Thebaine Controlled Substance Theobromine Theophylline Theophylline - Reference Spectrum Thiamazole Thiamazol impurity A 2,2-dimethoxy-N-methylethanamine Thiamazol impurity C 1-methyl-2-(methylsulphanyl)-1H-imidazole Thiamine hydrochloride Thiamine impurity E 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl) 4-methyl-4-thiazolidine-2-thione Thiamine nitrate - Reference Spectrum Thiamphenicol Thioctic acid Thioctic acid for system suitability Thioctic acid containing impurity B Thiomersal Thiopental Thiopental for system suitability Thioridazine Thioridazine hydrochloride Thioridazine for system suitability Thioxanthene Thioxanthone Threonine Thymol Tiabendazole Tiamulin for peak identification Tiamulin hydrogen fumarate Tiamulin - Reference Spectrum Tianeptine sodium - Reference Spectrum Tianeptine for system suitability Tianeptine impurity A ethyl 7-bromoheptanoate Tiapride hydrochloride Tiapride N-oxide Tiaprofenic acid Tiaprofenic acid impurity C (2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid Tibolone - Reference Spectrum Tibolone for system suitability Ticarcillin monosodium Ticarcillin impurity A (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]-amino]-4-thia-1azabicyclo[3.2.0]heptane-2-carboxylic acid (decarboxyticarcillin) Ticlopidine hydrochloride
100 mg 20 mg unit 20 mg 10 mg 10 mg 100 mg 100 mg unit 125 mg 15 mg 20 mg 10 mg 10 mg
EPY0000060 EPT1100000 EPY0000546 EPY0000592 EPY0000545 EPY0000109 EPT1200000 New EPY0001478 EPY0000704 EPT1300000 EPY0000541 EPT1305100 EPT1305000 EPT1340000 EPT1350000 EPT1410000 EPY0000414 EPY0000333 EPY0000379 EPY0000151 EPY0000152 EPY0000153 EPT1405000 EPT1405050 EPT1410900 EPT1410910 EPY0000748 EPY0000668 EPY0000465 EPT1420010
unit 125 mg 110 mg 10 mg 30 mg 30 mg 500 mg 10 mg 10 mg 100 mg 0.21 mg 20 mg 10 mg 50 mg 50 mg 50 mg 10 mg 500 mg unit unit 30 mg 20 mg 60 mg 20 mg 50 mg 20 mg unit 10 mg 250 mg 50 mg
EPT1423000
Edition 2012/2013
50 mg
303
Code Product Unit
EPT1423025 EPY0000325 EPY0001270 EPT1450000 EPY0000644 EPT1470000 EPY0000899 EPT1471000 EPT1490000 EPY0000292 EPY0000282 EPY0001188 EPY0001216 EPY0001179 EPY0001189 EPT1500000 EPY0001210 EPY0000383 EPY0000384 EPT1550000 EPT1600000 EPT1610000 EPT1700000 EPY0000154 EPT1707000 EPY0001123 EPY0000461 EPY0000462 EPY0001366 EPY0000155 EPY0000156 EPY0000157 EPY0000072 EPY0000065 EPY0000066
Ticlopidine impurity F 6-(2-chlorobenzyl)4,5,6,7-tetrahydrothieno [3,2-c]pyridine Tilidine hydrochloride hemihydrate - Reference Spectrum Timolol for system suitability Timolol maleate (R)-timolol Tinidazole Tinidazole impurity A 2-methyl-5-nitro-1H-imidazole Tinidazole impurity B 1-(2-ethylsulphonylethyl)-2-methyl-4-nitroimidazole Tinzaparin sodium Tioconazole - Reference Spectrum Tioconazole for system suitability Tiotropium bromide monohydrate Tiotropium impurity F dithiophen-2-ylmethanone Tiotropium impurity mixture Tiotropium for system suitability Tobramycin Tobramycin for identification All-rac-alpha-tocopherol for peak identification All-rac-alpha-tocopheryl acetate for peak identification alpha-Tocopherol alpha-Tocopheryl acetate RRR-alpha-Tocopheryl hydrogen succinate Tolbutamide Tolfenamic acid Tolnaftate Tolnaftate for system suitability Torasemide anhydrous Torasemide for system suitability Torasemide impurity E ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate Tramadol hydrochloride Tramadol impurity A (1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Tramadol impurity E (2RS)-2-[(dimethylamino)methyl]cyclohexanone Tramazoline hydrochloride monohydrate Tramazoline impurity A N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine Tramazoline impurity B mixture of: 1-acetyl-2-[(5,6,7,8-tetrahydronaphthalen-1-yl)amino]-4,5-dihydro-1H-imidazole and N-(4,5-dihydro-1H-imidazol-2-yl)-N-(5,6,7,8-tetrahydronaphthalen-1-yl)acetamide Trandolapril Trandolapril impurity C (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1(ethoxycarbonyl)propyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril) Trandolapril impurity D ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]4-phenylbutanoate (trandolapril diketopiperazine) Tranexamic acid Trapidil
10 mg unit 5.045 mg 100 mg 20 mg 100 mg 10 mg 20 mg 250 mg unit 50 mg 10 mg 10 mg 0.08 mg 10 mg 51 mg 250 mg 15 mg 30 mg 500 mg 500 mg 150 mg 100 mg 100 mg 60 mg 10 mg 10 mg 5 mg 0.0006 mg 75 mg 15 mg 15 mg 20 mg 10 mg 10 mg
EPY0000501 EPY0000495
10 mg 10 mg
EPY0000496
10 mg
EPT1810000 EPT1820000
50 mg 50 mg
304
Edition 2012/2013
Code Product Unit
EPT1820002 EPT1820004 EPY0001172 EPT1850000 EPT1899000 EPG0400010 EPT1899990 EPT1900000 New EPY0001459 EPT1950000 EPY0000050 EPY0000837 EPY0000870 EPT1975000 EPY0000165 EPY0000166 EPY0001055 EPY0000279 EPY0000799 EPT1977990 EPT1977995 EPT1978000 EPY0000111 EPT1985000 EPT1986000 EPT2000000 EPT2005000 EPT2005010 EPY0000720 EPY0000108 EPY0000068 EPT2009000 EPY0001260 EPY0001319 EPY0000092 EPY0000093 EPT2100000 EPT2200000 EPY0000684 EPT2200010 EPT2450000 EPT2500000 EPY0000759 EPT2500100 EPT2501200
Trapidil impurity A 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol Trapidil impurity B 1,2,4-triazol-3-amine Trehalose dihydrate Tretinoin 3,4,6-Tri-O-acetyl-D-glucal - Reference Spectrum Triacetin - Reference Spectrum Triamcinolone Triamcinolone acetonide Triamcinolone acetonide for system suitability Triamcinolone hexacetonide Triamcinolone impurity C 9-fluoro-11-16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione Triamterene Triamterene impurity B 2,7-diamino-6-phenylpteridin-4-ol Triazolam Controlled Substance Tribenoside Tribenoside impurity A 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)--D-glucofuranose Tributyl acetylcitrate Tri-n-butyl phosphate Tributyl acetylcitrate for peak identification Tricaprin Tricaproin Tricaprylin Trichloroacetic acid - Reference Spectrum Trichlorotrifluoroethane Triethyl citrate - Reference Spectrum Trifluoperazine hydrochloride Triflusal Triflusal impurity B 2-hydroxy-4-(trifluoromethyl)benzoic acid Triglycerol diisostearate Trihexyphenidyl hydrochloride Trihexyphenidyl impurity A 1-phenyl-3-(piperidin-1-yl)propan-1-one Trilaurin Trimebutine for system suitability Trimebutine maleate Trimetazidine dihydrochloride - Reference Spectrum Trimetazidine for system suitability Trimethadione Trimethoprim Trimethoprim for system suitability Trimethoprim impurity B (2,4-diaminopyrimidin-5-yl)(3,4,5- trimethoxyphenyl)methanone Trimethyltetradecylammonium bromide Trimipramine maleate Trimipramine for peak identification Trimyristin Tristearin
20 mg 20 mg 250 mg 50 mg unit unit 150 mg 150 mg 10 mg 100 mg 10 mg 10 mg 0.5 mg 10 mg 150 mg 60 mg 1 mL 300 L 25 mg 150 mg 40 mg 225 mg unit 2.5 mL unit 100 mg 50 mg 25 mg 200 mg 100 mg 20 mg 1250 mg 1.017 mg 10 mg unit 50 mg 250 mg 50 mg 0.00075 mg 15 mg 200 mg 100 mg 0.51 mg 500 mg 100 mg
Edition 2012/2013
305
Code Product Unit
EPT2545000 EPY0001184 EPY0001183 EPT2550000 EPT2580000 EPY0001316 EPY0001247 EPY0001248 EPY0000616 EPY0000618 EPT2580300 EPY0000429 EPY0000432 EPY0000431 EPY0000430 EPY0000497 EPT2600000 EPT2610000 EPT2800000 EPT2880000 EPT2880100 EPY0000498 EPT2880200 EPT2900000 EPT3000000 EPU0020000 EPU0020001 EPU0020008
Trolamine Trolamine impurity A Ethanolamine Trolamine impurity B Diethanolamine Trometamol Tropicamide Tropicamide for peak identification Tropicamide impurity C (2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid) Tropicamide impurity D Phenylacetic acid Drug Precursor Tropisetron hydrochloride Tropisetron impurity B 1H-indole-3-carboxylic acid Tropine Trospium chloride Trospium impurity A Hydroxydiphenylacetic acid (benzilic acid) Trospium impurity B (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate Trospium impurity C (1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium] Troxerutin Trypsin BRP Tryptophan Tubocurarine chloride Tylosin Tylosin D Tylosin phosphate for peak identification Tylosin tartrate - Reference Spectrum Tyrosine Tyrothricin Ubidecarenone Ubidecarenone for system suitability Ubidecarenone impurity D 5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl] benzene-1,4-dione Uracil arabinoside Urea Ursodeoxycholic acid Ursodeoxycholic acid for system suitability Ursolic acid Valaciclovir for system suitability Valaciclovir hydrochloride (anhydrous) Valaciclovir impurity D 2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate Valaciclovir impurity E 2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate Valaciclovir impurity F para-toluenesulfonate 2-hydroxyethyl L-valinate Valaciclovir impurity G N,N-dimethylpyridin-4-amine Valerian standardised dry extract Valine
2250 mg 250 mg 1 mL 100 mg 50 mg 10 mg 10 mg 10 mg 40 mg 10 mg 50 mg 10 mg 20 mg 20 mg 5 mg 30 mg 100 mg 100 mg 100 mg 150 mg 5 mg 10 mg unit 50 mg 20 mg 50 mg 1 mg 5 mg
EPU0100000 EPU0600000 EPU0800000 EPY0001163 New EPY0001523 EPY0001225 EPY0000834 EPY0001096 EPY0001097 EPY0001098 EPY0001099 EPY0000583 EPV0030000
306
60 mg 100 mg 100 mg 1.26 mg 25 mg 10 mg 100 mg 10 mg 10 mg 12 mg 10 mg 400 mg 50 mg

Edition 2012/2013
Code Product Unit
EPY0000584 EPY0000533 EPY0000585 EPY0000586
Valnemulin hydrochloride Valnemulin hydrogen tartrate Valnemulin for peak identification Valnemulin impurity E (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate (pleuromulin) Valproic acid Valproic acid for system suitability Valsartan Valsartan for peak identification Valsartan for system suitability Vancomycin hydrochloride Vanillin Varicella vaccine (live) Vecuronium bromide Vecuronium for peak identification Vedaprofen Vedaprofen impurity mixture Venlafaxine hydrochloride Venlafaxine for system suitability Verapamil hydrochloride Verapamil impurity I (2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4)dimethoxyphenyl)ethyl](methyl)amino]ethyl]3-methylbutanenitrile Verapamil impurity M 5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)2-(1-methylethyl)pentanenitrile Verbenalin VERO cells Vigabatrin Vigabatrin impurity A (5RS)-5-ethenylpyrrolidin-2-one Vigabatrin impurity B (2E)-2-(2-aminoethyl)but-2-enoic acid Vigabatrin impurity D 4-aminobutanoic acid Vigabatrin impurity E 2-[(2RS)-2-aminobut-3-enyl]propanedioic acid Viscosimeter calibration liquids Vinblastine sulphate Vinblastine sulfate - Reference Spectrum Vincristine sulphate Vincristine sulfate - Reference Spectrum Vindesine sulphate Vindesine sulfate - Reference Spectrum Vinorelbine tartrate Vinorelbine impurity B 4-O-deacetylvinorelbine Vinpocetine Vinpocetine impurity A (12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (ethyl vincaminate) Vinpocetine impurity B (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1ij][1,5]naphthyridine-12-carboxylate (apovincamine)
10 mg 120 mg 20 mg 10 mg
EPV0033000 New EPY0001422 EPY0001132 EPY0001131 EPY0001145 EPV0045000 EPV0050000 EPY0001198 EPY0000561 EPY0000625 EPY0001093 EPY0001118 EPY0000587 EPY0000588 EPV0100000 EPV0100018
100 mg 10 mg 10 mg 10 mg 0.202 mg 100 mg 100 mg 420 mg 10 mg 10 mg 5 mg 0.006 mg 50 mg 1 mg 100 mg 5 mg
EPV0100026
10 mg
EPY0000661 EPV0180000 New EPY0001400 New EPY0001401 New EPY0001402 New EPY0001404 New EPY0001403 EPV0200000 EPV0300000 EPV0305000 EPV0400000 EPV0405000 EPV0500000 EPV0500010 EPY0000463 EPY0000464 EPY0000589 EPY0000590
11 mg 2x1 mL 10 mg 25 mg 20 mg 50 mg 10 mg 250 mL 5 mg unit 4.98 mg unit 5.11 mg unit 50 mg 7 mg 10 mg 10 mg
EPY0000591
10 mg
Edition 2012/2013
307
Code Product Unit
EPY0000790
Vinpocetine impurity C ethyl(13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (methoxyvinpocetine) Vinpocetine impurity D (12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (dihydrovinpocetine) Vinyl acetate Voriconazole Voriconazole impurity B (2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Voriconazole impurity D (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (epi-voriconazole) Voriconazole impurity E [(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid ((+-)camphorsulfonic acid) Warfarin sodium Warfarin sodium clathrate Xylazine hydrochloride Xylazine impurity C 2,6-dimethylphenyl isothiocyanate Xylazine impurity E N-(2,6-dimethylphenyl)-S-methyldithiourea Xylazine impurity mixture Xylitol Xylometazoline Hydrochloride Xylometazoline impurity A N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl)acetamide Xylose Yohimbine hydrochloride Zidovudine Zidovudine impurity A 1-[(2R,5S)-5-hydroxymethyl-2,5-dihydro-2-furyl]-5-methylpyrimidine-2,4(1H,3H)-dione Zidovudine impurity B 1-(3-chloro-2,3-dideoxy--D-ribofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione Zinc acexamate Zinc acexamate impurity A 6-[[6-(acetylamino)hexanoyl]amino] hexanoic acid Ziprasidone for system suitability 1 Ziprasidone for system suitability 2 Ziprasidone hydrochloride monohydrate Zolpidem tartrate Controlled Substance Zolpidem impurity A N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol [1,2-a]pyridin-3-yl] acetamide Zopiclone Controlled Substance Zopiclone oxide Zuclopenthixol decanoate - Reference Spectrum Zuclopenthixol for system suitability Zuclopenthixol impurity B 2-chloro-9H-thioxanthen-9-one
10 mg
EPY0000760
10 mg
EPY0000793 New EPY0001395 New EPY0001396 New EPY0001398
200 mg 120 mg 10 mg 10 mg
New EPY0001397
50 mg
EPW0100000 EPY0000778 EPX0075000 EPY0000158 EPY0000159 EPY0001224 EPX0080000 EPX0100000 EPX0101000 EPX0200000 EPY0000656 EPZ1900000 EPZ1902000 EPZ1904000 EPZ2000000 EPZ2000010 EPY0001272 EPY0001241 EPY0001286 EPZ2500000 EPZ2500010
10 mg 10 mg 125 mg 50 mg 15 mg 0.02 mg 500 mg 100 mg 10 mg 100 mg 20 mg 60 mg 10 mg 10 mg 50 mg 50 mg 10 mg 0.465 mg 100 mg 200 mg 10 mg
EPZ3000000 EPZ3001000 EPY0000062 EPY0000534 EPY0000083
60 mg 20 mg unit 0.1 mg 10 mg
308
Edition 2012/2013
ATCC microbiology products

As a scientist you know the importance of using the best materials to support your quality control programme. As Europes only officially authorized distributor of ATCC cultures, LGC Standards can supply all ATCC organisms specified in the pharmacopoeia. ATCC maintains the highest standards for its biological materials, employing stringent quality control procedures to produce cultures which are well characterized and have low passage numbers. Long-term subculturing of biological materials can have adverse effects on the culture population, including genetic drift, unwanted selection, contamination, and varied cell responses. ATCC quality control cultures sold by LGC Standards are never subcultured or transferred in any way from ATCCs strains and our European stock-holding means orders are usually filled within 3 - 5 working days. So whether it is quality control strains, genomic DNA, media or growth supplements, antibiotics for selection, or a huge selection of organisms, take the time and guesswork out of ordering your microbiology supplies with authentic, high-quality ATCC materials - exclusively from LGC Standards.
European Pharmacopoeia, 7th Edition (2011-2013), general chapters

Code Product Unit
EP 2.6.1 - Sterility
ATCC-16404 ATCC-6633 ATCC-10231 ATCC-11437 ATCC-19404 ATCC-9027 ATCC-6538 Aspergillus brasiliensis Bacillus subtilis Candida albicans Clostridium sporogenes Clostridium sporogenes Pseudomonas aeruginosa Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp. amp. amp.
EP 2.6.2 - Mycobacteria
ATCC-25177 Mycobacterium tuberculosis amp.
EP 2.6.7 - Mycoplasmas
ATCC-23206 ATCC-19989 ATCC-19610 ATCC-17981 ATCC-29052 ATCC-23714 ATCC-15531 ATCC-25204 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii Mycoplasma fermentans Mycoplasma gallisepticum Mycoplasma hyorhinis Switzer Mycoplasma hyorhinis Mycoplasma orale Mycoplasma pneumoniae Mycoplasma synoviae amp. amp. amp. amp. amp. amp. amp. amp.
EP 2.6.12 - Microbiological examination of non-sterile products

ATCC-16404 ATCC-6633 ATCC-10231 ATCC-9027 ATCC-6538 Aspergillus brasiliensis Bacillus subtilis Candida albicans Pseudomonas aeruginosa Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp.
EP 2.6.13 - Microbiological examination of non-sterile products

ATCC-10231 ATCC-11437 ATCC-19404 ATCC-8739 ATCC-9027 ATCC-14028 ATCC-6538 Candida albicans Clostridium sporogenes Clostridium sporogenes Escherichia coli Pseudomonas aeruginosa Salmonella enterica subsp. enterica serovar Typhimurium Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp. amp. amp.
EP 2.6.27 - Microbiological control of cellular products

ATCC-16404 ATCC-6633
Edition 2012/2013
Aspergillus niger Bacillus subtilis

Looking for impurity reference standards with CofAs? See our LGC impurity chapter from page 11 on.
amp. amp.
309
European Pharmacopoeia, 7th Edition (2011-2013), general chapters

Code Product Unit
ATCC-10231 ATCC-19404 ATCC-11437 ATCC-9027 ATCC-6538
Candida albicans Clostridium sporogenes Clostridium sporogenes Pseudomonas aeruginosa Staphylococcus aureus ss. aureus
amp. amp. amp. amp. amp.
EP 2.7.2 - Microbiological assay of antibiotics

ATCC-14884 ATCC-11774 ATCC-6633 ATCC-4617 ATCC-10541 ATCC-9637 ATCC-10536 ATCC-10031 ATCC-9341 ATCC-10240 ATCC-607 ATCC-9763 ATCC-9144 ATCC-6538P ATCC-12228 Bacillus pumilus Bacillus subtilis Bacillus subtilis Bordetella bronchiseptica Enterococcus hirae (as Streptococcus faecalis) Escherichia coli Escherichia coli Klebsiella pneumoniae ss. pneumoniae Kocuria rhizophila Micrococcus luteus Mycobacterium smegmatis Saccharomyces cerevisiae Staphylococcus aureus ss. aureus Staphylococcus aureus subsp. aureus Staphylococcus epidermidis amp. amp. amp. amp. amp. amp. amp. amp. amp. amp. amp. amp. amp. amp. amp.
EP 5.1.1 - Methods of preparation of sterile products

ATCC-19146 Brevendimonas diminuta (as Pseudomonas diminuta) amp.
EP 5.1.2 - Biological indicators of sterilisation

ATCC-27142** ATCC-7953** ATCC-9372** Bacillus pumilus Bacillus stearothermophilus Bacillus atrophaeus amp. amp. amp.
EP 5.1.3 - Efficacy of antimicrobial preservation

ATCC-16404 ATCC-10231 ATCC-8739 ATCC-9027 ATCC-6538 Aspergillus brasiliensis Candida albicans Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus ss. aureus ** = Alternative strain All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia directly to confirm the testing requirements and recommended organisms before ordering or undertaking the testing procedures as described in the Pharmacopoeia. amp. amp. amp. amp. amp.
310
Edition 2012/2013
Certified Liquids for Viscosity Measurements in the European Pharmacopoeia
Certified Liquids for Viscosity Measurements in the European Pharmacopoeia

Newtonian liquids with a certified viscosity are supplied by Van Swinden Laboratorium BV and are distributed by LGC Standards. Liquids are available with kinematic viscosities up to 48000 mm2s-1 and certified at temperatures between 15C and 140C. Viscosities are certified in mm2s-1 (kinematic viscosity, v) or in mPa.s (dynamic viscosity,) 1 mPa.s = 1 cps (centipoise) 1 mm2.s-1= 1 cst (centistoke) Standard liquids are available from stock, in 250 ml packs and certified at 20C to following viscosities: v = 0,6 ; 1,0 ; 2,2; 4,9 ; 1; 20 ; 31 ; 56 ; 67 ; 85 ; 100 ; 132 ; 167 ; 217 ; 262; 340 ; 423 ; 537 ; 644 ; 783 ; 1000 ; 1260 ; 1800 ; 3650 ; 5075 ; 10175 ; 18400 ; 46500 = 0,4 ; 1,0 ; 1,8; 4,0 ; 8,9 ; 17,0 ; 26,0 ; 48,0 ; 58,0 ; 74,0 ; 87,0 ; 116,0 ; 146,0 ; 191,0 ; 230,0 ; 300,0 ; 375,0 ; 474,0 ; 572,0 ; 700,0 ; 862,0 ; 1085 ; 1560 ; 3175 ; 4430 ; 8935 ; 16300 ; 41300 All viscosities are calibrated relative to the viscosity of pure water. Stated values are nominal values, certified values will not deviate more than 10% from the nominal value. The uncertainty of the certified viscosities is at least 0.3% at the lowest viscosity, increasing up to 0.5% at 48000 mm2.s-1.
Shelf life
Standards up to 500 mPa.s are mineral oil based, and have a shelf life of 12 months from date of certification. Above 500 mPa.s Polyisobutylene is used, these materials have a shorter shelf life, and should be ordered as needed. Liquids can be prepared and certified to any viscosity between 0.6 mm2.s-1 and 80,000 mm2.s-1. The price depends on the viscosity required, the degree of precision between nominal viscosity required and certified viscosity achieved, and temperature of certification. Additional charges are applied for extra certification temperatures and for certification of dynamic viscosity. Please ask for a quotation. Liquids supplied by customers may be certified for viscosity, charges vary: please ask for a quotation.
Edition 2012/2013
311
International Commission on Pharmaceutical Enzymes
International Commission on Pharmaceutical Enzymes

The Commission on Pharmaceutical Enzymes was formed in 1960, with a remit to establish quantitative methods and an exact definition of enzyme activity for pharmacologically significant enzymes. One consequence of the work of FIP Federation International Pharmaceutique has been the production and certification of reference substances for both enzymes and substrates. More recently the work of the Commission has been reflected in those monographs of the European Pharmacopoeia which call for enzyme standards. The FIP products marked (EP) in this list are those which are required in certain EP monographs.
Enzymes
Code Product Unit
FIP1 FIP2(EP) FIP3 FIP4 FIP5 FIP6(EP) FIP7 FIP8(EP) FIP9 FIP10 FIP11(EP) FIP12(EP) FIP13(EP) FIP14(EP)
Fungal Amylase Amylase (pancreatic) Fungal Protease Bromelain Endocellulase Chymotrypsin Fungal Lipase Lipase (pancreatic) Lysozyme hydrochloride Papain Pepsin Protease (pancreatic) Trypsin Hyaluronidase
2g 2g 2g 250 mg 1g 100 mg 500 mg 2g 250 mg 2g 2g 2g 100 mg 50 mg
Substrates
FIP15(EP) FIP16 FIP17(EP) FIP18(EP) FIP19 FIP20 FIP21(EP) FIP22(EP) Enterokinase Micrococcus Luteus sp. Starch (EP) Casein Haemoglobin Hydroxyethylcellulose Sodium Taurocholate Sodium hyaluronate 200 mg 1g 50 g 100 g 10 g 100 g 10 g 300 mg
312
Edition 2012/2013
European Pharmacopoeia Reagents

Chapters 2 and 4 of the European Pharmacopoeia describe the preparation of several hundred reagents and standards used for the testing of pharmaceutical raw materials. LGC Standards offers a large number of these ready-to-use reagents and standard solutions within the spectrum of this new catalogue. The primary solutions for coloration are produced by LGC Standards, the other reagents are manufactured by Reagecon. All are manufactured and tested in compliance with the prescriptions of EP. The products are supplied with certificates of analysis. Lot numbers and expiry dates are stated on all product labels as well. The reagents are always supplied as per the most recently issued EP supplement. Reagents from other pharmacopoeias are also available on request. Please contact your local LGC Standards office for further details.
Reagents as outlined in Chapter 2

Code Product Unit
REAEPPOSO1
Primary opalescence suspension
100 mL
Coloration: primary solutions

WESEPYS01 WESEPRS01 WESEPBS01 Coloration-primary solution yellow Coloration-primary solution red Coloration-primary solution blue 100 mL 100 mL 100 mL
Coloration: standard solutions

REAEP703 REAEP704 REAEP706 REAEP705 REAEP707 REAHADM1 Standard solution B (brown) Standard solution BY (brownish yellow) Standard solution Y (yellow) Standard solution GY (greenish yellow) Standard solution R (red) HCL dilution matrix (10 g/l HCl) 125 mL 100 mL 125 mL 125 mL 125 mL 1L
Reference buffer solutions - all @ 25C

REAEP168 REAEP401 REAEP687 REAEP741 REAEP918 ph Buffer solution 1.68 @ 25C ph Buffer solution 4.01 @ 25C ph Buffer solution 6.87 @ 25C ph Buffer solution 7.41 @ 25C ph Buffer solution 9.18 @ 25C 500 mL 500 mL 500 mL 500 mL 500 mL
Conductivity & resistivity solutions - @ 20C

REAEP1330 Conductivity standard
Electrolytic conductivity ............. 1330 S/cm at 20C Resistivity ................................................... 752 cm
500 mL
REAEP133
Conductivity standard
Electrolytic conductivity ............... 133 S/cm at 20C Resistivity ................................................. 7519 cm
500 mL
REAEP266
Conductivity standard 26.6 uS/cm

Electrolytic conductivity .............. 26.6 S/cm at 20C Resistivity ............................................... 37594 cm
500 mL
Reagents as outlined in Chapter 4 (4.1) of Ph. Eur.

REA1000401 REA1000402 REA1000501 REA1002501 REA1004702 REA1004703 REA1005201 REA1007301 REA1007302
Edition 2012/2013
Acetic acid (30%) Acetic acid, dilute (12%) Acetic anhydride solution R1 Alcohol, aldehyde free Ammonia, dilute R1 Ammonia, dilute R2 Ammonium carbonate solution Anisaldehyde, solution Anisaldehyde, solution R1
1L 1L 1L 1L 1L 1L 1L 100 mL 100 mL
313

Code Product Unit
REA1009301 REA1009401 REA1011601 REA1012601 REA1012602 REA1012701 REA1012801 REA1012803 REA1012901 REA1015201 REA1022901 REA1023100 REA1023300 REA1031101 REA1032101 REA1032102 REA1037702 REA1038100 REA1039101 REA1039401 REA1039402 REA1043101 REA1043501 REA1043503 REA1043504 REA1045901 REA1046300 REA1048001 REA1048101 REA1048102 REA1052101 REA1053601 REA1054801 REA1054802 REA1055101 REA1055102 REA1056700 REA1056801 REA1057601 REA1058303 REA1058304 REA1058305 REA1058402 REA1062901 REA1063601 REA1063603 REA1063702 REA1063703 REA1065000 REA1065200 REA1065801
314
Barium chloride, solution R1 Barium hydroxide, solution Biuret reagent Bromocresol green solution Bromocresol green-methyl red solution Bromocresol purple solution Bromophenol blue solution Bromophenol blue solution R2 Bromothymol blue solution R1 Calcium sulphate solution Crystal violet solution Cupri-citric solution Cupri-tartaric (Solution I 500 mL & Solution II 500 mL) Dimidium bromide - sulphan blue mixed solution Diphenylamine solution Diphenylamine solution R1 Ferric ammonium sulphate solution R2 Ferroin Formaldehyde solution Fuchsin solution, decolorised Fuchsin solution, decolorised R1 Holmium perchlorate solution Hydrochloric acid R1 Hydrochloric acid, dilute Hydrochloric acid, dilute R1 Iodine bromide solution Iodoplatinate reagent Lanthanum nitrate solution Lead acetate cotton Lead acetate paper Mercuric bromide paper Methoxyphenylacetic reagent Methyl orange mixed solution Methyl orange solution Methyl red mixed solution Methyl red solution Molybdovanadic reagent Mordant black 11 triturate Naphtobenzein solution Ninhydrin, solution Ninhydrin solution R1 Ninhydrin solution R2 Nitric Acid, Dilute Perchloric acid solution Phenol red solution Phenol red solution R2 Phenolphthalein solution Phenolphthalein solution R1 Phosphomolybdotungstic reagent Phosphomolybdotungstic solution Picric acid solution
1L 1L 1L 100 mL 100 mL 100 mL 100 mL 100 mL 100 mL 1L 100 mL 1L 2x500 mL 1L 1L 1L 1l 100 mL 100 mL 100 mL 100 mL 1L 1L 1L 1L 1L 200 mL 1L 10 g Pck. Pck. 100 mL 100 mL 100 mL 100 mL 100 mL 100 mL 100 g 100 mL 100 mL 100 mL 100 mL 100 mL 100 mL 100 mL 500 mL 100 mL 100 mL 100 mL 100 mL 100 mL
Edition 2004/2005

Code Product Unit
REA1065802 REA1069101 REA1069201 REA1069501 REA1069801 REA1070001 REA1070302 REA1070303 REA1070501 REA1070502 REA1070600 REA1070602 REA1070902 REA1071301 REA1071600-A REA1071600-B REA1075201 REA1078301 REA1078302 REA1079301 REA1081401 REA1081402 REA1081404 REA10816005 REA1083901 REA1085103 REA1086804 REA1089602 REA1090701 REA1094201 REA1102301 REA1096601 REA1096602
Picric acid solution R1 Potassium chloride, 0.1 M Potassium chromate, solution Potassium dichromate, solution Potassium ferrocyanide, solution Potassium hydrogen phthalate, 0.2 M Potassium hydroxide in alcohol (10% v/v) Potassium hydroxide solution alcoholic Potassium iodide and starch solution Potassium iodide solution Potassium iodobismuthate, solution Potassium iodobismuthate, solution R2 Potassium permanganate, solution Potassium pyroantimonate, solution Potassium tetraiodomercurate solution, alkaline (Part A) Potassium tetraiodomercurate solution, alkaline (Part B) Ruthenium red solution Silver nitrate solution R1 Silver nitrate solution R2 Sodium carbonate solution Sodium hydroxide solution Sodium hydroxide solution dilute Sodium hydroxide solution strong Sodium hypochlorite solution strong Sodium sulfure solution Starch, solution Sulphuric acid, dilute Thiocetamide solution Thymolphthalein solution Tris(hydroymethyl) aminomethane solution Zinc acetate solution Zinc chloride formic acid solution Zinc chloride solution, iodinated
100 mL 1L 1L 1L 100 mL 1L 1L 100 mL 125 mL 1L 100 mL 100 mL 1L 125 mL 100 mL 100 mL 100 mL 1L 1L 1L 1L 1L 1L 500 mL 100 mL 100 mL 1L 1L 100 mL 100 mL 1L 1L 1L
Standard solutions for limit tests as outlined in Chapter 4 (4.1.2) of Ph. Eur.
REA5000200 REA5000300C REA5000500C REA5000700C REA5000800C REA5000802C REA5000900C REA5001000 REA5001100 REA5001200C REA5001400C REA5001600C REA5001602C REA5001701C REA5001800C REA5002000C Aluminium standard solution (200 ppm Al) Ammonium standard solution (100 ppm NH4) Arsenic standard solution (10 ppm As) Cadmium standard solution (0.1% Cd) Calcium standard solution (400 ppm Ca) Calcium standard solution alcoholic (400 ppm Ca) Chloride standard solution (8 ppm CI) Chromium standard solution (100 ppm Cr) Copper standard solution (0.1% Cu) Ferrocyanide standard solution (100 ppm Fe) Fluoride standard solution (10 ppm F) Iron standard solution (20 ppm Fe) Iron standard solution (8 ppm Fe) Lead standard solution (100 ppm Pb) Magnesium standard solution (100 ppm Mg) Nickel standard solution (10 ppm Ni) 100 mL 100 mL 100 mL 100 mL 100 mL 1L 100 mL 1L 100 mL 100 mL 100 mL 100 mL 100 mL 100 mL 100 mL 100 mL
Edition 2012/2013
315

Code Product Unit
REA5002100C REA5002200C REA5002400C REA5002700C REA5002800C REA5003100C REA5003401C
Nitrate standard solution (100 ppm NO3) Phosphate standard solution (5 ppm PO4) Potassium standard solution (100 ppm K) Sodium standard solution (200 ppm Na) Sulphate standard solution (10 ppm SO4) Tin standard solution (5 ppm Sn) Zinc standard solution (100 ppm Zn)
100 mL 100 mL 100 mL 100 mL 100 mL 1L 100 mL
Buffer solutions as outlined in Chapter 4 (4.1.3) of Ph. Eur.

REA4000100 REA4000600 REA4001400 REA4004800 REA4008300 REA4007200 REA4007300 Buffered acetone solution Buffer solution pH 3.5 Acetate buffer solution pH 4.6 Phosphate buffer solution pH 7.4 Buffer (phosphate) solution pH 9.0 Ammonium chloride buffer solution pH 9.5 Ammonium chloride buffer solution pH 10.0 1L 1L 1L 1L 1L 1L 1L
Volumetric solutions as outlined in Chapter 4 (4.2.2) of Ph. Eur.

REA3000100 REA3000200 REA3000300 REA3000500 REA3000600 REA3000900 REA3001100 REA3008700 REA3001300 REA3001500 REA3001700 REA3001800 REA3002100 REA3008800 REA3002700 REA3003100 REA3003300 REA3003500 REA3003900 REA3004200 REA3002900 REA3009100 REA3004800 REA3004900 REA3005000 REA3005100 REA3005300 REA3005600 REA3009300 REA3005800 REA3005900 REA3006300 REA3006600 REA3007000
316
0.1M Ammonium and cerium nitrate 0.01M Ammonium and cerium nitrate 0.1M Ammonium and cerium sulphate 0.1M Ammonium thiocyanate 0.1M Barium chloride 0.004M Benzethonium chloride 0.1M Cerium sulphate 1M Cupriethylenediamine hydroxide solution 0.1M Ferric ammonium sulphate 6M Hydrochloric acid 2M Hydrochloric acid 1M Hydrochloric acid 0.1M Hydrochloric acid 0.1M Hydrochloric acid, alcoholic 0.05M Iodine 0.1M Lead nitrate 0.1M Lithium methoxide 0.02M Mercuric nitrate 0.1M Perchloric acid 0.033M Potassium bromate 0.01M Iodine 11M Potassium hydroxide 0.1M Potassium hydroxide 0.5M Potassium hydroxide 0.5m Potassium Hydroxide, Alcoholic 0.1M Potassium hydroxide, alcoholic 0.02M Potassium permanganate 0.1M Silver nitrate 0.001M Sodium nitrate 0.1M Sodium arsenite 0.1M Sodium edetate 1M Sodium hydroxide 0.1M Sodium hydroxide 0.1M Sodium hydroxide, ethanolic
1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L
Edition 2004/2005

Code Product Unit
REA3007100 REA3007200 REA3007300 REA3007800 REA3008000 REA3008300 REA3008400 REA3008600
0.1M Sodium methoxide 0.1M Sodium nitrate 0.1M Sodium thiosulphate 0.5M Sulphuric acid 0.05M Sulphuric acid 0.1M Tetrabutylammonium hydroxide 0.1M Tetrabutylammonium hydroxide in 2-propanol 0.1M Zinc sulphate
1L 1L 1L 1L 1L 1L 1L 1L
Edition 2012/2013
317
WHO International Standards for Antibiotics
WHO International Standards for Antibiotics

In 2006, the EDQM has been designated a WHO Collaborative Centre for the International Standards for Antibiotics (ISA). These standards are essential in the standardisation and quality control of antibiotic material and pharmaceutical products. They are supplied for assays described in the specifications for quality control of antibiotic material. The EDQM is for example responsible for the establishment and storage of the WHO ISA materials. All biological preparations listed in this catalogue are supplied exclusively as WHO ISA materials for use as primary standards in the establishment of National/Regional secondary working standards and for no other purpose. You can order the ISA materials directly with your supplies for other reference materials available from LGC Standards. For further information please contact your local LGC Standards office.
Code
Product
Unit
EPISA_28168 EPISA_29078 EPISA_29384 EPISA_39036 EPISA_62_003 EPISA_62_008 EPISA_62_013 EPISA_65_062 EPISA_66_231 EPISA_66_254 EPISA_67_301 EPISA_68_041 EPISA_72_406 EPISA_76_538 EPISA_76_539 EPISA_78_547 EPISA_80_543 EPISA_82_510 EPISA_83_521 EPISA_83_577 EPISA_90_704 EPISA_92_670 EPISA_TYN
Gramicidin Second International Standard for Amphotericin B Third International Standard for Nystatin Vancomycin Bacitracin Spiramycin Dihydrostreptomycin Colistin Rifamycin SV Colistin Methane Sulfonate Polymoyxin B Neomycin B Neomycin Erythromycin Streptomycin Bleomycin Complex A2/B2 Sisomicin Tobramycin Kanamycin Netilmicin Teicoplanin Gentamicin Tylosin
100 mg 100 mg 100 mg 100 mg 100 mg 50 mg 200 mg 75 mg 100 mg 75 mg 75 mg 25 mg 50 mg 75 mg 100 mg 7 mg 63 mg 11.2 mg 13 mg 7.5 mg 54 mg 50 mg 40 mg
318
Edition 2012/2013
Background
British Pharmacopoeia chemical reference substances (BPCRS) available from BP are issued under the authority of the British Pharmacopoeia Commission and are solely for use in tests and assays of the British Pharmacopoeia or the British Pharmacopoeia (Veterinary). The list in this catalogue is current as of July 2012, and includes all available BPCRS needed to follow the current official monographs. Most BP monographs for active substances conform with the monographs issued by the European Pharmacopoeia, and so require the use of European Pharmacopoeia chemical reference substances. Details of these are to be found under the European Pharmacopoeia section of this catalogue.

British Pharmacopoeia reference substances and preparations are selected and verified by the BP Laboratories as being suitable for the use as prescribed in the relevant monographs of the British Pharmacopoeia.
Documentation
BPCRS are of two types normal CRS for identification purposes and Assay Standards. Assay Standards are provided with a documented assay value, determined by the BP Laboratories. The BP laboratories do not make available any other BPCRS certificates of analysis or other information, in connection with the prescribed use of the BPCRS.
Controlled drugs are subject to import and export control restrictions. Please contact LGC Standards for details.
Shelf life, expiry dates and size units

British Pharmacopoeia chemical reference substances are subjected to regular inspection and repeat analysis by BP scientific staff. Each BPCRS is, on receipt by the customer, fit for the intended use. BP supplies only current lots. Formally, all BPCRS are supplied with three months shelf life. For this reason users are advised to order only as many units as required immediately. Please note, that new lots can have different unit sizes, especially with pharmacopoeial reference standards, and LGC Standards is not responsible for such cases. If the unit size of a new batch changes, LGC Standards will provide this information to customers in new lot lists. Once opened, BP can no longer guarantee the stability of the material and any of the CRS/BRP not used should be disposed of and not kept for future use.
Products
Code Product Unit
BP 001 BP 904 BP 681 BP 907 BP 438 BP 003 BP 763 BP 436 BP 006 BP 007 BP 825 New BP 847 BP 415 New BP 870 BP 831 BP 832
Edition 2012/2013
Acepromazine maleate Acetazolamide Assay Standard 4-Acetyl 2-fluorobiphenyl Acetylcysteine Assay Standard Aciclovir Assay Standard Adrenaline (epinephrine) acid tartrate Assay Standard Albendazole Assay Standard Alexandrian senna fruit powder Assay Standard Alfadolone acetate Assay Standard Alfaxalone Assay Standard Alfuzosin hydrochloride Assay Standard Alfuzosin impurity standard Alimemazine tartrate Assay Standard Allopurinol Allopurinol Impurity A Allopurinol Impurity B
50 mg 600 mg 25 mg 200 mg 100 mg 100 mg 100 mg 1g 100 mg 100 mg 100 mg 25 mg 100 mg 200 mg 20 mg 10 mg
321
Code Product Unit
BP 843 BP 844 BP 845 BP 560 BP 725 BP 724 BP 530 BP 853 BP 008 BP 010 BP 374 BP 839 BP 813 BP 012 BP 011 BP 602 BP 684 BP 881 BP 417 BP 601 BP 536 BP 014 BP 532 BP 785 BP 021 BP 015 BP 016 BP 019 BP 748 BP 546 BP 694 BP 461 BP 617 BP 492 BP 370 BP 023 BP 366 BP 024 BP 025 BP 534 BP 515 BP 516 BP 517 BP 527 New BP 026 BP 028 BP 535 BP 030 BP 760 BP 761 BP 685
322
Allopurinol Impurity C Allopurinol Impurity D Allopurinol Impurity E 9-Allyl-2-chlorothioxanthen-9-ol Alverine citrate Assay Standard Alverine citrate impurity standard solution Amantadine hydrochloride Assay Standard Amikacin sulfate Assay Standard Amiloride hydrochloride Assay Standard 4-Amino-6-chlorobenzene-1-3-disulphonamide 3-Amino-6-chloro-1-methyl-4-phenylquinolin-2-ol 3-amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one 2-Amino-5-chloropyridine 2-Amino-4,6-Dichlorophenol hydrochloride 7-Aminodesacetoxycephalosporanic acid (E)-4-Amino-2-ethylidenebutyric acid hydrochloride Aminoglutethimide Assay Standard Aminoglutethimide impurity A 2-Amino-1-(4-nitrophenyl)propane-1,3-diol 3-Aminopent-4-ene-1,1-dicarboxylic acid 3-Amino-4-phenoxy-5-sulphamoylbenzoic acid 3-Amino-4-propoxybenzoic acid Amiodarone hydrochloride Assay Standard Anhydrous Ampicillin Assay Standard Ampicillin trihydrate Amitraz Assay Standard Amitriptyline hydrochloride Assay Standard Amoxicillin Trihydrate Assay Standard Amoxicillin impurity standard Apramycin Arginine hydrochloride Assay Standard Ascorbic acid Aspirin Assay Standard Atenolol Assay Standard Atenolol impurity standard Atropine sulfate Assay Standard 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-o-tolylsulphonylurea 2-Azahypoxanthine Azaperone Assay Standard Azapropazone Assay Standard Azapropazone Impurity A Azapropazone Impurity B Azapropazone Impurity C Azapropazone impurity standard Azathioprine Assay Standard Baclofen Assay Standard Baclofen lactam Beclometasone dipropionate Assay Standard Beclometasone 17-propionate Beclometasone 21-propionate Benserazide hydrochloride Assay Standard
10 mg 10 mg 20 mg 25 mg 100 mg 1 mL 200 mg 200 mg 100 mg 50 mg 50 mg 25 mg 25 mg 50 mg 20 mg 25 mg 100 mg 20 mg 50 mg 25 mg 25 mg 50 mg 100 mg 250 mg 500 mg 200 mg 150 mg 500 mg 25 mg 250 mg 100 mg 100 mg 100 mg 100 mg 50 mg 200 mg 30 mg 50 mg 100 mg 100 mg 10 mg 10 mg 10 mg 50 mg 100 mg 150 mg 25 mg 100 mg 25 mg 25 mg 100 mg
Edition 2012/2013
Code Product Unit
New BP 968 BP 036 BP 610 BP 426 BP 611 BP 037 BP 609 BP 824 BP 575 BP 041 BP 042 BP 043 BP 686 BP 755 BP 046 BP 047 BP 612 BP 613 BP 050 BP 440 BP 793 New BP 894 BP 537 BP 479 BP 403 BP 192 BP 531 BP 766 BP 355 BP 059 BP 538 BP 477 BP 523 BP 060 BP 749 BP 711 BP 767 BP 567 BP 792 BP 784 BP 061 BP 562 BP 819 BP 820 BP 063 BP 976 BP 977 BP 502 BP 925 BP 757 BP 926
Edition 2012/2013
Benserazide Impurity A Benzatropine mesilate Assay Standard Benzydamine hydrochloride Assay Standard Benzyl benzoate Assay Standard 1-Benzyl-3-(3-diethylamino-propoxy)-1H-indazole (1S,2R)-1-benzyl-3-dimethylamino-2-methyl-1-phenylpropyl acetate 1-Benzyl-1-H-indazol-3-ol Betahistine dihydrochloride Assay Standard Betamethasone Assay Standard Betamethasone sodium phosphate Betamethasone valerate Assay Standard Betamethasone 21-valerate Betaxolol hydrochloride Assay Standard Bezafibrate Assay Standard 2-(Biphenyl-4-yl)propionic acid Bisacodyl Assay Standard Bretylium tosilate Assay Standard 2-Bromobenzyldimethylamine hydrochloride Bromocriptine Mesilate Assay Standard Buclizine hydrochloride impurity standard Budesonide Assay Standard Budesonide impurity standard Bumetanide Assay Standard Bupivacaine hydrochloride Assay Standard Busulfan Assay Standard 2-tert-Butylamino-1-(4-hydroxy-3-methylphenyl)ethanol sulphate 2-Butyl-3-(4-hydroxy-3,5-di-iodobenzoyl)benzofuran Caffeine Assay Standard Calcitonin (salmon) Assay Standard Capreomycin sulfate Captopril Assay Standard 2-Carbamoyl-1-methyl-3-[2-(5-methylimidazol-4-yl-methylthio)ethyl]guanidine dihydrochloride Carbaryl Assay Standard Carbidopa Assay Standard Carbimazole Assay Standard Carboplatin Assay Standard Carmellose sodium Assay Standard Carteolol hydrochloride Assay Standard Cefaclor Assay Standard Cefadroxil Assay Standard Cefalexin Assay Standard Cefalonium Assay Standard Cefazolin Sodium Cefoxitin Sodium Assay Standard Cefradine Assay Standard Ceftriaxone sodium Assay Standard Ceftriaxone sodium E-isomer Cefuroxime axetil Assay Standard Cefuroxime sodium Assay Standard Celiprolol hydrochloride Assay Standard Chenodeoxycholic acid
20 mg 100 mg 100 mg 0.1 mL 50 mg 25 mg 50 mg 100 mg 100 mg 100 mg 100 mg 50 mg 100 mg 100 mg 25 mg 100 mg 200 mg 0.1 mL 100 mg 50 mg 110 mg 10 mg 100 mg 100 mg 25 mg 25 mg 25 mg 100 mg 1 mL 50 mg 100 mg 25 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 450 mg 100 mg 150 mg 100 mg 150 mg 200 mg 300 mg 100 mg 10 mg 100 mg 150 mg 100 mg 25 mg
323
Code Product Unit
BP 064 BP 854 BP 067 BP 068 BP 441 BP 756 BP 604 BP 376 BP 442 BP 470 BP 049 BP 446 BP 071 BP 965 BP 378 BP 443 BP 074 BP 075 BP 076 BP 559 BP 077 BP 079 BP 080 BP 081 BP 856 BP 467 BP 491 BP 783 BP 618 BP 475 BP 809 New BP 929 BP 833 BP 834 BP 525 BP 084 BP 507 BP 522 BP 521 BP 482 BP 406 BP 663 BP 543 BP 980 BP 983 BP 981 BP 484 BP 085 BP 565
Chlorambucil Assay Standard Chloramphenicol Assay Standard Chlorcyclizine hydrochloride Chlorhexidine acetate Assay Standard 1,4-bis(4-Chlorobenzhydryl)piperazine N-p-chlorobenzoyltyramine 4-Chlorobenzylphthalazinone 6-Chloro-4-(2-chlorophenyl)quinazoline-2-carboxaldehyde 6-Chloro-1,4-dihydro-1-methyl-4-phenylquinazolin-4-ol 7-Chloro-1-5-dihydro-5-phenyl-1,5-benzodiazepine-2,4(3H)-dione 17,17'-bis(3-[bis-(2-chloroethyl)carbamoyloxy] estra-1,3,5,(10)-trienyl)pyrophosphate 5-(2-Chloroethyl)-4-methyl-3-[2-(4-methylthiazol-5-yl)ethyl]thiazolium chloride 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulphonamide 5-Chloro-1-methyl-4-nitroimidazole 5-Chloro-2-methylaminobenzophenone 6-(2-Chlorophenyl)-2,4-dihydro-2-[(dimethylamino)methylene] 8-nitroimidazo[1,2-a][1,4]benzodiazepin-1-one 4-Chloro-5-sulphamoylanthranilic acid 2-(4-Chloro-3-sulphamoylbenzoyl)benzoic acid Chlorothiazide 2-Chlorothioxanthone 2-(6-Chlorothymoxy)ethyldimethylamine hydrochloride 2-Chlorotritanol Chloroxylenol Assay Standard Chlorphenamine maleate Assay Standard Chlorpromazine hydrochloride Chlorpromazine sulphoxide Chlortalidone Assay Standard Chlortetracycline hydrochloride Assay Standard Cholic acid Assay Standard Cimetidine Assay Standard Cisplatin Assay Standard Ciprofloxacin Hydrochloride Assay Standard Clarithromycin Assay Standard Clarithromycin Impurity E Clemastine fumarate Assay Standard Clioquinol Assay Standard Clobazam Assay Standard Controlled Substance Clobetasol Impurity A Clobetasol propionate Assay Standard Clobetasone butyrate Assay Standard Clocortolone hexanoate Clofazimine Assay Standard Clomethiazole edisilate Assay Standard Clomipramine hydrochloride Clomipramine Impurity F Clomipramine Impurity C Clonazepam Assay Standard Controlled Substance Clonidine hydrochloride Assay Standard trans-Clopenthixol acetate dihydrochloride
100 mg 500 mg 100 mg 100 mg 25 mg 25 mg 25 mg 50 mg 25 mg 25 mg 25 mg 25 mg 25 mg 100 mg 50 mg 25 mg 25 mg 25 mg 100 mg 25 mg 25 mg 25 mg 500 mg 100 mg 50 mg 50 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 20 mg 200 mg 200 mg 100 mg 25 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 10 mg 10 mg 100 mg 100 mg 50 mg
324
Edition 2012/2013
Code Product Unit
BP 566 BP 561 BP 628 BP 379 BP 088 BP 905 BP 091 BP 715 BP 514 BP 090 BP 787 BP 614 BP 551 BP 585 BP 094 BP 466 BP 478 BP 096 BP 886 BP 098 BP 380 BP 688 BP 383 BP 100 BP 771 BP 428 BP 429 BP 102 BP 103 BP 104 BP 791 BP 572 BP 631 BP 632 BP 789 BP 889 BP 504 BP 730 BP 987 BP 931 BP 689 BP 568 BP 816 BP 817 BP 594 BP 578 BP 108 BP 646 BP 811 BP 465 BP 549
Edition 2012/2013
trans-Clopenthixol decanoate dihydrochloride trans-Clopenthixol hydrochloride Cloprostenol sodium Assay Standard Clotrimazole Assay Standard Cloxacillin benzathine Assay Standard Clozapine Assay Standard Co-dergocrine mesilate Assay Standard Cocaine hydrochloride Assay Standard Controlled Substance Codeine hydrochloride Assay Standard Controlled Substance Codeine Phosphate Assay Standard Controlled Substance Colecalciferol Assay Standard Colestipol hydrochloride Colestyramine Assay Standard Cortisone acetate Assay Standard Crotamiton Assay Standard Cyanocobalamin Assay Standard 2-Cyano-1-methyl-3-[2-(5-methylimidazol-4-yl-methylsulphinyl)ethyl]guanidine Cyclizine hydrochloride Assay Standard Cyclobenzaprine hydrochloride Cyclopenthiazide Cyclopentolate hydrochloride Assay Standard Cyproterone acetate Assay Standard Cytarabine Assay Standard Dacarbazine Dantrolene Assay Standard Dantron Dantron impurity standard Dapsone Assay Standard Debrisoquine sulfate Decoquinate Delta-3-Cefaclor Deltamedrane Deltamethrin Assay Standard Deltamethrin impurity standard Demeclocycline hydrochloride Assay Standard N-Demethylerythromycin A Desacetylmetipranolol N-Desalkylflurazepam Desferrioxamine mesilate Desipramine hydrochloride Desmethyl benzatropine hydrochloride Desogestrel Assay Standard Desogestrel Impurity D Desogestrel Impurity E Desogestrel 3-isomer Dexamethasone Assay Standard Dexamethasone sodium phosphate Dexamethasone phosphate Assay Standard Dexamethasone impurity standard Dextropropoxyphene HCl Assay Standard Controlled Substance Diacetylfluorescein Assay Standard
25 mg 25 mg 50 mg 50 mg 250 mg 100 mg 50 mg 100 mg 100 mg 200 mg 500 mg 50 mg 500 mg 100 mg 100 mg 150 mg 25 mg 100 mg 25 mg 100 mg 100 mg 100 mg 100 mg 25 mg 100 mg 50 mg 100 mg 100 mg 100 mg 50 mg 20 mg 25 mg 100 mg 40 mg 100 mg 10 mg 25 mg 25 mg 30 mg 100 mg 50 mg 100 mg 25 mg 25 mg 25 mg 100 mg 50 mg 100 mg 25 mg 100 mg 200 mg
325
Code Product Unit
BP 887 BP 111 BP 114 BP 124 BP 858 BP 608 BP 116 BP 420 BP 721 BP 619 BP 598 BP 828 BP 810 BP 118 BP 361 BP 737 BP 119 BP 859 BP 677 BP 401 BP 397 BP 855 BP 431 BP 120 BP 122 BP 815 BP 726 BP 899 BP 582 BP 195 BP 607 BP 456 BP 865 BP 866 BP 511 BP 364 BP 690 BP 691 BP 902 BP 896 BP 128 BP 673 BP 659 BP 589 BP 131 BP 384 BP 615 BP 132 BP 385 BP 674
Diamorphine Hydrochloride Assay Standard Controlled Substance Diazepam Controlled Substance Dibenzo[b,e]thiepin-11(6H)-one 3-(Dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethylaminopropan1-amine-S-oxide hydrochloride Dibenzosuberone 3-(1,5-Dibenzyl-1H-indazole-3-yl)oxypropyl dimethylamine hydrochloride Dichlorophen Assay Standard Dichlorophen impurity standard Assay Standard 1-(2,5-Dichlorophenyl)-5-isopropylbiguanide hydrochloride Diclofenac sodium Assay Standard Diclofenac diethylamine Diclofenac Impurity A Dicloxacillin sodium Diethanolamine fusidate Assay Standard 2-Diethylaminoethyl-3-(1-naphthyl)-2-(1-naphthylmethyl)propionate oxalate Diethylcarbamazine citrate Diethyl-4-decyloxy-3-ethoxyanilinomethylenemalonate Diethylstilbestrol Assay Standard Diethyl stilbestrolmonophosphate Diflucortolone valerate Assay Standard Diflucortolone valerate impurity standard Digitoxin Assay Standard Dihydrocodeine Tartrate Assay Standard Controlled Substance Dihydroergocristine mesilate 2,3-Dihydro-6-phenylimidazo [2,1-b] thiazole bis-(1,7-dihydro-6H-purine)-6,6-disulphide Diltiazem HCl Diltiazem impurity standard 6,6-Dimethoxy-2,2'-binaphthyl 4-Dimethylamino-3-methyl-1,2-diphenylbutan-2-ol hydrochloride 3-Dimethylaminopropyl 2-benzylaminobenzoate hydrochloride 1,5-Dimethylhexyl(methyl)amine Dimethyl-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate Dimethyl-2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate Dimethyl{5-[2-(1-methylamino-2-nitrovinylamino) ethylsulphinylmethyl]furfuryl}amine 2,2-Dimethyl-5(2,4-xylyloxy)valeric acid Dimpylate Assay Standard Dimpylate for chromatography Dinoprostone Assay Standard Diphenhydramine hydrochloride Dipipanone hydrochloride Assay Standard Controlled Substance Dipivefrine hydrochloride Assay Standard Dipivefrine impurity standard Diprenorphine Assay Standard Dipyridamole Assay Standard N1,N2-Diquinoxalin-2-ylsulphanilamide Disodium pamidronate Assay Standard Disulfiram Assay Standard Dithranol Assay Standard Dobutamine hydrochloride Assay Standard
150 mg 100 mg 25 mg 25 mg 100 mg 25 mg 100 mg 100 mg 25 mg 100 mg 100 mg 25 mg 250 mg 100 mg 25 mg 100 mg 50 mg 100 mg 25 mg 100 mg 25 mg 250 mg 100 mg 25 mg 50 mg 25 mg 100 mg 25 mg 25 mg 25 mg 25 mg 50 mg 25 mg 25 mg 25 mg 25 mg 100 mg 0.1 mL 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 25 mg 100 mg 50 mg 100 mg 100 mg
326
Edition 2012/2013
Code Product Unit
BP 133 BP 669 BP 468 BP 134 BP 135 BP 136 BP 823 BP 990 BP 780 BP 675 BP 138 BP 139 BP 741 BP 742 BP 743 BP 387 New BP 871 BP 992 BP 788 BP 405 BP 141 BP 781 BP 794 BP 795 BP 796 BP 790 BP 798 BP 488 BP 396 BP 729 BP 142 BP 752 BP 753 BP 860 BP 616 BP 143 BP 421 BP 145 BP 146 BP 150 BP 437 BP 149 BP 529 BP 533 BP 541 BP 542 BP 885 BP 653 BP 655 BP 656 BP 654
Edition 2012/2013
Docusate sodium Assay Standard Domperidone maleate Assay Standard Dopamine hydrochloride Assay Standard Dosulepin hydrochloride Assay Standard Doxapram hydrochloride Assay Standard Doxepin hydrochloride Assay Standard Doxepin impurity standard Doxorubicin hydrochloride Assay Standard Doxycycline hyclate Assay Standard Droperidol Assay Standard Dydrogesterone Econazole nitrate Assay Standard Enalapril maleate Enalaprilat Enalapril diketopiperazine Ephedrine hydrochloride Assay Standard Drug Precursor 6-Epidoxycycline hydrochloride Epirubicin hydrochloride Ergocalciferol Assay Standard Ergometrine maleate Assay Standard Drug Precursor Ergotamine tartrate Assay Standard Drug Precursor Erythromycin Erythromycin A Assay Standard Erythromycin B Assay Standard Erythromycin C Assay Standard Erythromycin estolate Erythromycin ethyl succinate Erythromycin stearate Assay Standard Estradiol benzoate Assay Standard Estradiol hemihydrate Assay Standard Estramustine Estriol Assay Standard Estriol impurity standard Estrone Estropipate Assay Standard Etacrynic acid Assay Standard Ethinylestradiol Assay Standard Ethopabate Assay Standard Ethosuximide Assay Standard Ethyldimethyl [2-(2-methylbenzhydryloxy)ethyl]ammonium chloride N-Ethylglucamine hydrochloride Ethyl meclofenamate Etodolac Assay Standard Etodolac acid dimer Etodolac 1-methyl analogue Etodolac 8-methyl analogue Etoposide Assay Standard Famotidine Assay Standard Famotidine degradation impurity 1 Famotidine degradation impurity 2 Famotidine Impurity C
327
Code Product Unit
BP 620 BP 777 BP 758 BP 692 BP 693 BP 354 BP 661 BP 660 BP 665 BP 666 BP 156 BP 740 BP 571 BP 676 BP 159 BP 840 BP 160 BP 489 BP 161 BP 162 BP 163 BP 573 BP 797 BP 164 BP 738 BP 554 BP 556 BP 597 BP 167 BP 574 BP 587 BP 588 BP 600 BP 671 New BP 937 BP 627 BP 639 New BP 997 BP 623 BP 678 BP 547 BP 643 BP 363 BP 303 BP 365 BP 174 BP 175 BP 368 BP 580
Felbinac Assay Standard Felodipine Assay Standard Felodipine impurity standard Fenbendazole Fenbendazole Impurity C {5-(phenylthio)-2-aminobenzimidazole} Fenbufen Assay Standard Fenoterol degradation Impurity A Fenoterol hydrobromide Assay Standard Fentanyl citrate Assay Standard Controlled Substance Fentanyl Impurity A Fenthion Assay Standard Finasteride Assay Standard Flavoxate hydrochloride Assay Standard Flecainide acetate Assay Standard Fludrocortisone acetate Assay Standard Flunitrazepam Controlled Substance Fluocinolone acetonide Assay Standard Fluocinonide Assay Standard Fluocortolone hexanoate Assay Standard Fluocortolone pivalate Assay Standard 4'-Fluoro-4-chlorobutyrophenone Fluorometholone Assay Standard Fluoxetine hydrochloride Assay Standard Fluoxymesterone Controlled Substance cis-Flupentixol Flupentixol decanoate dihydrochloride Assay Standard trans-Flupentixol decanoate dihydrochloride cis-Flupenthixol propionate dihydrochloride Fluphenazine hydrochloride Assay Standard Flurbiprofen sodium Assay Standard Fluticasone propionate Assay Standard Fluticasone S-methyl impurity Fluvoxamine maleate Assay Standard Fluvoxamine maleate impurity standard Folic acid Assay Standard 3-Formylrifamycin SV Form-2',4'-xylidide Foscarnet Impurity B Foscarnet sodium Assay Standard Fosfestrol sodium Furosemide Assay Standard Gallamine impurity standard Gemfibrozil Assay Standard Gemfibrozil impurity A 2,2-dimethyl-5-(4-propen-1-yl)-2,5-xylyloxy)valeric acid Gemfibrozil methyl ester Gentamicin sulfate Glibenclamide Assay Standard Gliclazide Assay Standard Gliquidone Assay Standard
100 mg 100 mg 20 mg 100 mg 25 mg 100 mg 25 mg 100 mg 100 mg 25 mg 0.25 mL 100 mg 100 mg 100 mg 50 mg 25 mg 50 mg 100 mg 50 mg 50 mg 0.5 mL 100 mg 250 mg 50 mg 25 mg 100 mg 25 mg 100 mg 100 mg 100 mg 100 mg 25 mg 100 mg 100 mg 150 mg 25 mg 25 mg 10 mg 100 mg 50 mg 100 mg 100 mg 100 mg 10 mg 0.1 mL 25 mg 100 mg 200 mg 150 mg
328
Edition 2012/2013
Code Product Unit
BP 581 BP 652 BP 814 BP 180 BP 181 BP 879 BP 407 BP 185 BP 186 BP 576 BP 584 BP 187 BP 188 BP 190 BP 770 BP 197 BP 526 BP 196 BP 829 BP 888 BP 194 BP 198 BP 199 BP 774 BP 539 New BP 880 BP 202 BP 759 BP 664 BP 932 BP 999 BP 1000 BP 625 BP 557 BP 550 New BP 1083 BP 205 BP 778 BP 206 BP 799 BP 800 BP 499 BP 626 BP 621 BP 622 BP 624 BP 864 BP 861 BP 736 BP 668 BP 667
Edition 2012/2013
Gliquidone sulphonamide Glyceryl trinitrate solution Assay Standard Goserelin Hexapeptide Griseofulvin Assay Standard Guanethidine monosulfate Assay Standard Guanine Haloperidol Assay Standard Homatropine hydrobromide Assay Standard Hydrochlorothiazide Assay Standard Hydrocortisone Assay Standard Hydrocortisone acetate Assay Standard Hydrocortisone Hydrogen Succinate Hydrocortisone sodium phosphate Hydroflumethiazide 4'Hydroxyacetophenone Hydroxycarbamide Assay Standard 2-(2-Hydroxyethyl)-1-methylpyrrolidine 5-[1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl]salicylic acid hydrochloride D-alpha-(4-hydroxyphenyl)glycine (5RS)-3-(2-hydroxyphenyl)-5-phenylcyclohex-2-enone 2-(6-Hydroxythymoxy)ethyldimethylamine hydrochloride Hyoscine butylbromide Assay Standard Hyoscine Hydrobromide Assay Standard Hypromellose Assay Standard Ibuprofen Assay Standard Ibuprofen Impurity B Idoxuridine Assay Standard Ifosfamide Assay Standard Iminophenazine Imipramine hydrochloride Indapamide Assay Standard Indapamide Impurity B Ipratropium bromide Assay Standard 4'-Isobutylacetophenone Isoconazole nitrate Assay Standard Isoniazid Assay Standard Isoprenaline hydrochloride Assay Standard Isopromethazine hydrochloride Isosorbide dinitrate Isosorbide 2-nitrate Isosorbide mononitrate Assay Standard 4'-(2-Isopropylaminoethyl)methanesulphonanilide hydrochloride 8s-Isopropyl-3-hydroxytropanium bromide Isradipine Assay Standard Isradipine Impurity B Isradipine Impurity D Ivermectin Assay Standard Kanamycin monosulfate Ketamine Hydrochloride Controlled Substance Ketoprofen Assay Standard Ketoprofen ethyl ester
25 mg 50 mL 10 mg 100 mg 100 mg 25 mg 150 mg 100 mg 200 mg 100 mg 100 mg 100 mg 100 mg 100 mg 25 mg 200 mg 0.1 mL 50 mg 50 mg 25 mg 25 mg 100 mg 200 mg 100 mg 200 mg 1.15 mL 100 mg 100 mg 25 mg 50 mg 150 mg 10 mg 100 mg 100 mg 100 mg 100 mg 100 mg 25 mg 300 mg 50 mg 100 mg 25 mg 25 mg 100 mg 25 mg 25 mg 250 mg 50 mg 100 mg 100 mg 100 mg
329
Code Product Unit
BP 707 BP 647 BP 802 BP 872 BP 873 BP 212 BP 356 BP 213 BP 772 BP 723 BP 634 BP 501 BP 215 BP 727 BP 733 BP 695 BP 696 BP 433 BP 927 BP 697 BP 635 BP 636 BP 874 BP 875 BP 447 BP 434 BP 528 BP 867 BP 218 BP 776 BP 1008 BP 220 BP 221 BP 222 BP 223 New BP 1077 BP 629 BP 630 BP 391 BP 699 BP 583 BP 773 BP 762 BP 496 BP 226 BP 227 BP 552 BP 232 New BP 1078 BP 644 BP 606
330
Lacidipine Assay Standard Lacidipine impurity standard Lamivudine Assay Standard Lansoprazole Assay Standard Lansoprazole impurity standard Levamisole hydrochloride Levobunolol hydrochloride Assay Standard Levodopa Assay Standard Levomenthol Assay Standard Levomepromazine maleate Assay Standard Levomepromazine sulphoxide Levonorgestrel Assay Standard Lincomycin hydrochloride Assay Standard Lidocaine Assay Standard Linseed oil Lisinopril dihydrate Assay Standard Lisinopril diketopiperazine Lithium lactate Assay Standard Lithocholic acid Lofepramine hydrochloride Assay Standard Loperamide hydrochloride Assay Standard Loperamide N-oxide Loratadine Assay Standard Loratadine impurity standard Loprazolam mesilate Controlled Substance Lorazepam Assay Standard Controlled Substance Lormetazepam Assay Standard Controlled Substance Losartan Potassium Assay Standard Lymecycline Lynestrenol Mebendazole Meclozine hydrochloride Medroxyprogesterone acetate Assay Standard Megestrol Megestrol acetate Assay Standard Melatonin Assay Standard Meloxicam Assay Standard Meloxicam impurity standard Melphalan Assay Standard Mepivacaine hydrochloride Assay Standard Meptazinol hydrochloride Assay Standard Mercaptopurine Assay Standard Mercaptopurine impurity standard Mesoridazine besilate Metaraminol tartrate Metformin hydrochloride Assay Standard Methadone hydrochloride Assay Standard Controlled Substance 1-(2-Methoxyphenyl)piperazine 5-Methoxytryptamine Methyl 4-acetamido-2-hydroxybenzoate 1-Methylazepan-4-one hydrochloride
100 mg 25 mg 200 mg 100 mg 25 mg 100 mg 100 mg 100 mg 100 mg 100 mg 25 mg 100 mg 250 mg 100 mg 0.5 mL 100 mg 25 mg 100 mg 25 mg 100 mg 100 mg 25 mg 100 mg 25 mg 50 mg 50 mg 100 mg 150 mg 100 mg 25 mg 10 mg 100 mg 100 mg 25 mg 100 mg 100 mg 100 mg 50 mg 100 mg 100 mg 100 mg 100 mg 25 mg 50 mg 100 mg 100 mg 100 mg 25 mg 25 mg 25 mg 25 mg
Edition 2012/2013
Code Product Unit
BP 605 BP 239 BP 240 BP 241 BP 569 BP 570 BP 444 BP 457 BP 476 BP 237 BP 244 BP 245 BP 641 BP 662 BP 248 BP 249 BP 846 BP 445 BP 409 BP 642 BP 357 BP 540 BP 603 BP 735 BP 251 BP 252 BP 253 BP 884 BP 722 BP 394 BP 637 BP 842 BP 768 BP 254 BP 648 New BP 804 BP 358 BP 851 BP 362 BP 548 BP 257 BP 425 BP 259 BP 260 BP 360 BP 435 BP 460 BP 395 BP 462 BP 651
Edition 2012/2013
1-Methyl-4-(2-benzoylhydrazino)azepan hydrochloride 3-Methyl-2,2-diphenyl-4-piperidinobutyronitrile Methyldopa Assay Standard Methyldopate hydrochloride Assay Standard 3-Methylflavone-8-carboxylic acid 3-Methylflavone-8-carboxylic acid ethyl ester 4-methyl-5-(2-hydroxyethyl)thiazole 2-Methyl-6-methylaminoheptan-2-ol 1-methyl-3-[2-(5-methylimidazol-4-yl-methylthio)ethyl]guanidine dihydrochloride Methyl N-4[2-(5-chloro2-methoxybenzamido)ethyl]benzenesulphonyl carbamate 2-Methyl-5-Nitroimidazole (1-Methyl-5-nitroimidazol-2-yl)methanol N-Methyl-N'-(2,4-xylyl)formamidine hydrochloride Methylphenobarbital Assay Standard Controlled Substance Methylprednisolone Assay Standard Methylprednisolone acetate Assay Standard N-methyl-bis[beta-(2-pyridyl)ethyl]amine trihydrochloride 4-Methyl-5-vinylthiazole edisilate Methysergide maleate Assay Standard Metipranolol Assay Standard Metoclopramide hydrochloride Assay Standard Metoprolol tartrate Assay Standard Metronidazole Assay Standard Metronidazole benzoate Mexenone Mianserin hydrochloride Assay Standard Miconazole nitrate Assay Standard Miconazole Impurity A Midazolam Assay Standard Controlled Substance Minocycline hydrochloride Assay Standard Minoxidil Assay Standard Mirtazapine Assay Standard Mometasone furoate Assay Standard Monosulfiram Morphine sulphate Assay Standard Controlled Substance Mupirocin lithium Assay Standard Nabumetone Assay Standard Nabumetone Impurity D Naftidrofuryl oxalate Assay Standard Naloxone hydrochloride Assay Standard Nandrolone Assay Standard Controlled Substance Nandrolone decanoate Controlled Substance Nandrolone laurate Controlled Substance Nandrolone Phenylpropionate Assay Standard Controlled Substance 3-(1-Naphthyl)-2-tetrahydrofurfurylpropionic acid Naproxen Assay Standard Nicotinamide Assay Standard Nicotinyl alcohol tartrate Nifedipine Assay Standard Nimodipine Assay Standard
25 mg 50 mg 100 mg 100 mg 25 mg 25 mg 25 mg 50 mg 25 mg 25 mg 50 mg 25 mg 30 mg 100 mg 100 mg 200 mg 25 mg 25 mg 50 mg 100 mg 100 mg 100 mg 150 mg 100 mg 100 mg 100 mg 100 mg 25 mg 100 mg 125 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 200 mg 100 mg 100 mg 100 mg 100 mg 50 mg 50 mg 100 mg 25 mg 100 mg 100 mg 50 mg 100 mg 100 mg
331
Code Product Unit
BP 262 BP 263 BP 367 BP 512 BP 266 BP 267 BP 670 BP 714 BP 269 BP 765 BP 808 BP 806 BP 805 BP 272 BP 764 BP 700 BP 701 BP 273 BP 782 BP 276 BP 769 BP 277 BP 371 New BP 1024 BP 746 BP 278 BP 1073 New BP 1074 BP 422 BP 683 BP 901 BP 282 BP 520 BP 703 BP 284 BP 035 BP 423 BP 503 BP 682 New BP 1027 BP 450 BP 463 BP 411 BP 288 BP 1028 BP 289 BP 510 BP 399 BP 464 BP 292 BP 553
332
Nitrazepam Assay Standard Controlled Substance Nitrofurfural diacetate 3-Nitroso-3-azabicyclo[3.3.O]octane Noradrenaline (norepinephrine) acid tartrate Norethisterone Assay Standard Norethisterone acetate Assay Standard Norfloxacin Assay Standard Norgestrel Nortriptyline hydrochloride Assay Standard Omeprazole Assay Standard Ondansetron hydrochloride dihydrate Assay Standard Ondansetron impurity standard Ondansetron for TLC system suitability Orciprenaline sulfate Oxibendazole Oxybuprocaine hydrochloride Assay Standard Oxybutynin hydrochloride Assay Standard Oxyclozanide Oxytetracycline Assay Standard Pancuronium bromide Assay Standard Paeoniflorin Assay Standard Papaverine hydrochloride Assay Standard Paracetamol Assay Standard Paroxetine hydrochloride hemihydrate Assay Standard Paroxetine impurity standard Pentagastrin Perindopril Erbumine Assay Standard Perindopril impurity standard Perphenazine Assay Standard Pethidine hydrochloride Assay Standard Controlled Substance Phenobarbital Assay Standard Controlled Substance Phenoxymethylpenicillin potassium Assay Standard Phentolamine mesilate Phenylcyclohexylglycolic acid Phenylephrine Hydrochloride Assay Standard 1-Phenyl-3-pyrrolidinopropan-1-one hydrochloride Phytomenadione Assay Standard Pilocarpine nitrate Assay Standard Pimozide Assay Standard Piperacillin Assay Standard 3-Piperidylpropiophenone hydrochloride Piroxicam Assay Standard Pizotifen malate Assay Standard Poldine metisulfate Assay Standard Polymyxin B Sulfate Polythiazide Assay Standard Potassium trichloroammineplatinate Prazosin hydrochloride Assay Standard Prednisolone Assay Standard Prednisolone sodium phosphate Assay Standard Prednisone Assay Standard
100 mg 50 mg 0.1 mL 100 mg 50 mg 100 mg 100 mg 100 mg 200 mg 100 mg 100 mg 25 mg 25 mg 100 mg 25 mg 100 mg 100 mg 200 mg 100 mg 25 mg 20 mg 100 mg 100 mg 200 mg 25 mg 0.1 mg 100 mg 25 mg 100 mg 100 mg 100 mg 500 mg 50 mg 25 mg 100 mg 50 mg 0.25 mL 200 mg 100 mg 100 mg 50 mg 100 mg 50 mg 100 mg 100 mg 100 mg 25 mg 100 mg 100 mg 100 mg 250 mg
Edition 2012/2013
Code Product Unit
BP 497 BP 293 BP 295 BP 638 BP 493 BP 494 BP 296 BP 449 BP 297 BP 412 BP 505 New BP 1031 New BP 1032 BP 698 BP 868 BP 413 BP 717 BP 906 New BP 1033 BP 458 BP 863 BP 862 BP 751 BP 754 BP 471 BP 593 BP 592 BP 459 BP 400 BP 586 BP 451 BP 712 BP 852 BP 704 BP 302 BP 705 New BP 883 New BP 897 New BP 898 BP 739 BP 750 BP 453 BP 490 BP 452 BP 498 BP 818 BP 312 BP 310 BP 314 BP 779
Prilocaine hydrochloride Assay Standard Primidone Assay Standard Procaine benzylpenicillin Assay Standard Prochlorperazine maleate Assay Standard Prochlorperazine mesilate Assay Standard Prochlorperazine sulphoxide Procyclidine hydrochloride Assay Standard Progesterone Assay Standard Proguanil hydrochloride Assay Standard Promethazine hydrochloride Assay Standard Promethazine sulphoxide Propofol Assay Standard Propofol Impurity J Propofol dimer Propylene glycol Assay Standard Pseudoephedrine hydrochloride Assay Standard Drug Precursor Pseudomorphine trihydrate Pyrazinamide Assay Standard Pyridostigmine Bromide Pyridoxine hydrochloride Assay Standard Quinidine sulfate Quinine sulfate Ramipril Assay Standard Ramipril Impurity K Ramipril diketopiperazine acid Ranitidine hydrochloride Assay Standard Ribavirin Assay Standard Ribavirin impurity standard Riboflavin sodium phosphate Rifampicin N-oxide Ritodrine hydrochloride Assay Standard Salbutamol Assay Standard Salbutamol aldehyde impurity Salbutamol Impurity B Salbutamol ketone impurity Salbutamol sulphate Assay Standard Selegiline hydrochloride Assay Standard Sertraline hydrochloride Assay Standard Sertraline hydrochloride impurity standard Sertraline hydrochloride cis-isomer Simvastatin Assay Standard Sodium alginate Sodium nitroprusside Assay Standard Sodium picosulfate Assay Standard Sodium valproate Assay Standard Sotalol hydrochloride Sucrose Assay Standard Sulfadiazine Assay Standard Sulfadoxine Assay Standard Sulfamethoxazole Assay Standard Sulfasalazine Assay Standard
100 mg 100 mg 100 mg 100 mg 100 mg 25 mg 100 mg 50 mg 100 mg 100 mg 25 mg 1 mL 0.05 mL 25 mg 100 mg 100 mg 25 mg 100 mg 50 mg 100 mg 300 mg 300 mg 100 mg 25 mg 100 mg 100 mg 50 mg 50 mg 25 mg 200 mg 100 mg 25 mg 10 mg 25 mg 100 mg 100 mg 100 mg 20 mg 20 mg 100 mg 200 mg 200 mg 100 mg 500 mg 100 mg 1000 mg 100 mg 100 mg 100 mg 250 mg
Edition 2012/2013
333
Code Product Unit
BP 679 BP 745 BP 876 BP 877 BP 455 BP 708 BP 709 BP 318 New BP 1045 BP 650 BP 319 BP 321 BP 322 BP 702 BP 480 BP 327 BP 414 BP 495 BP 331 BP 332 BP 848 BP 849 New BP 1079 New BP 1080 BP 645 BP 687 BP 878 BP 333 BP 882 BP 744 New BP 893 BP 734 BP 544 BP 590 BP 591 BP 338 BP 339 BP 680 BP 340 BP 341 BP 555 BP 034 BP 344 BP 346 BP 347 BP 349 BP 350 BP 706 BP 563 BP 564 BP 672
334
Sulpiride Assay Standard Sumatriptan impurity standard Tamsulosin hydrochloride Assay Standard Tamsulosin hydrochloride impurity standard Temazepam Assay Standard Controlled Substance Tenoxicam Assay Standard Tenoxicam degradation impurity standard Terbutaline sulfate Assay Standard Terbutaline Impurity C Terfenadine Assay Standard Testosterone decanoate Controlled Substance Testosterone isocaproate Controlled Substance Testosterone phenylpropionate Assay Standard Controlled Substance Testosterone propionate Assay Standard Controlled Substance Tetracycline hydrochloride Assay Standard Theophylline Assay Standard Thiamine mononitrate Assay Standard Thioridazine Assay Standard Thiotepa Assay Standard 2-Thymoxyethyldimethylamine hydrochloride Tibolone Assay Standard Tibolone impurity standard Ticarcillin Impurity B Ticarcillin Impurity C Tioconazole Assay Standard Tioconazole impurity standard Tioguanine Assay Standard Tobramycin alpha-Tocopherol Assay Standard Tramadol hydrochloride Tramadol Impurity A Tranexamic acid impurity standard Transplatin Trazodone hydrochloride Assay Standard Trazodone hydrochloride impurity standard Triamcinolone Assay Standard Triamcinolone acetonide Assay Standard Triamcinolone hexacetonide Assay Standard Triamterene Assay Standard 3,5,6-Trichloro-2-hydroxybenzoic acid 2-Trifluoromethylthioxanthone Trihexyphenidyl hydrochloride Assay Standard Trimethoprim Assay Standard z-Triprolidine hydrochloride Triprolidine hydrochloride Tylosin Urea Assay Standard Ursodeoxycholic acid Assay Standard Vigabatrin Assay Standard 5-Vinyl-2-pyrrolidone Warfarin Assay Standard
100 mg 25 mg 100 mg 25 mg 100 mg 100 mg 25 mg 100 mg 15 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 25 mg 100 mg 10 mg 25 mg 25 mg 100 mg 100 mg 100 mg 100 mg 200 mg 100 mg 15 mg 25 mg 25 mg 100 mg 50 mg 100 mg 50 mg 100 mg 100 mg 50 mg 25 mg 100 mg 100 mg 50 mg 100 mg 50 mg 1g 150 mg 150 mg 25 mg 100 mg
Edition 2012/2013
Code Product Unit
BP 353 BP 640 BP 803 BP 895 BP 850 BP 812 BP 599 BP 596 BP 558
Xylometazoline hydrochloride Assay Standard N,N'-bis(2,4-Xylyl)formamidine Zidovudine Assay Standard Zidovudine impurity standard Zidovudine and Lamivudine impurity standard Zopiclone Assay Standard Zuclopenthixol acetate dihydrochloride Assay Standard Zuclopenthixol decanoate dihydrochloride Assay Standard Zuclopenthixol hydrochloride Assay Standard
100 mg 25 mg 150 mg 25 mg 50 mg 100 mg 100 mg 100 mg 100 mg
Edition 2012/2013
335

British Pharmacopoeia 2012, volume IV and Addenda

Code Product Unit
BP Appendix XIV A - Biological assay of antibiotics

ATCC-6633 ATCC-4617 ATCC-9637 ATCC-10536 ATCC-10031 ATCC-10240 ATCC-9763 ATCC-6538P ATCC-9144 ATCC-9341 ATCC-12228 ATCC-607 Bacillus subtilis Bordetella bronchiseptica Escherichia coli Escherichia coli Klebsiella pneumoniae ss. pneumoniae Micrococcus luteus Saccharomyces cerevisiae Staphylococcus aureus subsp. aureus Staphylococcus aureus ss. aureus Kocuria rhizophila Staphylococcus epidermidis Mycobacterium smegmatis amp. amp. amp. amp. amp. amp. amp. amp. amp. amp. amp. amp.
BP Appendix XVI - Test for absence of Mycoplasma

ATCC-23206 ATCC-19989 ATCC-19610 ATCC-17981 ATCC-23714 ATCC-15531 ATCC-25204 ATCC-CCL-81 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii Mycoplasma fermentans; PG18 G Mycoplasma gallisepticum Mycoplasma hyorhinis Switzer Mycoplasma orale Mycoplasma pneumoniae Mycoplasma synoviae Vero cells amp. amp. amp. amp. amp. amp. amp. amp.
BP Appendix XVI A - Test for sterility

ATCC-16404 ATCC-6633 ATCC-10231 ATCC-19404 ATCC-9027 ATCC-6538 Aspergillus niger Bacillus subtilis Candida albicans Clostridium sporogenes Pseudomonas aeruginosa Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp. amp.
BP Appendix XVI B - Tests for microbial contamination

ATCC-6633 ATCC-2091 ATCC-10231 ATCC-13124 ATCC-11437 ATCC-19404
336
Bacillus subtilis Candida albicans Candida albicans Clostridium perfringens Clostridium sporogenes Clostridium sporogenes
amp. amp. amp. amp. amp. amp.

Edition 2012/2013

Code Product Unit
ATCC-8739 ATCC-9027 ATCC-6538 ATCC-6538P
Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus ss. aureus Staphylococcus aureus subsp. aureus
amp. amp. amp. amp.
BP Appendix XVI C - Efficacy of antimicrobial preservation

ATCC-16404 ATCC-10231 ATCC-8739 ATCC-9027 ATCC-6538 Aspergillus niger Candida albicans Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp.
BP Appendix XVIII - Methods of sterilization

ATCC-27142** ATCC-7953** ATCC-9372** ATCC-19146 Bacillus pumilus Bacillus stearothermophilus Bacillus subtilis Brevendimonas diminuta (as Pseudomonas diminuta) amp. amp. amp. amp.
BP Appendix XVI (Vet) 3 - Test for absence of mycoplasmas

ATCC-23206 ATCC-19610 ATCC-17981 ATCC-23714 ATCC-25204 ATCC-CCL-81 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii Mycoplasma gallisepticum Mycoplasma hyorhinis Switzer Mycoplasma orale Mycoplasma synoviae Vero cells ** = Alternative strain All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia directly to confirm the testing requirements and recommended organisms before ordering or undertaking the testing procedures as described in the Pharmacopoeia. amp. amp. amp. amp. amp. amp.
Edition 2012/2013
337
Pharmacope Franaise
Pharmacope Franaise
The list of reference substances and reference spectra available from the Pharmacope Franaise (PF) are issued under the authority of the PF and are solely for use in tests and assays of the Pharmacopoeia Franaise and Pharmacopoeia Franaise (Vtrinaire). Since the beginning of July 2012 the French Pharmacopeia published the 11th edition that is enforceable since the 1st of July 2012. It replaces the previous edition that was official since 1983. The list in this catalogue is based on the PF list of May 2012. All PF CRS are available in restricted quantity and orders for multiple units will be reduced to a single unit.
Proper use
Reference substances from the PF are designed for specific applications, which are identified by a code number included in each product description. Uses other than those shown below are possible, but the user is responsible for checking the suitability of the PF CRS for any non-monograph use. 1 2 3 4 5 6 7 8 9 10 11 Identification by infrared spectrophotometry Identification by thin layer chromatography Test for related substances by thin layer chromatography Test for related substances by liquid chromatography Test for related substances by gas chromatography Assay by UV spectrophotometry by gas chromatography Assay by fluorimetry Assay by liquid chromatography Assay by gas chromatography Microbiological assay Assay by volumetric titration
Shelf life and expiry dates

French Pharmacopoeia chemical reference substances are subject to regular inspection and repeated analysis by PF scientific staff. Each PF CRS is, on receipt by the customer, fit for the intended use. The shelf life and the expiry date are not given, and PF advises that unopened vials should not be stored for a long period of time.
Products
Code Product Unit
FPC0050 FPC0071 FPC0072 FPC0141 FPC0190 FPC0210 FPC0271 FPC0600 FPC0610 FPC0892 FPC0950 FPC1222 FPC2900 FPC1560 FPC1600 FPC3300 FPC1780 FPC1785 FPC2032 FPC2034 FPC2036 FPC2044
338
Alimmazine tartrate Amodiaquine chlorhydrate Amprolium chlorhydrate (usage vtrinaire) Benzododecinium bromure Bleu patente V Butoform Chlormadinone acetate Eosine disodique Epivincamine Histamine Hysope (huile essentielle) Linalyle actate Lysine actylsalicylate Reference Spectrum Nifurtimox Oxyquinol Reference Spectrum Polytetrafluoroethylene Reference Spectrum Potassium gluconate Prasterone Strychnine sulfate (veterinary usage) Suc de papayer Sulconazole nitrate Sulfadimthoxine
25 mg 25 mg 25 mg 1000 mg 1000 mg 150 mg 100 mg 200 mg 50 mg 50 mg 1 mL 2 mL unit 250 mg unit unit 50 mg 300 mg 225 mg 500 mg 200 mg 100mg
Edition 2012/2013
Pharmacope Franaise
Code Product Unit
FPC2120 FPC2122 FPC2210 FPC2230 FPC2520 FPC2530
Sulfogaiacol Sulfogaiacol (exempt de gaiacol) Terpine Thiocolchicoside Vincamine Venin d'Abeille PBR
100 mg 1000 mg 1000 mg 300 mg 250 mg unit
Edition 2012/2013
339
Pharmacopoeia Helvetica
Pharmacopoeia Helvetica
Background
The range of reference substances available from the Pharmacopoeia Helvetica is issued under the authority of the Pharmacopoeia Helvetica, and is solely for use in tests and assays of the Pharmacopoeia Helvetica. The Pharmacopoeia Helvetica contains, in addition to harmonised European Pharmacopoeia monographs, a number of national monographs. Some of the national monographs require CRS described in the list below. The list in this catalogue is based on the current Pharmacopoeia Helvetica.
Products
Code Product Unit
SPC 015 SPC 160 SPC 170 SPC 190 SPC 204 SPC 210 SPC 300 SPC 335 SPC 320 SPC 340 SPC 380 SPC 455 SPC 505 SPC 515
-(2-Piperidyl)phenylessigsure Dexamfetaminsulfat Reference Spectrum Diamorphinhydrochlorid wasserfrei Reference Spectrum Drofeninhydrochlorid Ethanol 70% Reference Spectrum Ethanol with 2 % Ketone Reference Spectrum Methacholinchlorid Reference Spectrum Methylphenidathydrochlorid Reference Spectrum Moclobemid Reference Spectrum 2-Naphthol Reference Spectrum Oxychinolinsulfat Reference Spectrum Saponin Terpinhydrat Reference Spectrum Thiethylperazinhydrogenmaleat
50 mg unit unit 1g unit unit unit unit unit unit unit 500 mg unit 200 mg
340
Edition 2012/2013
International Pharmacopeia
Background
The World Health Organization (WHO) as a specialised agency of the United Nations with a primary responsibility for international health matters and public health, is the issuing body of the substances described in the International Pharmacopoeia. Progress towards better health requires international cooperation in the establishment of international standards for biological substances and pharmaceuticals. The WHO has therefore authorised the establishment and maintenance of a number of reference collections. Two are of particular interest to analysts involved in pharmaceutical and clinical measurement sciences: the collections of international biological reference substances and international chemical reference substances.
International biological reference substances

The range of biological reference substances was established to provide a means of ensuring International uniformity in the designation of the potency, activity or specificity of preparations that are used in the prevention, treatment or diagnosis of human or animal diseases, and for which chemical and physical assay terms are inappropriate. WHO biological reference substances are needed for certain antibiotic and hormone assays described in a number of pharmacopoeia. You find the WHO antibiotic standards in the European Pharmacopoeia section of this catalogue. They can be ordered conveniently from LGC Standards.
International chemical reference substances

International chemical reference substances are established upon the advice of the WHO expert committee on specifications for pharmaceutical preparations. They are intended for use in physical and chemical tests and assays described in the specifications for quality control published in the International Pharmacopoeia (IP CRS), or as proposed in draft monographs. The list in this catalogue is based on the current WHO information.
Proper use
Whilst the primary application of ICRS is in physical and chemical tests and assays as described in the International Pharmacopoeia, ICRS do have applications in other aspects of pharmaceutical analysis where a certificate of purity is required.
Documentation
Directions for use and analytical data are provided in certificates distributed with the ICRS. The certificates show how the identity and purity of the material was confirmed, and in many cases demonstrate traceability to another PRM. This information fulfills most of the requirements of a Certification Report as defined by the ISO Guides on the preparation and use of Certified Reference Materials.
Shelf life and expiry dates

International Pharmacopoeia chemical reference substances are subject to regular inspection and repeated analysis by the WHO Collaborating Centre. Each ICRS is, on receipt by the customer, suitable for the intended use. Shelf life and expiry dates are not given, and IP advises that once opened, vials should not be stored for long periods of time. Only current lots are supplied by IP. For this reason users are advised to order only as required. Once opened IP can no longer guarantee the stability of the material and any of the ICRS not used should be disposed of.
For information on ordering please contact LGC Standards.
Products
Code Product Unit
ICRS1422 ICRS1552 ICRS0201 ICRS0202 ICRS0204
Abacavir sulfate Abacavir sulfate for system suitability Acetanilide (116C) Melting Point Standard Acetazolamide Allopurinol
100 mg 10 mg 1g 100 mg 100 mg
Edition 2012/2013
Looking for impurity reference standard with CofAs? See our LGC impurity chapter from page 11 on.
341
Code Product Unit
ICRS0206 ICRS0191 ICRS0194 ICRS0193 ICRS0208 ICRS0209 ICRS1426 ICRS0210 ICRS0211 ICRS0212 ICRS0213 ICRS0214 ICRS1408 ICRS1407 ICRS1410 ICRS1409 ICRS0215 ICRS0216 ICRS0218 ICRS0221 ICRS0222 ICRS0225 ICRS0226 ICRS0227 ICRS0228 ICRS0229 ICRS0230 ICRS0233 ICRS0234 ICRS0235 ICRS0236 ICRS0237 ICRS0238 ICRS0239 ICRS0240 ICRS2132 ICRS0241 ICRS0242 ICRS0243 ICRS0199 ICRS0245 ICRS0190 ICRS0246 ICRS0247 ICRS0248 ICRS0249 ICRS0250 ICRS0252 ICRS0253 ICRS0255 ICRS0256
342
Amidotrizoic acid 2-Amino-5-nitrothiazole 3-Aminopyrazole-4-carboxamide hemisulfate 3-Amino-2,4,6-triiodobenzoic acid Amitriptyline hydrochloride Amodiaquine hydrochloride Amoxicillin trihydrate Amphotericin B Ampicillin (anhydrous) Ampicillin sodium Ampicillin trihydrate Anhydrotetracycline hydrochloride Artemether Artemotil Artenimol Artesunate Atropine sulfate Azathioprine Bacitracin zinc Benzanilide (165C) Melting Point Standard Benzil (96C) Melting Point Standard Benzylpenicillin potassium Benzylpenicillin sodium Bephenium hydroxynaphthoate Betamethasone Betamethasone sodium phosphate Betamethasone valerate Bupivacaine hydrochloride Caffeine Caffeine (237C) Melting Point Standard Calcium folinate (Leucovorin calcium) Captopril Captopril disulfide Carbamazepine Carbenicillin monosodium Carbidopa Chloramphenicol Chloramphenicol palmitate Chloramphenicol palmitate (Polymorph A) 5-Chloro-2-methylaminobenzophenone Chloroquine sulfate 2-(4-Chloro-3-sulfamoylbenzoyl)benzoic acid Chlorphenamine hydrogen maleate Chlorpromazine hydrochloride Chlortalidone Chlortetracycline hydrochloride Cimetidine Ciprofloxacin by compound A Ciprofloxacin desfluoro-compound Ciprofloxacin fluoroquinolonic acid Ciprofloxacin hydrochloride
100 mg 25 mg 100 mg 100 mg 100 mg 200 mg 100 mg 400 mg 200 mg 200 mg 200 mg 25 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 200 mg 1g 1g 200 mg 200 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 1g 100 mg 100 mg 25 mg 100 mg 200 mg 100 mg 200 mg 1g 200 mg 100 mg 200 mg 50 mg 100 mg 100 mg 100 mg 200 mg 100 mg 20 mg 20 mg 20 mg 400 mg
Edition 2012/2013
Code Product Unit
ICRS0258 ICRS0259 ICRS0260 ICRS0261 ICRS2130 ICRS0263 ICRS0265 ICRS0266 ICRS0267 ICRS0268 ICRS0270 ICRS0282 ICRS0283 ICRS0285 ICRS1413 ICRS1414 ICRS0286 ICRS0287 ICRS0288 ICRS0289 ICRS0290 ICRS0292 ICRS1411 ICRS0294 ICRS0197 ICRS0198 ICRS0295 ICRS0296 ICRS0297 ICRS0298 ICRS0299 ICRS0300 New ICRS46470 ICRS0301 ICRS0302 ICRS0304 ICRS0305 ICRS0306 ICRS0307 ICRS0309 ICRS0310 ICRS0311 ICRS0312 ICRS0315 ICRS0316 ICRS0195 ICRS0355 ICRS0318 ICRS0319 ICRS0322 ICRS0323
Edition 2012/2013
Cisplatin Clomifene citrate Zuclomifene (Clomifene citrate Z-isomer) Cloxacillin sodium Colchicine Cortisone acetate Dapsone Desoxycortone acetate Dexamethasone Dexamethasone acetate Dexamethasone sodium phosphate Diazoxide Dicloxacillin sodium Dicoumarol Didanosine Didanosine for system suitability Dicyanodiamide (210C) Melting Point Standard Diethylcarbamazine dihydrogen citrate Digitoxin Digoxin Dopamine hydrochloride Doxorubicin hydrochloride Efavirenz Emetine hydrochloride 4-Epianhydrotetracycline hydrochloride 4-Epitetracycline hydrochloride Ergocalciferol (Vitamin D2) Ergometrine hydrogen maleate Drug Precursor Ergotamine tartrate Drug Precursor Erythromycin Erythromycin B Erythromycin C Erythromycin ethylsuccinate Estradiol benzoate Estrone Ethambutol hydrochloride Ethinylestradiol Ethisterone Ethosuximide Flucloxacillin sodium Flucytosine Fludrocortisone acetate Fluorouracil Fluphenazine hydrochloride Folic acid 3-Formylrifamycin Framycetin sulfate (Neomycin B sulfate) Furosemide Gentamicin sulfate Griseofulvin Haloperidol
100 mg 100 mg 50 mg 200 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 200 mg 100 mg 10 mg 10 mg 1g 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 25 mg 25 mg 500 mg 50 mg 50 mg 250 mg 25 mg 25 mg 10 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 200 mg 100 mg 200 mg 100 mg 100 mg 100 mg 200 mg 200 mg 100 mg 100 mg 200 mg 100 mg
343
Code Product Unit
ICRS0324 ICRS0325 ICRS0326 ICRS0327 ICRS0188 ICRS0189 ICRS0328 ICRS0329 ICRS1415 ICRS0330 ICRS0331 ICRS1416 ICRS1553 ICRS0333 ICRS0334 ICRS0335 ICRS0336 ICRS0337 ICRS0338 ICRS0339 ICRS0340 ICRS2125 ICRS39627 ICRS0341 ICRS0454 ICRS1549 ICRS0345 ICRS0346 ICRS0347 ICRS0348 ICRS0350 ICRS0351 ICRS2128 ICRS1417 ICRS0356 ICRS1412 ICRS1423 ICRS0357 ICRS0358 New ICRS0360 ICRS0366 ICRS0367 ICRS2123 ICRS0369 ICRS0371 ICRS0372 ICRS0373 ICRS0374 ICRS0376 ICRS0377 ICRS0378
344
Hydrochlorothiazide Hydrocortisone Hydrocortisone acetate Hydrocortisone sodium succinate (-)-3-(4-Hydroxy-3-methoxyphenyl)-2-hydrazino-2-methylalanine (3-o-Methylcarbidopa) (-)-3-(4-Hydroxy-3-methoxyphenyl)-2-methylalanine (3-o-Methylmethyldopa) Ibuprofen Imipramine hydrochloride Indinavir Indometacin Isoniazid Lamivudine Lamivudine for system suitability Lanatoside C Levodopa Levonorgestrel Levothyroxine sodium Lidocaine Lidocaine hydrochloride Liothyronine sodium Loperamide hydrochloride Lumefantrine Lumefantrine for system suitability Mebendazole Medroxyprogesterone acetate DL-Methionine Methotrexate Methyldopa Methyltestosterone Meticillin sodium Metronidazole Nafcillin sodium Naloxone hydrochloride Nelfinavir mesilate Neostigmine metilsulfate Nevirapine anhydrous Nevirapine impurity B Nicotinamide Nicotinic acid Niridazole Norethisterone Norethisterone acetate Norethisterone enantate Nystatin Oubain Oxacillin sodium Oxytetracycline dihydrate Oxytetracycline hydrochloride Papaverine hydrochloride Paracetamol Paromomycin sulfate
Edition 2012/2013
Code Product Unit
ICRS0380 ICRS0382 ICRS0383 ICRS0384 ICRS0385 ICRS0387 ICRS0388 ICRS0389 ICRS0390 ICRS0391 ICRS0392 ICRS0393 ICRS0394 ICRS0395 ICRS0396 ICRS0397 ICRS0398 ICRS0399 ICRS0400 ICRS0402 ICRS0403 ICRS0404 ICRS1424 ICRS0405 New ICRS47051 ICRS0406 ICRS0408 ICRS0409 ICRS0410 ICRS1421 ICRS1418 ICRS0411 ICRS0412 ICRS0413 ICRS0415 ICRS1419 ICRS0416 ICRS0417 ICRS0419 ICRS0420 ICRS0421 ICRS0422 ICRS0423 ICRS0424 ICRS0425 ICRS0426 ICRS0427 ICRS0428 ICRS0429 ICRS0430 ICRS0196
Edition 2012/2013
Phenacetin (136C) Melting Point Standard Phenolphthalein (263C) Melting Point Standard Phenoxymethylpenicillin Phenoxymethylpenicillin calcium Phenoxymethylpenicillin potassium Phenytoin Piperazine adipate Piperazine citrate Praziquantel Prednisolone Prednisolone acetate Prednisolone hemisuccinate Prednisolone sodium phosphate Prednisone Prednisone acetate Probenecid Procaine hydrochloride Procarbazine hydrochloride Progesterone Propanolol hydrochlorid Propylthiouracil Pyrantel embonate (Pyrantel pamoate) Pyrazinamide Pyridostigmine bromide Pyrimethamine Reserpine Riboflavin Rifampicin Rifampicin quinone Ritonavir Saquinavir mesilate Saccharin (229C) Melting Point Standard Sodium amidotrizoate Sodium cromoglicate Spectinomycin hydrochloride Stavudine Streptomycin sulfate Sulfacetamide Sulfamethoxazole Sulfamethoxypyridazine Sulfanilamide Sulfanilamide (166C) Melting Point Standard Sulfapyridine (193C) Melting Point Standard Sulfasalazine Tamoxifen citrate Tamoxifen E-isomer Testosterone enantate Testosterone propionate Tetracycline hydrochloride Thioacetazone 4,4'-Thiodianiline
1g 1g 200 mg 200 mg 200 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 200 mg 200 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 500 mg 100 mg 100 mg 250 mg 100 mg 250 mg 300 mg 200 mg 100 mg 100 mg 1g 100 mg 100 mg 200 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 1g 4g 100 mg 100 mg 10 mg 200 mg 100 mg 200 mg 100 mg 50 mg
345
Code Product Unit
ICRS0431 ICRS0432 ICRS0433 ICRS0434 ICRS0435 ICRS0438 ICRS0439 ICRS1420 ICRS1554
Tolbutamide Tolnaftate Toluene-2-sulfonamide Trimethadione Trimethoprim Vanillin (83C) Melting Point Standard Warfarin Zidovudine Zidovudine impurity B
100 mg 100 mg 100 mg 200 mg 100 mg 1g 100 mg 100 mg 10 mg
346
Edition 2012/2013
VHG-LCDN-100 VHG-LPBN-100 VHG-LASN-100 VHG-LHGN-100 VHG-LCRN-100
Cadmium Lead Arsenic Mercury Chromium
10g/mL* 10g/mL* 10g/mL* 10g/mL* 10g/mL*
VHG-LMONF-100 VHG-LNIN-100 VHG-LVN-100 VHG-LCUN-100
Molybdenium Nickel Vanadium Copper
10g/mL* 10g/mL* 10g/mL* 10g/mL*

Background
USP reference standards are highly purified substances that are provided specifically for use in the official test methods of the United States Pharmacopeia and National Formulary. When used as a part of the relevant official monograph they provide the means to verify the compliance of a material with USP-NF standards for identity, concentration, quality and purity. Official USP and NF Reference Standards are made available as required for use in assays and tests appearing in the current edition of the USP-NF. They are collaboratively tested and approved for such use by the USP Reference Standards Committee and released only under the authority of the USP Board of Trustees. The range of USP reference standards includes: 1. 2. 3. 4. Official USP and NF Reference Standards. Former USP and NF Reference Standards, not required in the current USP or NF, but for which sufficient demand remains. Food Chemicals Codex (FCC) reference standards, specified in the current edition of the Food Chemicals Codex. Authentic Substances (AS), which are highly purified samples of chemicals, that are collaboratively tested and made available as a service to analysts.
The list in this catalogue includes all amendments and new products made official by USP to July 2011.

The development of USP reference standards is a multi-step process that makes much use of voluntary cooperation from the pharmaceutical industry, government agencies including the United States Food and Drug Administration (FDA), and both USP in-house scientific staff and the members of the Committee of Revision. The following steps are adhered to, and the process takes from one to two years. 1. 2. 3. 4. Preparation and purification of candidate material. Testing and characterisation through a collaborative study (ring test). Initial scientific and statistical review. Further analytical work is often required, and at this stage it is possible that the candidate material is rejected and the procedure restarted. Preparation of a USP Reference Standards Committee letter, containing the data from the collaborative study for use by the Reference Standards Committee. This document is USPs internal equivalent of a certification report. Approval of the document must be unanimous or further analytical work will be requested, or the whole cycle restarted. Packaging and final quality control testing for homogeneity, integrity of the package, etc.
5.
USP generally does not provide certificates of analysis for USP reference standards (as outlined in their Document Disclosure Policy). USP reference standards are solely for use in the official tests and methods of the current official compendia. When handled in accordance with labelled instructions and monographs, they are considered as a value of 100.0% for compendial purposes, unless otherwise stated. In response to requests from LGC Standards, USP began listing the labelled purity values for reference standards and authentic substances. Each value is followed by a code to indicate the basis of the assignment. For example, a reference standard with a labelled purity of 0.998 mg/mg calculated on the "as is" basis, will be listed as "0.998 mg/mg (ai)". From now on, the values will be included for new lots released since January 1, 2004 and they will be included for all lots as they are released in the future. Below is a list of the basis codes and their meaning: (ai) (dr) (an) (fb) as is dried anhydrous free base.
It must be noted that any other use of a USP reference standard in non-official procedures becomes the responsibility of the user.
Proper use
A full description of the background to, proper use of and lot control procedures for USP-NF reference standards is given in General Chapter <11> of the current USP-NF publication. Analysts are strongly advised to review this section on a regular basis. More information on USP publications and subscriptions is given in the Publications and subscriptions section of this catalogue.
Edition 2012/2013
349
United States Pharmacopeia and National Formulary Shelf life, expiry dates and size unit
USP reference standards are not labeled with an expiry date. The official lot number system provides greater flexibility than a simple expiry date system. USP reference standards stocks are regularly and rigorously checked. Under normal circumstances a new lot is made official and held for future use, before the old lot is sold out. The old lot remains official for a period of time so that in-house reference substances can be recertified against the out-going and incoming lots and also to prevent unnecessary waste. Please note, that new lots can have different unit sizes, especially with pharmacopoeial reference standards, and LGC Standards is not responsible for such cases. If the unit size of a new batch changes, LGC Standards will provide this information to customers in new lot lists. It is the responsibility of each analyst to ensure that his particular supply of USP reference substance is current. As your supplier of choice, LGC Standards can provide lists of current lot numbers of USP reference standards, so call us to receive these today. Please take this opportunity to subscribe to this free service by contacting your local LGC Standards office.
Validation of secondary standards against USP reference substances

All secondary in-house working standards have to be compared against the corresponding USP reference standard. Please make sure that the secondary material is used only for the same official purposes for which the primary pharmacopoeial material also was designed.
Replacement lots and back orders

Because of the rigorous nature of the approval process and the time taken, it is not always possible for USP to have a new lot available before an existing lot is depleted. USP provides LGC Standards with regular information about the projected availability of back-ordered USP RS. Please contact LGC Standards for any enquiry.
Storage conditions
The USP-NF states that generally, reference standards should be stored in their original sealed containers away from heat and protected from light. Avoid humid storage areas in particular. In addition, the USP-NF recommends in its General Notices, that where no specific storage directions or limitations are provided in the individual monograph, it is to be understood that conditions of storage include protection from moisture, freezing and excessive heat.
Controlled Substances
The USP list contains substances subject to Controlled Substance Regulations Schedules I, II, III, IV and V. Special ordering procedures apply, please contact LGC Standards for details and costs.
Restricted Reference Standards

The United States Government restricts the export of chemicals appearing on the US Munition list, the Commerce Control list or in the Chemical Weapons Convention Annex on chemicals. Listed below are USP reference standards that are now currently restricted and may not be exported to any country outside the U.S.A. USP1106001 Chlorambucil USP1157002 Cyclophosphamide USP1376505 Mechlorethamine Hydrochloride USP1379300 Melphalan Hydrochloride USP1706009 Uracil Mustard
Products
Code Product Unit
USP1000408 USP1000419 USP1000420 USP1000441 USP1000452
Abacavir Sulfate Abacavir Sulfate Racemic 4-[2-amino-6-(cyclopropylamino)9H-purin-9yl]-2-cyclopentene-1-methanol sulfate (2:1) Abacavir Related Compound A [4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol Abacavir Related Compound B [4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol Abacavir Related Compound C [(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol HCl
200 mg 20 mg 20 mg 20 mg 20 mg
350
Edition 2012/2013

Code Product Unit
USP1000485 USP1000496 USP1000500 USP1000601 USP1000612 USP1001003 USP1001502 USP1002505 USP1003009 USP1003010 New USP1003027 New USP1003031 New USP1003042 New USP1003100 USP1004001 USP1005004 USP1005706 USP1006007 USP1006506 USP1006801 USP1007000 USP1008501 USP1009005 USP1612619 New USP1009479 USP1009901 USP1009923 USP1010106 USP1011007 USP1011018 USP1011029 USP1012032 USP1012065 USP1012076 New USP1011709 New USP1011710 New USP1011721 New USP1011732 New USP1011743 New USP1011754 USP1012134
Abacavir Related Compounds Mixture Abacavir Stereoisomers Mixture Abacavir System Suitability Mixture Acebutolol HCl Acebutolol Related Compound A N-(3-acetyl-4-hydroxyphenyl)butanamide (AS) Acenocoumarol Acepromazine Maleate Acesulfame Potassium Acetaminophen Acetaminophen Related Compound A 4-(acetylamino)phenyl acetate Acetaminophen Related Compound B N-(4-hydroxyphenyl)propanamide Acetaminophen Related Compound C N-(2-hydroxyphenyl)acetamide Acetaminophen Related Compound D N-phenylacetamide Acetaminophen Related Compound J N-(4-chlorophenyl)acetamide Acetanilide Melting Point Standard (Approximately 114C) Acetazolamide Glacial Acetic Acid (AS) Acetohexamide Acetohydroxamic Acid Acetone Acetophenazine Maleate Acetylcholine Chloride Acetylcysteine N-Acetylneuraminic Acid 2-Acetylpyridine Acetyltributyl Citrate Acetyltriethyl Citrate N-Acetyl-L-Tyrosine Acitretin Acitretin Related Compound A (2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid Acitretin Related Compound B ethyl(all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate Actein Acyclovir Acyclovir Related Compound A 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate Adapalene Adapalene Related Compound A Methyl 6-bromo-2-naphthoate Adapalene Related Compound B Methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoate Adapalene Related Compound C 2-(adamant-1-yl)methoxybenzene Adapalene Related Compound D 4,4'-dimethoxy-3,3'-di(adamant-1-yl)biphenyl Adapalene Related Compound E 2,2'binaphthyl-6,6'-dicarboxylic acid Ademetionine Disulfate Tosylate
15 mg 15 mg 15 mg 125 mg 20 mg 200 mg 250 mg 200 mg 400 mg 15 mg 50 mg 50 mg 50 mg 50 mg 500 mg 2g 3x1.5 mL 250 mg 200 mg 3x1.5 mL 200 mg 200 mg 200 mg 200 mg 1g 500 mg 500 mg 100 mg 200 mg 20 mg 20 mg 20 mg 300 mg 50 mg 200 mg 50 mg 50 mg 25 mg 25 mg 25 mg 500 mg
Edition 2012/2013
351

Code Product Unit
USP1012101 USP1012123 USP1012112 USP1012178 USP1012190 USP1012214 USP1012145 USP1012203 USP1012495 USP1012509 USP1012553 New USP1012595 USP1012600 USP1012633 USP1012644 USP1012757 USP1012746 USP1012768 USP1012772 USP1012699 USP1012688 USP1012780 USP1012906 USP1012917 USP1012928 New USP1012871 USP1012848 USP1012939 USP1012950 USP1013002 USP1013024 USP1013013 USP1013035 USP1013046 USP1013068 USP1013079 USP1013057 USP1013512 USP1013523 USP1013534 USP1014005 USP1015008 USP1015019
Adenine Adenosine S-Adenosyl-L-Homocysteine 5'-Adenylic Acid Adipic Acid Agar Agigenin Agnuside Beta Alanine L-Alanine Albendazole rAlbumin Human (Recombinant Human Albumin) Albuterol Albuterol Sulfate Albuterol Related Compound A 4-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-methylphenol sulfate Alclometasone Dipropionate Alclometasone Dipropionate Related Compound A 11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate Alcohol Dehydrated Alcohol Alcohol Determination-Acetonitrile Alcohol Determination-Alcohol Alendronate Sodium Alfentanil HCl Controlled Substance CII Alfuzosin HCl Alfuzosin System Suitability Mixture Alfuzosin System Suitability Mixture A Alfuzosin HCl containing Impurity A, Impurity D, and Impurity E Alitame Allantoin Alliin Allopurinol Allopurinol Related Compound A 3-Amino-4-carboxamidopyrazole Hemisulfate Allopurinol Related Compound B 5-(formylamino)-1H-pyrazole-4-carboxamide Allopurinol Related Compound C 5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide Allopurinol Related Compound D ethyl 5-amino-1H-pyrazole-4-carboxylate Allopurinol Related Compound E ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate Allopurinol Related Compound F ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate S-Allyl-L-Cysteine Almotriptan Malate Almotriptan Related Compound A {3-[2-(Dimethylamino)ethyl]-5-[)pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol Almotriptan System Suitability Mixture of Almotriptan Malate and Almotriptan Monomethyl Analog Alphaprodine HCl Controlled Substance CII Alprazolam Controlled Substance CIV Alprazolam Related Compound A 2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine
200 mg 200 mg 50 mg 500 mg 100 mg 500 mg 25 mg 25 mg 100 mg 200 mg 200 mg 4.92 mg 200 mg 200 mg 25 mg 300 mg 20 mg 5x1.2 mL 5x1.2 mL 5x5 mL 5x5 mL 200 mg 500 mg 150 mg 15 mg 25 mg 250 mg 200 mg 25 mg 250 mg 25 mg 25 mg 25 mg 35 mg 25 mg 25 mg 25 mg 200 mg 20 mg 20 mg 250 mg 200 mg 30 mg
352
Edition 2012/2013

Code Product Unit
USP1016000 USP1017105 USP1017364 USP1017502 USP1018505 USP1019202 USP1019406 USP1019417 USP1019428 USP1019508 USP1019701 USP1019712 USP1019756 USP1019767 USP1019803 USP1020008 New USP1020023 USP1021000 USP1021204 USP1022808 USP1025205 USP1025307 USP1025351 USP1025602 USP1025806 USP1025908 USP1026004 USP1026401 USP1026605 USP1027007 USP1027302 USP1027346 USP1027357 USP1027380 USP1028000 USP1029002 USP1029013 USP1029024 USP1029501 USP1029512
Alprostadil Altretamine Aluminum Sulfate (AS) Dried Aluminum Hydroxide Gel Amantadine HCl Amcinonide Amifostine Amifostine Disulfide Amifostine Thiol 2-[(3-aminopropyl)amino]ethanethiol, dihydrochloride Amikacin Amiloride HCl Amiloride Related Compound A Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate (AS) Aminobenzoate Potassium Aminobenzoate Sodium Aminobenzoic Acid p-aminobenzoic acid Aminobutanol Gamma-Aminobutyric Acid Aminocaproic Acid 4-Aminophenol 2-Amino-5-chlorobenzophenone Aminoglutethimide m-Aminoglutethimide Aminohippuric Acid Amino Methacrylate Copolymer 2-[3-Amino-5-(n-methylacetamido)-2,4,6-triiodobenzamido]-2-deoxy-d-glucose Aminopentamide Sulfate m-Aminophenol Aminosalicylic Acid 3-Amino-2,4,6-triiodobenzoic Acid 5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid Amiodarone HCl Amiodarone Related Compound D (2-butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone Amiodarone Related Compound E (2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone Amiodarone Related Compound H 2-chloro-N,N-diethylethanamine HCl Amitraz Amitriptyline HCl Amitriptyline Related Compound A Dibenzosuberone Amitriptyline Related Compound B 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-ol Amlodipine Besylate Amlodipine Related Compound A 3-Ethyl,5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-3,5pyridinedicarboxylate]fumarate Ammonio Methacrylate Copolymer Type A Ammonio Methacrylate Copolymer Type B Ammonium Carbonate (AS) Ammonium Chloride
25 mg 500 mg 2g 200 mg 200 mg 200 mg 150 mg 100 mg 50 mg 300 mg 500 mg 30 mg 200 mg 200 mg 200 mg 500 mg 50 mg 200 mg 100 mg 25 mg 200 mg 100 mg 200 mg 1.5 g 25 mg 200 mg 300 mg 125 mg 50 mg 50 mg 200 mg 20 mg 25 mg 20 mg 200 mg 200 mg 25 mg 25 mg 350 mg 15 mg
USP1029909 USP1029910 USP1029942 USP1029953
500 mg 500 mg 2g 200 mg
Edition 2012/2013
353

Code Product Unit
New USP1029929 USP1029986 USP1030001 USP1031004 USP1031401 USP1031503 USP1031514 USP1031525 USP1031536
Ammonium Glycyrrhizate Ammonium Phosphate Dibasic (AS) Amobarbital Controlled Substance CII Amodiaquine HCl Amoxapine Amoxicillin Amoxicillin Related Compound A (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Amoxicillin Related Compound B L-amoxicillin Amoxicillin Related Compound C (4S)-2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]5,5-dimethylthiazolidine-4-carboxylic acid Amoxicillin Related Compound D (4S)-2-{[(R)-2-amino-2-(4-hydroxyphenyl)acetamido](carboxy)methyl}-5,5dimethylthiazolidine-4-carboxylic acid, monosodium salt Amoxicillin Related Compounds D and E Mixture Amoxicillin Related Compound F 3-(4-Hydroxyphenyl)pyrazin-2-ol; phenylpyrazinediol Amoxicillin Related Compound G (2S,5R,6R)-6-{(R)-2-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido]-2-(4hydroxyphenyl)acetamido}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2carboxylic acid; D-hydroxyphenylglycylamoxicillin Amoxicillin Related Compound I (R)-2-Amino-2-(4-hydroxyphenyl)acetic acid Amoxicillin Related Compound J Mixture of amoxicillin and amoxicillin related compound J (open ring dimer) Amphotericin B Ampicillin Ampicillin Sodium Ampicillin Trihydrate Amprolium Amrinone (Inamrinone) Amrinone Related Compound A 5-carboxamide[3,4'-bipyridin]-6(1H)-one (Inamrinone Related Compound A) Amrinone Related Compound B N-(1,6-dihydro-6-oxo-(3,4'-bipyridine)-5-yl)-2-hydroxypropanamide (Inamrinone Related Compound B) Amrinone Related Compound C 1,6-dihydro-6-oxo-(3,4'-bipyridine)-5-carbonitrile (Inamrinone Related Compound C) Anagrelide HCl Anagrelide Related Compound A ethyl 2-(6-amino-2,3-dichlorobenzylamino)acetate Anagrelide Related Compound B (2-amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid Anagrelide Related Compound C Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate Anastrozole Anastrozole Related Compound A 2,2'-(5-methyl-1,3-phenylene)bis(2-methylpropanenitrile) Andrographolide Powdered Andrographis Extract Anecortave Acetate Anecortave Acetate Related Compound A 9(11)-dehydrocortisol Anethole (AS) 1,6-Anhydro-D-glucose Anileridine HCl Controlled Substance CII
100 mg 1g 200 mg 500 mg 200 mg 200 mg 15 mg 15 mg 15 mg
USP1031547
50 mg
USP1031558 USP1031569 USP1031570
15 mg 15 mg 15 mg
USP1031591 USP1031605 USP1032007 USP1033000 USP1033203 USP1033407 USP1034002 USP1034308 USP1034320 USP1034341
USP1034363 USP1034738 USP1034749 USP1034750 USP1034771 USP1034807 USP1034818 USP1034862 USP1034873 USP1034909 USP1034910 USP1035005 USP1035300 USP1036008
354
50 mg 100 mg 25 mg 25 mg 25 mg 200 mg 20 mg 50 mg 500 mg 200 mg 20 mg 2 mL 50 mg 250 mg

Edition 2012/2013

Code Product Unit
USP1036507 USP1037011 USP1038003 USP1039006 New USP1039152 USP1040005 New USP1040016 USP1040683 USP1040708 New USP1040854 USP1041008 USP1041609 USP1041904 USP1041915
3-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile (AS) Anisole Antazoline Phosphate Anthralin Allyl Anthranilate Antipyrine Antipyrine Related Compound A 3-methyl-1-phenyl-1H-pyrazol-5(4H)-one Apigenin Apigenin-7-glucoside Apocarotenal Beta-Apo-8'-Carotenal Apomorphine HCl Apraclonidine HCl Aprepitant Aprepitant Related Compound A 3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one Aprepitant Related Compound B 3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4fluorophenyl)morpholino]methyl-1H-1,2,4-triazol-5(4H)-one L-Arabinitol L-Arginine Arginine Ethyl Ester Dihydrochloride Arginine HCl Aripirazole Aripiprazole Related Compound B 7-(4-hydroxy-butoxy)3,4-dihydroquinolin-2(1H)-one Aripiprazole Related Compound C 1-(2,3-dichlorophenyl)piperazine HCl Aripiprazole Related Compound F 4-(2,3-dichlorophenyl-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide Aripiprazole Related Compound G 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one Aripiprazole Related Compound H 7-(4-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2-(1H)-one Arsanilic Acid Artemether Artemether Related Compound A (3R,5aS,6R,8aS,9R,12R,12aR)-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12Hpyrano[4,3-j]-1,2-benzodioxepin Artemether Related Compound B (3R,5aS,6R,8aS,9R,10R,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy12H-pyrano[4,3-j]-1,2-benzodioxepin Artesunate Articaine Articaine HCl Articaine Related Compound A Methyl 4-methyl-3-[2-propylamino) acetamido)thiophene-2-carboxylate Articaine Related Compound B 4-methyl-3-{[2-(propylamino)propanoy]amino}thiophene-2-carboxylic acid Articaine Related Compound E Methyl 3-[2-(isopropylamino)propanamido]-4-methylthiophene-2-carboxylate Ascorbic Acid (Vitamin C) Ascorbyl Palmitate (AS) Powdered Ashwagandha Extract Asiaticoside
25 mg 3x1.2 mL 200 mg 200 mg 5x0.5 mL 200 mg 25 mg 30 mg 30 mg 3x50 mg 250 mg 100 mg 50 mg 10 mg
USP1041926
10 mg
USP1042102 USP1042500 USP1042554 USP1042601 New USP1042634 New USP1042645 New USP1042656 New USP1042689 New USP1042690 New USP1042714 USP1042703 USP1042780 USP1042791
500 mg 200 mg 250 mg 125 mg 200 mg 25 mg 25 mg 25 mg 25 mg 25 mg 25 mg 100 mg 15 mg
USP1042805
15 mg
Edition 2012/2013
200 mg 40 mg 125 mg 40 mg 25 mg 40 mg 1g 2g 1g 30 mg
355

Code Product Unit
USP1043502 USP1043513 USP1043706 USP1043750 USP1043728 USP1043819 USP1044006 USP1044301 USP1044403 USP1044469 USP1044470 USP1044488 USP1044491 USP1044913 USP1044516 USP1044527
Asparagine Anhydrous Asparagine Monohydrate Aspartame Aspartame Acesulfame Aspartame Related Compound A 5-Benzyl-3,6-dioxo-2-piperazineacetic Acid Aspartic Acid Aspirin Astemizole Atenolol Atomoxetine HCl Atomoxetine Related Compound A 3-(Methylamino)-1-phenylpropan-1ol Atomoxetine Related Compound B N-Methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine HCl Atomoxetine Related Compound C N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine HCl Atomoxetine S-Isomer (S)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine HCl Atorvastatin Calcium Atorvastatin Related Compound A Desfluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt Atorvastatin Related Compound B 3S,5R isomer,or (3S,5R)-7-[3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt Atorvastatin Related Compound C Difluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptcnoic acid calcium salt Atorvastatin Related Compound D Epoxide impurity, or 3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyl-oxirane-2carboxylic acid phenylamide Atorvastatin Related Compound E 3S,5S enantiomer of Atorvastatin Calcium Atorvastatin Related Compound H 5-(4-Fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide Atorvastatin Related Compound I tert-Butyl 2-((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl)1H-pyrrol-1-yl)]ethyl}-2,2-dimetyl-1,3-dioxan-4-yl)acetate Atovaquone Atovaquone Related Compound A cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone Atracurium Besylate Atropine Sulfate Aurothioglucose Avobenzone Azacitidine Related Compound A 4-Amino-1,3,5-triazin-2(1H)-one Azacitidine Related Compound B 1-O-Acetyl-2,3,5-tri-O-benzoyl-Beta-D-ribofuranose Azaerythromycin A 9-Deoxo-9a-aza-9a-homoerythromycin A Azaperone Azatadine Maleate Azathioprine Azithromycin Azithromycin Identity
200 mg 200 mg 200 mg 200 mg 25 mg 100 mg 500 mg 200 mg 200 mg 100 mg 10 mg 10 mg 10 mg 10 mg 100 mg 20 mg
USP1044538
20 mg
USP1044549
20 mg
USP1044550
20 mg
USP1044571 USP1044582
10 mg 20 mg
USP1044593
20 mg
USP1044651 USP1044662 USP1044800 USP1045009 USP1045508 USP1045337 New USP1045539 New USP1045541 USP1045600 USP1045756 USP1045803 USP1046001 USP1046056 USP1046067
356
200 mg 25 mg 100 mg 500 mg 100 mg 500 mg 15 mg 15 mg 100 mg 200 mg 200 mg 200 mg 100 mg 75 mg
Edition 2012/2013

Code Product Unit
USP1046012 USP1046090 USP1046045 USP1046023 USP1046147 USP1046205 USP1046307 USP1046409 USP1047300 USP1047503 USP1048007 USP1048200 USP1048222 USP1048244 USP1048233 USP1048255 USP1048266 USP1048277 USP1048506 USP1048550 USP1048572 USP1048583 USP1048619 USP1048620
Azithromycin Identification Mixture Azithromycin N-Oxide Azithromycin Related Compound F 3'-N-demethyl-3'-N-formylazithromycin Azithromycin Related Compound H 3'-N-[[4-(acetylamino)phenyl]sulfonyl]-3'-N-demethylazithromycin Azo-Aminoglutethimide Aztreonam Aztreonam E-Isomer Open Ring Aztreonam Bacampicillin HCl Bacitracin (Susceptibility disk standard) Bacitracin Zinc Baclofen Baclofen Related Compound A 4-(4-Chlorophenyl)-2-pyrrolidinone Powdered Bacopa Extract Bacoside A3 Balsalazide Disodium Balsalazide Related Compound A (E)-5-[(p-carboxyphenyl)azo]-2-salicylic acid, disodium salt Balsalazide Related Compound B (E)-5-((m-[(2-carboxyethyl)carbamoyl]phenyl)azo)-2-salicylic acid Beclomethasone Dipropionate Behenoyl Polyoxylglycerides Bemotrizinol Bemotrizinol Impurity Mixture Benazepril HCl Benazepril Related Compound A (3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1benazapine-1-acetic acid, monohydrochloride Benazepril Related Compound B (Mixture of (1R,3S) and (1S, 3R) 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride) Benazepril Related Compound C (3S)-3-[[(1S)-1-(carboxy)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine]1-acetic acid Benazepril Related Compound D 3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)benzazepine-1-acetic acid monohydrochloride Benazepril Related Compound E 3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, monohydrochloride Benazepril Related Compound F 3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, tert-butyl ester Benazepril Related Compound G 3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)benzazepine-1-acetic acid, ethyl ester Bendroflumethiazide Benoxinate HCl Benzaldehyde Benzalkonium Chloride Benzethonium Chloride Benzocaine Benzoic Acid Benzonatate 1,4-Benzoquinone
75 mg 15 mg 25 mg 15 mg 100 mg 200 mg 50 mg 15 mg 200 mg 1g 200 mg 350 mg 50 mg 500 mg 15 mg 200 mg 100 mg 25 mg 200 mg 500 mg 200 mg 100 mg 125 mg 25 mg
USP1048630
15 mg
USP1048641
50 mg
USP1048652
15 mg
USP1048663 USP1048674 USP1048685
25 mg 15 mg 15 mg
USP1049000 USP1050009 USP1050905 USP1051001 USP1051500 USP1054000 USP1055002 USP1056005 USP1056504
200 mg 200 mg 2x1 mL 5 mL 500 mg 500 mg 300 mg 1g 200 mg
Edition 2012/2013
357

Code Product Unit
USP1057507 USP1059003 USP1061005 USP1061901 USP1062008 USP1064003 USP1065006 USP1065210 New USP1065480 New USP1065491 USP1048288
Benzothiadiazine Related Compound A 4-Amino-6-chloro-1,3-benzenedisulfonamide Benzphetamine HCl Controlled Substance CIII Benztropine Mesylate Benzyl Alcohol Benzyl Benzoate 1-Benzyl-3-methyl-5-aminopyrazole HCl Bephenium Hydroxynaphthoate Berberine Chloride Beta Carotene Beta Carotene System Suitability Beta Glucan Beta Glucan from Baker's Yeast Saccharomyces cerevisiae Betadex Sulfobutyl Ether Sodium Betahistine HCl Betaine Betaine HCl Betamethasone Betamethasone Acetate Betamethasone Benzoate Betamethasone Dipropionate Betamethasone Sodium Phosphate Betamethasone Valerate Betamethasone Valerate Related Compound A Betamethasone 21-valerate (AS) Betaxolol HCl Betazole HCl Bethanechol Chloride Bicalutamide Bicalutamide Related Compound A N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfinyl]-2-hydroxy-2methyl-propanamide Bicalutamide Related Compound B (RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(3-fluorophenylsulfonyl)2-hydroxy-2-methylpropanamide Powdered Bilberry Extract Bile Salts Biochanin A Positive Bioreaction Biotin Biperiden Biperiden HCl Bisacodyl Bisacodyl Related Compound A 4,4'-(Pyridin-2-ylmethylene)diphenol Bisacodyl Related Compound B 2,4'-(Pyridin-2-ylmethylene)diphenol Bisacodyl Related Compound C 4-[(4-Hydroxyphenyl)(pyridin)-2-yl)methyl]phenyl acetate Bisacodyl Related Compound E 2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate 2,5-Bis-(D-arabino-1,2,3,4-tetrahydroxybutyl)pyrazine Bis(2-ethylhexyl)maleate Bisdesmethoxycurcumin
100 mg 200 mg 200 mg 500 mg 5g 25 mg 500 mg 50 mg 3x250 mg 200 mg 1g
USP1065550 USP1065618 USP1065695 USP1065709 USP1066009 USP1067001 USP1067307 USP1067704 USP1068004 USP1069007 USP1069018 USP1069903 USP1070006 USP1071009 USP1071202 USP1071213
500 mg 200 mg 1g 200 mg 200 mg 500 mg 200 mg 125 mg 500 mg 200 mg 50 mg 200 mg 200 mg 200 mg 200 mg 25 mg
USP1071224
10 mg
USP1071268 USP1071304 New USP1071381 USP1071439 USP1071508 USP1072001 USP1073004 USP1074007 USP1074030 USP1074042 USP1074051 USP1074073 USP1074700 USP1075203 USP1075305
358
500 mg 10 g 20 mg 3 strips 200 mg 200 mg 200 mg 125 mg 20 mg 20 mg 20 mg 20 mg 25 mg 2g 30 mg

Edition 2012/2013

Code Product Unit
USP1075509 USP1075531 USP1075600 USP1075622 USP1075644 USP1075553 USP1075677 USP1075688 USP1075699 USP1075757 USP1076206 USP1076308 USP1076341 New USP1076115 USP1076250 USP1076261 USP1076352 USP1076363 USP1076374
p-Bis(di-n-propyl)carbamylbenzenesulfonamide Bismuth Citrate Bismuth Subcarbonate (AS) Bismuth Subgallate (AS) Bismuth Subnitrate (AS) Bismuth Subsalicylate Bisoctrizole Bisoctrizole Related Compound A 2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol Bisoctrizole Resolution Mixture Bisoprolol Fumarate Powdered Black Cohosh Extract Bleomycin Sulfate Boric Acid (AS) Bosentan Boswellia Serrata Extract 3-Acetyl-11-Keto-Beta-Boswellic Acid Bretylium Tosylate Brinzolamide Brinzolamide Related Compound A (S)-(-)-4-ethylamino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine-6sulfonamide-1,1-dioxide Brinzolamide Related Compound B (R)-4-amino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine-6-sulfonamide1,1-dioxide ethanedioate Bromazepam (AS) Controlled Substance CIV Bromocriptine Mesylate Bromodiphenhydramine HCl 8-Bromotheophylline Bromperidol Decanoate Brompheniramine Maleate Budesonide Bumetanide Bumetanide Related Compound A 3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid Bumetanide Related Compound B 3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid Bupivacaine HCl Bupivacaine Related Compound A 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide (AS) Bupivacaine Related Compound B (2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (AS) Buprenorphine HCl Controlled Substance CIII Buprenorphine Related Compound A 21-[3-(1-propenyl)]7-alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14tetrahydrooripavine Controlled Substance CII Bupropion HCl Bupropion HCl Related Compound A 2-(tert-butylamino)-4'-chloropropiophenone hydrochloride Bupropion HCl Related Compound B 2-(tert-butylamino)-3'-bromopropiophenone hydrochloride Bupropion HCl Related Compound C 1-(3-chlorophenyl)-2-hydroxy-1-propanone Bupropion HCl Related Compound F 1-(3-chlorophenyl)-1-hydroxy-2-propanone Buspirone HCl
50 mg 100 mg 1g 2g 1.5 g 100 mg 200 mg 25 mg 50 mg 200 mg 1.5 g 15 mg 1g 200 mg 1g 20 mg 200 mg 200 mg 50 mg
USP1076385
50 mg
USP1076465 USP1076501 USP1077005 USP1077708 USP1077887 USP1078008 USP1078201 USP1078303 USP1078325 USP1078336 USP1078507 USP1078518 USP1078529 USP1078700 USP1078711
100 mg 150 mg 200 mg 400 mg 15 mg 125 mg 200 mg 250 mg 10 mg 25 mg 500 mg 50 mg 50 mg 50 mg 25 mg
USP1078733 USP1078744 USP1078755 USP1078766 USP1078799 USP1078802

Edition 2012/2013
200 mg 15 mg 15 mg 40 mg 30 mg 200 mg
359

Code Product Unit
USP1079000 USP1080000 USP1081002 USP1081501 USP1081807 USP1081829 USP1082300 USP1082504 USP1082606 USP1082708 USP1082901 USP1083008 USP1083100 USP1083303 USP1084000 USP1084306 USP1085003 USP1086006 New USP1086039 USP1086108 USP1086200 USP1086210 New USP1086221 USP1086301 USP1086312 USP1086334 USP1086356 USP1086378 USP1086403 USP1086436 USP1086447 USP1086800 USP1086855 USP1086866 USP1086888 USP1086902 USP1086935 USP1087009 USP1087031 USP1087202 USP1087359 USP1087406 USP1087508 USP1087701 USP1087803 USP1088001 USP1090706 USP1090717
Butabarbital Controlled Substance CIII Butacaine Sulfate Butalbital Controlled Substance CIII Butamben 1-Butanol 2-Butanol Butoconazole Nitrate Butorphanol Tartrate Controlled Substance CIV Butyl Acetate Butylated Hydroxytoluene Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate 2-tert-Butyl-4-hydroxyanisole 3-tert-Butyl-4-hydroxyanisole tert-Butylmethyl ether Butylparaben Cabergoline Caffeine Caffeine Melting Point Standard (Approximately 236C) Caftaric Acid Calcifediol Calcitonin Salmon Calcitonin Salmon Related Compound A N-acetyl-Cys(1)-calcitonin salmon Calcitonin Salmon Related Compound B calcitonin salmon-glycine Calcitriol Calcitriol Solution Calcium Acetate (AS) Calcium Ascorbate Calcium Benzoate Calcium Carbonate (AS) Calcium Chloride (AS) Calcium Cyclamate Calcium Gluceptate Calcium Hydroxide (AS) Calcium(-)-Hydroxycitrate Calcium Lactate Calcium Lactobionate Calcium Levulinate (AS) Calcium Pantothenate (Vitamin B5) Tribasic Calcium Phosphate (AS) Calcium Saccharate Calcium Stearate (AS) Calcium Sulfate (AS) Camphor Candelilla Wax Candesartan Cilexetil Candicidin Capecitabine Capecitabine Related Compound A 5'-deoxy-5-fluorocytidine
200 mg 600 mg 200 mg 200 mg 3x1.2 mL 3x1.2 mL 200 mg 350 mg 3x1.2 mL 500 mg 25 mg 200 mg 200 mg 3x1.2 mL 200 mg 125 mg 200 mg 1g 20 mg 75 mg 20 mg 20 mg 0.34 mg 10 mg 5 mL 1g 200 mg 200 mg 1g 1g 200 mg 200 mg 1g 150 mg 1g 200 mg 1g 200 mg 1g 200 mg 2g 1g 1g 250 mg 100 mg 200 mg 200 mg 10 mg
360
Edition 2012/2013

Code Product Unit
USP1090728 USP1090739 USP1091006 USP1091040 USP1091505 USP1091108 USP1091200 USP1091221 USP1092009 USP1093001 USP1093012 USP1093023 USP1093205 USP1093500 USP1094004 USP1095506 USP1095517 USP1096000 USP1096407 USP1096509 USP1096531 USP1096553 USP1096600 New USP1096597 USP1096611 USP1096724 USP1096735 USP1096699 USP1096702 USP1096757 USP1096622 USP1096633
Capecitabine Related Compound B 5'-deoxy-5-fluorouridine Capecitabine Related Compound C 2',3'-O-carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl) cytidine Capreomycin Sulfate Caprylic Acid Caprylocaproyl Polyoxylglycerides Capsaicin Captopril Captopril Disulfide Carbachol Carbamazepine (CRM) Carbamazepine Related Compound A 10,11-dihydrocarbamazepine Carbamazepine Related Compound B Iminostilbene Carbarsone Carbenicillin Indanyl Sodium Carbenicillin Monosodium Monohydrate Carbidopa Carbidopa Related Compound A 3-O-Methylcarbidopa Carbinoxamine Maleate Carboplatin Carboprost Tromethamine Carboxymethylcellulose Calcium (AS) Carboxymethylcellulose Sodium Carisoprodol Controlled Substance CIV Carisoprodol Related Compound A 2-hydroxymethyl-2-methylpentyl carbamate Carmellose Carmustine Carmustine Related Compound A 1,3-bis(2-chloroethyl)urea Carprofen Carprofen Related Compound A Carbazole Carteolol HCl Carvedilol Carvedilol Related Compound A 1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Carvedilol Related Compound B 3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol) Carvedilol Related Compound C 1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol Carvedilol Related Compound D 4-(Oxiran-2-ylmethoxy)-9H-carbazole Carvedilol Related Compound E 2-(2-methoxyphenoxy)ethylamine Carvedilol System Suitability Mixture carvedilol spiked with carvedilol related compound F Casticin (+)-Catechin Cathinone HCl alpha-Aminopropiophenone HCl Controlled Substance CI
20 mg 10 mg 250 mg 300 mg 200 mg 100 mg 200 mg 100 mg 200 mg 100 mg 50 mg 50 mg 200 mg 300 mg 200 mg 400 mg 25 mg 200 mg 100 mg 25 mg 1.5 g 1.5 g 1g 10 mg 500 mg 75 mg 10 mg 200 mg 50 mg 200 mg 200 mg 15 mg
USP1096644 USP1096655 USP1096666 USP1096677 USP1096688 USP1096779 USP1096790 USP1096804
Edition 2012/2013
361

Code Product Unit
Powdered Cat's Claw Extract Cefaclor Cefaclor, Delta-3-Isomer Cefadroxil Cefamandole Lithium Cefamandole Nafate Cefazolin Cefdinir Cefdinir Related Compound A 2(R)-2-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-2-[(2RS,5RS)5-methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid Cefdinir Related Compound B (6R,7R)-7-[2-(2-amino-4-thiazolyl)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid Cefditoren Pivoxil Cefepime HCl Cefepime HCl System Suitability Cefepime Related Compound D (Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid Cefepime Related Compound E 1-{[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en -3-yl]methyl}-1methylpyrrolidin-1-ium chloride Cefixime Cefmenoxime HCl Cefmetazole Cefonicid Sodium Cefoperazone Dihydrate Ceforanide Cefotaxime Sodium Cefotetan Cefotiam HCl Cefoxitin Cefpiramide Cefpodoxime Proxetil Cefprozil (E)-Isomer Cefprozil L-Epimer (6R,7R)-7-[(S)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Cefprozil (Z)-Isomer Cefprozil Cefprozil Related Compound D (6R,7R)-7-amino-8-oxo-3-[)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Cefprozil Related Compound H (6R,7R)-7{(R)-2-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2-(4hydroxyphenyl)acetamido}-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2carboxylic acid Cefprozil Related Compound K 3-(5-ethyl-7-oxo-2,4,5,7-tetrahydro1H-furo[3,4-d][1,3]thiazin-2-yl(-6-(4hydroxyphenyl)piperazine-2,5-dione Ceftazidime, Delta-3-Isomer Ceftazidime Pentahydrate Ceftiofur Sodium Ceftizoxime Ceftriaxone Sodium Ceftriaxone Sodium E-Isomer
1g 400 mg 30 mg 200 mg 200 mg 250 mg 400 mg 200 mg 10 mg
USP1097589
10 mg
USP1097590 USP1097636 USP1097647 New USP1097680 New USP1097691
350 mg 500 mg 25 mg 20 mg 25 mg
USP1097658 USP1097771 USP1097782 USP1097750 USP1097705 USP1097807 USP1097909 USP1097975 USP1098005 USP1098107 USP1098118 USP1098027 USP1098049 New USP1097997
500 mg 350 mg 200 mg 1g 200 mg 200 mg 350 mg 500 mg 350 mg 500 mg 300 mg 350 mg 50 mg 30 mg
USP1098050 New USP1098062 New USP1097986
200 mg 200 mg 30 mg
New USP1098016
30 mg
New USP1098038
30 mg

362
10 mg 300 mg 100 mg 350 mg 350 mg 25 mg

Edition 2012/2013

Code Product Unit
USP1098209 USP1098220 USP1098231 New USP1098504 New USP1098515 New USP1098526 USP1098322 USP1098355 USP1098300 USP1098388 USP1098399 USP1098402 USP1297770 USP1098708 USP1099008 USP1102000 USP1102408 USP1102500 USP1102805 USP1102929 USP1102930 USP1102974 USP1103003 USP1103105 USP1104006 USP1105009 New USP1105315 USP1105508 USP1107004 USP1107300 USP1107401 USP1107503 USP1109000 USP1110009 USP1110020 USP1111001 USP1111103 USP1111307 USP1111908 USP1112503 USP1115545 USP1115556 USP1115705 USP1117008 USP1118000 USP1118317 USP1118328
Cefuroxime Sodium Cefuroxime Axetil Cefuroxime Axetil Delta-3-Isomers Celecoxib Celecoxib Relaed Compound A 4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide Celecoxib Relaed Compound B 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide Cellaburate (Cellulose Acetate Butyrate) Cellacefate (Cellulose Acetate Phthalate) Cellulose Acetate Microcystalline Cellulose (AS) Silicified Microcystalline Cellulose Powdered Cellulose (AS) Powdered Centella Asiatica Extract Cephaeline HBr Cephalexin Cephalothin Sodium Cephapirin Benzathine Cephapirin Sodium Cephradine Cetirizine Hydrochloride Cetirizine Related Compound A (RS)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester Cetrimonium Bromide Cetyl Alcohol Cetyl Palmitate Cetylpyridinium Chloride Powdered Chaste Tree Extract Chicoric Acid Chitosan Chloramphenicol Chloramphenicol Palmitate Chloramphenicol Palmitate Nonpolymorph A Chloramphenicol Palmitate Polymorph A Chlordiazepoxide Controlled Substance CIV Chlordiazepoxide HCl Controlled Substance CIV Chlordiazepoxide Related Compound A 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide Chlorhexidine Chlorhexidine Acetate Chlorhexidine Related Compounds p-Chloroaniline Chlorobutanol Chlorogenic Acid -Chlorogenin Chloromethyl Isopropyl Carbonate Chloroprocaine HCl Chloroquine Phosphate Chloroquine Sulfate Chloroquine Related Compound A 4,7-dichloroquinoline
200 mg 350 mg 10 mg 200 mg 10 mg 10 mg 350 mg 125 mg 125 mg 1g 1g 1g 1g 200 mg 400 mg 200 mg 100 mg 500 mg 200 mg 250 mg 20 mg 1g 100 mg 50 mg 500 mg 1.5 g 100 mg 500 mg 200 mg 200 mg 200 mg 100 mg 200 mg 200 mg 25 mg 200 mg 200 mg 50 mg 200 mg 200 mg 50 mg 20 mg 100 mg 200 mg 500 mg 500 mg 25 mg
Edition 2012/2013
363

Code Product Unit
USP1121005 USP1122700 USP1122722 USP1123000 USP1123102 USP1124003 USP1125006 USP1126009 USP1129007 USP1130006 USP1119309 USP1130505 USP1130527 USP1131009 USP1131803 USP1132001 USP1133004 USP1133503 USP1133536 USP1133547 USP1133570 USP1133580 USP1133638 USP1134007 USP1134018 USP1134030 USP1134029 USP1134040 USP1134084 USP1134051 USP1134153 USP1134164 USP1134175 USP1134186
Chlorothiazide Chloroxylenol Chloroxylenol Related Compound A 2-chloro-3,5-dimethylphenol Chlorpheniramine Maleate Chlorpheniramine Maleate Extended-Release Tablets Drug Release Calibrator, Single Unit Chlorphenoxamine HCl Chlorpromazine HCl Chlorpropamide Chlortetracycline HCl Chlorthalidone Chlorthalidone Related Compound A 4'-Chloro-3'-sulfamoyl-2-benzophenone Carboxylic Acid Chlorzoxazone Chlorzoxazone Related Compound A 2-Amino-4-chlorophenol Cholecalciferol (Vitamin D3) Delta-4,6-cholestadienol Cholesteryl Caprylate Cholestyramine Resin Cholic Acid (AS) Choline Bitartrate Choline Chloride Chondroitin Sulfate Sodium Oversulfated Chondroitin Sulfate Chromium Picolinate Chymotrypsin Ciclopirox Ciclopirox Olamine Ciclopirox Related Compound A 3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxayzolyl acetic acid Ciclopirox Related Compound B 6-Cyclohexyl-4-methyl-2-pyrone Ciclopirox Related Compound C 6-Cyclohexyl-4-metylpyridin-2(1H)-one Cilistatin Ammonium Salt Cilostazol Cilostazol Related Compound A 6-hydroxy-3,4-dihydro-1H-quinolin-2-one Cilostazol Related Compound B 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one Cilostazol Related Compound C 1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4dihydroquinolin-2(1H)-one Cimetidine Cimetidine HCl Allyl Cinnamate Cinnamic Acid Cinoxacin Ciprofloxacin Ciprofloxacin Ethylenediamine Analog 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[(2-aminoethyl)-amino]-3-quinoline-carboxylic acid hydrochloride Ciprofloxacin Formamide
200 mg 125 mg 25 mg 125 mg 60 tablets 200 mg 200 mg 200 mg 200 mg 200 mg 10 mg 350 mg 50 mg 5x30 mg 30 mg 200 mg 500 mg 2g 200 mg 200 mg 300 mg 10 mg 100 mg 300 mg 50 mg 125 mg 25 mg 25 mg 10 mg 100 mg 200 mg 50 mg 50 mg 50 mg
USP1134062 USP1134073 New USP1133999 New USP1133933 USP1134109 USP1134313 USP1134324
200 mg 200 mg 5x0.5 mL 100 mg 200 mg 200 mg 25 mg
USP1134459
125 mg
364
Edition 2012/2013

Code Product Unit
USP1134335 USP1134346
Ciprofloxacin HCl Ciprofloxacin Related Compound A 7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride salt (AS) Cisapride Cisplatin Citalopram HBr R-Citalopram Oxalate R-(-)-1-[3-(dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate Citalopram Related Compound A 1-(3-(dimethyl)propyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide Citalopram Related Compound B 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran-5carbonitrile oxylate Citalopram Related Compound C 3-[3-(dimethylamino)-1-propyl](4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate Citalopram Related Compound D 1-(4'-fluorophenyl)-1-(3-(methylamino)propyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrochloride Citalopram Related Compound E 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-Noxide hydrochloride Citalopram Related Compound F dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine hydrochloride Citalopram Related Compound G 1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-chlorophthalane hydrobromide Citalopram Related Compound H 1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide Citric Acid Cladribine Cladribine Related Compound A 2-methoxy-2'-deoxyadenosine Clarithromycin Clarithromycin Identity Clarithromycin Related Compound A 6,11-di-O-methylerythromycin A Clarithromycin Impurity D N-desmethyl clarithromycin Clarithromycin Impurity H N-formyl clarithromycin Clarithromycin Impurity Q N-oxide clarithromycin Clarithromycin Impurity R N-desmethyl erythromycin A Clavam-2-carboxylate Potassium Clavulanate Lithium Clemastine Fumarate Clenbuterol HCl Clenbuterol Related Compound B 1-(4-amino-3,5-dichlorophenyl)-2-tert-butylaminoethanone HCl Clidinium Bromide Clidinium Bromide Related Compound A 3-Hydroxy-1-methylquinuclidinium Bromide Climbazole Clindamycin HCl Clindamycin Palmitate HCl Clindamycin Phosphate Clioquinol
400 mg 25 mg
200 mg 100 mg 200 mg 10 mg 25 mg 25 mg
USP1134266 USP1134277
25 mg 15 mg
USP1134288
25 mg
USP1134299 USP1134197 USP1134222 USP1134368 USP1134200 USP1134211 USP1134379 USP1134390 USP1134380 USP1134619 USP1134620 USP1134631 USP1134642 USP1134404 USP1134426 USP1134506 USP1134674 USP1134696 USP1135000 USP1135021 USP1135600 USP1136002 USP1137005 USP1138008 USP1138201
200 mg 25 mg 25 mg 200 mg 200 mg 20 mg 100 mg 20 mg 50 mg 10 mg 10 mg 10 mg 10 mg 3.4 g 200 mg 250 mg 100 mg 10 mg 500 mg 250 mg 400 mg 200 mg 500 mg 250 mg 500 mg
Edition 2012/2013
365

Code Product Unit
USP1138405 USP1138427
Clobetasol Propionate Clobetasol Propionate Related Compound A 9-alpha-fluoro-11-beta-hydroxy-16-beta-methyl-3-oxo-androsta-1,4-diene-17(R)-spiro-2'[4'-chloro-5'-ethylfuran-3'(2'H)-one] Clocortolone Pivalate Clofazimine Clofibrate Clomiphene Citrate Clomiphene Related Compound A (E,Z)-2-[4-(1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine hydrochloride Clomipramine HCl Clonazepam Controlled Substance CIV Clonazepam Related Compound A 3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril Clonazepam Related Compound B 2-Amino-2'-chloro-5-nitrobenzophenone Clonazepam Related Compound C 2-Bromo-2'-(2-chlorobenzoyl)-4'-nitroacetanilide Clonidine Clonidine HCl Clonidine Related Compound A Acetylclonidine Clonidine Related Compound B 2-[(E)-2,6-Dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}ethyl)-imidazolidine Clopidogrel Bisulfate Clopidogrel Related Compound A (S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5-(4H)acetic acid, hydrochloride Clopidogrel Related Compound B (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothienol[2,3-c]pyridine-6(7H)-acetate, hydrochloride Clopidogrel Related Compound C methyl(-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)acetate,hydrogen sulfate Cloprostenol Sodium Clorazepate Dipotassium Controlled Substance CIV Clorsulon Clotrimazole Clotrimazole Related Compound A (o-chlorophenyl)diphenylmethanol Cloxacillin Benzathine Cloxacillin Sodium Clozapine Clozapine Resolution Mixture Cocaine HCl Controlled Substance CII Cod Liver Oil Codeine N-Oxide Controlled Substance CI Codeine Phosphate Controlled Substance CII Codeine Sulfate Controlled Substance CII Colchicine Colestipol HCl Colistimethate Sodium Colistin Sulfate Copovidone Corn Oil (AS) Corticotropin
200 mg 50 mg
200 mg 200 mg 1g 500 mg 100 mg 200 mg 200 mg 25 mg 25 mg 25 mg 200 mg 200 mg 25 mg 25 mg
USP1140430 USP1140586
125 mg 20 mg
USP1140597 USP1140600
20 mg 20 mg
USP1140666 USP1140509 USP1140702 USP1141002 USP1141024 USP1141909 USP1142005 USP1142107 USP1142108 USP1143008 USP1145207 USP1143802 USP1144000 USP1145003 USP1146006 USP1146505 USP1147009 USP1148001 USP1148500 USP1148806 USP1149004
366
400 mg 125 mg 200 mg 200 mg 25 mg 200 mg 200 mg 100 mg 30 mg 250 mg 1g 50 mg 100 mg 250 mg 350 mg 200 mg 200 mg 200 mg 100 mg 1g 5 vials
Edition 2012/2013

Code Product Unit
USP1150003 USP1150207 USP1150353 USP1150502 USP1150513 USP1150706 USP1151006 USP1151709 USP1151855 USP1151866 USP1151924 USP1151935 USP1152009 New USP1152600 USP1152701 USP1154004 USP1154503 USP1154558 USP1154569 USP1154591 USP1154605 USP1154707 USP1154809 USP1154900 USP1156000 USP1157024 USP1157035 USP1157046 USP1157501 USP1158005 USP1158504 USP1158650 USP1159008 USP1161000 USP1161010 USP1161203 USP1161509 USP1161586 USP1162002 USP1162126 USP1162148 USP1162308 USP1162320 USP1162330 USP1162400 USP1162421
Cortisone Acetate Cottonseed Oil (AS) Creatinine Cromolyn Sodium Cromolyn Sodium Related Compound A 1,3-Bis-(2-acetyl-3-hydroxyphenoxy)-2-propanol (AS) Crospovidone Crotamiton Cumene Curcumin Curcuminoids Cyanidin Chloride Cyanidin-3-O-glucoside Chloride Cyanocobalamin (Vitamin B12) Cyclamic Acid Cyclandelate Cyclizine HCl Cyclobenzaprine HCl Alpha Cyclodextrin Beta Cyclodextrin Gamma Cyclodextrin Cyclohexylmethanol Cyclomethicone 4 Cyclomethicone 5 Cyclomethicone 6 Cyclopentolate HCl Cyclophosphamide Related Compound B 3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane Cyclophosphamide Related Compound C (3-aminopropyl dihydrogen phosphate Cyclophosphamide Related Compound D 3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride 2-Cyclopropylmethylamino-5-chlorobenzophenone Cycloserine Cyclosporine Cyclosporine Resolution Mixture Cyclothiazide (AS) Cyproheptadine HCl Cyproheptadine Related Compound A 5H-dibenzo[a,d]cycloheptene (AS) Cyromazine L-Cysteine HCl Cystine Cytarabine 5'-Cytidylic Acid Cytosine Dacarbazine Dacarbazine Related Compound A 5-aminoimidazole-4-carboxamide HCl Dacarbazine Related Compound B 2-azahypoxanthine Dactinomycin Daidzein
150 mg 1g 100 mg 500 mg 25 mg 100 mg 200 mg 3x1.2 mL 30 mg 300 mg 25 mg 15 mg 1.5 g 100 mg 200 mg 200 mg 200 mg 500 mg 250 mg 200 mg 2x1 mL 200 mg 200 mg 200 mg 300 mg 25 mg 25 mg 25 mg 50 mg 250 mg 50 mg 25 mg 200 mg 500 mg 40 mg 200 mg 200 mg 200 mg 250 mg 500 mg 100 mg 125 mg 50 mg 50 mg 50 mg 25 mg
Edition 2012/2013
367

Code Product Unit
USP1162432 USP1162501 USP1163140 USP1163151 USP1163162 USP1163173 USP1163184 USP1164008 USP1164700 USP1165408 USP1166003 USP1166309 USP1166400 USP1166502 USP1169001 USP1170000 USP1046089 USP1171003 USP1171207 USP1171251 USP1171455 USP1171706 USP1171900 USP1171910 USP1172006 USP1173009 USP1173100 USP1173202 USP1173235 USP1173246
Daidzin Danazol Dantrolene Dantrolene Sodium Dantrolene Related Compound A 5-(4-nitrophenyl)-2-furaldehyde azine Dantrolene Related Compound B 5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl)semicarbazone Dantrolene Related Compound C (5-(4-nitrophenyl)-2-furancarboxyaldehyde Dapsone Daunorubicin HCl Decoquinate Deferoxamine Mesylate Dehydroacetic Acid Dehydrocarteolol HCl Dehydrocholic Acid Demecarium Bromide Demeclocycline HCl N-Demethylazithromycin Denatonium Benzoate 23-EPI-26-Deoxyactein 2-Deoxy-D-Glucose (AS) Dermatan Sulfate Desacetyl Diltiazem HCl Desflurane Desflurane Related Compound A bis-(1,2,2,2-tetrafluoroethyl) ether Desipramine HCl Deslanoside Desmethoxycurcumin Desmopressin Acetate Desogestrel Desogestrel Related Compound A 13-ethyl-11-methylene-18,19-dinor-5alpha, 17alpha-pregn-3-en-20-yl-17-ol, desogestrel delta-3 isomer Desogestrel Related Compound B 3-Hydroxy-desogestrel Desogestrel Related Compound C 3-Keto-desogestrel Desosaminylazithromycin Desoximetasone Desoxycorticosterone Acetate Desoxycorticosterone Pivalate Dexamethasone Dexamethasone Acetate Dexamethasone Phosphate Dexbrompheniramine Maleate Dexchlorpheniramine Maleate Dexpanthenol Dextran 1 Dextran 40 Dextran 70
30 mg 200 mg 200 mg 100 mg 50 mg 50 mg 50 mg 125 mg 200 mg 200 mg 300 mg 200 mg 100 mg 200 mg 250 mg 200 mg 15 mg 200 mg 20 mg 100 mg 25 mg 50 mg 0.5 mL 0.1 mL 125 mg 100 mg 30 mg 1.93 mg 50 mg 15 mg
USP1173257 USP1173268 USP1046078 USP1173508 USP1174001 USP1175004 USP1176007 USP1176506 USP1177000 USP1178002 USP1179005 USP1179504 USP1179628 USP1179708 USP1179741
15 mg 25 mg 15 mg 200 mg 200 mg 125 mg 125 mg 200 mg 200 mg 200 mg 300 mg 500 mg 50 mg 50 mg 50 mg
368
Edition 2012/2013

Code Product Unit
USP1179854 USP1179865 USP1179876 USP1179720 USP1179887 USP1179763 USP1179898 USP1179650 USP1179800 USP1180004 USP1180015 USP1180026 USP1180503 USP1181007 USP1181302 USP1181506 USP1182000 USP1183002 USP1184005 USP1184027 USP1185008 USP1185020 USP1023403 USP1186000 USP1187003 USP1187080 USP1187091 USP1187207 USP1187954 USP1188006 USP1188301 USP1188560 USP1188571 USP1188709 USP1188800 USP1188811 USP1189009 USP1190008 USP1190904 USP1191000 USP1191204 USP1191226 USP1191237 USP1191215 USP1192003
Edition 2012/2013
Dextran 4 Calibration Dextran 10 Calibration Dextran 40 Calibration Dextran 40 System Suitability Dextran 70 Calibration Dextran 70 System Suitability Dextran 250 Calibration Dextran T-10 Dextran Vo Marker Dextroamphetamine Sulfate Controlled Substance CII Dextroamphetamine Related Compound A 1-Phenyl-2-propanol Dextroamphetamine Related Compound B Phenyl acetone Controlled Substance CII Dextromethorphan Dextromethorphan HBr (CRM) Dextrose Diacetylated Monoglycerides Diacetylfluorescein Diacetylmorphine HCl (Heroin HCl) (AS) Controlled Substance CI Diatrizoic Acid Diatrizoic Acid Related Compound A 5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid Diazepam Controlled Substance CIV Diazepam Related Compound A 2-Methyl-amino-5-chlorobenzophenone Diazepam Related Compound B 3-Amino-6-chloro-1-methyl-4-phenylcarbostyril Diazoxide Dibucaine HCl Dibutyl Phthalate Dibutyl Sebacate Dichloralphenazone Controlled Substance CIV 2,4-Dichlorophenol Dichlorphenamide Dichlorvos 2,2-dichlorovinyl dimethyl phosphate (AS) Diclazuril Diclazuril System Suitability Mixture Diclofenac Potassium Diclofenac Sodium Diclofenac Related Compound A N-(2,6-dichlorophenyl)indolin-2-one Dicloxacillin Sodium Dicumarol Dicyclohexyl Dicyclomine HCl Didanosine Didanosine Related Compound A Hypoxanthine Didanosine Related Compound B 2',3'-dideoxyadenosine Didanosine System Suitability Mixture Dienestrol
100 mg 100 mg 100 mg 200 mg 100 mg 200 mg 100 mg 200 mg 100 mg 500 mg 25 mg 25 mg 2g 500 mg 500 mg 200 mg 200 mg 25 mg 100 mg 50 mg 100 mg 25 mg 25 mg 200 mg 500 mg 200 mg 1 mL 200 mg 100 mg 200 mg 150 mg 200 mg 50 mg 200 mg 200 mg 25 mg 500 mg 200 mg 2x2 mL 125 mg 200 mg 25 mg 25 mg 10 mg 125 mg
369

Code Product Unit
USP1192808 USP1193006 USP1193265 USP1193301 USP1193505 USP1194009 USP1194803 USP1195001 USP1197007 USP1197302 USP1197506 USP1198000 USP1199002 USP1200000 USP1200600 USP1200804 USP1201002 USP1202005 USP1203008 USP1204000 USP1204102 USP1204805 USP1205003 USP1205014 USP1206006 USP1208001 USP1211006 USP1213001 USP1213103 New USP1213318 New USP1213329 USP1214004 USP1217909 USP1218005 USP1218016 USP1219008 USP1220302 USP1220506 USP1220700 USP1221000 USP1222002 USP1222400 USP1222501 USP1223005 USP1224008 USP1224201 USP1224507 USP1224551 USP1224562
Diethanolamine Diethylcarbamazine Citrate Diethylene Glycol Diethylene Glycol Monoethyl Ether Diethyl Phthalate Diethylpropion HCl Controlled Substance CIV Diethyl Sebacate Diethylstilbestrol Diethyltoluamide Diflorasone Diacetate Diflunisal Digitalis Digitoxin Digoxin Dihydrocapsaicin Dihydrocodeine Bitartrate Controlled Substance CII 17-Dihydroequilin Dihydroergotamine Mesylate Dihydrostreptomycin Sulfate Dihydrotachysterol Dihydroxyacetone Diloxanide Furoate Diltiazem HCl Diltiazem Related Compound A (AS) trans-diltiazem hydrochloride Dimenhydrinate Dimethisoquin HCl Dimethyl Sulfoxide Dinoprost Tromethamine Dinoprostone Diosmin Diosmin for System Suitability Dioxybenzone Diphenhydramine Citrate Diphenhydramine HCl Diphenhydramine Related Compound A 2-(Diphenylmethoxy)-N-methylethanamine HCl Diphenoxylate HCl Controlled Substance CII Dipivefrin HCl Dipyridamole Dirithromycin Disodium Guanylate Disodium Inosinate Disodium 5'-Uridylate Disopyramide Phosphate 2,4-Disulfamyl-5-trifluoromethylaniline Disulfiram Divalproex Sodium Dobutamine HCl Docetaxel Docetaxel Identification
3 mL 200 mg 0.5 mL 0.5 mL 200 mg 200 mg 1 mL 200 mg 3g 200 mg 200 mg 3g 200 mg 250 mg 25 mg 200 mg 50 mg 500 mg 200 mg 4x30 mg 250 mg 200 mg 200 mg 25 mg 200 mg 2g 3g 50 mg 50 mg 300 mg 15 mg 150 mg 200 mg 200 mg 15 mg 200 mg 200 mg 200 mg 200 mg 350 mg 500 mg 500 mg 200 mg 30 mg 200 mg 200 mg 600 mg 200 mg 50 mg
370
Edition 2012/2013

Code Product Unit
New USP1224573 USP1224620 USP1224664 USP1224700 USP1224904 USP1224802 USP1224824 USP1224937 USP1224948
Docetaxel System Suitability Mixture Docosahexaenoic Acid Ethyl Ester Docosyl Ferulate Docusate Calcium Docusate Potassium Docusate Sodium Docusate Sodium Related Compound B Disodium mono (2-ethylhexyl) sulfosuccinate Dofetilide Dofetilide Related Compound A N-[4-(2-(2-[4-(methanesulfonamido)phenoxy]ethyl)amino)phenyl] methanesulfonamide Dolasetron Mesylate Dolasetron Mesylate Related Compound A Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one HCl Donepezil HCl Donepezil Related Compound A (E)-2-[(1-benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one Dopamine HCl Dorzolamide HCl Dorzolamide Hydrochloride Related Compound A (4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno [2,3-b]thiopyran-2-sulfonamide 7,7-dioxide, monohydrochloride Dorzolamide Related Compound B (4R,6S)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2.3b]thiopyran-2sulfonamide 7,7-dioxide HCl Dorzolamide Related Compound D (4S,6S)-4-Amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2sulfonamide 7,7-dioxide HCl Doxapram HCl Doxazosin Mesylate Doxazosin Related Compound A N-(1,4-benzodioxane-2-carbonyl)piperazine hydrochloride Doxazosin Related Compound B 6,7-dimethoxyquinazoline-2,4-dione Doxazosin Related Compound C 2-chloro-4-amino-6,7-dimethoxyquinazoline Doxazosin Related Compound D 1,4-benzodioxane-2-carboxylic acid Doxazosin Related Compound E 2,4-dichloro-6,7-dimethoxyquinazoline Doxazosin Related Compound F N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine Doxepin HCl Doxepin Related Compound A dibenzo[b,e]oxepin-11(6H)-one Doxepin Related Compound B (11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol Doxepin Related Compound C (E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine HCl Doxorubicin HCl Doxycycline Hyclate Doxycycline Related Compound A 6-epidoxycycline Doxylamine Succinate Drometrizole 2-(2H-Benzotriazol-2-yl)-p-cresol
USP1224959 USP1224960 USP1224981 USP1224992 USP1225204 USP1225281 USP1225292
200 mg 25 mg 200 mg 25 mg 200 mg 200 mg 20 mg
New USP1225317
15 mg
New USP1225306
15 mg
USP1225000 USP1225419 USP1225420 USP1225441 USP1225452 USP1225463 USP1225474 USP1225485 USP1225500 USP1225511 USP1225522 USP1225533 USP1225703 USP1226003 USP1226014 USP1227006 USP1228009
200 mg 200 mg 20 mg 20 mg 20 mg 20 mg 20 mg 15 mg 500 mg 50 mg 50 mg 25 mg 50 mg 200 mg 10 mg 300 mg 25 mg
Edition 2012/2013
371

Code Product Unit
Drometrizole Trisiloxane 2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-p-cresol Drometrizole Trisiloxane Related Compound A 2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol Drometrizole Trisiloxane Related Compound B 2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol Drometrizole Trisiloxane Related Compound C 2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol Drometrizole Trisiloxane Related Compound D 2-(2H-Benzothiazol-2-yl)-6-isobutyl-p-cresol Drometrizole Trisiloxane Related Compound E 2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-O1[bis(trimethylsiloxy)methylsilyl]-p-cresol Heptamethyl Trisiloxane 1,1,1,3,5,5,5-Heptamethyltrisiloxane Droperidol Drospirenone Drospirenone Related Compound A 17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17beta-pregn-4ene-21-carboxylic acid, gamma-lactone Duloxetine HCl Duloxetine Related Compound A 5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone Duloxetine Related Compound F (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine HCl Duloxetine Related Compound H (S)-4-(Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino)-4-oxobutanoic acid Dyclonine HCl Dydrogesterone Dyphylline Ecamsule Solution Ecamsule Triethanolamine Ecamsule Related Compound A 1,4-Phenylenedimethanol Ecamsule Related Compound B 4-(hydroxymethyl)benzoic acid Ecamsule Related Compound C terephthalic acid Ecamsule Related Compound D ((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid Ecamsule Related Compound E sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate Ecamsule Related Compound F 4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2ylidene)methyl)benzoic acid Ecamsule Related Compound G 4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2ylidene)methyl)benzaldehydre, sodium salt Powdered Echinacea Angustifolia Extract Powdered Echinacea Pallida Extract Powdered Echinacea Purpurea Extract Econazole Nitrate Edetate Calcium Disodium Edetate Disodium Edetic Acid Edrophonium Chloride Efavirenz
200 mg 25 mg 25 mg 150 mg 25 mg 150 mg
USP1228075 USP1229001 USP1229409 USP1229410
150 mg 250 mg 200 mg 15 mg
100 mg 10 mg 10 mg 10 mg 200 mg 200 mg 200 mg 0.5 mL 200 mg 50 mg 50 mg 50 mg 50 mg 25 mg
USP1231660
25 mg
USP1231681
25 mg
1g 1g 1g 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg
372
Edition 2012/2013

Code Product Unit
USP1234114
Efavirenz Racemic (+/-)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)2H-3,1-benzoxazin-2-one Efavirenz Related Compound A (S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol) Efavirenz Related Compound B (S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one Efavirenz Related Compound C 6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline Eicosapentaenoic Acid Ethyl Ester Eleutheroside B (Syringin) Eleutheroside E (Syringaresinol diglucoside) Powdered Eleuthero Extract Emedastine Difumarate Emetine HCl Emtricitabine Emtricitabine System Suitability Mixture A Emtricitabine System Suitability Mixture B Enalaprilat Enalapril Maleate Endotoxin Enflurane Enoxaparin Sodium Enoxaparin Sodium for Bioassays Enoxaparin Sodium Molecular Weight Calibrant A Enoxaparin Sodium Molecular Weight Calibrant B Enrofloxacin Enrofloxacin Related Compound Mixture Entacapone Entacapone Related Compound A (Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide Ephedrine Sulfate Drug Precursor 4-Epianhydrotetracycline HCl (-)-Epigallocatechin-3-O-gallate Epilactose Epinephrine Bitartrate Epirubicin HCl Epitetracycline HCl (AS) Epoprostenol Sodium Epoprostenol Related Compound A 7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydrocyoct-1-enyl]cyclopentyl}-6oxoheptanoic acid Epoprostenol Related Compound B Sodium 5-(diphenylphosphinoyl)pentanoate Eprinomectin Eprosartan Mesylate (E)-2-Butyl-1-(pcarboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monomethanesulfonate Eprosartan Related Compound A (E)-3-(2-butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid HCl Eprosartan Related Compound B 3-(thiophen-2-yl)propanoic acid Eprosartan Related Compoud C 2-(thiophen-2-ylmethyl)malonic acid Eprosartan Related Compound D 4-(bromomethyl)benzoic acid
20 mg
USP1234125 USP1234147 USP1234136 USP1234307 USP1234668 USP1234680 USP1234704 USP1234806 USP1235004 USP1235106 USP1235128 USP1235139 USP1235274 USP1235300 USP1235503 USP1235809 USP1235820 New USP1235831 USP1235853 USP1235864 USP1235900 USP1235911 USP1235933 USP1235944 USP1236007 USP1236506 USP1236700 USP1236801 USP1237000 USP1237382 USP1237509 New USP1237600 New USP1237611
20 mg 15 mg 20 mg 500 mg 15 mg 15 mg 1.5 g 100 mg 300 mg 200 mg 15 mg 15 mg 300 mg 200 mg unit 1 mL 300 mg unit 6 mg 6 mg 200 mg 50 mg 150 mg 25 mg 200 mg 50 mg 20 mg 200 mg 200 mg 200 mg 200 mg 100 mg 15 mg
New USP1237622 New USP1237752 New USP1238217
15 mg 300 mg 50 mg
New USP1238228 New USP1238239 New USP1238240 New USP1238251
20 mg 15 mg 25 mg 15 mg
Edition 2012/2013
373

Code Product Unit
New USP1238262 USP1238002 USP1239005 USP1239504 USP1240004 USP1241007 USP1241506 USP1241550 USP1241823 USP1241903 USP1242000 USP1242010 USP1242021 USP1242032 USP1243002 USP1245008 USP1246000 USP1247003 USP1248006 USP1249202 USP1249406 USP1249417 USP1249701 USP1249789 USP1249905 USP1249916 USP1250008 USP1250020 USP1250041 USP1251000 USP1252003 USP1254009 USP1254508 USP1255001 USP1255500 New USP1255850 USP1256004 USP1257007 USP1257018 USP1257029 USP1258305 USP1260001 USP1260012 USP1260023
Eprosartan Related Compound E 4-(hydroxymethyl)benzoic acid Equilin Ergocalciferol (Vitamin D2) Ergoloid Mesylates Ergonovine Maleate Drug Precursor Ergosterol Ergotamine Tartrate Drug Precursor Ergotaminine Drug Precursor Erythorbic Acid Erythritol Erythromycin Erythromycin B Erythromycin C Erythromycin Related Compound N N-Demethylerythromycin A Erythromycin Estolate Erythromycin Ethylsuccinate Erythromycin Gluceptate Erythromycin Lactobionate Erythromycin Stearate Escin Escitalopram Oxalate Escitalopram Related Compound A (-)4-[(4-dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)]-3-(hydroxymethyl)benzonitrile Esmolol HCl Esomeprazole Magnesium Estazolam Controlled Substance CIV Estazolam Related Compound A 5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone Estradiol Estradiol Related Compound B 1,3,5(10),6-estratetraen-3,17beta-diol Estradiol Related Compound C 1,3,5(10)estratrien-3,17beta-diol-6-one Estradiol Benzoate (AS) Estradiol Cypionate Estradiol Valerate Estriol Estrone Estropipate Eszopiclone Controlled Substance CIV Ethacrynic Acid Ethambutol HCl Ethambutol Related Compound A (2R,2'S)-2,2'-[ethane-1,2-diylbis(azanediyl)]dibutan-1-ol Ethambutol Related Compound B ((2R,2'R)-2,2'-[ethane-1,2-diylbis(azanediyl]dibutan-1-ol)HCl Ethchlorvynol Controlled Substance CIV Ethinyl Estradiol Ethinyl Estradiol Related Compound A 6-Keto-ethinyl estradiol Ethinyl Estradiol Related Compound B 19-Nor-17alpha-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol
15 mg 25 mg 5x30 mg 300 mg 100 mg 50 mg 150 mg 100 mg 50 mg 200 mg 250 mg 100 mg 50 mg 50 mg 200 mg 200 mg 200 mg 200 mg 200 mg 350 mg 200 mg 10 mg 100 mg 10 mg 100 mg 10 mg 500 mg 10 mg 15 mg 250 mg 200 mg 100 mg 100 mg 200 mg 500 mg 100 mg 200 mg 200 mg 15 mg 15 mg 0.7 mL 150 mg 20 mg 10 mg
374
Edition 2012/2013

Code Product Unit
USP1261004 USP1262801 USP1262823 USP1264002 USP1264501 USP1265005 USP1265402 USP1265424 USP1265457 USP1265504 USP1265515 USP1265592 USP1265606 USP1265526 USP1265537 USP1265548 USP1265559 USP1265560
Ethionamide Ethopabate Ethopabate Related Compound A Methyl-4-acetamido-2-hydroxybenzoate Ethosuximide Ethotoin Ethoxzolamide Ethyl Acetate Ethyl Acrylate and Methyl Metacrylate Copolymer Dispersion Ethylbenzene Ethylcellulose Ethylene Glycol Ethylene Glycol and Vinyl Alcohol Graft Copolymer Ethyl Formate 2-Ethylhexan-1-ol Ethylhexyl Triazone Ethylhexyl Triazone Related Compound A 2-ethylhexyl 4-aminobenzoate Ethylhexyl Triazone Related Compound B 4-(4,6-bis(4-((2-ethylhexyloxy)carbonyl)phenylamino)-1,3,5-triazin-2-ylamino)benzoic acid Ethylhexyl Triazone Related Compound C bis(2-ethylhexyl)4,4'-(6-(4-(ethyoxycarbonyl)phenylamino)-1,3,5-triazine-2,4diyl)bis(azanediyl)dibenzoate Ethyl Laurate Ethyl Lauroyl Arginate Ethyl Maltol Ethylnorepinephrine HCl Ethylparaben N-Ethylpiperazine Ethyl Vanillin Ethynodiol Diacetate Etidronate Disodium Etidronate Disodium Related Compound A Sodium phosphite dibasic pentahydrate Etidronic Acid Monohydrate Etodolac Etodolac Related Compound A (+/-)-8-ethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid Etomidate Etoposide Etoposide Resolution Mixture Eucalyptol Eugenol Exemestane Exemestane Related Compound A 6-Methyleneandrosta-4-ene-3,17-dione Exemestane Related Compound B 6-hydroxymethylandrostra-1,4-diene-3,17-dione Exemestane Related Compound C androsta-1,4-diene-3,17-dione Controlled Substance CIII Exemestane System Suitability Mixture Famciclovir Famciclovir System Suitability Mixture Mixture of Famciclovir, Propionylfamciclovir and 6-Chlorofamciclovir
200 mg 125 mg 25 mg 500 mg 200 mg 200 mg 3x1.2 mL 1.5 g 3x0.5 mL 1g 0.5 mL 1g 3x1.2 mL 1.5 mL 200 mg 20 mg 20 mg 20 mg
USP1265752 New USP1265800 USP1266008 USP1266507 USP1267000 USP1266802 USP1267500 USP1268003 USP1268502 USP1268513 USP1268604 USP1268706 USP1268728 USP1268750 USP1268808 USP1268852 New USP1268900 USP1268965 USP1269050 USP1269061 USP1269072 USP1269083 USP1269094 USP1269152 USP1269163
500 mg 200 mg 1g 200 mg 200 mg 0.5 mL 200 mg 200 mg 200 mg 300 mg 1g 400 mg 25 mg 200 mg 300 mg 30 mg 200 mg 500 mg 150 mg 15 mg 15 mg 15 mg 25 mg 200 mg 20 mg
Edition 2012/2013
375

Code Product Unit
USP1269174 USP1269185 New USP1269196 New USP1269130 New USP1269141 USP1269119 USP1269200 USP1269221
Famciclovir Related Compound A 2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride Famciclovir Related Compound B 4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate Famciclovir Related Compound C 4-(2-amino-9H-purin-9-yl)-2-methylbutyl acetate Famciclovir Related Compound E 2-aminopurine Famciclovir Related Compound F 2-Amino-6-chloropurine FAME Standard Mixture Famotidine Famotidine Related Compound B 3,5-bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphany]ethyl]-4H1,2,4,6-thiatriazine1,1-dioxide (AS) Famotidine Related Compound C 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]-N-sulfamoylpropanamide HCl Famotidine Related Compound D 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide Famotidine Related Compound E 2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine Famotidine Related Compound F 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid Famotidine Sulfoxide 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylsulfinyl]-N'-sulfamoylpropanimidamide Felbamate Felbamate Related Compound A 3-Hydroxy-2-phenylpropyl carbamate Felbamate Related Compound B Phenethyl carbamate Felodipine Felodipine Related Compound A ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate Fenbendazole Fenbendazole Related Compound A Methyl(1H-benzimidazole-2-yl)carbamate Fenbendazole Related Compound B Methyl[5(6)-chlorobenzimidazole-2-yl]carbamate Fenofibrate Fenofibrate Related Compound A (4-chlorophenyl)(4-hydroxyphenyl) methanone Fenofibrate Related Compound B 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid Fenofibrate Related Compound C 1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2methylpropanoate Fenoldopam Mesylate Fenoldopam Related Compound A N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol HCl Fenoldopam Related Compound B 1H-3-Benzazapine-7,8-diol, 2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate Fenoprofen Calcium Fenoprofen Sodium Fentanyl Controlled Substance CII Fentanyl Citrate Controlled Substance CII Fentanyl Related Compound A (2-bromoethyl)benzene Fentanyl Related Compound B 4-Anilinopiperidine
376
Edition 2012/2013

Code Product Unit
Fentanyl Related Compound D N-Phenyl-1-(phenylmethyl)-4-piperidinamine Fentanyl Related Compound E N-Phenyl-1-(2-phenylethyl)-4-piperidinamine Controlled Substance CII Fentanyl Related Compound G Acetyl fentanyl Ferrous Sulfate Ferulic Acid trans-4-hydroxy-3-methoxycinnamic acid Fexofenadine HCl Fexofenadine Related Compound A 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl benzeneacetic acid Fexofenadine Related Compound B 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl benzeneacetic acid hydrochloride Fexofenadine Related Compound C (+)-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-isopropylbenzene (AS) Finasteride Fish Oil Flavoxate HCl Flavoxate Related Compound A 3-methylflavone-8-carboxylic acid Flavoxate Related Compound B 3-Methylflavone-8-carboxylic acid methyl ester Flavoxate Related Compound C 3-Methylflavone-8-carboxylic acid ethyl ester Flecainide Acetate Flecainide Related Compound A 3-[2,5-bis(2,2,2-trifluoroethoxy) phenyl]-1,5,6,7,8,8a-hexahydroimidazo-[1,5a]pyridine HCl Floxuridine Fluconazole Fluconazole Related Compound A 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol Fluconazole Related Compound B 2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol Fluconazole Related Compound C 1,1'-(1,3-phenylene)di(1H-1,2,4-triazole) Flucytosine Fludarabine Phosphate Fludeoxyglucose Fludeoxyglucose Related Compound A 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8.]hexacosane Fludeoxyglucose Related Compound B 2-chloro-2-deoxy-D-glucose Fludrocortisone Acetate Flumazenil Flumazenil Related Compound A 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha] [1,4]benzodiazepine-3-carboxylic acid Flumazenil Related Compound B Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha] [1,4]benzodiazepine-3-carboxylate Flumazenil Related Compound C N,N-Dimethylformamide diethyl acetal Flumethasone Pivalate Flunisolide Flunixin Meglumine
10 mg 10 mg 10 mg 1.5 g 25 mg 200 mg 25 mg
USP1270399
25 mg
USP1270446 USP1270402 USP1270424 USP1270708 USP1270719 USP1270720 USP1270731 USP1270800 USP1270821 USP1271008 USP1271700 USP1271711 USP1271722 USP1271733 USP1272000 USP1272204 USP1272907 USP1272918 USP1272929 USP1273003 USP1273808 USP1273819
15 mg 200 mg 1g 200 mg 25 mg 20 mg 20 mg 200 mg 75 mg 250 mg 200 mg 10 mg 10 mg 10 mg 200 mg 300 mg 100 mg 15 mg 10 mg 250 mg 200 mg 20 mg
USP1273820
20 mg
USP1273841 USP1274006 USP1274505 USP1274607
500 mg 200 mg 200 mg 300 mg
Edition 2012/2013
377

Code Product Unit
USP1275009 USP1276001 USP1277004 USP1277252 USP1277274 USP1277300 USP1277354 USP1277401 USP1277423 USP1277456 USP1278007 USP1278109 USP1278302 USP1279000 USP1279804 USP1279815 USP1279826 USP1279837 USP1280009 USP1280803 USP1281001 USP1282004 USP1284000 USP1285002 USP1285308 USP1285603 USP1285750 USP1285760 USP1285807 USP1285851 USP1285862 USP1285873 USP1285910 USP1285840 USP1285884 USP1285895 USP1285931 USP1285964
Fluocinolone Acetonide Fluocinonide Fluorescein Fluoride Dentifrice: Sodium Fluoride/Silica Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder Fluoride Dentifrice: Sodium Monofluorophosphate - Calcium Carbonate Fluoride Dentifrice: Sodium Monofluorophosphate/Dicalcium Phosphate Fluoride Dentifrice: Sodium Monofluorophosphate (1000 ppm)/Silica Fluoride Dentifrice: Sodium Monofluorophosphate (1500 ppm)/Silica Fluoride Dentifrice: Stannous Fluoride-Silica Fluorometholone Fluorometholone Acetate Fluoroquinolonic Acid Fluorouracil Fluoxetine HCl Fluoxetine Related Compound A N-methyl-3-phenyl-3-[(alpha,alpha,alpha-(trifluoro-m-tolyl)oxy]propylamine HCl Fluoxetine Related Compound B N-methyl-3-phenylpropylamine Controlled Substance Fluoxetine Related Compound C N-Methyl-N-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl] succinamic acid Fluoxymesterone Controlled Substance CIII Fluphenazine Decanoate Dihydrochloride Fluphenazine Enanthate Dihydrochloride Fluphenazine HCl Flurandrenolide Flurazepam HCL Controlled Substance CIV Flurazepam Related Compound C 5-chloro-2-(2-diethylaminoethyl(amino)-2'-fluorobenzophenone HCl Flurazepam Related Compound F 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one) Flurbiprofen Flurbiprofen Related Compound A 2-(4-Biphenylyl)propionic Acid Flurbiprofen Sodium Flutamide o-Flutamide Fluticasone Propionate Fluticasone Propionate Nasal Spray Resolution Mixture Fluticasone Propionate Related Compounds Mixture Fluticasone Propionate Resolution Mixture Fluticasone Propionate System Suitability Mixture Fluticasone Propionate and Fluticasone Propionate Related Compounds B, C and D Fluvastatin Sodium Fluvastatin Related Compound B [R*,S*-E](+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1-dimethylethyl ester Fluvastatin for System Suitability Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E](+/-)-7-[3-(4-fluorophenyl)-1(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt Fluvoxamine Maleate Folic Acid (Vitamin M or Vitamin Bc) Folic Acid Related Compound A Calcium Formyltetrahydrofolate Formic Acid
100 mg 100 mg 200 mg 4.6 oz 4 oz 4.6 oz 4.6 oz 5.25 oz 5.25 oz 4 oz 200 mg 200 mg 150 mg 250 mg 200 mg 15 mg 5 mL 15 mg 200 mg 500 mg 125 mg 125 mg 100 mg 200 mg 50 mg 50 mg 200 mg 100 mg 200 mg 200 mg 50 mg 100 mg 25 mg 25 mg 25 mg 25 mg 350 mg 15 mg
USP1285942
25 mg
USP1285909 USP1286005 USP1286027 USP1283200

378
200 mg 500 mg 50 mg 3x1.2 mL

Edition 2012/2013

Code Product Unit
Formononetin Formoterol Fumarate Formoterol Fumarate Resolution Mixture Formoterol Fumarate System Suitability Mixture 10-Formylfolic Acid Forskolin 7Beta-acetoxy-8,13-epoxy-1alpha,6Beta,9alpha-trihydroxy-labd-14-en-11-one Powdered Forskohlii Extract Foscarnet Sodium Foscarnet Related Compound B Disodium (Ethoxyoxidophosphanyl) formate Foscarnet Related Compound D O,O-diethyl ethoxycarbonylphosphonate Fosfomycin Tromethamine Fosinopril Sodium Fosinopril Related Compound A (4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]-acetyl-L-proline Fosinopril Related Compound B ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetylD-proline propionate (ester), hemibarium salt, sesquihydrate) Fosinopril Related Compound C (4S)-4-cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]-acetyl-Lproline propionate (ester),sodium salt Fosinopril Related Compound D (4R)-4-cyclohexyl-1-[(R)-[(S]-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-Lproline propionate (ester), sodium salt Fosinopril Related Compound E (4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl]phospinyl]acetyl-Lproline propionate (ester), sodium salt Fosinopril Related Compound F (4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phospinyl]acetyl-L-proline propionate (ester),sodium salt Fosinopril Related Compound G (4-phenylbutyl)phosphinyl acetic acid, disodium salt Fosinopril Related Compound H 4-phenylbutyl phosphonic acid Fosphenytoin Sodium Fructose L-Fucose (AS) Fulvestrant Fulvestrant System Suitability Mixture Fumaric Acid Furazolidone Furosemide Furosemide Related Compound A 2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid Furosemide Related Compound B 4-Chloro-5-sulfamoylanthranilic Acid Gabapentin Gabapentin Related Compound A 2-Azaspiro[4.5]decan-3-one Gabapentin Related Compound B (1-cyanocyclohexyl)acetic acid Gabapentin Related Compound D (1-(3-oxo-2-aza-spiro[4,5]dec-2-ylmethyl)-cyclohexyl)acetic acid Gabapentin Related Compound E carboxymethyl-cyclohexanecarboxylic Acid Gadodiamide
50 mg 100 mg 20 mg 20 mg 25 mg 40 mg 500 mg 50 mg 10 mg 0.27 mL 800 mg 200 mg 25 mg 15 mg
USP1283437
15 mg
USP1283448
15 mg
USP1283459
15 mg
USP1283460
15 mg
USP1283470 USP1283481 USP1286366 USP1286504 USP1286606 USP1286650 USP1286661 USP1286708 USP1286800 USP1287008 USP1287020 USP1287030 USP1287303 USP1287325 USP1287347 USP1287358 USP1287369 USP1287507
Edition 2012/2013
379

Code Product Unit
Gadodiamide Related Compound A gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide Gadodiamide Related Compound B gadolinium disodium diethylenetriamine pentaacetic Acid Gadopentetate Monomeglumine Gadoteridol Gadoteridol Related Compound A 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclodedodecane-1,4,7-triaacetic Acid Gadoteridol Related Compound B 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt Gadoteridol Related Compound C 1,4,7,10-Tetraaza-11-oxo-bicylco[8.2.2]tetradecan-4,7-diacetic Acid Gadoversetamide Gadoversetamide Related Compound A Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan16-oato(4-)]gadolinium Galactitol Galactosamine HCl Galactose Galantamine HBr Galantamine HBr Racemic Galantamine HBr Related Compounds Mixture Gallamine Triethiodide Ganciclovir Ganciclovir Related Compound A (RS)-2-Amino-9-(2,3-dihydroxy-propoxymethyl)-1,9-dihydropurin-6-one Ganciclovir Mono-N-methyl Valinate 2-(RS)-[(guanin-9-yl)methoxy]-3-hydroxypropyl N-methyl-L-valinate hydrochloride Gatifloxacin Powdered Garcinia Hydroxycitrate Extract Gemcitabine Hydrochloride Gemfibrozil Gemfibrozil Related Compound A 2,2-dimethyl-5-[2,5-dimethyl-4-propene-1-yl)phenoxy]valeric acid Genistein Genistin Gentamicin Sulfate Gentian Violet Gibberellic Acid Powdered Ginger Ginger Constituent Mixture 6-gingerol and 6-shogaol Ginkgo Terpene Lactones Ginkgolic Acids Powdered American Ginseng Extract Powdered Asian Ginseng Extract Gitoxin Glimepiride Glimepiride Related Compound A Glimepiride cis-isomer Glimepiride Related Compound B Glimepiride Sulfonamide Glimepiride Related Compound C Glimepiride urethane Glimepiride Related Compound D Glimepiride-3-isomer
USP1287711 USP1287722 USP1287700 USP1287755 USP1287766 USP1287777 USP1288000 USP1288306 USP1288317 USP1288339 USP1288408 USP1288340 USP1288463 USP1288500 USP1288510 USP1288816 USP1288805 USP1289003 USP1290002 USP1291005 USP1291504 USP1291446 USP1291559 USP1291548 USP1291683 USP1291708 USP1292008 USP1292303 USP1292314 USP1292325 USP1292336 USP1292347
500 mg 300 mg 200 mg 200 mg 15 mg 25 mg 200 mg 200 mg 15 mg 10 mg 300 mg 500 mg 200 mg 200 mg 20 mg 15 mg 30 mg 200 mg 650 mg 200 mg 500 mg 0.2 mg 50 mg 10 mg 1.5 g 1.5 g 50 mg 200 mg 20 mg 20 mg 20 mg 20 mg
380
Edition 2012/2013

Code Product Unit
USP1292507 USP1292609 USP1292610 USP1292631 New USP1294036 USP1294207 USP1294976 USP1294987 USP1294808 USP1294820 USP1294848 USP1295505 USP1295516 USP1295527 USP1295607 USP1295709 USP1295724 USP1295731 USP1295753 USP1295742 USP1295800 USP1295844 USP1295855 USP1294284 USP1296009 USP1296010 USP1296029 USP1296031 USP1296042 USP1295888 USP1296756 USP1296767 USP1297001 USP1297205 USP1297216 New USP1297250 USP1298004 USP1298106 USP1298117 USP1298128 USP1298139
Glipizide Glipizide Related Compound A N-{2-[(4-aminosulfonyl)phenyl]ethyl}-5-methyl-pyrazinecarboxamide Glipizide Related Compound B 6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide Glipizide Related Compound C 1-cyclohexyl-3-[[4-[2-[[(6-methylpyrazin-2-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]urea rGlucagon recombinant Glucagon (Human) Glucosamine HCl Glutamic Acid L-Glutamic Acid HCl Glutamine Glutathione gamma-Glutamyl-(S)-allyl-L-cysteine Glyburide Glyburide Related Compound A 5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide Glyburide Related Compound B methyl-[[4-[2-[5(-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate (AS) Glycerin Glyceryl Behenate Glyceryl Distearate Glyceryl Monolinoleate Glyceryl Monooleate 40% Glyceryl Monooleate 90% Glycine Glycitein Glycitin N-Glycolylneuraminic Acid Glycopyrrolate Glycopyrrolate Erythro Isomer (RS)-3-[(RS)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidinium bromide Glycopyrrolate Related Compound A 5-Nitrobenzene-1,3-dicarboxylic acid Glycopyrrolate Related Compound B 1-Metyhlpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Glycopyrrolate Related Compound C 2-Cyclopentyl-2-hydroxy-2-phenylacetic acid Glycyrrhizic Acid Gonadorelin Acetate Gonadorelin Acetate Related Compound A Gonadorelin free acid trifluoroacetate salt Human Chorionic Gonadotropin - 5,760 USP units per package Goserelin Acetate Goserelin Related Compound A 4-D-Serine Goserelin Goserelin System Suitability Mixture Gramicidin Granisetron HCl Granisetron Related Compound A 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide Granisetron Related Compound B N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide Granisetron Related Compound C N-[(1R,3r,5S)-9-azabicyclo[3.3.1]non-3-yl]-1-methyl-1H-indazole-3-carboxamide HCl
125 mg 25 mg 15 mg 15 mg 2x2.94 mg 200 mg 200 mg 100 mg 100 mg 300 mg 25 mg 200 mg 25 mg 25 mg 2 mL 200 mg 500 mg 500 mg 500 mg 250 mg 200 mg 15 mg 15 mg 200 mg 200 mg 25 mg 50 mg 75 mg 25 mg 25 mg 50 mg 10 mg vial 100 mg 2 mg 1 mg 200 mg 150 mg 15 mg 15 mg 15 mg
Edition 2012/2013
381

Code Product Unit
USP1298140 USP1298150 USP1298208 USP1298219 USP1298401 USP1299007 USP1299200 USP1300004 USP1301007 USP1301404 USP1301608 USP1301801 USP1302101 USP1302156 USP1302203 USP1302214 New USP1302247 New USP1302258 USP1302305 USP1302509 USP1302906 USP1303002 USP1303057 USP1303013 New USP1303024 USP1303501 USP1304005 USP1304016 USP1304038 USP1304049 USP1304050 USP1304209 USP1305008 USP1305303 USP1305507 USP1307003 USP1308006 USP1308200 USP1308307 USP1308505 USP1309009 USP1310008 USP1311000 USP1311306 USP1311408 USP1313006 USP1313210
Granisetron Related Compound D 1-methyl-1H-indazole-3-carboxylic acid Granisetron Related Compound E (1R,3r,5S)-9-azabicyclo[3.3.1]nonan-3-amine acetate Grape Seeds Oligomeric Proanthocyanidins Purified Grape Seeds Oligomeric Proanthocyanidins Powdered Decaffeinated Green Tea Extract Griseofulvin Griseofulvin Permeability Diameter Guaiacol Guaifenesin Guanabenz Acetate Guanadrel Sulfate Guanethidine Monosulfate Guanfacine HCl Guanine Purified Guggul Extract Guggulsterone Z Gymnemagenin Native Gymnema Extract Halazepam (AS) Controlled Substance CIV Halcinonide Halobetasol Propionate Haloperidol Haloperidol Decanoate Haloperidol Related Compound A 4,4'-Bis[4-(p-chlorophenyl)-4-hydroxy-piperidino]-butyrophenone Haloperidol Related Compound B 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(2-fluorophenyl)butan-1-one Halothane Heparin Sodium Heparin Sodium for Assays Heparin Sodium Identification Heparin Sodium System Suitability Heparin Sodium with Oversulfated Chondroitin Sulfate Heptane Hexachlorophene Hexacosanol 2E,4E-Hexadienoic Acid Isobutylamide Hexobarbital Controlled Substance CIII Hexylcaine HCl Hexylene Glycol Hexylresorcinol L-Histidine Histamine Dihydrochloride Homatropine HBr Homatropine Methylbromide Homopolymer Polypropylene Homosalate Hydralazine HCl Hydrastine
15 mg 15 mg 500 mg 500 mg 300 mg 200 mg 2g 1g 200 mg 200 mg 200 mg 200 mg 125 mg 100 mg 500 mg 25 mg 15 mg 1g 200 mg 200 mg 200 mg 200 mg 200 mg 10 mg 10 mg 1 mL 10x1 mL 9.5 mg 50 mg 50 mg 8.8 mg 3x1.2 mL 500 mg 100 mg 25 mg 500 mg 1g 125 mg 200 mg 200 mg 250 mg 200 mg 250 mg 3 strips 500 mg 200 mg 10 mg
382
Edition 2012/2013

Code Product Unit
USP1314009 New USP1314960 USP1315001 USP1315012 USP1316004 USP1317007 USP1317302 USP1318000 USP1319002 USP1320001 USP1321004 USP1322007 USP1323000 USP1323019 USP1323021 USP1324002 USP1325005 USP1327000 USP1327408 USP1329006 USP1329709 USP1329800 USP1331008 USP1332000 USP1333003 USP1333058 USP1334006 USP1335009 USP1335010 USP1335202 USP1330005 USP1335279 USP1335304 New USP1335417 USP1335428 USP1335508 USP1335541 USP1335701 USP1336001 USP1336205 USP1336500 USP1336806 USP1337004 USP1337809 USP1338007 USP1338313
Hydrochlorothiazide Hydrocodone Controlled Substance CII Hydrocodone Bitartrate Controlled Substance CII Hydrocodone Bitartrate Related Compound A Morphinan-6-one, 4-hydroxy-3-methoxy-17-methyl Controlled Substance CII Hydrocortisone Hydrocortisone Acetate Hydrocortisone Butyrate Hydrocortisone Cypionate Hydrocortisone Hemisuccinate Hydrocortisone Phosphate Triethylamine Hydrocortisone Valerate Hydroflumethiazide Hydromorphone HCl Controlled Substance CII Hydromorphone N-Oxide HCl Controlled Substance CII UB Hydromorphone Related Compound A Controlled Substance CII UB 7,8-didehydro-4,5alpha-epoxy-3-hydroxy-17-methylmorphinan-6-one hydrochloride Hydroquinone Hydroxyamphetamine HBr Hydroxychloroquine Sulfate 6-Hydroxynicotinic Acid Hydroxyprogesterone Caproate Hydroxypropyl Betadex Hydroxypropyl Cellulose 12-Hydroxystearic Acid Hydroxyurea Hydroxyzine HCl Hydroxyzine Related Compound A p-Chlorobenzhydrylpiperazine Hydroxyzine Pamoate Hyoscyamine Sulfate Hyoscyamine Related Compound A Norhyoscyamine Sulfate Hyperoside Hypromellose (Hydroxypropyl Methylcellulose) Hypromellose Acetate Succinate Hypromellose Phthalate Ibandronate Sodium Ibandronate Related Compound A 3-[Methyl(pentyl)amino]propanoic acid HCl Ibuprofen Ibuprofen Related Compound C 4-isobutylacetophenone Idarubicin HCl Idoxuridine Ifosfamide Imidazole Imidurea Iminodibenzyl Imipenem Monohydrate Imipramine HCl Imiquimod
200 mg 125 mg 100 mg 70 mg 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 50 mg 15 mg 10 mg 500 mg 200 mg 200 mg 50 mg 200 mg 200 mg 500 mg 200 mg 200 mg 500 mg 25 mg 500 mg 125 mg 10 mg 50 mg 250 mg 100 mg 100 mg 200 mg 25 mg 750 mg 3x0.2 mL 50 mg 250 mg 500 mg 200 mg 200 mg 25 mg 100 mg 200 mg 200 mg
Edition 2012/2013
383

Code Product Unit
USP1338324 USP1338346 USP1338357 USP1338368 USP1338801 USP1338812 USP1339000 USP1339178 USP1339189 USP1340009 USP1341001 USP1340960 USP1342004 New USP1342037 USP1342106 USP1342150 USP1342208 USP1342321 USP1342300 USP1343007 USP1343517 USP1343540
Imiquimod Related Compound A 1-Isobutyl-1H-imidazo[4,5-c]quinoline Imiquimod Related Compound C 4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinolone) Imiquimod Related Compound D 1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine Imiquimod Related Compound E N4-Isobutylquinoline-3,4-diamine Indapamide Indapamide Related Compound A 4-Chloro-N-(2-methyl-indol-1-yl)-3-sulfamoylbenzamide (AS) Indigotindisulfonate Sodium Indinavir Indinavir System Suitability Indocyanine Green Indomethacin Inositol Insulin Insulin Aspart Insulin Human High Molecular Weight Insulin Human Insulin (Beef) Insulin Lispro Insulin (Pork) Iodipamide Iodixanol Iodixanol Related Compound C 5-Acetyl[3-[[3,5-bis[[2,3-dihydroxypropyl) amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide Iodixanol Related Compound D 5-[Acetyl(2-hydroxy-3-methylpropyl)amino]-N,N'-bis(2,3-dihydroxypropyl) 2,4,6-triiodo-1,3-benzenedicarboxamide Iodixanol Related Compound E 5-[[3-[[3-[[(2,3-Dihydoxypropyl)amino]carbonyl]-5-[[amino]carbonyl]-2,4,6triiodophenyl](acetylimino)]-2-hydroxypropyl]-(acetylimino)]-N,N'-bis(2,3-dihydoxypropyl)2,4,6-triiodo-1,3-benzenedicarboxamide o-Iodohippuric Acid Iodoquinol Iohexol Iohexol Related Compound A 5-(acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide Iohexol Related Compound B 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide Iohexol Related Compound C N,N'-bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide Iopamidol Iopamidol Related Compound A N,N'Bis-(1,3-dihydroxy-2-propyl)5-amino-2,4,6-triiodoiso-phthalamide Iopamidol Related Compound B 5-Glycolamido-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodoisophthalamide Iopamidol Related Compound C 4-chloro-N1,N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide Iopromide Iopromide Related Compound A 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide
25 mg 25 mg 25 mg 25 mg 250 mg 50 mg 500 mg 100 mg 100 mg 200 mg 200 mg 500 mg 100 mg 7.45 mg 100 mg 8.4 mg 100 mg 5.97 mg 2x6.25mg 200 mg 200 mg 25 mg
USP1343550
50 mg
USP1343561
25 mg
USP1344305 USP1344509 USP1344600 USP1344622 USP1344644 USP1344666 USP1344702 USP1344724 USP1344735 USP1344746 USP1344804 USP1344826
100 mg 100 mg 200 mg 100 mg 50 mg 50 mg 200 mg 50 mg 50 mg 40 mg 400 mg 50 mg
384
Edition 2012/2013

Code Product Unit
USP1344837
Iopromide Related Compound B 5-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3benzenedicarboxamide Iothalamic Acid Ioversol Ioversol Related Compound A 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide Ioversol Related Compound B N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbonyl)methoxy]2,4,6-triiodoisophthalamide Ioxaglic Acid Ioxilan Ioxilan Related Compound A 5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic Acid Ipodate Sodium Ipratropium Bromide Ipratropium Bromide Related Compound A endo-3-Hydroxy-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide Ipratropium Bromide Related Compound B (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8azoniabicyclo[3.2.1]octane, bromide Ipratropium Bromide Related Compound C (2-RS)-3-hydroxy-2-phenylpropanoic acid Irbesartan Irbesartan Related Compound A 1-pentanoylamino-cyclopentanecarboxylic acid[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]amide Irinotecan Hydrochloride Irinotecan Related Compound A (S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione Irinotecan Related Compound B (S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione Irinotecan Related Compound C 11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1Hpyrano[3',4':6,7]indolizino[1,2-b]quinoline-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride Irinotecan Related Compound D [1,4'-Bipiperidine]-1'-carboxylic acid,4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride,trihydrate, (R) Irinotecan Related Compound E (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione Isoamyl Methoxycinnamate Isobutyl acetate Isocarboxazid Isoetharine HCl Isoflupredone Acetate Isoflurane Isoflurane Related Compound A 1-chloro-2,2,2-trifluoroethyl chlorodifluoromethyl ether Isoflurane Related Compound B 2,2,2-Trifluoroethyldifluoromethyl ether L-Isoleucine Isomalathion Isomalt Isomaltulose Isometheptene Mucate Isoniazid Isopropamide Iodide
50 mg
USP1345002 USP1345104 USP1345115 USP1345126
200 mg 200 mg 50 mg 50 mg
100 mg 400 mg 100 mg 200 mg 100 mg 10 mg 10 mg
USP1347530 USP1347700 USP1347711
15 mg 200 mg 25 mg
USP1347609 USP1347610 USP1347631
100 mg 10 mg 10 mg
USP1347642
10 mg
USP1347653
15 mg
New USP1347664 USP1347755 USP1347802 USP1348000 USP1348500 USP1348907 USP1349003 USP1349014 USP1349025 USP1349502 USP1349604 USP1349626 USP1349637 USP1349659 USP1349706 USP1350002
Edition 2012/2013
15 mg 750 mg 3x1.2 mL 200 mg 250 mg 200 mg 1 mL 0.1 mL 0.1 mL 200 mg 50 mg 200 mg 5g 200 mg 200 mg 200 mg
385

Code Product Unit
USP1350104 USP1350400 USP1350603 USP1351005 USP1351107 USP1351800 USP1352008 USP1353000 USP1353102 USP1353113 USP1353500 USP1354003 USP1354207 USP1354218 USP1354251 USP1354262 USP1354309 USP1354900 USP1355006 USP1355709 USP1355753 USP1354852 USP1356009 USP1356020 USP1356508 USP1356632 USP1356643 USP1356552 USP1356563 USP1356315
Isopropyl Acetate Isopropyl Myristate Isopropyl Palmitate Isoproterenol HCl Isopteropodine Isorhamnetin Isosorbide (75% solution) Diluted Isosorbide Dinitrate Diluted Isosorbide Mononitrate Diluted Isosorbide Mononitrate Related Compound A 1,4:3,6-dianhydro-D-glucitol 2-nitrate Isotretinoin Isoxsuprine HCl Isradipine Isradipine Related Compound A Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinecarboxylate Itraconazole Itraconazole System Suitability Mixture Ivermectin Kaempferol Kanamycin Sulfate Powdered Kava Extract Kawain KDN 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid Ketamine HCl Controlled Substance CIII Ketamine Related Compound A 1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol Ketoconazole Ketoprofen Ketoprofen Related Compound A alpha-Methyl-3-(4-methylbenzoyl) benzeneacetic Acid (AS) Ketoprofen Related Compound C (2-(3-carboxyphenyl)propionic acid) Ketoprofen Related Compound D 3-acetylbenzophenone Ketorolac Related Compound A 5-benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrroliine-1carboxamide Ketorolac Related Compound B 5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol Ketorolac Related Compound C 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-one Ketorolac Related Compound D 5-benzoyl-2,3-dihydro-1H-pyrrolizine Ketorolac Tromethamine Labetalol HCl Alpha-Lactalbumin Lactase Lactic Acid Lactitol Lactobionic Acid Anhydrous Lactose Lactose Monohydrate Lactulose
3x1.2 mL 500 mg 500 mg 125 mg 20 mg 15 mg 1g 500 mg 350 mg 100 mg 200 mg 200 mg 200 mg 15 mg 100 mg 25 mg 200 mg 15 mg 200 mg 1g 200 mg 100 mg 250 mg 50 mg 200 mg 200 mg 25 mg 20 mg 20 mg 20 mg
USP1356326 USP1356337 USP1356348 USP1356665 USP1356654 USP1013909 USP1356698 USP1356734 USP1356687 USP1356825 USP1356676 USP1356701 USP1356803
386
20 mg 20 mg 20 mg 200 mg 200 mg 400 mg 200 mg 3x1.5 mL 500 mg 200 mg 100 mg 500 mg 750 mg
Edition 2012/2013

Code Product Unit
USP1356836 USP1356847 USP1356858 USP1356756 USP1356778 USP1356789 USP1356790 USP1356880 USP1356905 USP1356916 USP1356927 USP1356931 New USP1357475 New USP1357486
Lamivudine Lamivudine Resolution Mixture A Lamivudine Resolution Mixture B Lamotrigine Lamotrigine Related Compound B 2,3-dichlorobenzoic acid Lamotrigine Related Compound C 3-amino-6-(2,3-dichlorophenyl)1,2,4-triazin-5(4H)-one Lamotrigine Related Compound D N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide Lanolin Lanolin Alcohols Lansoprazole Lansoprazole Related Compound A 2-[[[3-methyl-4-(2,2,2-triflouroethoxy)-2-pyridyl]methyl]sulfonyl]benzimidazole Lansoprazole Related Compound B 2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole Latanoprost Latanoprost Related Compound A Isopropy l(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate Latanoprost Related Compound E (Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5heptenoic acid Lauric Acid Lauroyl Arginine (S)-2-dodecanamido-5-guanidinopentanoic acid HCl Lauroyl Polyoxylglycerides Leflunomide Leflunomide Related Compound A 4-trifluoromethyl)aniline Leflunomide Related Compound B 2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide Leflunomide Related Compound C N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide Letrozole Letrozole Related Compound A 4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile L-Leucine Leucovorin Calcium Leuprolide Acetate Levalbuterol HCl Levalbuterol Related Compound A 4-(2-tert-butylamino-ethyl)-2-hydroxymethyl-phenol Levalbuterol Related Compound B alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol Levalbuterol Related Compound C alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol Levalbuterol Related Compound D 5-[2-{(1,1-dimethylethyl)amino}-1-hydroxyethyl]-2-hydroxy-benzaldehyde benzenesulfonic acid salt Levalbuterol Related Compound E alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol Levalbuterol Related Compound F alpha-[{(1,1-Dimethylethyl)amino}methyl}-4-(phenylmethoxy)-1,3-benzenedimethanol Levalbuterol Related Compound G alpha[{(1,1-Dimethylethyl)amino}methyl]-4,5-dihydroxy-1,3-benzenedimethanol
200 mg 10 mg 10 mg 100 mg 20 mg 10 mg 10 mg 20 g 5g 150 mg 25 mg 25 mg 50 mg 50 mg
New USP1357533
25 mg
USP1358831 USP1358842 USP1358853
30 mg 30 mg 20 mg
Edition 2012/2013
387

Code Product Unit
Levalbuterol Related Compound H 4-[2-(tert-butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol Levamisole HCl Levetiracetam Levetiracetam Racemic Mixture Levetiracetam Related Compound A (S)-N(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide Levetiracetam Related Compound B (S)-2-aminobutanamide HCl Levmetamfetamine Controlled Substance CII Levobunolol HCl Levocabastine HCl Levocabastine Related Compound A 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride Levocarnitine Levocarnitine Related Compound A 2-propen-1-aminium, 3-carboxy-N,N,N-trimethyl-,chloride Levodopa Levodopa Related Compound A 3-(3,4,6-Trihydroxyphenyl)-alanine Levodopa Related Compound B 3-Methoxytyrosine Levofloxacin Levofloxacin Related Compound A (S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3de][1,4]benzoxazine-6-carboxylic acid Levofloxacin Related Compound B (S)-9,10,difluro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6carboxylic acid Levofloxacin Related Compound C (S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate Levomenol Levonordefrin Levonorgestrel Levopropoxyphene Napsylate Levorphanol Tartrate Controlled Substance CII Levothyroxine Levothyroxine Sodium Levothyroxine for Peak Identification levothyroxine sodium spiked with liothyronine, triiodothyroacetic acid, tetraiodothyroacetic acid Lidocaine Lincomycin HCl Lindane Linoleoyl Polyoxylglycerides Liothyronine Alpha Lipoic Acid Lisinopril Lisinopril Related Compound A ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl}-4phenylbutanoic acid Lithium Carbonate Loperamide HCl Lopinavir Lopinavir System Suitability Mixture
400 mg 100 mg 200 mg 50 mg 50 mg 200 mg 25 mg
USP1362125
35 mg
USP1362136
15 mg
USP1362307 USP1362500 USP1362602 USP1363004 USP1364007 USP1365000 New USP1365065 USP1365021
USP1369000 USP1370000 USP1370101 USP1370156

388
300 mg 200 mg 350 mg 10 mg

Edition 2012/2013

Code Product Unit
Loracarbef Loracarbef L-Isomer Loratadine Loratadine Related Compound A 8-chloro-6,11-dihydro-11(4-piperidinylidene)-5H-benzo[5,6]cyclohepta [1,2-b]pyridine Loratadine Related Compound B 8-chloro-6,11-dihydro-11-(N-methyl-4-piperidinylidene)-5H-benzo[5,6]cyclohepta [1,2-b]pyridine Loratadine Related Compound C 8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one Lorazepam Controlled Substance CIV Lorazepam Related Compound A 7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepine-2-one Controlled Substance Lorazepam Related Compound B 2-Amino-2',5-dichlorobenzophenone Lorazepam Related Compound C 6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde Lorazepam Related Compound D 6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid Lorazepam Related Compound E 6-Chloro-4-(o-chlorophenyl)-2-quinazoline Methanol Losartan Potassium Lovastatin Lovastatin Related Compound A Dihydro-lovastatin Loxapine Succinate Loxapine Related Compound A 3-Chloro-11-(4-methylpiperazine-1-yl)dibenzo[b,f][1,4]oxazepine Lumefantrine Lumefantrine Related Compound A (RS,Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol Lutein Lycopene Lynestrenol Lypressin 8-L-lysine vasopressin Lysergic Acid Diethylamide Tartrate (AS) (LSD) Controlled Substance CI L-Lysine Acetate L-Lysine HCl Lysophosphatidylcholine Mafenide Acetate Mafenide Related Compound A 4-Formylbenzenesulfonamide Magaldrate Magnesium Carbonate (AS) Magnesium Chloride (AS) Magnesium Hydroxide (AS) Magnesium Phosphate (AS) Magnesium Salicylate Magnesium Stearate (AS) Magnesium Sulfate (AS) Powdered Malabar-Nut-Tree Leaf Extract Malathion Maleic Acid Malic Acid
200 mg 25 mg 200 mg 15 mg 15 mg
USP1370269 USP1370305 USP1370327
15 mg 200 mg 25 mg
USP1370338 USP1370349 USP1370350 USP1370360 USP1370462 USP1370600 USP1370611 USP1370702 USP1370713 USP1370746 USP1370757 USP1370804 USP1370860 USP1370906 USP1711133 USP1371002 USP1371501 USP1372005 USP1372050 USP1373008 USP1286209 USP1374000 USP1374226 USP1374248 USP1374260 USP1374292 USP1374306 USP1374340 USP1374361 USP1374383 USP1374408 USP1374500 USP1374601
Edition 2012/2013
25 mg 25 mg 25 mg 25 mg 250 mg 125 mg 20 mg 125 mg 20 mg 100 mg 25 mg 1 mL 500 mg 20 mg 2.2 mg 10 mg 200 mg 200 mg 250 mg 400 mg 50 mg 200 mg 2g 1g 1g 2g 200 mg 5g 1g 1g 500 mg 300 mg 500 mg
389

Code Product Unit
USP1374907 USP1375003 USP1375025 USP1375058 USP1375069 USP1375070 USP1375080 USP1375091 USP1375127 USP1375149 USP1375105 USP1375160 USP1375182 USP1375207 USP1539803 USP1375309 USP1375502 USP1375706 USP1376006 USP1376017 USP1377009 USP1377010 New USP1377029
Maltitol Maltol (FCC) Maltose Monohydrate Mandelic Acid (AS) Mangafodipir Trisodium Mangafodipir Related Comound A Manganese (II) dipyridoxyl monophosphate sodium salt Mangafodipir Related Comound B Manganese (II) dipyridoxyl diphosphate mono-overalkylated sodium salt Mangafodipir Related Comound C Manganese (III) dipyridoxyl diphosphate sodium salt Manganese Chloride (AS) Manganese Sulfate (AS) Mannitol Mannosamine HCl Mannose Maprotiline HCl Maritime Pine Extract Mazindol Controlled Substance CIV Mebendazole Mebrofenin Mecamylamine HCl Mecamylamine Related Compound A N,1,7,7-tetramethyl bicyclo[2.2.1]heptan-2-amine hydrochloride Meclizine HCl Meclizine Related Compound A 4-chlorobenzhydrol Meclizine Related Compound B 1-[(4-Chlorophenyl)(phenyl)methyl]-4-(2-methylbenzyl)piperazine dihydrochloride monohydrate Meclocycline Sulfosalicylate Meclofenamate Sodium Medroxyprogesterone Acetate Medroxyprogesterone Acetate Related Compound A 4,5-beta-Dihydromedroxyprogesterone acetate Medrysone Mefenamic Acid Mefloquine Hydrochloride Mefloquine Related Compound A threo-mefloquine Megestrol Acetate Meglumine (AS) Melamine 2,4,6-Triamino-1,3,5-triazine Melatonin (AS) Melatonin Related Compound A 2-(5-methoxy-1-H-indol-3-yl)ethanamine Melengestrol Acetate Melengestrol Acetate Related Compound A 17-hydroxy-16-methylenepregna-4-ene-3,20-dione 17-acetate Melengestrol Acetate Related Compound B 6,16-dimethylene-17-hydroxypregna-4-ene-3,20-dione 17-acetate Meloxicam Meloxicam Related Compound A ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide
200 mg 4g 500 mg 500 mg 200 mg 15 mg 15 mg 15 mg 1g 1g 200 mg 300 mg 300 mg 200 mg 2g 350 mg 200 mg 100 mg 200 mg 10 mg 500 mg 15 mg 15 mg
USP1377508 USP1377803 USP1378001 USP1378012 USP1379004 USP1379605 USP1379059 USP1379060 USP1379106 USP1379140 USP1379183 USP1380105 New USP1380116 USP1379254 USP1379265 USP1379276 USP1379401 USP1379412
390
Edition 2012/2013

Code Product Unit
USP1379423 USP1379434 USP1379445
Meloxicam Related Compound B 2-Amino-5-methylthiazole Meloxicam Related Compound C Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide Meloxicam Related Compound D 4-Methoxy-2-methyl-(5-methyl-1,3-thiazol-2yl)-2H-1,2-benzothiazine-3-carboxamide-1,1dioxide Menadione (Vitamin K3) Menhaden Oil Menthol Menthyl Anthranilate Mepenzolate Bromide Meperidine HCl Controlled Substance CII Mephenytoin Mephobarbital Controlled Substance CIV Mepivacaine HCl Meprednisone Meprobamate Controlled Substance CIV Meprylcaine HCl 3-Mercapto-2-methylpropanoic Acid 1,2-Diphenylethylamine Salt Mercaptopurine Meropenem Mesalamine Mesna Mesna Related Compound A 2-(Acetylsulfanyl)ethanesulfonic acid Mesna Related Compound B (2,2-(Disulfanediyl)bis(ethanesulfonic acid)) Mesoridazine Besylate Mestranol Metaproterenol Sulfate Metaraminol Bitartrate Metformin HCl Metformin Related Compound A 1-Cyanoguanidine Metformin Related Compound B 1-Methylbiguanide hydrochloride Metformin Related Compound C N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine Methacholine Chloride (AS) Methacrylic Acid Copolymer Type A Methacrylic Acid Copolymer Type B Methacrylic Acid Copolymer Type C Partially-Neutralized Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) Methacycline HCl Methadone HCl Controlled Substance CII Methamphetamine HCl Controlled Substance CII Methantheline Bromide Methapyrilene Fumarate Metharbital Controlled Substance CIII Methazolamide Methdilazine HCl Methenamine Methenamine Hippurate
25 mg 30 mg 30 mg
USP1381006 New USP1381200 USP1381709 USP1381742 USP1382009 USP1383001 USP1385007 USP1386000 USP1387002 USP1388005 USP1389008 USP1390007 USP1391000 USP1392002 USP1392454 USP1392705 USP1392807 USP1392818 USP1392829 USP1393005 USP1394008 USP1395500 USP1396003 USP1396309 USP1396310 USP1396331 USP1396342 USP1396364 USP1396400 USP1396502 USP1396604 USP1396659 USP1397006 USP1398009 USP1399001 USP1401001 USP1402004 USP1405002 USP1406005 USP1408000 USP1409003 USP1409502
Edition 2012/2013
200 mg 2 mL 250 mg 500 mg 200 mg 200 mg 250 mg 250 mg 200 mg 200 mg 200 mg 200 mg 75 mg 500 mg 300 mg 200 mg 200 mg 50 mg 50 mg 250 mg 200 mg 200 mg 200 mg 200 mg 30 mg 25 mg 25 mg 500 mg 200 mg 200 mg 200 mg 1g 200 mg 200 mg 125 mg 200 mg 200 mg 200 mg 500 mg 200 mg 500 mg 200 mg
391

Code Product Unit
USP1409604 USP1410002 USP1411005 USP1411504 USP1412008 USP1413000 USP1413988 USP1413999 USP1414003 USP1414025 USP1414036
Methenamine Mandelate Methicillin Sodium (AS) Methimazole L-Methionine Methocarbamol Methohexital Controlled Substance CIV R-Methotrexate (R)-2-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzamido)pentanedioic acid Methotrexate System Suitability Mixture Methotrexate Methotrexate Related Compound B (S)-2-{4-[2,4-diaminopteridin-6yl)methylamino]benzoamido}pentanedioic acid Methotrexate Related Compound C (S)-2-(4{[(2-amino-4-oxo-1,4-dihydropteridin-6yl)methyl](methyl)amino}benzamido)pentanedioic acid Methotrexate Related Compound E 4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride Methotrimeprazine Methoxamine HCl Methoxsalen Methoxyflurane Methoxymethylguanine Methscopolamine Bromide Methsuximide Methyclothiazide Methyclothiazide Related Compound A 4-amino-6-chloro-N-3-methyl-m-benzenedisulfonamide Methyl Acetate Methyl Alcohol Methylbenzhydrol Methylbenzethonium Chloride Methyl Benzylidene Camphor 3-Methyl-1-butanol Methyl Caprate Methyl Caproate Methyl Caprylate Methylcellulose (AS) 4-Methyl-2,5-dimethoxyamphetamine HCl (STP) (AS) Controlled Substance CI Methyldopa Methyldopate HCl Methylene Blue Methylenedioxy-3,4-amphetamine HCl (MDA) (AS) Controlled Substance CI Methylergonovine Maleate Methyl Ethyl Ketone Methyl Isobutyl Ketone Methyl Laurate Methyl Linoleate Methyl Linolenate 3-O-Methylmethyldopa Methyl Myristate Methyl Oleate Methyl Palmitate Methyl Palmitoleate
USP1414058 USP1415006 USP1416009 USP1417001 USP1418004 USP1418650 USP1421009 USP1422001 USP1424007 USP1424018 USP1424051 USP1424109 New USP1424209 USP1424211 USP1424222 USP1424153 USP1424233 USP1424244 USP1424255 USP1424506 USP1425000 USP1426002 USP1427005 USP1428008 USP1429000 USP1430000 USP1430101 USP1430203 USP1430305 USP1430327 USP1430349 USP1430509 USP1431501 USP1431556 USP1431603 USP1431625
392
50 mg 200 mg 200 mg 200 mg 1 mL 20 mg 200 mg 500 mg 200 mg 100 mg 3x1.2 mL 3x1.5 mL 50 mg 500 mg 200 mg 3x1.2 mL 300 mg 300 mg 300 mg 1g 25 mg 500 mg 200 mg 250 mg 25 mg 50 mg 3x1.2 mL 3x1.2 mL 500 mg 5x50 mg 5x50 mg 50 mg 300 mg 500 mg 300 mg 300 mg
Edition 2012/2013

Code Product Unit
USP1432005 USP1433008 USP1434011 USP1434022 USP1435003 USP1436006 USP1437009 USP1437202 USP1437053 USP1437450 USP1437508 USP1437600 USP1438001 USP1438205 USP1440003 USP1440808 USP1441200 USP1268772 USP1441287 USP1441232 USP1441243 USP1441254 USP1441265
Methylparaben Methylphenidate HCl Controlled Substance CII Methylphenidate HCl Erythro Isomer Solution Controlled Substance CII Methylphenidate Related Compound A alpha-Phenyl-2-piperidineacetic Acid HCl Methylprednisolone Methylprednisolone Acetate Methylprednisolone Hemisuccinate Methylpyrrolidone 2-Methyl-1-propanol Methyl Salicylate (AS) Methyl Stearate Methylsulfonylmethane Methyltestosterone Controlled Substance CIII Methyl Tricosanoate Methysergide Maleate Metoclopramide HCl Metolazone Metomidate HCl methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate hydrochloride Metoprolol Fumarate Metoprolol Related Compound A (+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol Metoprolol Related Compound B (+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propane Metoprolol Related Compound C (+/-)4-[2-Hydroxy-3-(1-methylethyl)aminopropoxy]benzaldehyde Metoprolol Related Compound D (+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl] (1-methylethyl)amine hydrochloride Metoprolol Succinate Metoprolol Tartrate Metrizamide Metronidazole Metronidazole Benzoate Metyrapone Metyrosine Mexiletine HCl Mezlocillin Sodium Mibolerone Controlled Substance CIII Miconazole Miconazole Nitrate Midazolam Controlled Substance CIV Midazolam HCl (AS) Controlled Substance CI Midodrine HCl Midodrine Related Compound A 2-amino-1-(2,5-dimethoxyphenyl)ethanol Mifepristone Milbemycin Oxime Powdered Milk Thistle Extract Milrinone Milrinone Related Compound A 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carboxamide Mineral Oil
125 mg 125 mg 0.5 mL 50 mg 200 mg 200 mg 200 mg 2g 3x1.2 mL 2 mL 300 mg 200 mg 200 mg 200 mg 350 mg 500 mg 200 mg 50 mg 200 mg 20 mg 100 mg 20 mg 50 mg
Edition 2012/2013
200 mg 200 mg 500 mg 100 mg 100 mg 200 mg 200 mg 200 mg 350 mg 200 mg 200 mg 200 mg 300 mg 200 mg 200 mg 40 mg 200 mg 200 mg 250 mg 500 mg 50 mg 1.5 mL
393

Code Product Unit
Minocycline HCl Minoxidil Mirtazapine Mirtazapine Related Compound A 1,2,3,4,10,14b-hexahydropyrazino[2,1-a}pyrido[2,3-c][2]benzazepine Mirtazapine Related Compound B 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate Mirtazapine Related Compound C 2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one Mirtazapine Related Compound D 2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one Mirtazapine Resolution Mixture Misoprostol Mitomycin Mitotane Mitoxantrone HCl Mitoxantrone System Suitability Mixture Modafinil Controlled Substance CIV Modafinil Related Compound A 2-[(diphenylmethyl)sulfinyl]acetic acid Modafinil Related Compound B 2-[diphenylmethyl)sulfonyl]acetamide Modafinil Related Compound C 2-[(diphenylmethyl)sulfenyl]acetamide Modafinil Related Compound D Bis(diphenylmethyl)ether Modafinil Related Compound E Bis(diphenylmethyl)disulfide Mogroside V Molindone HCl Mometasone Furoate Monensin Sodium Monk Fruit Extract Monobenzone Monoethanolamine Monoglycerides Monosodium Glutamate (AS) Monostearyl Maleate Montelukast Dicyclohexylamine Montelukast for Peak Identification Montelukast Racemate Montelukast Sodium Morantel Tartrate Moricizine HCl Morphine Monohydrate (AS) Controlled Substance CII Morphine Sulfate Controlled Substance CII Morphine Sulfate Related Compound A Morphine N-Oxide Controlled Substance CI Morphine Sulfate Related Compound B Pseudomorphine Controlled Substance CII Moxifloxacin HCl Moxifloxacin Related Compound A 1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4dihydroquinoline-3-carboxylic acid
350 mg 125 mg 350 mg 15 mg 25 mg
USP1444241 USP1444252 USP1444296 USP1444300 USP1444707 USP1445007 USP1445200 USP1445211 USP1445404 USP1445346 USP1445357 USP1445368 USP1445379 USP1445380 New USP1445448 USP1445459 USP1445470 USP1445481 New USP1445492 USP1445506 USP1445925 USP1446000 USP1446600 USP1446804 USP1446815 USP1446837 USP1446848 USP1446859 USP1446906 USP1446950 USP1447002 USP1448005 USP1448016 USP1448027 USP1448606 USP1448617
50 mg 50 mg 25 mg 100 mg 50 mg 500 mg 400 mg 0.3 mg 200 mg 20 mg 20 mg 20 mg 20 mg 20 mg 100 mg 500 mg 200 mg 200 mg 500 mg 200 mg 1 mL 125 mg 1g 100 mg 150 mg 20 mg 20 mg 150 mg 100 mg 250 mg 50 mg 500 mg 20 mg 20 mg 200 mg 25 mg
394
Edition 2012/2013

Code Product Unit
Mupirocin Mupirocin Calcium Mupirocin Lithium Mycophenolate Mofetil Mycophenolate Mofetil Related Compound A 2-morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4methyl-4-hexenoate Mycophenolate Mofetil Related Compound B [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3Hisobenzofuranyl-1-one] Myristic Acid Myristyl Alcohol Nabumetone Nabumetone Related Compound A 1-(6-methoxy-2-naphthyl)-but-1-en-3-one Nadolol Nafcillin Sodium Naftifine HCl Nalidixic Acid Nalorphine HCl Controlled Substance CIII Naloxone Naltrexone Naltrexone Related Compound A N-(3-butenyl)-noroxymorphone HCl Controlled Substance CII Nandrolone Controlled Substance CIII Nandrolone Decanoate Controlled Substance CIII Nandrolone Phenpropionate Controlled Substance CIII Naphazoline HCl Naphthalene Naproxen Naproxen Sodium Narasin Naratriptan HCl Naratriptan Resolution Mixture Natamycin Nateglinide Nateglinide Related Compound A trans-4-isopropylcyclohexanecarboxylic acid Nateglinide Related Compound B N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine Nateglinide Related Compound C N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine Near IR System Suitability Nefazodone HCl Nefazodone Related Compound A 1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride Nefazodone Related Compound B 2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)3H-1,2,4-triazol-3-one hydrochloride Nelfinavir Mesylate Nelfinavir Related Compound A (3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4(phenylsulfinyl)butyl]decahydroisoquinoline-2-carboxymide Neohesperidine Dihydrochalcone Neomycin Sulfate
50 mg 200 mg 100 mg 200 mg 15 mg
USP1448978
15 mg
USP1448990 USP1449008 USP1449518 USP1449530 USP1449700 USP1450007 USP1450404 USP1451000 USP1452002 USP1453005 USP1453504 USP1453526 USP1454008 USP1455000 USP1456003 USP1457006 USP1457083 USP1457301 USP1457403 USP1457458 USP1457469 USP1457491 USP1457505 USP1457607 USP1457618 USP1457629 USP1457630 USP1457844 USP1457902 USP1457913 USP1457924
200 mg 1g 200 mg 15 mg 200 mg 200 mg 200 mg 200 mg 250 mg 125 mg 200 mg 30 mg 50 mg 250 mg 250 mg 200 mg 200 mg 200 mg 200 mg 125 mg 125 mg 20 mg 200 mg 200 mg 10 mg 10 mg 5 mg unit 200 mg 25 mg 25 mg
USP1457968 USP1457979
200 mg 15 mg
New USP1458053 USP1458009
100 mg 200 mg
Edition 2012/2013
395

Code Product Unit
USP1459001 USP1460000 USP1460204 USP1460215 USP1460500 USP1460703 USP1460714 USP1460725 USP1460736 USP1461003 USP1462006 New USP1463224 USP1463304 USP1463508 USP1463600 USP1463701 USP1463858 USP1463870 USP1463869 USP1463960 USP1463971 USP1463950 USP1464001 USP1021703 USP1465004 USP1466007 USP1465503 USP1466506 USP1467804 USP1467950 USP1468002 USP1468400 USP1468501 USP1469005 USP1470004 USP1471506 USP1471914 USP1471925 USP1471958 USP1472000 USP1473002 USP1473206 USP1474005
Neostigmine Bromide Neostigmine Methylsulfate Neotame Neotame Related Compound A N-[N-(3-3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine Netilmicin Sulfate Nevirapine Anhydrous Nevirapine Hemihydrate Nevirapine Related Compound A 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one Nevirapine Related Compound B 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one Niacin Niacinamide (Vitamin B3) Nicardipine Hydrochloride Nicotine Bitartrate Dihydrate Nifedipine Nifedipine Nitrophenylpyridine Analog Nifedipine Nitrosophenylpyridine Analog Nimodipine Nimodipine Related Compound A 2-methoxyethyl-1-methylethyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate Nimodipine Related Compound B bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (AS) Nitazoxanide Niltazoxanide Related Compound A 2-Amino-5-nitrothiazole Nitrilotriacetic Acid Nitrofurantoin Nitrofurantoin Related Compound A N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine Nitrofurazone Nitrofurazone Related Compound A 5-Nitro-2-furfuraldazine Nitrofurfural Diacetate Diluted Nitroglycerin Nizatidine Nonoxynol 9 Nonoxynol 10 Nordazepam Controlled Substance CIV 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one Norepinephrine Bitartrate Norethindrone Norethindrone Acetate Norfloxacin Norgestimate Norgestimate Related Compound A Levonorgestrel Acetate Deacetylnorgestimate (E)- and (Z)-17-deacetyl norgestimate mixture Norgestrel Noroxymorphone HCl Controlled Substance CII Norphenylephrine Hydrochloride Nortriptyline HCl
200 mg 200 mg 200 mg 15 mg 500 mg 100 mg 100 mg 15 mg 15 mg 200 mg 500 mg 200 mg 500 mg 125 mg 25 mg 25 mg 125 mg 50 mg 50 mg 200 mg 25 mg 50 mg 500 mg 20 mg 200 mg 500 mg 100 mg 5 ampules 200 mg 0.5 mL 200 mg 50 mg 125 mg 200 mg 100 mg 200 mg 200 mg 25 mg 25 mg 125 mg 50 mg 25 mg 200 mg
396
Edition 2012/2013

Code Product Unit
USP1474504 USP1475008 USP1476000 USP1477003 USP1477900 USP1477943 New USP1477604 New USP1477615 USP1477411 USP1477502 USP1477808 USP1478108 USP1478119
Noscapine Novobiocin Nylidrin HCl Nystatin Octinoxate (Octyl Methoxycinnamate) Octisalate (Octyl Salicylate) Octreotide Acetate Octreotide Non-Cyclic System Suitability Marker Octocrylene Octoxynol 9 Octyldodecanol Ofloxacin Ofloxacin Related Compound A 9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4benzoxazine-6-carboxylic acid Olanzapine Olanzapine Related Compound A 5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile Olanzapine Related Compound B 2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one Olanzapine Related Compound C 2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4'-N-oxide Oleic Acid Oleoyl Polyoxylglycerides Oley Oleate Olive Oil (AS) Olmesartan Medoxomil Olmesartan Medoxomil Related Compound A 1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol6(4H)-one Olopatadine HCl Olopatadine Related Compound B (Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide Olopatadine Related Compound C (11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid Omeprazole Omeprazole Magnesium Omeprazole Related Compound A Omeprazole Sulfone or 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]1H-benzimidazole Omeprazole Related Compound F and G Mixture Ondansetron Ondansetron HCl Ondansetron Related Compound A 3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride Ondansetron Related Compound C 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one Ondansetron Related Compound D 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one Ondansetron Resolution Mixture Orbifloxacin Orlistat Orlistat Related Compound A (3S,4S)3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone
USP1478301 USP1478312 USP1478323 USP1478334 USP1478130 USP1478152 USP1478200 USP1478254 New USP1478367 USP1478378
200 mg 20 mg 15 mg 5 mg 1g 100 mg 0.5 mL 1g 100 mg 20 mg
USP1478403 USP1478425
150 mg 35 mg
USP1478436 USP1478505 USP1478549 USP1478516
35 mg 200 mg 10 mg 15 mg
New USP1478491 USP1478571 USP1478582 USP1478593 USP1478618 USP1478629 USP1478630 USP1478673 USP1478800 USP1478811
Edition 2012/2013
397

Code Product Unit
USP1478822 USP1478833 USP1478844 USP1478855 USP1479009 USP1479010 USP1479020 USP1479031 USP1479304 USP1479315 USP1481000 USP1481204 USP1481215 USP1481226 USP1481237 USP1481248 USP1481260 USP1481306 USP1482003 USP1482014
Orlistat Related Compound B diisopropyl bicarbamate Orlistat Related Compound C Triphenylphosphine oxide Orlistat Related Compound D N-formyl-L-leucine (3S,4R,6S)-tetrahydro-3-hexyl-2-oxo-6-undecyl-2H-pyran-4-yl ester Orlistat Related Compound E N-formyl-S-isoleucin-(S)-1-[[(2S, 3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester Orphenadrine Citrate Orphenadrine Related Compound A (RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate (AS) Orphenadrine Related Compound B N-ethyl-N,N-dimethyl[2-[2-methylbenzhydryloxy)ethyl]ammonium chloride Orphenadrine Related Compound C N-methyl-[2-(2-methylbenhydryloxy)ethyl]amine hydrochloride Oseltamivir Phosphate Oseltamivir Related Compound A (3S,4R,5S)-ethyl 4-acetamido-5-amino-2-azido-3-(penta-3-yloxy)cyclohexanecarboxylate Oxacillin Sodium Oxaliplatin Oxaliplatin Related Compound A Oxalic acid dihydrate Oxaliplatin Related Compound B [SP-4-2-(1R-trans-)]-(1,2-cyclohexanediamine-N,N')dinitratoplatinum (II) Oxaliplatin Related Compound C [1R-trans-(1,2-cyclohexanediamine-N,N')]-trans-dihydroxido-[oxalate(2-)-O,O']platinum (IV) Oxaliplatin Related Compound D cis[(1S,2S)-1,2-cyclohexanediamine-N,N'][oxalato(2-)-O,O']platinum Oxaliplatin Related Compound F [SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N-N')diiodidoplatinum(II) Oxaliplatin System Suitability [SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N')dichloridoplatinum (II) Oxandrolone Controlled Substance CIII Oxandrolone Related Compound A 17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one Controlled Substance CIII Oxandrolone Related Compound B 17 beta-hydroxy-17-alpha-methyl-4-oxa-5 alpha-androsta-3-one Controlled Substance CIII Oxandrolone Related Compound C 17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one Controlled Substance CIII Oxaprozin Oxazepam Controlled Substance CIV Oxcarbazepine Oxcarbazepine Related Compound B N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide Oxcarbazepine Related Compound C Acridin-9(10H)-one Oxcarbazepine Related Compound E 10(11H)-Oxo-5H-dibenz[b,f]azepine Oxfendazole Oxprenolol HCl Oxtriphylline Oxybenzone Oxybutynin Chloride Oxybutynin Related Compound A Phenylcyclohexylglycolic Acid
10 mg 25 mg 10 mg 10 mg 200 mg 50 mg 20 mg 20 mg 200 mg 10 mg 200 mg 125 mg 100 mg 15 mg 20 mg 10 mg 25 mg 25 mg 50 mg 20 mg
USP1482025
20 mg
USP1482036
20 mg
USP1482207 USP1483006 USP1483152 New USP1483174 USP1483185 New USP1483200 USP1483301 USP1483505 USP1484009 USP1485001 USP1485103 USP1485114
398
Edition 2012/2013

Code Product Unit
USP1485125 USP1485136 USP1485191 USP1485205 USP1485216 USP1485227 USP1485238 USP1486004 USP1487007 USP1488000 USP1490103 USP1491004 USP1491015 USP1491300 USP1491296 USP1491332 USP1491365 USP1491343 USP1491354 USP1491503 New USP1491809 New USP1491818 New USP1491820 New USP1491831 USP1492040 USP1492007 USP1492801 USP1493000 USP1494057 USP1494079 USP1494217 USP1494501 USP1494807 USP1494895 USP1494909 USP1494910 USP1494920 USP1494931 USP1494942
Oxybutynin Related Compound B Cyclohexyl mandelic acid methyl ester Oxybutynin Related Compound C 4-(Ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride Oxycodone Controlled Substance CII Oxycodone Hydrochloride Controlled Substance CII Oxycodone Related Compound A 14-hydroxycodeinone Controlled Substance CII Oxycodone Related Compound B Oxycodone N-oxide Controlled Substance CII Oxycodone Related Compound C Codeinone Controlled Substance CII Oxymetazoline HCl Oxymetholone Controlled Substance CIII Oxymorphone Controlled Substance CII Oxyquinoline Sulfate Oxytetracycline Oxytetracycline HCl Oxytocin Oxytocin Identification Paclitaxel Paclitaxel Impurity Mixture Paclitaxel Related Compound A Cephalomannine Paclitaxel Related Compound B 10-Deacetyl-7-epipaclitaxel Padimate O Paliperidone Paliperidone Related Compound A 3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-alpha]pyrimidin-4-one Paliperidone Related Compound B 6-fluoro-3-(piperidin-4-yl)benzoisoxazole HCl Paliperidone Related Compound C 3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4Hpyrido[1,2-alpha]pyrimidin-4-one Palm Oil (AS) Palmitic Acid Pamidronate Disodium Pamoic Acid Pancreatin Amylase and Protease Pancreatin Lipase Pancuronium Bromide Panthenol, Racemic Pantolactone Pantoprazole Sodium Pantoprazole Related Compound A 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole Pantoprazole Related Compound B 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]1-H-benzimidazole Pantoprazole Related Compound C 5-(difluoromethoxy)-1H-benzimidazole-2-thiol Pantoprazole Related Compounds D and F Mixture Pantoprazole Related Compound E 6,6'-bis(difluoromethoxy)-2,2'-bis[[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1H,1'H-5,5'bibenzimidazolyl Papain Papaverine HCl
20 mg 20 mg 200 mg 1g 10 mg 15 mg 15 mg 200 mg 200 mg 500 mg 200 mg 200 mg 200 mg 5 vials 15 mg 200 mg 10 mg 20 mg 20 mg 300 mg 200 mg 20 mg 20 mg 20 mg 1g 500 mg 100 mg 250 mg 2g 2g 200 mg 200 mg 500 mg 250 mg 25 mg 25 mg 20 mg 20 mg 20 mg
USP1495005 USP1496008
Edition 2012/2013
1g 200 mg
399

Code Product Unit
USP1496802 USP1496904 USP1497000 USP1498003 USP1498706 USP1499006 USP1499403 USP1499414 USP1500003 USP1500218 USP1500230 USP1500240 USP1500251 USP1500262 USP1500273 USP1500284 USP1500353 USP1500400 USP1500502 USP1500557 USP1500808 USP1501006 USP1501108 USP1502009 USP1502508 USP1502552 USP1502701 USP1504489 USP1504503 USP1504900 USP1504933 USP1504955 USP1505007 USP1505506 USP1507002 USP1508901 New USP1509019 USP1510801 USP1510845 USP1510867 New USP1510889 New USP1510890 New USP1510903
Parachlorophenol Paraffin Paramethadione Paramethasone Acetate Parbendazole Pargyline HCl Paricalcitol Paricalcitol Solution Paromomycin Sulfate Paroxetine HCl Paroxetine Related Compound B trans-4-phenyl-3-([(3,4-methylenedioxy)phenoxymethyl]piperidine HCl Paroxetine Related Compound C (+)-trans-Paroxetine HCl Paroxetine Related Compound D cis-Paroxetine HCl (AS) Paroxetine Related Compound E Mixture 1-Methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix Paroxetine Related Compound F trans(-)-1-methyl-3-[(1,3-benzodioxol-5-yloxy)Methyl]-4-(4-fluorophenyl)piperidine Paroxetine Related Compound G (+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine HCl Paroxetine System Suitability Mixture A Parthenolide Particle Count Set Peanut Oil (AS) Penbutolol Sulfate Penicillamine Penicillamine Disulfide Penicillin G Benzathine Penicillin G Potassium Penicillin G Procaine Pencillin G Sodium Penicillin V Penicillin V Potassium Pentamidine Isethionate Pentane 1-Pentanol Pentazocine Controlled Substance CIV Pentetic Acid Pentobarbital Controlled Substance CII Pentoxifylline Powdered Black Pepper Extract Perflubron Pergolide Mesylate Pergolide Sulfoxide Perindopril Erbumine Perindopril Related Compound A (2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid Perindopril Related Compound B (2S,3aS,7aS)-1-{(S)-2-[(S)-1-carboxybutylamino]propanoyl}octahydro-1Hindole-2-carboxylic acid
500 mg 1g 500 mg 200 mg 200 mg 200 mg 10 mg 3 mL 125 mg 350 mg 15 mg 15 mg 10 mg 25 mg 10 mg 10 mg 50 mg 25 mg unit 1g 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 150 mg 200 mg 200 mg 200 mg 3x1.2 mL 3x1.2 mL 500 mg 100 mg 200 mg 200 mg 1g 0.5 mL 200 mg 50 mg 100 mg 20 mg 10 mg
400
Edition 2012/2013

Code Product Unit
New USP1510925
Paliperidone Related Compound D (S)-2-{(3S,5aS,9aS,10aR)-3-metyhl-1,4-dioxodecahydropyrazino[1,2-a]indol2-(1H)-yl}pentanoic acid Perindopril Related Compound E (2S,3aS,7aS)-1-{(S)-2-[(S)-1-isopropoxy-1-oxopentan-2-ylamino]propanoyl}octahydro1H-indole-2-carboxylic acid, tert-butylamine Perindopril Related Compound F (S)-ethyl 2-{(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)yl}pentanoate Perindopril Related Compound K (3S,5aS,9aS,10aS)-3-methyldecahydropyrazino[1,2-a]indole-1,4-dione Perphenazine Perphenazine Sulfoxide Phenacetin Phenacetin Melting Point Standard (Approximately 135C) Phenazopyridine HCl Phencyclidine HCl (AS) Controlled Substance CII Phendimetrazine Tartrate Controlled Substance CIII Phenelzine Sulfate Phenformin HCl Phenindione Pheniramine Maleate Phenmetrazine HCl Controlled Substance CII Phenobarbital Controlled Substance CIV Phenol Phenolphthalein Phenolsulfonphthalein Phenothiazine Phenoxybenzamine HCl Phenoxyethanol 2-Phenoxyethanol Phensuximide Phentermine HCl Controlled Substance CIV Phentolamine HCl Phentolamine Mesylate L-Phenylalanine Ensulizole Phenylbenzimidazole Sulfonic Acid Phenylbutazone Phenylephrine HCl Phenylethyl Alcohol 5-Phenylhydantoin Phenylpropanediol Phenylpropanolamine Bitartrate Drug Precursor Phenylpropanolamine HCl Drug Precursor Phenyl Salicylate Melting Point Standard (Approximately 41C) Phenyltoloxamine Citrate Phenyltoloxamine Related Compound A 2-(2-benzylphenoxy)ethylmethylamine hydrochloride Phenytoin (CRM) Phenytoin Related Compound A 2,2-Diphenylglycine Phenytoin Related Compound B alpha-((aminocarbonyl)amino)-alpha-phenyl benzeneacetic acid Phenytoin Sodium
25 mg
New USP1510936
10 mg
New USP1510947
10 mg
New USP1510999 USP1511000 USP1511203 USP1513005 USP1514008 USP1515000 USP1516003 USP1516502 USP1517006 USP1520000 USP1522006 USP1522301 USP1523009 USP1524001 USP1524806 USP1524908 USP1525004 USP1525707 USP1526007 USP1526200 USP1528002 USP1528501 USP1529005 USP1530004 USP1530503 USP1530809 USP1531007 USP1533002 USP1533250 USP1533308 USP1533851 USP1533909 USP1534005 USP1534209 USP1534402 USP1534413 USP1535008 USP1535019 USP1535020 USP1535507
Edition 2012/2013
10 mg 200 mg 100 mg 500 mg 500 mg 200 mg 25 mg 350 mg 200 mg 200 mg 250 mg 150 mg 200 mg 200 mg 500 mg 250 mg 100 mg 500 mg 250 mg 500 mg 500 mg 200 mg 300 mg 200 mg 200 mg 200 mg 250 mg 125 mg 1 mL 100 mg 100 mg 100 mg 250 mg 500 mg 100 mg 50 mg 200 mg 50 mg 50 mg 200 mg
401

Code Product Unit
USP1535700 USP1535733 USP1535744 USP1535802 USP1536509 USP1536510 USP1537003 USP1538006 USP1538505 USP1538902 USP1539009 USP1539508 USP1539701 USP1539905 USP1541000 USP1541500 USP1541601 USP1541703 USP1541805 USP1541907 USP1542003 USP1543006 New USP1543200 USP1544304 USP1544406 USP1544417
Phosphated Riboflavin Phosphatidylcholine Phosphatidylethanolamine Phosphoric Acid (AS) Phyllanthin Powdered Phyllanthus Amarus Extract Physostigmine Salicylate Phytonadione (Vitamin K1) Pilocarpine Pilocarpine HCl Pilocarpine Nitrate Pimozide Pindolol Pioglitazone HCl Piperacetazine Piperacillin Piperazine Piperazine Adipate Piperazine Citrate Piperazine Dihydrochloride Piperazine Phosphate Piperidolate HCl Piperine Pirbuterol Acetate (AS) Piroctone Olamine Piroctone Related Compound A (2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl] acetic acid)2-aminoethanol salt Piroctone Related Compound B 4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one Piroxicam Plicamycin Polacrilex Resin Polacrilin Potassium Poloxalene Poloxamer Liquid Poloxamer Solid Polydextrose Polydimethylsiloxane Polyethylene Glycol 200 Polyethylene Glycol 300 Polyethylene Glycol 400 Polyethylene Glycol 600 Polyethylene Glycol 1000 Polyethylene Glycol 1500 Polyethylene Glycol 3000 Polyethylene Glycol 3350 Polyethylene Glycol 4000 Polyethylene Glycol 6000 Polyethylene Glycol 8000 Polyethylene Glycol 10000 Polyethylene Glycol 12000
100 mg 350 mg 100 mg 3x1.5 mL 15 mg 1g 200 mg 500 mg 300 mg 200 mg 200 mg 200 mg 200 mg 50 mg 250 mg 500 mg 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 20 mg 200 mg 200 mg 15 mg
USP1544428 USP1544508 USP1545205 USP1545409 USP1545500 USP1546106 USP1546150 USP1546161 USP1546285 USP1546300 USP1546401 USP1546423 USP1546445 USP1546467 USP1546489 USP1546503 USP1546525 USP1546547 USP1546569 USP1546580 USP1546605 USP1546627 USP1546649
402
25 mg 125 mg 50 mg 100 mg 200 mg 500 mg 1 mL 1g 200 mg 500 mg 1g 1g 1g 1g 1g 1g 1g 1g 1g 1g 1g 1g 1g

Edition 2012/2013

Code Product Unit
USP1546650 USP1546660 USP1546707 USP1546809 USP1546853 USP1546900 USP1546922 USP1546933 USP1546944 USP1546955 USP1546966 USP1547007 USP1547200 USP1547801 USP1547255 USP1372402 USP1372424 USP1372468 USP1372504 USP1547302 New USP1547379 New USP1547380 USP1547391 USP1547903 USP1547404 New USP1547459 New USP1547550 USP1547346 USP1372606 USP1547368 USP1547925 USP1547936 USP1547947 USP1547969 USP1548032 USP1548043 USP1548065 USP1549807 USP1548101 USP1548134 USP1549840 USP1548167 USP1548190 USP1548225 USP1550001 USP1551004 USP1548280 USP1548349 USP1551128 USP1551139
Polyethylene Glycol 20000 Polyethylene Glycol 35000 High-Density Polyethylene Polyethylene, Low Density Polyethylene Oxide Polyethylene Terephthalate (PET) Polyethylene Terephthalate G (PETG) Polyglyceryl 3 Dioleate Polyglyceryl 3 Diisostearate 1,2,3-Propanetriol, homopolymer, diisoactadecanoate Polyglyceryl 6 Dioleate Polyisobutylene Polymyxin B Sulfate Polyoxyl 35 Castor Oil Polyoxyl 20 Cetostearyl Ether Polyoxyl 15 Hydroxystearate Polyoxyl Lauryl Ether Polyoxyl 4 Lauryl Ether Polyoxyl 23 Lauryl Ether Polyoxyl Oleate Polyoxyl 10 Oleyl Ether Polyoxyl 6 Stearate Polyoxyl 8 Stearate Polyoxyl 32 Stearate Polyoxyl 40 Stearate Polyoxyl 50 Stearate Polyoxyl 75 Stearate Polyoxyl 100 Stearate Polyoxyl 2 Stearyl Ether (AS) Polyoxyl 10 Stearyl Ether Polyoxyl 20 Stearyl Ether Polysorbate 20 Polysorbate 40 Polysorbate 60 Polysorbate 80 (AS) Polyvinyl Acetate Polyvinyl Acetate Dispersion Polyvinyl Alcohol Potassium Acetate (AS) Potassium Benzoate Potassium Bicarbonate (AS) Potassium Bitartrate (AS) Potassium Carbonate (AS) Potassium Chloride (AS) Potassium Citrate (AS) Potassium Gluconate Potassium Guaiacolsulfonate Potassium Iodide (AS) Potassium Nitrate (AS) Dibasic Potassium Phosphate (AS) Monobasic Potassium Phosphate (AS)
1g 1g 3 strips 3 strips 100 mg 3 strips 3 strips 1g 1 mL 1g 1g 200 mg 1g 100 mg 500 mg 500 mg 1 mL 0.5 g 500 mg 1 mL 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 1g 1g 1g 2g 2g 2g 2g 1g 1g 100 mg 500 mg 1g 1g 3g 1g 1g 1g 200 mg 500 mg 1g 5g 5g 5g
Edition 2012/2013
403

Code Product Unit
USP1551140 USP1548407 USP1551150 USP1551300 USP1551503 USP1553000 USP1553859 USP1553768 USP1553815 USP1554002 USP1554206 USP1554192 USP1554217
Potassium Sodium Tartrate (AS) Potassium Sorbate Potassium Sucrose Octasulfate Potassium Trichloroammineplatinate Povidone Pralidoxime Chloride Pramipexole Dihydrochloride Monohydrate Pramipexole Related Compound A (S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine Pramipexole Related Compound D (R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole Pramoxine HCl Pravastatin Sodium Pravastatin 1,1,3,3-Tetramethylbutylamine Pravastatin Related Compound A Sodium(3R,5R)-3,5-dihydroxy-7-[(1S,2S,3S,8S,8aR)-3-hydroxy-2methyl-8-[[(2S)-2methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]heptanoate Pravastatin Related Compound B sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2methylbutanoyl]oxy]1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate Prazepam Controlled Substance CIV Praziquantel Praziquantel Related Compound A 2-benzoyl-1,2,3,6,7,11b-hexahydro-4 H-pyrazino[2,1-a]isoquinolin-4-one Praziquantel Related Compound B 2-(cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino[2,1-a]isoquinolin-4-one Praziquantel Related Compound C 2-(N-formylhexahydrohippuroyl-1,2,3,4-tetrahydroisoquinolin-1-one Prazosin HCl Prednicarbate Prednicarbate Related Compound A 1,2-dihydroprednicarbate Prednicarbate Related Compound B prednisolone-17-ethylcarbonate Prednicarbate Related Compound C prednisolone-21-propionate Prednisolone Prednisolone Acetate Prednisolone Hemisuccinate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisone Prednisone Tablets Dissolution calibrator tablets,Disintegrating Prilocaine Prilocaine HCl Prilocaine Related Compound A o-toluidine hydrochloride Prilocaine Related Compound B (RS)-N-(4-methylphenyl)-2-(propylamino)propanamide Primaquine Phosphate Primaquine Related Compound A 8-[(4-Aminopentyl)amino]-6-methoxyquinoline Primidone Primidone Related Compound A 2-ethyl-2-phenylmalonamide
2g 1g 300 mg 20 mg 100 mg 200 mg 200 mg 15 mg 25 mg 500 mg 50 mg 200 mg 15 mg
USP1554228
20 mg
500 mg 200 mg 20 mg 50 mg 50 mg 500 mg 200 mg 20 mg 20 mg 20 mg 200 mg 200 mg 125 mg 500 mg 200 mg 250 mg 30 tablets 200 mg 200 mg 100 mg 50 mg 200 mg 15 mg 200 mg 20 mg
404
Edition 2012/2013

Code Product Unit
USP1562033 USP1563003 USP1563309 USP1563320 USP1563331 USP1563342 USP1563502 USP1564006 USP1565009 USP1566001 USP1567004 USP1568007 USP1568040 USP1568051 USP1568062 USP1568506 USP1569000 USP1570009 USP1570304 USP1570326 USP1570483 USP1570406 USP1570428 USP1570439 USP1570450 USP1570508 USP1329505 USP1571001 USP1572208 USP1572503 USP1572536 USP1572547 USP1572558 USP1572525 USP1573007 USP1574000 USP1575002 USP1575206 USP1008002 USP1576005 USP1576402
Edition 2012/2013
Primidone Related Compound C 2-phenylbutyramide Probenecid Probucol Probucol Related Compound A 2,2',6,6'-tetra-tert-butyldiphenoquinone Probucol Related Compound B 4,4'-dithio-bis(2,6-di-tert-butylphenol) Probucol Related Compound C 4-[(3,5-di-tert-butyl-2-hydroxyphenylthio)isopropylidenethio]-2,6-di-tert-butylphenol Procainamide HCl Procaine HCl Procarbazine HCl Prochlorperazine Maleate Procyclidine HCl Progesterone Proguanil HCl Proguanil Related Compound C 1,5-bis(4-chlorophenyl)biguanide hydrochloride Proguanil Related Compound D 1,5-bis(1-methylethyl)biguanide hydrochloride L-Proline Promazine HCI Promethazine HCl Propafenone HCl Propafenone Related Compound B (2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one 1,3-Propanediol 1-Propanol 2-Propanol 2-Propanol System Suitability Propanolamine 3-aminopropan-1-ol Propantheline Bromide Propantheline Bromide Related Compound A 9-Hydroxypropantheline Bromide Proparacaine HCl Propionic Acid (AS) Propofol Propofol Related Compound A 3,3',5,5'-Tetraisopropyldiphenol Propofol Related Compound B 2,6-diisopropylbenzoquinone Propofol Related Compound C 2,6-diisopropylphenyl isopropylether Propofol Resolution Mixture Propofol;2,6-diisopropylphenyl isopropylether, and 2-isopropyl-6-n-propylphenol Propoxycaine HCl Propoxyphene HCl Controlled Substance CII Propoxyphene Napsylate Controlled Substance CII Propoxyphene Related Compound A alpha-d-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol HCl Propoxyphene Related Compound B alpha-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane Propranolol HCl Propyl Acetate
20 mg 200 mg 200 mg 25 mg 25 mg 25 mg 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 25 mg 25 mg 200 mg 200 mg 500 mg 200 mg 50 mg 1 mL 3x1.2 mL 3x1.2 mL 3x1 mL 100 mg 200 mg 50 mg 200 mg 3x1.5 mL 200 mg 10 mg 25 mg 50 mg 100 mg 200 mg 1g 1g 50 mg 50 mg 200 mg 3x1.2 mL
405

Code Product Unit
USP1576800 USP1576504 USP1576708 USP1576683 USP1576763 USP1576661 USP1576672 USP1576785 USP1576796 USP1576945 USP1577008 USP1578000 USP1578500 USP1578554 New USP1578805 USP1578816 USP1578827 USP1579310 USP1580002 USP1581005 USP1581504 USP1583805 USP1584003 USP1584014 USP1585006 USP1585505 USP1586009 USP1587001 USP1588004 USP1589007 USP1589109 USP1592001 USP1592205 USP1592227
Propyl Gallate Propylene Carbonate Propylene Glycol Propylene Glycol Dicaprylate/Dicaprate Propylene Glycol Dilaurate Propylene Glycol Monocaprylate Type I Propylene Glycol Monocaprylate Type II Propylene Glycol Monolaurate Type I Propylene Glycol Monolaurate Type II Propylene Oxide Propylparaben Propylthiouracil Prostaglandin A1 Prostaglandin B1 (13E,15S,)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic Acid Protein A rProtein A rProtein A, C-Cys Protocatechuic Acid 3,4-dihydroxybenzoic acid Protriptyline HCl Pseudoephedrine HCl Drug Precursor Pseudoephedrine Sulfate Drug Precursor Pygeum Extract Pyrantel Pamoate Pyrantel Related Compound A 1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine Pamoate Pyrazinamide Pyrethrum Extract Pyridostigmine Bromide Pyridoxine HCl (Vitamin B6) Pyrilamine Maleate Pyrimethamine Pyruvic Acid Pyrvinium Pamoate Quazepam Controlled Substance CIV Quazepam Related Compount A 7-Chloro-1-(2,2,2-trifluoroethyl)-5-(2-fluorophenyl)-1,3-dihydro2H-1,4-benzodiazepine-2-one Quercetin Quinacrine HCl Quinapril HCl Quinapril Related Compound A Ethyl[3S-[2(R*),3a,11a beta]]-1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxoalpha-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate Quinapril Related Compound B 3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]]Quinethazone Quinic Acid Quinidine Gluconate Quinidine Sulfate Quinine HCl Dihydrate Quinine Sulfate
200 mg 200 mg 1 mL 1 mL 500 mg 1g 1g 500 mg 500 mg 5x0.1mL 200 mg 200 mg 25 mg 25 mg 2x250 L 2x250 L 2x250 L 25 mg 200 mg 125 mg 200 mg 150 mg 500 mg 25 mg 200 mg 100 mg 200 mg 200 mg 200 mg 200 mg 500 mg 500 mg 200 mg 30 mg
USP1592409 USP1593004 USP1593401 USP1593412
500 mg 200 mg 400 mg 50 mg
USP1593423
50 mg

406
1.5 g 200 mg 200 mg 500 mg 1g 500 mg

Edition 2012/2013

Code Product Unit
USP1597504 New USP1598019 New USP1598020 New USP1598042 New USP1598053 USP1598064 USP1643292 USP1598100 USP1598201 USP1598234
Quininone Rabeprazole Sodium Rabeprazole Related Compound A 2-(1H-Benzimidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate, sodium salt Rabeprazole Related Compound C 1H-Benzimidazole-2-thiol Rabeprazole Related Compound D 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl]sulfonyl]benzimidazole Rabeprazole Related Compound E 2-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio}benzimidazole Racemethionine Ractopamine HCl Raloxifene HCl Raloxifene Related Compound C 2-(2-({4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}-ethyl)piperidine 1-oxide Ramipril Ramipril Related Compound A (2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid Ramipril Related Compound B Ramipril Isopropylester Ramipril Related Compound C Hexahydroramipil HCl Ramipril Related Compound D Ramipril Diketopiperazine Ranitidine HCl Ranitidine Related Compound A 5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine hemifumarate Ranitidine Related Compound B N,N'-bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine Ranitidine Related Compound C N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1ethenediamine Ranitidine Resolution Mixture Raspberry Alcohol 4-(3-Hydroxybutyl)phenol Raspberry Ketone 4-(4-hydroxyphenyl)-2-butanone Rauwolfia Serpentina Rebaudioside A Rebaudioside B Rebaudioside D Powdered Red Clover Extract Repaglinide Repaglinide Related Compound A (S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine, N-acetyl-L-glutamate Salt Repaglinide Related Compound B 3-Ethoxy-4-ethoxycarbonyl-phenylacetic Acid Repaglinide Related Compound C (S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl]benzoic Acid Reserpine Residual Solvent Mixture - Class 1 Residual Solvent Class 1 - Benzene Residual Solvent Class 1 - Carbon Tetrachloride Residual Solvent Class 1 - 1,2-Dichloroethane Residual Solvent Class 1 - 1,1-Dichloroethene
USP1598303 USP1598314
125 mg 30 mg
20 mg 20 mg 20 mg 200 mg 50 mg 50 mg 50 mg
USP1598450 USP1598802 USP1598813 USP1599000 USP1600121 New USP1600132 New USP1600154 USP1599500 USP1600813 USP1600824 USP1600835 USP1600846 USP1601000 USP1601102 USP1601146 USP1601168 USP1601180 USP1601204
20 mg 50 mg 100 mg 15 g 300 mg 100 mg 100 mg 500 mg 200 mg 10 mg 50 mg 25 mg 200 mg 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL
Edition 2012/2013
407

Code Product Unit
USP1601226 USP1601281 USP1601292 USP1601306 USP1601340 USP1601361 USP1601383 New USP1601394 USP1601408 USP1601420 USP1601463 USP1601485 USP1601500 USP1601521 USP1601543 USP1601565 USP1601587 USP1601601 USP1601623 USP1601645 USP1601667 USP1601689 USP1601441 USP1601703 USP1601725 USP1601747 USP1601769 USP1601770 USP1601780 USP1601805 USP1601827 USP1601849 USP1602003 USP1602502 USP1602706 New USP1602717 New USP1602740 USP1603006 USP1603108 USP1603800 USP1604009 USP1604202 USP1604337 USP1604348 USP1604508 USP1604600 USP1604610 USP1604621
Residual Solvent Class 1 - 1,1,1-Trichloroethane Residual Solvent Class 2 - Mixture A Residual Solvent Class 2 - Mixture B Residual Solvent Class 2 - Mixture C Residual Solvent Class 2 - Acetonitrile Residual Solvent Class 2 - Chlorobenzene Residual Solvent Class 2 - Chloroform Residual Solvent Class 2 - Cumene Residual Solvent Class 2 - Cyclohexane Residual Solvent Class 2 - 1,2-Dichloroethene Residual Solvent Class 2 - 1,2-Dimethoxyethane Residual Solvent Class 2 - N,N-Dimethylacetamide Residual Solvent Class 2 - N,N-Dimethylformamide Residual Solvent Class 2 - 1,4-Dioxane Residual Solvent Class 2 - 2-Ethoxyethanol Residual Solvent Class 2 - Ethylene Glycol Residual Solvent Class 2 - Formamide Residual Solvent Class 2 - Hexane Residual Solvent Class 2 - Methanol Residual Solvent Class 2 - 2-Methoxyethanol Residual Solvent Class 2 - Methylbutylketone Residual Solvent Class 2 - Methylcyclohexane Residual Solvent Class 2 - Methylene Chloride Residual Solvent Class 2 - N-Methylpyrrolidone Residual Solvent Class 2 - Nitromethane Residual Solvent Class 2 - Pyridine Residual Solvent Class 2 - Sulfolane Residual Solvent Class 2 - Tetrahydrofuran Residual Solvent Class 2 - Tetralin Residual Solvent Class 2 - Toluene Residual Solvent Class 2 - Trichloroethylene Residual Solvent Class 2 - Xylenes Resorcinol Retinyl Palmitate Ribavirin Ribavirin Related Compound A 1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid Ribavirin Related Compound D 1H-1,2,4-triazole-3-carboxamide Riboflavin (Vitamin B2) Ribose Rifabutin Rifampin Rifampin Quinone Riluzole Riluzole Related Compound A 4-trifluoromethoxyaniline Rimantadine HCl Rimexolone Risedronate Sodium Risedronate Related Compound A [1-hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid)
3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2ml 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 3x1.2 mL 200 mg 200 mg 200 mg 15 mg 15 mg 500 mg 300 mg 50 mg 300 mg 25 mg 200 mg 25 mg 300 mg 100 mg 350 mg 20 mg
408
Edition 2012/2013

Code Product Unit
USP1604632
Risedronate Related Compound B [3,6-bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6diyl]bis[phosphonic acid]disodium tetrahydrate salt Risedronate Related Compound C [2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid) Risperidone Risperidone Related Compounds Mixture Risperidone System Suitability Mixture Ritodrine HCl Ritonavir Ritonavir Related Compounds Mixture Rivastigmine Rivastigmine Tartrate Rivastigmine Tartrate R-Isomer (R)-3-[1-(Dimethylamino)ethyl]phenyl ethylmethylcarbamate, hydrogen tartrate Rivastigmine Related Compound A (+)-Di-p-toluoyl-D-(+)-tartaric acid Rivastigmine Related Compound B (R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate Rizatriptan Benzoate Rizatriptan Benzoate System Suitability Mixture Rocuronium Bromide Rocuronium Peak Identification Mixture rocuronium bromide spiked with rocuronium related compounds A,B,C,D,E,F,G and H Ropinirole HCl Ropinirole Related Compound A 4-(2-hydroxyethyl)indolin-2-one Ropinirole Related Compound B 4-[2-(Dipropylamino)ethyl]indoline-2,3-dione HCl Ropivacaine Ropivacaine HCl Ropivacaine Related Compound A 2,6-dimethylaniline hydrochloride Ropivacaine Related Compound B: (R)-(+)-1-Propylpiperidine-2-carboxylic acid (2,6dimethylphenyl)-amide hydrochloride monohydrate Rosiglitazone Maleate Rosiglitazone Related Compound A (5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}1,3-thiazolidine-2,4-dione Roxarsone Rubusoside Rufinamide Rufinamide Related Compound A 1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide Rufinamide Related Compound B Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate Rutin Saccharin Saccharin Calcium Saccharin Sodium Salicylamide Salicylic Acid Salicylic Acid Related Compound A 4-hydroxybenzoic acid Salicylic Acid Related Compound B 4-hydroxyisophthalic acid
20 mg
20 mg 200 mg 25 mg 10 mg 200 mg 200 mg 50 mg 0.1 mL 200 mg 20 mg 15 mg 15 mg 200 mg 15 mg 250 mg 25 mg 200 mg 50 mg 50 mg 200 mg 200 mg 25 mg 50 mg 200 mg 25 mg
USP1606208 New USP1606274 New USP1606401 New USP1606412 New USP1606423 USP1606503 USP1607007 USP1607029 USP1607040 USP1608000 USP1609002 USP1609013 USP1609024
Edition 2012/2013
409

Code Product Unit
Salicylic Acid Tablets Dissolution Calibrator, Non-disintegrating Salmeterol Xinafoate Salmeterol Related Compound A 4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol Salmeterol Related Compound B 4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}2-(hydroxymethyl)phenol Salsalate Saquinavir Mesylate Saquinavir Related Compound A N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-Dasparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide Scopolamine HBr Scopoletin Secobarbital Controlled Substance CII Selegiline HCl Selenomethionine Sennosides Sennoside A Sennoside B L-Serine Sertraline HCl Sertraline HCl Racemic Mixture 1:1 mixture of (1S,4S) and (1R, 4R)-4-(3,4-dichlorophenyl)N-methyl-1,2,3,4-tetrahydro-1-naphthylamine HCl Sertraline HCl Related Compound A 1:1 mixture of (1R, 4S) and (1S, 4R)-4-(3,4-dichlorophenyl)N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride Sesame Oil (AS) Sesame Oil Related Compound A 1,2-dilinoleoyl-3-oleoyl-rac-glycerol Sesame Oil Related Compound B 1,2-dilinoleoyl-3-palmitoyl-rac-glycerol, PLL Sevoflurane Sevoflurane Related Compound A 1,1,3,3,3-Pentafluoroisopropenyl fluoromethyl ether Sevoflurane Related Compound B 1,1,1,3,3,3-hexafluoro-2-methoxypropane Sevoflurane Related Compound C 1,1,1,3,3,3-hexafluoro-2-propanol Sibutramine HCl Controlled Substance CIV UB Sibutramine Related Compound A N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine HCl Sibutramine Related Compound B N-{1-[1-(3-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine HCl Sibutramine Related Compound C N-{1-[1-(4-chlorophenyl)cyclobutyl]pentyl}-N,N-dimethylamine HCl Sibutramine Related Compound D N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N-methylamine hydrochloride Silver Sulfadiazine Silybin Silydianin Simethicone Simvastatin Sisomicin Sulfate Beta-Sitosterol Sodium Acetate (AS)
30 tablets 150 mg 10 mg 10 mg 150 mg 200 mg 25 mg
USP1610001 USP1610090 USP1611004 USP1611900 USP1611955 USP1612007 USP1612018 USP1612029 USP1612506 USP1612539 USP1612517
USP1612528
25 mg
USP1612404 USP1612415 USP1612426 USP1612540 USP1612550 USP1612572 USP1612594 USP1612845 USP1612856 USP1612867 USP1612878 USP1612889 USP1612608 USP1612630 USP1612641 USP1612652 USP1612700 USP1612801 USP1612947 USP1613407
410
2x1 mL 3x6 mg 3x6 mg 1 mL 0.2 mL 0.2 mL 0.2 mL 125 mg 20 mg 20 mg 20 mg 20 mg 200 mg 50 mg 20 mg 50 g 200 mg 500 mg 300 mg 1g
Edition 2012/2013

Code Product Unit
USP1613509 USP1613564 USP1613655 USP1613597 USP1613600 USP1613757 USP1613804 USP1613859 USP1613860 USP1614239 USP1614308 USP1614363 USP1614396 New USP1614421 USP1614454 USP1614501 USP1614578 USP1614589 USP1614603 USP1614636 USP1614669 USP1614670 USP1614705 USP1614807 USP1614909 USP1615107 USP1615708 USP1615956 USP1616008 USP1617000 USP1617408 USP1617419 USP1617420 USP1617430 USP1617474 USP1618003 USP1619006 USP1619017 USP1619505 USP1607506 USP1620005 USP1620209 USP1620220 USP1621008 USP1621507 USP1622000 New USP1622317
Sodium Ascorbate Sodium Benzoate Sodium Bicarbonate (AS) Sodium Bromide Sodium Butyrate Sodium Carbonate Anhydrous (AS) Sodium Chloride Sodium Citrate (AS) Sodium Cyclamate Sodium Iron EDTA Sodium Lactate Sodium Lauryl Sulfate (AS) Sodium Metabisulfite Sodium Molybdate Dihydrate Sodium Nitrite (AS) Sodium Nitroprusside Sodium Picosulfate Sodium Picosulfate Related Compound A 4-[(pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate Sodium Propionate Sodium Salicylate Sodium Starch Glycolate Type A Sodium Starch Glycolate Type B Sodium Stearyl Fumarate Sodium Sulfate Anhydrous (AS) Sodium Tartrate Dihydrate Sodium Thiosulfate (AS) Somatropin Sorbic Acid 1,4-Sorbitan Sorbitol Sotalol HCl Sotalol Related Compound A N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride Sotalol Related Compound B N(4-Formylphenyl)methanesulfonamide Sotalol Related Compound C N-[4-[2-[(1-Methylethyl)amino]ethyl]phenyl]methanesulfonamide monohydrochloride) Defatted Powdered Soy Spectinomycin HCl Spironolactone Spironolactone Related Compound A Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21,17-carbolactone) (AS) Squalane Powdered St. John's Wort Extract Stanozolol Controlled Substance CIII Stavudine Stavudine System Suitability Mixture Stearic Acid Stearoyl Polyoxyglycerides Stearyl Alcohol Steviol Glycosides System Suitability
200 mg 1g 3g 1g 25 mg 1g 1g 1g 200 mg 200 mg 200 mg 1g 1g 200 mg 1g 500 mg 50 mg 20 mg 200 mg 500 mg 400 mg 400 mg 200 mg 1g 4x500 mg 1g unit 1g 300 mg 125 mg 300 mg 50 mg 50 mg 50 mg 2.5 g 200 mg 125 mg 100 mg 500 mg 600 mg 200 mg 250 mg 10 mg 500 mg 100 mg 125 mg 50 mg
Edition 2012/2013
411

Code Product Unit
New USP1622350 USP1622408 USP1623003 USP1623411 USP1623502 USP1623604 USP1623626 USP1623659 USP1623637 USP1623615 USP1623648 USP1623670 USP1623681 USP1623706 USP1623808 USP1624006 USP1624505 USP1625009 USP1626001 USP1626500 USP1628007 USP1629000 USP1630009 USP1631001 USP1631500 USP1632004 USP1633007 USP1633506 USP1634000 USP1635002 USP1635206 USP1635228 USP1636005 USP1636504 USP1637008 USP1638000 USP1639003 USP1642008 USP1642019 USP1642100 USP1642154 USP1642201 USP1642212
Steviolbioside Stevioside Streptomycin Sulfate Succinic Acid Succinylcholine Chloride Succinylmonocholine Chloride Sucralose Sucromalt Sucrose Sucrose Octaacetate Sufentanil Citrate Controlled Substance CII Sulbactam Sulconazole Nitrate Sulfabenzamide Sulfacetamide Sulfacetamide Sodium Sulfachlorpyridazine Sulfadiazine Sulfadimethoxine Sulfadoxine Sulfamerazine Sulfamethazine Sulfamethizole Sulfamethoxazole Sulfamethoxazole N4-glucoside Sulfanilamide Sulfanilamide Melting Point Standard (Approximately 165C) Sulfanilic Acid Sulfapyridine Sulfapyridine Melting Point Standard (Approximately 191C) Sulfaquinoxaline Sulfaquinoxaline Related Compound A N1-N2-diquinoxalin-2-ylsulfanilamide Sulfasalazine Sulfathiazole Sulfinpyrazone Sulfisoxazole Sulfisoxazole Acetyl Sulindac Sulindac Related Compound A trans-sulindac Sulisobenzone Sumatriptan Sumatriptan Succinate Sumatriptan Succinate Related Compound A [3-[2-(dimethylamino)ethyl]-2-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]1H-indol-5-yl]-N-methylmethansulfonamide, succinate Salt Sumatriptan Succinate Related Compound C [3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]N-methylmethanesulfonamide succinate salt Sumatriptan Succinate Related Impurities Suprofen Tacrine HCl
100 mg 30 mg 200 mg 100 mg 500 mg 125 mg 400 mg 200 mg 100 mg 500 mg 25 mg 250 mg 200 mg 200 mg 300 mg 500 mg 200 mg 200 mg 200 mg 200 mg 500 mg 1g 200 mg 200 mg 25 mg 5g 500 mg 200 mg 200 mg 1g 200 mg 25 mg 125 mg 350 mg 200 mg 200 mg 200 mg 200 mg 20 mg 500 mg 50 mg 200 mg 15 mg
USP1642223
50 mg
USP1642256 USP1642507 USP1642700

412
25 mg 200 mg 500 mg
Edition 2012/2013

Code Product Unit
USP1642802 USP1642813
Tacrolimus Tacrolimus Related Compound A (E)-17-ethyl-1,14-dihydroxy-12[(E)-2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl]-23,25dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0super4,9]octacos-18ene-2,3,10,16-tetrone Tacrolimus System Suitability Mixture Tadalafil Tagatose Tamoxifen Citrate Tamsulosin HCl Racemic Tamsulosin HCl Tannic Acid (AS) Tanshinone IIA Tartaric Acid Taurine Tazobactam Tazobactam Related Compound A (2S,3S)2-Amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid Telmisartan Telmisartan Related Compound A 1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole Telmisartan Related Compound B 4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl) methyl]biphenyl-2-carboxylic acid Temazepam Controlled Substance CIV Temazepam Related Compound A 5-chloro-2-methylaminobenzophenone Temazepam Related Compound F 7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione Temazepam Related Compound G 7-Chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione Temozolomide Temozolomide Related Compound A 4-diazo-4H-imidazole-5-carboxamide Temozolomide Related Compound B 3-methyl-1,1-dihenylurea Temozolomide Related Compound C diphenylcarbamic chloride Tenofovir Tenofovir Disoproxil Related Compound A (S)-5-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5phosphanonanedioic acid, bis(1-methylethyl)ester,5-oxide, (E)-2-butenedioate (1:1) Tenofovir Disoproxil Related Compound B (E)-9-(Prop-1-enyl)9H-purin-6-amine Tenofovir Disoproxil Fumarate Terazosin HCl Terazosin Related Compound A 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride Terazosin Related Compound B 1-(4-hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine Terazosin Related Compound C 1,4-bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride Terbinafine HCl Terbinafine Related Compound A N-methyl-C-(naphthalen-1-yl)methanamine hydrochloride Terbinafine Related Compound B (2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1amine hydrochloride
150 mg 15 mg
USP1642857 New USP1642879 USP1642904 USP1643306 USP1643260 USP1643281 USP1643328 New USP1643339 USP1643340 USP1643361 USP1643383 USP1643394 USP1643419 USP1643420 USP1643437
10 mg 200 mg 200 mg 200 mg 200 mg 50 mg 2g 20 mg 1g 100 mg 200 mg 20 mg 150 mg 20 mg 15 mg
USP1643623 USP1643656 USP1643452 USP1643463 USP1643474 USP1643485 USP1643496 New USP1424608 New USP1643532
Edition 2012/2013
413

Code Product Unit
New USP1353215
Terbinafine Related Compound C (2E)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1amine hydrochloride Terbinafine Related Compound D (2E)-N,6,6-trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]-hept-2-en4-yn-1-amine hydrochloride Terbutaline Sulfate Terbutaline Related Compound A tert-butylamino-3,5-dihydroxyacetophenone sulfate Terconazole Terfenadine Terfenadine Related Compound A 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butanone Terfenadine Related Compound B Terfenadine-N-oxide Terpin Hydrate Testolactone Controlled Substance CIII Testosterone Controlled Substance CIII Testosterone Cypionate Controlled Substance CIII Testosterone Enanthate Controlled Substance CIII Testosterone Propionate Controlled Substance CIII Tetracaine HCl Tetracycline HCl Delta-9-Tetrahydrocannabinol Controlled Substance Exo-tetrahydrocannabinol Controlled Substance Tetrahydrozoline HCl Thalidomide L-Theanine Theophylline (CRM) Theophylline Melting Point Standard (Approximately 271C) Thiabendazole Thiamine HCl (Vitamin B1 HCl) Thiethylperazine Malate Thiethylperazine Maleate Thimerosal Thioguanine Thiopental Controlled Substance CIII Thioridazine Thioridazine HCl Thiostrepton Thiotepa Thiothixene (E)-Thiothixene Thonzonium Bromide L-Threonine Thymol Tiagabine Hydrochloride Racemic Tiagabine Hydrochloride Mixture (S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, HCl Tiagabine Related Compound A (R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, HCl Tiamulin Tiamulin Fumarate
25 mg
New USP1437701
25 mg
USP1643500 USP1643510 USP1643703 USP1643805 USP1643907 USP1643929 USP1644003 USP1645006 USP1646009 USP1647001 USP1648004 USP1649007 USP1650006 USP1651009 USP1651621 USP1090014 USP1652001 USP1652500 USP1652704 USP1653004 USP1653117 USP1655000 USP1656002 USP1657005 USP1658008 USP1659000 USP1660000 USP1661002 USP1662504 USP1663008 USP1663700 USP1664000 USP1665003 USP1666006 USP1667100 USP1667202 USP1667213 USP1667280 USP1667235 USP1667224 USP1667355 USP1667290
125 mg 50 mg 200 mg 200 mg 100 mg 50 mg 750 mg 125 mg 125 mg 200 mg 200 mg 200 mg 200 mg 200 mg 1 mL 1 mL 200 mg 200 mg 200 mg 200 mg 500 mg 100 mg 500 mg 200 mg 200 mg 500 mg 200 mg 250 mg 200 mg 200 mg 200 mg 500 mg 250 mg 100 mg 200 mg 200 mg 500 mg 300 mg 25 mg 15 mg 100 mg 250 mg
414
Edition 2012/2013

Code Product Unit
USP1667337 USP1667304 USP1667144 USP1667155 USP1667166 USP1667359 USP1667370 USP1667406 USP1667520 USP1667530 USP1667541 USP1667439 USP1667450 USP1667461 USP1667472 USP1667585 USP1667905 USP1667916 USP1667924 USP1667938 USP1667508 USP1667552 USP1667600 USP1667701 USP1667803 USP1668001 USP1669004 USP1670003 USP1670207 USP1670218 USP1670229 USP1670502 USP1671006 USP1672010 USP1672020 USP1672100 USP1672206 USP1672210 USP1672304 USP1672315
Tiamulin Related Compound A Tosyl pleuromutilin Ticarcillin Monosodium Monohydrate Ticlopidine HCl Ticlopidine Related Compound A 4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine Ticlopidine Related Compound B 5-(2-chlorobenzyl)4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine Tiletamine HCl Tilmicosin Timolol Maleate Tinidazole Tinidazole Related Compound A 2-methyl-5-nitroimidazole Tinidazole Related Compound B (1-(2-ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole) Tioconazole Tioconazole Related Compound A 1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole HCl Tioconazole Related Compound B 1-[2,4-Dichloro-beta-[(2,5-dichloro-3-thenyl)oxy]phenethyl]imidazole HCl Tioconazole Related Compound C 1-[2,4-Dichloro-beta-[(5-bromo-2-chloro-3-thenyl)-oxy]-phenethyl]imidazole HCl Titanium Dioxide (AS) Tizanidine Hydrochloride Tizanidine Related Compound A 4-amino-5-chloro-2,1,3-benzothiadiazole Tizanidine Related Compound B N-acetyltizanidine Tizanidine Related Compound C 1-acetylimidazolidine-2-thione Tobramycin Tocainide HCl Alpha Tocopherol (Vitamin E Alcohol) Alpha Tocopheryl Acetate (Vitamin E Acetate) Alpha Tocopheryl Acid Succinate (Vitamin E Succinate) Tolazamide Tolazoline HCl Tolbutamide Tolcapone Tolcapone Related Compound A 4'-methyl-3,4-dihydroxybenzophenone Tolcapone Related Compound B 4-hydroxy-3-methoxy-4'-methyl-5-nitrobenzophenone Tolmetin Sodium Tolnaftate o-Toluenesulfonamide p-Toluenesulfonamide Tomato Extract Containing Lycopene Topiramate Topiramate Related Compound A 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose Torsemide Torsemide Related Compound A 4-[(3-methylphenyl)amino]-3-pyridinesulfonamide
50 mg 350 mg 150 mg 20 mg 20 mg 200 mg 250 mg 200 mg 200 mg 100 mg 20 mg 200 mg 25 mg 25 mg 25 mg 1g 200 mg 50 mg 50 mg 50 mg 350 mg 125 mg 250 mg 250 mg 250 mg 200 mg 300 mg 200 mg 200 mg 25 mg 25 mg 500 mg 200 mg 200 mg 200 mg 1g 150 mg 25 mg 200 mg 75 mg
Edition 2012/2013
415

Code Product Unit
USP1672326 USP1672337 New USP1672359 USP1672600 USP1672610 USP1672621 USP1672687 USP1672701
Torsemide Related Compound B N-[(n-butylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide Torsemide Related Compound C N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide Torsemide Related Compound E 4-m-tolyl-2H-pyrido[4,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide Tramadol HCl Tramadol Related Compound A (+/-)-trans-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol hydrochloride Tramadol Related Compound B 2-(dimethylaminomethyl)-1-cyclohexanone hydrochloride Trandolapril Trandolapril Related Compound C (2S,3aR,7aS)-1-[N-[(S)-1-Carboxy-3-cyclohexylpropyl]-L-alanyl]hexahydro-2indolinecarboxylic acid 1-ethyl ester HCl Trandolapril Related Compound D (S)-ethyl 2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol2(1H)-yl]-4-phenylbutanoate Tranexamic Acid Tranexamic Acid Related Compound C (RS)-4-(aminomethyl)cyclohex-1-enecarboxylic acid Transplatin Tranylcypromine Sulfate Tranylcypromine Related Compound A (+/-)-cis-2-phenylcyclopropanamine HCl; cis-tranylcypromine HCl Tranylcypromine Related Compound B trans-3-phenylallylamine hydrochloride; cinnamylamine hydrochloride Travoprost Travoprost Related Compound A (5Z,13E)-(9S,11R,15R)-9,11,15-trihydroxy-16-(m-trifluoromethylphenoxy)-17,18,19,20tetranor-5,13-prostadienoic acid Trazodone HCl Trehalose Trenbolone Controlled Substance CIII Trenbolone Acetate Controlled Substance CIII Trenbolone Acetate System Suitability Mixture Controlled Substance CIII Tretinoin Triacetin Triamcinolone Triamcinolone Acetonide Triamcinolone Diacetate Triamcinolone Hexacetonide Triamterene Triamterene Related Compound A 2,4,6-triamino-5-nitrosopyrimidine Triamterene Related Compound B 2,7-diamino-4-hydroxy-6-phenylpteridine Triamterene Related Compound C 2,4,diamino-7-hydroxy-6-phenylpteridine Triazolam Controlled Substance CIV Tributyl Citrate Tributyl Phosphine Oxide Trichlorfon Trichlormethiazide Triclosan Triclosan Related Compounds Mixture A
USP1672712
25 mg
200 mg 15 mg 25 mg 125 mg 40 mg 40 mg 3 mL 1.5 mL
200 mg 400 mg 50 mg 200 mg 30 mg 5x30 mg 1g 250 mg 500 mg 350 mg 200 mg 200 mg 50 mg 50 mg 50 mg 200 mg 500 mg 25 mg 200 mg 200 mg 200 mg 3x1.2 mL
416
Edition 2012/2013

Code Product Unit
USP1683005 USP1683504 USP1683559 USP1683606 USP1685000 USP1685500 USP1686003 USP1686309 USP1686310 USP1687006 USP1689001 USP1690000 USP1692006 USP1692505 USP1692516 USP1692527 USP1692709 USP1692710 USP1693009 USP1695004 USP1696007 USP1696109 USP1696200 USP1696153 USP1696958 USP1697000 USP1698002 USP1699005 USP1699300 USP1699311 USP1699322 USP1699333 USP1700002 USP1700501 USP1700512 USP1700523 USP1702008 USP1703805 USP1703850 USP1704003 USP1705006 USP1705301 USP1705323
Tridihexethyl Chloride Trientine HCl Triethylamine N,N-diethylethanamine Triethyl Citrate Trifluoperazine HCl 2-[N-(2,2,2-Trifluoro-ethyl)amino-5]-chlorobenzophenone Triflupromazine HCI Trifluridine Trifluridine Related Compound A 5-Carboxy-2'-deoxyuridine Trihexyphenidyl HCl Trimeprazine Tartrate Trimethadione Trimethobenzamide HCl Trimethoprim Trimethoprim Related Compound A 4-amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol (AS) Trimethoprim Related Compound B (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone (AS) Trimipramine Maleate Trimipramine Related Compound A Dehydro trimipramine Trioxsalen Tripelennamine HCl Triprolidine HCl Triprolidine HCl Z-Isomer Trisalicylic Acid Tritricosanoin Trolamine Troleandomycin Tromethamine Tropicamide Trospium Chloride Trospium Chloride Related Compound A Benzillic Acid Trospium Chloride Related Compound B (1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl-hydroxydiphenylacetate Trospium Chloride Related Compound C Azoniaspironortropanol chloride Trypsin Crystallized L-Tryptophan Tryptophan Related Compound A 1,1'-ethylidene-bis-(L-tryptophan) Tryptophan Related Compound B N-Acetyl-L-Tryptophan Tubocurarine Chloride Tylosin Tylosin Tartrate Tyloxapol L-Tyrosine Ubidecarenone Ubidecarenone Related Compound A Coenzyme Q 9
200 mg 200 mg 4x2 mL 500 mg 200 mg 25 mg 200 mg 100 mg 20 mg 200 mg 200 mg 200 mg 200 mg 300 mg 25 mg 25 mg 100 mg 25 mg 200 mg 200 mg 300 mg 50 mg 100 mg 50 mg 3 mL 250 mg 125 mg 200 mg 100 mg 20 mg 20 mg 20 mg 300 mg 200 mg 15 mg 25 mg 250 mg 250 mg 100 mg 600 mg 500 mg 200 mg 15 mg
Edition 2012/2013
417

Code Product Unit
USP1705312 USP1705505 New USP1705753 USP1705800 USP1706698 USP1706701 New USP1707114 USP1707806 USP1707839 USP1707855 USP1707861 USP1707872
Ubidecarenone for System Suitability Undecylenic Acid Uracil Uracil Arabinoside Urea Urea C 13 Uridine Ursodiol Valacyclovir HCl Valacyclovir Related Compound C 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate HCl Valacyclovir Related Compound D 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate Valacyclovir Related Compound E 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy]carbonyl]L-valinate Valacyclovir Related Compound F 2-hydroxyethyl valinate para-toluenesulfonate salt Valacyclovir Related Compound G N,N-dimethylpyridin-4-amine Valerenic Acid Valganciclovir HCl D-Valganciclovir 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride L-Valine Valproic Acid Valproic Acid Related Compound A Diallylacetic Acid Valproic Acid Related Compound B (2RS)-2-(1-methylethyl) pentanoic acid (AS) Valrubicin Valrubicin Resolution Mixture Valrubicin spiked with seven related substance Valsartan Valsartan Related Compound A (R)-N-Valeryl-N-([2'-(1-H-tetrazole)-5-yl)-biphenyl-4-yl]-methyl)-valine Valsartan Related Compound B: (S)-N-butyryl-N-{[2'-(1-H-tetrazole-5-yl)biphenyl-4-yl]-methyl}-valine Valsartan Related Compound C: (S)-N-Valeryl-N-([2'-(1-H-tetrazole)-5-yl)biphenyl-4-yl]-methyl)-valine benzyl ester Vancomycin HCl Vancomycin B with Monodechlorovancomycin Vanillin Vanillin Melting Point Standard (Approximately 82C) Vasicine Vasopressin 8-L-arginine vasopressin Vecuronium Bromide Vecuronium Bromide Related Compound A 3alpha, 17beta-diacetyl-oxy-2beta, 16beta-bispiperidinyl-5alpha-androstan Vecuronium Bromide Related Compound B Piperidinium,1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2(1-piperidinyl)androstan-16-yl]-1-methyl bromide Vecuronium Bromide Related Compound C [Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-dihydroxy-2(1-piperidinyl)androstan-16-yl]-1-methyl bromide]
25 mg 50 mg 15 mg 500 mg 10 mg
USP1708503 USP1708707 USP1708729 USP1708718 USP1708730 USP1708751 USP1708762 USP1708773 USP1708784 USP1708795 USP1709007 USP1709018 USP1710006 USP1711009 New USP1711031 USP1711100 USP1711155 USP1711166 USP1711177
200 mg 500 mg 0.25 mL 50 mg 100 mg 25 mg 350 mg 10 mg 10 mg 10 mg 4 vials 300 mg 200 mg 1g 20 mg 1.71 mg 50 mg 25 mg 15 mg
USP1711188
15 mg
418
Edition 2012/2013

Code Product Unit
USP1711224
Vecuronium Bromide Related Compound F Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2(1-piperidinyl)androstan-16-yl]-1-methyl bromide Venlafaxine HCl Venlafaxine Related Compound A 1-(1-(4-Methoxyphenyl)-2-(methylamino)ethyl)cyclohexanol hydrochloride Verapamil HCl Verapamil Related Compound A 3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)benzeneacetonitrile monoHCl Verapamil Related Compound B alpha-[2-[[2-(3,4-dimethoxyphenyl)-ethyl]methylamino]ethyl]-3,4-dimethoxyalpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride Verapamil Related Compound D 5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1methylethyl)pentanenitrile]hydrochloride Verapamil Related Compound E 3,4-dimethoxybenzaldehyde Verapamil Related Compound F 3,4-Dimethoxybenzyl alcohol Verteporfin Verteporfin Related Compound A (+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl23H,25H-benzo[b]prophine-9,13-dipropanoic Acid Vidarabine Vigabatrin Vigabatrin Related Compound A 5-vinylpyrrolidin-2-one Vigabatrin Related Compound B (E)-2-(2-aminoethyl)bu-2-enoic acid HCl Vigabatrin Related Compound E 2-(2-aminobut-3-enyl)malonic acid Vinblastine Sulfate Vincristine Sulfate Vincristine Sulfate (Assay) Vinorelbine Tartrate Vinorelbine Related Compound A 4-O-Deacetylvinorelbine Tartrate Vinpocetine Vinpocetine Related Compound A Ethyl(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate Vinpocetine Related Compound B Methyl(13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13bhexahydro-1H-indolo[3,2,1de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate Vinpocetine Related Compound C Ethyl(13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate Vinpocetine Related Compound D Ethyl(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13boctahydro-1H-indolo[3,2,1de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate Viomycin Sulfate Retinyl Acetate (Vitamin A) Vitamin D Assay System Suitability Vitexin Voriconazole Voriconazole Related Compound A (2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1(1H-1,2,4-triazol-1-yl)butan-2-ol
15 mg
USP1711268 USP1711279 USP1711202 USP1711304
100 mg 10 mg 200 mg 50 mg
USP1711406
50 mg
USP1711428
50 mg
USP1711439 USP1711440 USP1711461 USP1711472
50 mg 150 mg 200 mg 50 mg
USP1711508 New USP1712001 New USP1712012 New USP1712023 New USP1712045 USP1713004 USP1714007 USP1714018 USP1714506 USP1714528 USP1714608 USP1714619
USP1714620
30 mg
USP1714641
30 mg
USP1714652
30 mg
200 mg unit 1.5 g 25 mg 100 mg 10 mg
Edition 2012/2013
419

Code Product Unit
USP1718020 New USP1718039 New USP1718041 USP1718063 USP1719000 USP1719102 USP1719500 USP1719532 USP1720000 USP1720203 USP1720407 USP1720429 USP1720600 USP1721002 USP1722005 USP1724000 USP1724306 USP1724350 USP1724361
Voriconazole Related Compound B (2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Voriconazole Related Compound C 1(2,-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone Voriconazole Related Compound D (2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-,1,2,4-triazol-1-yl)butan-2-ol Voriconazole Related Compound F {(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1yl}methanesulphonic acid Warfarin Warfarin Related Compound A 3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one Withanolide A Withanoside IV Xanthanoic Acid Xanthone Xylazine Xylazine HCl Xylitol Xylometazoline HCl Xylose Yohimbine HCl Zalcitabine Zaleplon Controlled Substance CIV Zaleplon Related Compound A (E)-N-(3-[3-(dimethylamino)acryloyl]phenyl)-N-ethylacetamide Controlled Substance CIV Zaleplon Related Compund B N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamide Controlled Substance CIV Zalcitabine Related Compound A 2',3'-Didehydro-2',3'-dideoxycytidine Meso-Zeaxanthin Zidovudine Zidovudine Related Compound B 3'-chloro-3'-deoxythymidine Zidovudine Related Compound C thymine Zidovudine Related Compound D [1-(2-Deoxy-beta-D-ribofuranosyl)]thymine Zileuton Zileuton Related Compound A N-(1-Benzo[b]thien-2-ylethyl)urea Zileuton Related Compound B 2-(Benzo[b]thien-2-oyl)benzo[b]thiophene Zileuton Related Compound C 1-Benzo[b]thien-2-ylethanone Zinc Oxide (AS) Zinc Sulfate (AS) Ziprasidone HCl Ziprasidone Related Compound A 3-(Piperazin-1-yl)benzo[d]isothiazole monohydrochloride Ziprasidone Related Compound B 5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione Ziprasidone Related Compound C 5,5'-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6'-dichloro-3-hydroxy-3,3'biindoline-2,2'-dione
10 mg 10 mg 10 mg 50 mg 200 mg 50 mg 15 mg 15 mg 100 mg 100 mg 200 mg 200 mg 1g 250 mg 1g 200 mg 200 mg 200 mg 15 mg
USP1724372
15 mg
USP1724317 New USP1733119 USP1724500 USP1724521 USP1724532 USP1724543 USP1724656 USP1724667 USP1724678 USP1724689 USP1724747 USP1724769 USP1724408 USP1724419 USP1724420 USP1724441
50 mg 5x30mg 400 mg 25 mg 100 mg 50 mg 150 mg 50 mg 50 mg 50 mg 2g 1g 200 mg 10 mg 10 mg 10 mg
420
Edition 2012/2013

Code Product Unit
USP1724452
Ziprasidone Related Compound D 3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6chloroindolin-2-one Zolazepam HCl Zoledronic Acid Zoledronic Acid Related Compound A 2-(1H-Imidazol-1-yl)acetic acid Zolmitriptan Zolmitriptan R-Isomer (R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one Zolmitriptan Related Compound A (S)-4-({3-[2-(Methylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one Zolmitriptan Related Compound B (S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol Zolmitriptan Related Compound D (S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate Zolpidem Controlled Substance CIV Zolpidem Impurities Mixture Controlled Substance CIV Zolpidem Tartrate Controlled Substance CIV Zolpidem Related Compound A N,N-Dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl]acetamide Controlled Substance CIV Zonisamide Zonisamide Related Compound A 1,2-benzisoxazole-3-methanesulfonic acid sodium salt Zonisamide Related Compound C N'-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide Zopiclone R-Isomer Controlled Substance CIV (-)-(5R)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo{3,4-b]pyrazin-5-yl 4methylpiperazine-1-carboxylate
10 mg
USP1724805 USP1724827 USP1724838 USP1727009 USP1727018 USP1727020 USP1727031 USP1727053 USP1724893 USP1724951 USP1724907 USP1724918
USP1725003 USP1725014 USP1725036 USP1729118
200 mg 20 mg 20 mg 10 mg
Edition 2012/2013
421

US Pharmacopeia 35, monographs and general chapters

Code Product Unit
Oil- and water-soluble vitamins with minerals tablets Monograph

ATCC-7830 ATCC-8014 ATCC-8042 Lactobacillus delbrueckii ss. lactis (as L.Leichmannii) Lactobacillus plantarum 17-5 Pediococcus acidilactici amp. amp. amp.
Penicillamine Monograph
ATCC-9341 Kocuria rhizophila amp.
Penicillin G Procaine and novobiocin sodium intramammary infusion

ATCC-12692 Staphylococcus aureus ss.aureus amp.
Sargraostim Monograph
ATCC-CRL-2003 TF-1 Cells amp.
Tetracycline hydrochloride and novobiocin sodium tablets Monograph

ATCC-10536 ATCC-29737 Escherichia coli Staphylococcus aureus ss. aureus amp. amp.
Water-soluble vitamins capsules Monograph

ATCC-7830 ATCC-8014 ATCC-8042 Lactobacillus delbrueckii ss. lactis (as L.Leichmannii) Lactobacillus plantarum 17-5 Pediococcus acidilactici amp. amp. amp.
<51> Antimicrobial effectiveness testing

ATCC-16404 ATCC-10231 ATCC-8739 ATCC-9027 ATCC-6538 Aspergillus niger Candida albicans Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp.
<55> Biological indicator for dry-heat sterilization, paper carrier

ATCC-9372** Bacillus subtilis amp.
<55> Biological indicator for ethylene oxide sterilization, paper carrier

ATCC-9372** Bacillus subtilis amp.
<55> Biological indicator for steam sterilization, paper carrier

ATCC-7953** ATCC-12980 Bacillus stearothermophilus Bacillus stearothermophilus amp. amp.
<55> Biological indicator for steam sterilization, self contained

ATCC-7953** ATCC-12980 Bacillus stearothermophilus Bacillus stearothermophilus amp. amp.
422
Edition 2012/2013

Code Product Unit
<61> Microbiological examination of nonsterile products: Microbial enumberation tests

ATCC-16404 ATCC-6633 ATCC-10231 ATCC-9027 ATCC-6538 Aspergillus niger Bacillus subtilis Candida albicans Pseudomonas aeruginosa Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp.
<62> Microbiological examination of nonsterile products: Tests for specified microorganisms

ATCC-10231 ATCC-11437 ATCC-19404 ATCC-8739 ATCC-9027 ATCC-14028 ATCC-6538 Candida albicans Clostridium sporogenes Clostridium sporogenes Escherichia coli Pseudomonas aeruginosa Salmonella enterica subsp. enterica serovar Typhimurium Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp. amp. amp.
<63> Mycoplasma tests

ATCC-23206 ATCC-19989 ATCC-19610 ATCC-17981 ATCC-23714 ATCC-15531 ATCC-25204 ATCC-29747 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii Mycoplasma fermentans; PG18 G Mycoplasma gallisepticum Mycoplasma hyorhinis Switzer Mycoplasma orale Mycoplasma pneumoniae Mycoplasma synoviae Spiroplasma citri amp. amp. amp. amp. amp. amp. amp. each
<71> Sterility tests

ATCC-16404 ATCC-6633 ATCC-8482 ATCC-10231 ATCC-11437 ATCC-19404 ATCC-9341 ATCC-9027 ATCC-6538 Aspergillus niger Bacillus subtilis Bacteroides vulgatus Candida albicans Clostridium sporogenes Clostridium sporogenes Kocuria rhizophila Pseudomonas aeruginosa Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp. amp. amp. amp. amp.
<81> Antibiotics microbial assays

ATCC-6633 ATCC-4617 ATCC-10541 ATCC-10536 ATCC-10031 ATCC-9341 ATCC-10240 ATCC-607 ATCC-25619 ATCC-2601 ATCC-9763 ATCC-9144 ATCC-29737 Bacillus subtilis Bordetella bronchiseptica Enterococcus hirae (as Streptococcus faecalis) Escherichia coli Klebsiella pneumoniae ss. pneumoniae Kocuria rhizophila Micrococcus luteus Mycobacterium smegmatis Pseudomonas aeruginosa Saccharomyces cerevisiae Saccharomyces cerevisiae Staphylococcus aureus ss. aureus Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp. amp. amp. amp. amp. amp. amp. amp. amp.
Edition 2012/2013
423

Code Product Unit
ATCC-12228
Staphylococcus epidermidis
amp.
<87> Biological reactivity tests, in-vitro amp

ATCC-CCL-1 L-929 mammalian fibroblasts NCTC Clone 929 amp.
<90> Fetal bovine serum - Quality attributes and functionality tests

ATCC-CCL-153 ATCC-CCL-240 ATCC-CCL-64 ATCC-CCL-81 HFL1; Fetal Lung Fibroblast; Human (Homo sapiens) HL-60; Promyelocytic Leukemia; Human (Homo sapiens) Mv 1 Lu (NBL-7) Vero cells amp. amp. amp. amp.
<91> Calcium pantothenate assay

ATCC-8014 Lactobacillus plantarum 17-5 amp.
<92> Growth factors and cytokines used in cell therapy manufacturing

ATCC-CRL-2003 TF-1 Cells amp.
<115> Dexpanthenol assay

ATCC-8042 Pediococcus acidilactici amp.
<171> Vitamin B12 activity assay

ATCC-7830 Lactobacillus delbrueckii ss. lactis (as L.Leichmannii) amp.
<441> Niacin or niacinamide assay

ATCC-8014 Lactobacillus plantarum 17-5 amp.
<1046> Analytical methodologies

ATCC-VR-1448 ATCC-VR-1450 Hybrid Moloney Amphotropic murine leukemia virus Hybrid Moloney Amphotropic murine leukemia virus amp. amp.
<1047> Gene therapy products

ATCC-VR-1450 Hybrid Moloney Amphotropic murine leukemia virus amp.
<1072> Disinfectants and antiseptics

ATCC-16404 ATCC-19659 ATCC-2091 ATCC-10231 ATCC-11229 ATCC-15442 ATCC-11709 ATCC-6538 Aspergillus niger Bacillus subtilis Candida albicans Candida albicans Escherichia coli Pseudomonas aeruginosa Penicillium chrysogenum; Wis. 49-133 Staphylococcus aureus ss. aureus amp. amp. amp. amp. amp. amp. amp. amp.
<1211> Sterilzation and sterility assurance of compendial articles

ATCC-27142** ATCC-7953** ATCC-9372** ATCC-19146 ATCC-14756 Bacillus pumilus Bacillus stearothermophilus Bacillus subtilis Brevendimonas diminuta (as Pseudomonas diminuta) Serratia marcescens amp. amp. amp. amp. amp.
<2021> Microbial enumeration tests - Dietary supplements

ATCC-16404 ATCC-6633 ATCC-10231 ATCC-8739 ATCC-13311 ATCC-6538
** = Alternative strain
Aspergillus niger Bacillus subtilis Candida albicans Escherichia coli Salmonella choleraesuis ss. choleraesuis serotype typhimurium (as Salmonella typhimurium) Staphylococcus aureus ss. aureus
All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia directly to confirm the testing requirements and recommended organisms before ordering or undertaking the testing procedures as described in the Pharmacopoeia.
amp. amp. amp. amp. amp. amp.
424
Edition 2012/2013
Secondary Reference Standards traceable to USP, EP and BP

Background
The concept of secondary standards derived by direct comparison with pharmacopoeial reference standards is a proven one and recognised by all major regulation agencies and pharmacopoeias. Normally such secondary standards are established by the laboratory that uses them afterwards. To source them from a dedicated provider instead is a new concept and offers significant advantages. Efficiency: You can focus your resources on value producing activities, rather than the routine. Risk Mitigation: These standards are supplied by an independent 3rd party Reference Material Producer working according to acknowledged ISO standards. Economical savings: Attractively priced over pharmacopeial reference standards or in-house standards. Generous Quantities: Product contains 2-20x the amount offered by the Pharmacopeias, allowing multiple uses.
Certification
The Certificate of Analysis provided with the products in this catalogue section complies with the requirements of ISO Guide 31 and is traceable to the available United States, European, and British Pharmacopeial Reference Standard. Furthermore, every current Secondary Reference Standard from this catalogue section is re-certified after new pharmacopoeial lot or batch releases. Please contact your local LGC Standards office to obtain updated certificates for the materials purchased via us.
About RTC
The certified reference materials displayed in this catalogue section are manufactured by RTC, the Research Technology Corporation with headquarters in Laramie (WY) in the United States of America. We are proud to offer them conveniently to you in mainland Europe. RTC maintains the highest level of accreditation available in the industry like accreditation to ISO Guide 34 and ISO 17025.
Code
Product
Unit
RTC-PHR-1028 RTC-PHR-1072 RTC-PHR-1048 RTC-PHR-1005 RTC-PHR-1086 RTC-PHR-1053 RTC-PHR-1008 RTC-PHR-1003 RTC-PHR-1073 RTC-PHR-1088 RTC-PHR-1050 RTC-PHR-1019 RTC-PHR-1022 RTC-PHR-1009 RTC-PHR-1095 RTC-PHR-1067 RTC-PHR-1016 RTC-PHR-1075 RTC-PHR-1089 RTC-PHR-1044 RTC-PHR-1071 RTC-PHR-1038 RTC-PHR-1021 RTC-PHR-1058 RTC-PHR-1092 RTC-PHR-1070 RTC-PHR-1018 RTC-PHR-1000
Edition 2012/2013
1,4-Benzoquinone 2-Propanol 4-Hydroxybenzoic Acid Acetaminophen (Paracetamol) Acetanilide Melting Point Standard Albuterol Sulfate Ascorbic Acid Aspirin (Acetylsalicylic acid) Avobenzone Azithromycin Benzoic Acid Benzyl Alcohol Butylparaben (Butyl parahydroxybenzoate) Caffeine Caffeine Melting Point Standard Carbamazepine Chlorpheniramine Maleate Cimetidine Cimetidine Hydrochloride Ciprofloxacin Hydrochloride Citric Acid Clarithromycin Clindamycin Phosphate Clotrimazole Cyclosporine Dehydrated Alcohol Dectromethorphan Hydrobromide Dextrose (D-Glucose)
1g 3x1.2 mL 1g 1g 1g 1g 2g 1g 1g 1g 1g 1g 1g 1g 1g 1g 500 mg 1g 1g 1g 1g 500 mg 1g 1g 500 mg 5x1.2 mL 500 mg 1g

427

Code Product Unit
RTC-PHR-1045 RTC-PHR-1015 RTC-PHR-1090 RTC-PHR-1068 RTC-PHR-1039 RTC-PHR-1046 RTC-PHR-1011 RTC-PHR-1055 RTC-PHR-1035 RTC-PHR-1002 RTC-PHR-1057 RTC-PHR-1049 RTC-PHR-1020 RTC-PHR-1027 RTC-PHR-1085 RTC-PHR-1032 RTC-PHR-1014 RTC-PHR-1004 RTC-PHR-1025 RTC-PHR-1024 RTC-PHR-1007 RTC-PHR-1060 RTC-PHR-1084 RTC-PHR-1012 RTC-PHR-1076 RTC-PHR-1052 RTC-PHR-1040 RTC-PHR-1033 RTC-PHR-1080 RTC-PHR-1081 RTC-PHR-1083 RTC-PHR-1059 RTC-PHR-1074 RTC-PHR-1094 RTC-PHR-1017 RTC-PHR-1078 RTC-PHR-1043 RTC-PHR-1042 RTC-PHR-1051 RTC-PHR-1010 RTC-PHR-1036 RTC-PHR-1026 RTC-PHR-1064 RTC-PHR-1065 RTC-PHR-1066 RTC-PHR-1054 RTC-PHR-1013 RTC-PHR-1113 RTC-PHR-1006 RTC-PHR-1001 RTC-PHR-1093
428
Diethylene Glycol Diphenhydramine Hydrochloride Dopamine Hydrochloride Edetate Disodium Erythromycin Ethylene Glycol Ethylparaben (Ethyl parahydroxybenzoate) Famotidine Folic Acid Fructose Furosemide Gabapentin Glycerin (Glycerol) Guaifenesin Homosalate Hydrochlorothiazide Hydrocortisone Ibuprofen Lactose (anhydrous) Lactose monohydrate Mannitol Mesalamine Metformin Hydrochloride Methylparaben (Methyl parahydroxybenzoate) Metoprolol Tartrate Metronidazole Naproxen Niacinamide (Nicotinamide) Octinoxate Octisalate Octocrylene Omeprazole Oxybenzone Phenacetin Melting Point Standard Phenylephrine Hydrochloride Phytonadione Prednisolone Prednisone Propylene Glycol Propylparaben (Propyl parahydroxybenzoate) Pyridoxine Hydrochloride Ranitidine Hydrochloride Residual Solvents Mixture - Class IIA Residual Solvents Mixture - Class IIB Residual Solvents Mixture - Class IIC Riboflavin Salicylic Acid Sodium L-Lactate Sorbitol Sucrose Sulfanilamide Melting Point Standard
1g 1g 1g 1g 500 mg 1g 1g 1g 1g 1g 1g 1g 5g 1g 1g 1g 500 mg 1g 1g 1g 1g 1g 500 mg 1g 1g 1g 500 mg 1g 1g 1g 1g 1g 1g 1g 500 mg 1g 500 mg 1g 1.5 g 1g 500 mg 500 mg 3x1.2 mL 3x1.2 mL 3x1.2 mL 1g 1g 1g 1g 1g 1g
Edition 2012/2013

Code Product Unit
RTC-PHR-1087 RTC-PHR-1041 RTC-PHR-1023 RTC-PHR-1037 RTC-PHR-1056 RTC-PHR-1061 RTC-PHR-1091 RTC-PHR-1031 RTC-PHR-1030 RTC-PHR-1029 RTC-PHR-1096 RTC-PHR-1097 RTC-PHR-1098 RTC-PHR-1099 RTC-PHR-1100 RTC-PHR-1105
Sulfapyridine Melting Point Standard Tetracycline Hydrochloride Theophylline Thiamine Hydrochloride Trimethoprim Valproic Acid Vanillin Melting Point Standard alpha-Tocopherol alpha-Tocopheryl Acetate alpha-Tocopheryl Acid Succinate L-Lysine Acetate L-Tyrosine N-Acetyl-L-Cysteine L-Isoleucine L-Phenylalanine L-Leucine
1g 500 mg 1g 1g 1g 1g 1g 500 mg 500 mg 500 mg 1g 1g 1g 1g 1g 1g
Edition 2012/2013
429
We constantly add new products to our range, so please contact us to find out about our products and services and to make sure you are automatically kept up to date by subscribing to our free newsletter. Please send an e-mail to pharma-news@lgcstandards.com
430
Edition 2012/2013
Institute of Dyes and Organic Products
Institute of Dyes and Organic Products

The use of colouring agents in pharmaceutical preparations and dose forms is widespread. In most cases food colouring materials are used. The following standards of dyes, used in the pharmaceutical and food industry, are listed with common description, E code and colour index number (C.I.) for an easy assignment. The IBPO is accredited by the Polish Centre for Testing and Certification according to the standard PN-EN 45001 and ISO/IEC Guide 25:1990. Each colour reference standard is supplied with a detailed certificate of analysis, which includes dye content value determined by spectrophotometry and values of impurities.
Black
Code Product Unit
IBPO010
Brilliant Black PN (E 151)
1g
Blue
IBPO015 IBPO002 IBPO012 Brilliant Blue FCF (E 133) Indigotine (E 132) Patent Blue V (E 131) 1g 1g 1g
Brown
IBPO017 Brown HT(E 155) 1g
Green
IBPO016 Brilliant Green BS (E 142) 1g
Red
IBPO014 IBPO005 IBPO003 IBPO011 IBPO004 IBPO013 Allura Red AC (E 129) Amaranth (E 123) Azorubin (E 122) Erythrosine (E 127) Ponceau 4R (E 124) Red 2 G (E 128) 1g 1g 1g 1g 1g 1g
Yellow
IBPO007 IBPO009 IBPO008 Quinoline Yellow (E 104) Sunset Yellow FCF (E 110) Tartrazine (E 102) 1g 1g 1g
Edition 2012/2013
433

The revised EP general method 2.2.6 replaces CRS reference liquids with certified reference materials available from suppliers of chemical reagents or materials certified for metrology. 11 liquid CRMs, certified by the Physical Chemistry Division of the Central Office of Measures (GUM), Warsaw in Poland, cover the wide range of refractive index from 1,333 (water) to 1,657 (1-bromonaphthalene). These CRMs are intended for calibration and checking refractive index scales of laboratory refractometers of an uncertainty expected not less than 0,00005. The n values we determined on a Pulfrich refractometer, previously calibrated with solid class 1 CRMs, for which values were established using goniometric procedures. All CRMs are supplied with a certificate. Certified values to 5 significant figures for the refractive index at = 589.3 nm t = 20C and associated uncertainties are given. Reference liquids are packed in glass ampoules or plastic drop-bottles.
Code
Product
Unit
PRG 7.21 PRG 7.1 PRG 7.11 PRG 7.2 PRG 7.12 PRG 7.20 PRG 7.5 PRG 7.6 PRG 7.8
Water
Refractive index ................................. 1.333 at 20 C
10 mL 10 mL 10 mL 10 mL 10 mL 10 mL 10 mL 10 mL 10 mL
2,2,4-Trimethylpentane
Methylsilicone oil
Methylcyclohexane
Silicone oil DC 556

Paraffin oil
Toluene
Chlorobenzene
1-Bromonaphthalene
434
Edition 2012/2013
Publications and subscriptions

Code Product Unit
Printed versions USP

USP2350001 USP2357001 USP3934012 USP3372012 USP2FC0801 2012 USP35-NF30 Print Subscription (2012 book + Supplements 1 & 2) 2012 USP35-NF30 Print Subscription [Spanish Print Subscription] (2012 book + Supplements 1 & 2) 2012 USP Dictionary 2012 USP Dietary Supplements Compendium (Two Volume Set) USP Food Chemicals Codex 8th Editidion unit unit unit unit unit
Electronic versions USP

USP2100000 USP2350009 USP2PF0021 USP-NF Online, 365 days access 2012 USP35-NF30 USB Flash Drive Single User Subscription Pharmacopoiea Forum Online 1-Year Subscription per user unit per user
Printed versions EP
EPPUB200000 EPPUB200001 EPPUB200002 EPPUB200003 EP 2012 Book Subscription 7th Edition English (7.3-7.5) EP 2012 Book Subscription 7th Edition French (7.3-7.5) EP 2013 Book Subscription 7th Edition English (7.6-7.8) EP 2013 Book Subscription 7th Edition French (7.6-7.8) unit unit unit unit
Electronic versions EP
EPPUB200004 EPPUB200005 EPPUB200006 EPPUB200007 EP 2012 USB STICK Subscription 7th Edition (volumes 7.3 - 7.5) - Bilingual EP 2013 USB STICK Subscription 7th Edition (volumes 7.6 - 7.5) - Bilingual EP 2012 Online Subscription 7th Edition (7.3-7.5) - Bilingual EP 2013 Online Subscription 7th Edition (7.6-7.8) - Bilingual unit unit per user per user
BP 2012 BP 2013 British Pharmacopoeia 2012 (2012 book, (6 volumes) single user CD-ROM, Online) British Pharmacopoeia 2013 (2013 book, (6 volumes) single user CD-ROM, Online) unit unit
Printed versions Chinese Pharmacopoeia

USP3024463 2010 Chinese Pharmacopoeia English Edition 3-Volume Set unit
Edition 2012/2013
437
We constantly add new products to our range, so please contact us to find out about our products and services and to make sure you are automatically kept up to date by subscribing to our free newsletter. Please send an e-mail to pharma-news@lgcstandards.com
438
Edition 2012/2013
Solvents Products
SO-3230-B010 SO-3260-B005 SO-3210-B010 SO-3240-B010 N,N-dimethylformamide (DMF) 1,3-dimethyl-2-imidazolidinone (DMI) Dimethylsulfoxide (DMSO) N,N-dimethylacetamide (DMA)
Introduction
Introduction
Picograde solvents for residue analysis
Picograde solvents form the heart of the LGC Standards solvent range. Each batch undergoes rigorous testing in order to meet the demanding requirements of organic trace analysis every time. Environmental analysts are now expected to detect trace levels of an increasingly wide range of organic environmental contaminants including pesticides, PAHs, PCBs, PCDDs/PCDFs etc. with the highest possible accuracy. Consequently even the lowest levels of impurity in the solvent can affect the precision of analytical results. Picograde solvents are specifically tailored to this application. Carefully selected raw materials are chemically pre-treated and then fractionated in glass in the absence of air. Distillation and filling are similarly carried out in air free conditions. The glass bottles are sterile and dust free and are rinsed with the appropriate solvent prior to filling. Caps used to seal the bottles are subjected to the same stringent cleaning processes. The specification of the solvent includes the determination of water content, residue on evaporation and a comprehensive gas chromatographic analysis. To confirm the absence of contaminants samples of the solvent are concentrated to varying degrees and then analysed by gas chromatography. Flame ionisation and electron capture detectors (ECD) are used for the quantification of the contaminants. The specification of the Picograde solvent guarantees that no signal due to contamination will be larger than the internal standard peak (10 pg/mL heptachlor-epoxide) in the retention time window from 1,4-dichlorobenzene to decachlorobiphenyl. The very high specification of the Picograde solvents allows them to be used for residue analysis of trace quantities of organic contaminants right down to ppb and ppt levels.
Optigrade High purity solvents for HPLC

High performance liquid chromatography is now an essential analytical tool especially in the areas of research and development, pharmaceutical quality control and analysis in the food and environmental sectors. This technique demands the highest quality solvents to allow reproducible separations. The basic requirements include a high UV-transmission factor, low particle levels, slight acidity and alkalinity coupled with low levels of water and other non-volatile components. In addition there must be consistency between batches. Solvents for isocratic analytical HPLC together with gradient grade quality solvents are included in the HPLC range. Gradient grade has the highest purity and is specially designed for use with gradient elution HPLC using reversed phase materials and UV or fluorescence detection. Quality assurance procedures allow LGC Standards to offer a consistently premium quality product. Each batch is checked to make sure that the solvent has the required high level of UV-transmission in the wavelength range 190-350 nm. Solvents for LC/MS The presence of alkali and alkaline earth metals in the mobile phase when using LC/MS can make the interpretation of the mass spectrum very difficult. LGC Standards offers solvents designed for this technique with extremely low levels of these metals, at 0.1 ppm and less. Solvents for Ultra HPLC (UHPLC) ULTRA HPLC (UHPLC) requires solvents of superior quality. This range of high purity Optigrade solvents from LGC Standards has been designed to allow high resolution and sensitivity. Such Ultra HPLC solvents combine the highest specification for: UV, low gradient shift, minimal peak impurities and lowest ionic background for MS detection. All Ultra HPLC solvents are micro filtered at 0.1 m, have a residue following evaporation of max 1 ppm and are packed under inert gas for improved shelf life. Also available are selected buffers for mobile phase preparation and several blends of water and acetonitrile with formic acid, acetic acid and trifluoroacetic acid are offered.
Edition 2012/2013
Promochem is a trademark of LGC Standards
441
Introduction Specialist solvents

Solvents for VOCs and aromatic hydrocarbons It has become increasingly necessary to be able to determine a range of organic compounds in environmental samples including volatile organic compounds (VOCs) and BTEX-aromatics. Various extraction techniques are used for the separation and concentration of organic trace constituents from the sample matrix and it is essential to use solvents with very low levels of contamination. LGC Standards can provide the solvents to meet these exacting requirements. Solvents for GC headspace techniques Analysis of volatile organic impurities using the GC headspace technique, has become an important quality control tool in pharmaceutical and food related industries. The International Conference on Harmonization of technical requirements for registration of pharmaceuticals for Human use (ICH) has issued recommendations concerning the safe levels of residual solvents in pharmaceutical compounds. These solvents are divided into 3 classes according to their toxicity. Limit values of residual solvents in pharmaceutical products are specified by the United States and European Pharmacopeia. The quality of the solvent used to dissolve the sample is of prime importance. It must be of the highest purity and show virtually no background signal with both polar and non polar GC capillary columns. These headspace solvents are high boiling point solvents, specifically developed, analysed and packed for the headspace analysis of volatile solvent impurities. Solvents for the analysis of nitrosamines When extracting trace levels of nitrosamines in samples it is important to use a solvent that is free of nitrosamine contamination. For this application LGC Standards has solvents with a maximum level of 0.1ppb of specific nitrosamines. Solvents for the tobacco industry
High purity acids

LGC Standards offers the most frequently used mineral acids for trace analysis: hydrochloric acid, nitric acid, hydrofluoric acid, sulfuric acid, perchloric acid and acetic acid. These are produced by sub-boiling distillation of very pure starting materials. This purification results in most metallic impurities reduced to (or bellow) ppb ranges. The acids are delivered in special bottles (long - term leached borosilicate glass or modified HDPE) which ensure minimum contamination of the acid from the material of the bottle. Important note: Element concentrations are at the point of bottling. Concentrations of some elements may increase due to the storage container.
Trademarks
Promochem, Optigrade, Cyclotainer, Picograde - LGC Standards GmbH FLORISIL - U.S.SILICA COMPANY
442
Edition 2012/2013
Reagents/Sorbents
Reagents/Sorbents
Code Product Unit
SC-4592-A005 SC-4568-A005 SC-4569-A005 SC-4181-B005 SC-4181-S010 SC-4182-B005 SC-4182-S010 SC-4182-S020 SC-9700-B005 SC-4183-B005 SC-4183-S010 SC-4183-S020 SC-9982-B010 SC-9950-B005 SC-9950-B025 SC-8024-B005 SC-8024-B025 SC-8024-S025 SC-1024-B005 SC-1024-B025
ICN-Alumina A - Super I (acid) (50 - 200 m) ICN Alumina B - Super I (basic) (50 - 200 m) ICN-Alumina B - Super I (50 - 200 m) for dioxin analysis Florisil (Standard), 60 - 100 mesh (150 - 250 m) Florisil (Standard), 60 - 100 mesh (150 - 250 m) Florisil PR for residue analysis, 60 - 100 mesh (150 - 250 m) Florisil PR for residue analysis, 60 - 100 mesh (150 - 250 m) Florisil PR for residue analysis, 60 - 100 mesh (150 - 250 m) Florisil (Standard), 60 - 100 mesh (suitable for ISO 9377-2/H53) Florisil (Standard), 100-200 mesh Florisil (Standard), 100-200 mesh Florisil (Standard), 100-200 mesh Silica gel 60 (63 - 200 m) Sodium sulfate anhydrous, for analysis (ACS), powder Sodium sulfate anhydrous, for analysis (ACS), powder Sodium sulfate anhydrous, for analysis, in granular form Sodium sulfate anhydrous, for analysis, in granular form Sodium sulfate anhydrous, for analysis, in granular form Sodium sulfate Picograde anhydrous, for residue analysis (ACS), in granular form Sodium sulfate Picograde anhydrous, for residue analysis (ACS), in granular form

500 g 500 g 500 g 500 g 10 kg 500 g 10 kg 20 kg 500 g 500 g 10 kg 20 kg 1 kg 500 g 2.5 kg 500 g 2.5 kg 25 kg 500 g 2.5 kg
Ion pair reagents

Code Product Unit
SC-5330-F025 SC-5330-F100 SC-5650-F025 SC-5650-F100 SC-5430-F025 SC-5430-F100 SC-5230-F025 SC-5230-F100 SC-5550-F025 SC-5550-F100 SC-5150-F025 SC-5150-F100 SC-5730-F025 SC-5730-F100
1-Butanesulfonic acid sodium salt for HPLC 1-Butanesulfonic acid sodium salt for HPLC 1-Decanesulfonic acid sodium salt for HPLC 1-Decanesulfonic acid sodium salt for HPLC 1-Dodecanesulfonic acid sodium salt for HPLC 1-Dodecanesulfonic acid sodium salt for HPLC 1-Heptanesulfonic acid sodium salt for HPLC 1-Heptanesulfonic acid sodium salt for HPLC 1-Hexanesulfonic acid sodium salt for HPLC 1-Hexanesulfonic acid sodium salt for HPLC 1-Octanesulphonic acid sodium salt for HPLC 1-Octanesulphonic acid sodium salt for HPLC 1-Pentanesulfonic acid sodium salt for HPLC 1-Pentanesulfonic acid sodium salt for HPLC
25 g 100 g 25 g 100 g 25 g 100 g 25 g 100 g 25 g 100 g 25 g 100 g 25 g 100 g
Edition 2012/2013
443
LC-MS additives
LC-MS additives
Code Product Unit
SO-9685-B001
Ammonium acetate UHPLC-MS Optigrade

CAS number 631-61-8
100 g
Assay (GC, on anhydrous basis) .............. 99 % min. Water (KF) .............................................. 0.1 % max. Filter test (1M in water) ...........................Passes test pH (1M in water)............................................. 6.0-7.5 Transmission at 260 nm (1M in water) .................................... 96 % at 280 nm (1M in water) .................................... 98 % Chloride (Cl) ....................................... 0.0005% max. Sulfate (SO4) ........................................... 001% max. Al ............................................................ 1 ppm max. Ca .......................................................... 5 ppm max. Fe ........................................................... 1 ppm max. K ............................................................. 5 ppm max. Mg .......................................................... 1 ppm max. Na .......................................................... 5 ppm max.
SO-9679-B001
Formic acid UHPLC-MS Optigrade

UN 1779 CAS number 64-18-6 Assay (T, on anhydrous basis)............................... 99 % min. Water (KF) .............................................................. 1 % max. Residue after evaporation .......................... 0.001 %w/w max. Color (APHA) ............................................................ 10 max. Gradient specification HPLC gradient at 254 nm - H. Peak HPLC gradient at 254 nm - Drift Transmission at 260 nm ............................................................... 15 % min. at 270 nm ................................................................ 83% min. at 280 nm ............................................................... 90 % min. at 300 nm ................................................................ 97% min. at 320 nm ................................................................ 98% min. 0.005 AU max. 0.02 AU max.
100 mL
SO-9668-B001
Trifluoroacetic acid UHPLC-MS Optigrade

UN 2699 CAS-Nr. 76-05-1 Assay (T) ................................................................... 99.95-100 % Water (KF) ...................................................................... 0-0.02 % Residue after evaporation ....................................... 0-0.001 %w/w Color (APHA) ......................................................................... 0-10 Gradient specification HPLC gradient 254 nm - H. Peak ............................... 0-0.002 AU HPLC gradient at 254 nm - Drift.................................. 0-0.010 AU Fluorescence at 254 nm (25%, as quinine) ...................... 0-1 ppb Fluorescence at 365 nm (25%, as quinine) ...................... 0-1 ppb Transmission at 260 nm ....................................................................... 10-100 % at 270 nm ....................................................................... 79-100 % at 280 nm ....................................................................... 93-100 % at 300 nm ...................................................................... 95-100 % at 320 nm ....................................................................... 96-100 %
100 mL
444
Edition 2012/2013
High purity solvents and acids

Acetic acid
Code Product Unit
HPA-0050-B010
Acetic acid for trace analysis min 99.5 % (glass bottle)

UN 2789 Assay .......................................................... > 99.5 % Colour (APHA) ................................................... < 10 Residue ........................................................ < 2 ppm Ag................................ < 0.1 ppb Al ................................. < 0.1 ppb As ................................ < 0.1 ppb Ba................................ < 0.1 ppb Be................................ < 0.1 ppb Bi ................................. < 0.1 ppb Ca ............................... < 0.5 ppb Cd ............................... < 0.1 ppb Co ............................... < 0.1 ppb Chloride ..................................................... < 0.4 ppm Phosphate ................................................. < 0.5 ppm Sulfate ....................................................... < 0.4 ppm Ni................................. < 0.1 ppb Pb................................ < 0.1 ppb Se................................ < 0.5 ppb Sn................................ < 0.1 ppb Sr ................................ < 0.1 ppb Th ................................ < 0.1 ppb Ti ................................. < 0.1 ppb V.................................. < 0.1 ppb Zn ................................ < 0.5 ppb
1L
Cr.................................< 0.1 ppb Cu ................................< 0.1 ppb Fe ................................< 0.5 ppb K ..................................< 0.1 ppb Li ..................................< 0.1 ppb Mg................................< 0.1 ppb Mn................................< 0.1 ppb Mo................................< 0.1 ppb Na ................................< 0.5 ppb
Hydrochloric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si.
Acetone
SO-2435-B010 SO-2435-B025 SO-2435-B040 Acetone HPLC Optigrade Acetone HPLC Optigrade Acetone HPLC Optigrade
UN 1090 CAS-Nr. 67-64-1 C3H6O Assay ...................................................... 99.5% min. Water ....................................................... 0.5% max. Non-volatile matter ............................. 0.0005% max. Filtered through 0.2 m 1 L = 0.792 kg (at 20C) Specification Transmission at 330 nm ................................................... 10% min. at 340 nm ................................................... 79% min. at 350 nm ................................................... 89% min. at 370 nm ................................................... 98% min.
1L 2.5 L 4L
SO-1142-B010 SO-1142-B025 SO-1142-B040
Acetone Picograde for residue analysis Acetone Picograde for residue analysis Acetone Picograde for residue analysis
UN 1090 CAS number 67-64-1 C3H6O Assay ...................................................... 99.0% min. Water ....................................................... 0.5% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.792 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L 4L
Acetonitrile
SO-9128-B010 SO-9128-B025 Acetonitrile HPLC Optigrade Gradient Grade Acetonitrile HPLC Optigrade Gradient Grade 1L 2.5 L
Edition 2012/2013
445

Code Product Unit
SO-9128-B040
Acetonitrile HPLC Optigrade Gradient Grade

UN 1648 CAS-Nr. 75-05-8 C2H3N Assay ..................................................... 99.8% min. Water ..................................................... 0.02% max. Non-volatile matter ............................. 0.0003% max. Gradientspecification (210 nm) .......... 3.0 mAU max. Fluorescence (as Quinine at 254 nm) ..... 1 ppb max. Filtered through 0.2 m 1 L = 0.783 kg (at 20C) Specification Transmission at 190 nm .................................................... 20% min at 193 nm .................................................... 62% min at 195 nm .................................................... 76% min at 210 nm .................................................... 89% min at 220 nm .................................................... 98% min at 230 nm .................................................... 99% min This solvent in glass bottles fulfills the specifications according to chapter 4 of the European Pharmacopoeia.
4L
SO-9154-B010 SO-9154-B025
Acetonitrile HPLC Optigrade Super Gradient Grade Acetonitrile HPLC Optigrade Super Gradient Grade
UN 1648 CAS-Nr. 75-05-8 C2H3N Assay ...................................................... 99.8% min. Water ..................................................... 0.02% max. Non-volatile matter ............................. 0.0003% max. Gradient specification (210 nm) ..........3.0 mAE max. Fluorescence (as Quinine at 254 nm) ..... 1 ppb max. Filtered through 0.2 m 1 L = 0.783 kg (at 20C) Specification Transmission at 190 nm at 191 nm at 193 nm at 195 nm at 200 nm at 215 nm at 230 nm 40% min 50% min 66% min 83% min 95% min 98% min 99% min
1L 2.5 L
This solvent in glass bottles fulfills the specifications according to chapter 4 of the European Pharmacopoeia.
SO-2856-B010 SO-2856-B025 SO-2856-B040
Acetonitrile HPLC Optigrade Acetonitrile HPLC Optigrade

UN 1648 CAS-Nr. 75-05-8 C2H3N Assay ...................................................... 99.8% min. Water ..................................................... 0.02% max. Non-volatile matter ............................. 0.0003% max. Filtered through 0.2 m 1 L = 0.783 kg (at 20C) Specification Transmission at 190 nm ................................................... 10% min. at 200 nm ................................................... 79% min. at 210 nm ................................................... 89% min. at 220 nm ................................................... 95% min. at 230 nm ................................................... 98% min. at 235 nm ................................................... 99% min.
1L 2.5 L 4L
Acetonitrile HPLC Optigrade
SO-9184-B010
Acetonitrile HPLC Optigrade (for analysis of PAHs and pesticides)
1L
446
Edition 2012/2013

Code Product Unit
SO-9184-B025
Acetonitrile HPLC Optigrade (for analysis of PAHs and pesticides)

UN 1648 CAS-Nr. 75-05-8 C2H3N Assay ....................................................... 99.8% min Water ..................................................... 0.02% max. Non-volatile matter ............................. 0.0003% max. Filtered through 0.2 m 1 L = 0,783 kg (at 20C) Specification Transmission at 195 nm ................................................... 80% min. at 200 nm ................................................... 96% min. at 215 nm ................................................... 98% min. at 230 nm ................................................... 99% min.
2.5 L
SO-9340-B010 SO-9340-B025
Acetonitrile fr LC-MS Optigrade Acetonitrile fr LC-MS Optigrade

UN 1648 CAS-Nr. 75-05-8 C2H3N Assay ....................................................... 99.8% min Water ..................................................... 0.02% max. Non-volatile matter ............................. 0.0003% max. Filtered through 0.2 m 1 L = 0.783 kg (at 20C) Specification Ca ........................................................0.1 ppm max. K...........................................................0.1 ppm max. Mg ........................................................0.1 ppm max. Na ........................................................0.1 ppm max. Transmission at 195 nm .................................................. 78 % min. at 200 nm .................................................. 95 % min. at 220 nm .................................................. 98 % min. at 240 nm .................................................. 99 % min.
1L 2.5 L
SO-9640-B010 SO-4680-B025
Acetonitrile UHPLC-MS Optigrade Acetonitrile 0.1 % formic acid UHPLC-MS Optigrade

UN 1648 CAS number 75-05-8 C2H3N Assay ..................................................................... 0.095-0.105 % Water (KF) ................................................................ 0.02 % max. Purity of ACN (GC) .................................................. 99.97 % min. Purity of formic acid .................................................... 99.0% min. Gradient specification HPLC gradient at 254 nm - H. Peak ......................0.002 AU max. Fluorescence at 254 nm (as quinine) ....................... 0.5 ppb max. Fluorescence at 365 nm (as quinine) ....................... 0.5 ppb max. Transmission at 210 nm ........................................................................ 5 % min. at 230 nm ...................................................................... 15 % min. at 254 nm ...................................................................... 90 % min. Al ............................................................................... 30 ppb max. Ca .............................................................................100 ppb min. Fe ................................................................................50 ppb min. K................................................................................100 ppb min. Mg ...............................................................................30 ppb min. Na .............................................................................100 ppb min. Microfiltered through 0.1 m/bottled under inert gas
1L 2.5 L
Edition 2012/2013
447

Code Product Unit
SO-4686-B025
Acetonitrile 0.1 % acetic acid UHPLC-MS Optigrade

UN 1648 CAS number 75-05-8 C2H3N Assay ..................................................................... 0.095-0.105 % Purity of ACN (GC) ................................................... 99.97% min. Purity of acetic acid (GC) ............................................ 99.9% min. Gradient specification HPLC gradient at 254 nm - H. Peak ..................... 0.002 AU max. HPLC gradient at 254 nm - Drift............................ 0.010 AU max. Fluorescence at 254 nm (as quinine)........................0.5 ppb max. Fluorescence at 365 nm (as quinine)........................0.5 ppb max. Transmission at 210 nm ...................................................................... 20 % min. at 230 nm ...................................................................... 50 % min. at 254 nm ...................................................................... 98 % min. Al ...............................................................................30 ppb max. Ca ............................................................................100 ppb max. Fe ...............................................................................50 ppb max. K ...............................................................................100 ppb max. Mg ..............................................................................30 ppb max. Na ............................................................................100 ppb max. Microfiltered through 0.1 m/bottled under inert gas
2.5 L
SO-4692-B025
Acetonitrile 0.1 % trifluoroacetic acid UHPLC-MS Optigrade

UN 1648 CAS number 75-05-8 C2H3N Assay ..................................................................... 0.095-0.105 % Water (KF) ................................................................ 0.02 % max. Purity of ACN (GC) .................................................. 99.97 % min. Purity of trifluoroacetic acid ...................................... 99.95 % min. Gradient specification HPLC gradient at 254 nm - H. Peak ................... 0.0002 AU max. Fluorescence at 254 nm (as quinine)........................0.5 ppb max. Fluorescence at 365 nm (as quinine)........................0.5 ppb max. Transmission at 210 nm ...................................................................... 20 % min. at 230 nm ...................................................................... 50 % min. at 254 nm ...................................................................... 90 % min. Al ...............................................................................30 ppb max. Ca ............................................................................100 ppb max. Fe ...............................................................................50 ppb max. K ...............................................................................100 ppb max. Mg ..............................................................................30 ppb max. Na ............................................................................100 ppb max. Microfiltered through 0.1 m/bottled under inert gas
2.5 L
SO-9186-B025
Acetonitrile DNA. max. 0.001% water

UN 1648 CAS-Nr. 75-05-8 C2H3N Assay ...................................................... 99.9% min. Water by Karl Fischer titration.............. 0.001% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.783 kg (at 20C)
2.5 L
SO-9180-B025
Acetonitrile DNA. max. 0.003% water

UN 1648 CAS-Nr. 75-05-8 C2H3N Assay ...................................................... 99.9% min. Water by Karl Fischer titration.............. 0.003% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.783 kg (at 20C)
2.5 L
SO-1151-B010 SO-1151-B025
448
Acetonitrile Picograde for residue analysis Acetonitrile Picograde for residue analysis
1L 2.5 L
Edition 2012/2013

Code Product Unit
SO-1151-B040
Acetonitrile Picograde for residue analysis

UN 1648 CAS-Nr. 75-05-8 C2H3N Assay ...................................................... 99.5% min. Water ..................................................... 0.02% max. Non-volatile matter ............................... 0.001% max. 1 L = 0.783 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
4L
Ammonia solution
HPA-0070-B010 Ammonia solution for trace analysis (glass bottle)
UN 2672 Assay ............................................................. > 21 % Colour (Hazen)................................................... < 10 Carbonate .................................................. < 10 ppm Al ................................. < 0.5 ppb As ................................ < 0.1 ppb Ba................................ < 0.1 ppb Be................................ < 0.1 ppb Bi ................................. < 0.1 ppb Cd ............................... < 0.1 ppb Ca ............................... < 0.5 ppb Cr ................................ < 0.1 ppb Co ............................... < 0.1 ppb Chloride ..................................................... < 500 ppb Phosphate ................................................... < 50 ppb Sulfate ....................................................... < 500 ppb Se................................ < 0.1 ppb Ag................................ < 0.1 ppb Na ............................... < 0.5 ppb Sr ................................ < 0.1 ppb Th ................................ < 0.1 ppb Sn................................ < 0.1 ppb Ti ................................. < 0.1 ppb V.................................. < 0.1 ppb Zn ................................ < 0.2 ppb
1L
Cu ................................< 0.5 ppb Fe ................................< 0.5 ppb Pb ................................< 0.1 ppb Li ..................................< 0.1 ppb Mg................................< 0.2 ppb Mn................................< 0.1 ppb Mo................................< 0.1 ppb Ni .................................< 0.1 ppb K ..................................< 0.2 ppb
Benzene
SO-1163-B010 SO-1163-B025 Benzene Picograde for residue analysis Benzene Picograde for residue analysis
UN 1114 CAS-Nr.71-43-2 C6H6 Assay ...................................................... 99.0% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.871 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L
Benzyl alcohol
SO-9505-B005 Benzyl alcohol for the analysis of highly volatile halogenated compounds and EOX
CAS-Nr. 100-51-6 C7H8O Assay ...................................................... 99.0% min. Water ....................................................... 0.1% max. Non-volatile matter ................................. 0.05% max. 1 L = 1.05 kg (at 20C) Specification Highly volatile halogenated hydrocarbons In the GC/ECD chromatogram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 g/L parathion-methyl. BTEX for FID In the GC-FID chromatogram the sum of the signals of BTEX-compounds is not greater than the signal, given by 10 g/L n-Decane. Coulometric determination of EOX gives a halogen content as chloride of less than 0.3 mg/L.
500 mL
Edition 2012/2013
449

Code Product Unit
Carbon disulfide
SO-9056-B005 Carbon disulfide free from aromatic hydrocarbons
UN 1131 CAS-Nr. 75-15-0 CS2 Assay ...................................................... 99.8% min. Water ..................................................... 0.03% max. Non-volatile matter ............................. 0.0005% max. 1 L = 1.261 kg (at 20C) Specification BTEX for FID In the GC-FID chromatogram the sum of the signals of BTEX-compounds is not greater than the signal, given by 10 g/L n-Decane.
500 mL
Chloroform
SO-4443-B010 SO-4443-B025 SO-4443-B040 Chloroform HPLC Optigrade (alcohol-free. stabilised with amylene) Chloroform HPLC Optigrade (alcohol-free. stabilised with amylene) Chloroform HPLC Optigrade (alcohol-free. stabilised with amylene)
UN 1888 CAS-Nr. 67-66-3 CHCl3 Assay ...................................................... 99.9% min. Water ..................................................... 0.03% max. Non-volatile matter ............................. 0.0002% max. Filtered through 0.2 m 1 L = 1.475 kg (at 20C) stabilized with 50 - 200 ppm Amylen Specification Transmission at 245 nm ................................................... 10% min. at 255 nm ................................................... 70% min. at 260 nm ................................................... 89% min. at 270 nm ................................................... 96% min. at 290 nm ................................................... 98% min.
1L 2.5 L 4L
SO-1174-B010 SO-1174-B025 SO-1174-B040
Chloroform Picograde for residue analysis (stabilised with 0.2-1.8 % ethanol) Chloroform Picograde for residue analysis (stabilised with 0.2-1.8 % ethanol) Chloroform Picograde for residue analysis (stabilised with 0.2-1.8 % ethanol)
UN 1888 CAS-Nr. 67-66-3 CHCl3 Assay ...................................................... 99.8% min. Acid and phosgene (as HCI) .............. 0.0005% max. Non-volatile matter ............................. 0.0005% max. 1 L = 1.475 kg (at 20C) stabilized with 0.2 - 1.8% Ethanol Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L 4L
450
Edition 2012/2013

Code Product Unit
Cyclohexane
SO-9052-B010 SO-9052-B025 Cyclohexane HPLC Optigrade Cyclohexane HPLC Optigrade
UN 1145 CAS-Nr. 110-82-7 C6H12 Assay ...................................................... 99,5% min. Water ..................................................... 0,02% max. Non-volatile matter ............................. 0,0003% max. Filtered through 0.2 m 1 L = 0,779 kg (at 20C) Specification Transmission at 210 nm ................................................... 20% min. at 220 nm ................................................... 48% min. at 230 nm ................................................... 75% min. at 245 nm ................................................... 94% min. at 260 nm ................................................... 99% min.
1L 2.5 L
SO-1179-B010 SO-1179-B025 SO-1179-B040
Cyclohexane Picograde for residue analysis Cyclohexane Picograde for residue analysis Cyclohexane Picograde for residue analysis
UN 1145 CAS-Nr. 110-82-7 C6H12 Assay ...................................................... 99.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.779 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L 4L
Cyclopentane
SO-6157-B010 Cyclopentane HPLC Optigrade
UN 1146 CAS-Nr. 287-92-3 C5H10 Assay ......................................................... 75% min. Water ................................................... 0.005% max. Non-volatile matter ............................. 0.0001% max. Filtered through 0.2 m 1 L = 0.751 kg (at 20C) Specification Transmission at 200 nm ................................................... 10% min. at 215 nm ................................................... 50% min. at 225 nm ................................................... 95% min. at 300 nm ................................................... 99% min.
1L
Edition 2012/2013
451

Code Product Unit
n-Decane
SO-1182-B010 n-Decane Picograde for residue analysis
UN 2247 CAS-Nr. 124-18-5 CH3(CH2)8CH3 Assay ...................................................... 97,0% min. Water ..................................................... 0,01% max. Non-volatile matter ............................. 0,0005% max. 1 L = 0,731 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L
Dichloromethane
SO-4879-B010 SO-4879-B025 SO-4879-B040 Dichloromethane HPLC Optigrade (stabilised with amylene) Dichloromethane HPLC Optigrade (stabilised with amylene) Dichloromethane HPLC Optigrade (stabilised with amylene)
UN 1593 CAS-Nr. 75-09-2 CH2Cl2 Assay ...................................................... 99.8% min. Water ..................................................... 0.02% max. Non-volatile matter ............................. 0.0003% max. Filtered through 0.2 m 1 L = 1.335 kg (at 20C) stabilized with 60 - 100 ppm Amylene Specification Transmission at 233 nm ................................................... 10% min. at 240 nm ................................................... 70% min. at 254 nm ................................................... 98% min. at 280 nm ................................................... 99% min.
1L 2.5 L 4L
SO-1185-B010 SO-1185-B025 SO-1185-B040
Dichloromethane Picograde for residue analysis (stabilised with amylene) Dichloromethane Picograde for residue analysis (stabilised with amylene) Dichloromethane Picograde for residue analysis (stabilised with amylene)
UN 1593 CAS-Nr. 75-09-2 CH2Cl2 Assay ...................................................... 99.5% min. Water ..................................................... 0.02% max. Non-volatile matter ............................. 0.0002% max. 1 L = 1.335 kg (at 20C) stabilized with 60 - 100 ppm amylene Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1.4-dichlorobenzene and decachlorobiphenyl. by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40). by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L 4L
452
Edition 2012/2013

Code Product Unit
SO-9800-B025
Dichloromethane nitrosamine-free
Specification N-Nitrosodimethylamine ............................ 0.1 ppb max. N-Nitrosodiethylamine................................ 0.1 ppb max. N-Nitrosodi-n-propylamine ......................... 0.1 ppb max. N-Nitrosodi-i-propylamine .......................... 0.1 ppb max. N-Nitrosodi-n-butylamine ........................... 0.1 ppb max. N-Nitrosopiperidine .................................... 0.1 ppb max. N-Nitrosopyrrolidine ................................... 0.1 ppb max. N-Nitrosomorpholine .................................. 0.1 ppb max.
2.5 L
Diethyl ether
SO-9012-B010 SO-9012-B025 Diethyl ether HPLC Optigrade (stabilised with ethanol) Diethyl ether HPLC Optigrade (stabilised with ethanol)
UN 1155 CAS-Nr. 60-29-7 C4H10O Assay ...................................................... 99.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0005% max. Peroxide ..................................................5 ppm max. Filtered through 0.2 m 1 L = 0.713 kg (at 20C) stabilized with 2% Ethanol Specification Transmission at 215 nm ................................................... 10% min. at 230 nm ................................................... 50% min. at 254 nm ................................................... 83% min. at 270 nm ................................................... 91% min. at 280 nm ................................................... 95% min. at 300 nm ................................................... 99% min.
1L 2.5 L
SO-2854-B010 SO-2854-B025
Diethyl ether HPLC Optigrade (not stabilised) Diethyl ether HPLC Optigrade (not stabilised)
UN 1155 CAS-Nr. 60-29-7 C4H10O Assay ...................................................... 99.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0005% max. Peroxide ..................................................5 ppm max. Filtered through 0.2 m 1 L = 0.713 kg (at 20C) not stabilized Specification Transmission at 215 nm ................................................... 10% min. at 254 nm ................................................... 83% min. at 280 nm ................................................... 95% min.
1L 2.5 L
SO-1187-B010
Diethyl ether Picograde for residue analysis (stabilised with 1.5-2.5 % ethanol)
1L
Edition 2012/2013
453

Code Product Unit
SO-1187-B025
Diethyl ether Picograde for residue analysis (stabilised with 1.5-2.5 % ethanol)
UN 1155 CAS-Nr. 60-29-7 C4H10O Assay ...................................................... 99.0% min. Water ........................................................ 0.1%max. Non-volatile matter ................................ 0.001%max. Peroxide ................................................. 5 ppm max. 1 L = 0.6502 kg (at 20C) stabilized with 1.5 - 2.5% Ethanol Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
2.5 L
N,N-Dimethylacetamide
SO-5407-B025 SO-5407-B040 N,N-Dimethylacetamide HPLC Optigrade N,N-Dimethylacetamide HPLC Optigrade
CAS-Nr. 127-19-5 C4H9NO Assay ...................................................... 99.0% min. Water ..................................................... 0.03% max. Non-volatile matter ............................. 0.0006% max. Filtered through 0.2 m 1 L = 0.937 kg (at 20C) Specification Transmission at 270 nm ................................................... 10% min. at 280 nm ................................................... 50% min. at 290 nm ................................................... 71% min. at 310 nm ................................................... 89% min. at 360 nm ................................................... 98% min.
2.5 L 4L
SO-3240-B010
N,N-Dimethylacetamide Headspace Grade

CAS number 127-19-5 C4H9NO Assay (GC, on anhydrous basis) ......... 99.99 % min. Acidity (as acetic acid) .......................... 0.05 % max. Water (KF) ............................................ 0.03 % max. UV cutoff wavelength ............................. 190-268 nm Transmission at 268 nm .................................................. 10 % min. at 275 nm .................................................. 55 % min. at 300 nm .................................................. 85 % min. at 350 nm .................................................. 98 % min. at 400 nm .................................................. 99 % min. Headspace test for O.V.I. ........................ passes test
1L
454
Edition 2012/2013

Code Product Unit
N,N-Dimethylformamide
SO-5356-B025 N,N-Dimethylformamide HPLC Optigrade
UN 2265 CAS-Nr. 68-12-2 C3H7NO Assay ...................................................... 99.7% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0006% max. Filtered through 0.2 m 1 L = 0.951 kg (at 20C) Specification Transmission at 270 nm ................................................... 10% min. at 275 nm ................................................... 50% min. at 295 nm ................................................... 79% min. at 310 nm ................................................... 89% min. at 340 nm ................................................... 98% min.
2.5 L
SO-1189-B010 SO-1189-B025
N,N-Dimethylformamide Picograde N,N-Dimethylformamide Picograde

UN 2265 CAS-Nr. 68-12-2 C3H7NO Assay ...................................................... 99.0% min. Water ....................................................... 0.2% max. Non-volatile matter ............................... 0.001% max. 1 L = 0.951 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L
SO-3230-B010
N,N-Dimethylformamide Headspace Grade

UN 2265 CAS number 68-12-2 C3H7NO Assay (GC, on anhydrous basis) ......... 99.99 % min. Refractive index (20 C) ......................... 1.430-1.440 Water (KF) ............................................ 0.03 % max. UV cutoff wavelength ............................. 190-268 nm Transmission at 270 nm .................................................. 30 % min. at 275 nm .................................................. 60 % min. at 300 nm .................................................. 90 % min. at 320 nm .................................................. 97 % min. Headspace test for O.V.I........................... passes test
1L
1,3-Dimethyl-2-imidazolidinone (N,N'-Dimethylethyleneurea)
SO-3260-B005 1,3-Dimethyl-2-imidazolidinone (DMI) Headspace Grade
Assay (GC, on anhydrous basis) ........... 99.5 % min. Refractive index (20 C) .......................... 1.470-1473 Water (KF) .............................................. 0.1 % max. UV cutoff wavelength ............................. 190-270 nm Transmission at 275 nm .................................................. 40 % min. at 300 nm .................................................. 85 % min. at 325 nm .................................................. 95 % min. at >350 nm ................................................ 98 % min. Headspace test for O.V.I......................... passes test
500 mL
Edition 2012/2013
455

Code Product Unit
Dimethylsulfoxide (DMSO)
SO-3210-B010 Dimethylsulfoxide Headspace Grade
CAS-Nr 67-68-5 Assay (GC, on anhydrous basis) ......... 99.99 % min. Refractive index (20 C) ......................... 1.477-1.480 Water (KF) ............................................ 0.04 % max. UV cutoff wavelength ............................. 190-265 nm Transmission at 268 nm .................................................. 30 % min. at 275 nm .................................................. 60 % min. at 300 nm .................................................. 85 % min. at 350 nm .................................................. 95 % min. at 400 nm .................................................. 98 % min. Headspace test for O.V.I. ........................ passes test
1L
1,4-Dioxane
SO-9002-B010 SO-9002-B025 1,4-Dioxane HPLC Optigrade (not stabilised) 1,4-Dioxane HPLC Optigrade (not stabilised)
UN 1165 CAS-Nr. 123-91-1 C4H8O2 Assay ...................................................... 99.5% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0002% max. Filtered through 0.2 m 1 L = 1.034 kg (at 20C) not stabilized Specification Transmission at 225 nm ................................................... 31% min. at 250 nm ................................................... 56% min. at 270 nm ................................................... 79% min. at 280 nm ................................................... 89% min. at 295 nm ................................................... 98% min.
1L 2.5 L
Ethanol
SO-9063-B010 SO-9063-B025 Ethanol HPLC Optigrade Ethanol HPLC Optigrade
UN 1170 CAS-Nr. 64-17-5 C2H5OH Assay ...................................................... 99.7% min. Water ....................................................... 0.1% max. Non-volatile matter ............................. 0.0004% max. Filtered through 0.2 m 1 L = 0.789 kg (at 20C) Specification Transmission at 210 nm ................................................... 20% min. at 240 nm ................................................... 79% min. at 260 nm ................................................... 98% min.
1L 2.5 L
456
Edition 2012/2013

Code Product Unit
2-Ethoxyethanol
SO-2925-B025 2-Ethoxyethanol HPLC Optigrade
UN 1171 CAS-Nr. 110-80-5 C4H10O2 Assay ...................................................... 99.5% min. Water ..................................................... 0.08% max. Non-volatile matter ............................. 0.0002% max. Filtered through 0.2 m 1 L = 0.932 kg (at 20C) Specification Transmission at 222 nm ................................................... 10% min. at 225 nm ................................................... 18% min. at 250 nm ................................................... 56% min. at 300 nm ................................................... 98% min.
2.5 L
Ethyl acetate
SO-3442-B010 SO-3442-B025 SO-3442-B040 Ethyl acetate HPLC Optigrade Ethyl acetate HPLC Optigrade Ethyl acetate HPLC Optigrade
UN 1173 CAS-Nr. 141-78-6 CH3COOC2H5 Assay ...................................................... 99.5% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0005% max. Filtered through 0.2 m 1 L = 0.897 kg (at 20C) Specification Transmission at 225 nm ................................................... 10% min. at 260 nm ................................................... 79% min. at 280 nm ................................................... 89% min. at 300 nm ................................................... 98% min.
1L 2.5 L 4L
SO-9345-B010 SO-9345-B025
Ethyl acetate for LC-MS Optigrade Ethyl acetate for LC-MS Optigrade
UN 1173 CAS-Nr. 141-78-6 CH3COOC2H5 Assay ...................................................... 99,5% min. Water ..................................................... 0,05% max. Non-volatile matter ............................. 0,0005% max. Filtered through 0.2 m 1 L = 0,897 kg (at 20C) Specification Ca ........................................................0,1 ppm max. K...........................................................0,1 ppm max. Mg ........................................................0,1 ppm max. Na ........................................................0,1 ppm max. Transmission at 260 nm .................................................. 70 % min. at 280 nm .................................................. 99 % min.
1L 2.5 L
SO-1191-B010 SO-1191-B025
Ethyl acetate Picograde for residue analysis Ethyl acetate Picograde for residue analysis
1L 2.5 L
Edition 2012/2013
457

Code Product Unit
SO-1191-B040
Ethyl acetate Picograde for residue analysis

UN 1173 CAS-Nr. 141-78-6 CH3COOC2H5 Assay ...................................................... 99.0% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.897 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
4L
n-Heptane
SO-5139-B010 SO-5139-B025 SO-5139-B040 n-Heptane HPLC Optigrade n-Heptane HPLC Optigrade n-Heptane HPLC Optigrade
UN 1206 CAS-Nr. 142-82-5 C7H16 Assay ...................................................... 95.0% min. Water ..................................................... 0.02% max. Non-volatile matter ............................. 0.0003% max. Filtered through 0.2 m 1 L = 0.685 kg (at 20C) Specification Transmission at 197 nm ................................................... 10% min. at 210 nm ................................................... 39% min. at 225 nm ................................................... 79% min. at 254 nm ................................................... 98% min.
1L 2.5 L 4L
SO-1210-B025
n-Heptane Picograde for residue analysis

UN 1206 CAS-Nr. 142-82-5 C7H16 Assay ...................................................... 97.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0002% max. 1 L = 0.682 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4 dichlorobenzene and decachlorobiphenyl, by a 500 fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500 fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
2.5 L
n-Hexane
SO-5167-B010 SO-5167-B025 n-Hexane HPLC Optigrade n-Hexane HPLC Optigrade
1L 2.5 L
458
Edition 2012/2013

Code Product Unit
SO-5167-B040
n-Hexane HPLC Optigrade

UN 1208 CAS-Nr. 110-54-3 C6H14 Assay (of C6-isomers) ............................. 99.8% min. Water ....................................................... 0.1% max. Non-volatile matter ............................. 0.0003% max. Filtered through 0.2 m 1 L = 0.659 kg (at 20C) Specification Transmission at 195 nm ................................................... 10% min. at 210 nm ................................................... 56% min. at 220 nm ................................................... 79% min. at 254 nm ................................................... 98% min. at 280 nm ................................................... 99% min. at 350 nm ................................................... 99% min.
4L
SO-1244-B010 SO-1244-B025 SO-1244-B040
n-Hexane Picograde for residue analysis n-Hexane Picograde for residue analysis n-Hexane Picograde for residue analysis
UN 1208 CAS-Nr. 110-54-3 C6H14 Assay (of C6-isomers) ............................. 97.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0002% max. PCBs (#28,52,77,81,101,105,114, ......... passes test 118,123,126,138,153,156,157,167, 169,180,189) 1 L = 0.659 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L 4L
SO-9500-B010 SO-9500-B025
n-Hexane for the analysis of highly volatile halogenated hydrocarbons and EOX n-Hexane for the analysis of highly volatile halogenated hydrocarbons and EOX
UN 1208 CAS-Nr. 110-54-3 C6H14 Assay (of C6-isomers) ............................. 95.0% min. Wasser/Water ........................................ 0.01% max. Non-volatile matter ............................. 0.0002% max. 1 L = 0.651 kg (at 20C) Specification Highly volatile halogenated hydrocarbons/EOX In the GC/ECD chromatorgram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 g/L parathion-methyl. Coulometric determination of EOX gives a halogen content as chloride of less than 0.3 mg/L.
1L 2.5 L
Edition 2012/2013
459

Code Product Unit
Iso-Hexane
SO-9043-B025 Iso-Hexane HPLC Optigrade
UN 1208 CAS-Nr. 107-83-5 C6H14 Assay of C6-isomers ................................ 95.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0002% max. 1 L = 0.653 kg (at 20C) Specification Transmission at 195nm .................................................... 10% min. at 210nm .................................................... 56% min. at 217nm .................................................... 63% min. at 220nm .................................................... 75% min. at 245nm .................................................... 95% min.
2.5 L
SO-1251-B025
Iso-Hexane Picograde for residue analysis

UN 1208 CAS-Nr. 107-83-5 C6H14 Gehalt/Assay (of C6-isomers) .................. 95.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0002% max. 1 L = 0.653 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
2.5 L
Hydrochloric acid
HPA-0010-B010 Hydrochloric acid for trace analysis min. 36 % (glass bottle)
UN 1789 Assay ............................................................. > 36 % Residue ........................................................ < 3 ppm Colour (APHA) ................................................... < 10 Bromide...................................................... < 50 ppm Ag ................................ < 0.1 ppb Al ................................. < 0.5 ppb As ................................ < 0.1 ppb B ..................................... < 1 ppb Ba ................................ < 0.1 ppb Be ................................ < 0.1 ppb Bi ................................. < 0.1 ppb Ca ............................... < 0.5 ppb Cd ............................... < 0.1 ppb Co ............................... < 0.1 ppb Cr ................................ < 0.1 ppb free chlorine............................................... < 0.5 ppm Phosphate ............................................... < 0.05 ppm Sulfite ........................................................ < 0.5 ppm Sulfate ....................................................... < 0.5 ppm Sb ................................ < 0.1 ppb Se ................................ < 0.1 ppb Sn ................................ < 0.1 ppb Sr ................................ < 0.1 ppb Th ................................ < 0.1 ppb Ti ................................. < 0.1 ppb U ................................. < 0.1 ppb V .................................. < 0.1 ppb Zn ................................ < 0.5 ppb Zr ................................. < 0.1 ppb
1L
Cu ............................... < 0.1 ppb Fe .................................. < 1 ppb Hg ............................... < 0.2 ppb K ................................. < 0.1 ppb Li ................................. < 0.1 ppb Mg ............................... < 0.5 ppb Mn ............................... < 0.1 ppb Mo ............................... < 0.1 ppb Na ............................... < 0.5 ppb Ni ................................ < 0.1 ppb Pb ............................... < 0.1 ppb
Hydrochloric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si.
460
Edition 2012/2013

Code Product Unit
Hydrofluoric acid
HPA-0030-B010 Hydrofluoric acid for trace analysis min. 48 % ( HDPE bottle)
UN 1790 Assay ............................................................. > 48 % Colour (HAZEN) ................................................. < 10 Chloride........................................................ < 1 ppm Ag................................... < 1 ppb Al .................................... < 1 ppb As ................................... < 1 ppb Ba................................... < 1 ppb Be................................... < 1 ppb Bi .................................... < 1 ppb Ca .................................. < 1 ppb Cd .................................. < 1 ppb Co .................................. < 1 ppb Cr ................................... < 1 ppb Phosphate ................................................. < 0.1 ppm Sulfate ....................................................... < 0.5 ppm Hexafluorosilicate ....................................... < 20 ppm Pb................................... < 1 ppb Se................................... < 1 ppb Si .................................... < 1 ppb Sn................................... < 1 ppb Sr ................................... < 1 ppb Ti .................................... < 1 ppb V..................................... < 1 ppb Zn ................................... < 1 ppb
1L
Cu ...................................< 1 ppb Fe ...................................< 1 ppb Hg ...................................< 1 ppb K .....................................< 1 ppb Li .....................................< 1 ppb Mg...................................< 1 ppb Mn...................................< 1 ppb Mo...................................< 1 ppb Na ...................................< 1 ppb Ni ....................................< 1 ppb
Hydrofluoric acid stored in polyethylene bottles will see a rise in: Al, Ca, Fe, Na and Zn.
Methanol
SO-9510-B010 Methanol Purge & Trap
UN 1230 CAS-Nr. 67-56-1 CH3OH Assay ...................................................... 99,9% min. Water ............................................................. < 0.1% Non-volatile matter ....................................... < 0,10% 2-Butanone (GC/MS; P&T) ......................... < 10 g/l Other volatile impurities ........................ passes tests 1 L = 0,792 kg (at 20C)
1L
SO-9260-B010 SO-9260-B025
Methanol HPLC Optigrade Gradient Grade Methanol HPLC Optigrade Gradient Grade
UN 1230 CAS-Nr. 67-56-1 CH3OH Assay ...................................................... 99.9% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0003% max. Gradientspecification (235 nm) ..........0.002 AU max. Gradientspecification (254 nm) ..........0.001 AU max. Fluorescence (as Quinine at 254 nm) ......1 ppb max. Filtered through 0.2 m 1 L = 0.792 kg (at 20C) Specification Transmission at 210 nm ................................................... 37% min. at 220 nm ................................................... 56% min. at 230 nm ................................................... 76% min. at 235 nm ................................................... 83% min. at 254 nm ................................................... 97% min. at 280 nm ................................................... 99% min. This solvent in glass bottles fulfills the specifications according to chapter 4 of the European Pharmacopoeia.
1L 2.5 L
SO-3041-B010 SO-3041-B025
Methanol HPLC Optigrade Methanol HPLC Optigrade
1L 2.5 L
Edition 2012/2013
461

Code Product Unit
SO-3041-B040
Methanol HPLC Optigrade

UN 1230 CAS-Nr. 67-56-1 CH3OH Assay ...................................................... 99.9% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0003% max. Filtered through 0.2 m 1 L = 0.792 kg (at 20C) Specification Transmission at 205 nm ................................................... 10% min. at 220 nm ................................................... 56% min. at 240 nm ................................................... 89% min. at 254 nm ................................................... 96% min. at 280 nm ................................................... 98% min. at 350 nm ................................................... 99% min. This solvent in glass bottles fulfills the specifications according to chapter 4 of the European Pharmacopoeia.
4L
SO-9658-B010 SO-9658-B025
Methanol UHPLC-MS Optigrade Methanol UHPLC-MS Optigrade

UN 1230 CAS number 67-56-1 CH3OH Assay (GC, on anhydrous basis) ............................. 99.98 % min. Water (KF) ................................................................. 0.03% max. Residue after evaporation ............................... 0.0001 %w/w max. Acidity (as acetic acid) ............................................ 0.002 % max. Alkalinity (as ammonia) ......................................... 0.0001 % max. Color (APHA) ......................................................................5 max. Gradient specification HPLC gradient at 220 nm - Drift.............................. 0.01 AU max. HPLC gradient at 235 nm - Drift............................ 0.005 AU max. HPLC gradient at 220 nm - H. Peak ..................... 0.004 AU max. HPLC gradient at 235 nm - H. Peak ..................... 0.002 AU max. Fluorescence at 254 nm (as quinine)........................0.5 ppb max. Fluorescence at 365 nm (as quinine)........................0.3 ppb max. 1 L = 0.783 kg (at 20C) Transmission at 210 nm ...................................................................... 40 % min. at 220 nm ...................................................................... 65 % min. at 230 nm ...................................................................... 80 % min. at 260 nm ...................................................................... 98 % min. Al ................................................................................20 ppb max. Ca ............................................................................100 ppb max. Fe ...............................................................................20 ppb max. K .................................................................................50 ppb max. Mg ..............................................................................20 ppb max. Na ............................................................................100 ppb max. Microfiltered through 0.1 m/bottled under inert gas
1L 2.5 L
SO-9356-B010 SO-9356-B025
Methanol for LC-MS Optigrade Methanol for LC-MS Optigrade

UN 1230 CAS number 67-56-1 CH3OH Assay ...................................................... 99.9% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0003% max. Filtered through 0.2 m 1 L = 0.792 kg (at 20C) Ca ....................................................... 0.1 ppm max. K .......................................................... 0.1 ppm max. Mg ....................................................... 0.1 ppm max. Na ....................................................... 0.1 ppm max. Transmission at 210 nm .................................................. 40 % min. at 220 nm .................................................. 60 % min. at 235 nm .................................................. 80 % min. at 260 nm .................................................. 98 % min.
1L 2.5 L
SO-1263-B010
Methanol Picograde for residue analysis
1L
462
Edition 2012/2013

Code Product Unit
SO-1263-B025 SO-1263-B040
Methanol Picograde for residue analysis Methanol Picograde for residue analysis
UN 1230 CAS-Nr. 67-56-1 CH3OH Assay ...................................................... 99.0% min. Water ....................................................... 0.1% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.792 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
2.5 L 4L
2-Methoxyethanol
SO-9509-B010 2-Methoxyethanol for the analysis of highly volatile halogenated hydrocarbons
UN 1188 CAS-Nr. 109-86-4 C3H8O2 Assay ...................................................... 99.7% min. Water ..................................................... 0.08% max. Non-volatile matter ............................. 0.0006% max. 1 L = 0.961 kg (at 20C) Highly volatile halogenated hydrocarbons In the GC/ECD chromatorgram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 g/L parathion-methyl. BTEX for FID In the GC-FID chromatogram the sum of the signals of BTEX-compounds is not greater than the signal, given by 10 g/L n-decane.
1L
Methyl-tert-butyl ether
SO-5398-B025 Methyl-tert-butylether HPLC Optigrade
UN 2398 CAS-Nr. 1634-04-4 C5H12O Assay ...................................................... 99.7% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0006% max. Filtered through 0.2 m 1 L = 0.742 kg (at 20C) Specification Transmission at 225 nm ................................................... 32% min. at 250 nm ................................................... 71% min. at 300 nm ................................................... 89% min.
2.5 L
SO-1265-B010 SO-1265-B025
Methyl-tert-butylether Picograde Methyl-tert-butylether Picograde

UN 2398 CAS-Nr. 1634-04-4 C5H12O Assay ...................................................... 99.8% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.742 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L
Edition 2012/2013
463

Code Product Unit
Nitric acid
HPA-0020-B010 Nitric acid for trace analysis min 67 % (glass bottle)
UN 2031 Assay ............................................................. > 67 % Residue ........................................................ < 1 ppm Chloride ................................................... < 0.08 ppm Ag ................................ < 0.1 ppb Al ................................. < 0.5 ppb As ................................ < 0.1 ppb Ba ................................ < 0.1 ppb Be ................................ < 0.1 ppb Bi ................................. < 0.1 ppb Ca ............................... < 0.5 ppb Cd ............................... < 0.1 ppb Co ............................... < 0.1 ppb Cr ................................ < 0.2 ppb Phosphate ................................................. < 0.1 ppm Sulfate ....................................................... < 0.5 ppm Pb ................................ < 0.1 ppb Se ................................ < 0.1 ppb Sn ................................ < 0.1 ppb Sr ................................ < 0.1 ppb Th ................................ < 0.1 ppb Ti ................................. < 0.1 ppb V .................................. < 0.1 ppb Zn ................................ < 0.5 ppb
1L
Cu ............................... < 0.1 ppb Fe ............................... < 0.5 ppb Hg ............................... < 0.2 ppb K ................................. < 0.2 ppb Li ................................. < 0.1 ppb Mg ............................... < 0.5 ppb Mn ............................... < 0.1 ppb Mo ............................... < 0.1 ppb Na ............................... < 0.5 ppb Ni ................................ < 0.1 ppb
Nitric Acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si.
n-Nonane
SO-4436-B010 n-Nonane HPLC Optigrade
UN 1920 CAS-Nr. 111-84-2 C9H20 Assay ......................................................... 95% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0003% max. Filtered through 0.2 m 1 L = 0.719 kg (at 20C) Specification Transmission at 200 nm ................................................... 10% min. at 225 nm ................................................... 79% min. at 250 nm ................................................... 89% min. at 300 nm ................................................... 99% min.
1L
SO-1271-B010 SO-1271-B025
n-Nonane Picograde for residue analysis n-Nonane Picograde for residue analysis
UN 1920 CAS-Nr. 111-84-2 C9H20 Assay ...................................................... 95.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.719 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between decane (C10) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L
464
Edition 2012/2013

Code Product Unit
n-Octane
SO-1279-B010 n-Octane Picograde for residue analysis
UN 1262 CAS-Nr. 111-65-9 CH3(CH2)6CH3 Assay ...................................................... 95.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.703 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L
n-Pentane
SO-9081-B010 n-Pentane HPLC Optigrade
UN 1265 CAS-Nr. 109-66-0 C5H12 Assay ...................................................... 95.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................... 0.001% max. Filtered through 0.2 m 1 L = 0.626 kg (at 20C) Specification Transmission at 200 nm ................................................... 10% min. at 210 nm ................................................... 20% min. at 215 nm ................................................... 50% min. at 225 nm ................................................... 89% min. at 240 nm ................................................... 98% min.
1L
SO-1282-B010 SO-1282-B025 SO-1282-B040
n-Pentane Picograde for residue analysis n-Pentane Picograde for residue analysis n-Pentane Picograde for residue analysis
UN 1265 CAS-Nr. 109-66-0 C5H12 Assay ...................................................... 98.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.626 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L 4L
SO-9501-B010
n-Pentane for the analysis of highly volatile halogenated hydrocarbons

UN 1265 CAS-Nr. 109-66-0 C5H12 Assay ...................................................... 95.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.632 kg (at 20C) Specification Highly volatile halogenated hydrocarbons In the GC/ECD chromatogram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 g/L parathion-methyl.
1L
Edition 2012/2013
465

Code Product Unit
SO-9610-B005
n-Pentane for the analysis of highly volatile halogenated hydrocarbons, aromatic hydrocarbons and EOX
UN 1265 CAS-Nr. 109-66-0 C5H12 Assay ...................................................... 98.0% min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.626 kg (at 20C) Specification Highly volatile halogenated hydrocarbons In the GC/ECD chromatorgram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 g/L parathion-methyl. BTEX for FID In the GC-FID chromatogram the sum of the signals of BTEX-compounds is not greater than the signal, given by 10 g/L n-Decane. Coulometric determination of EOX gives a halogen content as chloride of less than 0.3 mg/L.
500 mL
Perchloric acid
HPA-0060-B010 Perchloric acid for trace analysis min 68 % (glass bottle)
UN 1802 Assay ............................................................. > 68 % Colour (APHA) ................................................... < 10 Phosphate ................................................. < 0.1 ppm Ag ................................ < 0.1 ppb Al ................................. < 0.5 ppb Ba ................................ < 0.1 ppb Be ................................ < 0.1 ppb Bi ................................. < 0.1 ppb Ca ............................... < 0.5 ppb Cd ............................... < 0.1 ppb Co ............................... < 0.1 ppb Sulfate .......................................................... < 5 ppm Total nitrogen ............................................. < 10 ppm Ni ................................. < 0.1 ppb Pb ................................ < 0.1 ppb Sn ................................ < 0.1 ppb Sr ................................ < 0.1 ppb Th ................................ < 0.1 ppb Tl ................................. < 0.1 ppb V .................................. < 0.5 ppb Zn ................................ < 0.5 ppb
1L
Cu ............................... < 0.1 ppb Fe ............................... < 0.5 ppb K ................................. < 0.5 ppb Li ................................. < 0.1 ppb Mg ............................... < 0.5 ppb Mn ............................... < 0.1 ppb Mo ............................... < 0.1 ppb Na ............................... < 0.5 ppb
Perchloric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si.
Petroleum ether
SO-1320-B010 SO-1320-B025 SO-1320-B040 Petroleum ether Picograde for residue analysis (30 - 60C) Petroleum ether Picograde for residue analysis (30 - 60C) Petroleum ether Picograde for residue analysis (30 - 60C)
UN 1268 CAS-Nr. 8032-32-4 Boiling point range ............................. 30 - 60C min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.625...0.655 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
1L 2.5 L 4L
SO-9502-B010 SO-9502-B025
Petroleum ether for the analysis of highly volatile halogenated hydrocarbons and EOX (40 60C) Petroleum ether for the analysis of highly volatile halogenated hydrocarbons and EOX (40 60C)
UN 1268 CAS-Nr. 8032-32-4 Boiling point ....................................... 40 - 60C min. Water ..................................................... 0.01% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.625...0.655 kg (bei/at 20C) Specification Highly volatile halogenated hydrocarbons/EOX In the GC/ECD chromatorgram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 g/L parathion-methyl. Coulometric determination of EOX gives a halogen content as chloride of less than 0.3 mg/L.
1L 2.5 L
466
Edition 2012/2013

Code Product Unit
Propan-1-ol
SO-5351-B025 Propan-1-ol HPLC Optigrade
UN 1274 CAS-Nr. 71-23-8 CH3CH2CH2OH Assay ...................................................... 99.8% min. Water ..................................................... 0.05% max. Non-volatile matter ............................... 0.001% max. Filtered through 0.2 m 1 L = 0.804 kg (at 20C) Specification Transmission at 225 nm ................................................... 31% min. at 250 nm ................................................... 89% min. at 270 nm ................................................... 98% min. at 300 nm ................................................... 99% min.
2.5 L
Propan-2-ol
SO-3043-B010 SO-3043-B025 SO-3043-B040 Propan-2-ol HPLC Optigrade Propan-2-ol HPLC Optigrade Propan-2-ol HPLC Optigrade
UN 1219 CAS-Nr. 67-63-0 C3H8O Assay ...................................................... 99.5% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0006% max. Filtered through 0.2 m 1 L = 0.786 kg (at 20C) Specification Transmission at 205 nm ................................................... 10% min. at 220 nm ................................................... 50% min. at 230 nm ................................................... 71% min. at 254 nm ................................................... 95% min. at 350 nm ................................................... 98% min.
1L 2.5 L 4L
SO-9352-B010 SO-9352-B025
Propan-2-ol for LC-MS Optigrade Propan-2-ol for LC-MS Optigrade

UN 1219 CAS number 67-63-0 C3H8O Assay ...................................................... 99.5% min. Water ..................................................... 0.05% max. Non-volatile matter ............................. 0.0006% max. Filtered through 0.2 m 1 L = 0.786 kg (at 20C) Ca ........................................................0.1 ppm max. K...........................................................0.1 ppm max. Mg ........................................................0.1 ppm max. Na ........................................................0.1 ppm max. Transmission at 220 nm .................................................. 60 % min. at 250 nm .................................................. 99 % min.
1L 2.5 L
SO-1334-B010 SO-1334-B025
Propan-2-ol Picograde for residue analysis Propan-2-ol Picograde for residue analysis
1L 2.5 L
Edition 2012/2013
467

Code Product Unit
SO-1334-B040
Propan-2-ol Picograde for residue analysis

UN 1219 CAS-Nr. 67-63-0 C3H8O Assay ..................................................... 99.5% min. Water ....................................................... 0.2% max. Non-volatile matter ............................. 0.0005% max. 1 L = 0.786 kg (at 20C) Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
4L
SO-3044-B040
Propan-2-ol for the tobacco industry

contains n-Heptadecan ................. 0.3 g/L Ethanol ............................ 2.0 g/L
4L
SO-3046-B040

contains n-Heptandecan ............... 0.8 g/L Ethanol abs ..................... 4.0 g/L Wasser .............................. 0.1 %
4L
SO-3047-B040

contains n-Heptandecan ............... 0.4 g/L Ethanol abs. ................... 2.0 g/ L
4L
Sulfuric acid
HPA-0040-B010 Sulfuric acid min 95 % (glass bottle)
UN 1830 Assay ................................................................ 95 % Density ...................................................... 1.83 g/mL Colour (APHA) ................................................... < 10 Residue ........................................................ < 2 ppm Ag ................................ < 0.1 ppb Al ................................. < 0.5 ppb As ................................... < 1 ppb Ba ................................ < 0.1 ppb Be ................................ < 0.1 ppb Bi ................................. < 0.1 ppb Ca ............................... < 0.5 ppb Cd ............................... < 0.1 ppb Co ............................... < 0.1 ppb Cr ................................ < 0.1 ppb Cu ............................... < 0.1 ppb Chloride ..................................................... < 0.1 ppm Phosphate ................................................. < 0.5 ppm Nitrate ...................................................... < 0.07 ppm Se ................................... < 5 ppb Sn ................................ < 0.1 ppb Sr ................................ < 0.1 ppb Th ................................ < 0.1 ppb Ti .................................... < 1 ppb U ................................. < 0.1 ppb V .................................. < 0.1 ppb Zn ................................ < 0.1 ppb Zr ................................. < 0.1 ppb
1L
Fe ............................... < 0.5 ppb Hg .................................. < 1 ppb K ................................. < 0.5 ppb Li ................................. < 0.1 ppb Mg ............................... < 0.5 ppb Mn ............................... < 0.1 ppb Mo ............................... < 0.1 ppb Na ............................... < 0.5 ppb Ni ................................ < 0.1 ppb Pb ............................... < 0.1 ppb Sb ............................... < 0.1 ppb
Sulfuric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si.
Tetrahydrofuran
SO-2858-B010 SO-2858-B025 Tetrahydrofuran HPLC Optigrade Tetrahydrofuran HPLC Optigrade 1L 2.5 L
468
Edition 2012/2013

Code Product Unit
SO-2858-B040
Tetrahydrofuran HPLC Optigrade

UN 2056 CAS-Nr. 109-99-9 C4H8O Assay ...................................................... 99.8% min. Water ..................................................... 0.03% max. Non-volatile matter ............................. 0.0007% max. Filtered through 0.2 m 1 L = 0.887 kg (at 20C) not stabilized Specification Transmission at 212 nm ................................................... 10% min. at 225 nm ................................................... 31% min. at 250 nm ................................................... 68% min. at 300 nm ................................................... 98% min.
4L
SO-9364-B010 SO-9364-B025
Tetrahydrofuran for LC-MS Optigrade Tetrahydrofuran for LC-MS Optigrade

UN 2056 CAS number 109-99-9 C4H8O Assay ...................................................... 99.8% min. Water ..................................................... 0.03% max. Non-volatile matter ............................. 0.0007% max. Filtered through 0.2 m 1 L = 0.887 kg (at 20C) not stabilised Ca ........................................................0.1 ppm max. K...........................................................0.1 ppm max. Mg ........................................................0.1 ppm max. Na ........................................................0.1 ppm max. Transmission at 250 nm .................................................. 80 % min. at 290 nm .................................................. 99 % min.
1L 2.5 L
Toluene
SO-4483-B010 SO-4483-B025 SO-4483-B040 Toluene HPLC Optigrade Toluene HPLC Optigrade
UN 1294 CAS-Nr. 108-88-3 C7H8 Assay ...................................................... 99.7% min. Water ..................................................... 0.03% max. Non-volatile matter ............................. 0.0005% max. Filtered through 0.2 m 1 L = 0.866 kg (at 20C) Specification Transmission at 285 nm ................................................... 10% min. at 288 nm ................................................... 39% min. at 300 nm ................................................... 70% min. at 335 nm ................................................... 95% min. at 350 nm ................................................... 98% min.
1L 2.5 L 4L
Toluene HPLC Optigrade
SO-1350-B010 SO-1350-B025
Toluene Picograde for residue analysis Toluene Picograde for residue analysis
1L 2.5 L
Edition 2012/2013
469

Code Product Unit
SO-1350-B040
Toluene Picograde for residue analysis

4L
1,1,2-Trichloro-1,2,2-trifluoroethane
SO-9145-B025 1,1,2-Trichloro-1,2,2-trifluoroethane for IR-Spectroscopy
UN 3082 CAS-Nr. 76-13-1 C2Cl3F3 Assay ...................................................... 99,8% min. Non-volatile matter ................................ 2 mg/L max. Water .................................................10 mg/kg max. Hydrocarbons .......................................5 mg/kg max. 1 L = 1.57 kg (at 20C)
2.5 L
2,2,4-Trimethylpentane
SO-6043-B010 SO-6043-B025 SO-6043-B040 2,2,4-Trimethylpentane HPLC Optigrade (Isooctane) 2,2,4-Trimethylpentane HPLC Optigrade (Isooctane) 2,2,4-Trimethylpentane HPLC Optigrade (Isooctane)
UN 1262 CAS-Nr. 540-84-1 C8H18 Assay ...................................................... 99.5% min. Water ..................................................... 0.02% max. Non-volatile matter ............................. 0.0005% max. Filtered through 0.2 m 1 L = 0.690 kg (at 20C) Specification Transmission at 205 nm ................................................... 10% min. at 220 nm ................................................... 63% min. at 230 nm ................................................... 79% min. at 254 nm ................................................... 98% min.
1L 2.5 L 4L
SO-1364-B010 SO-1364-B025 SO-1364-B040
2,2,4-Trimethylpentane (Isooctane) Picograde for residue analysis 2,2,4-Trimethylpentane (Isooctane) Picograde for residue analysis 2,2,4-Trimethylpentane (Isooctane) Picograde for residue analysis
1L 2.5 L 4L
470
Edition 2012/2013

Code Product Unit
Water
SO-6795-B025 SO-6795-B040 Water HPLC Optigrade Water HPLC Optigrade
CAS-Nr. 7732-18-5 H2O Specification Fluorescence at 254 nm (as Quinine) ....................... 0.1 ppb max. Fluorescence at 365 nm (as quinine) ....................... 0.1 ppb max. Non-volatile matter .................................1 mg/L max. Filtered through 0.2 m pH ................................................................ 5,0 - 8,0 This solvent in glass bottles fulfills the specifications according to chapter 4 of the European Pharmacopoeia.
2.5 L 4L
SO-9662-B010 SO-9662-B025
Water UHPLC-MS Optigrade Water UHPLC-MS Optigrade

CAS number 7732-18-5 H2O Residue after evaporation ............................... 0.0001 %w/w max. Acidity (as Acetic acid) ............................................ 0.002 % max. Alkalinity (as Ammonia) ...................................... 0.00005 % max. Resistivity (at manuf.) ................................... 18.2 Mohm*cm min. Gradient specification HPLC gradient at 210 nm - H. Peak ......................0.002 AU max. HPLC gradient at 254 nm - H. Peak ....................0.0005 AU max. Fluorescence at 254 nm (as quinine) ....................... 0.5 ppb max. Fluorescence at 365 nm (as quinine) ....................... 0.5 ppb max. TOC ........................................................................... 10 ppb max. Filter test ..................................................................... Passes test Ca ............................................................................0.1 ppm max. K...............................................................................0.1 ppm max. Mg ............................................................................0.1 ppm max. Na ........................................................................... 0.1 ppm max. Microfiltered through 0.1 m/bottled under inert gas
1L 2.5 L
SO-4661-B025
Water 0.1 % formic acid UHPLC-MS Optigrade

Assay ..................................................................... 0.095-0.105 % Purity of formic acid (GC)........................................... 99.0 % min. Gradient specification HPLC gradient at 254 nm - H. Peak ......................0.002 AU max. HPLC gradient at 254 nm - Drift ............................0.010 AU max. Fluorescence at 254 nm (as quinine) ....................... 0.5 ppb max. Fluorescence at 365 nm (as quinine) ...................... 0.5 ppb max. Transmission at 210 nm ........................................................................ 5 % min. at 230 nm ....................................................................... 45% min. at 254 nm ....................................................................... 99% min. Al ............................................................................... 30 ppb max. Ca ............................................................................ 100 ppb max. Fe ............................................................................... 50 ppb max. K............................................................................... 100 ppb max. Mg .............................................................................. 30 ppb max. Na ............................................................................ 100 ppb max. Microfiltered through 0.1 m/bottled under inert gas
2.5 L
Edition 2012/2013
471

Code Product Unit
SO-4667-B025
Water 0.1 % acetic acid UHPLC-MS Optigrade

Assay ..................................................................... 0.095-0.105 % pH ...................................................................................... 3.2-3.4 Purity of acetic acid (GC) ........................................... 99.9 % min. Gradient specification HPLC gradient at 254 nm - H. Peak ..................... 0.002 AU max. HPLC gradient at 254 nm - Drift............................ 0.010 AU max. Fluorescence at 254 nm (as quinine)........................0.5 ppb max. Fluorescence at 365 nm (as quinine)........................0.5 ppb max. Transmission at 210 nm ...................................................................... 20 % min. at 230 nm ...................................................................... 75 % min. at 254 nm ...................................................................... 99 % min. Al ...............................................................................30 ppb max. Ca ............................................................................100 ppb max. Fe ...............................................................................50 ppb max. K ...............................................................................100 ppb max. Mg ..............................................................................30 ppb max. Na ............................................................................100 ppb max. Microfiltered through 0.1 m/bottled under inert gas
2.5 L
SO-4673-B025
Water 0.1 % trifluoroacetic acid UHPLC-MS Optigrade

Assay ..................................................................... 0.095-0.105 % Purity of trifluoroacetic acid (GC) .............................. 99.95% min. Gradient specification HPLC gradient at 254 nm - H. Peak ..................... 0.002 AU max. HPLC gradient at 254 nm - Drift............................ 0.010 AU max. Fluorescence at 254 nm (as quinine)....................... 0.5 ppb max. Fluorescence at 365 nm (as quinine)........................0.5 ppb max. Transmission at 210 nm ...................................................................... 25 % min. at 230 nm ....................................................................... 85% min. at 254 nm ....................................................................... 99% min. Al ...............................................................................30 ppb max. Ca ............................................................................100 ppb max. Fe ...............................................................................50 ppb max. K ...............................................................................100 ppb max. Mg ..............................................................................30 ppb max. Na ............................................................................100 ppb max. Microfiltered through 0.1 m/bottled under inert gas
2.5 L
SO-9368-B010 SO-9368-B025
Water for LC-MS Optigrade Water for LC-MS Optigrade

Specification Fluorescence (as Quinine at 450 nm) . 1.10-7 g max. Non-volatile matter ................................ 5 mg/L max. Filtered through 0.2 m pH ................................................................ 5,0 - 8,0 Ca ....................................................... 0.1 ppm max. K .......................................................... 0.1 ppm max. Mg ....................................................... 0.1 ppm max. Na ....................................................... 0.1 ppm max. Transmission at 200 nm - 400 nm ................................... 99 % min.
1L 2.5 L
Solvent mixtures
SO-9534-B040 Mixture Cyclohexane/Ethylacetate 1:1
Specification GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide. GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).
4L
472
Edition 2012/2013
Notes
Edition 2012/2013
473
Notes
474
Edition 2012/2013

LGCS Pharma Cat 2012 13 LR Web

Transféré par

Informations du document

Description originale:

Titre original

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

LGCS Pharma Cat 2012 13 LR Web

Transféré par

Droits d'auteur :

Formats disponibles

+

United States Pharmacopeia and National Formulary

Secondary standards Institute of Dyes and Organic products

Publications and subscriptions High purity solvents

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

About the catalogue

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

Pharmaceutical reference substances

Pharmaceutical reference substances

Shelf Life, storage, expiry dates and unit sizes

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

Pharmaceutical reference substances Use, safety and handling

General ordering information

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

Pharmaceutical impurities Certification

Narcotics and drug precursors

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

Imp. C (EP) as Hydrochloride: Aniline Hydrochloride

Imp. A (EP): N-[3-Acetyl-4-[(2RS)-oxiran2-ylmethoxy]phenyl]butanamide

Imp. B (EP) as Hydrochloride:N-[3-Acetyl-4-[(2RS)2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide Hydrochloride (Diacetolol Hydrochloride) Imp. C (EP): N-(3-Acetyl-4-hydroxyphenyl)butanamide

Imp. D (EP) as Hydrochloride: 1-[5-Amino-2[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]ethanone Dihydrochloride

Imp. E (EP) as Hydrochloride: N-[4-[(2RS)-2Hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide Hydrochloride Imp. F (EP): N-[3-Acetyl-4-[(2RS)2,3-dihydroxypropoxy]phenyl]butanamide

Imp. G (EP): N,N'-[[(1-Methylethyl)imino]bis[(2-hydroxypropane-1,3-diyl)oxy(3-acetyl1,4-phenylene)]]dibutanamide (Acebutolol Biamine) Imp. H (EP): N,N'-[(2-Hydroxypropane1,3-diyl)bis[oxy(3-acetyl-1,4-phenylene)]]dibutanamide

Imp. I (EP): N-[3-Acetyl-4-[(2RS)-3-(ethylamino)2-hydroxypropoxy]phenyl]butanamide

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

Imp. A (EP): [2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid (Diclofenac)

Imp. B (EP): Methyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Methyl Ester of Diclofenac)

Imp. C (EP): Ethyl 2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetate (Ethyl Ester of Diclofenac)

Imp. D (EP): Methyl [[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (Methyl Ester of Aceclofenac)

Imp. E (EP): Ethyl [[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (Ethyl Ester of Aceclofenac)

Imp. F (EP): ): Benzyl[[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (Benzyl Ester of Aceclofenac)

Imp. G (EP): [[[[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl]oxy]acetic Acid (Acetic Aceclofenac)

Imp. H (EP): [[[[[[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl]oxy]acetyl]oxy]acetic Acid (Diacetic Aceclofenac)

Isopropyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Isopropyl Ester of Diclofenac)

Imp. A (EP): N-(5-Chloro-1,3,4-thiadiazol-2-yl)acetamide

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

Imp. B (EP): N-(1,3,4-Thiadiazol-2-yl)acetamide

Imp. A (EP): L-Cystine

Imp. B (EP): L-Cysteine Imp. C (EP): N,N-Diacetyl-L-cystine

Imp. D (EP): N,S-Diacetyl-L-cysteine

Imp. A (EP): 4-Hydroxybenzoic Acid

Imp. D (EP): 2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid (Acetylsalicylsalicylic Acid)

Imp. E (EP):2-[(2-Hydroxybenzoyl)oxy]benzoic Acid (Salicylsalicylic Acid)

Imp. F (EP): 2-(Acetyloxy)benzoic Anhydride (Acetylsalicylic Anhydride)

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

Imp. D (EP): (S)-2-Amino-3-(5-hydroxy1H-indol-3-yl)propanoic Acid (5-Hydroxy-tryptophan)

Imp. A (EP): 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin9-yl)methoxy]ethyl Acetate

Imp. B (EP): 2-Amino-1,7-dihydro-6H-purin-6-one (Guanine)

Imp. C (EP): 2-Amino-7-[(2-hydroxyethoxy)methyl]-1,7-dihydro-6H-purin6-one Aciclovir Imp. D (EP): 2-[(2-Amino-6-oxo-1,6-dihydro9H-purin-9-yl)methoxy]ethylBenzoate

Imp. F (EP): N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo6,9-dihydro-1H-purin-2-yl]acetamide

Imp. G (EP): 2-[[(2-(Acetylamino)-6-oxo-1,6-dihydro9H-purin-9-yl]methoxy]ethyl Acetate Aciclovir Imp. H (EP): 2-[[2-(Acetylamino)-6-oxo1,6-dihydro-9H-purin-9-yl]methoxy]ethyl Benzoate

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

Imp. C (EP): 1-(2-Methoxyphenyl)tricyclo3,7 [3.3.1.1 ]decane Imp. D (EP): 1,1'-[4,4'Bis(methoxy)biphenyl-3,3'3,7

Imp. A (EP) as Sulphate: 7H-Purin-6-amine Sulphate (Adenine Sulphate)

Imp. F (EP): 1--D-Ribofuranosylpyrimidine2,4(1H,3H)-dione (Uridine)

Imp. G (EP): 9--D-Ribofuranosyl-1,9-dihydro6H-purin-6-one (Inosine)

Imp. H (EP): 2-Amino-9--D-ribofuranosyl1,9-dihydro-6H-purin-6-one (Guanosine)

Imp. C (EP) as Hydrochloride: 1-(3,4-Dihydroxyphenyl)-2-(methylamino)ethanone Hydrochloride (Adrenalone Hydrochloride)

All your needs for pharmaceutical analysis email pharma@lgcstandards.com

(1R)-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanesulphonic Acid (Adrenaline -Sulphonate)

Imp. A (EP): 5-(Propylsulphanyl)-1H-benzimidazol-2-amine